,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,ptm_sources,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af,clinvar_variant_id,clinvar_germline_classification,clinvar_germline_condition,clinvar_germline_review_status,clinvar_oncogenicity_classification,clinvar_oncogenicity_condition,clinvar_oncogenicity_review_status,clinvar_clinical_impact_classification,clinvar_clinical_impact_condition,clinvar_clinical_impact_review_status
0,1,M,,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM",,,,,,,,,,,,,,,,,,,,,,,
1,2,E,D,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM",,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,17:7579907-7579907","hg19,17:g.7579907C>A",0.582,,,,,,,,,,,,,,,,
2,2,E,G,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM",,ClinVar,,,"hg19,17:7579908-7579908, hg38,17:7676590-7676590","hg19,17:g.7579908T>C, hg38,17:g.7676590T>C",0.481,,,,,,,926778,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
3,2,E,K,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM",,ClinVar,,,"hg19,17:7579909-7579909, hg38,17:7676591-7676591","hg19,17:g.7579909C>T, hg38,17:g.7676591C>T",0.547,,,0.0000039918566125,,,,490172,Conflicting classifications of pathogenicity,not provided;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,1,,,,,,
4,2,E,Q,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM",,cBioPortal,msk_ctdna_vte_2024,Mixed Cancer Types,"hg19,17:7579909-7579909","hg19,17:g.7579909C>G",0.558,,,,,,,,,,,,,,,,
5,3,E,A,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,cBioPortal,msk_chord_2024,Mixed Cancer Types,"hg19,17:7579905-7579905","hg19,17:g.7579905T>G",0.450,,,,,,,,,,,,,,,,
6,3,E,G,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579905-7579905, hg38,17:7676587-7676587","hg19,17:g.7579905T>C, hg38,17:g.7676587T>C",0.466,"central_nervous_system, brain, lung","carcinoma, small_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic",,,,,187706,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
7,3,E,K,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,ClinVar,,,"hg19,17:7579906-7579906, hg38,17:7676588-7676588","hg19,17:g.7579906C>T, hg38,17:g.7676588C>T",0.575,,,,,,,858236,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
8,3,E,Q,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,ClinVar,,,"hg19,17:7579906-7579906, hg38,17:7676588-7676588","hg19,17:g.7579906C>G, hg38,17:g.7676588C>G",0.471,,,,,,,861772,Uncertain significance,not specified;Lung adenocarcinoma;Li-Fraumeni syndrome,2,,,,,,
9,3,E,V,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,cBioPortal,pancan_hcmi_2025,Mixed Cancer Types,"hg19,17:7676587-7676587","hg19,17:g.7676587T>A",,,,,,,,,,,,,,,,,
10,4,P,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,ClinVar,,,"hg19,17:7579903-7579903, hg38,17:7676585-7676585","hg19,17:g.7579903G>C, hg38,17:g.7676585G>C",0.468,,,,,,,2848843,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
11,4,P,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,"cBioPortal,COSMIC,ClinVar","mds_mskcc_2020, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Myelodysplastic Syndromes, Stomach Adenocarcinoma","hg19,17:7579902-7579902, hg19,17:7676584-7676584, hg38,17:7676584-7676584","hg19,17:g.7579902G>A, hg19,17:g.7676584G>A, hg38,17:g.7676584G>A",0.533,"breast, lung, soft_tissue, fat, retroperitoneum, stomach","carcinoma, adenocarcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, small_cell_carcinoma, liposarcoma, myxoid-round_cell",,,,,237941,Likely benign,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
12,4,P,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,ClinVar,,,"hg19,17:7579902-7579902, hg38,17:7676584-7676584","hg19,17:g.7579902G>T, hg38,17:g.7676584G>T",0.582,,,,,,,2450740,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
13,4,P,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,ClinVar,,,"hg19,17:7579902-7579902, hg38,17:7676584-7676584","hg19,17:g.7579902G>C, hg38,17:g.7676584G>C",0.533,,,,,,,406582,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,,,,,,
14,4,P,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579903-7579903, hg38,17:7676585-7676585","hg19,17:g.7579903G>A, hg38,17:g.7676585G>A",0.505,pancreas,"carcinoma, ductal_carcinoma",,,,,1485939,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
15,5,Q,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,COSMIC,,,"hg38,17:7676580-7676580","hg38,17:g.7676580C>A, hg38,17:g.7676580C>G",0.489,"breast, upper_aerodigestive_tract, larynx","carcinoma, basal_(triple-negative)_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
16,5,Q,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM",,"cBioPortal,ClinVar",mds_iwg_2022,Myelodysplastic Syndromes,"hg19,17:7579899-7579899, hg38,17:7676581-7676581","hg19,17:g.7579899T>C, hg38,17:g.7676581T>C",0.557,,,0.0000119676395028,,,,233248,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
17,6,S,L,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM",,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7579896-7579896","hg19,17:g.7579896G>A",0.592,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
18,7,D,E,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,"ClinVar,ClinVar",,,"hg19,17:7579892-7579892, hg38,17:7676574-7676574","hg19,17:g.7579892A>C, hg19,17:g.7579892A>T, hg38,17:g.7676574A>C, hg38,17:g.7676574A>T",0.515,,,,,,,"485049, 140782","Likely benign, Likely benign",Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,"1, 3",,,,,,
19,7,D,H,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7579894-7579894, hg38,17:7676576-7676576","hg19,17:g.7579894C>G, hg38,17:g.7676576C>G",0.466,"skin, head_neck","carcinoma, squamous_cell_carcinoma",0.0000039886085340,,,,142689,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
20,7,D,N,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,"cBioPortal,ClinVar","luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021, nsclc_ctdx_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579894-7579894, hg38,17:7676576-7676576","hg19,17:g.7579894C>T, hg38,17:g.7676576C>T",0.400,,,,,,,1784158,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
21,7,D,Y,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,COSMIC,,,,,,breast,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
22,8,P,H,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,17:7579890-7579890","hg19,17:g.7579890G>T",0.415,,,,,,,,,,,,,,,,
23,8,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,ClinVar,,,"hg19,17:7579890-7579890, hg38,17:7676572-7676572","hg19,17:g.7579890G>A, hg38,17:g.7676572G>A",0.514,,,,,,,231868,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
24,8,P,R,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,ClinVar,,,"hg19,17:7579890-7579890, hg38,17:7676572-7676572","hg19,17:g.7579890G>C, hg38,17:g.7676572G>C",0.467,,,,,,,1790705,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
25,8,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,COSMIC,,,"hg38,17:7676573-7676573","hg38,17:g.7676573G>A",0.504,skin,malignant_melanoma,,,,,,,,,,,,,,
26,8,P,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,ClinVar,,,"hg19,17:7579891-7579891, hg38,17:7676573-7676573","hg19,17:g.7579891G>T, hg38,17:g.7676573G>T",0.537,,,,,,,664710,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
27,9,S,G,P,,,,,,,,,,PhosphoSite,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,"cBioPortal,COSMIC,ClinVar",mds_mskcc_2020,Myelodysplastic Syndromes,"hg19,17:7579888-7579888, hg38,17:7676570-7676570","hg19,17:g.7579888T>C, hg38,17:g.7676570T>C",0.489,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,2108374,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
28,9,S,N,P,,,,,,,,,,PhosphoSite,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,"cBioPortal,ClinVar",mixed_allen_2018,Mixed Cancer Types,"hg19,17:7579887-7579887, hg38,17:7676569-7676569","hg19,17:g.7579887C>T, hg38,17:g.7676569C>T",0.367,,,,,,,458531,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
29,9,S,R,P,,,,,,,,,,PhosphoSite,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,"ClinVar,ClinVar,ClinVar",,,"hg19,17:7579886-7579886, hg19,17:7579888-7579888, hg38,17:7676568-7676568, hg38,17:7676570-7676570","hg19,17:g.7579886G>C, hg19,17:g.7579886G>T, hg19,17:g.7579888T>G, hg38,17:g.7676568G>C, hg38,17:g.7676568G>T, hg38,17:g.7676570T>G","0.496, 0.572",,,0.0000039877496331,,,,"821828, 528238, 496047","Uncertain significance, Uncertain significance, Conflicting classifications of pathogenicity",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,"2, 1, 1",,,,,,
30,10,V,D,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,ClinVar,,,"hg19,17:7579884-7579884, hg38,17:7676566-7676566","hg19,17:g.7579884A>T, hg38,17:g.7676566A>T",0.603,,,,,,,2813114,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
31,10,V,F,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,ClinVar,,,"hg19,17:7579885-7579885, hg38,17:7676567-7676567","hg19,17:g.7579885C>A, hg38,17:g.7676567C>A",0.527,,,,,,,968647,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
32,10,V,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579884-7579884, hg38,17:7676566-7676566","hg19,17:g.7579884A>C, hg38,17:g.7676566A>C",0.559,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000039873362202,,,,822501,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
33,10,V,I,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,"cBioPortal,COSMIC,ClinVar","coadread_dfci_2016, egc_msk_2023, egc_msk_tp53_ccr_2022, pancan_mimsi_msk_2024, sarcoma_msk_2022, stad_oncosg_2018, stad_pfizer_uhongkong","Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Mixed Cancer Types, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7579885-7579885, hg38,17:7676567-7676567","hg19,17:g.7579885C>T, hg38,17:g.7676567C>T",0.474,"large_intestine, lung, pancreas, stomach","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable",0.0000319004705319,,,,127806,Benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;not specified;not provided;Squamous cell carcinoma of the head and neck;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
34,10,V,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 3-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 6-10, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 7-10, ggetELM",,ClinVar,,,"hg19,17:7579885-7579885, hg38,17:7676567-7676567","hg19,17:g.7579885C>G, hg38,17:g.7676567C>G",0.513,,,,,,,231387,Likely benign,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
35,11,E,K,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, cscc_hgsc_bcm_2014, mds_mskcc_2020, msk_chord_2024, msk_met_2021, pan_origimed_2020, thyroid_mskcc_2016","Cutaneous Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Thyroid","hg19,17:7579882-7579882, hg19,17:7676564-7676564, hg38,17:7676564-7676564","hg19,17:g.7579882C>T, hg19,17:g.7676564C>T, hg38,17:g.7676564C>T",0.525,"breast, haematopoietic_and_lymphoid_tissue, oesophagus, ovary, skin, head_neck, thyroid","carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, clear_cell_adenocarcinofibroma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",0.0000039880677014,0.0000318999617200,,,418693,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
36,11,E,Q,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_metabric, ccle_broad_2019, cellline_ccle_broad, sarcoma_msk_2022","Invasive Breast Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7579882-7579882, hg38,17:7676564-7676564","hg19,17:g.7579882C>G, hg38,17:g.7676564C>G",0.449,"breast, cervix, genital_tract, extragonadal, brain, haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, ovary, pancreas, prostate","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, mixed, germ_cell_tumour, seminoma, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",0.0000518448801187,0.0000318999617200,,,41723,Conflicting classifications of pathogenicity,TP53-related disorder;Hereditary cancer-predisposing syndrome;not specified;not provided;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
37,12,P,H,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM",,ClinVar,,,"hg19,17:7579878-7579878, hg38,17:7676560-7676560","hg19,17:g.7579878G>T, hg38,17:g.7676560G>T",0.530,,,,,,,578235,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
38,12,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM",,"cBioPortal,ClinVar",msk_ctdna_vte_2024,Mixed Cancer Types,"hg19,17:7579878-7579878, hg38,17:7676560-7676560","hg19,17:g.7579878G>A, hg38,17:g.7676560G>A",0.609,,,,,,,528258,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
39,12,P,R,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM",,ClinVar,,,"hg19,17:7579878-7579878, hg38,17:7676560-7676560","hg19,17:g.7579878G>C, hg38,17:g.7676560G>C",0.565,,,0.0000039879404680,,,,663876,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
40,12,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM",,"cBioPortal,ClinVar","crc_sysucc_2022, pan_origimed_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7579879-7579879, hg38,17:7676561-7676561","hg19,17:g.7579879G>A, hg38,17:g.7676561G>A",0.529,,,,,,,3809691,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
41,13,P,A,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,ClinVar,,,"hg19,17:7579876-7579876, hg38,17:7676558-7676558","hg19,17:g.7579876G>C, hg38,17:g.7676558G>C",0.641,,,,,,,1735038,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
42,13,P,F,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,17:7579875-7579876","hg19,17:g.7579875_7579876delinsAA",,,,,,,,,,,,,,,,,
43,13,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579875-7579875, hg38,17:7676557-7676557","hg19,17:g.7579875G>A, hg38,17:g.7676557G>A",0.769,"salivary_gland, parotid","carcinoma, salivary_duct_carcinoma",,,,,237949,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",1,,,,,,
44,13,P,R,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,"cBioPortal,ClinVar",mixed_selpercatinib_2020,Mixed Cancer Types,"hg19,17:7579875-7579875, hg38,17:7676557-7676557","hg19,17:g.7579875G>C, hg38,17:g.7676557G>C",0.726,,,,,,,485028,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
45,13,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 7-13, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,"cBioPortal,COSMIC,ClinVar","bcc_unige_2016, cscc_dfarber_2015","Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma","hg19,17:7579876-7579876, hg38,17:7676558-7676558","hg19,17:g.7579876G>A, hg38,17:g.7676558G>A",0.723,"liver, skin","carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, other, hepatoblastoma",0.0000039877814377,,,,406604,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
46,14,L,P,,,,,,,,,,,,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,cBioPortal,"ucec_cptac_2020, uec_cptac_gdc","Endometrial Carcinoma, Uterine Endometrioid Carcinoma","hg19,17:7579872-7579872, hg19,17:7676554-7676554","hg19,17:g.7579872A>G, hg19,17:g.7676554A>G",0.789,,,,,,,,,,,,,,,,
47,14,L,Q,,,,,,,,,,,,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,ClinVar,,,"hg19,17:7579872-7579872, hg38,17:7676554-7676554","hg19,17:g.7579872A>T, hg38,17:g.7676554A>T",0.732,,,,,,,2026528,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
48,14,L,V,,,,,,,,,,,,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,ClinVar,,,"hg19,17:7579873-7579873, hg38,17:7676555-7676555","hg19,17:g.7579873G>C, hg38,17:g.7676555G>C",0.668,,,,,,,577290,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
49,15,S,G,P,,,,,,,,,,PhosphoSite,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,ClinVar,,,"hg19,17:7579870-7579870, hg38,17:7676552-7676552","hg19,17:g.7579870T>C, hg38,17:g.7676552T>C",0.795,,,,,,,3605186,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
50,15,S,I,P,,,,,,,,,,PhosphoSite,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,COSMIC,,,,,,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
51,15,S,R,P,,,,,,,,,,PhosphoSite,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,ClinVar,,,"hg19,17:7579870-7579870, hg38,17:7676552-7676552","hg19,17:g.7579870T>G, hg38,17:g.7676552T>G",0.846,,,,,,,1016947,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
52,16,Q,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,ClinVar,,,"hg19,17:7579865-7579865, hg38,17:7676547-7676547","hg19,17:g.7579865C>G, hg38,17:g.7676547C>G",0.666,,,,,,,642623,Uncertain significance,"Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",2,,,,,,
53,16,Q,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,ClinVar,,,"hg19,17:7579867-7579867, hg38,17:7676549-7676549","hg19,17:g.7579867G>T, hg38,17:g.7676549G>T",0.737,,,,,,,1172924,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,3,,,,,,
54,16,Q,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,"cBioPortal,COSMIC","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad",Mixed Cancer Types,"hg19,17:7579866-7579866, hg19,17:7676548-7676548, hg38,17:7676548-7676548","hg19,17:g.7579866T>A, hg19,17:g.7676548T>A, hg38,17:g.7676548T>A",0.835,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
55,16,Q,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,ClinVar,,,"hg19,17:7579866-7579866, hg38,17:7676548-7676548","hg19,17:g.7579866T>C, hg38,17:g.7676548T>C",0.778,,,,,,,835067,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome",1,,,,,,
56,17,E,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,COSMIC,,,"hg38,17:7676546-7676546","hg38,17:g.7676546C>T",0.768,prostate,carcinoma,,,,,,,,,,,,,,
57,18,T,A,P,,,,,,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,COSMIC,,,"hg38,17:7676543-7676543","hg38,17:g.7676543T>C",0.797,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
58,18,T,S,P,,,,,,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 13-18, ggetELM",,ClinVar,,,"hg19,17:7579861-7579861, hg38,17:7676543-7676543","hg19,17:g.7579861T>A, hg38,17:g.7676543T>A",0.717,,,,,,,1415322,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
59,19,F,S,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 19-23, ggetELM",,COSMIC,,,"hg38,17:7676539-7676539","hg38,17:g.7676539A>G",0.905,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
60,20,S,L,P,,,,,,,,,,PhosphoSite,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 19-23, ggetELM",,"cBioPortal,COSMIC,ClinVar","blca_msk_2024, brca_igr_2015, msk_chord_2024, msk_met_2021, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579854-7579854, hg38,17:7676536-7676536","hg19,17:g.7579854G>A, hg38,17:g.7676536G>A",0.663,breast,"carcinoma, ER-PR-positive_carcinoma",,,,,826109,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
61,20,S,P,P,,,,,,,,,,PhosphoSite,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 19-23, ggetELM",,ClinVar,,,"hg19,17:7579855-7579855, hg38,17:7676537-7676537","hg19,17:g.7579855A>G, hg38,17:g.7676537A>G",0.749,,,,,,,232673,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
62,21,D,A,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 19-23, ggetELM",,ClinVar,,,"hg19,17:7579851-7579851, hg38,17:7676533-7676533","hg19,17:g.7579851T>G, hg38,17:g.7676533T>G",0.765,,,,,,,3972456,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
63,21,D,E,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 19-23, ggetELM",,ClinVar,,,"hg19,17:7579850-7579850, hg38,17:7676532-7676532","hg19,17:g.7579850G>C, hg38,17:g.7676532G>C",0.563,,,0.0000039936421217,,,,2694309,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
64,21,D,N,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 19-23, ggetELM",,ClinVar,,,"hg19,17:7579852-7579852, hg38,17:7676534-7676534","hg19,17:g.7579852C>T, hg38,17:g.7676534C>T",0.570,,,,,,,3634440,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
65,21,D,Y,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 19-23, ggetELM",,COSMIC,,,"hg38,17:7676534-7676534","hg38,17:g.7676534C>A",0.737,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",,,,,,,,,,,,,,
66,22,L,,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 16-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 17-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 18-22, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 19-23, ggetELM",,,,,,,,,,,,,,,,,,,,,,,
67,23,W,C,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 19-23, ggetELM",,"cBioPortal,COSMIC","mds_mskcc_2020, pan_origimed_2020","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7579844-7579844, hg38,17:7676526-7676526","hg19,17:g.7579844C>A, hg38,17:g.7676526C>A",0.898,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,,,,,,,,,,
68,24,K,,,,Ubq,,,,,,,,PhosphoSite,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,,,,,,,,,,,,,,,,,,,,,,
69,25,L,R,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,"cBioPortal,ClinVar",msk_ctdna_vte_2024,Mixed Cancer Types,"hg19,17:7579839-7579839, hg38,17:7676521-7676521","hg19,17:g.7579839A>C, hg38,17:g.7676521A>C",0.733,,,,,,,1759212,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
70,26,L,F,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,COSMIC,,,"hg38,17:7676402-7676402","hg38,17:g.7676402G>A",0.634,thyroid,"carcinoma, anaplastic_carcinoma",,,,,,,,,,,,,,
71,26,L,I,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,ClinVar,,,"hg19,17:7579720-7579720, hg38,17:7676402-7676402","hg19,17:g.7579720G>T, hg38,17:g.7676402G>T",0.608,,,,,,,923838,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
72,26,L,P,,,,,,,,,,,,"MDM2 binding motif (DEG_MDM2_SWIB_1), 19-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 20-26, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 21-26, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,COSMIC,,,"hg38,17:7676401-7676401","hg38,17:g.7676401A>G",0.775,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,,,,,,,,,,
73,27,P,A,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,"cBioPortal,ClinVar","gist_msk_2022, gist_msk_2023, msk_met_2021, prad_msk_2019, sarcoma_mskcc_2022","Gastrointestinal Stromal Tumor, Mixed Cancer Types, Prostate, Soft Tissue","hg19,17:7579717-7579717, hg38,17:7676399-7676399","hg19,17:g.7579717G>C, hg38,17:g.7676399G>C",0.617,,,0.0000000000000000,,,,1505620,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
74,27,P,L,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_metabric, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_eo_2020, crc_msk_2017, msk_chord_2024, pancan_mimsi_msk_2024, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018","Bowel, Colorectal Adenocarcinoma, Cutaneous Melanoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579716-7579716, hg19,17:7676398-7676398, hg38,17:7676398-7676398","hg19,17:g.7579716G>A, hg19,17:g.7676398G>A, hg38,17:g.7676398G>A",0.639,", central_nervous_system, brain, large_intestine, colon, ascending, lung, skin","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_III, anaplastic, malignant_melanoma",,,,,481176,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Colorectal cancer;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
75,27,P,R,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,ClinVar,,,"hg19,17:7579716-7579716, hg38,17:7676398-7676398","hg19,17:g.7579716G>C, hg38,17:g.7676398G>C",0.673,,,,,,,664352,Uncertain significance,Li-Fraumeni syndrome;not provided,2,,,,,,
76,27,P,S,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,"cBioPortal,COSMIC,ClinVar","bcc_unige_2016, brca_mapk_hp_msk_2021, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, cll_broad_2022, gist_msk_2023, heme_msk_impact_2022, mel_mskimpact_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_pdmr_2025, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, sarcoma_mskcc_2022, skcm_broad, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, tmb_mskcc_2018, ucec_cptac_2020, uec_cptac_gdc","Basal Cell Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Cutaneous Melanoma, Endometrial Carcinoma, Gastrointestinal Stromal Tumor, Invasive Breast Carcinoma, Mixed Cancer Types, Prostate Adenocarcinoma, Soft Tissue, Uterine Endometrioid Carcinoma","hg19,17:7579717-7579717, hg19,17:7676399-7676399, hg38,17:7676399-7676399","hg19,17:g.7579717G>A, hg19,17:g.7676399G>A, hg38,17:g.7676399G>A",0.623,"breast, lung, prostate, skin, skin, abdomen, skin, back, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, thymus","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, non_small_cell_carcinoma, gastrointestinal_stromal_tumour, malignant_melanoma, malignant_melanoma, nodular, thymic_carcinoma",0.0000080127563080,,,,528271,Uncertain significance,Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
77,27,P,T,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 17-27, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 18-27, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,"cBioPortal,COSMIC,ClinVar",mel_iatlas_riaz_nivolumab_2017,Melanoma,"hg19,17:7579717-7579717, hg19,17:7676399-7676399, hg38,17:7676399-7676399","hg19,17:g.7579717G>T, hg19,17:g.7676399G>T, hg38,17:g.7676399G>T",0.591,breast,"carcinoma, ER-positive_carcinoma",,,,,406600,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
78,28,E,K,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_msk_2025, breast_msk_2018, breast_msk_2025, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021","Breast, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579714-7579714, hg38,17:7676396-7676396","hg19,17:g.7579714C>T, hg38,17:g.7676396C>T",0.582,breast,"carcinoma, lobular_carcinoma",,,,,3634439,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
79,28,E,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 24-28, ggetELM",,"cBioPortal,ClinVar","crc_eo_2020, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024","Bowel, Mixed Cancer Types","hg19,17:7579713-7579713, hg38,17:7676395-7676395","hg19,17:g.7579713T>A, hg38,17:g.7676395T>A",0.529,,,,,,,185581,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,,,,,,
80,29,N,D,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,ClinVar,,,"hg19,17:7579711-7579711, hg38,17:7676393-7676393","hg19,17:g.7579711T>C, hg38,17:g.7676393T>C",0.270,,,,,,,822586,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
81,29,N,K,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,ClinVar,,,"hg19,17:7579709-7579709, hg38,17:7676391-7676391","hg19,17:g.7579709G>C, hg38,17:g.7676391G>C",0.328,,,,,,,638927,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
82,29,N,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,ClinVar,,,"hg19,17:7579710-7579710, hg38,17:7676392-7676392","hg19,17:g.7579710T>G, hg38,17:g.7676392T>G",0.401,,,,,,,842527,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
83,30,N,D,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,ClinVar,,,"hg19,17:7579708-7579708, hg38,17:7676390-7676390","hg19,17:g.7579708T>C, hg38,17:g.7676390T>C",0.328,,,,,,,3634438,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
84,30,N,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,"cBioPortal,COSMIC,ClinVar",pancan_pcawg_2020,Mixed Cancer Types,"hg19,17:7579707-7579707, hg38,17:7676389-7676389","hg19,17:g.7579707T>A, hg38,17:g.7676389T>A",0.502,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,,1515391,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
85,30,N,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,COSMIC,,,"hg38,17:7676388-7676388","hg38,17:g.7676388G>C",0.454,"adrenal_gland, adrenal_gland","adrenal_cortical_adenoma, aldosterone_producing",,,,,,,,,,,,,,
86,30,N,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,cBioPortal,pancan_mimsi_msk_2024,Mixed Cancer Types,"hg19,17:7579707-7579707","hg19,17:g.7579707T>C",0.381,,,,,,,,,,,,,,,,
87,30,N,Y,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,cBioPortal,msk_ch_2023,Mixed Cancer Types,"hg19,17:7579708-7579708","hg19,17:g.7579708T>A",0.491,,,,,,,,,,,,,,,,
88,31,V,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,ClinVar,,,"hg19,17:7579705-7579705, hg38,17:7676387-7676387","hg19,17:g.7579705C>A, hg38,17:g.7676387C>A",0.598,,,,,,,233852,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
89,31,V,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_genentech_2014, coad_cptac_2019, msk_met_2021, pancan_mimsi_msk_2024, sarcoma_msk_2022, ucec_ccr_cfdna_msk_2022, ucec_ccr_msk_2022","Colon Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7579705-7579705, hg38,17:7676387-7676387","hg19,17:g.7579705C>T, hg38,17:g.7676387C>T",0.569,"adrenal_gland, adrenal_gland, biliary_tract, gallbladder, central_nervous_system, pineal_gland, eye, uveal_tract, genital_tract, extragonadal, brain, haematopoietic_and_lymphoid_tissue, lung, pancreas, penis, skin, soft_tissue, fat, upper_leg, stomach, upper_aerodigestive_tract, mouth, urinary_tract","adrenal_cortical_adenoma, aldosterone_producing, benign_melanocytic_nevus, carcinoid-endocrine_tumour, non_functioning, carcinoma, adenocarcinoma, carcinoma, signet_ring_adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, yolk_sac_tumour, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, refractory_anaemia, liposarcoma, myxoid-round_cell, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, Ph-like, malignant_melanoma",0.0002524948899844,0.0000956632653061,,,127827,Conflicting classifications of pathogenicity,TP53-related disorder;Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;not specified;not provided;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
90,32,L,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_chord_2024","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579702-7579702","hg19,17:g.7579702G>T",0.350,,,,,,,,,,,,,,,,
91,32,L,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,ClinVar,,,"hg19,17:7579702-7579702, hg38,17:7676384-7676384","hg19,17:g.7579702G>C, hg38,17:g.7676384G>C",0.401,,,,,,,1767161,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
92,33,S,F,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,"cBioPortal,COSMIC,ClinVar","bm_nsclc_mskcc_2023, hcc_inserm_fr_2015, luad_mskcc_2020, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021","Cutaneous Melanoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579589-7579589, hg38,17:7676271-7676271","hg19,17:g.7579589G>A, hg38,17:g.7676271G>A",0.608,liver,"carcinoma, hepatocellular_carcinoma",,,,,649861,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
93,33,S,T,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579590-7579590, hg38,17:7676272-7676272","hg19,17:g.7579590A>T, hg38,17:g.7676272A>T",0.480,"soft_tissue, fibrous_tissue_and_uncertain_origin, stomach",gastrointestinal_stromal_tumour,,,,,1043464,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
94,33,S,Y,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,ClinVar,,,"hg19,17:7579589-7579589, hg38,17:7676271-7676271","hg19,17:g.7579589G>T, hg38,17:g.7676271G>T",0.554,,,,,,,482211,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
95,34,P,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,ClinVar,,,"hg19,17:7579587-7579587, hg38,17:7676269-7676269","hg19,17:g.7579587G>C, hg38,17:g.7676269G>C",0.432,,,,,,,186313,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
96,34,P,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,cBioPortal,skcm_vanderbilt_mskcc_2015,Cutaneous Melanoma,"hg19,17:7579586-7579587","hg19,17:g.7579586_7579587delinsAA",,,,,,,,,,,,,,,,,
97,34,P,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,"cBioPortal,COSMIC,ClinVar","bcc_unige_2016, hcc_inserm_fr_2015, luad_mskcc_2023_met_organotropism, msk_chord_2024, normal_skin_melanocytes_2024, pancan_pdmr_2025, sarcoma_msk_2022","Basal Cell Carcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Skin, Soft Tissue","hg19,17:7579586-7579586, hg38,17:7676268-7676268","hg19,17:g.7579586G>A, hg38,17:g.7676268G>A",0.446,"breast, liver, oesophagus, skin, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,818276,Uncertain significance,not provided;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,Tier I - Strong,Medulloblastoma WNT activated,1
98,34,P,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,ClinVar,,,"hg19,17:7579586-7579586, hg38,17:7676268-7676268","hg19,17:g.7579586G>C, hg38,17:g.7676268G>C",0.458,,,0.0000000000000000,,,,628478,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
99,34,P,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,"cBioPortal,ClinVar",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7579587-7579587, hg38,17:7676269-7676269","hg19,17:g.7579587G>A, hg38,17:g.7676269G>A",0.478,,,,,,,935999,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
100,34,P,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM|SH3 domain ligands (LIG_SH3_3), 28-34, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579587-7579587, hg38,17:7676269-7676269","hg19,17:g.7579587G>T, hg38,17:g.7676269G>T",0.435,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, chronic_neutrophilic_leukaemia",,,,,185157,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
101,35,L,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar",sarcoma_msk_2022,Soft Tissue,"hg19,17:7579582-7579582, hg38,17:7676264-7676264","hg19,17:g.7579582C>A, hg19,17:g.7579582C>G, hg38,17:g.7676264C>A, hg38,17:g.7676264C>G",0.486,"haematopoietic_and_lymphoid_tissue, lymph_node, liver, lung, pancreas","carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, lymphoid_neoplasm, angioimmunoblastic_T_cell_lymphoma",,0.0000318775900542,,,"142562, 12371","Likely benign, Uncertain significance",Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome|Carcinoma of pancreas;Li-Fraumeni syndrome,"3, 3",,,,,,
102,35,L,M,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 30-35, ggetELM",,ClinVar,,,"hg19,17:7579584-7579584, hg38,17:7676266-7676266","hg19,17:g.7579584A>T, hg38,17:g.7676266A>T",0.451,,,,,,,406609,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
103,36,P,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM",,cBioPortal,"lung_msk_mind_2020, msk_chord_2024, msk_met_2021","Lung, Mixed Cancer Types","hg19,17:7579581-7579581","hg19,17:g.7579581G>C",0.382,,,,,,,,,,,,,,,,
104,36,P,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM",,"cBioPortal,COSMIC,ClinVar","bcc_unige_2016, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, crc_sysucc_2022, lipo_msk_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, ucec_ccr_msk_2022","Basal Cell Carcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Liposarcoma, Mixed Cancer Types","hg19,17:7579580-7579580, hg19,17:7579580-7579581, hg19,17:7676262-7676263, hg38,17:7676262-7676262","hg19,17:g.7579580G>A, hg19,17:g.7579580_7579581delinsAA, hg19,17:g.7676262_7676263delinsAA, hg38,17:g.7676262G>A",0.542,"lung, skin, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma",0.0000039798143815,,,,818331,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Familial cancer of breast;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
105,36,P,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM",,ClinVar,,,"hg19,17:7579580-7579580, hg38,17:7676262-7676262","hg19,17:g.7579580G>T, hg38,17:g.7676262G>T",0.434,,,,,,,141597,Benign,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,,,
106,36,P,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_broad_2019, ccle_genentech_2014",Mixed Cancer Types,"hg19,17:7579581-7579581, hg38,17:7676263-7676263","hg19,17:g.7579581G>A, hg38,17:g.7676263G>A",0.462,lung,"carcinoma, adenocarcinoma",,,,,182921,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
107,37,S,C,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM",,ClinVar,,,"hg19,17:7579577-7579577, hg38,17:7676259-7676259","hg19,17:g.7579577G>C, hg38,17:g.7676259G>C",0.530,,,,,,,1794698,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
108,37,S,F,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM",,ClinVar,,,"hg19,17:7579577-7579577, hg38,17:7676259-7676259","hg19,17:g.7579577G>A, hg38,17:g.7676259G>A",0.544,,,,,,,567972,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome",1,,,,,,
109,37,S,T,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM",,"cBioPortal,COSMIC",sarcoma_msk_2022,Soft Tissue,"hg19,17:7579578-7579578, hg38,17:7676260-7676260","hg19,17:g.7579578A>T, hg38,17:g.7676260A>T",0.439,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
110,38,Q,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,17:7579575-7579575","hg19,17:g.7579575G>C",0.482,,,,,,,,,,,,,,,,
111,38,Q,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,COSMIC,,,"hg38,17:7676256-7676256","hg38,17:g.7676256T>A",0.530,urinary_tract,"carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
112,38,Q,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,ClinVar,,,"hg19,17:7579574-7579574, hg38,17:7676256-7676256","hg19,17:g.7579574T>G, hg38,17:g.7676256T>G",0.577,,,,,,,940878,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
113,38,Q,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 34-38, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,ClinVar,,,"hg19,17:7579574-7579574, hg38,17:7676256-7676256","hg19,17:g.7579574T>C, hg38,17:g.7676256T>C",0.422,,,,,,,1717844,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
114,39,A,S,,,,,,,,,,,,"Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,17:7579572-7579572, hg38,17:7676254-7676254","hg19,17:g.7579572C>A, hg38,17:g.7676254C>A",0.432,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,,2024235,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
115,39,A,T,,,,,,,,,,,,"Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579572-7579572, hg38,17:7676254-7676254","hg19,17:g.7579572C>T, hg38,17:g.7676254C>T",0.436,large_intestine,"carcinoma, adenocarcinoma",,,,,1035024,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
116,39,A,V,,,,,,,,,,,,"Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,ClinVar,,,"hg19,17:7579571-7579571, hg38,17:7676253-7676253","hg19,17:g.7579571G>A, hg38,17:g.7676253G>A",0.454,,,,,,,569629,Conflicting classifications of pathogenicity,Familial cancer of breast;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary breast ovarian cancer syndrome,1,,,,,,
117,40,M,I,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,"cBioPortal,COSMIC","coadread_dfci_2016, heme_msk_impact_2022","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7579567-7579567, hg38,17:7676249-7676249","hg19,17:g.7579567C>T, hg38,17:g.7676249C>G, hg38,17:g.7676249C>T",0.426,"large_intestine, skin, chest","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
118,40,M,T,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,ClinVar,,,"hg19,17:7579568-7579568, hg38,17:7676250-7676250","hg19,17:g.7579568A>G, hg38,17:g.7676250A>G",0.535,,,,,,,142995,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
119,40,M,V,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,ClinVar,,,"hg19,17:7579569-7579569, hg38,17:7676251-7676251","hg19,17:g.7579569T>C, hg38,17:g.7676251T>C",0.462,,,,,,,643576,Conflicting classifications of pathogenicity,not specified;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
120,41,D,E,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,COSMIC,,,,,,ovary,"carcinoma, serous_carcinoma",,,,,,,,,,,,,,
121,41,D,G,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,ClinVar,,,"hg19,17:7579565-7579565, hg38,17:7676247-7676247","hg19,17:g.7579565T>C, hg38,17:g.7676247T>C",0.556,,,,,,,863522,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
122,41,D,H,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, paired_bladder_2022, sarcoma_mskcc_2022","Bladder/Urinary Tract, Mixed Cancer Types, Soft Tissue","hg19,17:7579566-7579566, hg38,17:7676248-7676248","hg19,17:g.7579566C>G, hg38,17:g.7676248C>G",0.497,"soft_tissue, fibrous_tissue_and_uncertain_origin","undifferentiated_sarcoma, pleomorphic",,,,,,,,,,,,,,
123,41,D,N,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579566-7579566, hg38,17:7676248-7676248","hg19,17:g.7579566C>T, hg38,17:g.7676248C>T",0.323,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,485040,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
124,42,D,G,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,ClinVar,,,"hg19,17:7579562-7579562, hg38,17:7676244-7676244","hg19,17:g.7579562T>C, hg38,17:g.7676244T>C",0.292,,,,,,,141464,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,1,,,,,,
125,42,D,N,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,"cBioPortal,ClinVar","blca_msk_2025, mel_mskimpact_2020, msk_met_2021","Bladder Urothelial Carcinoma, Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7579563-7579563, hg38,17:7676245-7676245","hg19,17:g.7579563C>T, hg38,17:g.7676245C>T",0.189,,,0.0000039782311193,,,,1471049,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
126,42,D,Y,,,,,,,,,,,,"IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,17:7579563-7579563, hg38,17:7676245-7676245","hg19,17:g.7579563C>A, hg38,17:g.7676245C>A",0.422,ovary,"carcinoma, serous_carcinoma",,,,,,,,,,,,,,
127,43,L,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar","brca_msk_2025, breast_ink4_msk_2021, cfdna_msk_2019, gbc_mskcc_2022, hcc_msk_2024, msk_chord_2024, msk_ctdna_vte_2024, summit_2018","Breast, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579558-7579558, hg38,17:7676240-7676240","hg19,17:g.7579558C>A, hg19,17:g.7579558C>G, hg38,17:g.7676240C>A, hg38,17:g.7676240C>G",0.341,,"carcinoma, of_unknown_primary",0.0000039781994669,,,,"1692471, 864154","Conflicting classifications of pathogenicity, Uncertain significance",Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome,"1, 1",,,,,,
128,43,L,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,ClinVar,,,"hg19,17:7579560-7579560, hg38,17:7676242-7676242","hg19,17:g.7579560A>T, hg38,17:g.7676242A>T",0.409,,,,,,,663719,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
129,43,L,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,ClinVar,,,"hg19,17:7579560-7579560, hg38,17:7676242-7676242","hg19,17:g.7579560A>C, hg38,17:g.7676242A>C",0.425,,,,,,,2774655,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
130,43,L,W,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,17:7579559-7579559","hg19,17:g.7579559A>C",0.421,,,,,,,,,,,,,,,,
131,44,M,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579555-7579555, hg38,17:7676237-7676237","hg19,17:g.7579555C>T, hg38,17:g.7676237C>A, hg38,17:g.7676237C>T",0.272,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,,,,406565,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
132,44,M,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,ClinVar,,,"hg19,17:7579556-7579556, hg38,17:7676238-7676238","hg19,17:g.7579556A>T, hg38,17:g.7676238A>T",0.515,,,,,,,1769875,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
133,44,M,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,ClinVar,,,"hg19,17:7579557-7579557, hg38,17:7676239-7676239","hg19,17:g.7579557T>G, hg38,17:g.7676239T>G",0.334,,,,,,,2087249,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
134,44,M,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579556-7579556, hg38,17:7676238-7676238","hg19,17:g.7579556A>C, hg38,17:g.7676238A>C",0.474,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,928344,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
135,44,M,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579556-7579556, hg38,17:7676238-7676238","hg19,17:g.7579556A>G, hg38,17:g.7676238A>G",0.278,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,1769879,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
136,44,M,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579557-7579557, hg38,17:7676239-7676239","hg19,17:g.7579557T>C, hg38,17:g.7676239T>C",0.296,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,3460300,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
137,45,L,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579553-7579553, hg38,17:7676235-7676235","hg19,17:g.7579553A>G, hg38,17:g.7676235A>G",0.362,", oesophagus, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, small_cell_adenocarcinoma",,,,,246049,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
138,45,L,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,ClinVar,,,"hg19,17:7579554-7579554, hg38,17:7676236-7676236","hg19,17:g.7579554G>C, hg38,17:g.7676236G>C",0.354,,,,,,,659842,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
139,46,S,C,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,17:7579550-7579550","hg19,17:g.7579550G>C",0.342,,,,,,,,,,,,,,,,
140,46,S,F,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,COSMIC","bcc_unige_2016, mds_mskcc_2020, rcc_iatlas_immotion150_2018","Basal Cell Carcinoma, Myelodysplastic Syndromes, Renal Cell Carcinoma","hg19,17:7579550-7579550, hg19,17:7676232-7676232, hg38,17:7676232-7676232","hg19,17:g.7579550G>A, hg19,17:g.7676232G>A, hg38,17:g.7676232G>A",0.349,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, skin, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,,,,,,,,,,
141,46,S,P,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579551-7579551, hg38,17:7676233-7676233","hg19,17:g.7579551A>G, hg38,17:g.7676233A>G",0.341,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, skin","lymphoid_neoplasm, NK-T_cell_lymphoma, malignant_melanoma",,,,,232223,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
142,46,S,Y,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|IRF interaction and dimerisation motifs (LIG_IRF7_LxLS_2), 40-46, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,ClinVar","luad_mskcc_2023_met_organotropism, mixed_allen_2018, msk_chord_2024, msk_met_2021, nsclc_ctdx_msk_2022, skcm_dfci_2015","Cutaneous Melanoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579550-7579550, hg38,17:7676232-7676232","hg19,17:g.7579550G>T, hg38,17:g.7676232G>T",0.318,,,,,,,659626,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
143,47,P,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,ClinVar,,,"hg19,17:7579548-7579548, hg38,17:7676230-7676230","hg19,17:g.7579548G>C, hg38,17:g.7676230G>C",0.296,,,,,,,1721838,Uncertain significance,Li-Fraumeni syndrome,2,,,,,,
144,47,P,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,COSMIC","coadread_cass_2020, sft_sysucc_2023","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7579547-7579547, hg38,17:7676229-7676229","hg19,17:g.7579547G>A, hg38,17:g.7676229G>A",0.345,"breast, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, lung, left_lower_lobe","carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,,,,,,,,,,
145,47,P,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,COSMIC,,,"hg38,17:7676229-7676229","hg38,17:g.7676229G>T",0.330,"skin, back","malignant_melanoma, lentigo_maligna",,,,,,,,,,,,,,
146,47,P,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,ClinVar","mds_mskcc_2020, paired_bladder_2022","Bladder/Urinary Tract, Myelodysplastic Syndromes","hg19,17:7579547-7579547, hg38,17:7676229-7676229","hg19,17:g.7579547G>C, hg38,17:g.7676229G>C",0.353,,,,,,,819145,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
147,47,P,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,COSMIC,ClinVar","blca_msk_2024, msk_ctdna_vte_2024","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,17:7579548-7579548, hg38,17:7676230-7676230","hg19,17:g.7579548G>A, hg38,17:g.7676230G>A",0.320,"endometrium, kidney, liver, prostate","Wilms_tumour, carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, hepatocellular_carcinoma",0.0012332320226596,0.0044642857142857,,,43588,Benign,Hepatocellular carcinoma;Hereditary cancer-predisposing syndrome;Breast and/or ovarian cancer;not specified;not provided;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Malignant tumor of breast,3,Uncertain significance,Cervical cancer,0,,,
148,47,P,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|Pocket protein B Subdomain ligands (LIG_RB_pABgroove_1), 38-47, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,ClinVar,,,"hg19,17:7579548-7579548, hg38,17:7676230-7676230","hg19,17:g.7579548G>T, hg38,17:g.7676230G>T",0.302,,,,0.0000318877551020,,,406608,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
149,48,D,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,ClinVar,,,"hg19,17:7579543-7579543, hg38,17:7676225-7676225","hg19,17:g.7579543G>T, hg38,17:g.7676225G>T",0.364,,,,,,,141056,Likely benign,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
150,48,D,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579544-7579544, hg38,17:7676226-7676226","hg19,17:g.7579544T>C, hg38,17:g.7676226T>C",0.264,stomach,carcinoma,,,,,2795844,Likely benign,Li-Fraumeni syndrome,3,,,,,,
151,48,D,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,COSMIC","cfdna_msk_2019, luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579545-7579545, hg38,17:7676227-7676227","hg19,17:g.7579545C>G, hg38,17:g.7676227C>G",0.357,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
152,48,D,N,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 43-48, ggetELM|TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,COSMIC","ccle_broad_2019, ccle_broad_2025, mds_mskcc_2020, msk_met_2021, paired_bladder_2022, pancan_pcawg_2020, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Bladder/Urinary Tract, Cutaneous Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7579545-7579545, hg19,17:7676227-7676227, hg38,17:7676227-7676227","hg19,17:g.7579545C>T, hg19,17:g.7676227C>T, hg38,17:g.7676227C>T",0.206,"haematopoietic_and_lymphoid_tissue, skin","haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, refractory_anaemia, malignant_melanoma",,,,,,,,,,,,,,
153,49,D,E,,,,,,,,,,,,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"ClinVar,ClinVar",,,"hg19,17:7579540-7579540, hg38,17:7676222-7676222","hg19,17:g.7579540A>C, hg19,17:g.7579540A>T, hg38,17:g.7676222A>C, hg38,17:g.7676222A>T","0.278, 0.279",,,,,,,"1506044, 1361888","Conflicting classifications of pathogenicity, Uncertain significance",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Li-Fraumeni syndrome,"1, 1",,,,,,
154,49,D,G,,,,,,,,,,,,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,ClinVar,,,"hg19,17:7579541-7579541, hg38,17:7676223-7676223","hg19,17:g.7579541T>C, hg38,17:g.7676223T>C",0.309,,,0.0000079558292361,,,,231133,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
155,49,D,H,,,,,,,,,,,,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_broad_2019, cellline_ccle_broad, sarcoma_msk_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7579542-7579542, hg38,17:7676224-7676224","hg19,17:g.7579542C>G, hg38,17:g.7676224C>G",0.315,"biliary_tract, gallbladder, haematopoietic_and_lymphoid_tissue, lung, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, signet_ring_adenocarcinoma, carcinoma, squamous_cell_carcinoma, gastrointestinal_stromal_tumour, haematopoietic_neoplasm, chronic_myeloid_leukaemia",0.0000039782627722,,,,135948,Benign,Hereditary cancer-predisposing syndrome;not specified;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,,,
156,49,D,N,,,,,,,,,,,,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,COSMIC,ClinVar","coadread_dfci_2016, mds_iwg_2022, msk_chord_2024, msk_met_2021, sarcoma_msk_2022","Colorectal Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7579542-7579542, hg38,17:7676224-7676224","hg19,17:g.7579542C>T, hg38,17:g.7676224C>T",0.235,"central_nervous_system, brain, large_intestine","atypical_teratoid-rhabdoid_tumour, carcinoma, adenocarcinoma",0.0000079565255444,,,,186363,Benign,Hereditary cancer-predisposing syndrome;not provided;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
157,49,D,V,,,,,,,,,,,,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579541-7579541, hg38,17:7676223-7676223","hg19,17:g.7579541T>A, hg38,17:g.7676223T>A",0.465,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
158,49,D,Y,,,,,,,,,,,,"TRAF2 group (TRAF1,2,3,5) MATH domain binding motifs (LIG_TRAF2like_MATH_loPxQ_2), 44-49, ggetELM",,COSMIC,,,"hg38,17:7676224-7676224","hg38,17:g.7676224C>A",0.396,urinary_tract,"carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
159,50,I,L,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579539-7579539, hg38,17:7676221-7676221","hg19,17:g.7579539T>G, hg38,17:g.7676221T>G",0.406,,,,,,,2877402,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
160,50,I,N,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579538-7579538, hg38,17:7676220-7676220","hg19,17:g.7579538A>T, hg38,17:g.7676220A>T",0.289,,,,,,,187302,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
161,50,I,T,,,,,,,,,,,,,,"cBioPortal,ClinVar","luad_mskcc_2023_met_organotropism, msk_ch_2023, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579538-7579538, hg38,17:7676220-7676220","hg19,17:g.7579538A>G, hg38,17:g.7676220A>G",0.352,,,,,,,216464,Likely benign,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,,,
162,50,I,V,,,,,,,,,,,,,,cBioPortal,crc_eo_2020,Bowel,"hg19,17:7579539-7579539","hg19,17:g.7579539T>C",0.319,,,,,,,,,,,,,,,,
163,51,E,G,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579535-7579535, hg38,17:7676217-7676217","hg19,17:g.7579535T>C, hg38,17:g.7676217T>C",0.363,,,,,,,577888,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
164,51,E,K,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579536-7579536, hg38,17:7676218-7676218","hg19,17:g.7579536C>T, hg38,17:g.7676218C>T",0.471,,,,,,,850781,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
165,52,Q,H,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676213-7676213","hg38,17:g.7676213T>A, hg38,17:g.7676213T>G",0.296,"breast, urinary_tract","carcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
166,52,Q,K,,,,,,,,,,,,,,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,17:7579533-7579533","hg19,17:g.7579533G>T",0.232,,,,,,,,,,,,,,,,
167,52,Q,R,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579532-7579532, hg38,17:7676214-7676214","hg19,17:g.7579532T>C, hg38,17:g.7676214T>C",0.249,,,0.0000039781045128,,,,237942,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
168,53,W,C,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676210-7676210","hg38,17:g.7676210C>A, hg38,17:g.7676210C>G",0.367,"haematopoietic_and_lymphoid_tissue, lung, skin, face","carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,,,,,,,,,,
169,53,W,G,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676212-7676212","hg38,17:g.7676212A>C",0.442,lung,"carcinoma, small_cell_carcinoma",,,,,,,,,,,,,,
170,53,W,L,,,,,,,,,,,,,,"cBioPortal,ClinVar",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7579529-7579529, hg38,17:7676211-7676211","hg19,17:g.7579529C>A, hg38,17:g.7676211C>A",0.343,,,,,,,1775891,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
171,53,W,R,,,,,,,,,,,,,,"ClinVar,ClinVar",,,"hg19,17:7579530-7579530, hg38,17:7676212-7676212","hg19,17:g.7579530A>G, hg19,17:g.7579530A>T, hg38,17:g.7676212A>G, hg38,17:g.7676212A>T",0.385,,,,,,,"1775671, 1473030","Uncertain significance, Uncertain significance",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Li-Fraumeni syndrome,"2, 1",,,,,,
172,54,F,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar","mds_mskcc_2020, pancan_pdmr_2025","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7579527-7579527, hg38,17:7676207-7676207, hg38,17:7676209-7676209","hg19,17:g.7579527A>G, hg38,17:g.7676207G>T, hg38,17:g.7676209A>G","0.370, 0.387","haematopoietic_and_lymphoid_tissue, urinary_tract","carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,481098,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
173,55,T,I,P,,,,,,,,,,PhosphoSite,,,COSMIC,,,"hg38,17:7676205-7676205","hg38,17:g.7676205G>A",0.301,"central_nervous_system, temporal_lobe, lung","carcinoma, large_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic",,,,,,,,,,,,,,
174,55,T,P,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7579524-7579524, hg38,17:7676206-7676206","hg19,17:g.7579524T>G, hg38,17:g.7676206T>G",0.376,,,,,,,2705758,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
175,55,T,S,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7579523-7579523, hg38,17:7676205-7676205","hg19,17:g.7579523G>C, hg38,17:g.7676205G>C",0.344,,,,,,,2130489,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
176,56,E,G,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579520-7579520, hg38,17:7676202-7676202","hg19,17:g.7579520T>C, hg38,17:g.7676202T>C",0.292,,,,,,,3894270,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
177,56,E,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar","blca_msk_2024, msk_met_2021, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7579521-7579521, hg38,17:7676203-7676203","hg19,17:g.7579521C>T, hg38,17:g.7676203C>T",0.478,"breast, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, liver, urinary_tract","carcinoma, hepatocellular_carcinoma, carcinoma, transitional_cell_carcinoma, hyperplasia, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,3232051,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
178,56,E,V,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676202-7676202","hg38,17:g.7676202T>A",0.321,liver,"carcinoma, hepatocellular_carcinoma",,,,,,,,,,,,,,
179,57,D,A,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579517-7579517, hg38,17:7676199-7676199","hg19,17:g.7579517T>G, hg38,17:g.7676199T>G",0.379,,,,,,,1425412,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
180,57,D,E,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579516-7579516, hg38,17:7676198-7676198","hg19,17:g.7579516G>T, hg38,17:g.7676198G>T",0.258,,,,,,,142863,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
181,57,D,G,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7579517-7579517, hg38,17:7676199-7676199","hg19,17:g.7579517T>C, hg38,17:g.7676199T>C",0.382,"autonomic_ganglia, head_neck, carotid_body",paraganglioma,0.0000039802262361,,,,2695282,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
182,57,D,H,,,,,,,,,,,,,,cBioPortal,paired_bladder_2022,Bladder/Urinary Tract,"hg19,17:7579518-7579518","hg19,17:g.7579518C>G",0.430,,,,,,,,,,,,,,,,
183,57,D,N,,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,17:7579518-7579518, hg19,17:7676200-7676200, hg38,17:7676200-7676200","hg19,17:g.7579518C>T, hg19,17:g.7676200C>T, hg38,17:g.7676200C>T",0.219,"liver, lung, ovary, upper_aerodigestive_tract, mouth","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
184,57,D,V,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7579517-7579517, hg38,17:7676199-7676199","hg19,17:g.7579517T>A, hg38,17:g.7676199T>A",0.473,meninges,"meningioma, atypical",,,,,1778520,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
185,58,P,A,,,,,,,,,,,,,,"cBioPortal,ClinVar",blca_msk_2025,Bladder Urothelial Carcinoma,"hg19,17:7579515-7579515, hg38,17:7676197-7676197","hg19,17:g.7579515G>C, hg38,17:g.7676197G>C",0.319,,,,,,,1778944,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
186,58,P,L,,,,,,,,,,,,,,"cBioPortal,COSMIC",mds_iwg_2022,Myelodysplastic Syndromes,"hg19,17:7579514-7579514, hg38,17:7676196-7676196","hg19,17:g.7579514G>A, hg38,17:g.7676196G>A",0.341,"liver, oesophagus","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma",,,,,,,,,,,,,,
187,58,P,Q,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676196-7676196","hg38,17:g.7676196G>T",0.308,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma",,,,,,,,,,,,,,
188,58,P,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar","msk_chord_2024, msk_ctdna_vte_2024",Mixed Cancer Types,"hg19,17:7579514-7579514, hg38,17:7676196-7676196","hg19,17:g.7579514G>C, hg38,17:g.7676196G>C",0.314,kidney,Wilms_tumour,0.0000796102283221,0.0002231431303793,,,127804,Conflicting classifications of pathogenicity,TP53-related disorder;Hereditary cancer-predisposing syndrome;Breast and/or ovarian cancer;not specified;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
189,58,P,S,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676197-7676197","hg38,17:g.7676197G>A",0.337,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
190,58,P,T,,,,,,,,,,,,,,"cBioPortal,ClinVar",brca_smc_2018,Invasive Breast Carcinoma,"hg19,17:7579515-7579515, hg38,17:7676197-7676197","hg19,17:g.7579515G>T, hg38,17:g.7676197G>T",0.302,,,,,,,947099,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
191,59,G,A,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579511-7579511, hg38,17:7676193-7676193","hg19,17:g.7579511C>G, hg38,17:g.7676193C>G",0.317,,,,,,,2747093,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
192,59,G,C,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7579512-7579512, hg38,17:7676194-7676194","hg19,17:g.7579512C>A, hg38,17:g.7676194C>A",0.391,"upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract","carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,0.0000318755578223,,,2812726,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
193,59,G,D,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7579511-7579511, hg38,17:7676193-7676193","hg19,17:g.7579511C>T, hg38,17:g.7676193C>T",0.358,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,820048,Likely benign,Hereditary cancer-predisposing syndrome;Malignant tumor of breast,1,,,,,,
194,59,G,N,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676193-7676194","hg38,17:g.7676193_7676194delinsTT",,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
195,59,G,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar",msk_impact_2017,Mixed Cancer Types,"hg19,17:7579512-7579512, hg38,17:7676194-7676194","hg19,17:g.7579512C>G, hg38,17:g.7676194C>G",0.343,,"carcinoma, of_unknown_primary",,,,,1491657,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
196,59,G,S,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7579512-7579512, hg38,17:7676194-7676194","hg19,17:g.7579512C>T, hg38,17:g.7676194C>T",0.363,,,,,,,1779558,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
197,60,P,A,,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, msk_chord_2024","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579509-7579509, hg38,17:7676191-7676191","hg19,17:g.7579509G>C, hg38,17:g.7676191G>C",0.294,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
198,60,P,L,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7579508-7579508, hg38,17:7676190-7676190","hg19,17:g.7579508G>A, hg38,17:g.7676190G>A",0.313,prostate,"carcinoma, adenocarcinoma",,,,,820098,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
199,60,P,Q,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676190-7676190","hg38,17:g.7676190G>T",0.308,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,,,,,,,,,,
200,60,P,R,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676190-7676190","hg38,17:g.7676190G>C",0.362,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
201,60,P,S,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676191-7676191","hg38,17:g.7676191G>A",0.257,"haematopoietic_and_lymphoid_tissue, lung","carcinoma, adenocarcinoma, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia",,,,,,,,,,,,,,
202,60,P,T,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7676191-7676191","hg38,17:g.7676191G>T",0.318,"adrenal_gland, adrenal_gland",adrenal_cortical_carcinoma,,,,,,,,,,,,,,
203,60,P,X,,,,,,,,,,,,,,COSMIC,,,,,,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
204,61,D,E,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM",,ClinVar,,,"hg19,17:7579504-7579504, hg38,17:7676186-7676186","hg19,17:g.7579504A>T, hg38,17:g.7676186A>T",0.266,,,,,,,820144,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1",1,,,,,,
205,61,D,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM",,"cBioPortal,COSMIC,ClinVar","ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018",Endometrial Carcinoma,"hg19,17:7579505-7579505, hg19,17:7676187-7676187, hg38,17:7676187-7676187","hg19,17:g.7579505T>C, hg19,17:g.7676187T>C, hg38,17:g.7676187T>C",0.364,"haematopoietic_and_lymphoid_tissue, urinary_tract","carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",0.0000039821916390,,,,950660,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
206,61,D,H,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM",,"cBioPortal,COSMIC","brca_msk_2025, breast_msk_2025, msk_impact_2017, msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579506-7579506, hg38,17:7676188-7676188","hg19,17:g.7579506C>G, hg38,17:g.7676188C>G",0.315,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
207,61,D,N,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM",,COSMIC,,,"hg38,17:7676188-7676188","hg38,17:g.7676188C>T",0.202,"haematopoietic_and_lymphoid_tissue, salivary_gland, parotid, skin, arm","carcinoma, mucoepidermoid_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, other, keratosis",,,,,,,,,,,,,,
208,61,D,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM",,ClinVar,,,"hg19,17:7579505-7579505, hg38,17:7676187-7676187","hg19,17:g.7579505T>A, hg38,17:g.7676187T>A",0.446,,,,,,,1347666,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
209,61,D,Y,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM",,ClinVar,,,"hg19,17:7579506-7579506, hg38,17:7676188-7676188","hg19,17:g.7579506C>A, hg38,17:g.7676188C>A",0.385,,,,,,,1366182,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
210,62,E,A,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579502-7579502, hg38,17:7676184-7676184","hg19,17:g.7579502T>G, hg38,17:g.7676184T>G",0.337,,,,,,,1388326,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
211,62,E,D,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,COSMIC,,,"hg38,17:7676183-7676183","hg38,17:g.7676183T>G",0.329,"salivary_gland, parotid","carcinoma, acinic_cell_carcinoma",,,,,,,,,,,,,,
212,62,E,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579502-7579502, hg38,17:7676184-7676184","hg19,17:g.7579502T>C, hg38,17:g.7676184T>C",0.290,,,,,,,3809683,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
213,62,E,K,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC,ClinVar","blca_msk_2024, hgsoc_tcga_gdc, msk_met_2021, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, panet_msk_erc_2023, sarcoma_msk_2022","Bladder Urothelial Carcinoma, High-Grade Serous Ovarian Cancer, Mixed Cancer Types, Pancreas, Soft Tissue","hg19,17:7579503-7579503, hg19,17:7676185-7676185, hg38,17:7676185-7676185","hg19,17:g.7579503C>T, hg19,17:g.7676185C>T, hg38,17:g.7676185C>T",0.385,"ovary, thyroid, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, anaplastic_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, serous_carcinoma",,,,,859320,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
214,63,A,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579499-7579499, hg38,17:7676181-7676181","hg19,17:g.7579499G>C, hg38,17:g.7676181G>C",0.231,,,,0.0000318714941356,,,229693,Likely benign,Hereditary cancer-predisposing syndrome;not provided;not specified;Li-Fraumeni syndrome,3,,,,,,
215,63,A,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,COSMIC,,,"hg38,17:7676182-7676182","hg38,17:g.7676182C>A",0.265,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
216,63,A,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579500-7579500, hg38,17:7676182-7676182","hg19,17:g.7579500C>T, hg38,17:g.7676182C>T",0.265,"large_intestine, salivary_gland, parotid","carcinoma, adenocarcinoma",,,,,231015,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
217,63,A,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579499-7579499, hg38,17:7676181-7676181","hg19,17:g.7579499G>A, hg38,17:g.7676181G>A",0.282,,,0.0000119504772224,,,,182922,Benign,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
218,64,P,A,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,COSMIC,,,"hg38,17:7676179-7676179","hg38,17:g.7676179G>C",0.272,thyroid,"carcinoma, anaplastic_carcinoma",,,,,,,,,,,,,,
219,64,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC,ClinVar","bcc_unige_2016, bm_nsclc_mskcc_2023, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021, pancan_pdmr_2025","Basal Cell Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579496-7579496, hg38,17:7676178-7676178","hg19,17:g.7579496G>A, hg38,17:g.7676178G>A",0.293,", skin","carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,3634437,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
220,64,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC,ClinVar","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,17:7579497-7579497, hg38,17:7676179-7676179","hg19,17:g.7579497G>A, hg38,17:g.7676179G>A",0.239,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,2774654,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
221,64,P,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC,ClinVar","ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,17:7579497-7579497, hg19,17:7676179-7676179, hg38,17:7676179-7676179","hg19,17:g.7579497G>T, hg19,17:g.7676179G>T, hg38,17:g.7676179G>T",0.237,endometrium,"carcinoma, endometrioid_carcinoma",,,,,3706400,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
222,65,R,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579494-7579494, hg38,17:7676176-7676176","hg19,17:g.7579494T>C, hg38,17:g.7676176T>C",0.326,,,,,,,820372,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
223,65,R,K,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,COSMIC,,,,,,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
224,65,R,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,ClinVar","msk_chord_2024, pan_origimed_2020",Mixed Cancer Types,"hg19,17:7579493-7579493, hg38,17:7676175-7676175","hg19,17:g.7579493C>G, hg38,17:g.7676175C>G",0.311,,,,,,,406607,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
225,66,M,I,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC,ClinVar","hcc_jcopo_msk_2023, hcc_msk_2024, pan_origimed_2020","Hepatocellular Carcinoma, Mixed Cancer Types","hg19,17:7579489-7579489, hg38,17:7676171-7676171","hg19,17:g.7579489C>A, hg19,17:g.7579489C>T, hg38,17:g.7676171C>T",0.277,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity",lymphoid_neoplasm,,,,,480745,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
226,66,M,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,cBioPortal,paired_bladder_2022,Bladder/Urinary Tract,"hg19,17:7579491-7579491","hg19,17:g.7579491T>G",0.266,,,,,,,,,,,,,,,,
227,66,M,R,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC,ClinVar",bcc_unige_2016,Basal Cell Carcinoma,"hg19,17:7579490-7579490, hg38,17:7676172-7676172","hg19,17:g.7579490A>C, hg38,17:g.7676172A>C",0.338,"skin, upper_aerodigestive_tract, larynx","carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,1714129,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
228,66,M,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579490-7579490, hg38,17:7676172-7676172","hg19,17:g.7579490A>G, hg38,17:g.7676172A>G",0.327,,,,,,,1316731,Uncertain significance,not provided,1,,,,,,
229,66,M,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579491-7579491, hg38,17:7676173-7676173","hg19,17:g.7579491T>C, hg38,17:g.7676173T>C",0.251,,,,,,,1783578,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
230,67,P,A,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,ClinVar",brain_cptac_2020,CNS/Brain,"hg19,17:7579488-7579488, hg38,17:7676170-7676170","hg19,17:g.7579488G>C, hg38,17:g.7676170G>C",0.244,,,,,,,3074199,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
231,67,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,COSMIC,,,"hg38,17:7676169-7676169","hg38,17:g.7676169G>A",0.322,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
232,67,P,Q,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579487-7579487, hg38,17:7676169-7676169","hg19,17:g.7579487G>T, hg38,17:g.7676169G>T",0.272,,,,,,,528264,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
233,67,P,R,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,COSMIC,,,"hg38,17:7676169-7676169","hg38,17:g.7676169G>C",0.301,stomach,carcinoma,,,,,,,,,,,,,,
234,67,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 61-67, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC,ClinVar","ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018",Endometrial Carcinoma,"hg19,17:7579488-7579488, hg19,17:7676170-7676170, hg38,17:7676170-7676170","hg19,17:g.7579488G>A, hg19,17:g.7676170G>A, hg38,17:g.7676170G>A",0.220,"central_nervous_system, brain, prostate, urinary_tract, bladder","carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_I, pilocytic",,,,,835228,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
235,68,E,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC",msk_chord_2024,Mixed Cancer Types,"hg19,17:7579483-7579483","hg19,17:g.7579483C>A",0.222,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
236,68,E,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,COSMIC,,,"hg38,17:7676166-7676166","hg38,17:g.7676166T>C",0.281,"central_nervous_system, brain, liver","carcinoma, hepatocellular_carcinoma, glioma, astrocytoma_Grade_III, anaplastic",,,,,,,,,,,,,,
237,68,E,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC","msk_met_2021, sclc_ucologne_2015","Mixed Cancer Types, Small Cell Lung Cancer","hg19,17:7579485-7579485, hg38,17:7676167-7676167","hg19,17:g.7579485C>T, hg38,17:g.7676167C>T",0.361,"liver, lung, ovary, skin, face","adnexal_tumour, sebaceous_adenoma, carcinoma, hepatocellular_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, small_cell_carcinoma",,,,,,,,,,,,,,
238,68,E,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC,ClinVar",blca_bcan_hcrn_2022,Bladder Urothelial Carcinoma,"hg19,17:7579485-7579485, hg38,17:7676167-7676167","hg19,17:g.7579485C>G, hg38,17:g.7676167C>G",0.221,"adrenal_gland, adrenal_gland",pheochromocytoma,,,,,490170,Uncertain significance,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
239,69,A,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579481-7579481, hg38,17:7676163-7676163","hg19,17:g.7579481G>C, hg38,17:g.7676163G>C",0.260,"haematopoietic_and_lymphoid_tissue, lung, prostate, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach","carcinoma, adenocarcinoma, carcinoma, large_cell_carcinoma, gastrointestinal_stromal_tumour, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,230112,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
240,69,A,P,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579482-7579482, hg38,17:7676164-7676164","hg19,17:g.7579482C>G, hg38,17:g.7676164C>G",0.261,,,,,,,919370,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
241,69,A,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,ClinVar,,,"hg19,17:7579482-7579482, hg38,17:7676164-7676164","hg19,17:g.7579482C>T, hg38,17:g.7676164C>T",0.231,,,,,,,575773,Conflicting classifications of pathogenicity,Familial cancer of breast;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
242,69,A,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 62-69, ggetELM",,"cBioPortal,COSMIC,ClinVar","bowel_colitis_msk_2022, crc_sysucc_2022","Bowel, Colorectal Adenocarcinoma","hg19,17:7579481-7579481, hg38,17:7676163-7676163","hg19,17:g.7579481G>A, hg38,17:g.7676163G>A",0.314,"skin, leg","other, keratosis",,,,,528260,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
243,70,A,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,cBioPortal,msk_chord_2024,Mixed Cancer Types,"hg19,17:7579478-7579478","hg19,17:g.7579478G>C",0.354,,,,,,,,,,,,,,,,
244,70,A,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC","paad_tcga, paad_tcga_gdc",Pancreatic Adenocarcinoma,"hg19,17:7579479-7579479, hg19,17:7676161-7676161, hg38,17:7676161-7676161","hg19,17:g.7579479C>T, hg19,17:g.7676161C>T, hg38,17:g.7676161C>T",0.291,breast,hyperplasia,,,,,,,,,,,,,,
245,70,A,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC,ClinVar","blca_iatlas_imvigor210_2017, lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579478-7579478, hg19,17:7676160-7676160, hg38,17:7676160-7676160","hg19,17:g.7579478G>A, hg19,17:g.7676160G>A, hg38,17:g.7676160G>A",0.375,lung,"carcinoma, adenocarcinoma",,,,,630031,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
246,71,P,A,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC,ClinVar",brca_broad,Invasive Breast Carcinoma,"hg19,17:7579476-7579476, hg38,17:7676158-7676158","hg19,17:g.7579476G>C, hg38,17:g.7676158G>C",0.367,breast,"carcinoma, normal-like_carcinoma",,,,,577431,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
247,71,P,F,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,cBioPortal,bcc_unige_2016,Basal Cell Carcinoma,"hg19,17:7579475-7579476","hg19,17:g.7579475_7579476delinsAA",,,,,,,,,,,,,,,,,
248,71,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579475-7579475, hg38,17:7676157-7676157","hg19,17:g.7579475G>A, hg38,17:g.7676157G>A",0.286,"large_intestine, lung, skin","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma",,,,,,,,,,,,,,
249,71,P,R,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,ClinVar,,,"hg19,17:7579475-7579475, hg38,17:7676157-7676157","hg19,17:g.7579475G>C, hg38,17:g.7676157G>C",0.297,,,,,,,237943,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
250,71,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC,ClinVar","bcc_unige_2016, msk_impact_2017, msk_met_2021, thyroid_mskcc_2016","Basal Cell Carcinoma, Mixed Cancer Types, Thyroid","hg19,17:7579476-7579476, hg38,17:7676158-7676158","hg19,17:g.7579476G>A, hg38,17:g.7676158G>A",0.294,"skin, skin, neck, thyroid","adnexal_tumour, sebaceous_adenoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma",,,,,572378,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Hereditary breast ovarian cancer syndrome,1,,,,,,
251,72,P,A,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC,ClinVar","luad_mskcc_2015, msk_ch_2023, paad_tcga, pancan_pdmr_2025","Lung Adenocarcinoma, Mixed Cancer Types, Pancreatic Adenocarcinoma","hg19,17:7579473-7579473, hg38,17:7676155-7676155","hg19,17:g.7579473G>C, hg38,17:g.7676155G>C",0.319,"breast, kidney, large_intestine, large_intestine, colon, right, large_intestine, rectum, lung, ovary, skin, skin, eye, skin, face","Wilms_tumour, adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adnexal_tumour, other, sebaceoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",0.0000119678304717,0.0000318735258494,,,142854,Likely benign,TP53-related disorder;Familial pancreatic carcinoma;Familial pancreatic carcinoma;not provided;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,,,
252,72,P,C,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579472-7579473, hg38,17:7676154-7676155","hg19,17:g.7579472_7579473delinsCA, hg38,17:g.7676154_7676155delinsCA",,extrapulmonary,"carcinoma, small_cell_carcinoma",,,,,182953,Uncertain significance,TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
253,72,P,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,ClinVar,,,"hg19,17:7579472-7579473, hg38,17:7676154-7676155","hg19,17:g.7579472_7579473inv, hg38,17:g.7676154_7676155inv",,,,,,,,1786573,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
254,72,P,H,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC,ClinVar",pancan_pdmr_2025,Mixed Cancer Types,"hg19,17:7579472-7579472, hg38,17:7676154-7676154","hg19,17:g.7579472G>T, hg38,17:g.7676154G>T",0.352,"liver, ovary","carcinoma, carcinoma, hepatocellular_carcinoma",,,,,185120,Benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,3,,,,,,
255,72,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,ClinVar",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7579472-7579472, hg38,17:7676154-7676154","hg19,17:g.7579472G>A, hg38,17:g.7676154G>A",0.341,,,,,,,864652,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
256,72,P,R,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,ClinVar,ClinVar,ClinVar,ClinVar","blca_bcan_hcrn_2022, blca_tcga, blca_tcga_pub, chol_icgc_2017, coadread_dfci_2016, mixed_pipseq_2017, paad_utsw_2015, plmeso_nyu_2015, sclc_cancercell_gardner_2017, stad_tcga, stad_tcga_pub, stes_tcga_pub, thyroid_gatci_2024","Bladder Urothelial Carcinoma, Cholangiocarcinoma, Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Pancreatic Adenocarcinoma, Pleural Mesothelioma, Small Cell Lung Cancer, Stomach Adenocarcinoma, Thyroid","hg19,17:7579468-7579472, hg19,17:7579471-7579472, hg19,17:7579472-7579472, hg19,17:7579472-7579474, hg19,17:7676154-7676154, hg38,17:7676150-7676154, hg38,17:7676153-7676154, hg38,17:7676154-7676154, hg38,17:7676154-7676156","hg19,17:g.7579468_7579472delinsTACGC, hg19,17:g.7579471_7579472delinsAC, hg19,17:g.7579471_7579472delinsTC, hg19,17:g.7579471_7579472inv, hg19,17:g.7579472G>C, hg19,17:g.7579472_7579474delinsCGA, hg19,17:g.7676154G>C, hg38,17:g.7676150_7676154delinsTACGC, hg38,17:g.7676153_7676154delinsAC, hg38,17:g.7676153_7676154delinsTC, hg38,17:g.7676153_7676154inv, hg38,17:g.7676154G>C, hg38,17:g.7676154_7676156delinsCGA",0.368,"biliary_tract, bile_duct, bone, bone, mandible, bone, sacrum, bone, skull, breast, central_nervous_system, brain, central_nervous_system, corpus_callosum, central_nervous_system, frontoparietal, central_nervous_system, posterior_fossa, endometrium, large_intestine, large_intestine, caecum, large_intestine, rectum, liver, lung, lung, left_lower_lobe, lung, right_bronchus, meninges, pancreas, penis, pleura, prostate, skin, skin, arm, skin, face, skin, leg, small_intestine, small_intestine, duodenum, soft_tissue, blood_vessel, central_nervous_system, soft_tissue, fibrous_tissue_and_uncertain_origin, gastrointestinal_tract_(site_indeterminate), soft_tissue, fibrous_tissue_and_uncertain_origin, kidney, soft_tissue, striated_muscle, pelvis, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, bladder, urinary_tract, renal_pelvis","adenoma, tubular, adnexal_tumour, malignant_adnexal_tumour, adnexal_tumour, other, sebaceoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, enteric_adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma_non_invasive, cemento-ossifying_fibroma, chordoma, fibroepithelial_neoplasm, fibroadenoma, gastrointestinal_stromal_tumour, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, ependymoma, myxopapillary, glioma, ependymoma_Grade_III, anaplastic, haemangioblastoma, malignant_melanoma, meningioma, meningioma, atypical, meningioma, fibroblastic, meningioma, transitional, mesothelioma, mesothelioma, epithelial, odontogenic_keratocyst, other, dysplasia-in_situ_neoplasm, other, intestinal_metaplasia, other, neoplasm, rhabdomyosarcoma, embryonal, undifferentiated_sarcoma, pleomorphic",0.6681647999872273,0.6206566172713337,,,"4071424, 3809677, 3728507, 3460311, 237944, 12351","Benign, Benign, Likely benign, Benign, Benign/Likely benign, Benign",Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome|Hepatocellular carcinoma;Lip and oral cavity carcinoma;Hereditary cancer-predisposing syndrome;not specified;not provided;Hereditary breast ovarian cancer syndrome;Acute myeloid leukemia;Li-Fraumeni syndrome 1;TP53 POLYMORPHISM;Li-Fraumeni syndrome,"1, 1, 1, 2, 2, 3",Benign,Neoplasm;Cervical cancer,1,,,
257,72,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar","breast_msk_2025, mel_mskimpact_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, skcm_tcga_pan_can_atlas_2018, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Cutaneous Melanoma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,17:7579472-7579473, hg19,17:7579473-7579473, hg19,17:7579473-7579474, hg38,17:7676154-7676155, hg38,17:7676155-7676155, hg38,17:7676155-7676156","hg19,17:g.7579472_7579473delinsCT, hg19,17:g.7579473G>A, hg19,17:g.7579473_7579474delinsAA, hg38,17:g.7676154_7676155delinsCT, hg38,17:g.7676155G>A, hg38,17:g.7676155_7676156delinsAA",0.314,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, skin, skin, forearm, stomach, urinary_tract, bladder","adnexal_tumour, sebaceous_adenoma, carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, NK-T_cell_lymphoma, malignant_melanoma",0.0000159571072956,,,,"3328172, 485023","Uncertain significance, Conflicting classifications of pathogenicity",Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"1, 1",,,,,,
258,72,P,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,ClinVar,,,"hg19,17:7579473-7579473, hg38,17:7676155-7676155","hg19,17:g.7579473G>T, hg38,17:g.7676155G>T",0.273,,,0.0000039892768239,,,,232750,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
259,73,V,A,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,ClinVar",brca_fuscc_2020,Invasive Breast Carcinoma,"hg19,17:7579469-7579469, hg38,17:7676151-7676151","hg19,17:g.7579469A>G, hg38,17:g.7676151A>G",0.288,,,,,,,2168377,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
260,73,V,E,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579469-7579469, hg38,17:7676151-7676151","hg19,17:g.7579469A>T, hg38,17:g.7676151A>T",0.387,"central_nervous_system, brain","glioma, astrocytoma",,,,,3460312,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
261,73,V,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_pdmr_2025","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579470-7579470, hg38,17:7676152-7676152","hg19,17:g.7579470C>A, hg19,17:g.7579470C>G, hg38,17:g.7676152C>A, hg38,17:g.7676152C>G",0.283,"liver, ovary, urinary_tract, bladder","carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,3634436,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
262,73,V,M,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_ch_2023, msk_met_2021, pancan_mimsi_msk_2024, sarcoma_msk_2022, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7579470-7579470, hg38,17:7676152-7676152","hg19,17:g.7579470C>T, hg38,17:g.7676152C>T",0.370,"large_intestine, rectum, liver, skin, face, urinary_tract, bladder","adnexal_tumour, other, sebaceoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, transitional_cell_carcinoma",0.0000678637296309,0.0000956510649152,,,142386,Benign,Familial pancreatic carcinoma;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,3,,,,,,
263,74,A,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,ClinVar,,,"hg19,17:7579466-7579466, hg38,17:7676148-7676148","hg19,17:g.7579466G>C, hg38,17:g.7676148G>C",0.183,,,,,,,1787901,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
264,74,A,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"cBioPortal,ClinVar","ccle_broad_2019, ccle_broad_2025",Mixed Cancer Types,"hg19,17:7579467-7579467, hg19,17:7676149-7676149, hg38,17:7676149-7676149","hg19,17:g.7579467C>A, hg19,17:g.7676149C>A, hg38,17:g.7676149C>A",0.242,,,,,,,1361776,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
265,74,A,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"cBioPortal,COSMIC,ClinVar","prad_p1000, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018",Prostate Adenocarcinoma,"hg19,17:7579467-7579467, hg19,17:7676149-7676149, hg38,17:7676149-7676149","hg19,17:g.7579467C>T, hg19,17:g.7676149C>T, hg38,17:g.7676149C>T",0.244,"prostate, stomach","carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma",,,,,4552972,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
266,74,A,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579466-7579466, hg38,17:7676148-7676148","hg19,17:g.7579466G>A, hg38,17:g.7676148G>A",0.234,"central_nervous_system, temporal_lobe, oesophagus","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000079830758791,0.0000318694626809,,,141547,Likely benign,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,3,,,,,,
267,75,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,ClinVar,,,"hg19,17:7579463-7579463, hg38,17:7676145-7676145","hg19,17:g.7579463G>A, hg38,17:g.7676145G>A",0.388,,,,,,,836766,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
268,75,P,R,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,COSMIC,,,"hg38,17:7676145-7676145","hg38,17:g.7676145G>C",0.362,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
269,75,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"cBioPortal,COSMIC",sarcoma_msk_2022,Soft Tissue,"hg19,17:7579464-7579464, hg38,17:7676146-7676146","hg19,17:g.7579464G>A, hg38,17:g.7676146G>A",0.349,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
270,75,P,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 69-75, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,ClinVar,,,"hg19,17:7579464-7579464, hg38,17:7676146-7676146","hg19,17:g.7579464G>T, hg38,17:g.7676146G>T",0.315,,,,,,,2003705,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
271,76,A,E,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,cBioPortal,rcc_iatlas_immotion150_2018,Renal Cell Carcinoma,"hg19,17:7676142-7676142","hg19,17:g.7676142G>T",,,,,,,,,,,,,,,,,
272,76,A,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,ClinVar,,,"hg19,17:7579460-7579460, hg38,17:7676142-7676142","hg19,17:g.7579460G>C, hg38,17:g.7676142G>C",0.197,,,,,,,3460333,Benign,Hereditary cancer-predisposing syndrome,1,,,,,,
273,76,A,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579461-7579461, hg38,17:7676143-7676143","hg19,17:g.7579461C>T, hg38,17:g.7676143C>T",0.402,"central_nervous_system, occipital_lobe, stomach","carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,1171287,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
274,76,A,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579460-7579460, hg38,17:7676142-7676142","hg19,17:g.7579460G>A, hg38,17:g.7676142G>A",0.277,"oesophagus, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,,,,1941172,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
275,77,P,A,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579458-7579458, hg38,17:7676140-7676140","hg19,17:g.7579458G>C, hg38,17:g.7676140G>C",0.310,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, prostate","carcinoma, adenocarcinoma, lymphoid_neoplasm, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,1718262,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
276,77,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"cBioPortal,COSMIC,ClinVar","luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,17:7579457-7579457, hg19,17:7676139-7676139, hg38,17:7676139-7676139","hg19,17:g.7579457G>A, hg19,17:g.7676139G>A, hg38,17:g.7676139G>A",0.257,lung,"carcinoma, adenocarcinoma",,,,,4532980,Uncertain significance,not provided,1,,,,,,
277,77,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"cBioPortal,COSMIC,ClinVar",msk_ch_2023,Mixed Cancer Types,"hg19,17:7579458-7579458, hg38,17:7676140-7676140","hg19,17:g.7579458G>A, hg38,17:g.7676140G>A",0.288,"skin, chest_wall","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma",,0.0000637389253617,,,528266,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
278,77,P,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,ClinVar,,,"hg19,17:7579458-7579458, hg38,17:7676140-7676140","hg19,17:g.7579458G>T, hg38,17:g.7676140G>T",0.305,,,0.0000039916972697,,,,458528,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
279,78,A,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,ClinVar,,,"hg19,17:7579454-7579454, hg38,17:7676136-7676136","hg19,17:g.7579454G>C, hg38,17:g.7676136G>C",0.219,,,0.0000039921434617,,,,230368,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
280,78,A,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579455-7579455, hg38,17:7676137-7676137","hg19,17:g.7579455C>A, hg38,17:g.7676137C>A",0.269,"breast, large_intestine","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",,,,,848797,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
281,78,A,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,ClinVar,,,"hg19,17:7579455-7579455, hg38,17:7676137-7676137","hg19,17:g.7579455C>T, hg38,17:g.7676137C>T",0.322,,,,,,,485045,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
282,78,A,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579454-7579454, hg38,17:7676136-7676136","hg19,17:g.7579454G>A, hg38,17:g.7676136G>A",0.266,"breast, oesophagus","carcinoma, carcinoma, squamous_cell_carcinoma",,,,,1401526,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
283,79,A,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,ClinVar,,,"hg19,17:7579451-7579451, hg38,17:7676133-7676133","hg19,17:g.7579451G>C, hg38,17:g.7676133G>C",0.358,,,,,,,655254,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
284,79,A,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC",mds_iwg_2022,Myelodysplastic Syndromes,"hg19,17:7579452-7579452, hg38,17:7676134-7676134","hg19,17:g.7579452C>T, hg38,17:g.7676134C>T",0.359,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
285,79,A,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC,ClinVar","coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018","Colon Adenocarcinoma, Colorectal Adenocarcinoma","hg19,17:7579451-7579451, hg19,17:7676133-7676133, hg38,17:7676133-7676133","hg19,17:g.7579451G>A, hg19,17:g.7676133G>A, hg38,17:g.7676133G>A",0.399,"large_intestine, colon, sigmoid, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,4189271,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
286,80,P,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,cBioPortal,"lung_msk_mind_2020, msk_chord_2024","Lung, Mixed Cancer Types","hg19,17:7579449-7579449","hg19,17:g.7579449G>C",0.427,,,,,,,,,,,,,,,,
287,80,P,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,cBioPortal,crc_sysucc_2022,Colorectal Adenocarcinoma,"hg19,17:7579448-7579448","hg19,17:g.7579448G>T",0.447,,,,,,,,,,,,,,,,
288,80,P,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC,ClinVar",mel_dfci_2019,Melanoma,"hg19,17:7579448-7579448, hg38,17:7676130-7676130","hg19,17:g.7579448G>A, hg38,17:g.7676130G>A",0.419,"cervix, large_intestine, pancreas, skin, head_neck","carcinoma, adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, other, dysplasia-in_situ_neoplasm",,,,,1790682,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
289,80,P,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 74-80, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC,ClinVar",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,17:7579449-7579449, hg38,17:7676131-7676131","hg19,17:g.7579449G>A, hg38,17:g.7676131G>A",0.493,"lung, skin, head_neck","carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,406593,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
290,81,T,I,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579445-7579445, hg38,17:7676127-7676127","hg19,17:g.7579445G>A, hg38,17:g.7676127G>A",0.305,"central_nervous_system, brain, pancreas, skin, eye, skin, knee","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, ductal_carcinoma, glioma, astrocytoma_Grade_I, pilocytic, other, normal",,,,,583101,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
291,82,P,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,ClinVar,,,"hg19,17:7579443-7579443, hg38,17:7676125-7676125","hg19,17:g.7579443G>C, hg38,17:g.7676125G>C",0.367,,,,,,,482216,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;not provided;Hereditary cancer-predisposing syndrome,1,,,,,,
292,82,P,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC,ClinVar","blca_iatlas_imvigor210_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, prad_p1000, prad_tcga, prad_tcga_pan_can_atlas_2018, sarcoma_mskcc_2022, ucec_ccr_msk_2022","Bladder Urothelial Carcinoma, Endometrial Carcinoma, Mixed Cancer Types, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7579442-7579442, hg19,17:7676124-7676124, hg38,17:7676124-7676124","hg19,17:g.7579442G>A, hg19,17:g.7676124G>A, hg38,17:g.7676124G>A",0.570,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, rectum, prostate, salivary_gland, parotid, skin, skin, face, soft_tissue, smooth_muscle, upper_aerodigestive_tract, pharynx, oropharynx","adenoma, myoepithelial, adenoma, pleomorphic, adnexal_tumour, other, sebaceoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, leiomyosarcoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia",0.0000199643835398,,,,182946,Likely benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck;Malignant tumor of breast,3,,,,,,
293,82,P,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,ClinVar,,,"hg19,17:7579442-7579442, hg38,17:7676124-7676124","hg19,17:g.7579442G>C, hg38,17:g.7676124G>C",0.549,,,,,,,458530,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
294,82,P,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579443-7579443, hg38,17:7676125-7676125","hg19,17:g.7579443G>A, hg38,17:g.7676125G>A",0.449,thyroid,"carcinoma, anaplastic_carcinoma",,,,,1021579,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
295,83,A,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579439-7579439, hg38,17:7676121-7676121","hg19,17:g.7579439G>T, hg38,17:g.7676121G>T",0.400,skin,"other, keratosis",0.0000039941206544,,,,141956,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
296,83,A,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,ClinVar",msk_met_2021,Mixed Cancer Types,"hg19,17:7579440-7579440, hg38,17:7676122-7676122","hg19,17:g.7579440C>G, hg38,17:g.7676122C>G",0.380,,,,,,,3972448,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
297,83,A,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,ClinVar",pancan_pdmr_2025,Mixed Cancer Types,"hg19,17:7579440-7579440, hg38,17:7676122-7676122","hg19,17:g.7579440C>A, hg38,17:g.7676122C>A",0.299,,,,,,,3898631,Uncertain significance,not provided,1,,,,,,
298,83,A,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7579440-7579440, hg38,17:7676122-7676122","hg19,17:g.7579440C>T, hg38,17:g.7676122C>T",0.356,stomach,"carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable",,,,,2029805,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
299,83,A,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 78-83, ggetELM|SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_chord_2024, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7579439-7579439, hg38,17:7676121-7676121","hg19,17:g.7579439G>A, hg38,17:g.7676121G>A",0.377,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0001397942229039,,,,127805,Conflicting classifications of pathogenicity,TP53-related disorder;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
300,84,A,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,COSMIC,,,"hg38,17:7676118-7676118","hg38,17:g.7676118G>C",0.403,"large_intestine, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
301,84,A,N,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,ClinVar,,,"hg19,17:7579436-7579437, hg38,17:7676118-7676119","hg19,17:g.7579436_7579437delinsTT, hg38,17:g.7676118_7676119delinsTT",,,,,,,,2708097,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
302,84,A,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, msk_chord_2024, msk_met_2021","Breast, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579437-7579437, hg38,17:7676119-7676119","hg19,17:g.7579437C>T, hg38,17:g.7676119C>T",0.404,"skin, face","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma",0.0000119813091577,,,,140833,Likely benign,Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
303,84,A,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579436-7579436, hg38,17:7676117-7676118, hg38,17:7676118-7676118","hg19,17:g.7579436G>A, hg38,17:g.7676117_7676118delinsAA, hg38,17:g.7676118G>A",0.438,"central_nervous_system, brain, central_nervous_system, occipital_lobe, haematopoietic_and_lymphoid_tissue, skin, skin, head_neck, small_intestine, ileum","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, glioma, astrocytoma_Grade_I, pilocytic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia",,,,,1792511,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome",1,,,,,,
304,85,P,A,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,ClinVar",cfdna_msk_2019,Mixed Cancer Types,"hg19,17:7579434-7579434, hg38,17:7676116-7676116","hg19,17:g.7579434G>C, hg38,17:g.7676116G>C",0.397,,,,,,,2831218,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
305,85,P,L,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579433-7579433, hg38,17:7676115-7676115","hg19,17:g.7579433G>A, hg38,17:g.7676115G>A",0.436,"central_nervous_system, brain, skin","carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,2811095,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
306,85,P,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC,ClinVar","bcc_unige_2016, difg_glass, difg_glass_2019, lgg_ucsf_2014, metastatic_solid_tumors_mich_2017","Basal Cell Carcinoma, Diffuse Glioma, Mixed Cancer Types","hg19,17:7579434-7579434, hg19,17:7579434-7579435, hg38,17:7676116-7676116, hg38,17:7676116-7676117","hg19,17:g.7579434G>A, hg19,17:g.7579434_7579435delinsAA, hg38,17:g.7676116G>A, hg38,17:g.7676116_7676117delinsAA",0.459,"central_nervous_system, brain, skin, skin, face, upper_aerodigestive_tract, mouth, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,923486,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
307,85,P,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 79-85, ggetELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,17:7579434-7579434, hg38,17:7676116-7676116","hg19,17:g.7579434G>T, hg38,17:g.7676116G>T",0.455,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
308,86,A,E,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,COSMIC,,,,,,"central_nervous_system, brain","glioma, oligodendroglioma_Grade_III, anaplastic",,,,,,,,,,,,,,
309,86,A,G,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,cBioPortal,egc_msk_2017,Esophagogastric Adenocarcinoma,"hg19,17:7579430-7579430","hg19,17:g.7579430G>C",0.376,,,,,,,,,,,,,,,,
310,86,A,P,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,ClinVar",coadread_mskcc,Colorectal Adenocarcinoma,"hg19,17:7579431-7579431, hg38,17:7676113-7676113","hg19,17:g.7579431C>G, hg38,17:g.7676113C>G",0.473,,,,,,,1793227,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
311,86,A,S,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7579431-7579431","hg19,17:g.7579431C>A",0.364,"central_nervous_system, parietal_lobe","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
312,86,A,T,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579431-7579431, hg38,17:7676113-7676113","hg19,17:g.7579431C>T, hg38,17:g.7676113C>T",0.427,autonomic_ganglia,neuroblastoma,,,,,141967,Conflicting classifications of pathogenicity,Familial pancreatic carcinoma;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,1,,,,,,
313,86,A,V,,,,,,,,,,,,"SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7579430-7579430, hg38,17:7676112-7676112","hg19,17:g.7579430G>A, hg38,17:g.7676112G>A",0.389,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,,654187,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
314,87,P,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,ClinVar,,,"hg19,17:7579428-7579428, hg38,17:7676110-7676110","hg19,17:g.7579428G>C, hg38,17:g.7676110G>C",0.361,,,,,,,2861491,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
315,87,P,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_chord_2024, msk_met_2021",Mixed Cancer Types,"hg19,17:7579427-7579427, hg38,17:7676109-7676109","hg19,17:g.7579427G>A, hg38,17:g.7676109G>A",0.442,"salivary_gland, parotid","carcinoma, salivary_duct_carcinoma",,,,,942021,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
316,87,P,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,COSMIC,,,"hg38,17:7676109-7676109","hg38,17:g.7676109G>T",0.356,"central_nervous_system, brain, skin, chest, skin, face, skin, hand, skin, lower_leg, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, squamous_cell_carcinoma, gastrointestinal_stromal_tumour, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
317,87,P,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,ClinVar,,,"hg19,17:7579427-7579427, hg38,17:7676109-7676109","hg19,17:g.7579427G>C, hg38,17:g.7676109G>C",0.385,,,,,,,1793771,Uncertain significance,Hereditary cancer-predisposing syndrome,2,,,,,,
318,87,P,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_met_2021, pancan_mimsi_msk_2024, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7579428-7579428, hg38,17:7676110-7676110","hg19,17:g.7579428G>A, hg38,17:g.7676110G>A",0.457,skin,malignant_melanoma,,,,,2831109,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
319,88,A,G,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,ClinVar,,,"hg19,17:7579424-7579424, hg38,17:7676106-7676106","hg19,17:g.7579424G>C, hg38,17:g.7676106G>C",0.513,,,,,,,1343497,Uncertain significance,not specified,1,,,,,,
320,88,A,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,ClinVar,,,"hg19,17:7579425-7579425, hg38,17:7676107-7676107","hg19,17:g.7579425C>G, hg38,17:g.7676107C>G",0.554,,,,,,,629276,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
321,88,A,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,ClinVar,,,"hg19,17:7579424-7579424, hg38,17:7676106-7676106","hg19,17:g.7579424G>A, hg38,17:g.7676106G>A",0.510,,,,,,,480734,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
322,89,P,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,COSMIC,,,"hg38,17:7676103-7676104","hg38,17:g.7676103_7676104delinsAA",,skin,malignant_melanoma,,,,,,,,,,,,,,
323,89,P,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,COSMIC,ClinVar","mel_dfci_2019, mel_iatlas_liu_2019, mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Melanoma, Mixed Cancer Types","hg19,17:7579421-7579421, hg19,17:7676103-7676103, hg38,17:7676103-7676103","hg19,17:g.7579421G>A, hg19,17:g.7676103G>A, hg38,17:g.7676103G>A",0.362,", skin, arm","malignant_melanoma, other, keratosis",,,,,182923,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
324,89,P,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,17:7579422-7579422, hg38,17:7676104-7676104","hg19,17:g.7579422G>A, hg38,17:g.7676104G>A",0.485,"oesophagus, skin, skin, face, urinary_tract, bladder","adnexal_tumour, sebaceous_adenoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, transitional_cell_carcinoma, malignant_melanoma, spitzoid",,,,,,,,,,,,,,
325,89,P,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,ClinVar,,,"hg19,17:7579422-7579422, hg38,17:7676104-7676104","hg19,17:g.7579422G>T, hg38,17:g.7676104G>T",0.432,,,,,,,821636,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome,1,,,,,,
326,90,S,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,COSMIC,ClinVar","bm_nsclc_mskcc_2023, ccle_broad_2025, luad_mskcc_2023_met_organotropism, mixed_cfdna_msk_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, sarcoma_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7579418-7579418, hg19,17:7676100-7676100, hg38,17:7676100-7676100","hg19,17:g.7579418G>A, hg19,17:g.7676100G>A, hg38,17:g.7676100G>A",0.459,"haematopoietic_and_lymphoid_tissue, skin, skin, skin, knee, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,528268,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
327,90,S,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,COSMIC,,,"hg38,17:7676100-7676101","hg38,17:g.7676100_7676101delinsAG",,large_intestine,"adenoma, tubular",,,,,,,,,,,,,,
328,90,S,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,17:7579419-7579419","hg19,17:g.7579419A>G",0.433,,,,,,,,,,,,,,,,
329,90,S,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,COSMIC",paac_jhu_2014,Acinar Cell Carcinoma of the Pancreas,"hg19,17:7579419-7579419, hg38,17:7676101-7676101","hg19,17:g.7579419A>T, hg38,17:g.7676101A>T",0.450,"large_intestine, colon, left, pancreas","carcinoma, acinar_carcinoma, carcinoma, adenocarcinoma",,,,,,,,,,,,,,
330,91,W,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
331,91,W,C,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
332,91,W,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
333,91,W,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
334,91,W,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
335,91,W,G,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
336,91,W,H,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
337,91,W,I,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
338,91,W,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
339,91,W,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
340,91,W,M,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
341,91,W,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
342,91,W,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
343,91,W,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
344,91,W,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579416-7579416, hg38,17:7676098-7676098","hg19,17:g.7579416A>G, hg38,17:g.7676098A>G",0.507,,,,,,,845798,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
345,91,W,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7579415-7579415, hg38,17:7676097-7676097","hg19,17:g.7579415C>G, hg38,17:g.7676097C>G",0.485,,,,,,,3232053,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
346,91,W,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
347,91,W,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
348,91,W,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 87-91, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
349,92,P,A,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676095-7676095","hg38,17:g.7676095G>C",0.509,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, Burkitt_lymphoma",,,,,,,,,,,,,,
350,92,P,C,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
351,92,P,D,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
352,92,P,E,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
353,92,P,F,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
354,92,P,G,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
355,92,P,H,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",crc_hta11_htan_2021,Colorectal Adenocarcinoma,"hg19,17:7579412-7579412, hg38,17:7676094-7676094","hg19,17:g.7579412G>T, hg38,17:g.7676094G>T",0.452,breast,"carcinoma, ductal_carcinoma",,,,,3634435,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
356,92,P,I,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
357,92,P,K,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
358,92,P,L,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579412-7579412, hg38,17:7676094-7676094","hg19,17:g.7579412G>A, hg38,17:g.7676094G>A",0.487,"skin, head_neck","in_situ_epithelial_neoplasm, actinic_keratosis",0.0000039932274862,,,,480733,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Familial cancer of breast;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
359,92,P,M,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
360,92,P,N,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
361,92,P,Q,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
362,92,P,R,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
363,92,P,S,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7579413-7579413, hg19,17:7676095-7676095","hg19,17:g.7579413G>A, hg19,17:g.7676095G>A",0.502,,,,,,,,,,,,,,,,
364,92,P,T,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",brca_metabric,Invasive Breast Carcinoma,"hg19,17:7579413-7579413, hg38,17:7676095-7676095","hg19,17:g.7579413G>T, hg38,17:g.7676095G>T",0.434,"large_intestine, colon, left","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
365,92,P,V,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
366,92,P,W,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
367,92,P,Y,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM|SH3 domain ligands (LIG_SH3_3), 86-92, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
368,93,L,A,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
369,93,L,C,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
370,93,L,D,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
371,93,L,E,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
372,93,L,F,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
373,93,L,G,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
374,93,L,H,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
375,93,L,I,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
376,93,L,K,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
377,93,L,M,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676092-7676092","hg38,17:g.7676092G>T",0.369,lung,"carcinoma, large_cell_carcinoma",,,,,,,,,,,,,,
378,93,L,N,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
379,93,L,P,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",blca_bcan_hcrn_2022,Bladder Urothelial Carcinoma,"hg19,17:7579409-7579409, hg38,17:7676091-7676091","hg19,17:g.7579409A>G, hg38,17:g.7676091A>G",0.454,,,,,,,3359424,Uncertain significance,not specified;not provided,2,,,,,,
380,93,L,Q,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676091-7676091","hg38,17:g.7676091A>T",0.469,lung,"carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
381,93,L,R,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579409-7579409, hg38,17:7676091-7676091","hg19,17:g.7579409A>C, hg38,17:g.7676091A>C",0.498,,,,,,,2825997,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
382,93,L,S,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
383,93,L,T,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
384,93,L,V,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7579410-7579410","hg19,17:g.7579410G>C",0.523,,,,,,,,,,,,,,,,
385,93,L,W,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
386,93,L,Y,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
387,94,S,A,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579407-7579407, hg38,17:7676089-7676089","hg19,17:g.7579407A>C, hg38,17:g.7676089A>C",0.476,,,,,,,3460308,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
388,94,S,C,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
389,94,S,D,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
390,94,S,E,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
391,94,S,F,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
392,94,S,G,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
393,94,S,H,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
394,94,S,I,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
395,94,S,K,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
396,94,S,L,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","mel_mskimpact_2020, mixed_allen_2018, msk_met_2021, pancan_pdmr_2025","Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7579406-7579406, hg38,17:7676088-7676088","hg19,17:g.7579406G>A, hg38,17:g.7676088G>A",0.553,"lung, skin, face","adnexal_tumour, other, sebaceoma, carcinoma, adenocarcinoma",,,,,1796426,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
397,94,S,M,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
398,94,S,N,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
399,94,S,P,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676089-7676089","hg38,17:g.7676089A>G",0.528,breast,"carcinoma, ER-positive_carcinoma",,,,,,,,,,,,,,
400,94,S,Q,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
401,94,S,R,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
402,94,S,T,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579407-7579407, hg38,17:7676089-7676089","hg19,17:g.7579407A>T, hg38,17:g.7676089A>T",0.533,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine","adenoma, lymphoid_neoplasm",,,,,3634434,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
403,94,S,V,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
404,94,S,W,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
405,94,S,Y,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
406,95,S,A,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
407,95,S,C,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
408,95,S,D,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
409,95,S,E,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
410,95,S,F,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, cscc_ucsf_2021, sarcoma_msk_2022","Cutaneous Squamous Cell Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7579403-7579403, hg19,17:7676085-7676085, hg38,17:7676085-7676085","hg19,17:g.7579403G>A, hg19,17:g.7676085G>A, hg38,17:g.7676085G>A",0.751,"meninges, skin, arm, skin, face, skin, hand, skin, leg","carcinoma, squamous_cell_carcinoma, meningioma, other, keratosis",,,,,1796813,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
411,95,S,G,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
412,95,S,H,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
413,95,S,I,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
414,95,S,K,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
415,95,S,L,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
416,95,S,M,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
417,95,S,N,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
418,95,S,P,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
419,95,S,Q,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
420,95,S,R,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
421,95,S,T,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",blca_iatlas_imvigor210_2017,Bladder Urothelial Carcinoma,"hg19,17:7579404-7579404, hg19,17:7676086-7676086, hg38,17:7676086-7676086","hg19,17:g.7579404A>T, hg19,17:g.7676086A>T, hg38,17:g.7676086A>T",0.584,,,,,,,4189261,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
422,95,S,V,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
423,95,S,W,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
424,95,S,Y,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
425,96,S,A,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
426,96,S,C,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676082-7676082","hg38,17:g.7676082G>C",0.497,"urinary_tract, bladder",carcinoma,,,,,,,,,,,,,,
427,96,S,D,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
428,96,S,E,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
429,96,S,F,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,17:7579400-7579400, hg38,17:7676082-7676082","hg19,17:g.7579400G>A, hg38,17:g.7676082G>A",0.401,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, skin, skin, face, urinary_tract, bladder","adnexal_tumour, other, sebaceoma, adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,,,,,,,,,,
430,96,S,G,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
431,96,S,H,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
432,96,S,I,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
433,96,S,K,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
434,96,S,L,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
435,96,S,M,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
436,96,S,N,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
437,96,S,P,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676083-7676083","hg38,17:g.7676083A>G",0.522,"skin, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,,,,,,,,,,
438,96,S,Q,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
439,96,S,R,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
440,96,S,T,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
441,96,S,V,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
442,96,S,W,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
443,96,S,Y,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 92-96, ggetELM|USP7 binding motif (DOC_USP7_MATH_1), 92-96, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","crc_eo_2020, crc_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024","Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7579400-7579400, hg38,17:7676082-7676082","hg19,17:g.7579400G>T, hg38,17:g.7676082G>T",0.565,"large_intestine, colon, sigmoid, pleura","carcinoma, adenocarcinoma, mesothelioma",,,,,,,,,,,,,,
444,97,V,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",coad_silu_2022,Colon Adenocarcinoma,"hg19,17:7579397-7579397, hg38,17:7676079-7676079","hg19,17:g.7579397A>G, hg38,17:g.7676079A>G",0.854,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, penis","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,1797574,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
445,97,V,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
446,97,V,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018","Lung Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,17:7579397-7579397, hg19,17:7676079-7676079, hg38,17:7676079-7676079","hg19,17:g.7579397A>T, hg19,17:g.7676079A>T, hg38,17:g.7676079A>T",0.937,stomach,"carcinoma, adenocarcinoma",,,,,182924,Uncertain significance,not provided;Hereditary cancer-predisposing syndrome,2,,,,,,
447,97,V,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
448,97,V,F,,,,,,,,,,,,,,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","luad_msk_npjpo_2021, msk_chord_2024, msk_met_2021, nsclc_tracerx_2017","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579398-7579398, hg38,17:7676080-7676080","hg19,17:g.7579398C>A, hg38,17:g.7676080C>A",0.789,,,,,,,458532,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
449,97,V,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
450,97,V,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
451,97,V,I,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579398-7579398, hg38,17:7676080-7676080","hg19,17:g.7579398C>T, hg38,17:g.7676080C>T",0.593,"eye, uveal_tract, skin, face, urinary_tract","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, transitional_cell_carcinoma, malignant_melanoma",0.0000000000000000,,,,1026336,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
452,97,V,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
453,97,V,L,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579398-7579398, hg38,17:7676080-7676080","hg19,17:g.7579398C>G, hg38,17:g.7676080C>G",0.701,,,,,,,182962,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
454,97,V,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
455,97,V,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
456,97,V,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
457,97,V,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
458,97,V,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
459,97,V,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
460,97,V,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
461,97,V,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
462,97,V,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
463,98,P,A,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579395-7579395, hg38,17:7676077-7676077","hg19,17:g.7579395G>C, hg38,17:g.7676077G>C",0.935,,,,,,,1039474,Uncertain significance,not provided;Li-Fraumeni syndrome,2,,,,,,
464,98,P,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
465,98,P,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
466,98,P,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
467,98,P,F,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676076-7676077","hg38,17:g.7676076_7676077delinsAA",,,malignant_melanoma,,,,,,,,,,,,,,
468,98,P,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
469,98,P,H,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7579394-7579394","hg19,17:g.7579394G>T",0.953,,,,,,,,,,,,,,,,
470,98,P,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
471,98,P,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
472,98,P,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, glioma_mskcc_2019, nsclc_ctdx_msk_2022, pan_origimed_2020, sarcoma_msk_2022","Basal Cell Carcinoma, Diffuse Glioma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7579394-7579394, hg19,17:7676076-7676076, hg38,17:7676076-7676076","hg19,17:g.7579394G>A, hg19,17:g.7676076G>A, hg38,17:g.7676076G>A",0.943,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, oesophagus, skin, skin, face, skin, leg, skin, neck, urinary_tract","adnexal_tumour, sebaceous_adenoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, NK-T_cell_lymphoma, other, keratosis",0.0000039800361387,,,,528236,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
473,98,P,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
474,98,P,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
475,98,P,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
476,98,P,R,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579394-7579394, hg38,17:7676076-7676076","hg19,17:g.7579394G>C, hg38,17:g.7676076G>C",0.955,,,,,,,1444043,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
477,98,P,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, ccle_broad_2025, difg_glass, difg_glass_2019, luad_mskcc_2023_met_organotropism, mds_iwg_2022, mel_mskimpact_2020, mixed_allen_2018, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pog570_bcgsc_2020, sarcoma_msk_2022, tmb_mskcc_2018","Basal Cell Carcinoma, Cutaneous Melanoma, Diffuse Glioma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7579395-7579395, hg19,17:7579395-7579396, hg19,17:7676077-7676077, hg38,17:7676077-7676077, hg38,17:7676077-7676078","hg19,17:g.7579395G>A, hg19,17:g.7579395_7579396delinsAA, hg19,17:g.7676077G>A, hg38,17:g.7676077G>A, hg38,17:g.7676077_7676078delinsAA",0.952,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, kidney, oesophagus, skin, skin, face, skin, knee, skin, lip","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adnexal_tumour, other, sebaceoma, adnexal_tumour, sebaceous_adenoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, lymphoid_neoplasm, NK-T_cell_lymphoma, malignant_melanoma",,,,,822279,Uncertain significance,Familial cancer of breast;Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
478,98,P,T,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579395-7579395, hg38,17:7676077-7676077","hg19,17:g.7579395G>T, hg38,17:g.7676077G>T",0.957,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",,,,,1465351,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
479,98,P,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
480,98,P,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
481,98,P,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
482,99,S,A,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
483,99,S,C,P,,,,,,,,,,PhosphoSite,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579391-7579391, hg38,17:7676073-7676073","hg19,17:g.7579391G>C, hg38,17:g.7676073G>C",0.729,,,,,,,566954,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
484,99,S,D,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
485,99,S,E,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
486,99,S,F,P,,,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, sarcoma_msk_2022","Basal Cell Carcinoma, Soft Tissue","hg19,17:7579391-7579391, hg38,17:7676073-7676073","hg19,17:g.7579391G>A, hg38,17:g.7676073G>A",0.748,"endometrium, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, skin, ovary, skin, skin, trunk, small_intestine, jejunum, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, low_malignant_potential_(borderline)_tumour, mucinous, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, malignant_melanoma",,,,,579376,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
487,99,S,G,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
488,99,S,H,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
489,99,S,I,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
490,99,S,K,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
491,99,S,L,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
492,99,S,M,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
493,99,S,N,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
494,99,S,P,P,,,,,,,,,,PhosphoSite,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676074-7676074","hg38,17:g.7676074A>G",0.730,"ovary, stomach","carcinoma, adenocarcinoma, carcinoma, serous_carcinoma",,,,,,,,,,,,,,
495,99,S,Q,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
496,99,S,R,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
497,99,S,T,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
498,99,S,V,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
499,99,S,W,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
500,99,S,Y,P,,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
501,100,Q,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
502,100,Q,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
503,100,Q,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
504,100,Q,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
505,100,Q,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
506,100,Q,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
507,100,Q,H,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676069-7676069","hg38,17:g.7676069C>G",0.417,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
508,100,Q,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
509,100,Q,K,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676071-7676071","hg38,17:g.7676071G>T",0.541,"kidney, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, papillary_renal_cell_carcinoma",,,,,,,,,,,,,,
510,100,Q,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
511,100,Q,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
512,100,Q,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
513,100,Q,P,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579388-7579388, hg38,17:7676070-7676070","hg19,17:g.7579388T>G, hg38,17:g.7676070T>G",0.398,,,,,,,4189274,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
514,100,Q,R,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
515,100,Q,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
516,100,Q,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
517,100,Q,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
518,100,Q,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
519,100,Q,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
520,101,K,A,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
521,101,K,C,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
522,101,K,D,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
523,101,K,E,,,Ubq,,,,,,,,PhosphoSite,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579386-7579386, hg38,17:7676068-7676068","hg19,17:g.7579386T>C, hg38,17:g.7676068T>C",0.503,,,,,,,1059163,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
524,101,K,F,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
525,101,K,G,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
526,101,K,H,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
527,101,K,I,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
528,101,K,L,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
529,101,K,M,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
530,101,K,N,,,Ubq,,,,,,,,PhosphoSite,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579384-7579384, hg38,17:7676066-7676066","hg19,17:g.7579384T>A, hg38,17:g.7676066T>A",0.340,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified",,,,,237947,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
531,101,K,P,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
532,101,K,Q,,,Ubq,,,,,,,,PhosphoSite,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579386-7579386, hg38,17:7676068-7676068","hg19,17:g.7579386T>G, hg38,17:g.7676068T>G",0.496,,,,,,,649735,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
533,101,K,R,,,Ubq,,,,,,,,PhosphoSite,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676067-7676067","hg38,17:g.7676067T>C",0.533,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, urinary_tract, bladder","carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,,,,,,,,,,
534,101,K,S,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
535,101,K,T,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
536,101,K,V,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
537,101,K,W,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
538,101,K,Y,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
539,102,T,A,,,,,,,,,,,,,,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024","Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7579383-7579383, hg38,17:7676065-7676065","hg19,17:g.7579383T>C, hg38,17:g.7676065T>C",0.540,,,,,,,1799231,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
540,102,T,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
541,102,T,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
542,102,T,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
543,102,T,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
544,102,T,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
545,102,T,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
546,102,T,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",nsclc_unito_2016,Non-Small Cell Lung Cancer,"hg19,17:7579382-7579382, hg38,17:7676064-7676064","hg19,17:g.7579382G>A, hg38,17:g.7676064G>A",0.540,"adrenal_gland, adrenal_gland, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, oesophagus, skin, knee","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adrenal_cortical_adenoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma, pheochromocytoma",,,,,186132,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
547,102,T,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
548,102,T,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
549,102,T,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
550,102,T,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
551,102,T,P,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676065-7676065","hg38,17:g.7676065T>G",0.542,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
552,102,T,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
553,102,T,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
554,102,T,S,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579383-7579383, hg38,17:7676065-7676065","hg19,17:g.7579383T>A, hg38,17:g.7676065T>A",0.506,breast,"carcinoma, ductal_carcinoma",,,,,582041,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
555,102,T,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
556,102,T,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
557,102,T,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
558,103,Y,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
559,103,Y,C,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv","mel_iatlas_riaz_nivolumab_2017, msk_met_2021, pan_origimed_2020","Melanoma, Mixed Cancer Types","hg19,17:7579379-7579379, hg19,17:7676061-7676061","hg19,17:g.7579379T>C, hg19,17:g.7676061T>C",0.870,,,,,,,,,,,,,,,,
560,103,Y,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
561,103,Y,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
562,103,Y,F,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676061-7676061","hg38,17:g.7676061T>A",0.775,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,,,,,,,,,,
563,103,Y,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
564,103,Y,H,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, msk_chord_2024, msk_met_2021","Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579380-7579380","hg19,17:g.7579380A>G",0.870,,,,,,,,,,,,,,,,
565,103,Y,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
566,103,Y,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
567,103,Y,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
568,103,Y,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
569,103,Y,N,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7579380-7579380","hg19,17:g.7579380A>T",0.906,,,,,,,,,,,,,,,,
570,103,Y,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
571,103,Y,Q,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579378-7579380, hg38,17:7676060-7676062","hg19,17:g.7579378_7579380delinsCTG, hg38,17:g.7676060_7676062delinsCTG",,,,,,,,3010803,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
572,103,Y,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
573,103,Y,S,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579379-7579379, hg38,17:7676061-7676061","hg19,17:g.7579379T>G, hg38,17:g.7676061T>G",0.904,,,,,,,2729592,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
574,103,Y,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
575,103,Y,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
576,103,Y,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
577,104,Q,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
578,104,Q,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
579,104,Q,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
580,104,Q,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
581,104,Q,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
582,104,Q,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
583,104,Q,H,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, sarcoma_msk_2022","Lung Adenocarcinoma, Soft Tissue","hg19,17:7579375-7579375, hg19,17:7676057-7676057, hg38,17:7676057-7676057","hg19,17:g.7579375C>A, hg19,17:g.7676057C>A, hg38,17:g.7676057C>G",0.336,"adrenal_gland, adrenal_gland",adrenal_cortical_adenoma,,,,,,,,,,,,,,
584,104,Q,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
585,104,Q,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
586,104,Q,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7579376-7579376, hg38,17:7676058-7676058","hg19,17:g.7579376T>A, hg38,17:g.7676058T>A",0.520,urinary_tract,"carcinoma, transitional_cell_carcinoma",,,,,945802,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
587,104,Q,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
588,104,Q,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
589,104,Q,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
590,104,Q,R,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",mbn_sfu_2023,Mature B-Cell Neoplasms,"hg19,17:7676058-7676058","hg19,17:g.7676058T>C",,,,,,,,,,,,,,,,,
591,104,Q,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
592,104,Q,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
593,104,Q,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
594,104,Q,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
595,104,Q,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
596,105,G,A,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","heme_msk_impact_2022, mbn_msk_2024, msk_chord_2024, pancan_hcmi_2025, pancan_pdmr_2025","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,17:7579372-7579373, hg19,17:7579373-7579373, hg19,17:7676055-7676055, hg38,17:7676054-7676055, hg38,17:7676055-7676055","hg19,17:g.7579372_7579373delinsTG, hg19,17:g.7579373C>G, hg19,17:g.7676055C>G, hg38,17:g.7676054_7676055delinsTG, hg38,17:g.7676055C>G",0.905,", kidney, lung","carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, malignant_melanoma",,,,,"2035647, 822977","Uncertain significance, Uncertain significance",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome,"1, 1",,,,,,
597,105,G,C,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, crc_eo_2020, crc_msk_2017, hcc_clca_2024, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lihc_amc_prv, luad_broad, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024, rectal_radiation_msk_2024, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7579374-7579374, hg19,17:7676056-7676056, hg38,17:7676056-7676056","hg19,17:g.7579374C>A, hg19,17:g.7676056C>A, hg38,17:g.7676056C>A",0.942,"biliary_tract, bile_duct, extrapulmonary, large_intestine, caecum, large_intestine, rectum, lung, ovary, pancreas, prostate, small_intestine, ileum, thyroid, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
598,105,G,D,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, coad_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, mbn_sfu_2023, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022","Acute Myeloid Leukemia, Colon Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7579373-7579373, hg19,17:7676055-7676055, hg38,17:7676055-7676055","hg19,17:g.7579373C>T, hg19,17:g.7676055C>T, hg38,17:g.7676055C>T",0.884,"haematopoietic_and_lymphoid_tissue, lung, stomach, gastroesophageal_junction, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, Burkitt_lymphoma",0.0000000000000000,,,,141114,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,Tier I - Strong,Medulloblastoma SHH activated,1
599,105,G,E,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
600,105,G,F,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","luad_cptac_2020, mixed_kunga_msk_2022, msk_chord_2024, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579373-7579374","hg19,17:g.7579373_7579374delinsAA",,,,,,,,,,,,,,,,,
601,105,G,H,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
602,105,G,I,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
603,105,G,K,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
604,105,G,L,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
605,105,G,M,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
606,105,G,N,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
607,105,G,P,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
608,105,G,Q,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
609,105,G,R,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, difg_glass, difg_glass_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gct_msk_2020, heme_msk_impact_2022, hgsoc_tcga_gdc, lgggbm_tcga_pub, luad_msk_npjpo_2021, luad_mskcc_2020, lusc_cptac_2021, lusc_cptac_gdc, mds_mskcc_2020, mixed_selpercatinib_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_hcmi_2025, pancreas_cptac_gdc","Diffuse Glioma, High-Grade Serous Ovarian Cancer, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Testis","hg19,17:7579374-7579374, hg19,17:7676056-7676056, hg38,17:7676056-7676056","hg19,17:g.7579374C>G, hg19,17:g.7676056C>G, hg38,17:g.7676056C>G",0.918,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lung, ovary","carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,406574,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
610,105,G,S,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga_pub, pancan_hcmi_2025, sarcoma_msk_2022","High-Grade Serous Ovarian Cancer, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7579374-7579374, hg19,17:7676056-7676056, hg38,17:7676056-7676056","hg19,17:g.7579374C>T, hg19,17:g.7676056C>T, hg38,17:g.7676056C>T",0.883,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lung, oesophagus, ovary, skin, urinary_tract, bladder","carcinoma, Merkel_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,428884,Pathogenic/Likely pathogenic,"Adrenal cortex carcinoma;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary",2,,,,,,
611,105,G,T,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
612,105,G,V,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_mskcc_solit_2014, bm_nsclc_mskcc_2023, cfdna_msk_2019, chol_icgc_2017, crc_apc_impact_2020, crc_eo_2020, hcc_clca_2024, hcc_meric_2021, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_pdx, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_mskcc_2020, mixed_impact_subset_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, os_target_gdc, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bowel, Cholangiocarcinoma, Colorectal Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Osteosarcoma, Prostate Adenocarcinoma","hg19,17:7579372-7579373, hg19,17:7579373-7579373, hg19,17:7676055-7676055, hg38,17:7676055-7676055","hg19,17:g.7579372_7579373delinsAA, hg19,17:g.7579373C>A, hg19,17:g.7676055C>A, hg38,17:g.7676055C>A",0.919,"biliary_tract, bile_duct, breast, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, large_intestine, anorectal, large_intestine, colon, liver, lung, lung, left_upper_lobe, oesophagus, pancreas, prostate, skin, trunk, stomach, upper_aerodigestive_tract, head_neck","adnexal_tumour, malignant_adnexal_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, combined_small_cell_carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, tubular_adenocarcinoma, germ_cell_tumour, teratoma, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, other, neoplasm",,,,,634708,Conflicting classifications of pathogenicity,Ovarian neoplasm;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Lung adenocarcinoma;Hereditary cancer-predisposing syndrome,1,,,,,,
613,105,G,W,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
614,105,G,Y,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
615,106,S,A,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
616,106,S,C,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
617,106,S,D,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
618,106,S,E,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
619,106,S,F,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
620,106,S,G,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
621,106,S,H,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
622,106,S,I,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579370-7579370, hg38,17:7676052-7676052","hg19,17:g.7579370C>A, hg38,17:g.7676052C>A",0.450,lung,"carcinoma, adenocarcinoma",,,,,629791,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,1,,,,,,
623,106,S,K,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
624,106,S,L,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
625,106,S,M,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
626,106,S,N,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7579370-7579370","hg19,17:g.7579370C>T",0.340,,,,,,,,,,,,,,,,
627,106,S,P,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
628,106,S,Q,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
629,106,S,R,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, chol_msk_2018, crc_apc_impact_2020, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, hcc_msk_2024, hcc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_mskcc_2020, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2015, luad_mskcc_2023_met_organotropism, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mixed_allen_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, rectal_msk_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, stes_tcga_pub, summit_2018, thyroid_mskcc_2016","Bladder/Urinary Tract, Breast, CNS/Brain, Cholangiocarcinoma, Colorectal Adenocarcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Soft Tissue, Thyroid","hg19,17:7579369-7579369, hg19,17:7676051-7676051, hg38,17:7676051-7676051","hg19,17:g.7579369G>C, hg19,17:g.7676051G>C, hg38,17:g.7676051G>C",0.635,", biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, colon, sigmoid, liver, lung, oesophagus, pancreas, skin, head_neck, stomach, thyroid, upper_aerodigestive_tract, head_neck","Wilms_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, malignant_melanoma, superficial_spreading, other, cystic_tumour",,,,,492752,Pathogenic,not specified;not provided;Li-Fraumeni syndrome,3,,,,,,
630,106,S,T,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
631,106,S,V,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
632,106,S,W,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
633,106,S,Y,P,,,,,,,,,,PhosphoSite,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
634,107,Y,A,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
635,107,Y,C,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga_pub, brca_tcga_pub2015, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021","Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579367-7579367, hg38,17:7676049-7676049","hg19,17:g.7579367T>C, hg38,17:g.7676049T>C",0.883,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, mouth, retromolar_trigone","carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,142691,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
636,107,Y,D,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nhl_bcgsc_2013, prad_mich, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Bladder Urothelial Carcinoma, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Hodgkin Lymphoma, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7579368-7579368, hg19,17:7676050-7676050, hg38,17:7676050-7676050","hg19,17:g.7579368A>C, hg19,17:g.7676050A>C, hg38,17:g.7676050A>C",0.893,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, descending, oesophagus, prostate, stomach, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, lobular_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,,,,641482,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
637,107,Y,E,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
638,107,Y,F,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
639,107,Y,G,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
640,107,Y,H,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579368-7579368, hg38,17:7676050-7676050","hg19,17:g.7579368A>G, hg38,17:g.7676050A>G",0.569,"haematopoietic_and_lymphoid_tissue, bone, small_intestine, jejunum","carcinoma, adenocarcinoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",0.0000835488362841,0.0004142238083100,,,140786,Benign,Li-Fraumeni syndrome 1;TP53-related disorder;Li-Fraumeni syndrome 1;Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
641,107,Y,I,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
642,107,Y,K,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
643,107,Y,L,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
644,107,Y,M,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
645,107,Y,N,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579368-7579368, hg38,17:7676050-7676050","hg19,17:g.7579368A>T, hg38,17:g.7676050A>T",0.853,,,,,,,406572,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
646,107,Y,P,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
647,107,Y,Q,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676048-7676050","hg38,17:g.7676048_7676050delinsTTG",,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
648,107,Y,R,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
649,107,Y,S,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","heme_msk_impact_2022, pan_origimed_2020",Mixed Cancer Types,"hg19,17:7579367-7579367, hg38,17:7676049-7676049","hg19,17:g.7579367T>G, hg38,17:g.7676049T>G",0.854,,,,,,,142414,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
650,107,Y,T,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
651,107,Y,V,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
652,107,Y,W,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
653,108,G,A,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",glioma_mskcc_2019,Diffuse Glioma,"hg19,17:7579364-7579364","hg19,17:g.7579364C>G",0.668,,,,,,,,,,,,,,,,
654,108,G,C,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, msk_chord_2024","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579365-7579365, hg38,17:7676047-7676047","hg19,17:g.7579365C>A, hg38,17:g.7676047C>A",0.654,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0000079577918719,,,,1487358,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
655,108,G,D,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","mbn_mdacc_2013, nepc_wcm_2016, prad_p1000","Mature B-Cell Neoplasms, Prostate Adenocarcinoma","hg19,17:7579364-7579364, hg38,17:7676046-7676046","hg19,17:g.7579364C>T, hg38,17:g.7676046C>T",0.651,"endometrium, large_intestine, colon, lung, prostate, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, dedifferentiated_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,1371608,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
656,108,G,E,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
657,108,G,F,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
658,108,G,H,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
659,108,G,I,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
660,108,G,K,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
661,108,G,L,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
662,108,G,M,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
663,108,G,N,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
664,108,G,P,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
665,108,G,Q,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
666,108,G,R,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579365-7579365, hg38,17:7676047-7676047","hg19,17:g.7579365C>G, hg38,17:g.7676047C>G",0.724,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,458535,Uncertain significance,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Familial cancer of breast",2,,,,,,
667,108,G,S,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","csf_msk_2024, dlbcl_duke_2017, mds_mskcc_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, stad_tcga, stad_tcga_gdc, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Prostate, Prostate Adenocarcinoma, Stomach Adenocarcinoma","hg19,17:7579365-7579365, hg19,17:7676047-7676047, hg38,17:7676047-7676047","hg19,17:g.7579365C>T, hg19,17:g.7676047C>T, hg38,17:g.7676047C>T",0.612,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, prostate, skin, face, stomach","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",0.0000119366878079,,,,142431,Likely benign,"Hereditary cancer-predisposing syndrome;not provided;not specified;Hereditary breast ovarian cancer syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",3,,,,,,
668,108,G,T,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
669,108,G,V,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2025, msk_chord_2024",Mixed Cancer Types,"hg19,17:7579364-7579364, hg19,17:7676046-7676046, hg38,17:7676046-7676046","hg19,17:g.7579364C>A, hg19,17:g.7676046C>A, hg38,17:g.7676046C>A",0.658,,,,,,,1729287,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
670,108,G,W,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
671,108,G,Y,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
672,109,F,A,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
673,109,F,C,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_fuscc_2020, coad_tcga_gdc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, heme_msk_impact_2022, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_pdx, lung_pdx_msk_2021, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_msk_2024, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga_pub, pan_origimed_2020, pancan_pcawg_2020, pdac_msk_2024, prostate_msk_2024, read_tcga_gdc","Colon Adenocarcinoma, Colorectal Adenocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Rectal Adenocarcinoma","hg19,17:7579361-7579361, hg19,17:7676043-7676043, hg38,17:7676043-7676043","hg19,17:g.7579361A>C, hg19,17:g.7676043A>C, hg38,17:g.7676043A>C",0.965,"haematopoietic_and_lymphoid_tissue, large_intestine, caecum, large_intestine, rectum, lung, lung, right_lower_lobe, oesophagus, oesophagus, middle_third, ovary, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,634784,Likely pathogenic,Ovarian neoplasm;Li-Fraumeni syndrome 1,1,,,,,,
674,109,F,D,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
675,109,F,E,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
676,109,F,G,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
677,109,F,H,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
678,109,F,I,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, mel_mskimpact_2020, msk_chord_2024, msk_impact_2017, pan_origimed_2020, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579362-7579362, hg38,17:7676044-7676044","hg19,17:g.7579362A>T, hg38,17:g.7676044A>T",0.837,"penis, skin","carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,2627017,Likely pathogenic,Li-Fraumeni syndrome;not provided,2,,,,,,
679,109,F,K,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
680,109,F,L,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_msk_2018, msk_chord_2024, msk_met_2021","Breast, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579360-7579360, hg38,17:7676042-7676042","hg19,17:g.7579360G>T, hg38,17:g.7676042G>T",0.715,breast,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
681,109,F,M,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
682,109,F,N,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579361-7579363, hg38,17:7676043-7676045","hg19,17:g.7579361_7579363inv, hg38,17:g.7676043_7676045inv",,,,,,,,2417541,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
683,109,F,P,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
684,109,F,Q,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
685,109,F,R,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
686,109,F,S,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, brca_smc_2018, crc_eo_2020, crc_sysucc_2022, difg_tcga_gdc, dlbc_broad_2012, dlbcl_dfci_2018, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gct_msk_2020, heme_msk_impact_2022, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, mds_mskcc_2020, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, pdac_msk_2024, stes_tcga_pub, tmb_mskcc_2018","Ampullary Carcinoma, Bowel, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Testis","hg19,17:7579361-7579361, hg19,17:7676043-7676043, hg38,17:7676043-7676043","hg19,17:g.7579361A>G, hg19,17:g.7676043A>G, hg38,17:g.7676043A>G",0.952,"biliary_tract, gallbladder, breast, central_nervous_system, brain, oesophagus, pancreas, ampulla_of_Vater, penis, skin, skin, face, stomach, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, in_situ_epithelial_neoplasm, actinic_keratosis, malignant_melanoma",,,,,423970,Uncertain significance,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
687,109,F,T,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
688,109,F,V,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bowel_colitis_msk_2022, breast_msk_2025, coadread_dfci_2016, crc_eo_2020, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, gist_msk_2025, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_tsp, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, rectal_msk_2022, sarcoma_mskcc_2022","Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Esophagus/Stomach, Gastrointestinal Stromal Tumor, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Soft Tissue","hg19,17:7579362-7579362, hg19,17:7676044-7676044, hg38,17:7676044-7676044","hg19,17:g.7579362A>C, hg19,17:g.7676044A>C, hg38,17:g.7676044A>C",0.875,", central_nervous_system, brain, large_intestine, liver, lung, ovary, soft_tissue, fat, upper_leg, soft_tissue, fibrous_tissue_and_uncertain_origin, abdomen, stomach, testis","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, gastrointestinal_stromal_tumour, germ_cell_tumour, embryonal_carcinoma, glioma, glioma, astrocytoma_Grade_II, fibrillary, liposarcoma, myxoid-round_cell, other, neoplasm",,,,,389644,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
689,109,F,W,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
690,109,F,Y,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 105-109, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579361-7579361, hg38,17:7676043-7676043","hg19,17:g.7579361A>T, hg38,17:g.7676043A>T",0.848,,,,,,,1054035,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
691,110,R,A,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
692,110,R,C,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, bowel_colitis_msk_2022, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, coadread_dfci_2016, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_hgsc_bcm_2014, difg_msk_2023, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, hcc_meric_2021, hnsc_tcga, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, ohnca_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_broad, prad_p1000, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sft_sysucc_2023, stes_tcga_pub, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, uec_cptac_gdc, utuc_msk_2019, utuc_mskcc_2015","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Upper Tract Urothelial Carcinoma, Uterine Endometrioid Carcinoma","hg19,17:7579359-7579359, hg19,17:7579359-7579360, hg19,17:7676041-7676041, hg38,17:7676041-7676041, hg38,17:7676041-7676042","hg19,17:g.7579359G>A, hg19,17:g.7579359_7579360delinsAA, hg19,17:g.7676041G>A, hg38,17:g.7676041G>A, hg38,17:g.7676041_7676042delinsAA",0.471,", biliary_tract, bile_duct, central_nervous_system, temporal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, right, large_intestine, colon, sigmoid, liver, lung, oesophagus, penis, prostate, skin, face, skin, head_neck, small_intestine, duodenum, stomach, urinary_tract, bladder, vulva","adenoma, adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, medullary_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, glioma, gliosarcoma, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, malignant_melanoma, other, intraductal_papillary_neoplasm, other, metaplasia, epidermoid",0.0000198974881411,,,,142206,Uncertain significance,TP53-related disorder;Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Malignant tumor of breast,3,Uncertain significance,Neoplasm,1,,,
693,110,R,D,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
694,110,R,E,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
695,110,R,F,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
696,110,R,G,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_msk_2025, msk_chord_2024, msk_met_2021","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579359-7579359, hg38,17:7676041-7676041","hg19,17:g.7579359G>C, hg38,17:g.7676041G>C",0.577,", haematopoietic_and_lymphoid_tissue","haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, malignant_melanoma",,,,,823452,Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
697,110,R,H,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, brca_metabric, egc_msk_2023, glioma_mskcc_2019, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023","Ampullary Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579358-7579358, hg38,17:7676040-7676040","hg19,17:g.7579358C>T, hg38,17:g.7676040C>T",0.592,", breast, cervix, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, colon, large_intestine, rectum, pancreas, pancreas, ampulla_of_Vater, stomach, urinary_tract, bladder","carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, acinar_carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, of_unknown_primary, carcinoma, small_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia",0.0000477547316980,0.0000318694626809,,,127808,Likely benign,TP53-related disorder;not specified;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Malignant tumor of breast,3,,,,,,
698,110,R,I,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
699,110,R,K,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
700,110,R,L,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_metabric, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_cptac_2019, coad_cptac_gdc, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, gbc_mskcc_2022, gct_msk_2016, hcc_clca_2024, hcc_msk_2024, hgsoc_tcga_gdc, hnsc_broad, hnsc_jhu, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, ihch_mskcc_2020, lihc_amc_prv, lms_msk_2024, luad_cptac_gdc, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, mds_mskcc_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, os_target_gdc, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Osteosarcoma, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Testis","hg19,17:7579358-7579358, hg19,17:7676040-7676040, hg38,17:7676040-7676040","hg19,17:g.7579358C>A, hg19,17:g.7676040C>A, hg38,17:g.7676040C>A",0.632,"biliary_tract, bile_duct, breast, central_nervous_system, cerebellum, central_nervous_system, thalamus, endometrium, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, liver, lung, lung, right_lower_lobe, oesophagus, oesophagus, middle_third, oesophagus, upper_third, ovary, pancreas, prostate, skin, mucosal, vagina, soft_tissue, fibrous_tissue_and_uncertain_origin, kidney, soft_tissue, fibrous_tissue_and_uncertain_origin, pelvis, soft_tissue, smooth_muscle, uterus, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, yolk_sac_tumour, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, leiomyosarcoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, other, dysplasia-in_situ_neoplasm, other, intraductal_papillary_neoplasm, other, neoplasm, other, solid_pseudopapillary_neoplasm, sarcoma, undifferentiated_sarcoma, pleomorphic",0.0000000000000000,,,,406597,Pathogenic,Adrenal cortex carcinoma;Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome;not provided;Li-Fraumeni syndrome 1,3,Oncogenic,Neoplasm,1,Tier I - Strong,Adenocarcinoma of the large intestine,1
701,110,R,M,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
702,110,R,N,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
703,110,R,P,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, appendiceal_msk_2022, blca_bcan_hcrn_2022, blca_msk_2025, brca_cptac_2020, brca_igr_2015, brca_metabric, brca_msk_2025, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cfdna_msk_2019, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, heme_msk_impact_2022, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_mskcc_2023_met_organotropism, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, mixed_allen_2018, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, rectal_msk_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, usarc_msk_2020","Adenoid Cystic Carcinoma, Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Soft Tissue, Uterine Sarcoma/Mesenchymal","hg19,17:7579357-7579358, hg19,17:7579358-7579358, hg19,17:7676040-7676040, hg38,17:7676039-7676040, hg38,17:7676040-7676040","hg19,17:g.7579357_7579358delinsGG, hg19,17:g.7579358C>G, hg19,17:g.7676040C>G, hg38,17:g.7676039_7676040delinsGG, hg38,17:g.7676040C>G",0.593,"breast, central_nervous_system, brain, central_nervous_system, brainstem, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, spleen, large_intestine, large_intestine, colon, liver, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, submandibular, skin, skin, mucosal, vagina, soft_tissue, blood_vessel, pulmonary_artery, soft_tissue, fat, soft_tissue, fibrous_tissue_and_uncertain_origin, intracranial, soft_tissue, nerve_sheath, femur, soft_tissue, nerve_sheath, leg, thymus, thyroid, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, adenoid_cystic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, apocrine, carcinoma, hepatocellular_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, oligoastrocytoma_Grade_II, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, liposarcoma, myxoid-round_cell, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_peripheral_nerve_sheath_tumour, sarcoma, thymic_carcinoma",,,,,"641505, 233627","Pathogenic, Pathogenic","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Familial cancer of breast","1, 3",Oncogenic,Neoplasm,1,Tier I - Strong,"Astrocytoma, IDH-mutant, grade 3;IDH-wildtype glioblastoma",1
704,110,R,Q,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
705,110,R,S,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",sarcoma_msk_2022,Soft Tissue,"hg19,17:7579359-7579359, hg38,17:7676041-7676041","hg19,17:g.7579359G>T, hg38,17:g.7676041G>T",0.525,"large_intestine, colon, salivary_gland, major","carcinoma, adenocarcinoma, carcinoma, mucoepidermoid_carcinoma",,,,,140921,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
706,110,R,T,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
707,110,R,V,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
708,110,R,W,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
709,110,R,Y,,Me,,,,,,,,,PhosphoSite,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
710,111,L,A,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
711,111,L,C,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
712,111,L,D,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
713,111,L,E,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
714,111,L,F,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
715,111,L,G,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
716,111,L,H,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
717,111,L,I,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
718,111,L,K,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
719,111,L,M,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","glioma_mskcc_2019, mbn_sfu_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paired_bladder_2022, pan_origimed_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022","Bladder/Urinary Tract, Diffuse Glioma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7579356-7579356, hg19,17:7676038-7676038, hg38,17:7676038-7676038","hg19,17:g.7579356G>T, hg19,17:g.7676038G>T, hg38,17:g.7676038G>T",0.517,"central_nervous_system, brain, liver","carcinoma, hepatocellular_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,836750,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
720,111,L,N,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
721,111,L,P,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, crc_msk_2017, crc_orion_2024, difg_glass, difg_glass_2019, escc_icgc, hcc_clca_2024, hccihch_pku_2019, kirp_tcga, kirp_tcga_pan_can_atlas_2018, lihc_amc_prv, mixed_selpercatinib_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_pcawg_2020, prcc_tcga_gdc, rectal_msk_2019, sarcoma_msk_2022, sclc_cancercell_gardner_2017","Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Esophageal Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Papillary Renal Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7579355-7579355, hg19,17:7676037-7676037, hg38,17:7676037-7676037","hg19,17:g.7579355A>G, hg19,17:g.7676037A>G, hg38,17:g.7676037A>G",0.864,"bone, extraskeletal, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, kidney, large_intestine, large_intestine, rectum, oesophagus, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, papillary_renal_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, osteosarcoma, other, neoplasm",,,,,376630,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;not provided;Li-Fraumeni syndrome;Ovarian neoplasm,3,,,,,,
722,111,L,Q,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_msk_2025, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2025, coad_cptac_2019, coad_cptac_gdc, coadread_dfci_2016, heme_msk_impact_2022, luad_cas_2020, lung_msk_pdx, lung_pdx_msk_2021, lusc_tcga, lusc_tcga_pub, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, skcm_broad, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018","Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7579355-7579355, hg19,17:7676037-7676037, hg38,17:7676037-7676037","hg19,17:g.7579355A>T, hg19,17:g.7676037A>T, hg38,17:g.7676037A>T",0.869,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, rectum, lung, lung, right, oesophagus, ovary, pancreas, prostate, skin, mucosal, oesophagus, skin, neck, small_intestine, duodenum, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx","adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_melanoma, mixed",,,,,376632,Pathogenic,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
723,111,L,R,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_fuscc_2020, cll_broad_2015, cll_broad_2022, lcll_broad_2013, lihc_riken, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, pan_origimed_2020, pancreas_msk_2024, pdac_msk_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Endometrial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas","hg19,17:7579355-7579355, hg19,17:7676037-7676037, hg38,17:7676037-7676037","hg19,17:g.7579355A>C, hg19,17:g.7676037A>C, hg38,17:g.7676037A>C",0.862,"adrenal_gland, adrenal_gland, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, prostate, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,376631,Pathogenic,Li-Fraumeni syndrome,3,,,,,,
724,111,L,S,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
725,111,L,T,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
726,111,L,V,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mbcproject_2022, brca_mbcproject_wagle_2017, breast_alpelisib_2020, paired_bladder_2022","Bladder/Urinary Tract, Breast, Invasive Breast Carcinoma","hg19,17:7579356-7579356, hg38,17:7676038-7676038","hg19,17:g.7579356G>C, hg38,17:g.7676038G>C",0.456,,,,,,,1730178,Likely benign,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not specified,3,,,,,,
727,111,L,W,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
728,111,L,Y,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
729,112,G,A,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579352-7579352, hg38,17:7676034-7676034","hg19,17:g.7579352C>G, hg38,17:g.7676034C>G",,,,0.0000039801311851,,,,3634433,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
730,112,G,C,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676035-7676035","hg38,17:g.7676035C>A",,"large_intestine, colon","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
731,112,G,D,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579352-7579352, hg38,17:7676034-7676034","hg19,17:g.7579352C>T, hg38,17:g.7676034C>T",,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,1319402,Uncertain significance,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not provided,2,,,,,,
732,112,G,E,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
733,112,G,F,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
734,112,G,H,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
735,112,G,I,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
736,112,G,K,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
737,112,G,L,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
738,112,G,M,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
739,112,G,N,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
740,112,G,P,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
741,112,G,Q,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
742,112,G,R,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, luad_mskcc_2023_met_organotropism, msk_chord_2024","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579353-7579353","hg19,17:g.7579353C>G",,,,,,,,,,,,,,,,,
743,112,G,S,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579353-7579353, hg38,17:7676035-7676035","hg19,17:g.7579353C>T, hg38,17:g.7676035C>T",,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","carcinoma, adenocarcinoma, haematopoietic_neoplasm, myelofibrosis, lymphoid_neoplasm, NK-T_cell_lymphoma",0.0000039798777382,,,,492575,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
744,112,G,T,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
745,112,G,V,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
746,112,G,W,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
747,112,G,Y,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
748,113,F,A,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
749,113,F,C,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, coad_tcga_gdc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, escc_ucla_2014, gist_msk_2022, gist_msk_2023, hcc_tcga_gdc, heme_msk_impact_2022, lihc_tcga, lihc_tcga_pan_can_atlas_2018, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mpcproject_broad_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_ctdx_msk_2022, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_su2c_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, ucec_ancestry_cds_msk_2023","Bladder/Urinary Tract, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7579349-7579349, hg19,17:7676031-7676031, hg38,17:7676030-7676031, hg38,17:7676031-7676031","hg19,17:g.7579349A>C, hg19,17:g.7676031A>C, hg38,17:g.7676030_7676031delinsAC, hg38,17:g.7676031A>C",0.952,"biliary_tract, bile_duct, breast, large_intestine, colon, sigmoid, liver, lung, oesophagus, ovary, pancreas, skin, stomach, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, squamous_cell_carcinoma, other, adenoma",,,,,634690,Pathogenic,Ovarian neoplasm;Li-Fraumeni syndrome,1,,,,,,
750,113,F,D,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
751,113,F,E,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
752,113,F,G,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",pancan_pcawg_2020,Mixed Cancer Types,"hg19,17:7579349-7579350","hg19,17:g.7579349_7579350delinsCC",,,,,,,,,,,,,,,,,
753,113,F,H,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
754,113,F,I,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","lms_msk_2024, lung_nci_2022, msk_chord_2024, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, pan_origimed_2020, pancan_pcawg_2020","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma","hg19,17:7579350-7579350, hg38,17:7676032-7676032","hg19,17:g.7579350A>T, hg38,17:g.7676032A>T",,"large_intestine, rectum, liver, pancreas","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, other, neoplasm",,,,,1469551,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
755,113,F,K,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
756,113,F,L,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_msk_2025, breast_alpelisib_2020, ccle_broad_2019, ccle_broad_2025, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Breast, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,17:7579348-7579348, hg19,17:7579350-7579350, hg19,17:7676030-7676030, hg19,17:7676032-7676032, hg38,17:7676030-7676030, hg38,17:7676032-7676032","hg19,17:g.7579348G>C, hg19,17:g.7579348G>T, hg19,17:g.7579350A>G, hg19,17:g.7676030G>C, hg19,17:g.7676032A>G, hg38,17:g.7676030G>C, hg38,17:g.7676030G>T, hg38,17:g.7676032A>G",0.783,"central_nervous_system, brain, large_intestine, lung, skin, soft_tissue, smooth_muscle, abdomen, stomach, urinary_tract, bladder, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, invasive_mucinous_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, leiomyosarcoma",,,,,"3634432, 2702402, 2125367","Pathogenic, Pathogenic, Likely pathogenic",Li-Fraumeni syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome,"1, 1, 1",,,,,,
757,113,F,M,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
758,113,F,N,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
759,113,F,P,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","brca_mapk_hp_msk_2021, breast_msk_2018, breast_msk_2025, msk_chord_2024, msk_impact_2017, msk_met_2021","Breast, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579348-7579350, hg38,17:7676030-7676032","hg19,17:g.7579348_7579350delinsAGG, hg38,17:g.7676030_7676032delinsAGG",,breast,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
760,113,F,Q,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
761,113,F,R,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
762,113,F,S,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, acyc_fmi_2014, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, crc_eo_2020, crc_msk_2017, escc_ucla_2014, heme_msk_impact_2022, ilc_msk_2023, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, ptad_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Adenoid Cystic Carcinoma, Bowel, Breast, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Pituitary Adenoma, Soft Tissue","hg19,17:7579349-7579349, hg19,17:7676031-7676031, hg38,17:7676031-7676031","hg19,17:g.7579349A>G, hg19,17:g.7676031A>G, hg38,17:g.7676031A>G",0.952,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, large_intestine, colon, large_intestine, colon, sigmoid, lung, oesophagus, ovary, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,823709,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,1,,,,,,
763,113,F,T,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
764,113,F,V,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, brca_msk_2025, brca_sanger, brca_smc_2018, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, difg_tcga_gdc, egc_msk_tp53_ccr_2022, es_dsrct_msk_2023, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tracerx_2017, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024, sarcoma_msk_2022, soft_tissue_msk_2025, stes_tcga_pub, tmb_mskcc_2018","Acute Myeloid Leukemia, Breast, Diffuse Glioma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Ewing Sarcoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7579350-7579350, hg19,17:7676032-7676032, hg38,17:7676032-7676032","hg19,17:g.7579350A>C, hg19,17:g.7676032A>C, hg38,17:g.7676032A>C",,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, lung, oesophagus, ovary, prostate, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,141302,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
765,113,F,W,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
766,113,F,Y,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM|Pex14 ligand motif (LIG_Pex14_2), 109-113, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
767,114,L,A,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
768,114,L,C,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
769,114,L,D,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
770,114,L,E,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
771,114,L,F,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","ccle_genentech_2014, pan_origimed_2020",Mixed Cancer Types,"hg19,17:7579345-7579345, hg38,17:7676027-7676027","hg19,17:g.7579345C>A, hg19,17:g.7579345C>G, hg38,17:g.7676027C>A",,"oesophagus, middle_third","carcinoma, squamous_cell_carcinoma",0.0000039809868070,,,,,,,,,,,,,
772,114,L,G,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
773,114,L,H,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
774,114,L,I,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
775,114,L,K,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
776,114,L,M,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
777,114,L,N,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
778,114,L,P,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
779,114,L,Q,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
780,114,L,R,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
781,114,L,S,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579346-7579346, hg38,17:7676028-7676028","hg19,17:g.7579346A>G, hg38,17:g.7676028A>G",,,,0.0000039802896059,,,,458536,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not specified,1,,,,,,
782,114,L,T,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
783,114,L,V,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579347-7579347, hg38,17:7676029-7676029","hg19,17:g.7579347A>C, hg38,17:g.7676029A>C",0.573,,,,,,,1011474,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
784,114,L,W,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
785,114,L,Y,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 108-114, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
786,115,H,A,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
787,115,H,C,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
788,115,H,D,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
789,115,H,E,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
790,115,H,F,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
791,115,H,G,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
792,115,H,I,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
793,115,H,K,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
794,115,H,L,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
795,115,H,M,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
796,115,H,N,,Me,,,,,,,,,PhosphoSite,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579344-7579344, hg38,17:7676026-7676026","hg19,17:g.7579344G>T, hg38,17:g.7676026G>T",,,,,,,,480741,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
797,115,H,P,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
798,115,H,Q,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
799,115,H,R,,Me,,,,,,,,,PhosphoSite,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579343-7579343, hg38,17:7676025-7676025","hg19,17:g.7579343T>C, hg38,17:g.7676025T>C",0.484,,,,,,,182925,Likely benign,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,3,,,,,,
800,115,H,S,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
801,115,H,T,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
802,115,H,V,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
803,115,H,W,,Me,,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
804,115,H,Y,,Me,,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","chol_msk_2018, hcc_msk_2024, ihch_msk_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucec_msk_2024, ucs_msk_2024","Cholangiocarcinoma, Endometrial Carcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Mixed Cancer Types","hg19,17:7579344-7579344, hg38,17:7676026-7676026","hg19,17:g.7579344G>A, hg38,17:g.7676026G>A",0.517,"biliary_tract, bile_duct, endometrium, large_intestine, colon, oesophagus, middle_third","carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
805,116,S,A,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579341-7579341, hg38,17:7676023-7676023","hg19,17:g.7579341A>C, hg38,17:g.7676023A>C",,,,0.0000079620370075,,,,649358,Conflicting classifications of pathogenicity,"TP53-related disorder;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome",1,,,,,,
806,116,S,C,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_msk_2024, mds_iwg_2022, msk_met_2021, pan_origimed_2020","Bladder Urothelial Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7579340-7579340, hg38,17:7676022-7676022","hg19,17:g.7579340G>C, hg38,17:g.7676022G>C",0.706,"lung, ovary, upper_aerodigestive_tract, head_neck","carcinoma, large_cell_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma",,,,,,,,,,,,,,
807,116,S,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
808,116,S,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
809,116,S,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_msk_2025, breast_msk_2025, lms_msk_2024, metastatic_solid_tumors_mich_2017, mixed_allen_2018, msk_chord_2024, msk_ctdna_vte_2024, pan_origimed_2020","Bladder Urothelial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7579340-7579340, hg38,17:7676022-7676022","hg19,17:g.7579340G>A, hg38,17:g.7676022G>A",0.728,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, lung","carcinoma, adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,,,,,,,,,,
810,116,S,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
811,116,S,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
812,116,S,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
813,116,S,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
814,116,S,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
815,116,S,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
816,116,S,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
817,116,S,P,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676023-7676023","hg38,17:g.7676023A>G",,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
818,116,S,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
819,116,S,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
820,116,S,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
821,116,S,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
822,116,S,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
823,116,S,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
824,117,G,A,,,,,,,,,,,,,,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","msk_met_2021, pan_origimed_2020",Mixed Cancer Types,"hg19,17:7579337-7579337, hg38,17:7676019-7676019","hg19,17:g.7579337C>G, hg38,17:g.7676019C>G",0.778,,,0.0000039826357083,,,,1055289,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
825,117,G,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
826,117,G,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
827,117,G,E,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579337-7579337, hg38,17:7676019-7676019","hg19,17:g.7579337C>T, hg38,17:g.7676019C>T",0.784,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0000039826357083,,,,2450745,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
828,117,G,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
829,117,G,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
830,117,G,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
831,117,G,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
832,117,G,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
833,117,G,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
834,117,G,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
835,117,G,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
836,117,G,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
837,117,G,R,,,,,,,,,,,,,,"COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579338-7579338, hg38,17:7676020-7676020","hg19,17:g.7579338C>G, hg19,17:g.7579338C>T, hg38,17:g.7676020C>G, hg38,17:g.7676020C>T",0.770,"adrenal_gland, adrenal_gland",pheochromocytoma,,,,,"1462102, 480758","Uncertain significance, Uncertain significance",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome,"2, 2",,,,,,
838,117,G,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
839,117,G,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
840,117,G,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,17:7579337-7579337, hg38,17:7676019-7676019","hg19,17:g.7579337C>A, hg38,17:g.7676019C>A",0.832,"large_intestine, upper_aerodigestive_tract, mouth","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,837018,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
841,117,G,W,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",hcc_clca_2024,Hepatocellular Carcinoma,"hg19,17:7579338-7579338","hg19,17:g.7579338C>A",0.765,,,,,,,,,,,,,,,,
842,117,G,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
843,118,T,A,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676017-7676017","hg38,17:g.7676017T>C",0.842,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,,,,,,,,,,
844,118,T,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
845,118,T,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
846,118,T,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
847,118,T,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
848,118,T,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
849,118,T,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
850,118,T,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",mds_mskcc_2020,Myelodysplastic Syndromes,"hg19,17:7579334-7579334, hg38,17:7676016-7676016","hg19,17:g.7579334G>A, hg38,17:g.7676016G>A",0.897,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, ovary, upper_aerodigestive_tract, head_neck","carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,419837,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome,3,,,,,,
851,118,T,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
852,118,T,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
853,118,T,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
854,118,T,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
855,118,T,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
856,118,T,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
857,118,T,R,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579334-7579334, hg38,17:7676016-7676016","hg19,17:g.7579334G>C, hg38,17:g.7676016G>C",0.907,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,3460317,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
858,118,T,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
859,118,T,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
860,118,T,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
861,118,T,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
862,119,A,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
863,119,A,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",hcc_meric_2021,Hepatocellular Carcinoma,"hg19,17:7579331-7579331, hg38,17:7676013-7676013","hg19,17:g.7579331G>T, hg38,17:g.7676013G>T",0.944,"genital_tract, extragonadal, brain","germ_cell_tumour, seminoma",,,,,1732774,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
864,119,A,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
865,119,A,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
866,119,A,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","cfdna_msk_2019, lung_msk_2017, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024","Bladder/Urinary Tract, Lung Adenocarcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7579330-7579331, hg19,17:7579331-7579331, hg38,17:7676012-7676013, hg38,17:7676013-7676013","hg19,17:g.7579330_7579331delinsAC, hg19,17:g.7579331G>C, hg38,17:g.7676012_7676013delinsAC, hg38,17:g.7676013G>C",0.856,"haematopoietic_and_lymphoid_tissue, large_intestine, lung, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, undifferentiated_carcinoma, lymphoid_neoplasm, mantle_cell_lymphoma",,,,,949408,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
867,119,A,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
868,119,A,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
869,119,A,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
870,119,A,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
871,119,A,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
872,119,A,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
873,119,A,P,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579332-7579332, hg38,17:7676014-7676014","hg19,17:g.7579332C>G, hg38,17:g.7676014C>G",0.899,,,,,,,481073,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
874,119,A,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
875,119,A,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
876,119,A,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
877,119,A,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
878,119,A,V,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7676013-7676013","hg38,17:g.7676013G>A",0.906,"skin, scalp","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
879,119,A,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
880,119,A,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
881,120,K,A,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
882,120,K,C,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
883,120,K,D,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
884,120,K,E,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, difg_glass, difg_tcga_gdc, gbc_mskcc_2022, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, mbn_sfu_2023, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, skcm_yale, ucec_ancestry_cds_msk_2023","Bladder/Urinary Tract, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7579329-7579329, hg19,17:7676011-7676011, hg38,17:7676011-7676011","hg19,17:g.7579329T>C, hg19,17:g.7676011T>C, hg38,17:g.7676011T>C",0.925,"adrenal_gland, adrenal_gland, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, lung, right_lower_lobe, oesophagus, ovary, skin","adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma",,,,,141098,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
885,120,K,F,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
886,120,K,G,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
887,120,K,H,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
888,120,K,I,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
889,120,K,L,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
890,120,K,M,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, hcc_clca_2024, msk_ch_2020, msk_ch_2023, pan_origimed_2020, utuc_cornell_baylor_mdacc_2019","Basal Cell Carcinoma, Hepatocellular Carcinoma, Mixed Cancer Types, Upper Tract Urothelial Carcinoma","hg19,17:7579328-7579328, hg38,17:7676010-7676010","hg19,17:g.7579328T>A, hg38,17:g.7676010T>A",0.920,"central_nervous_system, brain, central_nervous_system, brainstem, liver, skin, soft_tissue, liver, urinary_tract, urinary_tract, bladder","carcinoma, basal_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_I, pilocytic, other, neoplasm, undifferentiated_sarcoma",,,,,917693,Uncertain significance,Hereditary cancer-predisposing syndrome;not specified,2,,,,,,
891,120,K,N,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, escc_icgc, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_pdmr_2025, pdac_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018","Esophageal Squamous Cell Carcinoma, Mixed Cancer Types, Pancreas, Soft Tissue","hg19,17:7579327-7579327, hg19,17:7676009-7676009, hg38,17:7676009-7676009","hg19,17:g.7579327C>A, hg19,17:g.7579327C>G, hg19,17:g.7676009C>A, hg38,17:g.7676009C>A",0.862,"oesophagus, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid","carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
892,120,K,P,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
893,120,K,Q,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, lusc_cptac_2021, lusc_cptac_gdc, mel_mskimpact_2020, msk_met_2021","Bladder Urothelial Carcinoma, Cutaneous Melanoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types","hg19,17:7579329-7579329, hg19,17:7676011-7676011, hg38,17:7676011-7676011","hg19,17:g.7579329T>G, hg19,17:g.7676011T>G, hg38,17:g.7676011T>G",0.899,breast,carcinoma,,,,,423255,Uncertain significance,TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
894,120,K,R,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2025, luad_mskcc_2023_met_organotropism, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, pancan_pdmr_2025, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, sarcoma_msk_2022","Breast, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7579328-7579328, hg38,17:7676009-7676010, hg38,17:7676010-7676010","hg19,17:g.7579328T>C, hg38,17:g.7676009_7676010delinsTC, hg38,17:g.7676010T>C",0.861,"pancreas, prostate, thyroid","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, papillary_carcinoma, hyperplasia",,,,,1360099,Uncertain significance,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
895,120,K,S,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
896,120,K,T,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579328-7579328, hg38,17:7676010-7676010","hg19,17:g.7579328T>G, hg38,17:g.7676010T>G",0.917,"breast, endometrium, lung","carcinoma, ER-positive_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,3780731,Uncertain significance,Li-Fraumeni syndrome 1,1,,,,,,
897,120,K,V,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
898,120,K,W,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
899,120,K,Y,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
900,121,S,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
901,121,S,C,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
902,121,S,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
903,121,S,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
904,121,S,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7579325-7579325, hg38,17:7676007-7676007","hg19,17:g.7579325G>A, hg38,17:g.7676007G>A",0.928,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon","carcinoma, adenocarcinoma, lymphoid_neoplasm",,,,,,,,,,,,,,
905,121,S,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
906,121,S,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
907,121,S,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
908,121,S,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
909,121,S,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
910,121,S,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
911,121,S,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
912,121,S,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579326-7579326, hg38,17:7676008-7676008","hg19,17:g.7579326A>G, hg38,17:g.7676008A>G",0.944,,,,,,,854451,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,2,,,,,,
913,121,S,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
914,121,S,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
915,121,S,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
916,121,S,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
917,121,S,W,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
918,121,S,Y,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,17:7579325-7579325, hg19,17:7676007-7676007, hg38,17:7676007-7676007","hg19,17:g.7579325G>T, hg19,17:g.7676007G>T, hg38,17:g.7676007G>T",0.921,"urinary_tract, bladder",carcinoma,,,,,4427947,,,,,,,,,
919,122,V,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579322-7579322, hg38,17:7676004-7676004","hg19,17:g.7579322A>G, hg38,17:g.7676004A>G",0.650,,,,,,,1465964,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
920,122,V,C,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
921,122,V,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
922,122,V,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
923,122,V,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
924,122,V,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
925,122,V,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
926,122,V,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
927,122,V,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
928,122,V,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579323-7579323, hg38,17:7676005-7676005","hg19,17:g.7579323C>A, hg38,17:g.7676005C>A",0.730,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,2121740,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
929,122,V,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",lung_nci_2022,Lung Adenocarcinoma,"hg19,17:7579323-7579323, hg38,17:7676005-7676005","hg19,17:g.7579323C>T, hg38,17:g.7676005C>T",0.770,,,,,,,141101,Likely benign,Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome,3,,,,,,
930,122,V,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
931,122,V,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
932,122,V,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
933,122,V,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
934,122,V,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
935,122,V,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
936,122,V,W,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
937,122,V,Y,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
938,123,T,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
939,123,T,C,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
940,123,T,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
941,123,T,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
942,123,T,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
943,123,T,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
944,123,T,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
945,123,T,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579319-7579319, hg38,17:7676001-7676001","hg19,17:g.7579319G>A, hg38,17:g.7676001G>A",0.859,"central_nervous_system, brain","glioma, astrocytoma",,,,,480737,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
946,123,T,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
947,123,T,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
948,123,T,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
949,123,T,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
950,123,T,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
951,123,T,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
952,123,T,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
953,123,T,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579319-7579319, hg38,17:7676001-7676001","hg19,17:g.7579319G>C, hg38,17:g.7676001G>C",0.729,,,,,,,1460570,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
954,123,T,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
955,123,T,W,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
956,123,T,Y,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
957,124,C,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
958,124,C,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
959,124,C,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
960,124,C,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675998-7675998","hg38,17:g.7675998C>A",0.792,"breast, haematopoietic_and_lymphoid_tissue","carcinoma, ductal_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,,,,,,,,,,
961,124,C,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, coad_tcga_gdc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7579317-7579317, hg19,17:7675999-7675999, hg38,17:7675999-7675999","hg19,17:g.7579317A>C, hg19,17:g.7675999A>C, hg38,17:g.7675999A>C",0.843,"large_intestine, colon, sigmoid, large_intestine, rectum, liver, oesophagus","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,230661,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
962,124,C,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
963,124,C,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
964,124,C,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
965,124,C,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_impact_2017, msk_met_2021, pdac_msk_2024","Mixed Cancer Types, Pancreas","hg19,17:7579315-7579316, hg38,17:7675997-7675998","hg19,17:g.7579315_7579316delinsTA, hg38,17:g.7675997_7675998delinsTA",,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
966,124,C,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
967,124,C,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
968,124,C,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
969,124,C,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
970,124,C,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_msk_2025, ccle_broad_2019, ccle_broad_2025, coad_tcga_gdc, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, mnm_washu_2016, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, paad_tcga, pan_origimed_2020, pancan_mimsi_msk_2024, rectal_msk_2022, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bowel, Colon Adenocarcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Invasive Breast Carcinoma, Mixed Cancer Types, Myeloid Neoplasm, Pancreatic Adenocarcinoma, Soft Tissue","hg19,17:7579317-7579317, hg19,17:7675999-7675999, hg38,17:7675999-7675999","hg19,17:g.7579317A>G, hg19,17:g.7675999A>G, hg38,17:g.7675999A>G",0.883,"central_nervous_system, brain, endometrium, large_intestine, colon, ovary, pleura, upper_aerodigestive_tract, mouth, tongue","carcinoma, adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, gliomatosis_cerebri, other, neoplasm, pulmonary_blastoma",,,,,4056245,Likely pathogenic,Li-Fraumeni syndrome,1,,,,,,
971,124,C,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579316-7579316, hg19,17:7579317-7579317, hg38,17:7675998-7675998, hg38,17:7675999-7675999","hg19,17:g.7579316C>G, hg19,17:g.7579317A>T, hg38,17:g.7675998C>G, hg38,17:g.7675999A>T","0.668, 0.716",ovary,"carcinoma, serous_carcinoma",0.0000079729557341,0.0000318430773150,,,"1021578, 182926","Uncertain significance, Likely benign",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,"1, 3",,,,,,
972,124,C,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
973,124,C,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
974,124,C,W,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579315-7579315, hg38,17:7675997-7675997","hg19,17:g.7579315G>C, hg38,17:g.7675997G>C",0.537,,,,,,,3809674,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
975,124,C,Y,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 120-124, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","chol_tcga, mixed_cfdna_msk_2020","Cholangiocarcinoma, Mixed Cancer Types","hg19,17:7579316-7579316, hg38,17:7675998-7675998","hg19,17:g.7579316C>T, hg38,17:g.7675998C>T",0.713,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, thyroid","carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,,,,,,,,,,
976,125,T,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, ccle_broad_2025, crc_msk_2017, hcc_jcopo_msk_2023, hcc_msk_2024, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, pcnsl_msk_2024, sarcoma_msk_2022, sclc_ucologne_2015","Ampullary Carcinoma, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Mixed Cancer Types, Primary DLBCL of the central nervous system, Small Cell Lung Cancer, Soft Tissue","hg19,17:7579314-7579314, hg19,17:7675996-7675996, hg38,17:7675996-7675996","hg19,17:g.7579314T>C, hg19,17:g.7675996T>C, hg38,17:g.7675996T>C",0.943,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, colon, sigmoid, lung, salivary_gland, parotid","carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, small_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,1734453,Uncertain significance,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,2,,,,Tier I - Strong,Adrenal cortex carcinoma,1
977,125,T,C,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
978,125,T,D,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
979,125,T,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
980,125,T,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
981,125,T,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
982,125,T,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
983,125,T,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021, nsclc_ctdx_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7579312-7579313","hg19,17:g.7579312_7579313delinsGA",,,,,,,,,,,,,,,,,
984,125,T,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_metabric, brca_smc_2018, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, luad_mskcc_2023_met_organotropism, lung_msk_2017, mel_iatlas_riaz_nivolumab_2017, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tracerx_2017, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sclc_jhu, summit_2018, tmb_mskcc_2018","Bowel, Breast, CNS/Brain, Invasive Breast Carcinoma, Lung Adenocarcinoma, Melanoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Small Cell Lung Cancer, Soft Tissue","hg19,17:7579313-7579313, hg19,17:7675995-7675995, hg38,17:7675995-7675995","hg19,17:g.7579313G>T, hg19,17:g.7675995G>T, hg38,17:g.7675995G>T",0.963,"biliary_tract, bile_duct, breast, liver, lung, pancreas, salivary_gland, soft_tissue, smooth_muscle, uterus, thyroid, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, ER-positive_carcinoma, carcinoma, Hurthle_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, leiomyosarcoma",,,,,216465,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
985,125,T,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
986,125,T,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_bcan_hcrn_2022, blca_bgi, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_tcga_2020, ccle_broad_2019, ccle_broad_2025, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_genentech, coadread_mskresistance_2022, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, egc_msk_2023, egc_mskcc_2020, gbc_mskcc_2022, glioma_mskcc_2019, hcc_msk_2024, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, mbn_mdacc_2013, mbn_sfu_2023, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, ov_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, read_tcga_gdc, rectal_msk_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, utuc_cornell_baylor_mdacc_2019","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreas, Rectal Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Upper Tract Urothelial Carcinoma","hg19,17:7579313-7579313, hg19,17:7675995-7675995, hg38,17:7675995-7675995","hg19,17:g.7579313G>A, hg19,17:g.7675995G>A, hg38,17:g.7675995G>A",0.925,", breast, central_nervous_system, brain, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, urinary_tract, bladder","adenoma, tubular, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, apocrine, carcinoma, mucinous_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, yolk_sac_tumour, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_ringed_sideroblasts, hyperplasia, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, intraepithelial_neoplasia, low_grade",,0.0000318471337580,,,183748,Conflicting classifications of pathogenicity,"Li-Fraumeni syndrome 1;TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,Likely oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
987,125,T,N,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, msk_chord_2024","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7579312-7579313","hg19,17:g.7579312_7579313delinsAT, hg19,17:g.7579312_7579313delinsGT",,,,,,,,,,,,,,,,,
988,125,T,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2025, cscc_ranson_2022, difg_tcga_gdc, hnc_mskcc_2016, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_cas_2020, luad_mskcc_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mel_mskimpact_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mappyacts_2022, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, uec_cptac_gdc","Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Head and Neck, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue, Uterine Endometrioid Carcinoma","hg19,17:7579314-7579314, hg19,17:7675996-7675996, hg38,17:7675996-7675996","hg19,17:g.7579314T>G, hg19,17:g.7675996T>G, hg38,17:g.7675996T>G",0.945,"breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, lung, skin, skin, head_neck","carcinoma, basal_(triple-negative)_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, oligodendroglioma_Grade_II",,,,,376666,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
989,125,T,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
990,125,T,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, all_stjude_2013, breast_msk_2025, ccle_broad_2025, coadread_dfci_2016, difg_glass, egc_msk_2023, glioma_mskcc_2019, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pediatric_dkfz_2017, prostate_msk_2024, sarcoma_msk_2022, sclc_ucologne_2015, skcm_broad_brafresist_2012, tmb_mskcc_2018","Adenoid Cystic Carcinoma, Bladder/Urinary Tract, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Esophagus/Stomach, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid, Prostate, Small Cell Lung Cancer, Soft Tissue","hg19,17:7579313-7579313, hg19,17:7675995-7675995, hg38,17:7675995-7675995","hg19,17:g.7579313G>C, hg19,17:g.7675995G>C, hg38,17:g.7675995G>C",0.963,", breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, lung, ovary, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, renal_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, malignant_melanoma, primitive_neuroectodermal_tumour-medulloblastoma",,,,,376667,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Likely oncogenic,Neoplasm,1,,,
991,125,T,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7579314-7579314, hg38,17:7675996-7675996","hg19,17:g.7579314T>A, hg38,17:g.7675996T>A",0.903,,,,,,,4427945,,,,,,,,,
992,125,T,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
993,125,T,W,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
994,125,T,Y,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
995,126,Y,A,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
996,126,Y,C,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, brain_cptac_gdc, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_dfci_2016, crc_eo_2020, crc_msk_2017, csf_msk_2024, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, gbm_mayo_pdx_sarkaria_2019, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mnm_washu_2016, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_msk_2025, ucec_ancestry_cds_msk_2023, ucec_tcga_pan_can_atlas_2018","Ampullary Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578553-7578553, hg19,17:7675235-7675235, hg38,17:7675235-7675235","hg19,17:g.7578553T>C, hg19,17:g.7675235T>C, hg38,17:g.7675235T>C",0.981,"bone, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, small_intestine, duodenum, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, Burkitt_lymphoma, sporadic_type, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, primitive_neuroectodermal_tumour-medulloblastoma, classic",,,,,458541,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1,1,Oncogenic,Neoplasm,1,Tier II - Potential,Synovial sarcoma,1
997,126,Y,D,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_dldccc_2022, breast_msk_2018, breast_msk_2025, ccle_broad_2019, coad_cptac_2019, coad_cptac_gdc, crc_apc_impact_2020, difg_glass, difg_glass_2019, difg_tcga_gdc, dlbcl_duke_2017, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, hcc_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lung_msk_pdx, mbn_msk_2024, mbn_sfu_2023, mds_mskcc_2020, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_icgc, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_mich, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub, ucec_ancestry_cds_msk_2023","Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578554-7578554, hg19,17:7675236-7675236, hg38,17:7675236-7675236","hg19,17:g.7578554A>C, hg19,17:g.7675236A>C, hg38,17:g.7675236A>C",0.979,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, rectum, liver, lung, oesophagus, pancreas, prostate, stomach, stomach, gastroesophageal_junction","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma",,,,,265333,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;not provided,1,,,,,,
998,126,Y,E,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
999,126,Y,F,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1000,126,Y,G,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1001,126,Y,H,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bowel_colitis_msk_2022, breast_msk_2025, cervix_msk_2023, crc_eo_2020, glioma_msk_2018, glioma_mskcc_2019, lihc_amc_prv, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019","Bowel, Cervix, Colorectal Adenocarcinoma, Diffuse Glioma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma","hg19,17:7578554-7578554, hg19,17:7675236-7675236, hg38,17:7675236-7675236","hg19,17:g.7578554A>G, hg19,17:g.7675236A>G, hg38,17:g.7675236A>G",0.961,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, mediastinum, haematopoietic_and_lymphoid_tissue, pelvis, haematopoietic_and_lymphoid_tissue, stomach, lung, oesophagus, oesophagus, lower_third, oesophagus, middle_third, stomach, urinary_tract, bladder, urachus","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, oligodendroglioma_Grade_III, anaplastic, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,,,,1734755,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1002,126,Y,I,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1003,126,Y,K,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1004,126,Y,L,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578553-7578554, hg38,17:7675235-7675236","hg19,17:g.7578553_7578554delinsAG, hg38,17:g.7675235_7675236delinsAG",,,,,,,,2687703,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1005,126,Y,M,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1006,126,Y,N,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, crc_sysucc_2022, hcc_inserm_fr_2015, hcc_tcga_gdc, ihch_msk_2021, ihch_mskcc_2020, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_tsp, mbn_sfu_2023, metastatic_solid_tumors_mich_2017, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_met_2021, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022","Bowel, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578554-7578554, hg19,17:7675236-7675236, hg38,17:7675236-7675236","hg19,17:g.7578554A>T, hg19,17:g.7675236A>T, hg38,17:g.7675236A>T",0.965,", breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, oesophagus, pancreas, thymus","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, thymic_carcinoma, undifferentiated_carcinoma",,,,,428871,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
1007,126,Y,P,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1008,126,Y,Q,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1009,126,Y,R,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1010,126,Y,S,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bowel_colitis_msk_2022, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pdac_msk_2024, sarcoma_msk_2022, stes_tcga_pub","Bowel, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Soft Tissue","hg19,17:7578553-7578553, hg19,17:7675235-7675235, hg38,17:7675235-7675235","hg19,17:g.7578553T>G, hg19,17:g.7675235T>G, hg38,17:g.7675235T>G",0.972,"biliary_tract, gallbladder, haematopoietic_and_lymphoid_tissue, liver, pancreas, prostate, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,1054765,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1011,126,Y,T,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1012,126,Y,V,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1013,126,Y,W,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1014,127,S,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1015,127,S,C,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, ccle_broad_2025, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, msk_chord_2024, nsclc_tcga_broad_2016, pan_origimed_2020, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578550-7578550, hg19,17:7675232-7675232, hg38,17:7675232-7675232","hg19,17:g.7578550G>C, hg19,17:g.7675232G>C, hg38,17:g.7675232G>C",0.916,"breast, central_nervous_system, lung, ovary","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, mucinous_carcinoma, other, embryonal_tumour",,,,,219532,Pathogenic,Li-Fraumeni syndrome,1,,,,,,
1016,127,S,D,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1017,127,S,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1018,127,S,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ampca_bcm_2016, bcc_unige_2016, blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_plasmacytoid_mskcc_2016, bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_cptac_2020, brca_metabric, brca_smc_2018, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccrcc_dfci_2019, cellline_ccle_broad, chol_icgc_2017, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_orion_2024, cscc_hgsc_bcm_2014, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_tmucih_2015, gbm_cptac_2021, gist_msk_2023, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, mbn_mdacc_2013, mel_dfci_2019, mel_iatlas_hugo_ucla_2016, mel_iatlas_liu_2019, mel_mskimpact_2020, mel_ucla_2016, mixed_impact_subset_2022, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_cptac_2021, paad_icgc, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_msk_stopsack_2021, prostate_msk_2024, ptad_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_broad, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, stad_utokyo, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_tcga_pan_can_atlas_2018","Adenoid Cystic Carcinoma, Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gastrointestinal Stromal Tumor, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Melanoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pituitary Adenoma, Prostate, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578549-7578550, hg19,17:7578550-7578550, hg19,17:7675232-7675232, hg38,17:7675231-7675232, hg38,17:7675232-7675232","hg19,17:g.7578549_7578550delinsAA, hg19,17:g.7578550G>A, hg19,17:g.7675232G>A, hg38,17:g.7675231_7675232delinsAA, hg38,17:g.7675232G>A",0.925,", biliary_tract, bile_duct, bone, extraskeletal, bone, pelvis, breast, central_nervous_system, brain, central_nervous_system, midbrain, endometrium, female_genital_tract_(site_indeterminate), gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, sigmoid, liver, lung, oesophagus, ovary, pancreas, penis, salivary_gland, skin, skin, back, skin, breast, skin, eye, skin, face, skin, head_neck, skin, scalp, skin, shoulder, small_intestine, small_intestine, ileum, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, urinary_tract, bladder, vulva","adnexal_tumour, malignant_adnexal_tumour, microcystic_adnexal_carcinoma, adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, chondrosarcoma, central, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_II, glioma, oligoastrocytoma_Grade_III, anaplastic, in_situ_epithelial_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, malignant_melanoma, malignant_melanoma, desmoplastic, malignant_melanoma, nodular, osteosarcoma, other, hamartoma",,,,,182928,Pathogenic/Likely pathogenic,"Hereditary cancer-predisposing syndrome;not specified;not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",2,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype;Diffuse midline glioma, H3 K27M-mutant;Rhabdomyosarcoma",1
1019,127,S,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1020,127,S,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1021,127,S,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1022,127,S,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1023,127,S,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1024,127,S,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1025,127,S,N,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1026,127,S,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","all_stjude_2016, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_dfci_2016, coadread_tcga, coadread_tcga_pub, luad_mskcc_2023_met_organotropism, lung_msk_2017, mbn_mdacc_2013, mel_mskimpact_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, read_tcga_gdc, sarcoma_msk_2022, sarcoma_msk_2023, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, uec_cptac_gdc","B-Lymphoblastic Leukemia/Lymphoma, Bladder/Urinary Tract, Breast, Colorectal Adenocarcinoma, Cutaneous Melanoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreas, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Uterine Endometrioid Carcinoma","hg19,17:7578551-7578551, hg19,17:7675233-7675233, hg38,17:7675233-7675233","hg19,17:g.7578551A>G, hg19,17:g.7675233A>G, hg38,17:g.7675233A>G",0.957,"biliary_tract, bile_duct, bone, breast, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, descending, large_intestine, rectum, large_intestine, right, lung, ovary","carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, medullary_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, mucinous_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, mantle_cell_lymphoma, osteosarcoma",,,,,934410,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Oncogenic,Neoplasm,1,,,
1027,127,S,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1028,127,S,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1029,127,S,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_aurora_2023, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, hcc_inserm_fr_2015, hcc_msk_2024, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, paad_qcmg_uq_2016, pan_origimed_2020, pancan_hcmi_2025, pdac_msk_2024","Colon Adenocarcinoma, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma","hg19,17:7578551-7578551, hg19,17:7675233-7675233, hg38,17:7675233-7675233","hg19,17:g.7578551A>T, hg19,17:g.7675233A>T, hg38,17:g.7675233A>T",0.924,"biliary_tract, gallbladder, breast, central_nervous_system, brain, large_intestine, large_intestine, colon, liver, oesophagus, oesophagus, upper_third, pancreas, pleura, stomach, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, mesothelioma, biphasic, primitive_neuroectodermal_tumour-medulloblastoma, large_cell",,,,,824232,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
1030,127,S,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1031,127,S,W,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1032,127,S,Y,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, blca_nmibc_2017, brca_cptac_2020, brca_msk_2025, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, breast_cptac_gdc, breast_msk_2018, breast_msk_2025, cscc_ucsf_2021, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, gbc_mskcc_2022, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, glioma_mskcc_2019, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, lung_msk_2017, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rcc_cptac_gdc, sarcoma_msk_2022, sarcoma_mskcc_2022, thyroid_gatci_2024, ucec_ancestry_cds_msk_2023, ucec_cptac_2020, ucec_msk_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucs_msk_2024, uec_cptac_gdc","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Renal Cell Carcinoma, Soft Tissue, Thyroid, Uterine Endometrioid Carcinoma","hg19,17:7578550-7578550, hg19,17:7675232-7675232, hg38,17:7675232-7675232","hg19,17:g.7578550G>T, hg19,17:g.7675232G>T, hg38,17:g.7675232G>T",0.918,", biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, lymph_node, liver, lung, oesophagus, ovary, pancreas, prostate, small_intestine, small_intestine, duodenum, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, oligoastrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, other, intraepithelial_neoplasia, high_grade, other, metaplasia, epidermoid, other, neoplasm, malignant",,,,,656751,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,,,
1033,128,P,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578548-7578548, hg38,17:7675230-7675230","hg19,17:g.7578548G>C, hg38,17:g.7675230G>C",0.482,"lung, salivary_gland, major","adenoma, pleomorphic, carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1034,128,P,C,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1035,128,P,D,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1036,128,P,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1037,128,P,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7578547-7578548","hg19,17:g.7578547_7578548delinsAA",,,,,,,,,,,,,,,,,
1038,128,P,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1039,128,P,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1040,128,P,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1041,128,P,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1042,128,P,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mbcproject_2022, mtnn_msk_2022","Invasive Breast Carcinoma, Mature T and NK Neoplasms","hg19,17:7578547-7578547, hg38,17:7675229-7675229","hg19,17:g.7578547G>A, hg38,17:g.7675229G>A",0.501,"breast, central_nervous_system, brain, lung, prostate","carcinoma, carcinoma, non_small_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, in_situ_neoplasm, glandular_intraepithelial_neoplasia_Grade_III",,,,,824286,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
1043,128,P,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1044,128,P,N,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1045,128,P,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1046,128,P,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578547-7578547, hg38,17:7675229-7675229","hg19,17:g.7578547G>C, hg38,17:g.7675229G>C",0.560,,,,,,,1718564,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
1047,128,P,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","crc_hta11_htan_2021, lung_msk_mind_2020, mel_dfci_2019, mel_iatlas_liu_2019, mel_mskimpact_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_pdmr_2025, tmb_mskcc_2018","Colorectal Adenocarcinoma, Cutaneous Melanoma, Lung, Melanoma, Mixed Cancer Types","hg19,17:7578548-7578548, hg19,17:7675230-7675230, hg38,17:7675230-7675230","hg19,17:g.7578548G>A, hg19,17:g.7675230G>A, hg38,17:g.7675230G>A",0.516,"breast, oesophagus, skin, stomach, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, fibroepithelial_neoplasm, phyllodes_tumour, benign, in_situ_epithelial_neoplasm, actinic_keratosis, malignant_melanoma",,,,,2687698,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1048,128,P,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578548-7578548, hg38,17:7675230-7675230","hg19,17:g.7578548G>T, hg38,17:g.7675230G>T",0.457,,,,,,,480743,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Breast and/or ovarian cancer;not provided,1,,,,,,
1049,128,P,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1050,128,P,W,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1051,128,P,Y,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1052,129,A,C,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1053,129,A,D,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578544-7578544, hg38,17:7675226-7675226","hg19,17:g.7578544G>T, hg38,17:g.7675226G>T",0.553,"soft_tissue, nerve_sheath",malignant_peripheral_nerve_sheath_tumour,,,,,1735669,Benign,Hereditary cancer-predisposing syndrome,1,,,,,,
1054,129,A,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1055,129,A,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1056,129,A,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578544-7578544, hg38,17:7675226-7675226","hg19,17:g.7578544G>C, hg38,17:g.7675226G>C",0.407,"large_intestine, colon","carcinoma, adenocarcinoma",,,,,458542,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1057,129,A,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1058,129,A,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1059,129,A,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1060,129,A,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1061,129,A,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1062,129,A,N,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1063,129,A,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1064,129,A,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1065,129,A,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1066,129,A,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024","Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578545-7578545, hg19,17:7578545-7578546, hg38,17:7675227-7675227","hg19,17:g.7578545C>A, hg19,17:g.7578545_7578546delinsAG, hg38,17:g.7675227C>A",0.475,,,,,,,824314,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1067,129,A,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578545-7578545, hg38,17:7675227-7675227","hg19,17:g.7578545C>T, hg38,17:g.7675227C>T",0.438,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, colon, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome",,,,,482217,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
1068,129,A,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",crc_sysucc_2022,Colorectal Adenocarcinoma,"hg19,17:7578544-7578544, hg38,17:7675226-7675226","hg19,17:g.7578544G>A, hg38,17:g.7675226G>A",0.468,"large_intestine, colon, lung, skin, face, stomach, upper_aerodigestive_tract, pharynx, oropharynx","adnexal_tumour, other, sebaceoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,133280,not provided,Familial cancer of breast,0,,,,,,
1069,129,A,W,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1070,129,A,Y,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 124-129, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1071,130,L,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1072,130,L,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1073,130,L,D,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578540-7578542, hg38,17:7675222-7675224","hg19,17:g.7578540_7578542delinsATC, hg38,17:g.7675222_7675224delinsATC",,,,,,,,2687693,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1074,130,L,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1075,130,L,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, bcc_unige_2016, blca_msk_2024, bm_nsclc_mskcc_2023, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, gbc_mskcc_2022, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gct_msk_2020, hcc_msk_2024, hcc_mskimpact_2018, hdcn_msk_2025, heme_msk_impact_2022, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, mbn_sfu_2023, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, pog570_bcgsc_2020, prad_broad, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Histiocytic and Dendritic Cell Neoplasms, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Testis","hg19,17:7578542-7578542, hg19,17:7675224-7675224, hg38,17:7675224-7675224","hg19,17:g.7578542G>A, hg19,17:g.7675224G>A, hg38,17:g.7675224G>A",0.921,"breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, central_nervous_system, parietooccipital, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, skin, back, skin, face, stomach, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, nodular, other, Barrett_oesophagus, with_high_grade_dysplasia, other, neoplasm",,,,,216466,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
1076,130,L,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1077,130,L,H,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","crc_apc_impact_2020, glioma_mskcc_2019, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024","Colorectal Adenocarcinoma, Diffuse Glioma, Mixed Cancer Types, Pancreas","hg19,17:7578541-7578541, hg38,17:7675223-7675223","hg19,17:g.7578541A>T, hg38,17:g.7675223A>T",0.924,"biliary_tract, bile_duct, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, rectum, oesophagus, lower_third, ovary, stomach, upper_aerodigestive_tract, mouth, gingiva, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, M4, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm",,,,,824351,Pathogenic,Hereditary cancer-predisposing syndrome,1,,,,,,
1078,130,L,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_met_2021, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7578542-7578542, hg38,17:7675224-7675224","hg19,17:g.7578542G>T, hg38,17:g.7675224G>T",0.795,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1079,130,L,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1080,130,L,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1081,130,L,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1082,130,L,P,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, brca_msk_2025, breast_msk_2025, egc_msk_tp53_ccr_2022, gbm_cptac_2021, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, hcc_msk_2024, lgggbm_tcga_pub, mbn_mdacc_2013, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, pdac_msk_2024","CNS/Brain, Diffuse Glioma, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreas","hg19,17:7578541-7578541, hg19,17:7675223-7675223, hg38,17:7675223-7675223","hg19,17:g.7578541A>G, hg19,17:g.7675223A>G, hg38,17:g.7675223A>G",0.927,"biliary_tract, gallbladder, breast, central_nervous_system, brain, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, colon, descending, stomach, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, M7, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,428873,Pathogenic,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome",2,,,,,,
1083,130,L,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1084,130,L,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, brca_mbcproject_2022, brca_mbcproject_wagle_2017, ccle_broad_2025, csf_msk_2024, difg_glass, difg_glass_2019, egc_msk_tp53_ccr_2022, hgsoc_msk_2021, lgg_ucsf_2014, luad_mskcc_2023_met_organotropism, mixed_impact_subset_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578541-7578541, hg19,17:7675223-7675223, hg38,17:7675223-7675223","hg19,17:g.7578541A>C, hg19,17:g.7675223A>C, hg38,17:g.7675223A>C",0.918,"breast, endometrium, haematopoietic_and_lymphoid_tissue, liver, lung, oesophagus, lower_third, ovary, pancreas, skin, mucosal, head_neck, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, malignant_melanoma",,,,,,,,,,,,,,
1085,130,L,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1086,130,L,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1087,130,L,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2024, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, cll_broad_2015, cll_broad_2022, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_tcga_gdc, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, glioma_msk_2018, glioma_mskcc_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_gdc, mds_iwg_2022, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, panet_msk_2018, panet_msk_erc_2023, pdac_msk_2024, sarcoma_msk_2022, stad_oncosg_2018, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, utuc_msk_2019, utuc_mskcc_2015","Bladder/Urinary Tract, Bowel, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine Tumor, Soft Tissue, Stomach Adenocarcinoma, Upper Tract Urothelial Carcinoma","hg19,17:7578542-7578542, hg19,17:7675224-7675224, hg38,17:7675224-7675224","hg19,17:g.7578542G>C, hg19,17:g.7675224G>C, hg38,17:g.7675224G>C",0.887,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, stomach, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, refractory_anaemia, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, other, neoplasm",,,,,458543,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,,,,,,
1088,130,L,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1089,130,L,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1090,131,N,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1091,131,N,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1092,131,N,D,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7578539-7578539","hg19,17:g.7578539T>C",0.724,,,,,,,,,,,,,,,,
1093,131,N,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1094,131,N,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1095,131,N,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1096,131,N,H,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578539-7578539, hg38,17:7675221-7675221","hg19,17:g.7578539T>G, hg38,17:g.7675221T>G",0.820,"large_intestine, colon, pancreas","adenoma, tubular, carcinoma, ductal_carcinoma",,,,,4279056,Likely pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 1",1,,,,,,
1097,131,N,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_bccrc, brca_metabric, breast_msk_2025, crc_eo_2020, crc_sysucc_2022, glioma_mskcc_2019, hcc_clca_2024, hgsoc_tcga_gdc, hnc_mskcc_2016, lihc_amc_prv, lms_msk_2024, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2023_met_organotropism, lung_msk_2017, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, mel_mskimpact_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022","Bowel, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Head and Neck, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578538-7578538, hg19,17:7675220-7675220, hg38,17:7675220-7675220","hg19,17:g.7578538T>A, hg19,17:g.7675220T>A, hg38,17:g.7675220T>A",0.939,", breast, central_nervous_system, basal_ganglia, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, kidney, liver, lung, ovary, pancreas, skin, skin, head_neck, upper_aerodigestive_tract, larynx, urinary_tract, bladder","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,428902,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
1098,131,N,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2025, luad_mskcc_2023_met_organotropism, lung_msk_2017, mds_mskcc_2020, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7578537-7578537, hg19,17:7675219-7675219, hg38,17:7675219-7675219","hg19,17:g.7578537G>C, hg19,17:g.7578537G>T, hg19,17:g.7675219G>T, hg38,17:g.7675219G>C, hg38,17:g.7675219G>T","0.661, 0.662","large_intestine, lung, oesophagus, skin","carcinoma, adenocarcinoma, malignant_melanoma",0.0000119697404960,0.0000318613394507,,,246429,Uncertain significance,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",3,,,,,,
1099,131,N,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1100,131,N,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1101,131,N,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1102,131,N,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1103,131,N,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1104,131,N,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","cfdna_msk_2019, crc_eo_2020, crc_msk_2017, difg_tcga_gdc, gbc_mskcc_2022, hcc_msk_2024, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578538-7578538, hg19,17:7675220-7675220, hg38,17:7675220-7675220","hg19,17:g.7578538T>C, hg19,17:g.7675220T>C, hg38,17:g.7675220T>C",0.859,"breast, central_nervous_system, brain, large_intestine, caecum, large_intestine, rectum, liver, lung, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, glioma",,,,,1057941,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,Uncertain significance,Neoplasm,1,,,
1105,131,N,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_met_2021, paired_bladder_2022, pancan_hcmi_2025, thyroid_gatci_2024","Bladder/Urinary Tract, Mixed Cancer Types, Thyroid","hg19,17:7578538-7578538, hg19,17:7675220-7675220, hg38,17:7675220-7675220","hg19,17:g.7578538T>G, hg19,17:g.7675220T>G, hg38,17:g.7675220T>G",0.907,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1106,131,N,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1107,131,N,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1108,131,N,Y,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, breast_msk_2025, hccihch_pku_2019, luad_cas_2020, mixed_allen_2018, msk_chord_2024, msk_met_2021, pan_origimed_2020, pdac_msk_2024, sarcoma_msk_2022","Adenoid Cystic Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Soft Tissue","hg19,17:7578539-7578539, hg38,17:7675221-7675221","hg19,17:g.7578539T>A, hg38,17:g.7675221T>A",0.879,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, liver, lung, ovary, pancreas, urinary_tract","carcinoid-endocrine_tumour, non_functioning, carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, serous_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,141988,Pathogenic,Hereditary cancer-predisposing syndrome,1,Likely oncogenic,Neoplasm,1,,,
1109,132,K,A,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1110,132,K,C,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1111,132,K,D,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1112,132,K,E,,,Ubq,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, blca_bcan_hcrn_2022, bm_nsclc_mskcc_2023, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, csf_msk_2024, gbc_msk_2018, glioma_mskcc_2019, hcc_msk_2024, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lusc_tcga_pan_can_atlas_2018, mds_mskcc_2020, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prostate_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, soft_tissue_tcga_gdc, stad_oncosg_2018, stad_pfizer_uhongkong, tmb_mskcc_2018","Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578536-7578536, hg19,17:7675218-7675218, hg38,17:7675218-7675218","hg19,17:g.7578536T>C, hg19,17:g.7675218T>C, hg38,17:g.7675218T>C",0.968,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, parietal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, sigmoid, lung, oesophagus, ovary, pancreas, skin, head_neck, skin, scalp, soft_tissue, soft_tissue, striated_muscle, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, mixed_acinar-neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_I, pilocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, lymphoid_neoplasm, lymphoid_neoplasm, anaplastic_large_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, desmoplastic, rhabdomyosarcoma, sarcoma",0.0000039885448990,,,,376626,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
1113,132,K,F,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1114,132,K,G,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1115,132,K,H,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1116,132,K,I,,,Ubq,,,,,,,,PhosphoSite,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578534-7578535","hg19,17:g.7578534_7578535delinsAA",,,,,,,,,,,,,,,,,
1117,132,K,L,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1118,132,K,M,,,Ubq,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, brca_mbcproject_2022, ccle_broad_2019, ccle_broad_2025, gbm_mayo_pdx_sarkaria_2019, glioma_mskcc_2019, hgsoc_tcga_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_access_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, sarcoma_msk_2022, ucs_jhu_2014","Bladder/Urinary Tract, Diffuse Glioma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578535-7578535, hg19,17:7675217-7675217, hg38,17:7675217-7675217","hg19,17:g.7578535T>A, hg19,17:g.7675217T>A, hg38,17:g.7675217T>A",,"bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, endometrium, haematopoietic_and_lymphoid_tissue, kidney, liver, lung, oesophagus, ovary, pancreas, prostate, skin, upper_aerodigestive_tract, mouth, urinary_tract","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, other, neoplasm",,,,,376629,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
1119,132,K,N,,,Ubq,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_tcga, acc_tcga_gdc, acc_tcga_pan_can_atlas_2018, ampca_bcm_2016, blca_bcan_hcrn_2022, blca_bgi, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brca_bccrc, brca_cptac_2020, brca_igr_2015, brca_metabric, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cesc_tcga, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, chol_icgc_2017, cll_broad_2022, cll_iuopa_2015, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_tcga_gdc, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, gct_msk_2016, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lusc_tcga_gdc, mbn_mdacc_2013, mds_mskcc_2020, mel_mskimpact_2020, meso_tcga, meso_tcga_pan_can_atlas_2018, mixed_allen_2018, mixed_impact_subset_2022, mixed_selpercatinib_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, plmeso_tcga_gdc, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, rectal_radiation_msk_2024, sarcoma_msk_2022, thyroid_gatci_2024, ucec_ancestry_cds_msk_2023, ucs_msk_2024, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Adrenocortical Carcinoma, Ampullary Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervical Squamous Cell Carcinoma, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Testis, Thyroid, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578534-7578534, hg19,17:7675216-7675216, hg38,17:7675216-7675216","hg19,17:g.7578534C>A, hg19,17:g.7578534C>G, hg19,17:g.7675216C>A, hg19,17:g.7675216C>G, hg38,17:g.7675216C>A, hg38,17:g.7675216C>G",,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, cervix, endometrium, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, sigmoid, liver, lung, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, penis, pleura, prostate, skin, soft_tissue, striated_muscle, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, tongue, urinary_tract, urinary_tract, bladder, urinary_tract, renal_pelvis",", adrenal_cortical_carcinoma, adrenal_cortical_carcinoma, functioning, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, micropapillary_transitional_cell_carcinoma, germ_cell_tumour, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, mesothelioma, other, neoplasm, rhabdomyosarcoma, alveolar",,,,,"634773, 376624","Pathogenic/Likely pathogenic, Likely pathogenic",Ovarian neoplasm;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome|not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck,"2, 3","Oncogenic, Likely oncogenic",Neoplasm|Neoplasm,"1, 1",Tier I - Strong,Choroid plexus carcinoma,1
1120,132,K,P,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1121,132,K,Q,,,Ubq,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_sysucc_2022, egc_msk_2023, egc_mskcc_2020, glioma_mskcc_2019, hccihch_pku_2019, luad_mskcc_2023_met_organotropism, lung_nci_2022, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_iwg_2022, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, pan_origimed_2020, pancan_pcawg_2020, pdac_msk_2024, ucec_ancestry_cds_msk_2023","Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma","hg19,17:7578536-7578536, hg19,17:7675218-7675218, hg38,17:7675218-7675218","hg19,17:g.7578536T>G, hg19,17:g.7675218T>G, hg38,17:g.7675218T>G",0.944,", breast, central_nervous_system, brain, fallopian_tube, haematopoietic_and_lymphoid_tissue, large_intestine, lung, ovary, pancreas, prostate, skin, soft_tissue, smooth_muscle, uterus, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M4, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, M4, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, B_cell_prolymphocytic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma",,,,,376628,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Adrenocortical carcinoma, hereditary",1,,,,,,
1122,132,K,R,,,Ubq,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, appendiceal_msk_2022, bladder_msk_2024, blca_bcan_hcrn_2022, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brain_cptac_gdc, brca_dldccc_2022, brca_metabric, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_sysucc_2022, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, gbm_cptac_2021, gist_msk_2023, hcc_msk_2024, hccihch_pku_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, ihch_msk_2021, ihch_smmu_2014, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, mds_iwg_2022, mds_mskcc_2020, mixed_cfdna_msk_2020, mixed_selpercatinib_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, rectal_radiation_msk_2024, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, soft_tissue_tcga_gdc, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Acute Myeloid Leukemia, Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature T and NK Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578535-7578535, hg19,17:7675217-7675217, hg38,17:7675217-7675217","hg19,17:g.7578535T>C, hg19,17:g.7675217T>C, hg38,17:g.7675217T>C",,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, peritoneum, pleura, prostate, soft_tissue, stomach, thyroid, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, upper_urinary_tract","adenoma-nodule-goitre, Hurthle_cell_tumour, carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, myelofibrosis, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, mesothelioma, other, dysplasia, other, neoplasm, sarcoma",0.0000000000000000,,,,376625,Pathogenic/Likely pathogenic,"TP53-related disorder;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Bone marrow failure syndrome 5;not provided;Li-Fraumeni syndrome 1",2,Likely oncogenic,Neoplasm,1,,,
1123,132,K,S,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1124,132,K,T,,,Ubq,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cfdna_msk_2019, coad_tcga_gdc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_sysucc_2022, csf_msk_2024, mbn_msk_2024, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_met_2021, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_p1000, prad_su2c_2015, prad_su2c_2019, rectal_msk_2022, ucec_ancestry_cds_msk_2023","Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma","hg19,17:7578535-7578535, hg19,17:7675217-7675217, hg38,17:7675217-7675217","hg19,17:g.7578535T>G, hg19,17:g.7675217T>G, hg38,17:g.7675217T>G",,"biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, mediastinum, large_intestine, colon, sigmoid, liver, lung, ovary, pancreas, prostate, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,376627,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1125,132,K,V,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1126,132,K,W,,,Ubq,,,,,,,,PhosphoSite,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675217-7675218","hg38,17:g.7675217_7675218delinsCA",,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
1127,132,K,Y,,,Ubq,,,,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1128,133,M,A,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1129,133,M,C,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1130,133,M,D,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1131,133,M,E,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1132,133,M,F,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1133,133,M,G,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1134,133,M,H,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1135,133,M,I,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hcc_clca_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, sarcoma_msk_2022","Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7578531-7578531, hg38,17:7675213-7675213","hg19,17:g.7578531C>A, hg19,17:g.7578531C>T, hg38,17:g.7675213C>A, hg38,17:g.7675213C>G, hg38,17:g.7675213C>T","0.477, 0.479","breast, large_intestine, colon, descending, liver, lung","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma",0.0000079728286001,,,,421437,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,,,,,,
1136,133,M,K,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_mskcc, crc_eo_2020, cscc_ucsf_2021, gbc_msk_2018, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lms_msk_2024, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, os_target_gdc, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pdac_msk_2024, prostate_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Bowel, Breast, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Endometrial Carcinoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Osteosarcoma, Pancreas, Prostate, Soft Tissue","hg19,17:7578532-7578532, hg19,17:7675214-7675214, hg38,17:7675214-7675214","hg19,17:g.7578532A>T, hg19,17:g.7675214A>T, hg38,17:g.7675214A>T",0.845,"breast, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, soft_tissue, large_intestine, colon, large_intestine, colon, right, oesophagus, oesophagus, lower_third, pancreas, prostate, skin, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, stomach, thymus, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, M6, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, thymic_carcinoma, undifferentiated-unclassified_sarcoma, mixed",,,,,2430159,Uncertain significance,Li-Fraumeni syndrome;Breast carcinoma,1,Likely oncogenic,Neoplasm,1,,,
1137,133,M,L,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",sarcoma_msk_2022,Soft Tissue,"hg19,17:7578533-7578533, hg38,17:7675215-7675215","hg19,17:g.7578533T>A, hg38,17:g.7675215T>A, hg38,17:g.7675215T>G",0.426,"genital_tract, extragonadal, brain, large_intestine","carcinoma, adenocarcinoma, germ_cell_tumour, seminoma",,,,,,,,,,,,,,
1138,133,M,N,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1139,133,M,P,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1140,133,M,Q,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1141,133,M,R,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, brca_smc_2018, breast_ink4_msk_2021, breast_msk_2018, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_sysucc_2022, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_impact_2017, msk_met_2021, paad_qcmg_uq_2016, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma","hg19,17:7578532-7578532, hg19,17:7675214-7675214, hg38,17:7675214-7675214","hg19,17:g.7578532A>C, hg19,17:g.7675214A>C, hg38,17:g.7675214A>C",0.849,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, colon, descending, lung, oesophagus, lower_third, pancreas, skin, stomach, thyroid, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, angioimmunoblastic_T_cell_lymphoma",,,,,2687699,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1142,133,M,S,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1143,133,M,T,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_glass, difg_glass_2019, lung_msk_pdx, lung_pdx_msk_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022","Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Lung, Mixed Cancer Types, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578532-7578532, hg38,17:7675214-7675214","hg19,17:g.7578532A>G, hg38,17:g.7675214A>G",0.780,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, rectum, liver, stomach, thyroid, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, papillary_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, lymphoid_neoplasm, plasma_cell_myeloma",,,,,12357,Pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
1144,133,M,V,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578533-7578533, hg38,17:7675215-7675215","hg19,17:g.7578533T>C, hg38,17:g.7675215T>C",0.503,"central_nervous_system, frontal_lobe, large_intestine, rectum","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000039868275219,,,,528246,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1145,133,M,W,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1146,133,M,Y,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1147,134,F,A,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1148,134,F,C,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_smc_2018, breast_msk_2018, breast_msk_2025, ccle_broad_2019, cellline_ccle_broad, chol_icgc_2017, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prostate_msk_2024, sarcoma_msk_2022, stad_tcga, stes_tcga_pub, ucec_ancestry_cds_msk_2023, ucec_msk_2018, uec_cptac_gdc","Bowel, Breast, Cholangiocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Prostate, Soft Tissue, Stomach Adenocarcinoma, Uterine Endometrioid Carcinoma","hg19,17:7578529-7578529, hg19,17:7675211-7675211, hg38,17:7675211-7675211","hg19,17:g.7578529A>C, hg19,17:g.7675211A>C, hg38,17:g.7675211A>C",0.949,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, spleen, large_intestine, colon, ascending, large_intestine, rectum, lung, ovary, pancreas, soft_tissue, smooth_muscle, uterus, stomach, upper_aerodigestive_tract, larynx, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, leiomyosarcoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",0.0000039849845781,,,,230477,Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,2,,,,,,
1149,134,F,D,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1150,134,F,E,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1151,134,F,G,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1152,134,F,H,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1153,134,F,I,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, luad_mskcc_2023_met_organotropism, mds_mskcc_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pancan_mimsi_msk_2024, pancreas_msk_2024, pdac_msk_2024","Appendiceal Adenocarcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas","hg19,17:7578530-7578530, hg38,17:7675212-7675212","hg19,17:g.7578530A>T, hg38,17:g.7675212A>T",0.955,"breast, haematopoietic_and_lymphoid_tissue, oesophagus, oesophagus, middle_third, pancreas, upper_aerodigestive_tract, mouth, cheek","carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, ductal_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,480953,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,2,,,,,,
1154,134,F,K,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1155,134,F,L,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_metabric, breast_msk_2025, ccle_broad_2019, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, dlbc_broad_2012, dlbcl_dfci_2018, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, ihch_smmu_2014, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, lung_msk_2017, lung_nci_2022, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, mel_iatlas_hugo_ucla_2016, mel_ucla_2016, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, nsclc_tracerx_2017, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prostate_pcbm_swiss_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub, tmb_mskcc_2018, uccc_nih_2017, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Basal Cell Carcinoma, Bowel, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Soft Tissue, Stomach Adenocarcinoma, Uterine Clear Cell Carcinoma","hg19,17:7578528-7578528, hg19,17:7578530-7578530, hg19,17:7675210-7675210, hg19,17:7675212-7675212, hg38,17:7675210-7675210, hg38,17:7675212-7675212","hg19,17:g.7578528A>C, hg19,17:g.7578528A>T, hg19,17:g.7578530A>G, hg19,17:g.7675210A>T, hg19,17:g.7675212A>G, hg38,17:g.7675210A>C, hg38,17:g.7675210A>T, hg38,17:g.7675212A>G","0.872, 0.942",", biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, kidney, large_intestine, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, skin, head_neck, stomach, upper_aerodigestive_tract, head_neck, vulva","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_melanoma, desmoplastic, other, neoplasm",,,,,"1018290, 871293, 80710","Uncertain significance, Conflicting classifications of pathogenicity, Uncertain significance",Hereditary cancer-predisposing syndrome;TP53-related disorder;Li-Fraumeni syndrome|Li-Fraumeni syndrome;not provided;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1|Li-Fraumeni syndrome,"1, 1, 1",Likely oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse glioma, H3 G34 mutant;Embryonal rhabdomyosarcoma",1
1156,134,F,M,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1157,134,F,N,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1158,134,F,P,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1159,134,F,Q,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1160,134,F,R,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1161,134,F,S,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, breast_msk_2025, ccle_broad_2025, coadread_dfci_2016, csf_msk_2024, esca_broad, gbc_mskcc_2022, glioma_mskcc_2019, hcc_msk_2024, mbn_msk_2024, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Adenoid Cystic Carcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Soft Tissue","hg19,17:7578529-7578529, hg19,17:7675211-7675211, hg38,17:7675211-7675211","hg19,17:g.7578529A>G, hg19,17:g.7675211A>G, hg38,17:g.7675211A>G",0.942,"biliary_tract, gallbladder, bone, femur, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, descending, large_intestine, colon, sigmoid, oesophagus, skin","adenoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, Burkitt_lymphoma, sporadic_type, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, osteosarcoma, high_grade_surface",,,,,1519634,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1162,134,F,T,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1163,134,F,V,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, brca_metabric, breast_msk_2018, breast_msk_2025, crc_sysucc_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, kirc_bgi, luad_msk_npjpo_2021, luad_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024","Bladder Urothelial Carcinoma, Breast, Colorectal Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Prostate, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma","hg19,17:7578530-7578530, hg19,17:7675212-7675212, hg38,17:7675212-7675212","hg19,17:g.7578530A>C, hg19,17:g.7675212A>C, hg38,17:g.7675212A>C",0.959,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, kidney, large_intestine, large_intestine, colon, lung, ovary, pancreas, prostate, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_small_cell_carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,988615,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Familial cancer of breast,1,,,,,,
1164,134,F,W,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1165,134,F,Y,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578529-7578529, hg38,17:7675211-7675211","hg19,17:g.7578529A>T, hg38,17:g.7675211A>T",0.637,,,,,,,1509393,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1166,135,C,A,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1167,135,C,D,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1168,135,C,E,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1169,135,C,F,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, bcc_unige_2016, bm_nsclc_mskcc_2023, brca_broad, brca_metabric, brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_cptac_2019, coad_cptac_gdc, coad_silu_2022, coadread_dfci_2016, crc_eo_2020, crc_msk_2017, crc_orion_2024, crc_sysucc_2022, cscc_ranson_2022, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, es_dfarber_broad_2014, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, hcc_msk_2024, heme_msk_impact_2022, ihch_msk_2021, ihch_mskcc_2020, luad_broad, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, mel_dfci_2019, mel_iatlas_liu_2019, mixed_selpercatinib_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ohnca_cptac_gdc, paac_msk_jco_2023, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pptc_2019, prad_p1000, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, rcc_iatlas_immotion150_2018, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Acinar Cell Carcinoma of the Pancreas, Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Head and Neck Carcinoma, Other, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate Adenocarcinoma, Renal Cell Carcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578525-7578526, hg19,17:7578526-7578526, hg19,17:7675208-7675208, hg38,17:7675208-7675208","hg19,17:g.7578525_7578526delinsAA, hg19,17:g.7578526C>A, hg19,17:g.7675208C>A, hg38,17:g.7675208C>A",0.960,", adrenal_gland, adrenal_gland, biliary_tract, gallbladder, bone, bone, scapula, breast, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, penis, pituitary, prostate, salivary_gland, skin, soft_tissue, blood_vessel, liver, soft_tissue, fat, stomach, stomach, gastroesophageal_junction, testis, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, bladder, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, adrenal_cortical_adenoma, angiosarcoma, carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, basal_cell_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, luminal_A_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, mixed_acinar-neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, renal_cell_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, tubular_adenocarcinoma, germ_cell_tumour, mixed, haematopoietic_neoplasm, acute_myeloid_leukaemia, liposarcoma, pleomorphic, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma",,,,,376559,Pathogenic/Likely pathogenic,Adrenal cortex carcinoma;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,2,,,,Tier I - Strong,Pleuropulmonary blastoma;Embryonal rhabdomyosarcoma,1
1170,135,C,G,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","cll_broad_2022, egc_msk_2017, egc_msk_2023, escc_icgc, luad_cptac_gdc, msk_impact_2017, msk_met_2021, pancan_hcmi_2025","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578527-7578527, hg19,17:7675209-7675209, hg38,17:7675209-7675209","hg19,17:g.7578527A>C, hg19,17:g.7675209A>C, hg38,17:g.7675209A>C",0.965,"breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, rectum, lung, oesophagus, penis, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,376563,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Ovarian neoplasm;Li-Fraumeni syndrome,3,,,,,,
1171,135,C,H,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1172,135,C,I,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1173,135,C,K,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1174,135,C,L,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1175,135,C,M,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1176,135,C,N,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1177,135,C,P,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1178,135,C,Q,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1179,135,C,R,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, lgg_ucsf_2014, luad_mskcc_2023_met_organotropism, mbn_mdacc_2013, mpcproject_broad_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tracerx_2017, ov_tcga, ov_tcga_pub, pan_origimed_2020, pancan_mappyacts_2022, pancan_pcawg_2020, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_tcga_gdc, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga_pan_can_atlas_2018","Bowel, Cholangiocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578527-7578527, hg19,17:7675209-7675209, hg38,17:7675209-7675209","hg19,17:g.7578527A>G, hg19,17:g.7675209A>G, hg38,17:g.7675209A>G",0.964,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, extraskeletal, breast, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, transverse, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, skin, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, back, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, gingiva, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, follicular_lymphoma, malignant_melanoma, osteosarcoma, sarcoma, undifferentiated_sarcoma, pleomorphic",,,,,376560,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
1180,135,C,S,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bgi, coad_tcga_gdc, coadread_tcga, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, heme_msk_impact_2022, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, mbn_msk_2024, mds_iwg_2022, mixed_allen_2018, mpcproject_broad_2021, msk_access_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_hcmi_2025, rectal_msk_2019, tmb_mskcc_2018, utuc_cornell_baylor_mdacc_2019","Bladder Urothelial Carcinoma, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Upper Tract Urothelial Carcinoma","hg19,17:7578526-7578526, hg19,17:7578527-7578527, hg19,17:7675208-7675208, hg38,17:7675208-7675208, hg38,17:7675209-7675209","hg19,17:g.7578526C>G, hg19,17:g.7578527A>T, hg19,17:g.7675208C>G, hg38,17:g.7675208C>G, hg38,17:g.7675209A>T","0.954, 0.957","bone, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, sigmoid, large_intestine, rectum, oesophagus, skin, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, myeloproliferative_neoplasm, lymphoid_neoplasm, B_cell_lymphoma_unspecified, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, malignant_melanoma",,,,,"3893309, 376562","Likely pathogenic, Conflicting classifications of pathogenicity",not provided|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"1, 1",,,,,,
1181,135,C,T,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675208-7675210","hg38,17:g.7675208_7675210delinsGTG",,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1182,135,C,V,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1183,135,C,W,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_fuscc_2020, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, coad_silu_2022, coadread_dfci_2016, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_tracerx_2017, os_target_gdc, pan_origimed_2020, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, pediatric_dkfz_2017, prad_cpcg_2017, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prad_tcga, prad_tcga_pan_can_atlas_2018, prostate_msk_2024, sarcoma_msk_2022, thyroid_gatci_2024, ucec_ancestry_cds_msk_2023","Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Osteosarcoma, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Thyroid","hg19,17:7578525-7578525, hg19,17:7675207-7675207, hg38,17:7675207-7675207","hg19,17:g.7578525G>C, hg19,17:g.7675207G>C, hg38,17:g.7675207G>C",0.884,"adrenal_gland, adrenal_gland, biliary_tract, gallbladder, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, lung, oesophagus, ovary, pancreas, pleura, prostate, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, urinary_tract, bladder","adenoma, adrenal_cortical_adenoma, adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, mesothelioma, epithelial, other, neoplasm",,,,,376561,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
1184,135,C,X,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,COSMIC,,,,,,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
1185,135,C,Y,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_tcga, acc_tcga_pan_can_atlas_2018, appendiceal_msk_2022, blca_bcan_hcrn_2022, blca_msk_2025, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brain_cptac_gdc, brca_dfci_2020, brca_iatlas_anders_2022, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_cptac_2021, gbm_mayo_pdx_sarkaria_2019, gbm_tcga_pub, glioma_mskcc_2019, hccihch_pku_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, mds_mskcc_2020, mixed_pipseq_2017, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mich, prad_msk_stopsack_2021, prad_p1000, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, summit_2018, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Adrenocortical Carcinoma, Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Thyroid","hg19,17:7578526-7578526, hg19,17:7675208-7675208, hg38,17:7675208-7675208","hg19,17:g.7578526C>T, hg19,17:g.7675208C>T, hg38,17:g.7675208C>T",0.955,"adrenal_gland, adrenal_gland, autonomic_ganglia, biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, ovary, pancreas, prostate, skin, skin, head_neck, skin, mucosal, sinonasal, small_intestine, duodenum, small_intestine, ileum, soft_tissue, striated_muscle, stomach, stomach, gastroesophageal_junction, testis, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, urinary_tract, bladder, vulva","adrenal_cortical_carcinoma, adrenal_cortical_carcinoma, functioning, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, micropapillary, carcinoma, ductolobular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, lobular_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, epithelioid, neuroblastoma, other, hyperplasia, other, neoplasm, papilloma, typical, primitive_neuroectodermal_tumour-medulloblastoma, large_cell, rhabdomyosarcoma, embryonal, sex_cord-stromal_tumour, Leydig_cell_tumour, thymic_carcinoma, poorly_differentiated",0.0000000000000000,,,,141762,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
1186,136,Q,A,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1187,136,Q,C,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1188,136,Q,D,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1189,136,Q,E,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mbcproject_2022, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, cervix_msk_2023, crc_sysucc_2022, difg_tcga_gdc, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, glioma_msk_2018, glioma_mskcc_2019, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, luad_oncosg_2020, lusc_tcga_gdc, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_su2c_2019, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Breast, Cervix, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578524-7578524, hg19,17:7675206-7675206, hg38,17:7675206-7675206","hg19,17:g.7578524G>C, hg19,17:g.7675206G>C, hg38,17:g.7675206G>C",0.862,", breast, central_nervous_system, brain, cervix, endometrium, liver, lung, oesophagus, pancreas, stomach, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, other, intraepithelial_neoplasia, low_grade",,,,,480751,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
1190,136,Q,F,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1191,136,Q,G,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1192,136,Q,H,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, hcc_clca_2024, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, msk_chord_2024, msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7578522-7578522, hg19,17:7675204-7675204, hg38,17:7675204-7675204","hg19,17:g.7578522T>A, hg19,17:g.7578522T>G, hg19,17:g.7675204T>A, hg38,17:g.7675204T>A, hg38,17:g.7675204T>G",0.946,"biliary_tract, gallbladder, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, lung, prostate, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, anaplastic_large_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,"482213, 186301","Uncertain significance, Uncertain significance",Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,"2, 2",,,,,,
1193,136,Q,I,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1194,136,Q,K,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675206-7675206","hg38,17:g.7675206G>T",0.869,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1195,136,Q,L,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hccihch_pku_2019, nccrcc_genentech_2014","Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Renal Non-Clear Cell Carcinoma","hg19,17:7578523-7578523, hg38,17:7675205-7675205","hg19,17:g.7578523T>A, hg38,17:g.7675205T>A",0.959,"kidney, urinary_tract","carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,3906024,Uncertain significance,not provided,1,,,,,,
1196,136,Q,M,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1197,136,Q,N,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1198,136,Q,P,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, breast_msk_2025, difg_glass, difg_glass_2019, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lung_pdx_msk_2021, mds_mskcc_2020, mixed_impact_subset_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, sarcoma_msk_2022","Diffuse Glioma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Soft Tissue","hg19,17:7578523-7578523, hg19,17:7675205-7675205, hg38,17:7675205-7675205","hg19,17:g.7578523T>G, hg19,17:g.7675205T>G, hg38,17:g.7675205T>G",0.964,", breast, large_intestine, colon, liver, lung, ovary, skin, skin, head_neck, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,580807,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
1199,136,Q,R,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675205-7675205","hg38,17:g.7675205T>C",0.877,"breast, urinary_tract, bladder","carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1200,136,Q,S,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1201,136,Q,T,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1202,136,Q,V,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1203,136,Q,W,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1204,136,Q,Y,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1205,137,L,A,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1206,137,L,C,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1207,137,L,D,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1208,137,L,E,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578520-7578521, hg38,17:7675202-7675203","hg19,17:g.7578520_7578521delinsTC, hg38,17:g.7675202_7675203delinsTC",,,,,,,,1713937,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1209,137,L,F,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1210,137,L,G,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1211,137,L,H,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1212,137,L,I,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1213,137,L,K,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1214,137,L,M,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675203-7675203","hg38,17:g.7675203G>T",0.637,"ovary, skin, head_neck","carcinoma, basal_cell_carcinoma, carcinoma, serous_carcinoma",,,,,,,,,,,,,,
1215,137,L,N,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1216,137,L,P,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675202-7675202","hg38,17:g.7675202A>G",0.950,"haematopoietic_and_lymphoid_tissue, prostate, stomach","carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome",,,,,,,,,,,,,,
1217,137,L,Q,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, brca_metabric, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2025, chol_msk_2018, crc_orion_2024, dlbcl_duke_2017, escc_ucla_2014, hcc_msk_2024, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lung_msk_2017, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pdac_msk_2024, sarcoma_msk_2022","Bowel, Breast, Cholangiocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue","hg19,17:7578520-7578520, hg19,17:7675202-7675202, hg38,17:7675202-7675202","hg19,17:g.7578520A>T, hg19,17:g.7675202A>T, hg38,17:g.7675202A>T",0.951,"biliary_tract, bile_duct, breast, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, right, lung, oesophagus, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, lymphoid_neoplasm, plasma_cell_myeloma",,,,,3972459,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1218,137,L,R,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1219,137,L,S,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1220,137,L,T,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1221,137,L,V,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_met_2021, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7578521-7578521, hg38,17:7675203-7675203","hg19,17:g.7578521G>C, hg38,17:g.7675203G>C",0.731,"haematopoietic_and_lymphoid_tissue, oesophagus","carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,1005829,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1222,137,L,W,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1223,137,L,Y,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1224,138,A,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1225,138,A,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578517-7578517, hg38,17:7675199-7675199","hg19,17:g.7578517G>T, hg38,17:g.7675199G>T",0.901,"biliary_tract, gallbladder, endometrium, haematopoietic_and_lymphoid_tissue","carcinoma, adenocarcinoma, carcinoma, undifferentiated_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,528270,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
1226,138,A,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1227,138,A,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1228,138,A,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578517-7578517, hg38,17:7675199-7675199","hg19,17:g.7578517G>C, hg38,17:g.7675199G>C",0.842,,,,,,,1375764,Uncertain significance,"Prostate cancer, hereditary, 1;Li-Fraumeni syndrome",3,,,,,,
1229,138,A,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1230,138,A,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1231,138,A,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1232,138,A,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1233,138,A,M,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1234,138,A,N,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1235,138,A,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_fuscc_2020, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_mskcc, crc_eo_2020, crc_msk_2017, egc_msk_tp53_ccr_2022, glioma_mskcc_2019, hccihch_pku_2019, hnsc_broad, lusc_cptac_2021, lusc_cptac_gdc, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rcc_iatlas_immotion150_2018, sarcoma_msk_2022, sarcoma_mskcc_2022","Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Pancreas, Prostate, Prostate Adenocarcinoma, Renal Cell Carcinoma, Soft Tissue","hg19,17:7578518-7578518, hg19,17:7675200-7675200, hg38,17:7675200-7675200","hg19,17:g.7578518C>G, hg19,17:g.7675200C>G, hg38,17:g.7675200C>G",0.949,"breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, colon, sigmoid, lung, oesophagus, oesophagus, middle_third, ovary, skin, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, adenosarcoma, other, neoplasm, malignant",,,,,12376,Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
1236,138,A,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1237,138,A,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1238,138,A,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675200-7675200","hg38,17:g.7675200C>A",0.911,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1239,138,A,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_2020, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, lgggbm_tcga_pub, luad_msk_npjpo_2021, mds_iwg_2022, msk_chord_2024, msk_met_2021, pancan_pdmr_2025, ucec_tcga_pan_can_atlas_2018","CNS/Brain, Diffuse Glioma, Endometrial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7578518-7578518, hg19,17:7675200-7675200, hg38,17:7675200-7675200","hg19,17:g.7578518C>T, hg19,17:g.7675200C>T, hg38,17:g.7675200C>T",0.910,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, large_intestine, rectum, pancreas, soft_tissue, blood_vessel, chest, upper_aerodigestive_tract, mouth","angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, secretory, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,1053218,Uncertain significance,"Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",3,,,,,,
1240,138,A,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_mskcc_solit_2014, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, chol_icgc_2017, cll_broad_2022, coad_cptac_2019, coad_cptac_gdc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, cscc_hgsc_bcm_2014, csf_msk_2024, difg_glass, difg_glass_2019, egc_msk_2023, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_msk_2024, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lung_pdx_msk_2021, mbn_sfu_2023, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_pik3r1_msk_2021, prostate_msk_2024, read_tcga_gdc, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bowel, Breast, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7578517-7578517, hg19,17:7675199-7675199, hg38,17:7675198-7675199, hg38,17:7675199-7675199","hg19,17:g.7578517G>A, hg19,17:g.7675199G>A, hg38,17:g.7675198_7675199delinsAA, hg38,17:g.7675199G>A",0.870,"biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, upper_lobe, oesophagus, ovary, prostate, skin, skin, head_neck, soft_tissue, blood_vessel, abdomen, soft_tissue, fibrous_tissue_and_uncertain_origin, pleura, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder, urinary_tract, ureter, vulva","angiosarcoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, gastrointestinal_stromal_tumour, spindle_and_epithelioid, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, dysplasia-carcinoma_in_situ, other, metaplasia, other, neoplasm, solitary_fibrous_tumour, malignant",0.0000000000000000,,,,184863,Likely pathogenic,"Adrenal cortex carcinoma;Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1",3,Likely oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype;Choroid plexus carcinoma",1
1241,138,A,W,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1242,138,A,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1243,139,K,A,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1244,139,K,C,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1245,139,K,D,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1246,139,K,E,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","lihc_riken, mbn_msk_2024, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, pan_origimed_2020, sarc_tcga, sarc_tcga_pub, sarcoma_msk_2022, soft_tissue_tcga_gdc","Hepatocellular Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Soft Tissue","hg19,17:7578515-7578515, hg19,17:7675197-7675197, hg38,17:7675197-7675197","hg19,17:g.7578515T>C, hg19,17:g.7675197T>C, hg38,17:g.7675197T>C",0.844,"liver, thyroid, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma",,,,,658923,Uncertain significance,Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome,2,,,,,,
1247,139,K,F,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1248,139,K,G,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1249,139,K,H,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1250,139,K,I,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1251,139,K,L,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1252,139,K,M,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1253,139,K,N,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, blca_msk_tcga_2020, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_igr_2015, breast_alpelisib_2020, ccle_broad_2025, hcc_tcga_gdc, heme_msk_impact_2022, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, lung_msk_2017, metastatic_solid_tumors_mich_2017, mixed_impact_subset_2022, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pptc_2019, sarcoma_msk_2022, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Endometrial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578513-7578513, hg19,17:7675195-7675195, hg38,17:7675195-7675195","hg19,17:g.7578513C>A, hg19,17:g.7578513C>G, hg19,17:g.7675195C>A, hg19,17:g.7675195C>G, hg38,17:g.7675195C>A, hg38,17:g.7675195C>G",0.730,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, liver, lung, ovary, skin, thymus, thyroid, upper_aerodigestive_tract, mouth, lip, urinary_tract, bladder","carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, Hodgkin_lymphoma, mixed_cellularity, lymphoid_neoplasm, plasma_cell_myeloma, primitive_neuroectodermal_tumour-medulloblastoma, thymic_carcinoma",,,,,584923,Uncertain significance,Li-Fraumeni syndrome,2,,,,,,
1254,139,K,P,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1255,139,K,Q,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578515-7578515, hg38,17:7675197-7675197","hg19,17:g.7578515T>G, hg38,17:g.7675197T>G",0.768,"breast, large_intestine, rectum",carcinoma,,,,,1692473,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
1256,139,K,R,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578514-7578514, hg38,17:7675196-7675196","hg19,17:g.7578514T>C, hg38,17:g.7675196T>C",0.760,"breast, kidney","Wilms_tumour, carcinoma",,,,,1500748,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1257,139,K,S,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1258,139,K,T,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, mel_dfci_2019, mel_iatlas_liu_2019, msk_chord_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Melanoma, Mixed Cancer Types","hg19,17:7578514-7578514, hg19,17:7675196-7675196, hg38,17:7675196-7675196","hg19,17:g.7578514T>G, hg19,17:g.7675196T>G, hg38,17:g.7675196T>G",0.800,"haematopoietic_and_lymphoid_tissue, large_intestine, rectum, lung","carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, plasma_cell_myeloma",,,,,1338658,Uncertain significance,not specified;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
1259,139,K,V,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1260,139,K,W,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1261,139,K,Y,,,Ubq,,,Ac,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 133-139, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1262,140,T,A,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","coad_cptac_2019, coad_cptac_gdc, mds_mskcc_2020","Colon Adenocarcinoma, Myelodysplastic Syndromes","hg19,17:7578512-7578512, hg19,17:7675194-7675194, hg38,17:7675194-7675194","hg19,17:g.7578512T>C, hg19,17:g.7675194T>C, hg38,17:g.7675194T>C",0.806,,,,,,,644101,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1263,140,T,C,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1264,140,T,D,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1265,140,T,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1266,140,T,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1267,140,T,G,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1268,140,T,H,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1269,140,T,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","glioma_mskcc_2019, msk_impact_2017, tmb_mskcc_2018","Diffuse Glioma, Mixed Cancer Types","hg19,17:7578511-7578511, hg38,17:7675192-7675193, hg38,17:7675193-7675193","hg19,17:g.7578511G>A, hg38,17:g.7675192_7675193delinsAA, hg38,17:g.7675193G>A",0.842,"biliary_tract, gallbladder, central_nervous_system, brain, eye, conjunctiva, genital_tract, extragonadal, brain, liver, lung, skin, arm, skin, face, stomach","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, seminoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma_Grade_III, anaplastic, other, hepatoblastoma, other, keratosis",,,,,,,,,,,,,,
1270,140,T,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1271,140,T,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1272,140,T,M,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1273,140,T,N,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","difg_glass, difg_glass_2019, mds_mskcc_2020","Diffuse Glioma, Myelodysplastic Syndromes","hg19,17:7578511-7578511, hg38,17:7675193-7675193","hg19,17:g.7578511G>T, hg38,17:g.7675193G>T",0.783,"biliary_tract, gallbladder, haematopoietic_and_lymphoid_tissue","carcinoma, adenocarcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,185918,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Hereditary breast ovarian cancer syndrome,1,,,,,,
1274,140,T,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1275,140,T,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1276,140,T,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1277,140,T,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578512-7578512, hg38,17:7675194-7675194","hg19,17:g.7578512T>A, hg38,17:g.7675194T>A",0.835,,,,,,,1525853,Uncertain significance,not provided;Li-Fraumeni syndrome,2,,,,,,
1278,140,T,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1279,140,T,W,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1280,140,T,Y,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1281,141,C,A,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675189-7675191","hg38,17:g.7675189_7675191delinsCGC",,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
1282,141,C,D,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1283,141,C,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1284,141,C,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, luad_tcga_pan_can_atlas_2018, msk_chord_2024, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022","Bladder/Urinary Tract, Head and Neck Squamous Cell Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578507-7578508, hg19,17:7578508-7578508, hg19,17:7675190-7675190, hg38,17:7675190-7675190","hg19,17:g.7578507_7578508delinsAA, hg19,17:g.7578508C>A, hg19,17:g.7675190C>A, hg38,17:g.7675190C>A",0.880,"biliary_tract, bile_duct, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, lung, right_upper_lobe, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",,,,,376568,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck,1,,,,,,
1285,141,C,G,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, coadread_mskresistance_2022, csf_msk_2024, luad_mskcc_2023_met_organotropism, mixed_selpercatinib_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cpcg_2017, prad_p1000, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Colorectal Adenocarcinoma, Cutaneous Melanoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578509-7578509, hg19,17:7675191-7675191, hg38,17:7675191-7675191","hg19,17:g.7578509A>C, hg19,17:g.7675191A>C, hg38,17:g.7675191A>C",0.859,"central_nervous_system, brainstem, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, lung, ovary, pancreas, prostate, skin, soft_tissue, fat, leg, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, diffuse_midline_glioma, liposarcoma, pleomorphic, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma",,,,,,,,,,,,,,
1286,141,C,H,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1287,141,C,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1288,141,C,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1289,141,C,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1290,141,C,M,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1291,141,C,N,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1292,141,C,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1293,141,C,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1294,141,C,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2025, chol_tcga, chol_tcga_gdc, chol_tcga_pan_can_atlas_2018, coadread_tcga, coadread_tcga_pub, csf_msk_2024, egc_msk_2023, egc_mskcc_2020, glioma_mskcc_2019, luad_mskcc_2023_met_organotropism, lung_msk_2017, mixed_impact_subset_2022, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ohnca_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, read_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Bladder/Urinary Tract, Bowel, Cholangiocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Head and Neck Carcinoma, Other, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7578509-7578509, hg19,17:7675191-7675191, hg38,17:7675191-7675191","hg19,17:g.7578509A>G, hg19,17:g.7675191A>G, hg38,17:g.7675191A>G",0.861,"biliary_tract, gallbladder, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, descending, large_intestine, rectum, lung, oesophagus, ovary, pancreas, prostate, soft_tissue, striated_muscle, bladder, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, low_grade_mucinous_neoplasm, rhabdomyosarcoma, embryonal",,,,,376565,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1295,141,C,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","coad_tcga_gdc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, pan_origimed_2020, sarcoma_msk_2022","Colon Adenocarcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578508-7578508, hg19,17:7578509-7578509, hg19,17:7675190-7675190, hg38,17:7675190-7675190, hg38,17:7675191-7675191","hg19,17:g.7578508C>G, hg19,17:g.7578509A>T, hg19,17:g.7675190C>G, hg38,17:g.7675190C>G, hg38,17:g.7675191A>T","0.790, 0.813","large_intestine, colon, ascending, prostate, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
1296,141,C,T,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1297,141,C,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1298,141,C,W,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, chrcc_tcga_gdc, coad_silu_2022, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, egc_trap_ccr_msk_2023, egc_trap_msk_2020, gbc_msk_2018, hcc_inserm_fr_2015, heme_msk_impact_2022, hgsoc_msk_2021, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_mskcc_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, prad_su2c_2019, rectal_msk_2022, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Acute Myeloid Leukemia, Bowel, Breast, Chromophobe Renal Cell Carcinoma, Colon Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578507-7578507, hg19,17:7675189-7675189, hg38,17:7675189-7675189","hg19,17:g.7578507G>C, hg19,17:g.7675189G>C, hg38,17:g.7675189G>C",0.808,", biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, liver, lung, ovary, pancreas, prostate, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia",,,,,376564,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
1299,141,C,Y,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, braf_msk_impact_2024, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_sanger, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2025, coad_cptac_2019, coad_cptac_gdc, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_orion_2024, crc_sysucc_2022, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, gbc_msk_2018, gbc_mskcc_2022, gist_msk_2022, hcc_msk_2024, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, ihch_msk_2021, ihch_mskcc_2020, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_pdx, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_kunga_msk_2022, mm_broad, mnm_washu_2016, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ohnca_cptac_gdc, paad_tcga, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_mich, prad_msk_mdanderson_2023, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Bladder Urothelial Carcinoma, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Gastrointestinal Stromal Tumor, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Plasma Cell Myeloma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Thyroid","hg19,17:7578508-7578508, hg19,17:7675190-7675190, hg38,17:7675190-7675190","hg19,17:g.7578508C>T, hg19,17:g.7675190C>T, hg38,17:g.7675190C>T",0.897,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, soft_tissue, blood_vessel, abdomen, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach, gastroesophageal_junction, testis, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, non_small_cell_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, seminoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, oligodendroglioma, haematopoietic_neoplasm, chronic_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, neoplasm, other, neoplasm, malignant, synovial_sarcoma",,,,,140801,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Oncogenic,Neoplasm,1,,,
1300,142,P,A,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578506-7578506, hg38,17:7675188-7675188","hg19,17:g.7578506G>C, hg38,17:g.7675188G>C",0.901,"lung, stomach","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,3809688,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1301,142,P,C,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1302,142,P,D,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1303,142,P,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1304,142,P,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,17:7578505-7578506, hg38,17:7675187-7675188","hg19,17:g.7578505_7578506delinsAA, hg38,17:g.7675187_7675188delinsAA",,"skin, face, upper_aerodigestive_tract, head_neck","carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, in_situ_epithelial_neoplasm",,,,,,,,,,,,,,
1305,142,P,G,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1306,142,P,H,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675187-7675187","hg38,17:g.7675187G>T",0.914,"breast, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, lung, stomach, upper_aerodigestive_tract, head_neck","carcinoid-endocrine_tumour, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
1307,142,P,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1308,142,P,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1309,142,P,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, bowel_colitis_msk_2022, lgg_tcga_pan_can_atlas_2018, msk_impact_2017, sarcoma_mskcc_2022","Appendiceal Adenocarcinoma, Bowel, Diffuse Glioma, Mixed Cancer Types, Soft Tissue","hg19,17:7578505-7578505, hg38,17:7675187-7675187","hg19,17:g.7578505G>A, hg38,17:g.7675187G>A",0.879,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, head_neck, large_intestine, rectum, prostate, skin, skin, eye, soft_tissue, blood_vessel, skin, scalp, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, vulva","angiosarcoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, in_situ_neoplasm, glandular_intraepithelial_neoplasia_Grade_III, lymphoid_neoplasm, NK-T_cell_lymphoma",0.0000039800678204,,,,864520,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1310,142,P,M,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1311,142,P,N,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1312,142,P,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1313,142,P,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025",Mixed Cancer Types,"hg19,17:7578505-7578505, hg19,17:7675187-7675187","hg19,17:g.7578505G>C, hg19,17:g.7675187G>C",0.907,,,,,,,,,,,,,,,,
1314,142,P,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,17:7578506-7578506, hg38,17:7675188-7675188","hg19,17:g.7578506G>A, hg38,17:g.7675188G>A",0.887,"haematopoietic_and_lymphoid_tissue, lymph_node, ovary, skin, head_neck, urinary_tract, renal_pelvis","carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm",,,,,824720,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1315,142,P,T,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578506-7578506, hg38,17:7675188-7675188","hg19,17:g.7578506G>T, hg38,17:g.7675188G>T",0.891,"breast, large_intestine","carcinoma, carcinoma, adenocarcinoma",,,,,3972446,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1316,142,P,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1317,142,P,W,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1318,142,P,Y,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1319,143,V,A,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_cass_2020, coadread_tcga, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, heme_msk_impact_2022, mbn_mdacc_2013, mbn_msk_2024, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_pdmr_2025, pdac_msk_2024, sarcoma_msk_2022, stes_tcga_pub","Bladder Urothelial Carcinoma, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Soft Tissue","hg19,17:7578502-7578502, hg19,17:7675184-7675184, hg38,17:7675184-7675184","hg19,17:g.7578502A>G, hg19,17:g.7675184A>G, hg38,17:g.7675184A>G",0.574,"breast, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, lung, lung, lower_lobe, oesophagus, ovary, pancreas, pleura, skin, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, urinary_tract, bladder, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, M1, mesothelioma, epithelial, other, neoplasm, other, neoplasm, malignant",,,,,804214,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
1320,143,V,C,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1321,143,V,D,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1322,143,V,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","escc_ucla_2014, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, sarcoma_msk_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Esophageal Squamous Cell Carcinoma, Mixed Cancer Types, Pancreatic Adenocarcinoma, Soft Tissue","hg19,17:7578502-7578502, hg19,17:7675184-7675184, hg38,17:7675184-7675184","hg19,17:g.7578502A>T, hg19,17:g.7675184A>T, hg38,17:g.7675184A>T",0.683,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, colon, lung, oesophagus, pancreas, skin, upper_aerodigestive_tract, head_neck, urinary_tract","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma",,,,,2687706,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1323,143,V,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1324,143,V,G,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, difg_tcga_gdc, hcc_msk_2024, ihch_msk_2021, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Breast, Cutaneous Melanoma, Diffuse Glioma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578502-7578502, hg19,17:7675184-7675184, hg38,17:7675184-7675184","hg19,17:g.7578502A>C, hg19,17:g.7675184A>C, hg38,17:g.7675184A>C",0.692,"breast, haematopoietic_and_lymphoid_tissue, bone, large_intestine, colon, oesophagus, prostate, skin, skin, shoulder, upper_aerodigestive_tract, mouth, tongue","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma",,,,,486556,Conflicting classifications of pathogenicity,not provided;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1325,143,V,H,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1326,143,V,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1327,143,V,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1328,143,V,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","msk_ch_2023, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,17:7578503-7578503, hg38,17:7675185-7675185","hg19,17:g.7578503C>A, hg19,17:g.7578503C>G, hg38,17:g.7675185C>A, hg38,17:g.7675185C>G",0.607,"large_intestine, colon, lung, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,"2687704, 185729","Uncertain significance, Uncertain significance","Prostate cancer, hereditary, 1|Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome","0, 2",,,,,,
1329,143,V,M,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2022, appendiceal_msk_2022, blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_msk_2024, breast_alpelisib_2020, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, ccrcc_utokyo_2013, cellline_ccle_broad, cfdna_msk_2019, cll_broad_2022, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_sysucc_2022, glioma_msk_2018, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_msk_2024, hcc_tcga_gdc, hdcn_msk_2025, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lihc_tcga, lms_msk_2024, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, mds_iwg_2022, mds_mskcc_2020, mixed_selpercatinib_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nhl_bcgsc_2013, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_p1000, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018","Acute Myeloid Leukemia, Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Histiocytic and Dendritic Cell Neoplasms, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Pancreas, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue","hg19,17:7578503-7578503, hg19,17:7675185-7675185, hg38,17:7675185-7675185","hg19,17:g.7578503C>T, hg19,17:g.7675185C>T, hg38,17:g.7675185C>T",0.659,"breast, central_nervous_system, brain, cervix, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, prostate, salivary_gland, major, soft_tissue, blood_vessel, heart, soft_tissue, smooth_muscle, pelvis, soft_tissue, smooth_muscle, uterus, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, cheek, urinary_tract, bladder","adenoma, pleomorphic, angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, lobular_carcinoma, carcinoma, mixed_endometrioid_and_clear_cell_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, fibroepithelial_neoplasm, phyllodes_tumour, borderline, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M0, haematopoietic_neoplasm, acute_myeloid_leukaemia_myelodysplastic_syndrome_therapy_related_NOS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, M0, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, leiomyosarcoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, variant, lymphoid_neoplasm, plasma_cell_myeloma",,,,,142657,Pathogenic/Likely pathogenic,"Glioma susceptibility 1;Hereditary cancer-predisposing syndrome;Breast neoplasm;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Malignant tumor of breast",2,,,,,,
1330,143,V,N,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1331,143,V,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1332,143,V,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1333,143,V,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1334,143,V,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1335,143,V,T,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1336,143,V,W,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1337,143,V,Y,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1338,144,Q,A,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1339,144,Q,C,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1340,144,Q,D,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1341,144,Q,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1342,144,Q,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1343,144,Q,G,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1344,144,Q,H,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_pdx, lung_pdx_msk_2021, msk_ctdna_vte_2024, msk_met_2021, nsclc_tcga_broad_2016, pancan_mimsi_msk_2024","Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578498-7578498, hg19,17:7675180-7675180, hg38,17:7675180-7675180","hg19,17:g.7578498C>A, hg19,17:g.7578498C>G, hg19,17:g.7675180C>A, hg38,17:g.7675180C>A, hg38,17:g.7675180C>G",0.708,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, rectum, lung, middle_lobe","adenoma, carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, Burkitt_lymphoma",,,,,376648,Uncertain significance,not provided,1,,,,Tier I - Strong,Medulloblastoma SHH activated and TP53 mutant,1
1345,144,Q,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1346,144,Q,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",msk_ctdna_vte_2024,Mixed Cancer Types,"hg19,17:7578500-7578500, hg38,17:7675180-7675182, hg38,17:7675182-7675182","hg19,17:g.7578500G>T, hg38,17:g.7675180_7675182delinsTTT, hg38,17:g.7675182G>T",0.763,"lung, upper_aerodigestive_tract, mouth","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1347,144,Q,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578499-7578499, hg38,17:7675181-7675181","hg19,17:g.7578499T>A, hg38,17:g.7675181T>A",0.764,"haematopoietic_and_lymphoid_tissue, trachea, large_intestine, colon, ascending, large_intestine, rectum, lung, lung, right_upper_lobe, pancreas, upper_aerodigestive_tract, head_neck, urinary_tract","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,376647,Uncertain significance,Li-Fraumeni syndrome,3,,,,,,
1348,144,Q,M,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1349,144,Q,N,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1350,144,Q,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","coad_silu_2022, crc_eo_2020, dlbcl_duke_2017, egc_msk_2023, lung_msk_pdx, lung_pdx_msk_2021, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, rectal_msk_2022, sarcoma_msk_2022","Bowel, Colon Adenocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Esophagus/Stomach, Lung, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578498-7578499, hg19,17:7578499-7578499, hg19,17:7675181-7675181, hg38,17:7675181-7675181","hg19,17:g.7578498_7578499delinsCC, hg19,17:g.7578498_7578499delinsGG, hg19,17:g.7578499T>G, hg19,17:g.7675181T>G, hg38,17:g.7675181T>G",0.801,"breast, large_intestine, liver, lung, oesophagus, ovary, soft_tissue, nerve_sheath, lower_leg","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_peripheral_nerve_sheath_tumour, epithelioid",,,,,186594,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
1351,144,Q,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pancan_pdmr_2025,Mixed Cancer Types,"hg19,17:7578499-7578499, hg38,17:7675181-7675181","hg19,17:g.7578499T>C, hg38,17:g.7675181T>C",0.751,"bone, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, lung","carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, undifferentiated_sarcoma, pleomorphic",,,,,2080519,Uncertain significance,"Prostate cancer, hereditary, 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome",2,,,,,,
1352,144,Q,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1353,144,Q,T,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1354,144,Q,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1355,144,Q,W,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1356,144,Q,Y,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 138-144, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1357,145,L,A,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1358,145,L,C,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1359,145,L,D,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1360,145,L,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1361,145,L,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1362,145,L,G,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1363,145,L,H,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1364,145,L,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1365,145,L,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1366,145,L,M,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pancan_pdmr_2025,Mixed Cancer Types,"hg19,17:7578497-7578497, hg38,17:7675179-7675179","hg19,17:g.7578497G>T, hg38,17:g.7675179G>T",0.505,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
1367,145,L,N,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1368,145,L,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_msk_2025, ccle_broad_2025, cfdna_msk_2019, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_tcga_gdc, escc_ucla_2014, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_cptac_2021, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancreas_cptac_gdc, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578496-7578496, hg19,17:7675178-7675178, hg38,17:7675178-7675178","hg19,17:g.7578496A>G, hg19,17:g.7675178A>G, hg38,17:g.7675178A>G",0.818,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, rectum, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, prostate, stomach, upper_aerodigestive_tract, pharynx, urinary_tract, bladder","carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000000000000000,,,,142050,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
1369,145,L,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_mskcc_solit_2014, cervix_msk_2023, crc_eo_2020, egc_msk_2017, egc_msk_2023, hcc_clca_2024, hcc_inserm_fr_2015, hcc_jcopo_msk_2023, heme_msk_impact_2022, hgsoc_tcga_gdc, mds_mskcc_2020, mixed_selpercatinib_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022","Bladder Urothelial Carcinoma, Bowel, Cervix, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas","hg19,17:7578496-7578496, hg19,17:7675178-7675178, hg38,17:7675178-7675178","hg19,17:g.7578496A>T, hg19,17:g.7675178A>T, hg38,17:g.7675178A>T",0.846,"breast, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, pleura, prostate, stomach, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, mesothelioma, epithelial",,,,,480760,Conflicting classifications of pathogenicity,"Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary",1,,,,,,
1370,145,L,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_iatlas_anders_2022, brca_mapk_hp_msk_2021, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, cscc_ucsf_2021, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022","Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578495-7578496, hg19,17:7578496-7578496, hg19,17:7675177-7675178, hg19,17:7675178-7675178, hg38,17:7675177-7675178, hg38,17:7675178-7675178","hg19,17:g.7578495_7578496delinsAC, hg19,17:g.7578496A>C, hg19,17:g.7675177_7675178delinsAC, hg19,17:g.7675178A>C, hg38,17:g.7675177_7675178delinsAC, hg38,17:g.7675178A>C",0.845,", breast, haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, colon, transverse, liver, lung, ovary, salivary_gland, skin","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, malignant_melanoma",,,,,1027110,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1371,145,L,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1372,145,L,T,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1373,145,L,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578497-7578497, hg38,17:7675179-7675179","hg19,17:g.7578497G>C, hg38,17:g.7675179G>C",0.462,"central_nervous_system, brain, large_intestine","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,2774652,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome,1,,,,,,
1374,145,L,W,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1375,145,L,Y,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1376,146,W,A,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1377,146,W,C,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578492-7578492, hg38,17:7675174-7675174","hg19,17:g.7578492C>A, hg19,17:g.7578492C>G, hg38,17:g.7675174C>A, hg38,17:g.7675174C>G",0.629,"liver, lung","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma",,,,,"1740219, 824855","Uncertain significance, Uncertain significance",Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,"1, 2",,,,,,
1378,146,W,D,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1379,146,W,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1380,146,W,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1381,146,W,G,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_su2c_2019, prostate_msk_2024, sarcoma_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578494-7578494, hg38,17:7675176-7675176","hg19,17:g.7578494A>C, hg38,17:g.7675176A>C",0.536,"central_nervous_system, brain, prostate","carcinoma, adenocarcinoma, carcinoma, small_cell_carcinoma, glioma, astrocytoma",,,,,186587,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
1382,146,W,H,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1383,146,W,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1384,146,W,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1385,146,W,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1386,146,W,M,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1387,146,W,N,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1388,146,W,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1389,146,W,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1390,146,W,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675176-7675176","hg38,17:g.7675176A>G, hg38,17:g.7675176A>T",0.464,"biliary_tract, gallbladder, breast, haematopoietic_and_lymphoid_tissue, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
1391,146,W,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,17:7578493-7578493, hg19,17:7675175-7675175, hg38,17:7675175-7675175","hg19,17:g.7578493C>G, hg19,17:g.7675175C>G, hg38,17:g.7675175C>G",0.521,"large_intestine, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1392,146,W,T,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1393,146,W,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1394,146,W,Y,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1395,147,V,A,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021",Mixed Cancer Types,"hg19,17:7578490-7578490, hg38,17:7675172-7675172","hg19,17:g.7578490A>G, hg38,17:g.7675172A>G",0.812,"large_intestine, lung, skin, scalp","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma, desmoplastic",,,,,842812,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1396,147,V,C,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1397,147,V,D,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coadread_dfci_2016, egc_msk_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, paired_bladder_2022, rectal_msk_2022, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophagus/Stomach, Mixed Cancer Types, Soft Tissue","hg19,17:7578490-7578490, hg19,17:7675172-7675172, hg38,17:7675172-7675172","hg19,17:g.7578490A>T, hg19,17:g.7675172A>T, hg38,17:g.7675172A>T",0.896,"breast, large_intestine","carcinoma, carcinoma, adenocarcinoma",,,,,1351017,Conflicting classifications of pathogenicity,"not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1",1,,,,,,
1398,147,V,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675171-7675172","hg38,17:g.7675171_7675172inv",,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
1399,147,V,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675173-7675173","hg38,17:g.7675173C>A",0.747,"breast, haematopoietic_and_lymphoid_tissue","carcinoma, basal_(triple-negative)_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
1400,147,V,G,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, chol_msk_2018, gct_msk_2016, hcc_msk_2024, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, lymphoma_cellline_msk_2020, mixed_impact_subset_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, rectal_msk_2022","Bowel, Cholangiocarcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Lung Adenocarcinoma, Lymphoid, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Testis","hg19,17:7578490-7578490, hg19,17:7675172-7675172, hg38,17:7675172-7675172","hg19,17:g.7578490A>C, hg19,17:g.7675172A>C, hg38,17:g.7675172A>C",0.895,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, lung, oesophagus, ovary, stomach, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, lymphoid_neoplasm, mantle_cell_lymphoma",,,,,3602769,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1401,147,V,H,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1402,147,V,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578491-7578491, hg38,17:7675173-7675173","hg19,17:g.7578491C>T, hg38,17:g.7675173C>T",0.549,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, appendix, liver, lung, pleura","carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, plasma_cell_myeloma, mesothelioma",,,,,528255,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1403,147,V,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1404,147,V,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1405,147,V,M,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1406,147,V,N,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1407,147,V,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1408,147,V,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1409,147,V,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1410,147,V,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1411,147,V,T,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1412,147,V,W,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1413,147,V,Y,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 139-147, ggetELM|WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1414,148,D,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578487-7578487, hg38,17:7675169-7675169","hg19,17:g.7578487T>G, hg38,17:g.7675169T>G",0.404,,,,,,,485032,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
1415,148,D,C,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1416,148,D,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, lung_msk_mind_2020, lung_msk_pdx, msk_chord_2024, msk_impact_2017","Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578486-7578486, hg38,17:7675168-7675168","hg19,17:g.7578486A>C, hg19,17:g.7578486A>T, hg38,17:g.7675168A>C, hg38,17:g.7675168A>T",0.289,"haematopoietic_and_lymphoid_tissue, lymph_node, lung, oesophagus","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,1478891,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1417,148,D,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1418,148,D,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","ccle_broad_2025, ccle_genentech_2014",Mixed Cancer Types,"hg19,17:7578487-7578487, hg19,17:7675169-7675169, hg38,17:7675169-7675169","hg19,17:g.7578487T>C, hg19,17:g.7675169T>C, hg38,17:g.7675169T>C",0.467,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1419,148,D,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","cervix_msk_2023, lusc_cptac_2021, lusc_cptac_gdc, msk_chord_2024, msk_met_2021","Cervix, Lung Squamous Cell Carcinoma, Mixed Cancer Types","hg19,17:7578488-7578488, hg19,17:7675170-7675170, hg38,17:7675170-7675170","hg19,17:g.7578488C>G, hg19,17:g.7675170C>G, hg38,17:g.7675170C>G",0.482,breast,"carcinoma, HER-positive_carcinoma",,,,,,,,,,,,,,
1420,148,D,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1421,148,D,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1422,148,D,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1423,148,D,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1424,148,D,N,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_msk_2025, breast_msk_2025, hcc_msk_2024, msk_chord_2024, msk_met_2021","Bladder Urothelial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7578488-7578488, hg19,17:7675170-7675170, hg38,17:7675170-7675170","hg19,17:g.7578488C>T, hg19,17:g.7675170C>T, hg38,17:g.7675170C>T",0.277,"bone, extraskeletal, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, large_intestine, colon, sigmoid, soft_tissue, blood_vessel, arm, thyroid, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, vulva","angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, NK-T_cell_lymphoma, osteosarcoma",,,,,568069,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1425,148,D,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1426,148,D,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1427,148,D,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1428,148,D,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1429,148,D,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1430,148,D,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578487-7578487, hg38,17:7675169-7675169","hg19,17:g.7578487T>A, hg38,17:g.7675169T>A",0.551,"lung, oesophagus","carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,2687708,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1431,148,D,W,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1432,148,D,Y,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578488-7578488, hg38,17:7675170-7675170","hg19,17:g.7578488C>A, hg38,17:g.7675170C>A",0.531,lung,"carcinoma, non_small_cell_carcinoma",0.0000039790859244,,,,428863,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
1433,149,S,A,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1434,149,S,C,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578484-7578484, hg38,17:7675166-7675166","hg19,17:g.7578484G>C, hg38,17:g.7675166G>C",0.482,,,,,,,3328163,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1435,149,S,D,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1436,149,S,E,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1437,149,S,F,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578484-7578484, hg38,17:7675165-7675166, hg38,17:7675166-7675166","hg19,17:g.7578484G>A, hg38,17:g.7675165_7675166delinsAA, hg38,17:g.7675166G>A",0.457,"large_intestine, colon, lung, ovary, skin, arm, skin, face, thyroid, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, mixed_adenosquamous_carcinoma, in_situ_epithelial_neoplasm, other, keratosis, other, neoplasm",,,,,486559,Uncertain significance,not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
1438,149,S,G,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1439,149,S,H,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1440,149,S,I,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1441,149,S,K,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1442,149,S,L,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1443,149,S,M,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1444,149,S,N,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1445,149,S,P,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",crc_sysucc_2022,Colorectal Adenocarcinoma,"hg19,17:7578485-7578485, hg38,17:7675167-7675167","hg19,17:g.7578485A>G, hg38,17:g.7675167A>G",0.558,"upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, tongue","carcinoma, squamous_cell_carcinoma",,,,,2679232,Uncertain significance,"Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",2,,,,,,
1446,149,S,Q,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1447,149,S,R,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1448,149,S,T,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675167-7675167","hg38,17:g.7675167A>T",0.327,"lung, oesophagus","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1449,149,S,V,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1450,149,S,W,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1451,149,S,Y,P,,,,,,,,O-GlcNAc,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, msk_access_2021, msk_chord_2024, msk_met_2021, nsclc_ctdx_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578484-7578484, hg38,17:7675166-7675166","hg19,17:g.7578484G>T, hg38,17:g.7675166G>T",0.448,endometrium,"carcinoma, endometrioid_carcinoma",,,,,2754115,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1452,150,T,A,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675164-7675164","hg38,17:g.7675164T>C",0.333,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia",,,,,,,,,,,,,,
1453,150,T,C,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1454,150,T,D,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1455,150,T,E,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1456,150,T,F,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1457,150,T,G,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1458,150,T,H,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1459,150,T,I,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578481-7578481, hg38,17:7675163-7675163","hg19,17:g.7578481G>A, hg38,17:g.7675163G>A",0.381,"breast, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, left, ovary, skin, face, stomach, upper_aerodigestive_tract, head_neck","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm",,,,,1350373,Conflicting classifications of pathogenicity,Acute myeloid leukemia;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1460,150,T,K,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675163-7675163","hg38,17:g.7675163G>T",0.394,lung,carcinoma,,,,,,,,,,,,,,
1461,150,T,L,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1462,150,T,M,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1463,150,T,N,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1464,150,T,P,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1465,150,T,Q,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1466,150,T,R,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675163-7675163","hg38,17:g.7675163G>C",0.441,"large_intestine, colon, sigmoid",adenoma,,,,,,,,,,,,,,
1467,150,T,S,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1468,150,T,V,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1469,150,T,W,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1470,150,T,Y,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1471,151,P,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brain_cptac_gdc, brca_iatlas_anders_2022, brca_metabric, brca_msk_2025, brca_tcga, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cervix_msk_2023, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, difg_tcga_gdc, escc_icgc, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, lihc_riken, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_pdx, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_unito_2016, pan_origimed_2020, pancan_pcawg_2020, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018","Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Bowel, Breast, CNS/Brain, Cervix, Colorectal Adenocarcinoma, Diffuse Glioma, Esophageal Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578479-7578479, hg19,17:7675161-7675161, hg38,17:7675161-7675161","hg19,17:g.7578479G>C, hg19,17:g.7675161G>C, hg38,17:g.7675161G>C",0.889,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, appendix, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, prostate, salivary_gland, skin, skin, trunk, stomach, stomach, gastroesophageal_junction, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma",,,,,376641,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1472,151,P,C,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1473,151,P,D,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1474,151,P,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1475,151,P,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, msk_impact_2017, msk_met_2021, skcm_tcga_pub_2015","Basal Cell Carcinoma, Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7578478-7578479, hg38,17:7675160-7675161","hg19,17:g.7578478_7578479delinsAA, hg38,17:g.7675160_7675161delinsAA",,"skin, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,824960,Likely pathogenic,Hereditary cancer-predisposing syndrome,1,,,,,,
1476,151,P,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1477,151,P,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, aml_ohsu_2018, aml_ohsu_2022, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brain_cptac_gdc, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, chol_icgc_2017, cll_broad_2022, coadread_dfci_2016, coadread_genentech, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, cscc_ucsf_2021, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_cptac_2021, hcc_tcga_gdc, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_mskcc_2023_met_organotropism, mbn_msk_2024, mbn_sfu_2023, mds_mskcc_2020, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, ntrk_msk_2019, ohnca_cptac_gdc, ovarian_msk_2025, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, read_tcga_gdc, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_jhu, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Thyroid","hg19,17:7578477-7578478, hg19,17:7578478-7578478, hg19,17:7675160-7675160, hg38,17:7675159-7675160, hg38,17:7675160-7675160","hg19,17:g.7578477_7578478delinsAT, hg19,17:g.7578478G>T, hg19,17:g.7675160G>T, hg38,17:g.7675159_7675160delinsAT, hg38,17:g.7675160G>T",0.870,", adrenal_gland, adrenal_gland, breast, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, salivary_gland, parotid, skin, chest, skin, head_neck, small_intestine, duodenum, soft_tissue, smooth_muscle, soft_tissue, smooth_muscle, retroperitoneum, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, vulva","Wilms_tumour, adrenal_cortical_carcinoma, non_functioning, carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, papillary_adenocarcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, leiomyosarcoma, low_malignant_potential_(borderline)_tumour, mucinous, lymphoid_neoplasm, MALT_lymphoma, malignant_melanoma, other, dysplasia-in_situ_neoplasm",,,,,376639,Uncertain significance,Ovarian neoplasm;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,Tier I - Strong,Embryonal rhabdomyosarcoma,1
1478,151,P,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1479,151,P,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1480,151,P,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018",Cutaneous Melanoma,"hg19,17:7578478-7578478, hg19,17:7675160-7675160, hg38,17:7675159-7675160, hg38,17:7675160-7675160","hg19,17:g.7578478G>A, hg19,17:g.7675160G>A, hg38,17:g.7675159_7675160delinsAA, hg38,17:g.7675160G>A",0.771,"adrenal_gland, adrenal_gland, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, lung, oesophagus, skin, skin, eye, soft_tissue, blood_vessel, arm, stomach","adrenal_cortical_carcinoma, angiosarcoma, carcinoma, adenocarcinoma, carcinoma, blastoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, lymphoid_neoplasm, NK-T_cell_lymphoma, malignant_melanoma",,,,,,,,,,,,,,
1481,151,P,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1482,151,P,N,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1483,151,P,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1484,151,P,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, breast_msk_2018, breast_msk_2025, crc_eo_2020, crc_msk_2017, hgsoc_msk_2021, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, mds_mskcc_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nccrcc_genentech_2014, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, paad_cptac_2021, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Acute Myeloid Leukemia, Bladder/Urinary Tract, Bowel, Breast, Colorectal Adenocarcinoma, Endometrial Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Renal Non-Clear Cell Carcinoma, Thyroid, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578478-7578478, hg19,17:7675160-7675160, hg38,17:7675160-7675160","hg19,17:g.7578478G>C, hg19,17:g.7675160G>C, hg38,17:g.7675160G>C",0.912,"breast, central_nervous_system, frontal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, descending, large_intestine, colon, sigmoid, lung, oesophagus, ovary, pancreas, stomach, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_II, gemistocytic, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related",,,,,376640,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
1485,151,P,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, acyc_mskcc_2013, aml_ohsu_2018, aml_ohsu_2022, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_metabric, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_caseccc_2015, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_ranson_2022, csf_msk_2024, difg_tcga_gdc, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_trap_ccr_msk_2023, egc_trap_msk_2020, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_mayo_pdx_sarkaria_2019, gist_msk_2022, gist_msk_2023, hcc_clca_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_selpercatinib_2020, mm_broad, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_dkfz_2018, prostate_msk_2024, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, soft_tissue_tcga_gdc, stes_tcga_pub, thyroid_gatci_2024, tmb_mskcc_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gastrointestinal Stromal Tumor, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Plasma Cell Myeloma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Thyroid, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578478-7578479, hg19,17:7578479-7578479, hg19,17:7578479-7578480, hg19,17:7675161-7675161, hg38,17:7675160-7675161, hg38,17:7675161-7675161","hg19,17:g.7578478_7578479delinsCT, hg19,17:g.7578479G>A, hg19,17:g.7578479_7578480delinsAA, hg19,17:g.7675161G>A, hg38,17:g.7675160_7675161delinsCT, hg38,17:g.7675161G>A",0.898,", biliary_tract, gallbladder, bone, femur, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, central_nervous_system, occipital_lobe, central_nervous_system, temporal_lobe, endometrium, gastrointestinal_tract_(site_indeterminate), genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, kidney, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right, oesophagus, oesophagus, lower_third, ovary, pancreas, peritoneum, appendix, prostate, salivary_gland, salivary_gland, major, skin, skin, head_neck, skin, neck, soft_tissue, soft_tissue, blood_vessel, arm, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, soft_tissue, smooth_muscle, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, vulva","angiosarcoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, adenocarcinoma, transformed_to_small_cell_carcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, other_carcinoma, resembling_tall_cell_variant_of_papillary_thyroid_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, chondrosarcoma, gastrointestinal_stromal_tumour, germ_cell_tumour, teratoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, granulocytic_sarcoma, leiomyosarcoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma, malignant_melanoma, other, other, pseudomyxoma_peritonei, sarcoma",,,,,"2700111, 12370","Pathogenic, Pathogenic/Likely pathogenic",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Rhabdomyosarcoma;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Breast adenocarcinoma,"1, 2",,,,Tier I - Strong,"Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype",1
1486,151,P,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, brca_metabric, csf_msk_2024, gct_msk_2016, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, lung_nci_2022, mds_mskcc_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_cptac_2021, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, sarcoma_msk_2022, soft_tissue_msk_2025, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Bladder Urothelial Carcinoma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Pancreatic Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Testis","hg19,17:7578479-7578479, hg19,17:7675161-7675161, hg38,17:7675161-7675161","hg19,17:g.7578479G>T, hg19,17:g.7675161G>T, hg38,17:g.7675161G>T",0.911,"bone, breast, central_nervous_system, brain, central_nervous_system, cerebellum, endometrium, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, rectum, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, choriocarcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome",,,,,12369,Pathogenic/Likely pathogenic,"Rhabdomyosarcoma;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Breast adenocarcinoma;Adrenocortical carcinoma, hereditary",2,,,,,,
1487,151,P,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1488,151,P,W,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1489,151,P,X,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,COSMIC,,,,,,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
1490,151,P,Y,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1491,152,P,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675158-7675158","hg38,17:g.7675158G>C",0.803,"central_nervous_system, brain, liver","carcinoma, hepatocellular_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
1492,152,P,C,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1493,152,P,D,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1494,152,P,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1495,152,P,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1496,152,P,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1497,152,P,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1498,152,P,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1499,152,P,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","mel_mskimpact_2020, msk_impact_2017, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7578475-7578476, hg38,17:7675157-7675158","hg19,17:g.7578475_7578476delinsTT, hg38,17:g.7675157_7675158delinsTT",,,malignant_melanoma,,,,,,,,,,,,,,
1500,152,P,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, blca_msk_2024, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bowel_colitis_msk_2022, brca_metabric, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, coad_cptac_2019, coad_cptac_gdc, coad_silu_2022, coadread_dfci_2016, coadread_genentech, coadread_mskcc, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_orion_2024, crc_sysucc_2022, difg_glass, difg_glass_2019, difg_tcga_gdc, dlbc_broad_2012, dlbcl_dfci_2018, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, escc_ucla_2014, gbm_columbia_2019, gbm_mayo_pdx_sarkaria_2019, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, hnsc_broad, ihch_msk_2021, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mel_mskimpact_2020, mixed_allen_2018, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, nsclc_tracerx_2017, paad_qcmg_uq_2016, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_mich, prad_pik3r1_msk_2021, prostate_dkfz_2018, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578475-7578475, hg19,17:7578475-7578476, hg19,17:7675157-7675157, hg38,17:7675157-7675157, hg38,17:7675157-7675158","hg19,17:g.7578475G>A, hg19,17:g.7578475_7578476delinsAA, hg19,17:g.7675157G>A, hg38,17:g.7675157G>A, hg38,17:g.7675157_7675158delinsAA",0.878,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, central_nervous_system, parietal_lobe, central_nervous_system, parietooccipital, central_nervous_system, temporal_lobe, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, large_intestine, right, liver, lung, oesophagus, pancreas, prostate, salivary_gland, skin, skin, hand, skin, head_neck, small_intestine, jejunum, soft_tissue, blood_vessel, liver, soft_tissue, fibrous_tissue_and_uncertain_origin, parietal_lobe, soft_tissue, smooth_muscle, soft_tissue, smooth_muscle, abdomen, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, urinary_tract, bladder, vulva","adrenal_cortical_adenoma, adrenal_cortical_carcinoma, angiosarcoma, carcinoma, carcinoma, acinar_adenocarcinoma, carcinoma, acinar_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, lymphoepithelioma_like_carcinoma, carcinoma, medullary_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, anaplastic_large_cell_lymphoma, ALK_positive, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, other, dysplasia-in_situ_neoplasm, other, neoplasm, primitive_neuroectodermal_tumour-medulloblastoma, sarcoma",0.0000079594387004,,,,142766,Pathogenic,"TP53-related disorder;Lip and oral cavity carcinoma;Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Squamous cell carcinoma of the head and neck;Familial cancer of breast",3,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse glioma, H3 G34 mutant",1
1501,152,P,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1502,152,P,N,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1503,152,P,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, crc_sysucc_2022, difg_tcga_gdc, glioma_msk_2018, glioma_mskcc_2019, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lusc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_met_2021, nsclc_tcga_broad_2016, ntrk_msk_2019, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578475-7578475, hg19,17:7675157-7675157, hg38,17:7675157-7675157","hg19,17:g.7578475G>T, hg19,17:g.7675157G>T, hg38,17:g.7675157G>T",0.843,"central_nervous_system, brain, large_intestine, colon, liver, lung, oesophagus, stomach, vulva","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma",,,,,1058730,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1504,152,P,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, coadread_tcga, coadread_tcga_pub, egc_tmucih_2015, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pdac_msk_2024, sarcoma_msk_2022","Bladder/Urinary Tract, CNS/Brain, Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Soft Tissue","hg19,17:7578475-7578475, hg19,17:7675157-7675157, hg38,17:7675157-7675157","hg19,17:g.7578475G>C, hg19,17:g.7675157G>C, hg38,17:g.7675157G>C",0.853,"biliary_tract, bile_duct, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, lung, pancreas, skin, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, oligoastrocytoma_Grade_II, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia",,,,,824998,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,Tier II - Potential,Neuroblastoma,1
1505,152,P,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, bcc_unige_2016, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cscc_dfarber_2015, egc_msk_2023, egc_mskcc_2020, gbc_mskcc_2022, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, hcc_msk_2024, lgggbm_tcga_pub, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_mimsi_msk_2024, rectal_msk_2022, skcm_tcga_pan_can_atlas_2018, ucec_ccr_cfdna_msk_2022","Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Bowel, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Gallbladder Cancer, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578476-7578476, hg19,17:7675158-7675158, hg38,17:7675158-7675158","hg19,17:g.7578476G>A, hg19,17:g.7675158G>A, hg38,17:g.7675158G>A",0.863,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, lung, pancreas, skin, skin, arm, skin, face, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, urinary_tract, urinary_tract, renal_pelvis, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, fibroepithelial_neoplasm, fibroadenoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, malignant_melanoma",0.0000039791175909,,,,482230,Conflicting classifications of pathogenicity,not provided;Hereditary cancer-predisposing syndrome;Glioma susceptibility 1;Li-Fraumeni syndrome,1,,,,,,
1506,152,P,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, bowel_colitis_msk_2022, luad_mskcc_2023_met_organotropism, lung_msk_2017, mixed_selpercatinib_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, pancan_pdmr_2025, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Bowel, Lung Adenocarcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578476-7578476, hg38,17:7675158-7675158","hg19,17:g.7578476G>T, hg38,17:g.7675158G>T",0.866,"bone, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, large_intestine, lung, lung, left, oesophagus, stomach, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, blastoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, other, intraepithelial_neoplasia, low_grade",,,,,2687709,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1507,152,P,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1508,152,P,W,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1509,152,P,Y,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 147-152, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1510,153,P,A,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578473-7578473, hg38,17:7675155-7675155","hg19,17:g.7578473G>C, hg38,17:g.7675155G>C",0.369,lung,"carcinoma, squamous_cell_carcinoma",,,,,2687700,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1511,153,P,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1512,153,P,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1513,153,P,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1514,153,P,F,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675154-7675155","hg38,17:g.7675154_7675155delinsAA",,"eye, conjunctiva","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1515,153,P,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1516,153,P,H,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",msk_met_2021,Mixed Cancer Types,"hg19,17:7578472-7578472, hg38,17:7675154-7675154","hg19,17:g.7578472G>T, hg38,17:g.7675154G>T",0.391,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1517,153,P,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1518,153,P,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1519,153,P,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, glioma_mskcc_2019, msk_impact_2017, tmb_mskcc_2018","Basal Cell Carcinoma, Diffuse Glioma, Mixed Cancer Types","hg19,17:7578472-7578472, hg38,17:7675154-7675154","hg19,17:g.7578472G>A, hg38,17:g.7675154G>A",0.370,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, appendix, lung, oesophagus, skin, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, oligodendroglioma_Grade_III, anaplastic, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,645432,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1520,153,P,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1521,153,P,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1522,153,P,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1523,153,P,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1524,153,P,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","crc_eo_2020, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,17:7578473-7578473, hg38,17:7675155-7675155","hg19,17:g.7578473G>A, hg38,17:g.7675155G>A",0.359,"breast, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, oesophagus, pancreas, small_intestine, duodenum, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, urinary_tract, renal_pelvis","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,422563,Conflicting classifications of pathogenicity,TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
1525,153,P,T,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675155-7675155","hg38,17:g.7675155G>T",0.382,"large_intestine, stomach, upper_aerodigestive_tract, pharynx, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
1526,153,P,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1527,153,P,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1528,153,P,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1529,154,G,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",cervix_msk_2023,Cervix,"hg19,17:7578469-7578469, hg38,17:7675151-7675151","hg19,17:g.7578469C>G, hg38,17:g.7675151C>G",0.728,"large_intestine, rectum",carcinoma,,,,,2840669,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1530,154,G,C,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","coadread_tcga, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,17:7578470-7578470, hg38,17:7675152-7675152","hg19,17:g.7578470C>A, hg38,17:g.7675152C>A",0.715,"large_intestine, oesophagus","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,1741887,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1531,154,G,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","lung_msk_2017, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7578468-7578469, hg19,17:7578469-7578469, hg38,17:7675150-7675151, hg38,17:7675151-7675151","hg19,17:g.7578468_7578469delinsAT, hg19,17:g.7578469C>T, hg38,17:g.7675150_7675151delinsAT, hg38,17:g.7675151C>T",0.721,"breast, haematopoietic_and_lymphoid_tissue, lung, pancreas, prostate, small_intestine, jejunum, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, gastric_type, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, in_situ_neoplasm, glandular_intraepithelial_neoplasia_Grade_III, other, normal",0.0000079595020536,,,,"2687710, 237950","Uncertain significance, Uncertain significance","Prostate cancer, hereditary, 1|Li-Fraumeni syndrome;Breast-ovarian cancer, familial, susceptibility to, 2;Hereditary cancer-predisposing syndrome;Malignant tumor of urinary bladder;Familial cancer of breast;Adrenocortical carcinoma, hereditary;not specified;not provided;Li-Fraumeni syndrome 1","0, 3",,,,,,
1532,154,G,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1533,154,G,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1534,154,G,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1535,154,G,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",luad_tsp,Lung Adenocarcinoma,"hg19,17:7578469-7578470, hg38,17:7675151-7675152","hg19,17:g.7578469_7578470delinsAT, hg38,17:g.7675151_7675152delinsAT",,"large_intestine, rectum, lung, skin, stomach","carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma",,,,,,,,,,,,,,
1536,154,G,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1537,154,G,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1538,154,G,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1539,154,G,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1540,154,G,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1541,154,G,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1542,154,G,R,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578470-7578470, hg38,17:7675152-7675152","hg19,17:g.7578470C>G, hg38,17:g.7675152C>G",0.711,bone,Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour,,,,,482229,Uncertain significance,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not specified,3,,,,,,
1543,154,G,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, mds_mskcc_2020, msk_ch_2023, msk_chord_2024, pan_origimed_2020, pancan_hcmi_2025, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7578470-7578470, hg19,17:7675152-7675152, hg38,17:7675152-7675152","hg19,17:g.7578470C>T, hg19,17:g.7675152C>T, hg38,17:g.7675152C>T",0.638,"cervix, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, right, lung, oesophagus, ovary, pancreas, small_intestine, ileum, stomach, upper_aerodigestive_tract, mouth, buccal_mucosa","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia",0.0000039800678204,0.0001593371574251,,,133284,Uncertain significance,"TP53-related disorder;Bone marrow failure syndrome 5;Sarcoma;Hereditary cancer-predisposing syndrome;not specified;not provided;Adrenocortical carcinoma, hereditary;Malignant tumor of urinary bladder;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",2,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant;Embryonal rhabdomyosarcoma",1
1544,154,G,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1545,154,G,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, bladder_msk_2023, blca_bcan_hcrn_2022, blca_msk_2025, blca_msk_tcga_2020, bm_nsclc_mskcc_2023, brca_metabric, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, hgsoc_tcga_gdc, lihc_amc_prv, luad_broad, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, metastatic_solid_tumors_mich_2017, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ov_tcga_pan_can_atlas_2018, paad_tcga, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, sarcoma_mskcc_2022, sclc_ucologne_2015, tmb_mskcc_2018","Ampullary Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578468-7578469, hg19,17:7578469-7578469, hg19,17:7675150-7675151, hg19,17:7675151-7675151, hg38,17:7675151-7675151","hg19,17:g.7578468_7578469delinsAA, hg19,17:g.7578469C>A, hg19,17:g.7675150_7675151delinsAA, hg19,17:g.7675151C>A, hg38,17:g.7675151C>A",0.754,", adrenal_gland, adrenal_gland, bone, kidney, large_intestine, large_intestine, colon, large_intestine, colon, left, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, salivary_gland, stomach, thyroid, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, maxilla, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, adrenal_cortical_carcinoma, adrenal_cortical_carcinoma, non_functioning, carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma",,,,,651769,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1546,154,G,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1547,154,G,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1548,155,T,A,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",ov_tcga,High-Grade Serous Ovarian Cancer,"hg19,17:7578467-7578467, hg38,17:7675149-7675149","hg19,17:g.7578467T>C, hg38,17:g.7675149T>C",0.337,"bone, central_nervous_system, brain, large_intestine, rectum, lung, oesophagus, ovary, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, serous_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, other, ameloblastoma",0.0000079589319113,,,,458544,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1,1,,,,,,
1549,155,T,C,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1550,155,T,D,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1551,155,T,E,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1552,155,T,F,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",msk_met_2021,Mixed Cancer Types,"hg19,17:7578466-7578467","hg19,17:g.7578466_7578467delinsAA",,,,,,,,,,,,,,,,,
1553,155,T,G,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1554,155,T,H,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1555,155,T,I,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_cornell_2016, ccle_broad_2019, cll_broad_2022, cll_iuopa_2015, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, difg_glass, difg_msk_2023, glioma_mskcc_2019, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, pancan_pdmr_2025, sarcoma_msk_2022, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578466-7578466, hg19,17:7675148-7675148, hg38,17:7675148-7675148","hg19,17:g.7578466G>A, hg19,17:g.7675148G>A, hg38,17:g.7675148G>A",0.597,"adrenal_gland, adrenal_gland, breast, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, colon, large_intestine, colon, ascending, liver, lung, oesophagus, ovary, small_intestine, duodenum, soft_tissue, fat, soft_tissue, fibrous_tissue_and_uncertain_origin, pleura, stomach, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal_type, carcinoma, diffuse_adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, liposarcoma, pleomorphic, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, solitary_fibrous_tumour, malignant",,,,,1005876,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
1556,155,T,K,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1557,155,T,L,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675147-7675149","hg38,17:g.7675147_7675149delinsAAG",,lung,"carcinoma, large_cell_neuroendocrine_carcinoma",,,,,,,,,,,,,,
1558,155,T,M,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1559,155,T,N,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2022, blca_msk_2024, brca_bccrc, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, difg_tcga_gdc, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, hcc_msk_2024, hcc_mskimpact_2018, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_cptac_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancreas_cptac_gdc, pdac_msk_2024, rectal_msk_2022, rms_nih_2014, sarc_mskcc, sarcoma_msk_2022, sarcoma_mskcc_2022","Acute Myeloid Leukemia, Bladder Urothelial Carcinoma, Bowel, Breast, Diffuse Glioma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Rhabdomyosarcoma, Soft Tissue","hg19,17:7578466-7578466, hg19,17:7675148-7675148, hg38,17:7675148-7675148","hg19,17:g.7578466G>C, hg19,17:g.7578466G>T, hg19,17:g.7675148G>T, hg38,17:g.7675148G>T",0.548,", breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, liver, lung, oesophagus, ovary, pancreas, pleura, soft_tissue, striated_muscle, orbit, soft_tissue, striated_muscle, vagina, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, angioimmunoblastic_T_cell_lymphoma, mesothelioma, rhabdomyosarcoma, embryonal",,0.0000318775900542,,,406564,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,Tier I - Strong,Malignant peripheral nerve sheath tumor,1
1560,155,T,P,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, difg_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_broad, luad_tsp, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_sfu_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Diffuse Glioma, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue","hg19,17:7578467-7578467, hg19,17:7675149-7675149, hg38,17:7675149-7675149","hg19,17:g.7578467T>G, hg19,17:g.7675149T>G, hg38,17:g.7675149T>G",0.581,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lung, oesophagus, ovary, pancreas, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,2768025,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,Likely oncogenic,Neoplasm,1,,,
1561,155,T,Q,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1562,155,T,R,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1563,155,T,S,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,17:7578466-7578466, hg38,17:7675148-7675148, hg38,17:7675149-7675149","hg19,17:g.7578466G>C, hg38,17:g.7675148G>C, hg38,17:g.7675149T>A","0.359, 0.424","soft_tissue, nerve_sheath, trunk, urinary_tract, bladder","carcinoma, transitional_cell_carcinoma, malignant_peripheral_nerve_sheath_tumour",,0.0000318775900542,,,186179,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;not specified;Li-Fraumeni syndrome,1,,,,,,
1564,155,T,V,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1565,155,T,W,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1566,155,T,Y,P,,,,,,,,,,PhosphoSite,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1567,156,R,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1568,156,R,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, crc_nigerian_2020, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, glioma_mskcc_2019, lgggbm_tcga_pub, msk_chord_2024, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022","Basal Cell Carcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Mixed Cancer Types, Soft Tissue","hg19,17:7578464-7578464, hg19,17:7675146-7675146, hg38,17:7675146-7675146","hg19,17:g.7578464G>A, hg19,17:g.7675146G>A, hg38,17:g.7675146G>A",0.493,", central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon, lung, oesophagus, ovary, skin, upper_aerodigestive_tract, head_neck, vulva","carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, basal_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, malignant_melanoma",0.0000039795926489,,,,127810,Conflicting classifications of pathogenicity,"Glioma susceptibility 1;Hereditary cancer-predisposing syndrome;Glioma susceptibility 1;not specified;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,,,,Tier II - Potential,High-grade astrocytoma with piloid features,1
1569,156,R,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1570,156,R,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1571,156,R,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1572,156,R,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, gbm_cptac_2021, lms_msk_2024, luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mappyacts_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_tcga_gdc","CNS/Brain, Diffuse Glioma, Lung Adenocarcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578464-7578464, hg19,17:7675146-7675146, hg38,17:7675146-7675146","hg19,17:g.7578464G>C, hg19,17:g.7675146G>C, hg38,17:g.7675146G>C",0.580,"biliary_tract, gallbladder, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lymph_node, lung, oesophagus, soft_tissue, thyroid","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, sarcoma",,,,,1517870,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
1573,156,R,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, difg_tcga_gdc, glioma_mskcc_2019, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lung_msk_mind_2020, mbn_sfu_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, paired_bladder_2022, pancan_mimsi_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018","Bladder/Urinary Tract, Diffuse Glioma, Lung, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578463-7578463, hg19,17:7675145-7675145, hg38,17:7675145-7675145","hg19,17:g.7578463C>T, hg19,17:g.7675145C>T, hg38,17:g.7675145C>T",0.627,"breast, central_nervous_system, brain, cervix, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, caecum, large_intestine, colon, lung, ovary, stomach, upper_aerodigestive_tract, mouth, lip, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_adenocarcinoma, glioma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, essential_thrombocythaemia",0.0000159192575258,,,,127811,Uncertain significance,"Bone marrow failure syndrome 5;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;not specified;not provided;Hereditary breast ovarian cancer syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck;Familial cancer of breast",3,,,,,,
1574,156,R,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1575,156,R,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1576,156,R,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_impact_2017, pancreas_msk_2024","Mixed Cancer Types, Pancreas","hg19,17:7578463-7578463, hg38,17:7675145-7675145","hg19,17:g.7578463C>A, hg38,17:g.7675145C>A",0.512,"central_nervous_system, brain, large_intestine, large_intestine, colon, lung, pancreas","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
1577,156,R,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1578,156,R,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1579,156,R,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_eo_2020, crc_msk_2017, cscc_dfarber_2015, gbc_msk_2018, gbc_mskcc_2022, hcc_msk_2024, hcc_tcga_gdc, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, normal_skin_keratinocytes_2024, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, tmb_mskcc_2018, usarc_msk_2020","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Skin, Small Cell Lung Cancer, Soft Tissue, Uterine Sarcoma/Mesenchymal","hg19,17:7578463-7578463, hg19,17:7675145-7675145, hg38,17:7675145-7675145","hg19,17:g.7578463C>G, hg19,17:g.7675145C>G, hg38,17:g.7675145C>G",0.609,"biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, ovary, prostate, salivary_gland, parotid, skin, soft_tissue, smooth_muscle, uterus, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","Wilms_tumour, adnexal_tumour, poroma, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, leiomyosarcoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,634768,Pathogenic/Likely pathogenic,Ovarian neoplasm;Li-Fraumeni syndrome;not provided;Hereditary cancer-predisposing syndrome,2,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
1580,156,R,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1581,156,R,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, msk_chord_2024","Breast, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7578464-7578464, hg38,17:7675146-7675146","hg19,17:g.7578464G>T, hg38,17:g.7675146G>T",0.523,"central_nervous_system, brain, genital_tract, extragonadal, brain","germ_cell_tumour, yolk_sac_tumour, glioma, astrocytoma_Grade_III, anaplastic",,,,,1742298,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1582,156,R,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1583,156,R,V,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1584,156,R,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1585,156,R,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1586,157,V,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2025, chol_msk_2018, crc_eo_2020, crc_msk_2017, hcc_msk_2024, lymphoma_cellline_msk_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, ntrk_msk_2019, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024","Bowel, Breast, Cholangiocarcinoma, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lymphoid, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578460-7578460, hg38,17:7675142-7675142","hg19,17:g.7578460A>G, hg38,17:g.7675142A>G",0.848,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, large_intestine, caecum, liver, oesophagus, oesophagus, lower_third, stomach","carcinoma, adenocarcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_myeloid_leukaemia, other, neoplasm",,,,,428887,Conflicting classifications of pathogenicity,Adrenal cortex carcinoma;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
1587,157,V,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1588,157,V,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, crc_sysucc_2022, difg_tcga_gdc, egc_tmucih_2015, glioma_mskcc_2019, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_mskcc_2022","Appendiceal Adenocarcinoma, Bladder/Urinary Tract, Colorectal Adenocarcinoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578460-7578460, hg19,17:7675142-7675142, hg38,17:7675142-7675142","hg19,17:g.7578460A>T, hg19,17:g.7675142A>T, hg38,17:g.7675142A>T",0.863,"biliary_tract, bile_duct, breast, central_nervous_system, brain, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, large_intestine, rectum, lung, oesophagus, ovary, pancreas, prostate, stomach, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, carcinoma, acinic_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,482231,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
1589,157,V,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675141-7675142","hg38,17:g.7675141_7675142delinsTT",,breast,carcinoma,,,,,,,,,,,,,,
1590,157,V,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, bcc_unige_2016, bladder_msk_2023, bladder_msk_2024, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_mskcc_solit_2014, blca_nmibc_2017, blca_plasmacytoid_mskcc_2016, bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_bccrc, brca_broad, brca_dldccc_2022, brca_metabric, brca_msk_2025, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, chol_icgc_2017, cll_broad_2022, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, cscc_dfarber_2015, csf_msk_2024, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_tmucih_2015, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_ucla_2014, gbc_msk_2018, gbm_cptac_2021, gbm_mayo_pdx_sarkaria_2019, glioma_msk_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, hcc_meric_2021, hcc_msk_2024, hcc_tcga_gdc, hccihch_pku_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_broad, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_impact_subset_2022, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, nsclc_unito_2016, ohnca_cptac_gdc, os_target_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paad_qcmg_uq_2016, paad_tcga, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, pediatric_dkfz_2017, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_ucologne_2015, stes_tcga_pub, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Osteosarcoma, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Thyroid","hg19,17:7578461-7578461, hg19,17:7675143-7675143, hg38,17:7675143-7675143, hg38,17:7675143-7675144","hg19,17:g.7578461C>A, hg19,17:g.7675143C>A, hg38,17:g.7675143C>A, hg38,17:g.7675143_7675144delinsAA, hg38,17:g.7675143_7675144delinsAT",0.708,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, frontal_lobe, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, left, large_intestine, colon, sigmoid, large_intestine, left, large_intestine, rectum, liver, lung, lung, bronchus, lung, left, lung, left_upper_lobe, lung, right_lower_lobe, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, skin, skin, face, soft_tissue, soft_tissue, smooth_muscle, uterus, soft_tissue, striated_muscle, stomach, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, glottis, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, buccal_mucosa, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, epiglottis, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, vulva","adenoma, mucinous, adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, combined_small_cell_carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_adenocarcinoma, carcinoma, undifferentiated_carcinoma, chondrosarcoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, M6, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, leiomyosarcoma, lymphoid_neoplasm, NK_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, other, hepatoblastoma, other, intraductal_papillary_neoplasm, other, neoplasm, malignant, rhabdomyosarcoma, sarcoma, thymoma",,,,,12353,Pathogenic/Likely pathogenic,Squamous cell carcinoma;Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Hepatocellular carcinoma;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Oncogenic,Neoplasm,1,,,
1591,157,V,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, cfdna_msk_2019, crc_nigerian_2020, crc_sysucc_2022, egc_msk_2023, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_tcga, luad_mskcc_2023_met_organotropism, lung_pdx_msk_2021, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prostate_msk_2024, sarcoma_msk_2022, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Bladder/Urinary Tract, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Prostate, Soft Tissue","hg19,17:7578459-7578460, hg19,17:7578460-7578460, hg19,17:7675142-7675142, hg38,17:7675141-7675142, hg38,17:7675142-7675142","hg19,17:g.7578459_7578460delinsAC, hg19,17:g.7578460A>C, hg19,17:g.7675142A>C, hg38,17:g.7675141_7675142delinsAC, hg38,17:g.7675142A>C",0.872,"biliary_tract, gallbladder, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, small_intestine, large_intestine, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, skin, mucosal, vagina, small_intestine, jejunum, stomach, upper_aerodigestive_tract, mouth, tongue","carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma",,,,,"3148383, 915695","Likely pathogenic, Pathogenic/Likely pathogenic",Li-Fraumeni syndrome 1|Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,"1, 2",,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
1592,157,V,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1593,157,V,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_msk_2025, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas, Soft Tissue","hg19,17:7578461-7578461, hg38,17:7675143-7675143","hg19,17:g.7578461C>T, hg38,17:g.7675143C>T",0.425,"central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, oesophagus, prostate, salivary_gland, maxilla, skin, upper_aerodigestive_tract, larynx, glottis, upper_aerodigestive_tract, larynx, supraglottis, upper_aerodigestive_tract, pharynx, nasopharynx, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, malignant_melanoma",0.0000397921259341,,,,185404,Likely benign,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,3,,,,,,
1594,157,V,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1595,157,V,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_dfarber_mskcc_2014, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, coadread_mskresistance_2022, crc_sysucc_2022, hdcn_msk_2025, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_mind_2020, mixed_selpercatinib_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Colorectal Adenocarcinoma, Histiocytic and Dendritic Cell Neoplasms, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578461-7578461, hg19,17:7675143-7675143, hg38,17:7675143-7675143","hg19,17:g.7578461C>G, hg19,17:g.7675143C>G, hg38,17:g.7675143C>G",0.546,"biliary_tract, bile_duct, liver, lung, ovary, pancreas, stomach, upper_aerodigestive_tract, larynx, glottis, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,1515529,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1596,157,V,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1597,157,V,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1598,157,V,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1599,157,V,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1600,157,V,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1601,157,V,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1602,157,V,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1603,157,V,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1604,157,V,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1605,158,R,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1606,158,R,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","all_phase2_target_2018_pub, ampca_bcm_2016, bcc_unige_2016, blca_bgi, blca_plasmacytoid_mskcc_2016, breast_msk_2025, chol_icgc_2017, coadread_dfci_2016, egc_msk_2023, glioma_mskcc_2019, hdcn_msk_2025, lung_msk_2017, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, prad_su2c_2019, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Ampullary Carcinoma, B-Lymphoblastic Leukemia/Lymphoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Cholangiocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Histiocytic and Dendritic Cell Neoplasms, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Prostate Adenocarcinoma","hg19,17:7578458-7578458, hg19,17:7578458-7578459, hg19,17:7675140-7675140, hg38,17:7675138-7675140, hg38,17:7675140-7675140, hg38,17:7675140-7675141","hg19,17:g.7578458G>A, hg19,17:g.7578458_7578459delinsAA, hg19,17:g.7675140G>A, hg38,17:g.7675138_7675140delinsACA, hg38,17:g.7675140G>A, hg38,17:g.7675140_7675141delinsAA",0.835,"central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, lung, lung, left_lower_lobe, lung, upper_lobe, oesophagus, pancreas, ampulla_of_Vater, prostate, skin, skin, face, skin, head_neck, soft_tissue, blood_vessel, head_neck, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, urinary_tract, bladder","adenoma, adnexal_tumour, other, sebaceoma, angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_lymphoblastic_leukaemia, in_situ_epithelial_neoplasm, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, other, bronchiolar_adenoma, other, dysplasia, high_grade-carcinoma_in_situ, other, neoplasm, malignant",0.0000079593753482,,,,127812,Uncertain significance,Lip and oral cavity carcinoma;Hereditary cancer-predisposing syndrome;not specified;not provided;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
1607,158,R,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1608,158,R,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1609,158,R,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","luad_tsp, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, sarcoma_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578456-7578458, hg19,17:7578457-7578458, hg38,17:7675139-7675140","hg19,17:g.7578456_7578458delinsAAA, hg19,17:g.7578457_7578458delinsAA, hg38,17:g.7675139_7675140delinsAA",,lung,"carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1610,158,R,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_silu_2022, difg_glass, difg_glass_2019, difg_tcga_gdc, glioma_mskcc_2019, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_pdmr_2025, pediatric_dkfz_2017, rectal_msk_2022, sarcoma_msk_2022, sclc_clcgp, sclc_ucologne_2015, ucec_msk_2018","Bowel, Colon Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578458-7578458, hg19,17:7675140-7675140, hg38,17:7675140-7675140","hg19,17:g.7578458G>C, hg19,17:g.7675140G>C, hg38,17:g.7675140G>C",0.862,"biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, cingulate_gyrus, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, anus, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, M1, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,856171,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,Tier I - Strong,"Diffuse glioma, H3 G34 mutant;Malignant glioma",1
1611,158,R,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_nmibc_2017, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brain_cptac_gdc, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, chol_icgc_2017, chol_nccs_2013, coad_silu_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_genentech, coadread_mskcc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_glass, difg_glass_2019, difg_msk_2023, difg_tcga_gdc, dlbcl_duke_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbc_mskcc_2022, gbm_cptac_2021, gbm_mayo_pdx_sarkaria_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gbm_tcga_pub2013, glioma_mskcc_2019, hcc_msk_2024, hcc_tcga_gdc, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, kirc_bgi, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_broad, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_sfu_2023, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nhl_bcgsc_2013, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, pog570_bcgsc_2020, pptc_2019, prad_broad, prad_cdk12_mskcc_2020, prad_cpcg_2017, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_msk_2024, ptad_msk_2024, rectal_msk_2019, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_tcga_gdc, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, summit_2018, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Pancreas, Pituitary Adenoma, Prostate, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue, Stomach Adenocarcinoma, Thyroid","hg19,17:7578457-7578457, hg19,17:7675139-7675139, hg38,17:7675139-7675139","hg19,17:g.7578457C>T, hg19,17:g.7675139C>T, hg38,17:g.7675139C>T",0.844,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, cerebellum, central_nervous_system, medulla, central_nervous_system, thalamus, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, meninges, oesophagus, pancreas, pancreas, ampulla_of_Vater, pituitary, prostate, salivary_gland, parotid, skin, neck, skin, vulva, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, pelvis, soft_tissue, smooth_muscle, stomach, stomach, gastroesophageal_junction, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, middle_ear, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, urinary_tract, bladder, urinary_tract, upper_urinary_tract","Wilms_tumour, adenoma, ACTH, adenoma, tubulovillous, high_grade_dysplasia, adnexal_tumour, malignant_adnexal_tumour, spiradenocarcinoma, adrenal_cortical_carcinoma, functioning, carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, of_unknown_primary, carcinoma, salivary_duct_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, in_situ_neoplasm, glandular_intraepithelial_neoplasia_Grade_III, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, meningioma, primitive_neuroectodermal_tumour-medulloblastoma, primitive_neuroectodermal_tumour-medulloblastoma, classic, sarcoma, solitary_fibrous_tumour, dedifferentiated, thymic_carcinoma, undifferentiated-unclassified_sarcoma, epithelioid_cell",0.0000039798143815,,,,141963,Pathogenic/Likely pathogenic,"TP53-related disorder;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Breast and/or ovarian cancer;Rhabdomyosarcoma;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1",2,Oncogenic,Neoplasm,1,,,
1612,158,R,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578456-7578458, hg38,17:7675138-7675140","hg19,17:g.7578456_7578458delinsAAT, hg38,17:g.7675138_7675140delinsAAT",,,,,,,,958850,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1613,158,R,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1614,158,R,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_msk_2025, blca_mskcc_solit_2014, blca_pdx_msk_2025, bm_nsclc_mskcc_2023, brca_metabric, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cll_broad_2015, cll_broad_2022, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, hcc_clca_2024, hcc_jcopo_msk_2023, hcc_msk_2024, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_broad, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_nci_2022, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_tracerx_2017, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sclc_jhu, sclc_ucologne_2015, stes_tcga_pub, summit_2018, thyroid_gatci_2024, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Thyroid","hg19,17:7578456-7578457, hg19,17:7578457-7578457, hg19,17:7675139-7675139, hg38,17:7675138-7675139, hg38,17:7675139-7675139","hg19,17:g.7578456_7578457delinsAA, hg19,17:g.7578457C>A, hg19,17:g.7675139C>A, hg38,17:g.7675138_7675139delinsAA, hg38,17:g.7675139C>A",0.891,"biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, colon, right, liver, lung, lung, bronchus, lung, left, lung, right, lung, right_lower_lobe, lung, right_upper_lobe, oesophagus, pancreas, ampulla_of_Vater, skin, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, small_intestine, stomach, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, urinary_tract, bladder, urinary_tract, ureter","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, signet_ring_adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, gastrointestinal_stromal_tumour, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, MALT_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, other, adenoma, other, dysplasia-carcinoma_in_situ, primitive_neuroectodermal_tumour-medulloblastoma, sarcoma, thymic_carcinoma",0.0000039798143815,,,,"568285, 528248","Pathogenic/Likely pathogenic, Pathogenic",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1|not provided;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"2, 3",,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
1615,158,R,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1616,158,R,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1617,158,R,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, heme_msk_impact_2022, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lusc_cptac_2021, lusc_cptac_gdc, mds_iwg_2022, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, pediatric_dkfz_2017, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, tmb_mskcc_2018, usarc_msk_2020, wt_target_2018_pub","Bladder/Urinary Tract, Diffuse Glioma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Uterine Sarcoma/Mesenchymal, Wilms' Tumor","hg19,17:7578456-7578457, hg19,17:7578457-7578457, hg19,17:7578457-7578459, hg19,17:7675139-7675139, hg38,17:7675139-7675139","hg19,17:g.7578456_7578457delinsAG, hg19,17:g.7578457C>G, hg19,17:g.7578457_7578459delinsGGA, hg19,17:g.7675139C>G, hg38,17:g.7675139C>G",0.916,"biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, kidney, lung, lung, right_upper_lobe, oesophagus, oesophagus, middle_third, ovary, pancreas, prostate, soft_tissue, smooth_muscle, uterus, stomach, upper_aerodigestive_tract, head_neck","Wilms_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, ependymoma_Grade_III-IV, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, leiomyosarcoma",,,,,246118,Pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck,3,Oncogenic,Neoplasm,1,Tier I - Strong,IDH-wildtype glioblastoma,1
1618,158,R,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1619,158,R,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_msk_2025, coadread_dfci_2016, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, msk_chord_2024, msk_met_2021, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, tmb_mskcc_2018","Colorectal Adenocarcinoma, Diffuse Glioma, Esophagus/Stomach, Invasive Breast Carcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578458-7578458, hg19,17:7675140-7675140, hg38,17:7675140-7675140","hg19,17:g.7578458G>T, hg19,17:g.7675140G>T, hg38,17:g.7675140G>T",0.864,"central_nervous_system, brain, endometrium, large_intestine","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, glioma",,,,,1067910,Pathogenic,Li-Fraumeni syndrome,1,,,,Tier I - Strong,"Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype",1
1620,158,R,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1621,158,R,V,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1622,158,R,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1623,158,R,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1624,159,A,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1625,159,A,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, brca_metabric, brca_msk_2025, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cll_broad_2022, coad_silu_2022, egc_msk_2023, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, ohnca_cptac_gdc, paad_cptac_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, prad_p1000, prad_su2c_2015, prad_su2c_2019","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Esophagus/Stomach, Head and Neck Carcinoma, Other, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma","hg19,17:7578454-7578454, hg19,17:7675136-7675136, hg38,17:7675136-7675136","hg19,17:g.7578454G>T, hg19,17:g.7675136G>T, hg38,17:g.7675136G>T",0.836,"breast, central_nervous_system, brain, central_nervous_system, medulla, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, transverse, large_intestine, rectum, lung, lung, left_lower_lobe, lung, left_upper_lobe, lung, right_lower_lobe, oesophagus, prostate, stomach, urinary_tract, bladder, urachus","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, transformed_to_small_cell_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, oligoastrocytoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, primitive_neuroectodermal_tumour-medulloblastoma, classic",,,,,1026335,Pathogenic/Likely pathogenic,"Prostate cancer, hereditary, 1;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1",2,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
1626,159,A,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1627,159,A,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578454-7578455, hg38,17:7675136-7675137","hg19,17:g.7578454_7578455delinsAA, hg38,17:g.7675136_7675137delinsAA",,,,,,,,182961,Uncertain significance,not specified,1,,,,,,
1628,159,A,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1629,159,A,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1630,159,A,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","heme_msk_impact_2022, mds_mskcc_2020","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7578454-7578455","hg19,17:g.7578454_7578455delinsAT",,,,,,,,,,,,,,,,,
1631,159,A,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1632,159,A,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1633,159,A,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1634,159,A,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1635,159,A,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_msk_2025, blca_msk_tcga_2020, blca_pdx_msk_2025, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_bccrc_xenograft_2014, brca_metabric, breast_alpelisib_2020, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cfdna_msk_2019, chrcc_tcga_gdc, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, glioma_mskcc_2019, hcc_clca_2024, hcc_meric_2021, hcc_msk_2024, hcc_mskimpact_2018, hccihch_pku_2019, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, ihch_smmu_2014, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lihc_amc_prv, luad_cas_2020, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_mdacc_2013, mds_iwg_2022, mixed_allen_2018, mm_broad, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, paad_cptac_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, pog570_bcgsc_2020, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, stad_oncosg_2018, tmb_mskcc_2018, ucec_cptac_2020, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, uec_cptac_gdc","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bowel, Breast, Chromophobe Renal Cell Carcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Plasma Cell Myeloma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Uterine Endometrioid Carcinoma","hg19,17:7578455-7578455, hg19,17:7675137-7675137, hg38,17:7675137-7675137","hg19,17:g.7578455C>G, hg19,17:g.7675137C>G, hg38,17:g.7675137C>G",0.815,"biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, ascending, large_intestine, colon, sigmoid, liver, lung, lung, middle_lobe, oesophagus, pancreas, pleura, salivary_gland, skin, skin, ear, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, acinar_adenocarcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, osteoclast-like_giant_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, lymphoid_neoplasm, plasma_cell_myeloma, mesothelioma, mesothelioma, epithelial, osteosarcoma",,,,,182929,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Oncogenic,Neoplasm;Meningioma,2,,,
1636,159,A,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1637,159,A,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1638,159,A,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675137-7675137","hg38,17:g.7675137C>A",0.727,"bone, breast, endometrium, lung, stomach, urinary_tract, bladder","carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, osteosarcoma",,,,,,,,,,,,,,
1639,159,A,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, pdac_msk_2024","Mixed Cancer Types, Pancreas","hg19,17:7578455-7578455, hg38,17:7675137-7675137","hg19,17:g.7578455C>T, hg38,17:g.7675137C>T",0.715,"breast, endometrium, large_intestine, large_intestine, colon, ascending, lung, oesophagus, pancreas, skin, face, soft_tissue, fibrous_tissue_and_uncertain_origin","adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, squamous_cell_carcinoma, other, dysplasia, synovial_sarcoma",0.0000000000000000,,,,1909172,Conflicting classifications of pathogenicity,not provided;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
1640,159,A,V,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2023, blca_nmibc_2017, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_metabric, brca_smc_2018, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cesc_tcga_pan_can_atlas_2018, cll_broad_2022, coad_silu_2022, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_hgsc_bcm_2014, difg_tcga_gdc, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_trap_msk_2020, escc_icgc, gbm_mayo_pdx_sarkaria_2019, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, hcc_meric_2021, hcc_msk_2024, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_broad, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_mdacc_2013, mbn_sfu_2023, mds_iwg_2022, mel_dfci_2019, mel_iatlas_liu_2019, mel_mskimpact_2020, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_unito_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paad_qcmg_uq_2016, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_su2c_2019, prostate_msk_2024, read_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_dacruzpaula_2025, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervical Squamous Cell Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Thyroid","hg19,17:7578453-7578454, hg19,17:7578454-7578454, hg19,17:7675136-7675136, hg38,17:7675135-7675136, hg38,17:7675136-7675136","hg19,17:g.7578453_7578454delinsAA, hg19,17:g.7578454G>A, hg19,17:g.7675136G>A, hg38,17:g.7675135_7675136delinsAA, hg38,17:g.7675136G>A",0.774,", breast, central_nervous_system, brain, central_nervous_system, brainstem, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right, meninges, oesophagus, oesophagus, lower_third, ovary, pancreas, prostate, skin, skin, back, skin, head_neck, skin, knee, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, medullary_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma_non_invasive, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, malignant_melanoma, malignant_melanoma, superficial_spreading, meningioma, other, neoplasm, benign",,,,,458545,Pathogenic/Likely pathogenic,"Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",2,Oncogenic,Neoplasm,1,Tier I - Strong,Embryonal rhabdomyosarcoma,1
1641,159,A,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1642,159,A,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 155-159, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1643,160,M,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1644,160,M,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1645,160,M,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1646,160,M,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1647,160,M,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1648,160,M,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1649,160,M,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1650,160,M,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bowel_colitis_msk_2022, crc_orion_2024, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_spectrum_tme_2022, pan_origimed_2020","Bowel, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Ovary/Fallopian Tube","hg19,17:7578450-7578450, hg19,17:7675132-7675132, hg38,17:7675132-7675132","hg19,17:g.7578450C>A, hg19,17:g.7578450C>G, hg19,17:g.7578450C>T, hg19,17:g.7675132C>A, hg38,17:g.7675132C>A, hg38,17:g.7675132C>G, hg38,17:g.7675132C>T","0.656, 0.657","eye, conjunctiva, large_intestine, liver, lung, skin, face, skin, trunk, urinary_tract, bladder","adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, other, intraepithelial_neoplasia",0.0000119374477737,,,,230758,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
1651,160,M,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_mskcc_2022","Mixed Cancer Types, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578451-7578451, hg38,17:7675133-7675133","hg19,17:g.7578451A>T, hg38,17:g.7675133A>T",0.860,"haematopoietic_and_lymphoid_tissue, ovary, stomach","carcinoma, diffuse_adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, serous_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,,,,,,,,,,
1652,160,M,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,17:7578452-7578452, hg38,17:7675134-7675134","hg19,17:g.7578452T>G, hg38,17:g.7675134T>G",0.569,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine","carcinoma, adenocarcinoma, lymphoid_neoplasm, MALT_lymphoma",,,,,,,,,,,,,,
1653,160,M,N,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",nsclc_tcga_broad_2016,Non-Small Cell Lung Cancer,"hg19,17:7578450-7578451","hg19,17:g.7578450_7578451delinsAT",,,,,,,,,,,,,,,,,
1654,160,M,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1655,160,M,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1656,160,M,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","lung_nci_2022, pan_origimed_2020","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578451-7578451, hg38,17:7675133-7675133","hg19,17:g.7578451A>C, hg38,17:g.7675133A>C",0.865,"large_intestine, ovary","carcinoma, adenocarcinoma, carcinoma, mixed_adenosquamous_carcinoma",,,,,,,,,,,,,,
1657,160,M,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1658,160,M,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",paad_qcmg_uq_2016,Pancreatic Adenocarcinoma,"hg19,17:7578451-7578451, hg38,17:7675133-7675133","hg19,17:g.7578451A>G, hg38,17:g.7675133A>G",0.669,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,2915501,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1659,160,M,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_met_2021, pancan_mimsi_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578452-7578452, hg38,17:7675134-7675134","hg19,17:g.7578452T>C, hg38,17:g.7675134T>C",0.689,"biliary_tract, gallbladder, breast, haematopoietic_and_lymphoid_tissue, prostate, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000039793709410,,,,444396,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;not provided;Adrenocortical carcinoma, hereditary",1,,,,,,
1660,160,M,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1661,160,M,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1662,161,A,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1663,161,A,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_dfarber_mskcc_2014, blca_msk_tcga_2020, brca_smc_2018, breast_msk_2018, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_eo_2020, crc_orion_2024, crc_sysucc_2022, hcc_msk_2024, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga_pan_can_atlas_2018, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancreas_msk_2024, pdac_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sclc_clcgp, sclc_ucologne_2015, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bowel, Breast, Colorectal Adenocarcinoma, Endometrial Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578448-7578448, hg19,17:7675130-7675130, hg38,17:7675130-7675130","hg19,17:g.7578448G>T, hg19,17:g.7675130G>T, hg38,17:g.7675130G>T",0.908,"biliary_tract, gallbladder, breast, central_nervous_system, brain, cervix, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, colon, right, lung, oesophagus, ovary, pancreas, penis, salivary_gland, skin, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, plasma_cell_myeloma, other, neoplasm, malignant",,,,,422295,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
1664,161,A,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1665,161,A,F,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675130-7675131","hg38,17:g.7675130_7675131delinsAA",,ovary,carcinoma,,,,,,,,,,,,,,
1666,161,A,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,17:7578447-7578448, hg19,17:7578448-7578448, hg38,17:7675129-7675130, hg38,17:7675130-7675130","hg19,17:g.7578447_7578448delinsTC, hg19,17:g.7578448G>C, hg38,17:g.7675129_7675130delinsTC, hg38,17:g.7675130G>C",0.809,"central_nervous_system, brain","glioma, astrocytoma",,,,,3460338,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1667,161,A,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1668,161,A,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1669,161,A,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1670,161,A,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1671,161,A,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1672,161,A,N,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
1673,161,A,P,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","cll_broad_2022, skcm_tcga_pan_can_atlas_2018","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Cutaneous Melanoma","hg19,17:7578449-7578449, hg38,17:7675131-7675131","hg19,17:g.7578449C>G, hg38,17:g.7675131C>G",0.641,"haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, malignant_melanoma",,,,,3258033,,,,Uncertain significance,Neoplasm,1,,,
1674,161,A,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1675,161,A,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1676,161,A,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bowel_colitis_msk_2022, cll_broad_2022, cll_iuopa_2015, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_orion_2024, hcc_tcga_gdc, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mixed_cfdna_msk_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_pcawg_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024","Bladder Urothelial Carcinoma, Bowel, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578449-7578449, hg19,17:7675131-7675131, hg38,17:7675131-7675131","hg19,17:g.7578449C>A, hg19,17:g.7675131C>A, hg38,17:g.7675131C>A",0.752,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, caecum, large_intestine, colon, sigmoid, liver, lung, oesophagus, prostate, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,,,,,,,,,,
1677,161,A,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2024, blca_iatlas_imvigor210_2017, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_msk_2025, brca_smc_2018, brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, egc_trap_ccr_msk_2023, egc_trap_msk_2020, gbc_mskcc_2022, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, luad_tsp, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_iatlas_hugo_ucla_2016, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, npc_nusingapore, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nst_nfosi_ntap, pact_jhu_2011, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancan_ped_mai_msk_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, utuc_msk_2019, utuc_mskcc_2015","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cystic Tumor of the Pancreas, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mature T and NK Neoplasms, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Nasopharyngeal Carcinoma, Nerve Sheath Tumor, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Upper Tract Urothelial Carcinoma","hg19,17:7578449-7578449, hg19,17:7675131-7675131, hg38,17:7675129-7675131, hg38,17:7675131-7675131","hg19,17:g.7578449C>T, hg19,17:g.7675131C>T, hg38,17:g.7675129_7675131delinsAGT, hg38,17:g.7675131C>T",0.790,"biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, parietal_lobe, endometrium, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, meninges, oesophagus, ovary, pancreas, peritoneum, pleura, prostate, skin, skin, face, skin, mucosal, urinary_tract, small_intestine, duodenum, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder, urinary_tract, bladder, urachus, urinary_tract, ureter","adenoma, adnexal_tumour, sebaceous_adenoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, blastoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_II, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, meningioma, other, cystic_tumour, other, intraepithelial_neoplasia, other, neoplasm, other, solitary_fibrous_tumour, malignant, pulmonary_blastoma, undifferentiated-unclassified_sarcoma, spindle_cell",,,,,161518,Pathogenic/Likely pathogenic,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Prostate cancer",2,,,,,,
1678,161,A,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, msk_ch_2023, msk_ctdna_vte_2024, nsclc_tcga_broad_2016","Bladder Urothelial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578448-7578448, hg19,17:7675130-7675130, hg38,17:7675130-7675130","hg19,17:g.7578448G>A, hg19,17:g.7675130G>A, hg38,17:g.7675130G>A",0.803,"breast, central_nervous_system, cerebellum, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, appendix, lung, lung, right_upper_lobe, oesophagus, skin, stomach, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma",,,,,2019530,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1679,161,A,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1680,161,A,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1681,162,I,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1682,162,I,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1683,162,I,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1684,162,I,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1685,162,I,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, bm_nsclc_mskcc_2023, brain_cptac_gdc, ccle_broad_2025, hcc_clca_2024, heme_msk_impact_2022, luad_cas_2020, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Bladder Urothelial Carcinoma, CNS/Brain, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578446-7578446, hg19,17:7675128-7675128, hg38,17:7675128-7675128","hg19,17:g.7578446T>A, hg19,17:g.7675128T>A, hg38,17:g.7675128T>A",0.676,"breast, central_nervous_system, brain, liver, lung, oesophagus, prostate, soft_tissue, blood_vessel, stomach, urinary_tract","Kaposi_sarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,948225,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1686,162,I,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1687,162,I,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1688,162,I,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1689,162,I,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1690,162,I,M,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_msk_2025, brca_metabric","Bladder Urothelial Carcinoma, Invasive Breast Carcinoma","hg19,17:7578444-7578444, hg38,17:7675126-7675126","hg19,17:g.7578444G>C, hg38,17:g.7675126G>C",0.629,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, large_intestine, stomach","adenoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma",,,,,,,,,,,,,,
1691,162,I,N,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coad_tcga_gdc, coadread_dfci_2016, coadread_mskcc, coadread_tcga_pan_can_atlas_2018, esca_broad, lms_msk_2024, msk_chord_2024, msk_impact_2017, paad_qcmg_uq_2016, pan_origimed_2020, pancan_pcawg_2020, prad_msk_stopsack_2021","Colon Adenocarcinoma, Colorectal Adenocarcinoma, Esophageal Adenocarcinoma, Mixed Cancer Types, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma","hg19,17:7578445-7578445, hg19,17:7675127-7675127, hg38,17:7675127-7675127","hg19,17:g.7578445A>T, hg19,17:g.7675127A>T, hg38,17:g.7675127A>T",0.800,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, large_intestine, large_intestine, caecum, large_intestine, colon, oesophagus, pancreas, skin, stomach, upper_aerodigestive_tract, head_neck","carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, essential_thrombocythaemia, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,1408611,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1692,162,I,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1693,162,I,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1694,162,I,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1695,162,I,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","dlbcl_duke_2017, hcc_inserm_fr_2015, hcc_msk_2024, heme_msk_impact_2022, luad_mskcc_2020, mbn_msk_2024, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, ucec_ancestry_cds_msk_2023","Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578445-7578445, hg38,17:7675127-7675127","hg19,17:g.7578445A>C, hg38,17:g.7675127A>C",0.865,"haematopoietic_and_lymphoid_tissue, liver, lung, oesophagus, pancreas","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,127813,Conflicting classifications of pathogenicity,not provided;Li-Fraumeni syndrome,1,,,,,,
1696,162,I,T,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578445-7578445, hg38,17:7675127-7675127","hg19,17:g.7578445A>G, hg38,17:g.7675127A>G",0.798,,,,,,,1992967,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1697,162,I,V,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578446-7578446, hg38,17:7675128-7675128","hg19,17:g.7578446T>C, hg38,17:g.7675128T>C",0.498,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, lymph_node, ovary","carcinoma, carcinoma, endometrioid_carcinoma, glioma, astrocytoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,1743548,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1698,162,I,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1699,162,I,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1700,163,Y,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1701,163,Y,C,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, blca_bcan_hcrn_2022, blca_msk_tcga_2020, blca_mskcc_solit_2014, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brain_cptac_gdc, brca_bccrc_xenograft_2014, brca_broad, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_metabric, brca_msk_2025, brca_sanger, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, cll_broad_2022, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_tmucih_2015, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, escc_ucla_2014, gbc_msk_2018, gbc_mskcc_2022, gbm_cptac_2021, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, hcc_mskimpact_2018, hccihch_pku_2019, hdcn_msk_2025, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_broad, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_nci_2022, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mixed_cfdna_msk_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_unito_2016, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovarian_msk_2025, ovary_cptac_gdc, paad_cptac_2021, paad_qcmg_uq_2016, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_organoids_msk_2022, prad_p1000, prad_pik3r1_msk_2021, prostate_dkfz_2018, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_jhu, sclc_ucologne_2015, stad_oncosg_2018, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_msk_2018, ucec_msk_2024, utuc_cornell_baylor_mdacc_2019","Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Histiocytic and Dendritic Cell Neoplasms, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Upper Tract Urothelial Carcinoma","hg19,17:7578442-7578442, hg19,17:7675124-7675124, hg38,17:7675124-7675124","hg19,17:g.7578442T>C, hg19,17:g.7675124T>C, hg38,17:g.7675124T>C",0.872,", biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, frontal_lobe, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, colon, left, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, prostate, salivary_gland, salivary_gland, parotid, skin, head_neck, skin, mucosal, sinonasal, small_intestine, jejunum, soft_tissue, soft_tissue, blood_vessel, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, urinary_tract, bladder","adenoma, adenoma, Brenner_tumour, adenoma, pleomorphic, angiosarcoma, carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, combined_small_cell_carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, invasive_mucinous_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, normal-like_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, M6, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, superficial_spreading, other, adenosis, other, neoplasm, sarcoma",,,,,127814,Pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
1702,163,Y,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_msk_2025, breast_msk_2025, csf_msk_2024, difg_glass, difg_glass_2019, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, mixed_impact_subset_2022, msk_access_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, sarcoma_msk_2022, skcm_broad, skcm_broad_dfarber","Basal Cell Carcinoma, Cutaneous Melanoma, Diffuse Glioma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578443-7578443, hg19,17:7675125-7675125, hg38,17:7675125-7675125","hg19,17:g.7578443A>C, hg19,17:g.7675125A>C, hg38,17:g.7675125A>C",0.906,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, spleen, large_intestine, liver, lung, lung, right_lower_lobe, oesophagus, skin, skin, back, skin, trunk","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma, malignant_melanoma, malignant_melanoma, superficial_spreading",,,,,187052,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1703,163,Y,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1704,163,Y,F,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",pancan_pdmr_2025,Mixed Cancer Types,"hg19,17:7578442-7578442","hg19,17:g.7578442T>A",0.723,,,,,,,,,,,,,,,,
1705,163,Y,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1706,163,Y,H,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, bcc_unige_2016, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_cptac_2019, coad_cptac_gdc, coadread_cass_2020, difg_msk_2023, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, hcc_mskimpact_2018, hgsoc_msk_2021, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, makeanimpact_ccr_2023, mbn_mdacc_2013, mbn_sfu_2023, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_cfdna_msk_2020, mixed_kunga_msk_2022, mixed_pipseq_2017, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paac_msk_jco_2023, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pcnsl_mayo_2015, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, prostate_msk_2024, sarcoma_msk_2022, stad_oncosg_2018, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Acinar Cell Carcinoma of the Pancreas, Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Primary DLBCL of the central nervous system, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578443-7578443, hg19,17:7675125-7675125, hg38,17:7675125-7675125","hg19,17:g.7578443A>G, hg19,17:g.7675125A>G, hg38,17:g.7675125A>G",0.904,", central_nervous_system, brain, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, ovary, pancreas, prostate, skin, skin, arm, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, oligoastrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma, other, intraepithelial_neoplasia, low_grade, other, keratosis",,,,,376680,Pathogenic,"Li-Fraumeni syndrome 1;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome",3,,,,,,
1707,163,Y,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1708,163,Y,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1709,163,Y,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1710,163,Y,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1711,163,Y,N,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","csf_msk_2024, difg_tcga_gdc, egc_msk_tp53_ccr_2022, escc_icgc, glioma_msk_2018, hcc_inserm_fr_2015, hcc_msk_2024, hcc_mskimpact_2018, hgsoc_tcga_gdc, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_riken, lung_msk_2017, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, prad_cdk12_mskcc_2020, prad_fhcrc, prad_msk_mdanderson_2023, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, soft_tissue_tcga_gdc, tmb_mskcc_2018","Diffuse Glioma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Head and Neck Carcinoma, Other, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578443-7578443, hg19,17:7578443-7578444, hg19,17:7675125-7675125, hg38,17:7675125-7675125","hg19,17:g.7578443A>T, hg19,17:g.7578443_7578444delinsTA, hg19,17:g.7675125A>T, hg38,17:g.7675125A>T",0.907,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, penis, prostate, soft_tissue, stomach, stomach, gastroesophageal_junction, upper_aerodigestive_tract, mouth, lip","adrenal_cortical_carcinoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma, sarcoma",,,,,376679,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
1712,163,Y,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1713,163,Y,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1714,163,Y,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1715,163,Y,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","crc_sysucc_2022, mbn_msk_2024, pan_origimed_2020","Colorectal Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,17:7578442-7578442, hg38,17:7675124-7675124","hg19,17:g.7578442T>G, hg38,17:g.7675124T>G",0.901,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, haematopoietic_and_lymphoid_tissue, large_intestine, rectum, liver, lung, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, hepatocellular_carcinoma, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, lymphoid_neoplasm, plasma_cell_myeloma",,,,,2757988,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1716,163,Y,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1717,163,Y,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1718,163,Y,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1719,164,K,A,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1720,164,K,C,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1721,164,K,D,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1722,164,K,E,,,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, brca_tcga, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, egc_msk_2017, egc_msk_2023, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, heme_msk_impact_2022, hgsoc_tcga_gdc, lgggbm_tcga_pub, lms_msk_2024, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, rectal_msk_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_cptac_2020, uec_cptac_gdc","Adenoid Cystic Carcinoma, Bowel, Cervical Squamous Cell Carcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Carcinoma, Other, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue, Uterine Endometrioid Carcinoma","hg19,17:7578440-7578440, hg19,17:7675122-7675122, hg38,17:7675122-7675122","hg19,17:g.7578440T>C, hg19,17:g.7675122T>C, hg38,17:g.7675122T>C",0.875,"biliary_tract, bile_duct, breast, central_nervous_system, brain, cervix, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, rectum, liver, lung, oesophagus, ovary, stomach, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, clonal_cytopenia_of_undetermined_significance, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelofibrosis, primary, low_malignant_potential_(borderline)_tumour, mucinous, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, other, neoplasm",,,,,246416,Pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,,,
1723,164,K,F,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1724,164,K,G,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1725,164,K,H,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1726,164,K,I,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1727,164,K,L,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1728,164,K,M,,,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578439-7578439, hg38,17:7675121-7675121","hg19,17:g.7578439T>A, hg38,17:g.7675121T>A",0.925,"breast, large_intestine, stomach","carcinoma, carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1729,164,K,N,,,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, hcc_clca_2024, luad_cas_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_ctdna_vte_2024, nsclc_ctdx_msk_2022, pan_origimed_2020","Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578438-7578438, hg19,17:7675120-7675120, hg38,17:7675120-7675120","hg19,17:g.7578438C>A, hg19,17:g.7578438C>G, hg19,17:g.7675120C>A, hg38,17:g.7675120C>A, hg38,17:g.7675120C>G",0.794,"breast, central_nervous_system, brain, lung, oesophagus, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,"2848594, 428899","Uncertain significance, Uncertain significance",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome,"1, 1",,,,,,
1730,164,K,P,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1731,164,K,Q,,,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","egc_msk_2023, pancan_mimsi_msk_2024","Esophagus/Stomach, Mixed Cancer Types","hg19,17:7578440-7578440, hg38,17:7675122-7675122","hg19,17:g.7578440T>G, hg38,17:g.7675122T>G",0.899,lung,"carcinoma, squamous_cell_carcinoma",,,,,2687712,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1732,164,K,R,,,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","glioma_mskcc_2019, mds_iwg_2022, tmb_mskcc_2018","Diffuse Glioma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7578439-7578439, hg38,17:7675121-7675121","hg19,17:g.7578439T>C, hg38,17:g.7675121T>C",0.906,"soft_tissue, blood_vessel, bone",angiosarcoma,,,,,,,,,,,,,,
1733,164,K,S,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1734,164,K,T,,,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578439-7578439, hg38,17:7675121-7675121","hg19,17:g.7578439T>G, hg38,17:g.7675121T>G",0.927,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1735,164,K,V,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1736,164,K,W,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1737,164,K,Y,,,Ubq,,,Ac,,,,,PhosphoSite,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1738,165,Q,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1739,165,Q,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1740,165,Q,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1741,165,Q,E,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578437-7578437, hg38,17:7675119-7675119","hg19,17:g.7578437G>C, hg38,17:g.7675119G>C",0.572,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, Hodgkin_lymphoma",,,,,3634431,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1742,165,Q,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1743,165,Q,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1744,165,Q,H,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, msk_chord_2024, msk_impact_2017, msk_met_2021","Breast, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7578435-7578435, hg38,17:7675117-7675117","hg19,17:g.7578435C>A, hg38,17:g.7675117C>A, hg38,17:g.7675117C>G",0.600,"breast, central_nervous_system, brain, large_intestine, colon, left","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
1745,165,Q,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1746,165,Q,K,,,,,,,,,,,,,,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, coadread_mskresistance_2022, csf_msk_2024, mbl_dkfz_2017","Colorectal Adenocarcinoma, Medulloblastoma, Mixed Cancer Types","hg19,17:7578437-7578437, hg38,17:7675119-7675119","hg19,17:g.7578437G>T, hg38,17:g.7675119G>T",0.481,,,,,,,482232,Conflicting classifications of pathogenicity,not specified;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
1747,165,Q,L,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578436-7578436, hg38,17:7675118-7675118","hg19,17:g.7578436T>A, hg38,17:g.7675118T>A",0.574,"haematopoietic_and_lymphoid_tissue, lymph_node, salivary_gland, parotid, soft_tissue, blood_vessel","Kaposi_sarcoma, carcinoma, mucoepidermoid_carcinoma, lymphoid_neoplasm, MALT_lymphoma",,,,,2505496,Pathogenic,Acute myeloid leukemia,0,,,,,,
1748,165,Q,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1749,165,Q,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1750,165,Q,P,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675118-7675118","hg38,17:g.7675118T>G",0.653,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lymph_node","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, MALT_lymphoma",,,,,,,,,,,,,,
1751,165,Q,R,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675118-7675118","hg38,17:g.7675118T>C",0.475,"large_intestine, large_intestine, colon, skin, shoulder, stomach","carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1752,165,Q,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1753,165,Q,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1754,165,Q,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1755,165,Q,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1756,165,Q,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1757,166,S,A,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578434-7578434, hg38,17:7675116-7675116","hg19,17:g.7578434A>C, hg38,17:g.7675116A>C",0.487,"oesophagus, pancreas, skin, upper_aerodigestive_tract, mouth","benign_melanocytic_nevus, dysplastic, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,2687713,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1758,166,S,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1759,166,S,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1760,166,S,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1761,166,S,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1762,166,S,G,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675115-7675116","hg38,17:g.7675115_7675116delinsCC",,"central_nervous_system, brain","glioma, astrocytoma_Grade_II, gemistocytic",,,,,,,,,,,,,,
1763,166,S,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1764,166,S,I,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675114-7675116","hg38,17:g.7675114_7675116delinsGAT",,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1765,166,S,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1766,166,S,L,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578433-7578433, hg38,17:7675115-7675115","hg19,17:g.7578433G>A, hg38,17:g.7675115G>A",0.613,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, lung, oesophagus","carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,528239,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1767,166,S,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1768,166,S,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1769,166,S,P,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675116-7675116","hg38,17:g.7675116A>G",0.707,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, prostate, salivary_gland, major","adenoma, pleomorphic, carcinoma, adenoid_cystic_carcinoma, hyperplasia, lymphoid_neoplasm, lymphoid_neoplasm, follicular_lymphoma",,,,,,,,,,,,,,
1770,166,S,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1771,166,S,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1772,166,S,T,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578434-7578434, hg38,17:7675116-7675116","hg19,17:g.7578434A>T, hg38,17:g.7675116A>T",0.512,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,,,,3809673,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
1773,166,S,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1774,166,S,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1775,166,S,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1776,167,Q,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1777,167,Q,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1778,167,Q,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1779,167,Q,E,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675113-7675113","hg38,17:g.7675113G>C",0.467,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1780,167,Q,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1781,167,Q,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1782,167,Q,H,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_msk_2025, metastatic_solid_tumors_mich_2017, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7578429-7578429, hg38,17:7675111-7675111","hg19,17:g.7578429C>A, hg19,17:g.7578429C>G, hg38,17:g.7675111C>A, hg38,17:g.7675111C>G","0.589, 0.592","haematopoietic_and_lymphoid_tissue, lymph_node, salivary_gland, parotid","carcinoma, mucoepidermoid_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified",,,,,,,,,,,,,,
1783,167,Q,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1784,167,Q,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",brca_fuscc_2020,Invasive Breast Carcinoma,"hg19,17:7578431-7578431, hg38,17:7675113-7675113","hg19,17:g.7578431G>T, hg38,17:g.7675113G>T",0.647,breast,carcinoma,,,,,2736423,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1785,167,Q,L,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675112-7675112","hg38,17:g.7675112T>A",0.569,"breast, large_intestine, colon","carcinoma, carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1786,167,Q,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1787,167,Q,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1788,167,Q,P,,,,,,,,,,,,,,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578430-7578430, hg38,17:7675112-7675112","hg19,17:g.7578430T>G, hg38,17:g.7675112T>G",0.633,,,,0.0000318735258494,,,490173,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided;Li-Fraumeni syndrome 1,2,,,,,,
1789,167,Q,R,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578430-7578430, hg38,17:7675112-7675112","hg19,17:g.7578430T>C, hg38,17:g.7675112T>C",0.566,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, rectum","carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,653104,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1790,167,Q,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1791,167,Q,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1792,167,Q,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1793,167,Q,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1794,167,Q,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1795,168,H,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1796,168,H,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1797,168,H,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675110-7675110","hg38,17:g.7675110G>C",0.551,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1798,168,H,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1799,168,H,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1800,168,H,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1801,168,H,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1802,168,H,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1803,168,H,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, es_iocurie_2014, hcc_msk_2024, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, mds_iwg_2022, msk_chord_2024, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_hcmi_2025, pancan_pcawg_2020, pdac_msk_2024, sclc_ucologne_2015, skcm_vanderbilt_mskcc_2015","Breast, Cutaneous Melanoma, Ewing Sarcoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Small Cell Lung Cancer","hg19,17:7578427-7578427, hg19,17:7675109-7675109, hg38,17:7675109-7675109","hg19,17:g.7578427T>A, hg19,17:g.7675109T>A, hg38,17:g.7675109T>A",0.550,"bone, breast, haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, upper_aerodigestive_tract, head_neck","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,1744933,Pathogenic,Hereditary cancer-predisposing syndrome,1,,,,Tier I - Strong,"Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype",1
1804,168,H,M,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1805,168,H,N,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578428-7578428, hg38,17:7675110-7675110","hg19,17:g.7578428G>T, hg38,17:g.7675110G>T",0.566,stomach,"carcinoma, diffuse_adenocarcinoma",,,,,2687697,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
1806,168,H,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, coadread_mskcc, crc_eo_2020, crc_msk_2017, lms_msk_2024, luad_cptac_gdc, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, ucec_ancestry_cds_msk_2023","Bowel, Colorectal Adenocarcinoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas","hg19,17:7578426-7578427, hg19,17:7578427-7578427, hg19,17:7675109-7675109, hg38,17:7675109-7675109","hg19,17:g.7578426_7578427delinsCG, hg19,17:g.7578427T>G, hg19,17:g.7675109T>G, hg38,17:g.7675109T>G",0.526,", breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, sigmoid, liver, lung, ovary, prostate, thyroid, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, hypopharynx, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, of_unknown_primary, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,3328154,Likely pathogenic,Hereditary cancer-predisposing syndrome,1,,,,Tier I - Strong,Embryonal tumor with multilayered rosettes,1
1807,168,H,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hcc_clca_2024, luad_cptac_gdc, msk_ctdna_vte_2024","Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578426-7578426, hg19,17:7675108-7675108, hg38,17:7675108-7675108","hg19,17:g.7578426G>C, hg19,17:g.7578426G>T, hg19,17:g.7675108G>C, hg38,17:g.7675108G>C, hg38,17:g.7675108G>T",0.568,"large_intestine, colon, prostate","carcinoma, carcinoma, adenocarcinoma",,,,,1745001,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1808,168,H,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mapk_hp_msk_2021, breast_msk_2025, crc_eo_2020, crc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_ucla_2014, glioma_mskcc_2019, hcc_msk_2024, hcc_mskimpact_2018, lihc_amc_prv, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, mbn_mdacc_2013, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paad_cptac_2021, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Thyroid","hg19,17:7578426-7578427, hg19,17:7578427-7578427, hg19,17:7675109-7675109, hg38,17:7675109-7675109","hg19,17:g.7578426_7578427delinsTC, hg19,17:g.7578427T>C, hg19,17:g.7675109T>C, hg38,17:g.7675109T>C",0.562,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, small_intestine, duodenum, soft_tissue, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, tubular_adenocarcinoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, bcr-abl_positive, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm, haematopoietic_neoplasm, myeloid_neoplasm_unspecified_therapy_related, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm, sarcoma",,,,,428866,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
1809,168,H,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1810,168,H,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1811,168,H,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1812,168,H,W,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1813,168,H,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578428-7578428, hg38,17:7675110-7675110","hg19,17:g.7578428G>A, hg38,17:g.7675110G>A",0.501,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, lung, skin, skin, face, urinary_tract, bladder, urachus, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, other, keratosis",,,,,4552487,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1814,169,M,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1815,169,M,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1816,169,M,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1817,169,M,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1818,169,M,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1819,169,M,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1820,169,M,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1821,169,M,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, breast_msk_2025, luad_broad, msk_ctdna_vte_2024, nsclc_tcga_broad_2016, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578423-7578423, hg19,17:7675105-7675105, hg38,17:7675105-7675105","hg19,17:g.7578423C>A, hg19,17:g.7578423C>T, hg19,17:g.7675105C>T, hg38,17:g.7675105C>A, hg38,17:g.7675105C>T",0.597,"breast, large_intestine, colon, lung, prostate, skin, eye, stomach, thymus, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, thymic_carcinoma",,,,,919322,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
1822,169,M,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1823,169,M,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578425-7578425, hg38,17:7675107-7675107","hg19,17:g.7578425T>A, hg38,17:g.7675107T>A",0.562,,,,,,,2886753,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1824,169,M,N,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1825,169,M,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1826,169,M,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1827,169,M,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578424-7578424, hg38,17:7675106-7675106","hg19,17:g.7578424A>C, hg38,17:g.7675106A>C",0.740,,,,,,,568736,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1828,169,M,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1829,169,M,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,17:7578424-7578424, hg19,17:7675106-7675106, hg38,17:7675106-7675106","hg19,17:g.7578424A>G, hg19,17:g.7675106A>G, hg38,17:g.7675106A>G",0.726,"haematopoietic_and_lymphoid_tissue, large_intestine, rectum, oesophagus, stomach, upper_aerodigestive_tract, mouth","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, other, dysplasia",,,,,,,,,,,,,,
1830,169,M,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7578425-7578425, hg38,17:7675107-7675107","hg19,17:g.7578425T>C, hg38,17:g.7675107T>C",0.503,"breast, haematopoietic_and_lymphoid_tissue, prostate, soft_tissue, blood_vessel","Kaposi_sarcoma, carcinoma, carcinoma, adenocarcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia",,,,,844926,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1831,169,M,W,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1832,169,M,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1833,170,T,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578422-7578422, hg38,17:7675104-7675104","hg19,17:g.7578422T>C, hg38,17:g.7675104T>C",0.518,"pancreas, skin, head_neck, skin, mucosal, sinonasal","carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,135949,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1834,170,T,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1835,170,T,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1836,170,T,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1837,170,T,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1838,170,T,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1839,170,T,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1840,170,T,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1841,170,T,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",mixed_cfdna_msk_2020,Mixed Cancer Types,"hg19,17:7578421-7578421","hg19,17:g.7578421G>T",0.827,,,,,,,,,,,,,,,,
1842,170,T,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1843,170,T,M,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_msk_2025, crc_eo_2020, crc_msk_2017, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, sft_sysucc_2023, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucs_msk_2024","Bowel, Colorectal Adenocarcinoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7578421-7578421, hg38,17:7675103-7675103","hg19,17:g.7578421G>A, hg38,17:g.7675103G>A",0.868,", central_nervous_system, brainstem, haematopoietic_and_lymphoid_tissue, large_intestine, caecum, large_intestine, colon, ovary, penis, skin, arm, skin, face, stomach, thyroid, upper_aerodigestive_tract, head_neck","adnexal_tumour, other, sebaceoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, other, keratosis",0.0000477475111610,0.0000318633698700,,,184014,Likely benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
1844,170,T,N,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1845,170,T,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675104-7675104","hg38,17:g.7675104T>G",0.808,cervix,carcinoma,,,,,,,,,,,,,,
1846,170,T,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1847,170,T,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578421-7578421, hg38,17:7675103-7675103","hg19,17:g.7578421G>C, hg38,17:g.7675103G>C",0.867,"pancreas, penis","carcinoma, squamous_cell_carcinoma, other, dysplasia-in_situ_neoplasm",,,,,490174,Uncertain significance,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
1848,170,T,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578422-7578422, hg38,17:7675104-7675104","hg19,17:g.7578422T>A, hg38,17:g.7675104T>A",0.629,prostate,carcinoma,,,,,3460324,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1849,170,T,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1850,170,T,W,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1851,170,T,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1852,171,E,A,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675100-7675100","hg38,17:g.7675100T>G",0.896,stomach,carcinoma,,,,,,,,,,,,,,
1853,171,E,C,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1854,171,E,D,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",brca_tcga_pub,Invasive Breast Carcinoma,"hg19,17:7578417-7578417, hg38,17:7675099-7675099","hg19,17:g.7578417C>A, hg19,17:g.7578417C>G, hg38,17:g.7675099C>A, hg38,17:g.7675099C>G",0.597,"central_nervous_system, brain, liver, ovary","carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, primitive_neuroectodermal_tumour-medulloblastoma",,,,,2446885,Pathogenic,Acute myeloid leukemia,0,,,,,,
1855,171,E,F,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1856,171,E,G,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, brca_metabric, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pdac_msk_2024, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue","hg19,17:7578418-7578418, hg38,17:7675100-7675100","hg19,17:g.7578418T>C, hg38,17:g.7675100T>C",0.917,"central_nervous_system, brain, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, large_intestine, colon, liver, skin, soft_tissue, smooth_muscle, bone, stomach, gastroesophageal_junction","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, leiomyosarcoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, malignant_melanoma",,,,,1745525,Pathogenic,Hereditary cancer-predisposing syndrome,1,,,,,,
1857,171,E,H,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1858,171,E,I,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1859,171,E,K,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2024, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, msk_chord_2024, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_ancestry_cds_msk_2023, utuc_mskcc_2015","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Upper Tract Urothelial Carcinoma","hg19,17:7578419-7578419, hg19,17:7675101-7675101, hg38,17:7675101-7675101","hg19,17:g.7578419C>T, hg19,17:g.7675101C>T, hg38,17:g.7675101C>T",0.873,"breast, endometrium, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, skin, large_intestine, appendix, large_intestine, colon, lung, oesophagus, skin, stomach, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, bladder","carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, malignant_melanoma, spitzoid",,,,,141566,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,3,,,,,,
1860,171,E,L,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1861,171,E,M,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1862,171,E,N,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1863,171,E,P,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1864,171,E,Q,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675101-7675101","hg38,17:g.7675101C>G",0.849,"large_intestine, large_intestine, rectum, skin, head_neck, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
1865,171,E,R,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1866,171,E,S,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1867,171,E,T,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1868,171,E,V,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675099-7675100, hg38,17:7675100-7675100","hg38,17:g.7675099_7675100delinsGA, hg38,17:g.7675100T>A",0.922,"breast, lung","carcinoma, carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
1869,171,E,W,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1870,171,E,Y,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1871,172,V,A,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_met_2021, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7578415-7578415, hg38,17:7675097-7675097","hg19,17:g.7578415A>G, hg38,17:g.7675097A>G",0.850,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, prostate, skin, shoulder","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,528245,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1872,172,V,C,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1873,172,V,D,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, breast_msk_2025, crc_sysucc_2022, dlbcl_duke_2017, esca_broad, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, pediatric_dkfz_2017, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Colorectal Adenocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas","hg19,17:7578415-7578415, hg19,17:7675097-7675097, hg38,17:7675097-7675097","hg19,17:g.7578415A>T, hg19,17:g.7675097A>T, hg38,17:g.7675097A>T",0.952,"biliary_tract, bile_duct, breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, large_intestine, lung, oesophagus, pancreas, testis, thyroid, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, mixed, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, Burkitt_lymphoma, sporadic_type, lymphoid_neoplasm, MALT_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, other, intraepithelial_neoplasia, low_grade",,,,,836761,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;TP53-related disorder;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,1,,,,,,
1874,172,V,E,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1875,172,V,F,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, blca_iatlas_imvigor210_2017, bowel_colitis_msk_2022, braf_msk_impact_2024, brca_mapk_hp_msk_2021, breast_ink4_msk_2021, breast_msk_2025, coadread_cass_2020, crc_eo_2020, crc_msk_2017, egc_msk_tp53_ccr_2022, egc_mskcc_2020, escc_icgc, gbc_msk_2018, gbc_mskcc_2022, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_msk_2024, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lipo_msk_2024, luad_broad, luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_sfu_2023, mds_iwg_2022, meso_tcga, meso_tcga_pan_can_atlas_2018, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, plmeso_tcga_gdc, pog570_bcgsc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sclc_ucologne_2015, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Liposarcoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Thyroid","hg19,17:7578416-7578416, hg19,17:7675098-7675098, hg38,17:7675098-7675098","hg19,17:g.7578416C>A, hg19,17:g.7675098C>A, hg38,17:g.7675098C>A",0.917,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, ovary, pancreas, penis, prostate, skin, thyroid, upper_aerodigestive_tract, head_neck, urinary_tract, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, osteosarcoma",,,,,428909,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,Likely oncogenic,Neoplasm,1,,,
1876,172,V,G,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, hcc_clca_2024, lgggbm_tcga_pub, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016","Diffuse Glioma, Hepatocellular Carcinoma, Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,17:7578415-7578415, hg19,17:7675097-7675097, hg38,17:7675097-7675097","hg19,17:g.7578415A>C, hg19,17:g.7675097A>C, hg38,17:g.7675097A>C",0.953,"central_nervous_system, brain, liver, lung, prostate, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,428883,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1877,172,V,H,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1878,172,V,I,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578416-7578416, hg38,17:7675098-7675098","hg19,17:g.7578416C>T, hg38,17:g.7675098C>T",0.645,"breast, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, appendix, large_intestine, rectum, lung, oesophagus, small_intestine, jejunum, urinary_tract, bladder, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, gastric_type, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,825481,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1879,172,V,K,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1880,172,V,L,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675098-7675098","hg38,17:g.7675098C>G",0.815,"large_intestine, colon","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1881,172,V,M,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1882,172,V,N,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1883,172,V,P,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1884,172,V,Q,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1885,172,V,R,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1886,172,V,S,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1887,172,V,T,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1888,172,V,W,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1889,172,V,Y,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1890,173,V,A,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bowel_colitis_msk_2022, coad_silu_2022, difg_glass, difg_glass_2019, difg_tcga_gdc, gct_msk_2016, hcc_inserm_fr_2015, heme_msk_impact_2022, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pediatric_dkfz_2017, prostate_msk_2024, rcc_cptac_gdc, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, usarc_msk_2020","Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Hepatocellular Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Prostate, Renal Cell Carcinoma, Soft Tissue, Testis, Uterine Sarcoma/Mesenchymal","hg19,17:7578412-7578412, hg19,17:7675094-7675094, hg38,17:7675094-7675094","hg19,17:g.7578412A>G, hg19,17:g.7675094A>G, hg38,17:g.7675094A>G",0.758,"biliary_tract, gallbladder, central_nervous_system, brain, central_nervous_system, brainstem, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, liver, lung, prostate, soft_tissue, smooth_muscle, uterus, testis, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, mixed, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, leiomyosarcoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,376017,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,2,Oncogenic,Neoplasm,1,Tier I - Strong,Astrocytoma IDH-mutant,1
1891,173,V,C,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1892,173,V,D,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1893,173,V,E,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_ch_2020, msk_ch_2023, msk_chord_2024, pan_origimed_2020, pancan_pcawg_2020, pancan_pdmr_2025, rectal_msk_2022, sarcoma_msk_2022","Bowel, Mixed Cancer Types, Soft Tissue","hg19,17:7578412-7578412, hg38,17:7675094-7675094","hg19,17:g.7578412A>T, hg38,17:g.7675094A>T",0.749,"central_nervous_system, spinal_cord, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, rectum, liver, oesophagus, stomach, urinary_tract","carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_I, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, atypical",,,,,376669,Conflicting classifications of pathogenicity,not specified;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Oncogenic,Neoplasm,1,,,
1894,173,V,F,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1895,173,V,G,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_metabric, breast_msk_2025, cll_broad_2022, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lms_msk_2024, luad_oncosg_2020, mbn_mdacc_2013, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, stes_tcga_pub, usarc_msk_2020, wt_target_2018_pub","Basal Cell Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreas, Soft Tissue, Uterine Sarcoma/Mesenchymal, Wilms' Tumor","hg19,17:7578412-7578412, hg19,17:7675094-7675094, hg38,17:7675094-7675094","hg19,17:g.7578412A>C, hg19,17:g.7675094A>C, hg38,17:g.7675094A>C",0.769,"bone, bone, scapula, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, rectum, lung, oesophagus, pancreas, skin, skin, ear, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, lip, vulva","Wilms_tumour, carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, dedifferentiated_carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, tubular_adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, follicular_lymphoma, osteosarcoma, osteosarcoma, chondroblastic",,,,,376016,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",1,,,,Tier I - Strong,"Diffuse glioma, H3 G34 mutant",1
1896,173,V,H,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1897,173,V,I,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1898,173,V,K,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1899,173,V,L,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_tcga, acc_tcga_gdc, acc_tcga_pan_can_atlas_2018, bladder_msk_2024, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brain_cptac_gdc, brca_mapk_hp_msk_2021, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cfdna_msk_2019, cll_iuopa_2015, coad_silu_2022, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_ucsf_2021, csf_msk_2024, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, es_dsrct_msk_2023, escc_icgc, gct_msk_2016, hcc_jcopo_msk_2023, heme_msk_impact_2022, hgsoc_msk_2021, hnsc_broad, hnsc_jhu, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_broad, luad_cas_2020, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2015, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbc_msk_2021, mbn_sfu_2023, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mpcproject_broad_2021, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2015, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pub, paad_cptac_2021, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_ucologne_2015, skcm_broad, skcm_broad_dfarber, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, usarc_msk_2020, utuc_msk_2019, wt_target_gdc","Adrenocortical Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, CNS/Brain, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Metaplastic Breast Cancer, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Testis, Thyroid, Upper Tract Urothelial Carcinoma, Uterine Sarcoma/Mesenchymal, Wilms' Tumor","hg19,17:7578413-7578413, hg19,17:7675095-7675095, hg38,17:7675095-7675095","hg19,17:g.7578413C>A, hg19,17:g.7578413C>G, hg19,17:g.7675095C>A, hg19,17:g.7675095C>G, hg38,17:g.7675095C>A, hg38,17:g.7675095C>G",0.880,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, endometrium, extrapulmonary, female_genital_tract_(site_indeterminate), genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, oesophagus, middle_third, ovary, pancreas, prostate, skin, skin, arm, skin, trunk, small_intestine, ileum, soft_tissue, smooth_muscle, uterus, stomach, stomach, gastroesophageal_junction, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, Wilms_tumour, bilateral, adrenal_cortical_carcinoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, blastoma, carcinoma, clear_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, enteric_adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, germ_cell_tumour, yolk_sac_tumour, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, normal_karyotype, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, leiomyoma, leiomyosarcoma, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, other, adenoma, other, intraepithelial_neoplasia, low_grade, primitive_neuroectodermal_tumour-medulloblastoma",,,,,"2185665, 376668","Conflicting classifications of pathogenicity, Pathogenic/Likely pathogenic",Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,"1, 2","Oncogenic, Oncogenic",Neoplasm|Neoplasm,"1, 1",Tier III - Unknown,"Primary intracranial sarcoma, DICER1-mutant",1
1900,173,V,M,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, angs_painter_2025, bladder_msk_2023, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_nmibc_2017, blca_plasmacytoid_mskcc_2016, brca_dldccc_2022, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, cll_broad_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_ucsf_2021, csf_msk_2024, difg_tcga_gdc, dlbcl_duke_2017, egc_msk_2023, egc_mskcc_2020, es_iocurie_2014, glioma_msk_2018, glioma_mskcc_2019, hcc_meric_2021, hcc_msk_2024, hccihch_pku_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_mind_2020, lung_msk_pdx, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_kunga_msk_2022, mixed_selpercatinib_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, ovary_cptac_gdc, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_pub, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, rectal_radiation_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stad_utokyo, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, wt_target_2018_pub","Acute Myeloid Leukemia, Angiosarcoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mature T and NK Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Wilms' Tumor","hg19,17:7578413-7578413, hg19,17:7675095-7675095, hg38,17:7675095-7675095","hg19,17:g.7578413C>T, hg19,17:g.7675095C>T, hg38,17:g.7675095C>T",0.892,", biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, parietal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, thyroid, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_lower_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pleura, prostate, skin, face, soft_tissue, fibrous_tissue_and_uncertain_origin, soft_tissue, nerve_sheath, leg, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, urinary_tract, bladder, urinary_tract, upper_urinary_tract","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, adenoma, carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, oligoastrocytoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia_with_ringed_sideroblasts, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, variant, lymphoid_neoplasm, plasma_cell_myeloma, malignant_peripheral_nerve_sheath_tumour, mesothelioma, mesothelioma, epithelial, osteosarcoma, synovial_sarcoma",,,,,233951,Pathogenic,TP53-related disorder;Lip and oral cavity carcinoma;Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome,3,Oncogenic,Neoplasm,1,,,
1901,173,V,N,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1902,173,V,P,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1903,173,V,Q,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_met_2021, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7578412-7578413","hg19,17:g.7578412_7578413delinsTG",,,,,,,,,,,,,,,,,
1904,173,V,R,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021",Mixed Cancer Types,"hg19,17:7578412-7578413","hg19,17:g.7578412_7578413delinsCT",,,,,,,,,,,,,,,,,
1905,173,V,S,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1906,173,V,T,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1907,173,V,W,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675094-7675095","hg38,17:g.7675094_7675095delinsCA",,stomach,"carcinoma, tubular_adenocarcinoma",,,,,,,,,,,,,,
1908,173,V,Y,,,,,,,,,,,,"Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1909,174,R,A,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1910,174,R,C,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1911,174,R,D,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1912,174,R,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, msk_chord_2024, nsclc_ctdx_msk_2022","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578409-7578410","hg19,17:g.7578409_7578410delinsTC",,,,,,,,,,,,,,,,,
1913,174,R,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1914,174,R,G,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, ucec_ancestry_cds_msk_2023","Breast, Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7578410-7578410, hg38,17:7675092-7675092","hg19,17:g.7578410T>C, hg38,17:g.7675092T>C",0.724,"biliary_tract, bile_duct, breast, prostate","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",,,,,219487,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1915,174,R,H,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1916,174,R,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1917,174,R,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578409-7578409, hg38,17:7675091-7675091","hg19,17:g.7578409C>T, hg38,17:g.7675091C>T",0.381,"breast, central_nervous_system, cerebellum, haematopoietic_and_lymphoid_tissue, small_intestine, liver, lung, skin, face","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, primitive_neuroectodermal_tumour-medulloblastoma",,,,,423887,Likely benign,not provided;not specified,2,,,,,,
1918,174,R,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1919,174,R,M,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675091-7675091","hg38,17:g.7675091C>A",0.628,"lung, small_intestine, jejunum","carcinoma, adenocarcinoma, gastric_type, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
1920,174,R,N,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",pancan_pcawg_2020,Mixed Cancer Types,"hg19,17:7578408-7578409","hg19,17:g.7578408_7578409delinsAT",,,,,,,,,,,,,,,,,
1921,174,R,P,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1922,174,R,Q,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1923,174,R,S,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578408-7578408, hg38,17:7675090-7675090","hg19,17:g.7578408C>G, hg38,17:g.7675090C>A, hg38,17:g.7675090C>G",0.639,"liver, skin, face, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,1058186,Uncertain significance,Li-Fraumeni syndrome,2,,,,,,
1924,174,R,T,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578409-7578409","hg19,17:g.7578409C>G",0.633,,,,,,,,,,,,,,,,
1925,174,R,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1926,174,R,W,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_msk_2025, cll_broad_2015, cll_broad_2022, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, hcc_clca_2024, hcc_tcga_gdc, ihch_smmu_2014, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lusc_tcga_gdc, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, stes_tcga_pub, ucec_ancestry_cds_msk_2023","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Soft Tissue","hg19,17:7578410-7578410, hg19,17:7675092-7675092, hg38,17:7675092-7675092","hg19,17:g.7578410T>A, hg19,17:g.7675092T>A, hg38,17:g.7675092T>A",0.634,", biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, liver, lung, oesophagus, pancreas, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, other, neoplasm",,,,,964680,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
1927,174,R,Y,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|FHA phosphopeptide ligands (LIG_FHA_1), 168-174, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1928,175,R,A,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1929,175,R,C,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, difg_tcga_gdc, gbc_mskcc_2022, hcc_msk_2024, lgg_tcga_pan_can_atlas_2018, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pancan_mimsi_msk_2024, prostate_msk_2024, ptad_msk_2024, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_msk_dacruzpaula_2025, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucs_msk_2024, uec_cptac_gdc","Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pituitary Adenoma, Prostate, Soft Tissue, Stomach Adenocarcinoma, Uterine Endometrioid Carcinoma","hg19,17:7578407-7578407, hg19,17:7675089-7675089, hg38,17:7675089-7675089","hg19,17:g.7578407G>A, hg19,17:g.7675089G>A, hg38,17:g.7675089G>A",0.833,"central_nervous_system, brain, cervix, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, colon, transverse, lung, oesophagus, prostate, salivary_gland, major, stomach, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, urinary_tract, renal_pelvis, urinary_tract, upper_urinary_tract, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mucoepidermoid_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, hyperplasia, atypical, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",0.0000159182438993,0.0000318613394507,,,245851,Uncertain significance,"Hereditary cancer-predisposing syndrome;not specified;not provided;Hereditary breast ovarian cancer syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Breast-ovarian cancer, familial, susceptibility to, 1",3,,,,,,
1930,175,R,D,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1931,175,R,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1932,175,R,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1933,175,R,G,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_metabric, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, coadread_dfci_2016, coadread_mskcc, difg_tcga_gdc, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_tcga_pub, heme_msk_impact_2022, hgsoc_msk_2021, hgsoc_tcga_gdc, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_mskimpact_2021, lung_msk_2017, lung_msk_pdx, lung_pdx_msk_2021, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, mnm_washu_2016, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_oncosg_2018, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stad_utokyo, stes_tcga_pub, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578407-7578407, hg19,17:7675089-7675089, hg38,17:7675089-7675089","hg19,17:g.7578407G>C, hg19,17:g.7675089G>C, hg38,17:g.7675089G>C",0.829,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, rectum, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, skin, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, bladder, urachus","adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, intraepithelial_neoplasia, low_grade, other, thrombocytosis",,,,,376649,Pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,Oncogenic,Neoplasm,1,,,
1934,175,R,H,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, all_stjude_2016, aml_ohsu_2018, aml_ohsu_2022, aml_target_gdc, ampca_bcm_2016, appendiceal_msk_2022, bcc_unige_2016, biliary_tract_summit_2022, bladder_msk_2023, blca_bcan_hcrn_2022, blca_bgi, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_mskcc_solit_2014, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bll_target_gdc, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brain_cptac_2020, brain_cptac_gdc, brca_aurora_2023, brca_bccrc, brca_cptac_2020, brca_dldccc_2022, brca_fuscc_2020, brca_iatlas_anders_2022, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_pareja_msk_2020, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, cervix_msk_2023, cfdna_msk_2019, chl_sccc_2023, chol_icgc_2017, chol_jhu_2013, cll_broad_2015, cll_broad_2022, cll_iuopa_2015, coad_cptac_2019, coad_cptac_gdc, coad_silu_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_genentech, coadread_mskcc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_dd_2022, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_orion_2024, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_msk_2023, difg_tcga_gdc, dlbcl_dfci_2018, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_tmucih_2015, egc_trap_ccr_msk_2023, egc_trap_msk_2020, es_dfarber_broad_2014, es_dsrct_msk_2023, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, escc_ucla_2014, gbc_msk_2018, gbc_mskcc_2022, gbc_shanghai_2014, gbm_cptac_2021, gbm_mayo_pdx_sarkaria_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gbm_tcga_pub2013, gist_msk_2023, glioma_msk_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, hgsoc_msk_2021, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_broad, hnsc_jhu, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, ihch_mskcc_2020, ihch_smmu_2014, lcll_broad_2013, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, lihc_amc_prv, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_cas_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lung_nci_2022, lung_pdx_msk_2021, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbl_dkfz_2017, mbl_icgc, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_dfci_2019, mel_iatlas_liu_2019, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_cfdna_msk_2020, mixed_impact_subset_2022, mixed_pipseq_2017, mpcproject_broad_2021, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nccrcc_genentech_2014, npc_nusingapore, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, nst_nfosi_ntap, ohnca_cptac_gdc, os_target_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovarian_msk_2025, ovary_cptac_gdc, paad_cptac_2021, paad_icgc, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, panet_msk_2018, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, pptc_2019, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_mich, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_dkfz_2018, prostate_msk_2024, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, rectal_radiation_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, skcm_dfci_2015, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, soft_tissue_msk_2025, soft_tissue_tcga_gdc, stad_oncosg_2018, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stad_uhongkong, stad_utokyo, stes_tcga_pub, summit_2018, thyroid_gatci_2024, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_cptac_2020, ucec_msk_2018, ucec_msk_2024, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014, ucs_msk_2024, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc, usarc_msk_2020, utuc_igbmc_2021, utuc_msk_2019, utuc_mskcc_2015, wt_target_2018_pub, wt_target_gdc","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Ampullary Carcinoma, Appendiceal Adenocarcinoma, B-Lymphoblastic Leukemia/Lymphoma, Basal Cell Carcinoma, Biliary Tract, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cervix, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Classical Hodgkin Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gallbladder Cancer, Gastrointestinal Stromal Tumor, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Medulloblastoma, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Nasopharyngeal Carcinoma, Nerve Sheath Tumor, Non-Small Cell Lung Cancer, Osteosarcoma, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine Tumor, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Renal Non-Clear Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Thyroid, Upper Tract Urothelial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma, Uterine Sarcoma/Mesenchymal, Wilms' Tumor","hg19,17:7578405-7578406, hg19,17:7578406-7578406, hg19,17:7675088-7675088, hg38,17:7675088-7675088","hg19,17:g.7578405_7578406delinsAT, hg19,17:g.7578406C>T, hg19,17:g.7675088C>T, hg38,17:g.7675088C>T",0.922,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, corpus_callosum, central_nervous_system, frontal_lobe, central_nervous_system, medulla, central_nervous_system, middle_frontal_gyrus, central_nervous_system, occipital_lobe, central_nervous_system, parietal_lobe, central_nervous_system, superior_frontal_gyrus, central_nervous_system, temporal_lobe, central_nervous_system, temporooccipital, central_nervous_system, thalamus, cervix, endometrium, eye, conjunctiva, female_genital_tract_(site_indeterminate), gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, breast, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, large_intestine, anorectal, large_intestine, anus, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, left, large_intestine, rectum, large_intestine, right, liver, lung, lung, bronchus, lung, right, lung, right_lower_lobe, lung, right_middle_lobe, meninges, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, peritoneum, appendix, pleura, prostate, salivary_gland, salivary_gland, major, salivary_gland, minor, skin, skin, eye, skin, lower_leg, skin, mucosal, skin, mucosal, oral_cavity, skin, mucosal, vagina, skin, penis, skin, perianal, skin, scalp, skin, trunk, skin, vulva, small_intestine, duodenum, small_intestine, ileum, small_intestine, jejunum, soft_tissue, soft_tissue, blood_vessel, heart, soft_tissue, fat, soft_tissue, fat, mediastinum, soft_tissue, fat, upper_leg, soft_tissue, fibrous_tissue_and_uncertain_origin, soft_tissue, fibrous_tissue_and_uncertain_origin, forearm, soft_tissue, fibrous_tissue_and_uncertain_origin, retroperitoneum, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, soft_tissue, smooth_muscle, abdomen, soft_tissue, smooth_muscle, arm, soft_tissue, smooth_muscle, retroperitoneum, soft_tissue, striated_muscle, soft_tissue, striated_muscle, upper_leg, stomach, stomach, gastroesophageal_junction, testis, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, supraglottis, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, alveolus, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, lingual_mucosa, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, retromolar, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, hypopharynx, piriform_sinus, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, urinary_tract, bladder, urinary_tract, bladder, urachus, urinary_tract, upper_urinary_tract, urinary_tract, ureter, vulva",", Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, adenoma, adenoma, mucinous, adenoma, tubular, adenoma, tubulovillous, high_grade_dysplasia, adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, adnexal_tumour, malignant_adnexal_tumour, extramammary_Pagets_disease, adnexal_tumour, malignant_adnexal_tumour, hidradenocarcinoma, adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adnexal_tumour, malignant_adnexal_tumour, spiradenocarcinoma, adrenal_cortical_carcinoma, adrenal_cortical_carcinoma, cortisol_and_virilizing_syndrome-producing, adrenal_cortical_carcinoma, cortisol_producing, angiosarcoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, acinic_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, classic, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, squamous_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, apocrine, carcinoma, ductal_carcinoma, cancerization_of_ducts, carcinoma, ductal_carcinoma, metaplastic_sarcomatoid, carcinoma, ductal_carcinoma, micropapillary, carcinoma, ductal_carcinoma, papillary, carcinoma, ductolobular_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, follicular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, lobular_carcinoma, pleomorphic, carcinoma, luminal_A_carcinoma, carcinoma, medullary_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenocarcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_carcinoma, carcinoma, mixed_ductal-neuroendocrine_carcinoma, carcinoma, mixed_endometrioid_and_clear_cell_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_adenocarcinoma, carcinoma, papillary_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, renal_cell_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, spindle_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, micropapillary_transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, non_papillary_transitional_cell_carcinoma_non_invasive, carcinoma, tubular_adenocarcinoma, carcinoma, undifferentiated_carcinoma, carcinoma_(Schneiderian), low_grade_papillary_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, germ_cell_tumour, mixed, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, glioma, astroblastoma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, gliosarcoma, glioma, oligoastrocytoma, glioma, oligoastrocytoma_Grade_II, glioma, oligoastrocytoma_Grade_III, anaplastic, glioma, oligodendroglioma, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_basophilic_leukaemia, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_leukaemic_transformation_of_polycythaemia_vera, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M0, haematopoietic_neoplasm, acute_myeloid_leukaemia_myelodysplastic_syndrome_therapy_related_NOS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic-myeloproliferative_neoplasm, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_ringed_sideroblasts, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, myelofibrosis, leiomyosarcoma, liposarcoma, pleomorphic, lymphoid_neoplasm, lymphoid_neoplasm, B_cell_lymphoma_unspecified, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, lymphoid_neoplasm, Langerhans_cell_histiocytosis, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, anaplastic_large_cell_lymphoma, lymphoid_neoplasm, breast_implant_associated_anaplastic_large_cell_lymphoma, ALK_negative, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, malignant_melanoma, meningioma, meningothelial, mesothelioma, mesothelioma, biphasic, mesothelioma, epithelial, osteosarcoma, other, Barrett_oesophagus, with_high_grade_dysplasia, other, Crohn_disease, other, adenosis, other, bronchiolar_adenoma, other, dysplasia, other, dysplasia-in_situ_neoplasm, other, intraepithelial_neoplasia, high_grade, other, intraepithelial_neoplasia, low_grade, other, metaplasia, other, metaplasia, epidermoid, other, neoplasm, other, normal, other, oncocytoma, other, pseudomyxoma_peritonei, other, solid_neoplasm, other, ulcerative_colitis, dysplasia, pancreatic_intraepithelial_neoplasia_(PanIN), primitive_neuroectodermal_tumour-medulloblastoma, primitive_neuroectodermal_tumour-medulloblastoma, classic, primitive_neuroectodermal_tumour-medulloblastoma, desmoplastic, primitive_neuroectodermal_tumour-medulloblastoma, large_cell, rhabdomyosarcoma, pleomorphic, sarcoma, serrated_polyp, serrated_adenoma, sex_cord-stromal_tumour, granulosa_cell_tumour, undifferentiated-unclassified_sarcoma, mixed, undifferentiated-unclassified_sarcoma, pleomorphic, undifferentiated_sarcoma, pleomorphic",0.0000039796876741,,,,12374,Pathogenic,"TP53-related disorder;Colorectal cancer;Hereditary cancer-predisposing syndrome;Gastric cancer;Colorectal cancer;Lip and oral cavity carcinoma;not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Malignant tumor of esophagus;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck;Familial cancer of breast",3,Oncogenic,Neoplasm,1,Tier I - Strong,"Medulloblastoma SHH activated and TP53 mutant;Diffuse midline glioma, H3 K27M-mutant;Undifferentiated embryonal sarcoma of the liver;Small intestine adenocarcinoma;IDH-wildtype glioblastoma;Astrocytoma IDH-mutant;Neuroblastoma",1
1935,175,R,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1936,175,R,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1937,175,R,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_dfarber_mskcc_2014, blca_msk_tcga_2020, braf_msk_impact_2024, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, chol_jhu_2013, crc_apc_impact_2020, crc_eo_2020, hcc_inserm_fr_2015, hcc_meric_2021, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, prad_msk_mdanderson_2023, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, soft_tissue_tcga_gdc, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Cholangiocarcinoma, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Soft Tissue","hg19,17:7578406-7578406, hg19,17:7675088-7675088, hg38,17:7675088-7675088","hg19,17:g.7578406C>A, hg19,17:g.7675088C>A, hg38,17:g.7675088C>A",0.960,"biliary_tract, bile_duct, biliary_tract, gallbladder, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, rectum, liver, lung, lung, bronchus, oesophagus, pancreas, skin, mucosal, urinary_tract, soft_tissue, soft_tissue, smooth_muscle, abdomen, thymus, thyroid, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, leiomyosarcoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, malignant_melanoma, other, hyperplasia, sarcoma, thymic_carcinoma, squamous_cell_carcinoma",,,,,182963,Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
1938,175,R,M,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1939,175,R,N,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1940,175,R,P,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675088-7675088","hg38,17:g.7675088C>G",0.966,", central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, lung, stomach, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, of_unknown_primary, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
1941,175,R,Q,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1942,175,R,S,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578407-7578407, hg38,17:7675089-7675089","hg19,17:g.7578407G>T, hg38,17:g.7675089G>T",0.831,"adrenal_gland, adrenal_gland, breast, central_nervous_system, brain, central_nervous_system, occipital_lobe, genital_tract, extragonadal, brain, large_intestine, liver, lung, salivary_gland, major","adrenal_cortical_carcinoma, adrenal_cortical_carcinoma, functioning, carcinoma, carcinoma, adenocarcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, germ_cell_tumour, mixed, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,4189264,Conflicting classifications of pathogenicity,not provided;Hereditary cancer-predisposing syndrome,1,,,,,,
1943,175,R,T,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1944,175,R,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1945,175,R,W,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1946,175,R,Y,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Separase cleavage motif (CLV_Separin_Metazoa), 171-175, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 173-175, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1947,176,C,A,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1948,176,C,D,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1949,176,C,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1950,176,C,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, bcc_unige_2016, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brca_bccrc, brca_dldccc_2022, brca_fuscc_2020, brca_igr_2015, brca_metabric, brca_msk_2025, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, chrcc_tcga_gdc, coad_silu_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_genentech, coadread_mskcc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_ucsf_2021, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, dlbc_broad_2012, dlbcl_dfci_2018, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, es_dfarber_broad_2014, es_iocurie_2014, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_ucla_2014, hcc_clca_2024, hcc_inserm_fr_2015, hcc_msk_2024, hccihch_pku_2019, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, ihch_msk_2021, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, lihc_riken, luad_broad, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_mdacc_2013, mbn_sfu_2023, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, paad_icgc, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, pptc_2019, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_organoids_msk_2022, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_msk_2023, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Chromophobe Renal Cell Carcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rhabdomyosarcoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578402-7578403, hg19,17:7578403-7578403, hg19,17:7675085-7675085, hg38,17:7675084-7675085, hg38,17:7675085-7675085","hg19,17:g.7578402_7578403delinsAA, hg19,17:g.7578403C>A, hg19,17:g.7675085C>A, hg38,17:g.7675084_7675085delinsAA, hg38,17:g.7675085C>A",0.951,", adrenal_gland, adrenal_gland, autonomic_ganglia, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, bone, extraskeletal, bone, femur, bone, scapula, breast, central_nervous_system, brain, central_nervous_system, frontoparietal, cervix, endometrium, genital_tract, extragonadal, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, lung, right_lower_lobe, oesophagus, ovary, pancreas, pleura, prostate, salivary_gland, skin, skin, chest, skin, ear, skin, leg, skin, mucosal, vulva, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, soft_tissue, striated_muscle, soft_tissue, striated_muscle, head_neck, soft_tissue, striated_muscle, lower_arm, soft_tissue, striated_muscle, lymph_node, stomach, stomach, gastroesophageal_junction, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, supraglottis, upper_aerodigestive_tract, larynx, vocal_cord, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, alveolus, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, mouth_roof, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid, urinary_tract, bladder, urinary_tract, renal_pelvis, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, adenoma, tubular, adrenal_cortical_carcinoma, adrenal_cortical_carcinoma, functioning, carcinoid-endocrine_tumour, atypical, carcinoma, carcinoma, Brenner_tumour, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_small_cell_carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, osteoclast-like_giant_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, carcinoma, undifferentiated_carcinoma, germ_cell_tumour, seminoma, germ_cell_tumour, yolk_sac_tumour, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_ringed_sideroblasts, in_situ_epithelial_neoplasm, Bowen_disease, lymphoid_neoplasm, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, superficial_spreading, neuroblastoma, osteosarcoma, fibroblastic, other, adenosis, other, dysplasia, other, dysplasia, high_grade-carcinoma_in_situ, other, hyperplasia, other, neoplasm, pulmonary_blastoma, rhabdomyosarcoma, rhabdomyosarcoma, embryonal, undifferentiated-unclassified_sarcoma, spindle_cell",0.0000039795609748,,,,376569,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,2,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant;Ewing sarcoma;Embryonal rhabdomyosarcoma;Alveolar rhabdomyosarcoma",1
1951,176,C,G,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bowel_colitis_msk_2022, crc_msk_2017, hgsoc_tcga_gdc, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nhl_bcgsc_2013, ov_tcga_pan_can_atlas_2018, paad_qcmg_uq_2016, paad_tcga, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, rectal_msk_2019, rectal_msk_2022, skcm_dfci_2015","Bowel, Colorectal Adenocarcinoma, Cutaneous Melanoma, High-Grade Serous Ovarian Cancer, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma, Pancreas, Pancreatic Adenocarcinoma","hg19,17:7578404-7578404, hg19,17:7675086-7675086, hg38,17:7675086-7675086","hg19,17:g.7578404A>C, hg19,17:g.7675086A>C, hg38,17:g.7675086A>C",0.946,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, rectum, liver, ovary, pancreas, skin, soft_tissue, striated_muscle, retroperitoneum","Wilms_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, serous_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, B_cell_lymphoma_unspecified, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, rhabdomyosarcoma",,,,,376571,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1,1,,,,,,
1952,176,C,H,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1953,176,C,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1954,176,C,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1955,176,C,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_ctdna_vte_2024, msk_met_2021, sarcoma_msk_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7578402-7578403, hg19,17:7578403-7578404","hg19,17:g.7578402_7578403delinsTA, hg19,17:g.7578403_7578404delinsAG",,,,,,,,,,,,,,,,,
1956,176,C,M,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1957,176,C,N,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1958,176,C,P,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1959,176,C,Q,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1960,176,C,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, brca_mapk_hp_msk_2021, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, coadread_dfci_2016, crc_msk_2017, csf_msk_2024, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, mds_iwg_2022, mds_mskcc_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, prostate_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578402-7578404, hg19,17:7578404-7578404, hg19,17:7675086-7675086, hg38,17:7675084-7675086, hg38,17:7675086-7675086","hg19,17:g.7578402_7578404delinsCCG, hg19,17:g.7578404A>G, hg19,17:g.7675086A>G, hg38,17:g.7675084_7675086delinsCCG, hg38,17:g.7675086A>G",0.940,"breast, central_nervous_system, brain, central_nervous_system, cerebellum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, rectum, oesophagus, pancreas, prostate, soft_tissue, fibrous_tissue_and_uncertain_origin, chest_wall, stomach, upper_aerodigestive_tract, mouth, buccal_mucosa, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, tubular_adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia_myelodysplastic_syndrome_therapy_related_NOS, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, solitary_fibrous_tumour, malignant",,,,,"634759, 376573","Likely pathogenic, Conflicting classifications of pathogenicity",Ovarian neoplasm|Hereditary cancer-predisposing syndrome;Breast neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Ovarian neoplasm,"0, 1",,,,,,
1961,176,C,S,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","all_stjude_2013, brca_mbcproject_2022, brca_metabric, brca_tcga_gdc, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, dlbc_broad_2012, dlbcl_dfci_2018, dlbcl_duke_2017, escc_ucla_2014, glioma_mskcc_2019, hcc_msk_2024, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_smmu_2014, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, lung_msk_2017, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, ohnca_cptac_gdc, ov_tcga_pan_can_atlas_2018, paad_cptac_2021, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, prad_su2c_2019, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018","Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Esophageal Squamous Cell Carcinoma, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578402-7578403, hg19,17:7578403-7578403, hg19,17:7578404-7578404, hg19,17:7675085-7675085, hg19,17:7675086-7675086, hg38,17:7675085-7675085, hg38,17:7675086-7675086, hg38,17:7675086-7675087","hg19,17:g.7578402_7578403delinsAG, hg19,17:g.7578403C>G, hg19,17:g.7578404A>T, hg19,17:g.7675085C>G, hg19,17:g.7675086A>T, hg38,17:g.7675085C>G, hg38,17:g.7675086A>T, hg38,17:g.7675086_7675087delinsTA","0.945, 0.946",", biliary_tract, bile_duct, breast, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, alveolus, urinary_tract, bladder, urinary_tract, bladder, urachus, vulva","adenoma-nodule-goitre, Hurthle_cell_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, squamous_cell_carcinoma, of_unknown_primary, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia_therapy_related, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, other, neoplasm, malignant",,,,,376570,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,Tier I - Strong,Embryonal rhabdomyosarcoma,1
1962,176,C,T,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1963,176,C,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578403-7578404","hg19,17:g.7578403_7578404delinsAC",,,,,,,,,,,,,,,,,
1964,176,C,W,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mapk_hp_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cll_broad_2022, coad_tcga_gdc, coadread_cass_2020, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_trap_ccr_msk_2023, egc_trap_msk_2020, esca_broad, hcc_tcga_gdc, hccihch_pku_2019, heme_msk_impact_2022, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, lusc_cptac_2021, lusc_cptac_gdc, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sarcoma_msk_2023, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub, ucec_ancestry_cds_msk_2023","Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578402-7578402, hg19,17:7675084-7675084, hg38,17:7675084-7675084","hg19,17:g.7578402G>C, hg19,17:g.7675084G>C, hg38,17:g.7675084G>C",0.863,", breast, cervix, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, skin, upper_arm, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, paranasal","adnexal_tumour, poroma, carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_myelodysplastic_syndrome_therapy_related_NOS, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, malignant_melanoma, malignant_melanoma, desmoplastic",0.0000000000000000,,,,376572,Conflicting classifications of pathogenicity,Ovarian neoplasm;Choroid plexus papilloma;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;TP53-related disorder;Li-Fraumeni syndrome 1,1,Likely oncogenic,Neoplasm,1,Tier I - Strong,Embryonal rhabdomyosarcoma,1
1965,176,C,Y,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 174-176, ggetELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","all_phase2_target_2018_pub, appendiceal_msk_2022, blca_iatlas_imvigor210_2017, blca_plasmacytoid_mskcc_2016, bowel_colitis_msk_2022, brca_bccrc_xenograft_2014, brca_cptac_2020, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_tcga, brca_tcga_pub2015, breast_cptac_gdc, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, chol_msk_2018, cll_iuopa_2015, coad_tcga_gdc, coadread_dfci_2016, coadread_genentech, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, es_dfarber_broad_2014, es_dsrct_msk_2023, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, gbm_tcga_pub, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_cptac_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_cfdna_msk_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_cptac_gdc, pdac_msk_2024, pediatric_dkfz_2017, pptc_2019, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, prostate_pcbm_swiss_2019, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sclc_ucologne_2015, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucs_jhu_2014","Acute Myeloid Leukemia, Appendiceal Adenocarcinoma, B-Lymphoblastic Leukemia/Lymphoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578403-7578403, hg19,17:7675085-7675085, hg38,17:7675085-7675085","hg19,17:g.7578403C>T, hg19,17:g.7675085C>T, hg38,17:g.7675085C>T",0.949,", biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, anorectal, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, salivary_gland, salivary_gland, nasopharynx, skin, skin, face, soft_tissue, fibrous_tissue_and_uncertain_origin, shoulder, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, stomach, thymus, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, adnexal_tumour, malignant_adnexal_tumour, eccrine_adenocarcinoma, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, adenoid_cystic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_adenocarcinoma, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_lymphoblastic_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, myeloproliferative_neoplasm, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, lymphoid_neoplasm, plasma_cell_myeloma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, malignant_melanoma, osteosarcoma, other, dysplasia-in_situ_neoplasm, other, neoplasm, thymic_carcinoma, undifferentiated-unclassified_sarcoma, spindle_cell",,,,,186451,Pathogenic,"Squamous cell carcinoma;Adrenal cortex carcinoma;Familial ovarian cancer;TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",2,,,,,,
1966,177,P,A,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578401-7578401, hg38,17:7675083-7675083","hg19,17:g.7578401G>C, hg38,17:g.7675083G>C",0.866,,,,,,,2585883,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
1967,177,P,C,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1968,177,P,D,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1969,177,P,E,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1970,177,P,F,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",bcc_unige_2016,Basal Cell Carcinoma,"hg19,17:7578400-7578401, hg38,17:7675082-7675083","hg19,17:g.7578400_7578401delinsAA, hg38,17:g.7675082_7675083delinsAA",,skin,"carcinoma, basal_cell_carcinoma, malignant_melanoma",,,,,,,,,,,,,,
1971,177,P,G,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1972,177,P,H,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","difg_glass, difg_glass_2019, difg_msk_2023, difg_tcga_gdc, glioma_mskcc_2019, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021","Diffuse Glioma, Mixed Cancer Types","hg19,17:7578400-7578400, hg19,17:7675082-7675082, hg38,17:7675081-7675082, hg38,17:7675082-7675082","hg19,17:g.7578400G>T, hg19,17:g.7675082G>T, hg38,17:g.7675081_7675082delinsAT, hg38,17:g.7675082G>T",0.844,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon, liver, oesophagus, skin","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, glioma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, lymphoid_neoplasm, plasma_cell_myeloma",,,,,956854,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1973,177,P,I,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675082-7675083","hg38,17:g.7675082_7675083delinsAT",,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,,,,,,,,,,,,,
1974,177,P,K,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1975,177,P,L,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, mel_mskimpact_2020, msk_ch_2020, msk_ch_2023, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_pdmr_2025, prad_pik3r1_msk_2021, sarcoma_msk_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, skcm_yale","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Cutaneous Melanoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578399-7578400, hg19,17:7578400-7578400, hg19,17:7675082-7675082, hg38,17:7675081-7675082, hg38,17:7675082-7675082","hg19,17:g.7578399_7578400delinsAA, hg19,17:g.7578400G>A, hg19,17:g.7675082G>A, hg38,17:g.7675081_7675082delinsAA, hg38,17:g.7675082G>A",0.865,", breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, colon, descending, large_intestine, rectum, lung, oesophagus, prostate, skin, skin, chest, skin, face, skin, head_neck, skin, shoulder, stomach, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary","adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, oligodendroglioma_Grade_III, anaplastic, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, malignant_melanoma, malignant_melanoma, nodular, malignant_melanoma, superficial_spreading, other, intraepithelial_neoplasia, low_grade",0.0000039793076005,,,,406583,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,Uncertain significance,Neoplasm,1,,,
1976,177,P,M,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1977,177,P,N,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1978,177,P,Q,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1979,177,P,R,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, breast_ink4_msk_2021, csf_msk_2024, difg_tcga_gdc, hcc_msk_venturaa_2018, hgsoc_tcga_gdc, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tsp, mds_mskcc_2020, mel_mskimpact_2020, mixed_selpercatinib_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pdac_msk_2024, prad_p1000, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, sarcoma_msk_2022, thyroid_mskcc_2016","Breast, Cutaneous Melanoma, Diffuse Glioma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate Adenocarcinoma, Soft Tissue, Thyroid","hg19,17:7578400-7578400, hg19,17:7675082-7675082, hg38,17:7675082-7675082","hg19,17:g.7578400G>C, hg19,17:g.7675082G>C, hg38,17:g.7675082G>C",0.893,"breast, central_nervous_system, brain, central_nervous_system, occipital_lobe, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, rectum, liver, lung, ovary, pancreas, prostate, stomach, thyroid, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, serous_carcinoma, carcinoma, signet_ring_adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000000000000000,,,,458547,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not provided,2,,,,,,
1980,177,P,S,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, cscc_ucsf_2021, dlbcl_duke_2017, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_tcga_pub, hdcn_msk_2025, heme_msk_impact_2022, mel_mskimpact_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, pdac_msk_2024, stes_tcga_pub","Basal Cell Carcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Histiocytic and Dendritic Cell Neoplasms, Mixed Cancer Types, Pancreas","hg19,17:7578401-7578401, hg19,17:7675083-7675083, hg38,17:7675083-7675083","hg19,17:g.7578401G>A, hg19,17:g.7675083G>A, hg38,17:g.7675083G>A",0.877,", biliary_tract, gallbladder, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lymph_node, lung, oesophagus, prostate, skin, skin, scalp, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, renal_pelvis","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, malignant_melanoma",,,,,646495,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
1981,177,P,T,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, msk_ch_2023, msk_chord_2024, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578401-7578401, hg19,17:7675083-7675083, hg38,17:7675083-7675083","hg19,17:g.7578401G>T, hg19,17:g.7675083G>T, hg38,17:g.7675083G>T",0.878,"lung, oesophagus","carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma",,,,,482220,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
1982,177,P,V,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675081-7675083","hg38,17:g.7675081_7675083delinsCAC",,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1983,177,P,W,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1984,177,P,Y,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1985,178,H,A,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1986,178,H,C,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1987,178,H,D,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_msk_2025, ccle_broad_2019, ccle_broad_2025, csf_msk_2024, gct_msk_2016, luad_mskcc_2023_met_organotropism, mds_iwg_2022, mds_mskcc_2020, mixed_msk_tcga_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Endometrial Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue, Testis","hg19,17:7578398-7578398, hg19,17:7675080-7675080, hg38,17:7675080-7675080","hg19,17:g.7578398G>C, hg19,17:g.7675080G>C, hg38,17:g.7675080G>C",0.892,"bone, breast, endometrium, genital_tract, extragonadal, mediastinum, lung, ovary, prostate, thyroid, urinary_tract, bladder","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, mixed_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, germ_cell_tumour, undifferentiated_sarcoma, pleomorphic",,,,,482223,Pathogenic,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,3,,,,,,
1988,178,H,E,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1989,178,H,F,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1990,178,H,G,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1991,178,H,I,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1992,178,H,K,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1993,178,H,L,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578397-7578397, hg38,17:7675079-7675079","hg19,17:g.7578397T>A, hg38,17:g.7675079T>A",0.843,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
1994,178,H,M,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
1995,178,H,N,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_ctdna_vte_2024, ov_tcga","High-Grade Serous Ovarian Cancer, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578398-7578398, hg38,17:7675080-7675080","hg19,17:g.7578398G>T, hg38,17:g.7675080G>T",0.722,"skin, skin, face, upper_aerodigestive_tract, larynx","carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,421546,Uncertain significance,not provided;Li-Fraumeni syndrome,2,,,,,,
1996,178,H,P,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, brca_metabric, chol_msk_2018, glioma_mskcc_2019, hcc_msk_2024, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, rectal_msk_2022, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Bladder Urothelial Carcinoma, Bowel, Cholangiocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Soft Tissue","hg19,17:7578397-7578397, hg38,17:7675079-7675079","hg19,17:g.7578397T>G, hg38,17:g.7675079T>G",0.918,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, soft_tissue, haematopoietic_and_lymphoid_tissue, spleen, large_intestine, colon, descending, lung, thyroid","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, bcr-abl_positive, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",,,,,485030,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome",1,,,,,,
1997,178,H,Q,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, chol_icgc_2017, chrcc_tcga_gdc, egc_tmucih_2015, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gbm_tcga_pub2013, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lgggbm_tcga_pub, pan_origimed_2020, pancan_pcawg_2020, sarcoma_msk_2022","Cholangiocarcinoma, Chromophobe Renal Cell Carcinoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578396-7578396, hg19,17:7675078-7675078, hg38,17:7675078-7675078","hg19,17:g.7578396G>C, hg19,17:g.7578396G>T, hg19,17:g.7675078G>T, hg38,17:g.7675078G>C, hg38,17:g.7675078G>T",0.814,"biliary_tract, bile_duct, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, rectum, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, glottis, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,"947223, 575702","Pathogenic/Likely pathogenic, Pathogenic/Likely pathogenic",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Hereditary breast ovarian cancer syndrome,"2, 2",,,,,,
1998,178,H,R,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7578397-7578397, hg38,17:7675079-7675079","hg19,17:g.7578397T>C, hg38,17:g.7675079T>C",0.882,,,,,,,2780373,Uncertain significance,Li-Fraumeni syndrome;not provided;Hereditary cancer-predisposing syndrome,2,,,,,,
1999,178,H,S,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2000,178,H,T,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2001,178,H,V,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2002,178,H,W,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2003,178,H,Y,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675080-7675080, hg38,17:7675080-7675081","hg38,17:g.7675080G>A, hg38,17:g.7675080_7675081delinsAA",0.870,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, lung, ovary, pancreas, skin, skin, face, skin, head_neck, skin, scalp, stomach, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, NK-T_cell_lymphoma, malignant_melanoma, desmoplastic",,,,,,,,,,,,,,
2004,179,H,A,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2005,179,H,C,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2006,179,H,D,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, bladder_msk_2024, blca_mskcc_solit_2014, brca_metabric, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cll_broad_2015, cll_broad_2022, crc_eo_2020, crc_msk_2017, difg_tcga_gdc, gbc_mskcc_2022, hcc_msk_2024, hdcn_msk_2025, hgsoc_tcga_gdc, ihch_msk_2021, ihch_mskcc_2020, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_cas_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, mds_mskcc_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, pediatric_dkfz_2017, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, tmb_mskcc_2018, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Histiocytic and Dendritic Cell Neoplasms, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578395-7578395, hg19,17:7675077-7675077, hg38,17:7675077-7675077","hg19,17:g.7578395G>C, hg19,17:g.7675077G>C, hg38,17:g.7675077G>C",0.916,", breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, rectum, liver, lung, oesophagus, oesophagus, upper_third, ovary, pancreas, salivary_gland, soft_tissue, striated_muscle, lung, thyroid, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx","Wilms_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, blastoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, invasive_mucinous_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M4, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, rhabdomyosarcoma, embryonal",,,,,376610,Pathogenic/Likely pathogenic,"Adrenocortical carcinoma, hereditary;not provided;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1",2,,,,Tier I - Strong,"Diffuse glioma, H3 G34 mutant",1
2007,179,H,E,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2008,179,H,F,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2009,179,H,G,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2010,179,H,I,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2011,179,H,K,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2012,179,H,L,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, bm_nsclc_mskcc_2023, brca_metabric, breast_msk_2025, cll_broad_2022, coadread_dfci_2016, crc_apc_impact_2020, gbc_msk_2018, hcc_clca_2024, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, lihc_amc_prv, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lung_smc_2016, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_jhu, sclc_ucologne_2015, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Endometrial Carcinoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578394-7578394, hg19,17:7675076-7675076, hg38,17:7675076-7675076","hg19,17:g.7578394T>A, hg19,17:g.7675076T>A, hg38,17:g.7675076T>A",0.882,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, temporal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, anus, large_intestine, rectum, liver, lung, oesophagus, ovary, salivary_gland, parotid, skin, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract, urinary_tract, bladder, urinary_tract, upper_urinary_tract","adenoma, myoepithelial, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, lymphoepithelioma_like_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, ependymoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, osteosarcoma",,,,,376608,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome",1,Oncogenic,Neoplasm,1,,,
2013,179,H,M,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2014,179,H,N,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2022, brca_msk_2025, breast_msk_2025, ccle_broad_2025, cscc_ucsf_2021, csf_msk_2024, glioma_mskcc_2019, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, ihch_msk_2021, ihch_mskcc_2020, lms_msk_2024, luad_mskcc_2023_met_organotropism, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ohnca_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_mappyacts_2022, pancreas_msk_2024, pdac_msk_2024, prostate_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_mskcc_2022, sclc_jhu, sclc_ucologne_2015, soft_tissue_tcga_gdc, stad_oncosg_2018, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub, ucs_jhu_2014","Acute Myeloid Leukemia, Bladder/Urinary Tract, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578395-7578395, hg19,17:7675077-7675077, hg38,17:7675077-7675077","hg19,17:g.7578395G>T, hg19,17:g.7675077G>T, hg38,17:g.7675077G>T",0.902,", biliary_tract, bile_duct, breast, central_nervous_system, brain, cervix, endometrium, large_intestine, large_intestine, colon, descending, large_intestine, rectum, liver, lung, oesophagus, skin, skin, eye, skin, head_neck, skin, scalp, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, lung, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, malignant_melanoma, sarcoma, undifferentiated_sarcoma, pleomorphic",0.0000039792442619,,,,376609,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
2015,179,H,P,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_msk_2018, breast_msk_2025, cfdna_msk_2019, crc_eo_2020, crc_msk_2017, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, mbn_mdacc_2013, mnm_washu_2016, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Bowel, Breast, Colorectal Adenocarcinoma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myeloid Neoplasm, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578394-7578394, hg19,17:7675076-7675076, hg38,17:7675076-7675076","hg19,17:g.7578394T>G, hg19,17:g.7675076T>G, hg38,17:g.7675076T>G",0.911,"biliary_tract, bile_duct, breast, central_nervous_system, frontal_lobe, large_intestine, rectum, liver, lung, skin, lower_leg, small_intestine, duodenum, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic",,,,,376611,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
2016,179,H,Q,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_aurora_2023, brca_metabric, brca_msk_2025, brca_tcga, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coadread_dfci_2016, crc_eo_2020, crc_msk_2017, cscc_ucsf_2021, csf_msk_2024, escc_ucla_2014, hcc_msk_2024, heme_msk_impact_2022, lihc_riken, luad_cptac_2020, luad_cptac_gdc, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pub, paad_icgc, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pptc_2019, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, soft_tissue_tcga_gdc","Basal Cell Carcinoma, Bowel, Breast, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578393-7578393, hg19,17:7675075-7675075, hg38,17:7675075-7675075","hg19,17:g.7578393A>C, hg19,17:g.7578393A>T, hg19,17:g.7675075A>C, hg19,17:g.7675075A>T, hg38,17:g.7675075A>C, hg38,17:g.7675075A>T",0.790,"biliary_tract, gallbladder, bone, bone, femur, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, central_nervous_system, thalamus, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, colon, transverse, liver, lung, lung, right_upper_lobe, oesophagus, ovary, pancreas, prostate, skin, skin, mucosal, female_genitourinary_system, soft_tissue, stomach, upper_aerodigestive_tract, head_neck","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, polycythaemia_vera, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, osteosarcoma, sarcoma",0.0000000000000000,,,,"406578, 376607","Pathogenic, Pathogenic/Likely pathogenic",Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Acute myeloid leukemia;Ovarian neoplasm|Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,"3, 2",,,,,,
2017,179,H,R,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, aml_tcga_gdc, ampca_bcm_2016, bladder_msk_2024, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bowel_colitis_msk_2022, brca_bccrc, brca_fuscc_2020, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, chol_icgc_2017, cll_broad_2015, cll_broad_2022, coad_silu_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, egc_tmucih_2015, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, gbc_mskcc_2022, gbc_shanghai_2014, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, gct_msk_2016, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, histiocytosis_cobi_msk_2019, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_cas_2020, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2015, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lung_pdx_msk_2021, lung_smc_2016, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_mdacc_2013, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_cfdna_msk_2020, mixed_impact_subset_2022, mixed_pipseq_2017, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, normal_skin_keratinocytes_2024, nsclc_ctdx_msk_2022, nsclc_mskcc_2015, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, ptad_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_cancercell_gardner_2017, sclc_ucologne_2015, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc, utuc_msk_2019, utuc_mskcc_2015","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Ampullary Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Histiocytic and Dendritic Cell Neoplasms, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pituitary Adenoma, Prostate, Prostate Adenocarcinoma, Skin, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Testis, Upper Tract Urothelial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma","hg19,17:7578394-7578394, hg19,17:7675076-7675076, hg38,17:7675076-7675076","hg19,17:g.7578394T>C, hg19,17:g.7675076T>C, hg38,17:g.7675076T>C",0.935,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, ilium, breast, central_nervous_system, brain, central_nervous_system, choroid_plexus, central_nervous_system, frontal_lobe, central_nervous_system, parietal_lobe, cervix, endometrium, gastrointestinal_tract_(site_indeterminate), genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, skin, haematopoietic_and_lymphoid_tissue, stomach, kidney, large_intestine, large_intestine, anorectal, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, large_intestine, right, liver, lung, lung, left_lower_lobe, oesophagus, oesophagus, lower_third, ovary, pancreas, pancreas, ampulla_of_Vater, pituitary, pleura, prostate, salivary_gland, skin, lower_leg, soft_tissue, fibrous_tissue_and_uncertain_origin, chest_wall, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, glottis, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, buccal_mucosa, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, bladder","Wilms_tumour, adenoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_B_carcinoma, carcinoma, micropapillary_adenocarcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, osteoclast-like_giant_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, undifferentiated_carcinoma, chondrosarcoma, conventional, fibrosarcoma, myxofibrosarcoma, germ_cell_tumour, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, gliomatosis_cerebri, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M5, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_myelodysplastic_syndrome_therapy_related_NOS, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm, haematopoietic_neoplasm, chronic_myeloid_leukaemia, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia_therapy_related, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, myeloid_neoplasm_unspecified_therapy_related, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia_therapy_related, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, mesothelioma, other, choroid_plexus_carcinoma, other, neoplasm, primitive_neuroectodermal_tumour-medulloblastoma",0.0000039786743057,,,,376606,Conflicting classifications of pathogenicity,TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Oncogenic,Neoplasm,1,Tier I - Strong,"Astrocytoma IDH-mutant;Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype;Medulloblastoma SHH activated and TP53 mutant",1
2018,179,H,S,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7578394-7578395","hg19,17:g.7578394_7578395delinsCT",,,,,,,,,,,,,,,,,
2019,179,H,T,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2020,179,H,V,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2021,179,H,W,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2022,179,H,Y,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ampca_bcm_2016, bcc_unige_2016, blca_mskcc_solit_2014, blca_nmibc_2017, bm_nsclc_mskcc_2023, brca_dldccc_2022, brca_metabric, brca_sanger, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2025, cfdna_msk_2019, coad_cptac_gdc, coad_silu_2022, coadread_dfci_2016, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_hgsc_bcm_2014, cscc_ranson_2022, cscc_ucsf_2021, csf_msk_2024, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gbm_tcga_pub2013, glioma_msk_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, hgsoc_tcga_gdc, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgggbm_tcga_pub, luad_cas_2020, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_msk_2024, mel_mskimpact_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, panet_msk_erc_2023, pdac_msk_2024, pog570_bcgsc_2020, rcc_iatlas_immotion150_2018, rectal_msk_2022, sarcoma_msk_2022, sarcoma_msk_2023, sarcoma_mskcc_2022, sarcoma_ucla_2024, sclc_ucologne_2015, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_yale, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Adenoid Cystic Carcinoma, Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Renal Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578395-7578395, hg19,17:7578395-7578396, hg19,17:7675077-7675077, hg38,17:7675077-7675077, hg38,17:7675077-7675078","hg19,17:g.7578395G>A, hg19,17:g.7578395_7578396delinsAA, hg19,17:g.7675077G>A, hg38,17:g.7675077G>A, hg38,17:g.7675077_7675078delinsAA",0.948,", biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, posterior_fossa, cervix, endometrium, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, jaw, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, skin, large_intestine, large_intestine, anus, large_intestine, appendix, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, skin, skin, abdomen, skin, arm, skin, face, skin, head_neck, skin, mucosal, oral_cavity, skin, shoulder, skin, upper_leg, small_intestine, duodenum, small_intestine, jejunum, soft_tissue, nerve_sheath, rectum, soft_tissue, smooth_muscle, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid, urinary_tract, bladder, vulva","adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, lobular_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_serous_and_clear_cell_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, in_situ_epithelial_neoplasm, actinic_keratosis, leiomyosarcoma, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant, lymphoid_neoplasm, MALT_lymphoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, malignant_melanoma, malignant_melanoma, nodular, malignant_melanoma, superficial_spreading, malignant_peripheral_nerve_sheath_tumour, osteosarcoma, other, Barrett_oesophagus, with_high_grade_dysplasia, other, adenosarcoma, other, intraductal_papillary_neoplasm, other, neoplasm, other, pterygium",,,,,127815,Pathogenic/Likely pathogenic,"Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",2,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant;Primary intracranial sarcoma, DICER1-mutant",1
2023,180,E,A,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2024,180,E,C,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2025,180,E,D,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_plasmacytoid_mskcc_2016, msk_impact_2017, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, sclc_jhu","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types, Small Cell Lung Cancer","hg19,17:7578390-7578390, hg38,17:7675072-7675072","hg19,17:g.7578390C>A, hg19,17:g.7578390C>G, hg38,17:g.7675072C>A, hg38,17:g.7675072C>G",0.798,"large_intestine, liver, lung, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,"1521256, 1509915","Uncertain significance, Uncertain significance","Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary|not provided;Li-Fraumeni syndrome","2, 2",,,,,,
2026,180,E,F,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2027,180,E,G,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pancan_mimsi_msk_2024,Mixed Cancer Types,"hg19,17:7578391-7578391, hg38,17:7675073-7675073","hg19,17:g.7578391T>C, hg38,17:g.7675073T>C",0.915,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
2028,180,E,H,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2029,180,E,I,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2030,180,E,K,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_nmibc_2017, brca_mapk_hp_msk_2021, brca_msk_2025, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_genentech_2014, egc_mskcc_2020, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, makeanimpact_ccr_2023, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas","hg19,17:7578392-7578392, hg19,17:7675074-7675074, hg38,17:7675074-7675074","hg19,17:g.7578392C>T, hg19,17:g.7675074C>T, hg38,17:g.7675074C>T",0.823,"adrenal_gland, adrenal_gland, breast, central_nervous_system, brain, genital_tract, extragonadal, mediastinum, kidney, large_intestine, large_intestine, anus, large_intestine, colon, liver, lung, lung, right_upper_lobe, ovary, skin, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, urinary_tract, bladder","Wilms_tumour, adnexal_tumour, malignant_adnexal_tumour, extramammary_Pagets_disease, adrenal_cortical_carcinoma, non_functioning, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, germ_cell_tumour, yolk_sac_tumour, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,245711,Likely pathogenic,Hereditary cancer-predisposing syndrome;TP53-related disorder;not provided;Li-Fraumeni syndrome,3,,,,,,
2031,180,E,L,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2032,180,E,M,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2033,180,E,N,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2034,180,E,P,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2035,180,E,Q,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",blca_iatlas_imvigor210_2017,Bladder Urothelial Carcinoma,"hg19,17:7675074-7675074, hg38,17:7675074-7675074","hg19,17:g.7675074C>G, hg38,17:g.7675074C>G",0.659,breast,"carcinoma, carcinoma, ER-positive_carcinoma",,,,,,,,,,,,,,
2036,180,E,R,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2037,180,E,S,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2038,180,E,T,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2039,180,E,V,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2040,180,E,W,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2041,180,E,Y,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 176-180, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2042,181,R,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2043,181,R,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, angs_painter_2025, brca_metabric, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coadread_dfci_2016, crc_eo_2020, csf_msk_2024, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, glioma_mskcc_2019, hcc_clca_2024, luad_mskcc_2015, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, mbn_sfu_2023, mel_mskimpact_2020, mixed_allen_2018, mpcproject_broad_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_dkfz_2018, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_jhu, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc","Adenoid Cystic Carcinoma, Angiosarcoma, Bowel, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma","hg19,17:7578389-7578389, hg19,17:7675071-7675071, hg38,17:7675066-7675071, hg38,17:7675071-7675071","hg19,17:g.7578389G>A, hg19,17:g.7675071G>A, hg38,17:g.7675066_7675071delinsACAGCA, hg38,17:g.7675071G>A",0.891,", biliary_tract, bile_duct, bone, bone, femur, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, pleura, prostate, skin, small_intestine, duodenum, small_intestine, jejunum, soft_tissue, blood_vessel, skin, scalp, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, pharynx, oropharynx","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, angiosarcoma, carcinoid-endocrine_tumour, atypical, carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, chondrosarcoma, peripheral, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelofibrosis, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, malignant_melanoma, mesothelioma",,,,,142624,Likely pathogenic,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Familial cancer of breast",3,Likely oncogenic,Neoplasm,1,Tier I - Strong,Colorectal cancer,1
2044,181,R,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2045,181,R,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2046,181,R,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2047,181,R,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675071-7675071","hg38,17:g.7675071G>C",0.886,"haematopoietic_and_lymphoid_tissue, oesophagus","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
2048,181,R,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, ccle_broad_2019, ccle_broad_2025, cfdna_msk_2019, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, difg_tcga_gdc, hcc_jcopo_msk_2023, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_tcga, luad_tcga_pub, mbn_mdacc_2013, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, ptad_msk_2024, rectal_msk_2022, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Pancreatic Adenocarcinoma, Pituitary Adenoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578388-7578388, hg19,17:7675070-7675070, hg38,17:7675070-7675070","hg19,17:g.7578388C>T, hg19,17:g.7675070C>T, hg38,17:g.7675070C>T",0.797,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, liver, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, oesophagus, ovary, pancreas, penis, prostate, skin, skin, buttock, skin, knee, small_intestine, duodenum, small_intestine, jejunum, stomach, thyroid, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder","adenoma, tubular, adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adrenal_cortical_carcinoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, mixed_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, hyperplasia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, other, dysplasia-in_situ_neoplasm, other, perforating_folliculitis, BRAF_inhibitor_related, pheochromocytoma, benign, primitive_neuroectodermal_tumour-medulloblastoma, classic, primitive_neuroectodermal_tumour-medulloblastoma, large_cell",0.0000119367827983,0.0000318430773150,,,142320,Pathogenic/Likely pathogenic,"TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Hereditary breast ovarian cancer syndrome;Adrenocortical carcinoma, hereditary;Carcinoma of pancreas;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck;Familial cancer of breast",2,,,,,,
2049,181,R,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2050,181,R,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2051,181,R,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578388-7578388, hg38,17:7675070-7675070","hg19,17:g.7578388C>A, hg38,17:g.7675070C>A",0.680,"breast, large_intestine, large_intestine, rectum, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,39420,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Glioma susceptibility 1,1,,,,,,
2052,181,R,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2053,181,R,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2054,181,R,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, ccle_broad_2019, ccle_broad_2025, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, lgg_ucsf_2014, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, mixed_allen_2018, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pub, paad_cptac_2021, paired_bladder_2022, pan_origimed_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prostate_msk_2024, sarcoma_msk_2022, sclc_ucologne_2015, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, High-Grade Serous Ovarian Cancer, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mature T and NK Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578388-7578388, hg19,17:7675070-7675070, hg38,17:7675070-7675070","hg19,17:g.7578388C>G, hg19,17:g.7675070C>G, hg38,17:g.7675070C>G",0.894,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, sigmoid, liver, lung, oesophagus, ovary, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, other, neoplasm, malignant",,,,,825729,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,Tier I - Strong,Embryonal rhabdomyosarcoma,1
2055,181,R,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2056,181,R,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578389-7578389, hg38,17:7675071-7675071","hg19,17:g.7578389G>T, hg38,17:g.7675071G>T",0.778,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia",,,,,230764,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
2057,181,R,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2058,181,R,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2059,181,R,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2060,181,R,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2061,182,C,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2062,182,C,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2063,182,C,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2064,182,C,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2065,182,C,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578386-7578386, hg38,17:7675068-7675068","hg19,17:g.7578386A>C, hg38,17:g.7675068A>C",0.644,,,,,,,1489700,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2066,182,C,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2067,182,C,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2068,182,C,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2069,182,C,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2070,182,C,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2071,182,C,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2072,182,C,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2073,182,C,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2074,182,C,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578386-7578386, hg38,17:7675068-7675068","hg19,17:g.7578386A>G, hg38,17:g.7675068A>G",0.644,"lung, upper_aerodigestive_tract, larynx","carcinoma, blastoma, carcinoma, squamous_cell_carcinoma",,,,,2774651,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2075,182,C,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578386-7578386, hg38,17:7675067-7675067, hg38,17:7675068-7675068","hg19,17:g.7578386A>T, hg38,17:g.7675067C>G, hg38,17:g.7675068A>T","0.438, 0.455","haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, salivary_gland, major, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach","carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, gastrointestinal_stromal_tumour, lymphoid_neoplasm, plasma_cell_myeloma",,,,,3572141,Uncertain significance,not provided,1,,,,,,
2076,182,C,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2077,182,C,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2078,182,C,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578384-7578384, hg38,17:7675066-7675066","hg19,17:g.7578384G>C, hg38,17:g.7675066G>C",0.659,breast,"carcinoma, ductal_carcinoma",,,,,423137,Uncertain significance,TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2079,182,C,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675067-7675067","hg38,17:g.7675067C>T",0.634,"large_intestine, colon, large_intestine, colon, descending, lung, skin, shoulder","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2080,183,S,A,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2081,183,S,C,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2082,183,S,D,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2083,183,S,E,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2084,183,S,F,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2085,183,S,G,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2086,183,S,H,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2087,183,S,I,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2088,183,S,K,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2089,183,S,L,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",blca_msk_2025,Bladder Urothelial Carcinoma,"hg19,17:7578382-7578382, hg38,17:7675064-7675064","hg19,17:g.7578382G>A, hg38,17:g.7675064G>A",0.556,"breast, large_intestine, anus, prostate, skin, face, small_intestine, jejunum, soft_tissue, fibrous_tissue_and_uncertain_origin, back","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, adenocarcinoma, gastric_type, carcinoma, squamous_cell_carcinoma, dermatofibrosarcoma_protuberans, fibrosarcomatous",,,,,480735,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,1,,,,,,
2090,183,S,M,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2091,183,S,N,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2092,183,S,P,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578383-7578383, hg38,17:7675065-7675065","hg19,17:g.7578383A>G, hg38,17:g.7675065A>G",0.457,"biliary_tract, bile_duct, central_nervous_system, brain, prostate","carcinoma, adenocarcinoma, glioma, astrocytoma",,,,,3328150,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
2093,183,S,Q,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2094,183,S,R,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2095,183,S,T,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2096,183,S,V,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2097,183,S,W,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2098,183,S,Y,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2099,184,D,A,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2100,184,D,C,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7578379-7578380","hg19,17:g.7578379_7578380delinsCA",,,,,,,,,,,,,,,,,
2101,184,D,E,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",msk_impact_2017,Mixed Cancer Types,"hg19,17:7578378-7578378, hg38,17:7675060-7675060","hg19,17:g.7578378A>T, hg38,17:g.7675060A>T",0.558,"haematopoietic_and_lymphoid_tissue, small_intestine","lymphoid_neoplasm, B_cell_lymphoma_unspecified",,,,,,,,,,,,,,
2102,184,D,F,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2103,184,D,G,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",ucec_ancestry_cds_msk_2023,Endometrial Carcinoma,"hg19,17:7578379-7578379, hg38,17:7675061-7675061","hg19,17:g.7578379T>C, hg38,17:g.7675061T>C",0.666,"large_intestine, appendix","other, low_grade_mucinous_neoplasm",,,,,406606,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2104,184,D,H,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, blca_plasmacytoid_mskcc_2016, brca_sanger, mcl_idibips_2013, pan_origimed_2020, pancan_hcmi_2025, pancan_pcawg_2020, pancan_pdmr_2025","Bladder Urothelial Carcinoma, Invasive Breast Carcinoma, Mantle Cell Lymphoma, Mixed Cancer Types","hg19,17:7578380-7578380, hg19,17:7675062-7675062, hg38,17:7675062-7675062","hg19,17:g.7578380C>G, hg19,17:g.7675062C>G, hg38,17:g.7675062C>G",0.700,"breast, large_intestine, colon, large_intestine, rectum, oesophagus, salivary_gland, parotid, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, mucoepidermoid_carcinoma, carcinoma, squamous_cell_carcinoma, serrated_polyp, serrated_adenoma",,,,,2687701,Uncertain significance,"Prostate cancer, hereditary, 1",0,,,,,,
2105,184,D,I,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2106,184,D,K,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2107,184,D,L,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2108,184,D,M,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2109,184,D,N,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","brca_mapk_hp_msk_2021, breast_ink4_msk_2021, breast_msk_2025, cfdna_msk_2019, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021","Breast, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578380-7578380, hg38,17:7675062-7675062","hg19,17:g.7578380C>T, hg38,17:g.7675062C>T",0.433,"breast, cervix, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, colon, oesophagus, prostate, skin, neck, soft_tissue, fibrous_tissue_and_uncertain_origin, abdominal_wall, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, dermatofibrosarcoma_protuberans, fibrosarcomatous, transformed_to_fibrosarcoma, gastrointestinal_stromal_tumour, lymphoid_neoplasm, NK-T_cell_lymphoma, other, intraepithelial_neoplasia, high_grade",,,,,,,,,,,,,,
2110,184,D,P,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2111,184,D,Q,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2112,184,D,R,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2113,184,D,S,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2114,184,D,T,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2115,184,D,V,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2116,184,D,W,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2117,184,D,Y,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675062-7675062","hg38,17:g.7675062C>A",0.715,"central_nervous_system, brain, large_intestine, rectum, liver, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
2118,185,S,A,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2119,185,S,C,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675059-7675059","hg38,17:g.7675059T>A",0.425,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, hairy_cell_leukaemia",,,,,,,,,,,,,,
2120,185,S,D,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2121,185,S,E,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2122,185,S,F,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2123,185,S,G,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675059-7675059","hg38,17:g.7675059T>C",0.497,"oesophagus, ovary, prostate","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2124,185,S,H,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2125,185,S,I,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675058-7675058","hg38,17:g.7675058C>A",0.452,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
2126,185,S,K,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2127,185,S,L,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2128,185,S,M,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2129,185,S,N,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578376-7578376, hg38,17:7675058-7675058","hg19,17:g.7578376C>T, hg38,17:g.7675058C>T",0.325,"large_intestine, colon, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",0.0000039786743057,,,,141359,Likely benign,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
2130,185,S,P,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2131,185,S,Q,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2132,185,S,R,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578375-7578375, hg38,17:7675057-7675057","hg19,17:g.7578375G>C, hg38,17:g.7675057G>C, hg38,17:g.7675057G>T",0.520,"breast, lung, oesophagus, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,1748280,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
2133,185,S,T,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675057-7675058","hg38,17:g.7675057_7675058delinsCG",,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
2134,185,S,V,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2135,185,S,W,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2136,185,S,Y,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2137,186,D,A,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2138,186,D,C,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2139,186,D,E,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578372-7578372, hg38,17:7675054-7675054","hg19,17:g.7578372A>T, hg38,17:g.7675054A>T",0.643,"endometrium, upper_aerodigestive_tract, mouth","carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, squamous_cell_carcinoma",0.0000039784843566,,,,230006,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
2140,186,D,F,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2141,186,D,G,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675055-7675055","hg38,17:g.7675055T>C",0.680,"central_nervous_system, brain, large_intestine, pancreas, stomach","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, glioma, astrocytoma_Grade_III, anaplastic",,,,,,,,,,,,,,
2142,186,D,H,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675056-7675056","hg38,17:g.7675056C>G",0.692,"breast, lung, right_upper_lobe, ovary","carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, serous_carcinoma",,,,,,,,,,,,,,
2143,186,D,I,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2144,186,D,K,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2145,186,D,L,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2146,186,D,M,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2147,186,D,N,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_msk_2025, ihch_msk_2021, msk_chord_2024, msk_met_2021","Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7578374-7578374, hg38,17:7675056-7675056","hg19,17:g.7578374C>T, hg38,17:g.7675056C>T",0.532,"large_intestine, colon, oesophagus, ovary, pancreas, skin, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, mouth_floor, urinary_tract, renal_pelvis","adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",0.0000079577285460,,,,406601,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,3,,,,,,
2148,186,D,P,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2149,186,D,Q,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2150,186,D,R,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2151,186,D,S,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2152,186,D,T,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2153,186,D,V,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7675055-7675055","hg38,17:g.7675055T>A",0.800,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2154,186,D,W,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2155,186,D,X,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,COSMIC,,,,,,"large_intestine, colon, right","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2156,186,D,Y,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2157,187,G,A,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578289-7578289, hg38,17:7674971-7674971","hg19,17:g.7578289C>G, hg38,17:g.7674971C>G",0.610,,,,,,,1479275,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2158,187,G,C,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, crc_sysucc_2022, lihc_amc_prv, msk_chord_2024, sarcoma_msk_2022","Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578371-7578371, hg19,17:7675053-7675053, hg38,17:7675053-7675053","hg19,17:g.7578371C>A, hg19,17:g.7675053C>A, hg38,17:g.7675053C>A",0.705,"breast, upper_aerodigestive_tract, mouth, tongue","carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2159,187,G,D,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7578289-7578289, hg38,17:7674971-7674971","hg19,17:g.7578289C>T, hg38,17:g.7674971C>T",0.625,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, large_intestine, rectum, lung, skin, skin, scalp, stomach, upper_aerodigestive_tract, larynx, vocal_cord, urinary_tract, bladder","carcinoid-endocrine_tumour, atypical, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, malignant_melanoma, other, dysplasia",,,,,422532,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;not provided,2,,,,,,
2160,187,G,E,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2161,187,G,F,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2162,187,G,H,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2163,187,G,I,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2164,187,G,K,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2165,187,G,L,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2166,187,G,M,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2167,187,G,N,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2168,187,G,P,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2169,187,G,Q,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2170,187,G,R,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, crc_eo_2020, crc_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, pan_origimed_2020, pancan_mimsi_msk_2024, tmb_mskcc_2018","Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578371-7578371, hg19,17:7675053-7675053, hg38,17:7675053-7675053","hg19,17:g.7578371C>G, hg19,17:g.7675053C>G, hg38,17:g.7675053C>G",0.700,"large_intestine, colon, sigmoid, lung","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,635392,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
2171,187,G,S,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2025, cfdna_msk_2019, crc_orion_2024, heme_msk_impact_2022, luad_cas_2020, lung_msk_pdx, mds_iwg_2022, msk_chord_2024, msk_met_2021, pan_origimed_2020, pancan_pdmr_2025, sarcoma_msk_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, ucec_ancestry_cds_msk_2023, utuc_msk_2019, utuc_mskcc_2015","Bowel, Breast, Cutaneous Melanoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue, Upper Tract Urothelial Carcinoma","hg19,17:7578371-7578371, hg19,17:7675053-7675053, hg38,17:7675053-7675053","hg19,17:g.7578371C>T, hg19,17:g.7675053C>T, hg38,17:g.7675053C>T",0.649,"bone, femur, breast, central_nervous_system, parietooccipital, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, colon, ascending, large_intestine, colon, right, large_intestine, rectum, liver, lung, meninges, oesophagus, pancreas, skin, skin, eye, skin, face, upper_aerodigestive_tract, head_neck, urinary_tract, urinary_tract, bladder","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, chondrosarcoma, dedifferentiated, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, follicular_lymphoma, malignant_melanoma, malignant_melanoma, superficial_spreading, meningioma, anaplastic, other, intraepithelial_neoplasia, high_grade, other, metaplasia, epidermoid",,,,,840399,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not specified,1,,,,Tier II - Potential,"Diffuse midline glioma, H3 K27M-mutant",1
2172,187,G,T,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2173,187,G,V,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_cptac_gdc, sarcoma_msk_2022","Lung Adenocarcinoma, Soft Tissue","hg19,17:7578289-7578289, hg19,17:7674971-7674971, hg38,17:7674971-7674971, hg38,17:7674972-7674972","hg19,17:g.7578289C>A, hg19,17:g.7674971C>A, hg38,17:g.7674971C>A, hg38,17:g.7674972del",0.666,"breast, large_intestine, rectum, lung, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,2032550,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2174,187,G,W,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2175,187,G,Y,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 183-187, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2176,188,L,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2177,188,L,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2178,188,L,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2179,188,L,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2180,188,L,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2181,188,L,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2182,188,L,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2183,188,L,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2184,188,L,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2185,188,L,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674969-7674969","hg38,17:g.7674969G>T",0.473,"bone, central_nervous_system, cerebellum","glioma, astrocytoma_Grade_III, anaplastic, osteosarcoma",,,,,,,,,,,,,,
2186,188,L,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2187,188,L,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578286-7578286, hg38,17:7674968-7674968","hg19,17:g.7578286A>G, hg38,17:g.7674968A>G",0.617,,,,,,,4189268,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2188,188,L,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_impact_2017, msk_met_2021, pdac_msk_2024","Mixed Cancer Types, Pancreas","hg19,17:7578286-7578286, hg38,17:7674968-7674968","hg19,17:g.7578286A>T, hg38,17:g.7674968A>T",0.581,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
2189,188,L,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2190,188,L,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2191,188,L,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2192,188,L,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578287-7578287, hg38,17:7674969-7674969","hg19,17:g.7578287G>C, hg38,17:g.7674969G>C",0.572,"haematopoietic_and_lymphoid_tissue, urinary_tract, bladder","lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, papilloma, typical",,,,,933702,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2193,188,L,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2194,188,L,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 181-188, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2195,189,A,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2196,189,A,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","cfdna_msk_2019, luad_mskcc_2023_met_organotropism, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578283-7578283, hg38,17:7674965-7674965","hg19,17:g.7578283G>T, hg38,17:g.7674965G>T",0.817,"liver, thyroid","carcinoma, anaplastic_carcinoma, carcinoma, hepatocellular_carcinoma",,,,,2137906,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2197,189,A,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2198,189,A,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2199,189,A,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7578283-7578283, hg38,17:7674965-7674965","hg19,17:g.7578283G>C, hg38,17:g.7674965G>C",0.754,"pancreas, soft_tissue, fibrous_tissue_and_uncertain_origin, pleura, stomach","carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, solitary_fibrous_tumour, malignant",,,,,1378428,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2200,189,A,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2201,189,A,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2202,189,A,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2203,189,A,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2204,189,A,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2205,189,A,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2206,189,A,P,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","egc_msk_2017, egc_msk_2023, egc_mskcc_2020, egc_trap_ccr_msk_2023, egc_trap_msk_2020, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024, tmb_mskcc_2018","Esophagogastric Adenocarcinoma, Esophagus/Stomach, Mixed Cancer Types","hg19,17:7578284-7578284, hg38,17:7674966-7674966","hg19,17:g.7578284C>G, hg38,17:g.7674966C>G",0.721,"ovary, skin, hand","carcinoma, clear_cell_carcinoma, carcinoma, squamous_cell_carcinoma, other, neoplasm",,,,,,,,,,,,,,
2207,189,A,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2208,189,A,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2209,189,A,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7578284-7578284, hg38,17:7674966-7674966","hg19,17:g.7578284C>A, hg38,17:g.7674966C>A",0.700,breast,carcinoma,,,,,528262,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2210,189,A,T,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578284-7578284, hg38,17:7674966-7674966","hg19,17:g.7578284C>T, hg38,17:g.7674966C>T",0.728,"large_intestine, large_intestine, colon, large_intestine, rectum, pleura, skin, hand, skin, neck, upper_aerodigestive_tract, pharynx, oropharynx","adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, mesothelioma",,,,,3972441,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2211,189,A,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_dfci_2020, nsclc_ctdx_msk_2022","Invasive Breast Carcinoma, Non-Small Cell Lung Cancer","hg19,17:7578283-7578283, hg38,17:7674965-7674965","hg19,17:g.7578283G>A, hg38,17:g.7674965G>A",0.790,"bone, humerus, breast, fallopian_tube, large_intestine, colon, ovary, skin, face, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, thymus, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, vocal_cord","adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, chondrosarcoma, gastrointestinal_stromal_tumour, low_malignant_potential_(borderline)_tumour, serous, other, dysplasia, thymoma, epithelial_predominant",0.0000238617924979,,,,12382,Conflicting classifications of pathogenicity,Familial cancer of breast;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Familial colorectal cancer;Hereditary breast ovarian cancer syndrome,1,,,,,,
2212,189,A,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2213,189,A,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2214,190,P,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_ch_2020, msk_ch_2023, msk_met_2021, paired_bladder_2022, pancan_pdmr_2025","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7578281-7578281, hg38,17:7674963-7674963","hg19,17:g.7578281G>C, hg38,17:g.7674963G>C",0.757,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue","carcinoma, adenocarcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,1021934,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2215,190,P,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2216,190,P,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2217,190,P,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2218,190,P,F,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674962-7674963","hg38,17:g.7674962_7674963delinsAA",,", skin","carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,,,,,,,,,,
2219,190,P,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2220,190,P,H,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674962-7674962","hg38,17:g.7674962G>T",0.731,"lung, salivary_gland, parotid","carcinoma, mucoepidermoid_carcinoma, carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
2221,190,P,I,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7578280-7578281","hg19,17:g.7578280_7578281delinsAT",,,,,,,,,,,,,,,,,
2222,190,P,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2223,190,P,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2023, blca_mskcc_solit_2012, bowel_colitis_msk_2022, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, chrcc_tcga_gdc, coad_cptac_2019, coad_cptac_gdc, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_glass, difg_glass_2019, difg_tcga_gdc, dlbcl_duke_2017, gbc_msk_2018, gbc_mskcc_2022, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, glioma_mskcc_2019, hcc_meric_2021, hcc_msk_2024, hccihch_pku_2019, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, lms_msk_2024, luad_cas_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mel_mskimpact_2020, mpcproject_broad_2021, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Chromophobe Renal Cell Carcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578280-7578280, hg19,17:7674962-7674962, hg38,17:7674962-7674962","hg19,17:g.7578280G>A, hg19,17:g.7674962G>A, hg38,17:g.7674962G>A",0.824,", breast, central_nervous_system, brain, central_nervous_system, cerebellum, central_nervous_system, frontal_lobe, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, thyroid, kidney, large_intestine, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, middle_third, pancreas, pituitary, prostate, skin, skin, face, skin, leg, small_intestine, jejunum, soft_tissue, striated_muscle, brain, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, cheek, urinary_tract, bladder, vulva","adenoma, ACTH, adenoma, ACTH_non_functioning, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, in_situ_epithelial_neoplasm, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, other, high_grade_mucinous_neoplasm, other, keratosis, rhabdomyosarcoma",,,,,418517,Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
2224,190,P,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2225,190,P,N,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674962-7674963","hg38,17:g.7674962_7674963delinsTT",,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2226,190,P,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2227,190,P,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","difg_tcga_gdc, glioma_mskcc_2019, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pdac_msk_2024, rectal_msk_2022, sarcoma_msk_2022","Bladder/Urinary Tract, Bowel, Diffuse Glioma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Soft Tissue","hg19,17:7578280-7578280, hg19,17:7674962-7674962, hg38,17:7674962-7674962","hg19,17:g.7578280G>C, hg19,17:g.7674962G>C, hg38,17:g.7674962G>C",0.846,", central_nervous_system, brain, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, skin, lung, oesophagus, stomach","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, oligoastrocytoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, malignant_melanoma",,,,,234061,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2228,190,P,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, difg_glass, difg_glass_2019, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, glioma_mskcc_2019, lms_msk_2024, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_pcawg_2020, panet_msk_2018, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024, sarcoma_mskcc_2022","CNS/Brain, Diffuse Glioma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreatic Neuroendocrine Tumor, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578281-7578281, hg19,17:7674963-7674963, hg38,17:7674963-7674963","hg19,17:g.7578281G>A, hg19,17:g.7674963G>A, hg38,17:g.7674963G>A",0.788,"breast, central_nervous_system, brain, central_nervous_system, cerebellum, large_intestine, lung, ovary, pancreas, prostate, skin, face, skin, leg, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, malignant_melanoma, desmoplastic, other, keratosis, other, solid_pseudopapillary_neoplasm",,,,,646725,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2229,190,P,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, appendiceal_msk_2022, brca_metabric, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, dlbcl_duke_2017, heme_msk_impact_2022, lms_msk_2024, luad_cptac_2020, luad_cptac_gdc, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022","Adenoid Cystic Carcinoma, Appendiceal Adenocarcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578281-7578281, hg19,17:7674963-7674963, hg38,17:7674963-7674963","hg19,17:g.7578281G>T, hg19,17:g.7674963G>T, hg38,17:g.7674963G>T",0.822,"biliary_tract, gallbladder, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, transverse, liver, lung, oesophagus, pancreas, prostate, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, other, neoplasm",,,,,233197,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2230,190,P,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2231,190,P,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2232,190,P,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2233,191,P,A,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674960-7674960","hg38,17:g.7674960G>C",0.598,"large_intestine, colon, left","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2234,191,P,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2235,191,P,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2236,191,P,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2237,191,P,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2238,191,P,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2239,191,P,H,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_met_2021, pancan_mimsi_msk_2024, ucec_msk_dacruzpaula_2025","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7578277-7578277, hg38,17:7674959-7674959","hg19,17:g.7578277G>T, hg38,17:g.7674959G>T",0.797,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, Burkitt_lymphoma",0.0000039765226105,,,,853530,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2240,191,P,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2241,191,P,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2242,191,P,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","pan_origimed_2020, sarcoma_msk_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578277-7578277, hg19,17:7674959-7674959, hg38,17:7674959-7674959","hg19,17:g.7578277G>A, hg19,17:g.7674959G>A, hg38,17:g.7674959G>A",0.748,"biliary_tract, gallbladder, haematopoietic_and_lymphoid_tissue, skin, large_intestine, colon, skin, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, malignant_melanoma",0.0000039765226105,,,,2703874,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2243,191,P,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2244,191,P,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2245,191,P,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2246,191,P,R,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578277-7578277, hg38,17:7674959-7674959","hg19,17:g.7578277G>C, hg38,17:g.7674959G>C",0.617,"oesophagus, prostate",carcinoma,0.0000119295678315,,,,127816,Likely benign,Hereditary cancer-predisposing syndrome;not provided;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
2247,191,P,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, mel_mskimpact_2020, msk_met_2021, nsclc_unito_2016","Basal Cell Carcinoma, Cutaneous Melanoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578278-7578278, hg38,17:7674960-7674960","hg19,17:g.7578278G>A, hg38,17:g.7674960G>A",0.722,"large_intestine, colon, lung, oesophagus, skin, skin, face","adnexal_tumour, other, sebaceoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,1024017,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2248,191,P,T,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674960-7674960","hg38,17:g.7674960G>T",0.727,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2249,191,P,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2250,191,P,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2251,191,P,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2252,192,Q,A,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2253,192,Q,C,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2254,192,Q,D,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2255,192,Q,E,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578275-7578275, hg38,17:7674957-7674957","hg19,17:g.7578275G>C, hg38,17:g.7674957G>C",0.557,,,,,,,2679236,Uncertain significance,"Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",2,,,,,,
2256,192,Q,F,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2257,192,Q,G,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2258,192,Q,H,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","lung_msk_pdx, lung_pdx_msk_2021, ovary_cptac_gdc, paad_qcmg_uq_2016","Lung, Ovary/Fallopian Tube, Pancreatic Adenocarcinoma","hg19,17:7578273-7578273, hg19,17:7674955-7674955, hg38,17:7674955-7674955","hg19,17:g.7578273C>A, hg19,17:g.7578273C>G, hg19,17:g.7674955C>A, hg38,17:g.7674955C>A, hg38,17:g.7674955C>G","0.534, 0.537","large_intestine, liver, pancreas, stomach","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma",,,,,"988617, 922531","Likely benign, Uncertain significance",Malignant tumor of esophagus|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,"1, 2",,,,,,
2259,192,Q,I,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2260,192,Q,K,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674957-7674957","hg38,17:g.7674957G>T",0.640,"biliary_tract, bile_duct, large_intestine, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
2261,192,Q,L,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","lms_msk_2024, msk_impact_2017, msk_met_2021, sarcoma_mskcc_2022, usarc_msk_2020","Mixed Cancer Types, Soft Tissue, Uterine Sarcoma/Mesenchymal","hg19,17:7578274-7578274, hg38,17:7674956-7674956","hg19,17:g.7578274T>A, hg38,17:g.7674956T>A",0.718,"soft_tissue, smooth_muscle, uterus",leiomyosarcoma,,,,,,,,,,,,,,
2262,192,Q,M,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2263,192,Q,N,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2264,192,Q,P,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578274-7578274, hg38,17:7674956-7674956","hg19,17:g.7578274T>G, hg38,17:g.7674956T>G",0.769,,,,,,,1036209,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2265,192,Q,R,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","coadread_dfci_2016, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Stomach Adenocarcinoma","hg19,17:7578274-7578274, hg19,17:7674956-7674956, hg38,17:7674956-7674956","hg19,17:g.7578274T>C, hg19,17:g.7674956T>C, hg38,17:g.7674956T>C",0.677,"breast, haematopoietic_and_lymphoid_tissue, abdomen, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, MALT_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,182931,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,,,,,,
2266,192,Q,S,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2267,192,Q,T,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2268,192,Q,V,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2269,192,Q,W,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2270,192,Q,Y,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2271,193,H,A,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2272,193,H,C,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2273,193,H,D,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_msk_2025, crc_sysucc_2022, lihc_amc_prv, luad_mskcc_2023_met_organotropism, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, prad_msk_stopsack_2021, prad_p1000, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma","hg19,17:7578272-7578272, hg19,17:7674954-7674954, hg38,17:7674954-7674954","hg19,17:g.7578272G>C, hg19,17:g.7674954G>C, hg38,17:g.7674954G>C",0.922,"breast, central_nervous_system, brainstem, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, liver, lung, ovary, prostate, skin, scalp, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,376613,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,Tier I - Strong,Pleuropulmonary blastoma,1
2274,193,H,E,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2275,193,H,F,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2276,193,H,G,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2277,193,H,I,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2278,193,H,K,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2279,193,H,L,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, bowel_colitis_msk_2022, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_dfci_2016, coadread_mskcc, csf_msk_2024, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, escc_ucla_2014, hcc_clca_2024, hcc_inserm_fr_2015, hcc_msk_2024, hcc_mskimpact_2018, heme_msk_impact_2022, hnsc_broad, hnsc_jhu, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ilc_msk_2023, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_sfu_2023, mds_iwg_2022, metastatic_solid_tumors_mich_2017, mnm_washu_2016, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ovary_cptac_gdc, paad_cptac_2021, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_organoids_msk_2022, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_cptac_2020, uec_cptac_gdc","Adenoid Cystic Carcinoma, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Uterine Endometrioid Carcinoma","hg19,17:7578271-7578271, hg19,17:7674953-7674953, hg38,17:7674953-7674953","hg19,17:g.7578271T>A, hg19,17:g.7674953T>A, hg38,17:g.7674953T>A",0.864,"adrenal_gland, adrenal_gland, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, mucosal, vulva, skin, scalp, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, oropharynx","adenoma, adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_B_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, epithelioid, other, intraepithelial_neoplasia, low_grade, other, neoplasm",,,,,185822,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Oncogenic,Neoplasm,1,,,
2280,193,H,M,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2281,193,H,N,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","egc_mskcc_2020, glioma_mskcc_2019, hcc_msk_2024, hcc_mskimpact_2018, ihch_msk_2021, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, paired_bladder_2022, pancan_mimsi_msk_2024, prad_p1000, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, read_tcga_gdc, sarcoma_msk_2022","Bladder/Urinary Tract, Diffuse Glioma, Esophagus/Stomach, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7578272-7578272, hg19,17:7578272-7578273, hg19,17:7674954-7674954, hg38,17:7674954-7674954","hg19,17:g.7578272G>T, hg19,17:g.7578272_7578273delinsTT, hg19,17:g.7674954G>T, hg38,17:g.7674954G>T",0.875,"biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, colon, left, lung, oesophagus, lower_third, oesophagus, middle_third, prostate, stomach, upper_aerodigestive_tract, larynx, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, metaplastic_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,3460301,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2282,193,H,P,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cll_broad_2015, cll_broad_2022, difg_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, kirp_tcga, kirp_tcga_pan_can_atlas_2018, lcll_broad_2013, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2019, prcc_tcga_gdc, prostate_msk_2024, tmb_mskcc_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Bladder/Urinary Tract, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Papillary Renal Cell Carcinoma, Prostate, Prostate Adenocarcinoma","hg19,17:7578271-7578271, hg19,17:7674953-7674953, hg38,17:7674953-7674953","hg19,17:g.7578271T>G, hg19,17:g.7674953T>G, hg38,17:g.7674953T>G",0.870,", breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, rectum, liver, lung, oesophagus, pancreas, prostate, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, tongue","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_renal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, intraepithelial_neoplasia, high_grade, primitive_neuroectodermal_tumour-medulloblastoma",,,,,376612,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
2283,193,H,Q,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_nmibc_2017, bowel_colitis_msk_2022, crc_apc_impact_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, prad_p1000, prad_su2c_2019","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types, Prostate Adenocarcinoma","hg19,17:7578270-7578270, hg38,17:7674952-7674952","hg19,17:g.7578270A>C, hg19,17:g.7578270A>T, hg38,17:g.7674952A>T",0.807,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,825975,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
2284,193,H,R,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, ampca_bcm_2016, angs_painter_2020, angs_painter_2025, biliary_tract_summit_2022, bladder_msk_2024, blca_iatlas_imvigor210_2017, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_mskcc_solit_2014, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, bm_nsclc_mskcc_2023, braf_msk_impact_2024, brca_aurora_2023, brca_broad, brca_cptac_2020, brca_dfci_2020, brca_iatlas_anders_2022, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_mskcc_2019, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, ccrcc_irc_2014, cellline_ccle_broad, cfdna_msk_2019, chol_icgc_2017, cll_broad_2015, cll_broad_2022, coadread_cass_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, es_dsrct_msk_2023, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_ucla_2014, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, glioma_msk_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, hcc_msk_2024, hcc_mskimpact_2018, hcc_tcga_gdc, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_pdx, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, mbn_mdacc_2013, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_impact_subset_2022, mnm_washu_2016, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, pptc_2019, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, prostate_msk_2024, sarcoma_msk_2022, sclc_clcgp, soft_tissue_msk_2025, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, utuc_msk_2019, utuc_mskcc_2015, utuc_pdx_msk_2019","Acute Myeloid Leukemia, Ampullary Carcinoma, Angiosarcoma, Biliary Tract, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Upper Tract Urothelial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578270-7578271, hg19,17:7578271-7578271, hg19,17:7674953-7674953, hg38,17:7674953-7674953","hg19,17:g.7578270_7578271delinsGC, hg19,17:g.7578271T>C, hg19,17:g.7674953T>C, hg38,17:g.7674953T>C",0.884,", biliary_tract, bile_duct, breast, central_nervous_system, central_nervous_system, brain, central_nervous_system, temporal_lobe, central_nervous_system, thalamus, endometrium, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, spleen, kidney, large_intestine, large_intestine, colon, large_intestine, colon, left, large_intestine, colon, right, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, salivary_gland, soft_tissue, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract, bladder, urinary_tract, renal_pelvis","carcinoid-endocrine_tumour, non_functioning, carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, squamous_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, enteric_adenocarcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, follicular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, luminal_B_carcinoma, carcinoma, medullary_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, gliosarcoma, glioma, oligoastrocytoma, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M4, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, M4, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma, other, neoplasm, other, neoplasm, malignant, papilloma, typical, primitive_neuroectodermal_tumour-medulloblastoma, sarcoma, sex_cord-stromal_tumour, granulosa_cell_tumour",,,,,184979,Pathogenic/Likely pathogenic,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck",2,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
2285,193,H,S,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2286,193,H,T,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2287,193,H,V,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2288,193,H,W,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2289,193,H,Y,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, aml_tcga_gdc, appendiceal_msk_2022, blca_dfarber_mskcc_2014, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_igr_2015, brca_metabric, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccrcc_tcga_gdc, cellline_ccle_broad, cervix_msk_2023, coadread_dfci_2016, coadread_genentech, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_msk_2023, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, es_iocurie_2014, esca_broad, gbc_mskcc_2022, glioma_mskcc_2019, hcc_msk_2024, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, kirc_tcga, kirc_tcga_pan_can_atlas_2018, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lms_msk_2024, luad_mskcc_2023_met_organotropism, lung_msk_pdx, lung_pdx_msk_2021, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_msk_2024, mds_mskcc_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_icgc, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, tet_nci_2014, tmb_mskcc_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Acute Myeloid Leukemia, Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervix, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue, Stomach Adenocarcinoma, Thymic Epithelial Tumor, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578272-7578272, hg19,17:7674954-7674954, hg38,17:7674954-7674954","hg19,17:g.7578272G>A, hg19,17:g.7674954G>A, hg38,17:g.7674954G>A",0.887,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, bone, breast, central_nervous_system, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, cerebrum, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, kidney, large_intestine, large_intestine, colon, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, pleura, prostate, salivary_gland, soft_tissue, soft_tissue, fat, mediastinum, soft_tissue, fibrous_tissue_and_uncertain_origin, soft_tissue, smooth_muscle, retroperitoneum, soft_tissue, striated_muscle, leg, stomach, thymus, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, lip, urinary_tract, bladder, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, adrenal_cortical_carcinoma, non_functioning, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, leiomyosarcoma, liposarcoma, pleomorphic, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, mesothelioma, epithelial, other, Barrett_oesophagus, with_high_grade_dysplasia, other, embryonal_tumour, other, neoplasm, rhabdomyosarcoma, pleomorphic, sarcoma, synovial_sarcoma, thymic_carcinoma, undifferentiated_carcinoma",,,,,230256,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Malignant tumor of urinary bladder;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
2290,194,L,A,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2291,194,L,C,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2292,194,L,D,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2293,194,L,E,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2294,194,L,F,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2023, bladder_msk_2024, blca_cornell_2016, blca_msk_tcga_2020, blca_nmibc_2017, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, cesc_tcga, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, coadread_cass_2020, coadread_dfci_2016, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_ucsf_2021, egc_msk_tp53_ccr_2022, gbc_mskcc_2022, hcc_clca_2024, hcc_msk_2024, hnc_mskcc_2016, ihch_msk_2021, luad_broad, luad_cas_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, read_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022, tmb_mskcc_2018","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Cervical Squamous Cell Carcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Head and Neck, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7578269-7578269, hg19,17:7674951-7674951, hg38,17:7674951-7674951","hg19,17:g.7578269G>A, hg19,17:g.7674951G>A, hg38,17:g.7674951G>A",0.851,", breast, cervix, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, skin, skin, face, skin, hand, skin, head_neck, skin, leg, skin, neck, soft_tissue, blood_vessel, scalp, soft_tissue, fibrous_tissue_and_uncertain_origin, shoulder, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, urinary_tract, bladder","adenoma, angiosarcoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, B_cell_lymphoma_unspecified, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, primary_central_nervous_system_B_cell_lymphoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, malignant_melanoma, malignant_melanoma, desmoplastic, other, hyperplasia, other, metaplasia, undifferentiated-unclassified_sarcoma, spindle_cell",,,,,127817,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Adrenal cortex carcinoma,2,Oncogenic,Neoplasm,1,,,
2295,194,L,G,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2296,194,L,H,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_broad, breast_msk_2025, coadread_tcga, coadread_tcga_pub, egc_msk_2023, hcc_clca_2024, hcc_msk_2024, hcc_mskimpact_2018, heme_msk_impact_2022, lung_nci_2022, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_mskcc_2020, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_tcga_broad_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, thyroid_gatci_2024, ucec_ancestry_cds_msk_2023, ucs_msk_2024","Bladder Urothelial Carcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Endometrial Carcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Thyroid","hg19,17:7578268-7578268, hg19,17:7674950-7674950, hg38,17:7674950-7674950","hg19,17:g.7578268A>T, hg19,17:g.7674950A>T, hg38,17:g.7674950A>T",0.918,"biliary_tract, bile_duct, breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, lung, oesophagus, pancreas, stomach, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, lymphoid_neoplasm, lymphoid_neoplasm, MALT_lymphoma, other, dysplasia-in_situ_neoplasm",,,,,376634,Conflicting classifications of pathogenicity,Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
2297,194,L,I,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578269-7578269, hg38,17:7674951-7674951","hg19,17:g.7578269G>T, hg38,17:g.7674951G>T",0.791,"large_intestine, rectum",carcinoma,,,,,,,,,,,,,,
2298,194,L,K,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2299,194,L,M,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2300,194,L,N,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2301,194,L,P,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, crc_apc_impact_2020, difg_glass_2019, egc_msk_2023, hcc_meric_2021, hcc_msk_2024, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lms_msk_2024, luad_mskcc_2023_met_organotropism, lusc_cptac_gdc, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578268-7578268, hg19,17:7674950-7674950, hg38,17:7674950-7674950","hg19,17:g.7578268A>G, hg19,17:g.7674950A>G, hg38,17:g.7674950A>G",0.937,", breast, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, rectum, liver, oesophagus, soft_tissue, smooth_muscle, abdomen, stomach, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, leiomyosarcoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, malignant_melanoma, other, neoplasm",,,,,376635,Uncertain significance,Li-Fraumeni syndrome,1,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
2302,194,L,Q,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2303,194,L,R,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2022, bladder_columbia_msk_2018, bladder_msk_2023, blca_bgi, blca_pdx_msk_2025, brca_bccrc_xenograft_2014, brca_cptac_2020, brca_fuscc_2020, brca_mapk_hp_msk_2021, brca_metabric, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cfdna_msk_2019, chol_icgc_2017, coad_silu_2022, coadread_dfci_2016, coadread_mskcc, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, egc_tmucih_2015, gbc_mskcc_2022, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, hcc_clca_2024, hcc_msk_2024, hccihch_pku_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_nci_2022, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_impact_subset_2022, mpcproject_broad_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pptc_2019, read_tcga_gdc, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sclc_jhu, soft_tissue_tcga_gdc, summit_2018, thym_tcga, thym_tcga_gdc, thym_tcga_pan_can_atlas_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, wt_target_2018_pub","Acute Myeloid Leukemia, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Thymoma, Wilms' Tumor","hg19,17:7578268-7578268, hg19,17:7674950-7674950, hg38,17:7674950-7674950","hg19,17:g.7578268A>C, hg19,17:g.7674950A>C, hg38,17:g.7674950A>C",0.933,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, fallopian_tube, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, salivary_gland, salivary_gland, parotid, skin, soft_tissue, soft_tissue, striated_muscle, uterus, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, adenoma-nodule-goitre, Hurthle_cell_adenoma, adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, transformed_to_small_cell_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia_with_ringed_sideroblasts, haematopoietic_neoplasm, polycythaemia_vera, lymphoid_neoplasm, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia_therapy_related, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, malignant_melanoma, osteosarcoma, other, intraepithelial_neoplasia, low_grade, other, neoplasm, malignant, rhabdomyosarcoma, pleomorphic, sarcoma",0.0000039763644895,,,,376633,Conflicting classifications of pathogenicity,TP53-related disorder;Hereditary cancer-predisposing syndrome;Colorectal cancer;Hereditary breast ovarian cancer syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2304,194,L,S,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2305,194,L,T,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2306,194,L,V,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, pdac_msk_2024","Mixed Cancer Types, Pancreas","hg19,17:7578269-7578269, hg38,17:7674951-7674951","hg19,17:g.7578269G>C, hg38,17:g.7674951G>C",0.833,"oesophagus, ovary, urinary_tract, bladder","carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
2307,194,L,W,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2308,194,L,Y,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2309,195,I,A,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_chord_2024, pdac_msk_2024","Mixed Cancer Types, Pancreas","hg19,17:7578265-7578266","hg19,17:g.7578265_7578266delinsGC",,,,,,,,,,,,,,,,,
2310,195,I,C,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2311,195,I,D,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2312,195,I,E,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2313,195,I,F,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2024, blca_msk_tcga_2020, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brca_metabric, brca_smc_2018, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, coadread_cass_2020, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, difg_tcga_gdc, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, glioma_mskcc_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, ihch_msk_2021, ihch_mskcc_2020, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_pdx, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_msk_2024, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, read_tcga_gdc, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sclc_ucologne_2015, soft_tissue_tcga_gdc, stes_tcga_pub, ucec_ancestry_cds_msk_2023, ucec_msk_2018, utuc_msk_2019, utuc_mskcc_2015","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Upper Tract Urothelial Carcinoma","hg19,17:7578266-7578266, hg19,17:7674948-7674948, hg38,17:7674948-7674948","hg19,17:g.7578266T>A, hg19,17:g.7674948T>A, hg38,17:g.7674948T>A",0.904,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, large_intestine, anorectal, large_intestine, colon, left, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, skin, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, vocal_cord, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, other, dysplasia, other, neoplasm, sarcoma, synovial_sarcoma",,,,,376617,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Malignant tumor of esophagus,1,,,,,,
2314,195,I,G,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2315,195,I,H,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2316,195,I,K,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578264-7578265, hg38,17:7674946-7674947","hg19,17:g.7578264_7578265delinsTT, hg38,17:g.7674946_7674947delinsTT",,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2317,195,I,L,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674948-7674948","hg38,17:g.7674948T>G",0.724,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
2318,195,I,M,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,17:7578264-7578264, hg19,17:7674946-7674946, hg38,17:7674946-7674946","hg19,17:g.7578264G>C, hg19,17:g.7674946G>C, hg38,17:g.7674946G>C",0.755,"haematopoietic_and_lymphoid_tissue, lung, lung, right_bronchus","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, plasma_cell_myeloma",,,,,376620,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2319,195,I,N,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_igr_2015, breast_msk_2018, breast_msk_2025, chol_icgc_2017, crc_eo_2020, crc_msk_2017, difg_tcga_gdc, esca_tcga, esca_tcga_pan_can_atlas_2018, escc_icgc, gbm_tcga, heme_msk_impact_2022, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lipo_msk_2024, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, mbn_mdacc_2013, mds_mskcc_2020, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_oncosg_2018, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_ancestry_cds_msk_2023","Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Head and Neck Carcinoma, Other, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Liposarcoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578264-7578265, hg19,17:7578265-7578265, hg19,17:7674947-7674947, hg38,17:7674946-7674947, hg38,17:7674947-7674947","hg19,17:g.7578264_7578265delinsAT, hg19,17:g.7578265A>T, hg19,17:g.7674947A>T, hg38,17:g.7674946_7674947delinsAT, hg38,17:g.7674947A>T",0.840,", biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, large_intestine, colon, right, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, pleura, stomach","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, undifferentiated_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, mesothelioma, epithelial, other, dysplasia-in_situ_neoplasm, other, neoplasm",,,,,"3656084, 376618","Uncertain significance, Conflicting classifications of pathogenicity",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1,"1, 1",Likely oncogenic,Neoplasm,1,Tier I - Strong,Embryonal rhabdomyosarcoma,1
2320,195,I,P,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2321,195,I,Q,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2322,195,I,R,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2323,195,I,S,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_bccrc, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, hcc_tcga_gdc, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_organoids_msk_2022, sarcoma_msk_2022, sclc_ucologne_2015","Acute Myeloid Leukemia, Breast, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578265-7578265, hg19,17:7674947-7674947, hg38,17:7674947-7674947","hg19,17:g.7578265A>C, hg19,17:g.7674947A>C, hg38,17:g.7674947A>C",0.865,"biliary_tract, bile_duct, breast, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, oesophagus, ovary, pancreas, ampulla_of_Vater, skin","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma",,,,,376619,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,1,,,,,,
2324,195,I,T,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, ampca_bcm_2016, bladder_msk_2023, blca_bcan_hcrn_2022, bowel_colitis_msk_2022, brain_cptac_gdc, brca_broad, brca_iatlas_anders_2022, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_mskcc_2019, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cfdna_msk_2019, chol_icgc_2017, cll_broad_2015, cll_broad_2022, coad_cptac_2019, coad_cptac_gdc, coad_silu_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_orion_2024, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, gbc_mskcc_2022, gbm_cptac_2021, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gbm_tcga_pub2013, glioma_msk_2018, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lcll_broad_2013, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2015, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, lusc_cptac_2021, lusc_cptac_gdc, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mm_broad, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_qcmg_uq_2016, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_cpcg_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_dkfz_2018, prostate_msk_2024, prostate_pcbm_swiss_2019, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc","Acute Myeloid Leukemia, Ampullary Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Plasma Cell Myeloma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Thyroid, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma","hg19,17:7578265-7578265, hg19,17:7674947-7674947, hg38,17:7674947-7674947","hg19,17:g.7578265A>G, hg19,17:g.7674947A>G, hg38,17:g.7674947A>G",0.851,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, central_nervous_system, brain, central_nervous_system, temporal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, skin, kidney, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, pleura, prostate, salivary_gland, parotid, skin, mucosal, vulva, small_intestine, jejunum, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, tongue, urinary_tract, urinary_tract, bladder","Wilms_tumour, bilateral, adenoma, tubular, high_grade_dysplasia, carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, acinic_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, luminal_B_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, lymphoepithelioma_like_carcinoma, carcinoma, medullary_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M2, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, mesothelioma, mesothelioma, biphasic, other, dysplasia-in_situ_neoplasm, other, neoplasm, other, neoplasm, malignant, primitive_neuroectodermal_tumour-medulloblastoma",0.0000000000000000,,,,216077,Pathogenic,"Hereditary cancer-predisposing syndrome;Familial cancer of breast;TP53-related disorder;not provided;Breast and/or ovarian cancer;Ovarian neoplasm;Adrenocortical carcinoma, hereditary;Lung adenocarcinoma;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",2,Oncogenic,Neoplasm,1,Tier I - Strong,Astrocytoma IDH-mutant,1
2325,195,I,V,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_access_2021, nsclc_ctdx_msk_2022, prad_organoids_msk_2022","Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate Adenocarcinoma","hg19,17:7578266-7578266","hg19,17:g.7578266T>C",0.725,,,,,,,,,,,,,,,,
2326,195,I,W,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2327,195,I,Y,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2328,196,R,A,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2329,196,R,C,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2330,196,R,D,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2331,196,R,E,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2332,196,R,F,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2333,196,R,G,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, prad_msk_stopsack_2021, prostate_msk_2024","Breast, Invasive Breast Carcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578263-7578263, hg38,17:7674945-7674945","hg19,17:g.7578263G>C, hg38,17:g.7674945G>C",0.897,"breast, haematopoietic_and_lymphoid_tissue, oesophagus, ovary, salivary_gland, non-salivary_gland, salivary_gland, parotid","carcinoma, ductal_carcinoma, carcinoma, hybrid_salivary_gland_carcinoma, squamous_cell_and_salivary_duct_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",,,,,232344,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2334,196,R,H,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2335,196,R,I,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2336,196,R,K,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2337,196,R,L,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","heme_msk_impact_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,17:7578261-7578262, hg19,17:7578262-7578262, hg38,17:7674944-7674944","hg19,17:g.7578261_7578262delinsAA, hg19,17:g.7578262C>A, hg38,17:g.7674944C>A",0.933,"adrenal_gland, adrenal_gland, pancreas, skin, eye, upper_aerodigestive_tract, mouth","adrenal_cortical_adenoma, cortisol_producing, carcinoma, squamous_cell_carcinoma, other, dysplasia-in_situ_neoplasm",,,,,100814,Conflicting classifications of pathogenicity,Glioma susceptibility 1;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2338,196,R,M,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2339,196,R,N,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2340,196,R,P,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, blca_mskcc_solit_2014, blca_plasmacytoid_mskcc_2016, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coadread_dfci_2016, crc_eo_2020, difg_glass, difg_glass_2019, difg_tcga_gdc, escc_icgc, hcc_clca_2024, hcc_msk_2024, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, luad_tsp, lung_nci_2022, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, paad_icgc, paad_qcmg_uq_2016, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_ucologne_2015","Bladder Urothelial Carcinoma, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mature T and NK Neoplasms, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578262-7578262, hg19,17:7674944-7674944, hg38,17:7674944-7674944","hg19,17:g.7578262C>G, hg19,17:g.7674944C>G, hg38,17:g.7674944C>G",0.941,"biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, parotid, skin, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, tongue, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, glioma, glioma, astrocytoma_Grade_II, fibrillary, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, mantle_cell_lymphoma, malignant_melanoma, papilloma, typical",,,,,231165,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,Likely oncogenic,Neoplasm,1,,,
2341,196,R,Q,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, hcc_msk_2024, heme_msk_impact_2022, luad_mskcc_2023_met_organotropism, mds_mskcc_2020, mixed_allen_2018, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, rectal_msk_2022, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Bowel, Breast, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578262-7578262, hg19,17:7674944-7674944, hg38,17:7674944-7674944","hg19,17:g.7578262C>T, hg19,17:g.7674944C>T, hg38,17:g.7674944C>T",0.888,"breast, central_nervous_system, parietal_lobe, eye, uveal_tract, haematopoietic_and_lymphoid_tissue, large_intestine, rectum, salivary_gland, small_intestine, duodenum, soft_tissue, fibrous_tissue_and_uncertain_origin, thymus, urinary_tract, bladder, urinary_tract, bladder, urachus","carcinoma, carcinoma, adenocarcinoma, carcinoma, lobular_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, malignant_melanoma, synovial_sarcoma, thymic_carcinoma, squamous_cell_carcinoma",0.0000039763961127,,,,216467,Uncertain significance,"Familial cancer of breast;Hereditary cancer-predisposing syndrome;Familial cancer of breast;not specified;not provided;Adrenocortical carcinoma, hereditary;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1",3,,,,,,
2342,196,R,S,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2343,196,R,T,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2344,196,R,V,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2345,196,R,W,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2346,196,R,Y,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2347,197,V,A,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",ccle_genentech_2014,Mixed Cancer Types,"hg19,17:7578259-7578259, hg38,17:7674941-7674941","hg19,17:g.7578259A>G, hg38,17:g.7674941A>G",0.823,"lung, skin, hand","carcinoma, squamous_cell_carcinoma, other, pneumocytoma_(sclerosing_haemangioma)",,,,,3460294,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2348,197,V,C,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2349,197,V,D,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2350,197,V,E,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, breast_msk_2018, breast_msk_2025, crc_eo_2020, cscc_dfarber_2015, luad_cas_2020, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, prad_msk_stopsack_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022","Bowel, Breast, Cutaneous Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578259-7578259, hg38,17:7674941-7674941","hg19,17:g.7578259A>T, hg38,17:g.7674941A>T",0.897,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, liver, lung, ovary, skin, stomach, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, Burkitt_lymphoma, sporadic_type, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,634757,Uncertain significance,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome,2,,,,,,
2351,197,V,F,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2352,197,V,G,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, cll_broad_2022, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_pcawg_2020, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer","hg19,17:7578259-7578259, hg19,17:7674941-7674941, hg38,17:7674941-7674941","hg19,17:g.7578259A>C, hg19,17:g.7674941A>C, hg38,17:g.7674941A>C",0.914,"breast, endometrium, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, lung, oesophagus, soft_tissue, blood_vessel, head_neck, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, vulva","angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, enteric_adenocarcinoma, carcinoma, renal_cell_carcinoma_unclassified, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma",,,,,826051,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
2353,197,V,H,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2354,197,V,I,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2355,197,V,K,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2356,197,V,L,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, ccle_broad_2019, ccle_broad_2025, difg_glass, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, hcc_tcga_gdc, lihc_riken, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lung_nci_2022, mixed_selpercatinib_2020, msk_chord_2024, pancan_hcmi_2025, sarcoma_msk_2022, stad_utokyo, stes_tcga_pub, ucec_ancestry_cds_msk_2023, ucs_msk_2024","CNS/Brain, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578260-7578260, hg19,17:7674942-7674942, hg38,17:7674942-7674942","hg19,17:g.7578260C>A, hg19,17:g.7578260C>G, hg19,17:g.7674942C>A, hg19,17:g.7674942C>G, hg38,17:g.7674942C>A, hg38,17:g.7674942C>G",0.730,"breast, large_intestine, colon, liver, lung, ovary, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,"480766, 216468","Uncertain significance, Uncertain significance",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"2, 2",,,,,,
2357,197,V,M,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_metabric, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, gbm_cptac_2021, heme_msk_impact_2022, luad_mskcc_2023_met_organotropism, mds_iwg_2022, mixed_cfdna_msk_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, summit_2018, tmb_mskcc_2018","Ampullary Carcinoma, Bladder/Urinary Tract, Bowel, CNS/Brain, Colorectal Adenocarcinoma, Diffuse Glioma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578260-7578260, hg19,17:7674942-7674942, hg38,17:7674942-7674942","hg19,17:g.7578260C>T, hg19,17:g.7674942C>T, hg38,17:g.7674942C>T",0.758,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, lung, oesophagus, pancreas, pancreas, ampulla_of_Vater, stomach, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, urinary_tract, bladder, urinary_tract, upper_urinary_tract","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, signet_ring_adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, MALT_lymphoma",0.0000000000000000,,,,188060,Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,Likely oncogenic,Neoplasm,1,,,
2358,197,V,N,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2359,197,V,P,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2360,197,V,Q,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2361,197,V,R,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674941-7674942","hg38,17:g.7674941_7674942delinsCT",,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related",,,,,,,,,,,,,,
2362,197,V,S,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2363,197,V,T,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2364,197,V,W,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2365,197,V,Y,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2366,198,E,A,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2367,198,E,C,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2368,198,E,D,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, msk_met_2021","Esophagogastric Adenocarcinoma, Esophagus/Stomach, Mixed Cancer Types","hg19,17:7578255-7578255","hg19,17:g.7578255T>A",0.824,,,,,,,,,,,,,,,,
2369,198,E,F,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2370,198,E,G,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578256-7578256, hg38,17:7674938-7674938","hg19,17:g.7578256T>C, hg38,17:g.7674938T>C",0.915,"upper_aerodigestive_tract, larynx","carcinoma, squamous_cell_carcinoma",,,,,1750606,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
2371,198,E,H,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2372,198,E,I,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2373,198,E,K,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","nsclc_unito_2016, sarcoma_msk_2022","Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578257-7578257, hg38,17:7674939-7674939","hg19,17:g.7578257C>T, hg38,17:g.7674939C>T",0.910,"large_intestine, colon, oesophagus, ovary, salivary_gland, skin, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx","carcinoma, adenocarcinoma, carcinoma, mucinous_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma, superficial_spreading",,,,,,,,,,,,,,
2374,198,E,L,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2375,198,E,M,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2376,198,E,N,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2377,198,E,P,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2378,198,E,Q,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674939-7674939","hg38,17:g.7674939C>G",0.889,"haematopoietic_and_lymphoid_tissue, skin, upper_aerodigestive_tract, larynx, glottis","carcinoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,,,,,,,,,,
2379,198,E,R,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2380,198,E,S,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2381,198,E,T,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2382,198,E,V,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674938-7674938","hg38,17:g.7674938T>A",0.926,stomach,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2383,198,E,W,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2384,198,E,Y,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 194-198, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2385,199,G,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674935-7674935","hg38,17:g.7674935C>G",0.888,"soft_tissue, blood_vessel",Kaposi_sarcoma,,,,,,,,,,,,,,
2386,199,G,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2387,199,G,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2388,199,G,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_nmibc_2017, brca_aurora_2023, cll_broad_2022, glioma_mskcc_2019, heme_msk_impact_2022, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_pdx, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_cfdna_msk_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, paired_bladder_2022, pan_origimed_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Glioma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578253-7578253, hg19,17:7674935-7674935, hg38,17:7674935-7674935","hg19,17:g.7578253C>T, hg19,17:g.7674935C>T, hg38,17:g.7674935C>T",0.880,", breast, central_nervous_system, brain, central_nervous_system, parietooccipital, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, large_intestine, large_intestine, appendix, lung, meninges, peritoneum, skin, soft_tissue, smooth_muscle, adrenal_gland, urinary_tract, bladder","carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, leiomyosarcoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, anaplastic_large_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, meningioma",,,,,582257,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;not provided;Li-Fraumeni syndrome,2,,,,,,
2389,199,G,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2390,199,G,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2391,199,G,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021, nsclc_ctdx_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578253-7578254","hg19,17:g.7578253_7578254delinsAT",,,,,,,,,,,,,,,,,
2392,199,G,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2393,199,G,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2394,199,G,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2395,199,G,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2396,199,G,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2397,199,G,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2398,199,G,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",sarcoma_msk_2022,Soft Tissue,"hg19,17:7578254-7578254, hg38,17:7674936-7674936","hg19,17:g.7578254C>T, hg38,17:g.7674936C>T",0.883,"biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, parietal_lobe, haematopoietic_and_lymphoid_tissue, kidney, lung, soft_tissue, fibrous_tissue_and_uncertain_origin, urinary_tract, bladder","Wilms_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, small_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, papilloma, typical, synovial_sarcoma",,,,,1015039,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
2399,199,G,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2400,199,G,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674935-7674936","hg38,17:g.7674935_7674936delinsGT",,breast,carcinoma,,,,,,,,,,,,,,
2401,199,G,V,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, braf_msk_impact_2024, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_genentech_2014, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, gbm_tcga_gdc, hcc_inserm_fr_2015, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, mbl_dkfz_2017, mbl_pcgp, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paad_cptac_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancreas_cptac_gdc, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, prostate_msk_2024, ptad_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Medulloblastoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Pituitary Adenoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578253-7578253, hg19,17:7674935-7674935, hg38,17:7674935-7674935","hg19,17:g.7578253C>A, hg19,17:g.7674935C>A, hg38,17:g.7674935C>A",0.899,"biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, cerebellum, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, left, large_intestine, rectum, liver, ovary, pancreas, prostate, skin, scalp, stomach, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder","adenoma, tubular, carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, small_cell_carcinoma, carcinoma, tubular_adenocarcinoma, primitive_neuroectodermal_tumour-medulloblastoma, SHH_subtype, primitive_neuroectodermal_tumour-medulloblastoma, medullomyoblastoma",,,,,451799,Likely pathogenic,not provided,1,,,,Tier I - Strong,"Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype",1
2402,199,G,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2403,199,G,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2404,200,N,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2405,200,N,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2406,200,N,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578251-7578251, hg38,17:7674933-7674933","hg19,17:g.7578251T>C, hg38,17:g.7674933T>C",0.840,"large_intestine, anorectal, thymus","carcinoma, adenocarcinoma, thymic_carcinoma, squamous_cell_carcinoma",,,,,1061739,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2407,200,N,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2408,200,N,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2409,200,N,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2410,200,N,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578251-7578251, hg38,17:7674933-7674933","hg19,17:g.7578251T>G, hg38,17:g.7674933T>G",0.850,,,,,,,2006345,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2411,200,N,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674932-7674932","hg38,17:g.7674932T>A",0.792,"large_intestine, rectum, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
2412,200,N,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2413,200,N,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2414,200,N,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2415,200,N,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2416,200,N,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2417,200,N,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2418,200,N,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578250-7578250, hg38,17:7674932-7674932","hg19,17:g.7578250T>C, hg38,17:g.7674932T>C",0.678,"large_intestine, colon, liver","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma",,,,,924379,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2419,200,N,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674932-7674932","hg38,17:g.7674932T>G",0.768,"central_nervous_system, cerebellum","other, central_neurocytoma",,,,,,,,,,,,,,
2420,200,N,V,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2421,200,N,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2422,200,N,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021",Mixed Cancer Types,"hg19,17:7578251-7578251, hg38,17:7674933-7674933","hg19,17:g.7578251T>A, hg38,17:g.7674933T>A",0.900,stomach,"carcinoma, adenocarcinoma",,,,,2450739,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2423,201,L,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2424,201,L,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2425,201,L,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2426,201,L,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2427,201,L,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674928-7674928","hg38,17:g.7674928C>A, hg38,17:g.7674928C>G",0.446,"large_intestine, colon, large_intestine, rectum, lung, ovary, thymus, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, thymic_carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2428,201,L,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2429,201,L,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2430,201,L,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2431,201,L,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2432,201,L,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578248-7578248, hg38,17:7674930-7674930","hg19,17:g.7578248A>T, hg38,17:g.7674930A>T",0.485,,,,,,,1751128,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2433,201,L,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2434,201,L,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674929-7674930","hg38,17:g.7674929_7674930delinsGG",,"breast, large_intestine, rectum","carcinoid-endocrine_tumour, carcinoma",,,,,,,,,,,,,,
2435,201,L,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2436,201,L,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2437,201,L,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674929-7674929","hg38,17:g.7674929A>G",0.505,"upper_aerodigestive_tract, larynx","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2438,201,L,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2439,201,L,V,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674930-7674930","hg38,17:g.7674930A>C",0.447,"large_intestine, pancreas, skin, neck","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, malignant_melanoma, desmoplastic",,,,,,,,,,,,,,
2440,201,L,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2441,201,L,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2442,202,R,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2443,202,R,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022","Bowel, Lung Adenocarcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578245-7578245, hg38,17:7674927-7674927","hg19,17:g.7578245G>A, hg38,17:g.7674927G>A",0.498,"breast, endometrium, large_intestine, colon, right, lung, prostate, small_intestine, jejunum, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, lip, urinary_tract","carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, neuroendocrine_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",0.0000278352155241,0.0000318654005481,,,127818,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,,,,,,
2444,202,R,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2445,202,R,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2446,202,R,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2447,202,R,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578245-7578245, hg38,17:7674927-7674927","hg19,17:g.7578245G>C, hg38,17:g.7674927G>C",0.483,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia, M1",,,,,231661,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
2448,202,R,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578244-7578244, hg38,17:7674926-7674926","hg19,17:g.7578244C>T, hg38,17:g.7674926C>T",0.528,"biliary_tract, gallbladder, breast, large_intestine, oesophagus, ovary, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,135358,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome;Malignant tumor of breast,1,,,,,,
2449,202,R,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2450,202,R,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2451,202,R,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578244-7578244, hg38,17:7674926-7674926","hg19,17:g.7578244C>A, hg38,17:g.7674926C>A",0.530,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, rectum, lung, skin","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, M7",,,,,182932,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2452,202,R,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2453,202,R,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2454,202,R,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578244-7578244, hg38,17:7674925-7674926, hg38,17:7674926-7674926","hg19,17:g.7578244C>G, hg38,17:g.7674925_7674926delinsCG, hg38,17:g.7674926C>G",0.528,"breast, skin, thyroid, upper_aerodigestive_tract, mouth","carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,826165,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2455,202,R,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2456,202,R,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674927-7674927","hg38,17:g.7674927G>T",0.486,"breast, large_intestine, oesophagus, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2457,202,R,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2458,202,R,V,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2459,202,R,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2460,202,R,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2461,203,V,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674923-7674923","hg38,17:g.7674923A>G",0.526,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,,,,,,,,,,
2462,203,V,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2463,203,V,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2464,203,V,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","mds_mskcc_2020, msk_chord_2024, msk_met_2021, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024","Mixed Cancer Types, Myelodysplastic Syndromes, Prostate, Prostate Adenocarcinoma","hg19,17:7578241-7578241, hg38,17:7674923-7674923","hg19,17:g.7578241A>T, hg38,17:g.7674923A>T",0.630,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, pancreas, upper_aerodigestive_tract, mouth, tongue","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,644883,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2465,203,V,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2466,203,V,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2467,203,V,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2468,203,V,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2469,203,V,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2470,203,V,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","biliary_tract_summit_2022, bm_nsclc_mskcc_2023, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coad_cptac_2019, coad_cptac_gdc, coadread_mskcc, crc_orion_2024, hcc_clca_2024, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, prad_pik3r1_msk_2021, prostate_msk_2024, rcc_cptac_gdc, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, soft_tissue_tcga_gdc","Biliary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Renal Cell Carcinoma, Soft Tissue","hg19,17:7578242-7578242, hg19,17:7674924-7674924, hg38,17:7674924-7674924","hg19,17:g.7578242C>A, hg19,17:g.7578242C>G, hg19,17:g.7674924C>A, hg19,17:g.7674924C>G, hg38,17:g.7674924C>A, hg38,17:g.7674924C>G",0.506,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, appendix, large_intestine, colon, liver, lung, oesophagus, ovary, pleura, soft_tissue, thyroid, vulva","carcinoid-endocrine_tumour, goblet_cell, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, other, neoplasm, pulmonary_blastoma, sarcoma",,,,,"482235, 482218","Uncertain significance, Uncertain significance",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome|Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,"2, 2",,,,,,
2471,203,V,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","difg_glass, difg_glass_2019, heme_msk_impact_2022, lgg_ucsf_2014, mds_iwg_2022, mds_mskcc_2020, msk_chord_2024, pancan_mimsi_msk_2024, pdac_msk_2024, sarcoma_msk_2022","Diffuse Glioma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Soft Tissue","hg19,17:7578242-7578242, hg38,17:7674924-7674924","hg19,17:g.7578242C>T, hg38,17:g.7674924C>T",0.519,"central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, descending, liver, lung, lung, right_upper_lobe, pancreas, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,182933,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,3,,,,,,
2472,203,V,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2473,203,V,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2474,203,V,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2475,203,V,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2476,203,V,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2477,203,V,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2478,203,V,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2479,203,V,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 198-203, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2480,204,E,A,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",sarcoma_msk_2022,Soft Tissue,"hg19,17:7578238-7578238, hg38,17:7674920-7674920","hg19,17:g.7578238T>G, hg38,17:g.7674920T>G",0.600,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2481,204,E,C,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2482,204,E,D,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","gist_msk_2022, gist_msk_2023, msk_met_2021, sarcoma_mskcc_2022, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Gastrointestinal Stromal Tumor, Mixed Cancer Types, Soft Tissue","hg19,17:7578237-7578237, hg19,17:7674919-7674919, hg38,17:7674919-7674919","hg19,17:g.7578237C>A, hg19,17:g.7578237C>G, hg19,17:g.7674919C>G, hg38,17:g.7674919C>G",0.494,"endometrium, ovary","carcinoma, endometrioid_carcinoma, carcinoma, serous_carcinoma",,,,,3460304,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
2483,204,E,F,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2484,204,E,G,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","coadread_dfci_2016, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7578238-7578238, hg38,17:7674920-7674920","hg19,17:g.7578238T>C, hg38,17:g.7674920T>C",0.604,"haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, transverse, large_intestine, rectum, soft_tissue, striated_muscle, arm","carcinoma, adenocarcinoma, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, rhabdomyosarcoma, alveolar",,0.0000318796225453,,,949463,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2485,204,E,H,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2486,204,E,I,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2487,204,E,K,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674921-7674921","hg38,17:g.7674921C>T",0.624,"large_intestine, large_intestine, appendix","carcinoid-endocrine_tumour, carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2488,204,E,L,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2489,204,E,M,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2490,204,E,N,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2491,204,E,P,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2492,204,E,Q,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,17:7578239-7578239, hg19,17:7674921-7674921, hg38,17:7674921-7674921","hg19,17:g.7578239C>G, hg19,17:g.7674921C>G, hg38,17:g.7674921C>G",0.458,"haematopoietic_and_lymphoid_tissue, urinary_tract, bladder","carcinoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",,,,,,,,,,,,,,
2493,204,E,R,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2494,204,E,S,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2495,204,E,T,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2496,204,E,V,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578238-7578238, hg38,17:7674920-7674920","hg19,17:g.7578238T>A, hg38,17:g.7674920T>A",0.588,"autonomic_ganglia, ovary","carcinoma, serous_carcinoma, neuroblastoma",,,,,1751713,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2497,204,E,W,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2498,204,E,Y,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2499,205,Y,A,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2500,205,Y,C,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2023, blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_msk_tcga_2020, blca_plasmacytoid_mskcc_2016, brca_cptac_2020, brca_mapk_hp_msk_2021, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, chrcc_tcga_gdc, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, cscc_dfarber_2015, csf_msk_2024, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, escc_ucla_2014, gbc_mskcc_2022, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, hcc_tcga_gdc, hgsoc_msk_2021, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, ihch_smmu_2014, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lgggbm_tcga_pub, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_cas_2020, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, makeanimpact_ccr_2023, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_mskcc_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pptc_2019, prad_msk_stopsack_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_tcga_gdc, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub, tmb_mskcc_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Chromophobe Renal Cell Carcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578235-7578235, hg19,17:7674917-7674917, hg38,17:7674917-7674917","hg19,17:g.7578235T>C, hg19,17:g.7674917T>C, hg38,17:g.7674917T>C",0.873,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, bone, tibia, breast, central_nervous_system, brain, central_nervous_system, temporoparietal, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, sigmoid, large_intestine, rectum, large_intestine, right, liver, lung, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, skin, skin, head_neck, skin, mucosal, oral_cavity, small_intestine, duodenum, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, glottis, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, urinary_tract, bladder, urinary_tract, ureter, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, squamous_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, pleomorphic, carcinoma, medullary_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, spindle_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_II, pleomorphic_xanthoastrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, lymphoid_neoplasm, B_cell_prolymphocytic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_melanoma, nodular, osteosarcoma, other, dysplasia-carcinoma_in_situ, other, dysplasia-in_situ_neoplasm, other, neoplasm",,,,,376681,Pathogenic,TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2501,205,Y,D,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, coadread_tcga_pan_can_atlas_2018, escc_ucla_2014, hcc_msk_2024, mbn_mdacc_2013, mds_iwg_2022, mds_mskcc_2020, mm_broad, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, ohnca_cptac_gdc, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_organoids_msk_2022, prad_pik3r1_msk_2021, read_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Head and Neck Carcinoma, Other, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Plasma Cell Myeloma, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7578236-7578236, hg19,17:7674918-7674918, hg38,17:7674918-7674918","hg19,17:g.7578236A>C, hg19,17:g.7674918A>C, hg38,17:g.7674918A>C",0.925,", breast, central_nervous_system, cerebellum, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, rectum, lung, oesophagus, ovary, pancreas, prostate, skin, leg, soft_tissue, blood_vessel, head_neck, stomach, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, urinary_tract, bladder","angiosarcoma, carcinoid-endocrine_tumour, goblet_cell, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, M0, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, M4, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, granulocytic_sarcoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, keratosis",,,,,376686,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,2,,,,,,
2502,205,Y,E,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2503,205,Y,F,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, bm_nsclc_mskcc_2023, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, chl_sccc_2023, crc_eo_2020, csf_msk_2024, egc_tmucih_2015, lihc_amc_prv, luad_mskcc_2023_met_organotropism, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024","Bladder Urothelial Carcinoma, Bowel, Breast, Classical Hodgkin Lymphoma, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma","hg19,17:7578235-7578235, hg19,17:7674917-7674917, hg38,17:7674917-7674917","hg19,17:g.7578235T>A, hg19,17:g.7674917T>A, hg38,17:g.7674917T>A",0.823,"breast, haematopoietic_and_lymphoid_tissue, lung, pancreas, prostate, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, small_cell_carcinoma, gastrointestinal_stromal_tumour, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
2504,205,Y,G,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2505,205,Y,H,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2022, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, chol_msk_2018, cll_broad_2022, crc_eo_2020, crc_sysucc_2022, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, hcc_msk_2024, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, mbn_sfu_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Acute Myeloid Leukemia, Bowel, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578236-7578236, hg19,17:7674918-7674918, hg38,17:7674918-7674918","hg19,17:g.7578236A>G, hg19,17:g.7674918A>G, hg38,17:g.7674918A>G",0.900,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, large_intestine, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, soft_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, rectum, lung, oesophagus, pancreas, prostate, stomach, testis, vulva","carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, sarcomatoid_renal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, mixed, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000000000000000,,,,376685,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Likely oncogenic,Neoplasm,1,,,
2506,205,Y,I,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2507,205,Y,K,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2508,205,Y,L,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2509,205,Y,M,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2510,205,Y,N,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, crc_orion_2024, dlbcl_duke_2017, heme_msk_impact_2022, mbn_mdacc_2013, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, pancan_pcawg_2020, pediatric_dkfz_2017, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Bowel, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578236-7578236, hg19,17:7674918-7674918, hg38,17:7674918-7674918","hg19,17:g.7578236A>T, hg19,17:g.7674918A>T, hg38,17:g.7674918A>T",0.897,"biliary_tract, gallbladder, breast, endometrium, haematopoietic_and_lymphoid_tissue, ovary, upper_aerodigestive_tract, larynx","carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma",,,,,376684,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2511,205,Y,P,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2512,205,Y,Q,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2513,205,Y,R,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2514,205,Y,S,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, breast_msk_2018, breast_msk_2025, ccle_genentech_2014, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, difg_tcga_gdc, dlbcl_duke_2017, hcc_msk_2024, hcc_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, mbl_dkfz_2017, mbl_icgc, mbl_sickkids_2016, mds_iwg_2022, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_pcawg_2020, pediatric_dkfz_2017, read_tcga_gdc","Bowel, Breast, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Medulloblastoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreatic Adenocarcinoma, Rectal Adenocarcinoma","hg19,17:7578235-7578235, hg19,17:7674917-7674917, hg38,17:7674917-7674917","hg19,17:g.7578235T>G, hg19,17:g.7674917T>G, hg38,17:g.7674917T>G",0.852,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, oesophagus, ovary, pancreas, skin, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, lobular_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, mixed, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm, primitive_neuroectodermal_tumour-medulloblastoma, large_cell",,,,,3634430,Uncertain significance,Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
2515,205,Y,T,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2516,205,Y,V,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2517,205,Y,W,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2518,206,L,A,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2519,206,L,C,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2520,206,L,D,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2521,206,L,E,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2522,206,L,F,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578231-7578231, hg38,17:7674913-7674913","hg19,17:g.7578231C>G, hg38,17:g.7674913C>G",0.421,breast,carcinoma,,,,,3972452,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2523,206,L,G,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2524,206,L,H,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2525,206,L,I,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2526,206,L,K,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2527,206,L,M,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2528,206,L,N,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2529,206,L,P,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2530,206,L,Q,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2531,206,L,R,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2532,206,L,S,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578232-7578232, hg38,17:7674914-7674914","hg19,17:g.7578232A>G, hg38,17:g.7674914A>G",0.605,,,,,,,439319,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome,1,,,,,,
2533,206,L,T,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2534,206,L,V,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2535,206,L,W,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578232-7578232, hg38,17:7674914-7674914","hg19,17:g.7578232A>C, hg38,17:g.7674914A>C",0.526,,,,,,,2679229,Uncertain significance,"Adrenocortical carcinoma, hereditary",1,,,,,,
2536,206,L,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2537,207,D,A,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674911-7674911","hg38,17:g.7674911T>G",0.518,"large_intestine, liver","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma",,,,,,,,,,,,,,
2538,207,D,C,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2539,207,D,E,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578228-7578228, hg38,17:7674910-7674910","hg19,17:g.7578228A>C, hg38,17:g.7674910A>C, hg38,17:g.7674910A>T","0.435, 0.436",stomach,"carcinoma, adenocarcinoma",,,,,3809687,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
2540,207,D,F,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2541,207,D,G,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7578229-7578229, hg38,17:7674911-7674911","hg19,17:g.7578229T>C, hg38,17:g.7674911T>C",0.616,"breast, haematopoietic_and_lymphoid_tissue, thyroid","carcinoma, carcinoma, poorly_differentiated_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia",,,,,3972466,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2542,207,D,H,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7578230-7578230, hg38,17:7674912-7674912","hg19,17:g.7578230C>G, hg38,17:g.7674912C>G",0.538,,,,,,,919639,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2543,207,D,I,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2544,207,D,K,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2545,207,D,L,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2546,207,D,M,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2547,207,D,N,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","cfdna_msk_2019, coadread_tcga, coadread_tcga_pub","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7578230-7578230, hg38,17:7674912-7674912","hg19,17:g.7578230C>T, hg38,17:g.7674912C>T",0.406,,,,,,,2969522,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
2548,207,D,P,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2549,207,D,Q,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2550,207,D,R,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2551,207,D,S,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2552,207,D,T,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2553,207,D,V,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2554,207,D,W,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2555,207,D,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 192-207, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",blca_iatlas_imvigor210_2017,Bladder Urothelial Carcinoma,"hg19,17:7674912-7674912, hg38,17:7674912-7674912","hg19,17:g.7674912C>A, hg38,17:g.7674912C>A",0.606,"biliary_tract, gallbladder, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
2556,208,D,A,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578226-7578226, hg38,17:7674908-7674908","hg19,17:g.7578226T>G, hg38,17:g.7674908T>G",0.931,stomach,"carcinoma, intestinal_adenocarcinoma",,,,,2759300,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2557,208,D,C,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2558,208,D,E,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,17:7578225-7578225, hg38,17:7674907-7674907","hg19,17:g.7578225G>C, hg19,17:g.7578225G>T, hg38,17:g.7674907G>C, hg38,17:g.7674907G>T",0.767,"breast, central_nervous_system, brain, lung, pancreas","carcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic",,,,,3972451,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
2559,208,D,F,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2560,208,D,G,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, coad_silu_2022, difg_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, mbn_mdacc_2013, mbn_sfu_2023, msk_chord_2024, msk_ctdna_vte_2024, pan_origimed_2020, pancan_mappyacts_2022, pancan_pcawg_2020, prad_mcspc_mskcc_2020, sarcoma_msk_2022","Colon Adenocarcinoma, Diffuse Glioma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578226-7578226, hg19,17:7674908-7674908, hg38,17:7674908-7674908","hg19,17:g.7578226T>C, hg19,17:g.7674908T>C, hg38,17:g.7674908T>C",0.944,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, skin, large_intestine, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,584922,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2561,208,D,H,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578227-7578227, hg38,17:7674909-7674909","hg19,17:g.7578227C>G, hg38,17:g.7674909C>G",0.930,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,826261,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
2562,208,D,I,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674908-7674909","hg38,17:g.7674908_7674909delinsAT",,ovary,"carcinoma, serous_carcinoma",,,,,,,,,,,,,,
2563,208,D,K,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2564,208,D,L,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2565,208,D,M,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2566,208,D,N,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7578227-7578227, hg19,17:7674909-7674909, hg38,17:7674909-7674909","hg19,17:g.7578227C>T, hg19,17:g.7674909C>T, hg38,17:g.7674909C>T",0.760,"breast, large_intestine, appendix, large_intestine, colon, lung, pancreas, small_intestine, ileum, stomach, urinary_tract, bladder","carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",,,,,1752332,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
2567,208,D,P,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2568,208,D,Q,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2569,208,D,R,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2570,208,D,S,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2571,208,D,T,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2572,208,D,V,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mapk_hp_msk_2021, brca_metabric, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, cfdna_msk_2019, cll_broad_2022, difg_glass, difg_glass_2019, dlbcl_duke_2017, hgsoc_tcga_gdc, ihch_smmu_2014, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_unito_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucs_msk_2024","Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578226-7578226, hg19,17:7674908-7674908, hg38,17:7674908-7674908","hg19,17:g.7578226T>A, hg19,17:g.7674908T>A, hg38,17:g.7674908T>A",0.950,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, liver, lung, ovary, pancreas, prostate, stomach, thyroid, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, oligodendroglioma_Grade_II, glioma, oligodendroglioma_Grade_III, anaplastic, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, pterygium",,,,,1036023,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
2573,208,D,W,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2574,208,D,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 205-208, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7578227-7578227, hg38,17:7674909-7674909","hg19,17:g.7578227C>A, hg38,17:g.7674909C>A",0.943,"central_nervous_system, brain, large_intestine, skin, trunk, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,1350980,Conflicting classifications of pathogenicity,Lung adenocarcinoma;Li-Fraumeni syndrome,1,,,,,,
2575,209,R,A,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2576,209,R,C,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2577,209,R,D,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2578,209,R,E,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2579,209,R,F,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2580,209,R,G,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578224-7578224, hg38,17:7674906-7674906","hg19,17:g.7578224T>C, hg38,17:g.7674906T>C",0.635,"skin, face","carcinoma, squamous_cell_carcinoma",,,,,627819,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2581,209,R,H,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2582,209,R,I,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,17:7578223-7578223, hg19,17:7674905-7674905, hg38,17:7674905-7674905","hg19,17:g.7578223C>A, hg19,17:g.7674905C>A, hg38,17:g.7674905C>A",0.532,"breast, endometrium, thyroid, upper_aerodigestive_tract, head_neck","carcinoma, ER-positive_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, papillary_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2583,209,R,K,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, paired_bladder_2022, pancan_pdmr_2025, stes_tcga_pub, tmb_mskcc_2018","Bladder/Urinary Tract, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578223-7578223, hg19,17:7674905-7674905, hg38,17:7674905-7674905","hg19,17:g.7578223C>T, hg19,17:g.7674905C>T, hg38,17:g.7674905C>T",0.453,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, lung, oesophagus, skin, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, superficial_spreading",,,,,962629,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Familial cancer of breast,1,,,,,,
2584,209,R,L,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2585,209,R,M,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2586,209,R,N,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2587,209,R,P,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2588,209,R,Q,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2589,209,R,S,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578222-7578222, hg38,17:7674904-7674904","hg19,17:g.7578222T>A, hg19,17:g.7578222T>G, hg38,17:g.7674904T>A, hg38,17:g.7674904T>G",0.588,"lung, urinary_tract, bladder","carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,2450746,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome",1,,,,,,
2590,209,R,T,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","luad_cas_2020, msk_met_2021, paired_bladder_2022, utuc_igbmc_2021","Bladder/Urinary Tract, Lung Adenocarcinoma, Mixed Cancer Types, Upper Tract Urothelial Carcinoma","hg19,17:7578223-7578223, hg38,17:7674905-7674905","hg19,17:g.7578223C>G, hg38,17:g.7674905C>G",0.503,"cervix, haematopoietic_and_lymphoid_tissue, soft_tissue, striated_muscle","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, rhabdomyosarcoma, pleomorphic",,,,,,,,,,,,,,
2591,209,R,V,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2592,209,R,W,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2593,209,R,Y,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2594,210,N,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2595,210,N,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2596,210,N,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674903-7674903","hg38,17:g.7674903T>C",0.300,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
2597,210,N,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2598,210,N,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2599,210,N,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2600,210,N,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",sarcoma_msk_2022,Soft Tissue,"hg19,17:7578221-7578221, hg38,17:7674903-7674903","hg19,17:g.7578221T>G, hg38,17:g.7674903T>G",0.340,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2601,210,N,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2602,210,N,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674901-7674901","hg38,17:g.7674901G>C",0.369,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
2603,210,N,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2604,210,N,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2605,210,N,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2606,210,N,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2607,210,N,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2608,210,N,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578220-7578220, hg38,17:7674902-7674902","hg19,17:g.7578220T>C, hg38,17:g.7674902T>C",0.262,"breast, liver","carcinoma, carcinoma, hepatocellular_carcinoma",,,,,3232058,Likely benign,Hereditary cancer-predisposing syndrome;TP53-related disorder,1,,,,,,
2609,210,N,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674902-7674902","hg38,17:g.7674902T>G",0.380,breast,carcinoma,,,,,,,,,,,,,,
2610,210,N,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2611,210,N,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2612,210,N,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578221-7578221, hg38,17:7674903-7674903","hg19,17:g.7578221T>A, hg38,17:g.7674903T>A",0.480,,,,,,,406588,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2613,211,T,A,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_cptac_2019, lihc_amc_prv, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_met_2021, nsclc_ctdx_msk_2022, pancan_mimsi_msk_2024, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Colon Adenocarcinoma, Endometrial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578218-7578218, hg19,17:7674900-7674900, hg38,17:7674900-7674900","hg19,17:g.7578218T>C, hg19,17:g.7674900T>C, hg38,17:g.7674900T>C",0.881,"endometrium, large_intestine, lung, oesophagus, lower_third, soft_tissue, smooth_muscle, uterus, thymus, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma, leiomyosarcoma, thymoma",,,,,406581,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2614,211,T,C,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2615,211,T,D,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2616,211,T,E,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2617,211,T,F,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2618,211,T,G,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2619,211,T,H,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2620,211,T,I,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_tcga_gdc, coadread_cass_2020, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_sysucc_2022, difg_glass, difg_glass_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, glioma_mskcc_2019, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgggbm_tcga_pub, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, mel_mskimpact_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, normal_skin_keratinocytes_2024, paad_qcmg_uq_2016, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pdac_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucs_msk_2024","Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Skin, Soft Tissue","hg19,17:7578217-7578217, hg19,17:7674899-7674899, hg38,17:7674899-7674899","hg19,17:g.7578217G>A, hg19,17:g.7674899G>A, hg38,17:g.7674899G>A",0.944,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, colon, left, large_intestine, colon, sigmoid, large_intestine, colon, transverse, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, skin, face, soft_tissue, fibrous_tissue_and_uncertain_origin, breast, soft_tissue, fibrous_tissue_and_uncertain_origin, buttock, stomach, upper_aerodigestive_tract, head_neck","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, hyperplasia, solitary_fibrous_tumour, malignant, undifferentiated_sarcoma, pleomorphic",,,,,1503185,Conflicting classifications of pathogenicity,not provided;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2621,211,T,K,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2622,211,T,L,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2623,211,T,M,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2624,211,T,N,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,17:7578217-7578217, hg38,17:7674899-7674899","hg19,17:g.7578217G>T, hg38,17:g.7674899G>T",0.756,"bone, haematopoietic_and_lymphoid_tissue, lymph_node, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm",,,,,,,,,,,,,,
2625,211,T,P,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2024, brca_igr_2015, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021","Bladder/Urinary Tract, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7578218-7578218, hg38,17:7674900-7674900","hg19,17:g.7578218T>G, hg38,17:g.7674900T>G",0.911,"breast, large_intestine, liver, lung","carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, other, neoplasm",,,,,528235,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
2626,211,T,Q,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2627,211,T,R,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2628,211,T,S,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578217-7578217, hg38,17:7674899-7674899","hg19,17:g.7578217G>C, hg38,17:g.7674899G>C",0.753,"large_intestine, colon","carcinoma, adenocarcinoma",,,,,1019369,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2629,211,T,V,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2630,211,T,W,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2631,211,T,Y,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2632,212,F,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2633,212,F,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_ch_2020, msk_ch_2023, prad_mskcc_cheny1_organoids_2014","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,17:7578214-7578214","hg19,17:g.7578214A>C",0.647,,,,,,,,,,,,,,,,
2634,212,F,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2635,212,F,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2636,212,F,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2637,212,F,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2638,212,F,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, sarcoma_msk_2022","Basal Cell Carcinoma, Soft Tissue","hg19,17:7578215-7578215, hg38,17:7674897-7674897","hg19,17:g.7578215A>T, hg38,17:g.7674897A>T",0.478,"breast, haematopoietic_and_lymphoid_tissue, skin","carcinoma, carcinoma, basal_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia",,,,,422414,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
2639,212,F,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2640,212,F,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674895-7674895, hg38,17:7674897-7674897","hg38,17:g.7674895A>T, hg38,17:g.7674897A>G","0.481, 0.489","haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, MALT_lymphoma",,,,,,,,,,,,,,
2641,212,F,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2642,212,F,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2643,212,F,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2644,212,F,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2645,212,F,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2646,212,F,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578214-7578214, hg38,17:7674896-7674896","hg19,17:g.7578214A>G, hg38,17:g.7674896A>G",0.554,breast,carcinoma,,,,,3460339,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
2647,212,F,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2648,212,F,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","breast_msk_2018, breast_msk_2025, msk_chord_2024, msk_met_2021, paired_bladder_2022, pancan_pcawg_2020, rectal_msk_2019","Bladder/Urinary Tract, Breast, Colorectal Adenocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7578215-7578215, hg38,17:7674897-7674897","hg19,17:g.7578215A>C, hg38,17:g.7674897A>C",0.471,"breast, large_intestine, liver, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
2649,212,F,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2650,212,F,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pancan_mimsi_msk_2024,Mixed Cancer Types,"hg19,17:7578214-7578214, hg38,17:7674896-7674896","hg19,17:g.7578214A>T, hg38,17:g.7674896A>T",0.395,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
2651,213,R,A,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2652,213,R,C,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2653,213,R,D,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2654,213,R,E,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2655,213,R,F,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2656,213,R,G,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, blca_msk_tcga_2020, ccle_broad_2025, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_sfu_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nccrcc_genentech_2014, nsclc_tcga_broad_2016, paired_bladder_2022, sarcoma_msk_2022, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Renal Non-Clear Cell Carcinoma, Soft Tissue","hg19,17:7578212-7578212, hg19,17:7674894-7674894, hg38,17:7674894-7674894","hg19,17:g.7578212G>C, hg19,17:g.7674894G>C, hg38,17:g.7674894G>C",0.915,", central_nervous_system, brain, kidney, liver, lung, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, of_unknown_primary, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, malignant_melanoma",,,,,376651,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2657,213,R,H,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2658,213,R,I,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2659,213,R,K,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2660,213,R,L,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bgi, blca_iatlas_imvigor210_2017, blca_msk_tcga_2020, brain_cptac_2020, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, escc_icgc, hcc_clca_2024, hcc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, nbl_target_gdc, nccrcc_genentech_2014, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, paad_cptac_2021, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, pog570_bcgsc_2020, prad_mich, rectal_msk_2022, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, CNS/Brain, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Neuroblastoma, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Renal Non-Clear Cell Carcinoma, Soft Tissue","hg19,17:7578211-7578211, hg19,17:7674892-7674893, hg19,17:7674893-7674893, hg38,17:7674892-7674893, hg38,17:7674893-7674893","hg19,17:g.7578211C>A, hg19,17:g.7674892_7674893delinsCA, hg19,17:g.7674893C>A, hg38,17:g.7674892_7674893delinsCA, hg38,17:g.7674893C>A",0.929,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, thalamus, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, spleen, kidney, large_intestine, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, upper_arm, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, retromolar_trigone, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, classic, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, gastrointestinal_stromal_tumour, glioma, astrocytoma_Grade_II, fibrillary, glioma, oligoastrocytoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, superficial_spreading, other, neoplasm, other, pterygium",,,,,376650,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
2661,213,R,M,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2662,213,R,N,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2663,213,R,P,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2023, bladder_msk_2024, difg_glass, difg_glass_2019, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, lgg_ucsf_2014, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, pancan_pcawg_2020, pancan_pdmr_2025, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, soft_tissue_tcga_gdc, utuc_msk_2019, utuc_pdx_msk_2019","Basal Cell Carcinoma, Bladder/Urinary Tract, Diffuse Glioma, Head and Neck Squamous Cell Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue, Upper Tract Urothelial Carcinoma","hg19,17:7578211-7578211, hg19,17:7674893-7674893, hg38,17:7674893-7674893","hg19,17:g.7578211C>G, hg19,17:g.7674893C>G, hg38,17:g.7674893C>G",0.951,"eye, conjunctiva, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, left, liver, oesophagus, ovary, skin, soft_tissue, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, other, pterygium, sarcoma",,,,,231214,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Oncogenic,Neoplasm,1,,,
2664,213,R,Q,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ampca_bcm_2016, bcc_unige_2016, bladder_msk_2023, bladder_msk_2024, blca_dfarber_mskcc_2014, blca_iatlas_imvigor210_2017, blca_msk_2025, blca_msk_tcga_2020, blca_plasmacytoid_mskcc_2016, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bowel_colitis_msk_2022, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, ccrcc_tcga_gdc, cellline_ccle_broad, cll_broad_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_orion_2024, crc_sysucc_2022, csf_msk_2024, difg_msk_2023, difg_tcga_gdc, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, egc_tmucih_2015, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_tcga_gdc, ihch_msk_2021, ihch_mskcc_2020, kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_cas_2020, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, lymphoma_cellline_msk_2020, mbn_mdacc_2013, mbn_msk_2024, mbn_sfu_2023, mcl_idibips_2013, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, npc_nusingapore, paad_cptac_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_cptac_gdc, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, read_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_msk_2024, uec_cptac_gdc, usarc_msk_2020","Adenoid Cystic Carcinoma, Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lymphoid, Mantle Cell Lymphoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Nasopharyngeal Carcinoma, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue, Uterine Endometrioid Carcinoma, Uterine Sarcoma/Mesenchymal","hg19,17:7578210-7578211, hg19,17:7578211-7578211, hg19,17:7674893-7674893, hg38,17:7674892-7674893, hg38,17:7674893-7674893","hg19,17:g.7578210_7578211delinsCT, hg19,17:g.7578211C>T, hg19,17:g.7674893C>T, hg38,17:g.7674892_7674893delinsCT, hg38,17:g.7674893C>T",0.920,", biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, central_nervous_system, brain, central_nervous_system, superior_frontal_gyrus, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, anorectal, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, prostate, skin, small_intestine, duodenum, soft_tissue, fibrous_tissue_and_uncertain_origin, kidney, soft_tissue, fibrous_tissue_and_uncertain_origin, knee, soft_tissue, fibrous_tissue_and_uncertain_origin, liver, soft_tissue, smooth_muscle, uterus, stomach, thymus, thyroid, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, maxilla, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, urinary_tract, bladder, vulva","adenoma, villous, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal_type, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, fibrosarcoma, fibrosarcoma, myxofibrosarcoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, M6, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, malignant_melanoma, other, metaplasia, epidermoid, other, neoplasm, primitive_neuroectodermal_tumour-medulloblastoma, sarcoma, thymic_carcinoma",0.0000039767440011,,,,135359,Pathogenic/Likely pathogenic,"TP53-related disorder;Lip and oral cavity carcinoma;Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;not specified;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Poly (ADP-Ribose) polymerase inhibitor response",2,Oncogenic,Neoplasm,1,Tier I - Strong,Adrenal cortex carcinoma;Embryonal rhabdomyosarcoma,1
2665,213,R,S,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2666,213,R,T,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2667,213,R,V,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2668,213,R,W,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","heme_msk_impact_2022, mds_mskcc_2020, pancan_pdmr_2025","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7578210-7578212, hg38,17:7674892-7674894","hg19,17:g.7578210_7578212delinsCCA, hg38,17:g.7674892_7674894delinsCCA",,"central_nervous_system, brain, large_intestine, rectum, ovary, pancreas, stomach, gastroesophageal_junction","carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,3460335,Pathogenic,Hereditary cancer-predisposing syndrome,1,,,,,,
2669,213,R,Y,,Me,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 209-213, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2670,214,H,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
2671,214,H,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2672,214,H,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","cll_broad_2022, lung_msk_mind_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Lung, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578209-7578209, hg38,17:7674891-7674891","hg19,17:g.7578209G>C, hg38,17:g.7674891G>C",0.844,"bone, pelvis, breast, central_nervous_system, brain, lung, pancreas, thyroid","adenoma-nodule-goitre, carcinoma, carcinoma, ductal_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, non_small_cell_carcinoma, chondrosarcoma, dedifferentiated, glioma, astrocytoma",,,,,,,,,,,,,,
2673,214,H,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2674,214,H,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2675,214,H,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2676,214,H,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2677,214,H,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2678,214,H,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, luad_mskcc_2023_met_organotropism, lung_msk_pdx, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020","Chromophobe Renal Cell Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7578208-7578208, hg38,17:7674890-7674890","hg19,17:g.7578208T>A, hg38,17:g.7674890T>A",0.869,"kidney, lung, oesophagus, peritoneum","carcinoma, adenocarcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, mesothelioma, epithelial",,,,,376616,Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
2679,214,H,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2680,214,H,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578209-7578209, hg38,17:7674891-7674891","hg19,17:g.7578209G>T, hg38,17:g.7674891G>T",0.735,,,,,,,230254,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2681,214,H,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_ch_2023, msk_impact_2017, sarcoma_mskcc_2022, sft_sysucc_2023, usarc_msk_2020","Mixed Cancer Types, Soft Tissue, Uterine Sarcoma/Mesenchymal","hg19,17:7578208-7578208, hg38,17:7674890-7674890","hg19,17:g.7578208T>G, hg38,17:g.7674890T>G",0.932,"soft_tissue, smooth_muscle, endometrium, stomach","carcinoma, adenocarcinoma, leiomyosarcoma",0.0000000000000000,,,,643078,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2682,214,H,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_impact_2017,Mixed Cancer Types,"hg19,17:7578207-7578207, hg38,17:7674889-7674889","hg19,17:g.7578207A>C, hg38,17:g.7674889A>C, hg38,17:g.7674889A>T",0.550,"cervix, haematopoietic_and_lymphoid_tissue, large_intestine, haematopoietic_and_lymphoid_tissue, soft_tissue, large_intestine, ovary","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000318134459529,,,,140943,Conflicting classifications of pathogenicity,Hereditary cancer;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2683,214,H,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, appendiceal_msk_2022, bcc_unige_2016, blca_bcan_hcrn_2022, blca_msk_tcga_2020, blca_plasmacytoid_mskcc_2016, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_mbcproject_2022, brca_metabric, brca_mskcc_2019, breast_alpelisib_2020, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cfdna_msk_2019, cll_broad_2015, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, egc_tmucih_2015, esca_broad, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, glioma_mskcc_2019, heme_msk_impact_2022, hgsoc_msk_2021, hgsoc_tcga_gdc, lcll_broad_2013, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_riken, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_mdacc_2013, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, mpcproject_broad_2021, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_tracerx_2017, nsclc_unito_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, paad_tcga, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_jhu, sclc_ucologne_2015, soft_tissue_tcga_gdc, stad_oncosg_2018, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_tcga_pan_can_atlas_2018","Adenoid Cystic Carcinoma, Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Thyroid","hg19,17:7578208-7578208, hg19,17:7674890-7674890, hg38,17:7674890-7674890","hg19,17:g.7578208T>C, hg19,17:g.7674890T>C, hg38,17:g.7674890T>C",0.885,"biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, cerebellum, central_nervous_system, frontal_lobe, central_nervous_system, occipital_lobe, central_nervous_system, spinal_cord, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, caecum, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, lung, left, oesophagus, oesophagus, lower_third, ovary, pancreas, pleura, prostate, salivary_gland, parotid, skin, skin, mucosal, vagina, small_intestine, soft_tissue, soft_tissue, fat, shoulder, soft_tissue, fibrous_tissue_and_uncertain_origin, pleura, soft_tissue, upper_leg, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, urinary_tract, urinary_tract, bladder, urinary_tract, renal_pelvis","adenoma, tubular, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, acinar_adenocarcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_acinar-neuroendocrine_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, non_small_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_adenocarcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_II, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_of_childhood, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia_with_ringed_sideroblasts, liposarcoma, dedifferentiated, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, mesothelioma, mesothelioma, epithelial, other, metaplasia, epidermoid, other, neoplasm, sarcoma, solitary_fibrous_tumour, undifferentiated-unclassified_sarcoma, epithelioid_cell",,,,,376615,Pathogenic,Li-Fraumeni syndrome;Bone marrow failure syndrome 5;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1,3,Oncogenic,Neoplasm,1,,,
2684,214,H,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2685,214,H,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2686,214,H,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2687,214,H,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2688,214,H,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","cscc_ucsf_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, nsclc_ctdx_msk_2022, pan_origimed_2020, sarcoma_msk_2022","Cutaneous Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578209-7578209, hg19,17:7578209-7578210, hg38,17:7674891-7674891, hg38,17:7674891-7674892","hg19,17:g.7578209G>A, hg19,17:g.7578209_7578210inv, hg38,17:g.7674891G>A, hg38,17:g.7674891_7674892inv",0.736,"adrenal_gland, adrenal_gland, autonomic_ganglia, sinonasal_and_nasal_cavity, breast, skin, chest, soft_tissue, fat, abdomen, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, liposarcoma, myxoid-round_cell, olfactory_neuroblastoma",,,,,"4530422, 1053808",Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,Tier I - Strong,Embryonal rhabdomyosarcoma,1
2689,215,S,A,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2690,215,S,C,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, crc_apc_impact_2020, escc_ucla_2014, msk_chord_2024, msk_impact_2017, msk_met_2021, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, tmb_mskcc_2018","Colorectal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578206-7578206, hg19,17:7674888-7674888, hg38,17:7674888-7674888","hg19,17:g.7578206T>A, hg19,17:g.7674888T>A, hg38,17:g.7674888T>A",0.902,"breast, haematopoietic_and_lymphoid_tissue, oesophagus, ovary, prostate, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,1753522,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2691,215,S,D,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2692,215,S,E,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2693,215,S,F,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2694,215,S,G,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, ccle_broad_2019, ccle_broad_2025, cll_iuopa_2015, coadread_dfci_2016, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, hcc_clca_2024, hcc_inserm_fr_2015, heme_msk_impact_2022, hnc_mskcc_2016, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, mixed_allen_2018, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_tracerx_2017, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, pog570_bcgsc_2020, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Acute Myeloid Leukemia, Bowel, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Soft Tissue","hg19,17:7578206-7578206, hg19,17:7674888-7674888, hg38,17:7674888-7674888","hg19,17:g.7578206T>C, hg19,17:g.7674888T>C, hg38,17:g.7674888T>C",0.896,"biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, pancreas, salivary_gland, salivary_gland, major, skin, eye, thyroid, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,265337,Conflicting classifications of pathogenicity,not specified;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Ovarian neoplasm,1,,,,Tier I - Strong,"Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype",1
2695,215,S,H,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2696,215,S,I,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, bcc_unige_2016, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_cass_2020, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, csf_msk_2024, escc_ucla_2014, glioma_mskcc_2019, hcc_tcga_gdc, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_broad, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tsp, lung_msk_2017, lung_msk_mind_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, read_tcga_gdc, sarcoma_msk_2022, sclc_jhu, sclc_ucologne_2015, tmb_mskcc_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578205-7578205, hg19,17:7674887-7674887, hg38,17:7674887-7674887","hg19,17:g.7578205C>A, hg19,17:g.7674887C>A, hg38,17:g.7674887C>A",0.913,", breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, left_upper_lobe, oesophagus, oesophagus, middle_third, ovary, pancreas, prostate, skin, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, urinary_tract","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, other, neoplasm",,,,,376660,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome,1,,,,,,
2697,215,S,K,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2698,215,S,L,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2699,215,S,M,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2700,215,S,N,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, bcc_unige_2016, blca_msk_tcga_2020, brca_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, coad_cptac_2019, coad_cptac_gdc, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, hcc_clca_2024, hcc_tcga_gdc, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_iwg_2022, mel_mskimpact_2020, mixed_pipseq_2017, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, nsclc_unito_2016, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, rectal_msk_2019, rectal_msk_2022","Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma","hg19,17:7578205-7578205, hg19,17:7674887-7674887, hg38,17:7674887-7674887","hg19,17:g.7578205C>T, hg19,17:g.7674887C>T, hg38,17:g.7674887C>T",0.785,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, central_nervous_system, brain, large_intestine, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, pancreas, prostate, skin, small_intestine, ileum, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, malignant_melanoma",,,,,376662,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;not specified;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome",1,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
2701,215,S,P,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2702,215,S,Q,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2703,215,S,R,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, brain_cptac_gdc, brca_mbcproject_2022, brca_metabric, brca_tcga_pub, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_dfci_2016, crc_eo_2020, crc_msk_2017, egc_msk_2023, esca_broad, heme_msk_impact_2022, hgsoc_tcga_gdc, ihch_msk_2021, ihch_mskcc_2020, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, mbn_mdacc_2013, mbn_sfu_2023, mds_mskcc_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_pd1_msk_2018, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, skcm_dfci_2015, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, soft_tissue_tcga_gdc, stad_oncosg_2018, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Acute Myeloid Leukemia, Bowel, Breast, CNS/Brain, Colorectal Adenocarcinoma, Cutaneous Melanoma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagus/Stomach, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7578204-7578204, hg19,17:7578206-7578206, hg19,17:7674886-7674886, hg19,17:7674888-7674888, hg38,17:7674886-7674886, hg38,17:7674888-7674888","hg19,17:g.7578204A>C, hg19,17:g.7578204A>T, hg19,17:g.7578206T>G, hg19,17:g.7674886A>C, hg19,17:g.7674886A>T, hg19,17:g.7674888T>G, hg38,17:g.7674886A>C, hg38,17:g.7674886A>T, hg38,17:g.7674888T>G","0.812, 0.917",", autonomic_ganglia, biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, large_intestine, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, small_intestine, large_intestine, large_intestine, colon, large_intestine, colon, descending, large_intestine, rectum, liver, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, prostate, salivary_gland, skin, soft_tissue, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, micropapillary_transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, glioma, astrocytoma_Grade_II, fibrillary, haematopoietic_neoplasm, acute_myeloid_leukaemia, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, Burkitt_lymphoma, sporadic_type, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_melanoma, superficial_spreading, neuroblastoma, sarcoma",,,,,"2020649, 428895, 376661","Conflicting classifications of pathogenicity, Conflicting classifications of pathogenicity, Conflicting classifications of pathogenicity",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;not provided;Ovarian neoplasm;Li-Fraumeni syndrome,"1, 1, 1",Oncogenic,Neoplasm,1,,,
2704,215,S,T,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, luad_msk_npjpo_2021, luad_mskcc_2023_met_organotropism, mbn_sfu_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, sarcoma_msk_2022, summit_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Breast, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Soft Tissue","hg19,17:7578205-7578205, hg19,17:7674887-7674887, hg38,17:7674887-7674887","hg19,17:g.7578205C>G, hg19,17:g.7674887C>G, hg38,17:g.7674887C>G",0.852,"adrenal_gland, adrenal_gland, biliary_tract, gallbladder, breast, central_nervous_system, brain, endometrium, kidney, lung, oesophagus, prostate, urinary_tract, bladder","adrenal_cortical_carcinoma, functioning, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,142012,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2705,215,S,V,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2706,215,S,W,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2707,215,S,Y,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2708,216,V,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674884-7674884","hg38,17:g.7674884A>G",0.961,"lung, small_intestine, ileum, soft_tissue, smooth_muscle, abdomen, upper_aerodigestive_tract, mouth, tongue, urinary_tract, urinary_tract, ureter","carcinoid-endocrine_tumour, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, leiomyosarcoma",,,,,,,,,,,,,,
2709,216,V,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2710,216,V,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2711,216,V,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, sarcoma_msk_2022, stes_tcga_pub","Breast, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578202-7578202, hg19,17:7674884-7674884, hg38,17:7674884-7674884","hg19,17:g.7578202A>T, hg19,17:g.7674884A>T, hg38,17:g.7674884A>T",0.982,"breast, haematopoietic_and_lymphoid_tissue, lymph_node, lung, ovary, skin, hand, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,376672,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2712,216,V,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2713,216,V,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, cscc_hgsc_bcm_2014, gbc_msk_2018, gbc_mskcc_2022, hcc_msk_2024, mel_mskimpact_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, ov_tcga, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, skcm_vanderbilt_mskcc_2015, ucec_ccr_msk_2022","Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas","hg19,17:7578202-7578202, hg19,17:7674884-7674884, hg38,17:7674884-7674884","hg19,17:g.7578202A>C, hg19,17:g.7674884A>C, hg38,17:g.7674884A>C",0.980,"biliary_tract, bile_duct, biliary_tract, gallbladder, large_intestine, colon, large_intestine, colon, descending, oesophagus, ovary, pancreas, skin, skin, face, skin, head_neck, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_roof, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,376671,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
2714,216,V,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2715,216,V,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2716,216,V,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2717,216,V,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, blca_bcan_hcrn_2022, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_eo_2020, difg_tcga_gdc, egc_msk_2023, escc_ucla_2014, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, hcc_mskimpact_2018, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, lung_msk_2017, lusc_tcga_pan_can_atlas_2018, meso_tcga, meso_tcga_pan_can_atlas_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, plmeso_tcga_gdc, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Bowel, Breast, Diffuse Glioma, Esophageal Squamous Cell Carcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578203-7578203, hg19,17:7674885-7674885, hg38,17:7674885-7674885","hg19,17:g.7578203C>A, hg19,17:g.7578203C>G, hg19,17:g.7674885C>A, hg38,17:g.7674885C>A, hg38,17:g.7674885C>G",0.948,", biliary_tract, gallbladder, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, abdomen, large_intestine, liver, lung, oesophagus, ovary, pancreas, prostate, skin, trunk, urinary_tract, bladder, urachus","adnexal_tumour, malignant_adnexal_tumour, carcinoma, carcinoma, acinar_adenocarcinoma, carcinoma, adenocarcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, low_malignant_potential_(borderline)_tumour, mucinous, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant, malignant_melanoma",,,,,"406596, 376670","Conflicting classifications of pathogenicity, Conflicting classifications of pathogenicity",Squamous cell carcinoma of the head and neck;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Ovarian neoplasm;Li-Fraumeni syndrome,"1, 1",,,,,,
2718,216,V,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2022, blca_bcan_hcrn_2022, blca_msk_2025, brain_cptac_gdc, brca_broad, brca_dfci_2020, brca_dldccc_2022, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_tcga_gdc, dlbcl_duke_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gist_msk_2022, gist_msk_2023, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, mbn_mdacc_2013, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mixed_cfdna_msk_2020, mixed_selpercatinib_2020, mnm_washu_2016, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ohnca_cptac_gdc, os_target_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, usarc_msk_2020","Acute Myeloid Leukemia, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gastrointestinal Stromal Tumor, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Osteosarcoma, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Uterine Sarcoma/Mesenchymal","hg19,17:7578203-7578203, hg19,17:7674885-7674885, hg38,17:7674885-7674885","hg19,17:g.7578203C>T, hg19,17:g.7674885C>T, hg38,17:g.7674885C>T",0.956,", biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, large_intestine, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, small_intestine, haematopoietic_and_lymphoid_tissue, soft_tissue, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, penis, pleura, salivary_gland, skin, hand, soft_tissue, fibrous_tissue_and_uncertain_origin, endometrium, soft_tissue, fibrous_tissue_and_uncertain_origin, small_intestine, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, soft_tissue, liver, soft_tissue, smooth_muscle, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, vulva","carcinoid-endocrine_tumour, carcinoid-endocrine_tumour, atypical, carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, medullary_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, endometrial_stromal_sarcoma, gastrointestinal_stromal_tumour, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_leukaemic_transformation_of_essential_thrombocythaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M0, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, M0, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, leiomyosarcoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, mesothelioma, epithelial, osteosarcoma, other, dysplasia-in_situ_neoplasm, undifferentiated_sarcoma, undifferentiated_sarcoma, pleomorphic",,,,,182965,Pathogenic/Likely pathogenic,"not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;not specified;Li-Fraumeni syndrome",2,Oncogenic,Neoplasm,1,,,
2719,216,V,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2720,216,V,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2721,216,V,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2722,216,V,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7578202-7578203","hg19,17:g.7578202_7578203delinsCT",,,,,,,,,,,,,,,,,
2723,216,V,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2724,216,V,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2725,216,V,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2726,216,V,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2727,217,V,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","breast_msk_2025, egc_msk_2023, msk_chord_2024, msk_met_2021, prad_msk_stopsack_2021, prostate_msk_2024","Esophagus/Stomach, Invasive Breast Carcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7578199-7578199, hg38,17:7674881-7674881","hg19,17:g.7578199A>G, hg38,17:g.7674881A>G",0.647,"breast, liver, small_intestine, upper_aerodigestive_tract, mouth","carcinoid-endocrine_tumour, carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2728,217,V,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2729,217,V,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2730,217,V,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021",Mixed Cancer Types,"hg19,17:7578199-7578199, hg38,17:7674881-7674881","hg19,17:g.7578199A>T, hg38,17:g.7674881A>T",0.723,"haematopoietic_and_lymphoid_tissue, lung, stomach","carcinoma, diffuse_adenocarcinoma, carcinoma, small_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
2731,217,V,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2732,217,V,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","brca_cptac_2020, breast_cptac_gdc, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coadread_cass_2020, crc_sysucc_2022, egc_tmucih_2015, gct_msk_2016, msk_access_2021, msk_chord_2024, msk_impact_2017, pancan_pcawg_2020","Breast, Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Testis","hg19,17:7578198-7578199, hg19,17:7578199-7578199, hg19,17:7674881-7674881, hg38,17:7674881-7674881","hg19,17:g.7578198_7578199delinsAC, hg19,17:g.7578199A>C, hg19,17:g.7674881A>C, hg38,17:g.7674881A>C",0.731,"central_nervous_system, brain, genital_tract, extragonadal, mediastinum, oesophagus, oesophagus, middle_third, pancreas, prostate, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, other, Barrett_oesophagus, with_high_grade_dysplasia",,,,,,,,,,,,,,
2733,217,V,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2734,217,V,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2735,217,V,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2736,217,V,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578200-7578200, hg38,17:7674882-7674882","hg19,17:g.7578200C>A, hg19,17:g.7578200C>G, hg38,17:g.7674882C>A",0.544,"central_nervous_system, brain, upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma, glioma, astrocytoma",,,,,1386154,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
2737,217,V,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pancan_mimsi_msk_2024,Mixed Cancer Types,"hg19,17:7578200-7578200, hg38,17:7674882-7674882","hg19,17:g.7578200C>T, hg38,17:g.7674882C>T",0.451,"liver, pancreas","carcinoma, acinar_carcinoma, carcinoma, hepatocellular_carcinoma",0.0000039769970491,,,,183071,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome",1,,,,,,
2738,217,V,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2739,217,V,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2740,217,V,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2741,217,V,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2742,217,V,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2743,217,V,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2744,217,V,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2745,217,V,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 213-217, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2746,218,V,A,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674878-7674878","hg38,17:g.7674878A>G",0.974,"liver, lung, upper_aerodigestive_tract, mouth, urinary_tract, ureter","carcinoma, hepatocellular_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, other, dysplasia-carcinoma_in_situ",,,,,,,,,,,,,,
2747,218,V,C,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2748,218,V,D,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2749,218,V,E,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_mbcproject_2022, brca_mbcproject_wagle_2017, breast_msk_2018, breast_msk_2025, coad_cptac_2019, coad_cptac_gdc, msk_chord_2024, msk_met_2021, ohnca_cptac_gdc, pan_origimed_2020, pdac_msk_2024, rectal_msk_2022, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Bowel, Breast, Colon Adenocarcinoma, Head and Neck Carcinoma, Other, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas, Soft Tissue","hg19,17:7578196-7578196, hg19,17:7674878-7674878, hg38,17:7674878-7674878","hg19,17:g.7578196A>T, hg19,17:g.7674878A>T, hg38,17:g.7674878A>T",0.977,"breast, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, oesophagus, ovary, pancreas, skin, face, stomach, upper_aerodigestive_tract, mouth, urinary_tract, bladder","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma, other, intraepithelial_neoplasia, high_grade",,,,,1754112,Likely pathogenic,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,2,Likely oncogenic,Neoplasm,1,,,
2750,218,V,F,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2751,218,V,G,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, cscc_dfarber_2015, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_cptac_2020, luad_cptac_gdc, mbn_msk_2024, mds_iwg_2022, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_hcmi_2025, pog570_bcgsc_2020, rectal_msk_2022, sarcoma_msk_2022, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Basal Cell Carcinoma, Bowel, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7578196-7578196, hg19,17:7674878-7674878, hg38,17:7674878-7674878","hg19,17:g.7578196A>C, hg19,17:g.7674878A>C, hg38,17:g.7674878A>C",0.972,", central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, rectum, lung, ovary, skin, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_I, pilocytic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, malignant_melanoma",,,,,528249,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
2752,218,V,H,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2753,218,V,I,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2754,218,V,K,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2755,218,V,L,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, luad_mskcc_2023_met_organotropism, lung_msk_2017, mixed_cfdna_msk_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7578197-7578197, hg19,17:7674879-7674879, hg38,17:7674879-7674879","hg19,17:g.7578197C>A, hg19,17:g.7674879C>A, hg38,17:g.7674879C>A",0.864,"lung, oesophagus","carcinoma, carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2756,218,V,M,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_msk_npjpo_2021, luad_mskcc_2020, mel_iatlas_hugo_ucla_2016, mel_ucla_2016, msk_chord_2024, msk_impact_2017, msk_met_2021, sarcoma_msk_2022","Lung Adenocarcinoma, Melanoma, Mixed Cancer Types, Soft Tissue","hg19,17:7578197-7578197, hg19,17:7578197-7578198, hg19,17:7674879-7674880, hg38,17:7674879-7674879, hg38,17:7674879-7674880","hg19,17:g.7578197C>T, hg19,17:g.7578197_7578198delinsTT, hg19,17:g.7674879_7674880delinsTT, hg38,17:g.7674879C>T, hg38,17:g.7674879_7674880delinsTT",0.873,"haematopoietic_and_lymphoid_tissue, pancreas, peritoneum, skin, skin, leg, soft_tissue, smooth_muscle, arm, urinary_tract, bladder","carcinoma, Merkel_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, transitional_cell_carcinoma, leiomyosarcoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, other, keratosis",,,,,237952,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
2757,218,V,N,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2758,218,V,P,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2759,218,V,Q,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2760,218,V,R,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2761,218,V,S,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2762,218,V,T,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2763,218,V,W,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",sarcoma_msk_2022,Soft Tissue,"hg19,17:7578196-7578197","hg19,17:g.7578196_7578197delinsCA",,,,,,,,,,,,,,,,,
2764,218,V,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2765,219,P,A,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7578194-7578194, hg38,17:7674876-7674876","hg19,17:g.7578194G>C, hg38,17:g.7674876G>C",0.937,,,,,,,2850523,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2766,219,P,C,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674875-7674876","hg38,17:g.7674875_7674876delinsCA",,"upper_aerodigestive_tract, head_neck",carcinoma,,,,,,,,,,,,,,
2767,219,P,D,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2768,219,P,E,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2769,219,P,F,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2770,219,P,G,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2771,219,P,H,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,17:7578193-7578193, hg38,17:7674875-7674875","hg19,17:g.7578193G>T, hg38,17:g.7674875G>T",0.957,breast,carcinoma,,,,,,,,,,,,,,
2772,219,P,I,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2773,219,P,K,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2774,219,P,L,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_msk_2018, breast_msk_2025, msk_chord_2024, msk_met_2021","Breast, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7578193-7578193, hg38,17:7674874-7674875, hg38,17:7674875-7674875","hg19,17:g.7578193G>A, hg38,17:g.7674874_7674875delinsAA, hg38,17:g.7674875G>A",0.947,"breast, kidney, lung, oesophagus, pancreas, skin, face, skin, knee, skin, scalp, stomach, thyroid","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma, desmoplastic, other, hyperplasia",0.0000039777563863,,,,826488,Uncertain significance,not provided;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2775,219,P,M,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2776,219,P,N,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2777,219,P,Q,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2778,219,P,R,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","glioma_mskcc_2019, msk_impact_2017, pan_origimed_2020, sarcoma_mskcc_2022","Diffuse Glioma, Mixed Cancer Types, Soft Tissue","hg19,17:7578193-7578193, hg38,17:7674875-7674875","hg19,17:g.7578193G>C, hg38,17:g.7674875G>C",0.966,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, oesophagus","carcinoma, squamous_cell_carcinoma, glioma, oligoastrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,953426,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2779,219,P,S,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_genentech_2014, msk_ch_2023",Mixed Cancer Types,"hg19,17:7578194-7578194, hg38,17:7674876-7674876","hg19,17:g.7578194G>A, hg38,17:g.7674876G>A",0.960,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, oesophagus, skin, head_neck, soft_tissue, smooth_muscle, abdomen, upper_aerodigestive_tract, tonsil","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, leiomyosarcoma, lymphoid_neoplasm, NK-T_cell_lymphoma",0.0000039775665248,,,,245673,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
2780,219,P,T,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, msk_ch_2023","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,17:7578194-7578194, hg38,17:7674876-7674876","hg19,17:g.7578194G>T, hg38,17:g.7674876G>T",0.962,"haematopoietic_and_lymphoid_tissue, skin, urinary_tract, bladder, vulva","carcinoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,2758381,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2781,219,P,V,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2782,219,P,W,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2783,219,P,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 213-219, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2784,220,Y,A,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2785,220,Y,C,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, aml_ohsu_2018, aml_ohsu_2022, ampca_bcm_2016, bcc_unige_2016, bladder_msk_2023, blca_bcan_hcrn_2022, blca_cornell_2016, blca_dfarber_mskcc_2014, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bowel_colitis_msk_2022, brca_bccrc, brca_broad, brca_cptac_2020, brca_dfci_2020, brca_dldccc_2022, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_sanger, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cervix_msk_2023, cfdna_msk_2019, cll_broad_2022, cll_iuopa_2015, coad_caseccc_2015, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_mskcc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_msk_2023, difg_tcga_gdc, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, es_dfarber_broad_2014, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_ucla_2014, gbm_columbia_2019, gbm_mayo_pdx_sarkaria_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gist_msk_2022, gist_msk_2023, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, hcc_meric_2021, hcc_msk_2024, hcc_mskimpact_2018, hcc_tcga_gdc, hccihch_pku_2019, hdcn_msk_2025, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_broad, hnsc_jhu, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2015, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lung_pdx_msk_2021, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_impact_subset_2022, mixed_selpercatinib_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_mskcc_2015, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ohnca_cptac_gdc, os_target_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, pptc_2019, prad_cdk12_mskcc_2020, prad_fhcrc, prad_mich, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_dkfz_2018, prostate_msk_2024, ptad_msk_2024, rcc_iatlas_immotion150_2018, rectal_msk_2019, rectal_msk_2022, rectal_radiation_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_msk_2023, sarcoma_mskcc_2022, sclc_cancercell_gardner_2017, sclc_jhu, sclc_ucologne_2015, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, soft_tissue_tcga_gdc, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_ccr_msk_2022, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_msk_2024, uec_cptac_gdc, utuc_cornell_baylor_mdacc_2019","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervix, Chromophobe Renal Cell Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gastrointestinal Stromal Tumor, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Histiocytic and Dendritic Cell Neoplasms, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Osteosarcoma, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pituitary Adenoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Renal Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Thyroid, Upper Tract Urothelial Carcinoma, Uterine Endometrioid Carcinoma","hg19,17:7578190-7578190, hg19,17:7674872-7674872, hg38,17:7674872-7674872","hg19,17:g.7578190T>C, hg19,17:g.7674872T>C, hg38,17:g.7674872T>C",0.936,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, central_nervous_system, temporal_lobe, cervix, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, skin, kidney, large_intestine, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, lung, right_lower_lobe, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, peritoneum, peritoneum, appendix, pituitary, pleura, prostate, salivary_gland, salivary_gland, major, salivary_gland, parotid, salivary_gland, submandibular, skin, small_intestine, small_intestine, duodenum, small_intestine, jejunum, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, soft_tissue, fibrous_tissue_and_uncertain_origin, pelvis, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, soft_tissue, nerve_sheath, chest, soft_tissue, smooth_muscle, abdomen, soft_tissue, smooth_muscle, chest, soft_tissue, smooth_muscle, kidney, soft_tissue, smooth_muscle, leg, soft_tissue, smooth_muscle, uterus, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, glottis, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, retromolar_trigone, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, trachea, urinary_tract, urinary_tract, bladder, urinary_tract, renal_pelvis, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, adenoma, carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, invasive_mucinous_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, lobular_carcinoma, pleomorphic, carcinoma, luminal_B_carcinoma, carcinoma, medullary_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, myoepithelial_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, normal-like_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, carcinoma, undifferentiated_adenocarcinoma, fibrosarcoma, myxofibrosarcoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma, glioma, oligoastrocytoma_Grade_II, glioma, oligoastrocytoma_Grade_III, anaplastic, glioma, oligodendroglioma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M6, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_myelodysplastic_syndrome_therapy_related_NOS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia, haematopoietic_neoplasm, chronic_neutrophilic_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_ringed_sideroblasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia_with_ringed_sideroblasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, myeloid_neoplasm_unspecified_therapy_related, haematopoietic_neoplasm, polycythaemia_vera, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_peripheral_nerve_sheath_tumour, mesothelioma, mesothelioma, epithelial, osteosarcoma, other, other, Barrett_oesophagus, with_high_grade_dysplasia, other, cystic_tumour, other, dysplasia-carcinoma_in_situ, other, dysplasia-in_situ_neoplasm, other, neoplasm, other, neoplasm, malignant, other, pseudomyxoma_peritonei, sarcoma, solitary_fibrous_tumour",0.0000079551963342,,,,127819,Pathogenic,"Bone osteosarcoma;TP53-related disorder;Adrenal cortex carcinoma;Gastric cancer;Hereditary cancer-predisposing syndrome;not provided;B-cell chronic lymphocytic leukemia;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Breast carcinoma",3,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant;Embryonal rhabdomyosarcoma;Astrocytoma IDH-mutant;Adenocarcinoma of the large intestine;Ovarian mucinous adenocarcinoma",1
2786,220,Y,D,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, egc_msk_2023, egc_mskcc_2020, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, glioma_mskcc_2019, lihc_amc_prv, mbn_sfu_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, soft_tissue_tcga_gdc, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreatic Adenocarcinoma, Soft Tissue","hg19,17:7578191-7578191, hg19,17:7674873-7674873, hg38,17:7674873-7674873","hg19,17:g.7578191A>C, hg19,17:g.7674873A>C, hg38,17:g.7674873A>C",0.934,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon, lung, oesophagus, middle_third, pancreas, soft_tissue, soft_tissue, smooth_muscle, inferior_vena_cava, stomach, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, alveolus","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, leiomyosarcoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, sarcoma",,,,,376689,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2787,220,Y,E,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2788,220,Y,F,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2789,220,Y,G,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2790,220,Y,H,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2022, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, cll_broad_2022, crc_eo_2020, cscc_ucsf_2021, csf_msk_2024, difg_msk_2023, difg_tcga_gdc, dlbcl_duke_2017, glioma_mskcc_2019, hcc_msk_2024, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, mds_iwg_2022, mds_mskcc_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prostate_dkfz_2018, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, soft_tissue_tcga_gdc, thyroid_mskcc_2016","Acute Myeloid Leukemia, Bowel, Breast, Cervical Squamous Cell Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Soft Tissue, Thyroid","hg19,17:7578191-7578191, hg19,17:7578191-7578192, hg19,17:7674873-7674873, hg38,17:7674873-7674873","hg19,17:g.7578191A>G, hg19,17:g.7578191_7578192delinsGA, hg19,17:g.7674873A>G, hg38,17:g.7674873A>G",0.909,"biliary_tract, bile_duct, breast, central_nervous_system, brain, cervix, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, large_intestine, colon, lung, oesophagus, ovary, pancreas, soft_tissue, stomach, stomach, gastroesophageal_junction, thyroid, urinary_tract","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, sarcoma",0.0000039777247414,,,,376687,Pathogenic/Likely pathogenic,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Ovarian neoplasm;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",2,,,,,,
2791,220,Y,I,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2792,220,Y,K,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2793,220,Y,L,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2794,220,Y,M,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2795,220,Y,N,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, coadread_dfci_2016, escc_ucla_2014, lihc_amc_prv, luad_oncosg_2020, mbn_sfu_2023, mel_mskimpact_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, paad_qcmg_uq_2016, pan_origimed_2020, pancan_hcmi_2025, pancan_pcawg_2020, pdac_msk_2024, pog570_bcgsc_2020, prad_organoids_msk_2022, sarcoma_msk_2022, tmb_mskcc_2018","Ampullary Carcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Esophageal Squamous Cell Carcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578191-7578191, hg19,17:7578191-7578192, hg19,17:7674873-7674873, hg38,17:7674873-7674873","hg19,17:g.7578191A>T, hg19,17:g.7578191_7578192delinsTA, hg19,17:g.7674873A>T, hg38,17:g.7674873A>T",0.910,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, sigmoid, liver, lung, oesophagus, ovary, pancreas, prostate, skin, face, skin, leg, skin, trunk, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, pharynx, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mucinous_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, yolk_sac_tumour, lymphoid_neoplasm, other, keratosis, other, neoplasm",,,,,376688,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;not provided;Hereditary cancer-predisposing syndrome,1,Likely oncogenic,Neoplasm,1,Tier II - Potential,Pleomorphic xanthoastrocytoma,1
2796,220,Y,P,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2797,220,Y,Q,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2798,220,Y,R,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2799,220,Y,S,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ampca_bcm_2016, brca_mbcproject_2022, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, cscc_ranson_2022, egc_msk_2023, hcc_msk_2024, hcc_mskimpact_2018, kirp_tcga, kirp_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, lung_msk_2017, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancreas_msk_2024, pdac_msk_2024, prcc_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022, sarcoma_ucla_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Adenoid Cystic Carcinoma, Ampullary Carcinoma, Bowel, Cutaneous Squamous Cell Carcinoma, Endometrial Carcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Papillary Renal Cell Carcinoma, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578190-7578190, hg19,17:7674872-7674872, hg38,17:7674872-7674872","hg19,17:g.7578190T>G, hg19,17:g.7674872T>G, hg38,17:g.7674872T>G",0.918,", biliary_tract, bile_duct, breast, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, liver, lung, oesophagus, peritoneum, pleura, stomach, thymus, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_renal_cell_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astroblastoma_Grade_III, glioma, astrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, mesothelioma, mesothelioma, epithelial, other, neoplasm, malignant, thymic_carcinoma, squamous_cell_carcinoma",,,,,12383,Pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,Tier I - Strong,Undifferentiated embryonal sarcoma of the liver,1
2800,220,Y,T,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2801,220,Y,V,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2802,220,Y,W,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2803,220,Y,X,P,,,,,,,,,,PhosphoSite,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM",,COSMIC,,,,,,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,,,,,,,,,,
2804,221,E,A,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578187-7578187, hg38,17:7674869-7674869","hg19,17:g.7578187T>G, hg38,17:g.7674869T>G",0.880,,,,,,,573679,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2805,221,E,C,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2806,221,E,D,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674868-7674868","hg38,17:g.7674868C>A, hg38,17:g.7674868C>G",0.669,"large_intestine, colon, stomach","carcinoma, adenocarcinoma, carcinoma, tubular_adenocarcinoma",,,,,,,,,,,,,,
2807,221,E,F,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2808,221,E,G,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pancreas_cptac_gdc,Pancreas,"hg19,17:7674869-7674869, hg38,17:7674869-7674869","hg19,17:g.7674869T>C, hg38,17:g.7674869T>C",0.826,"large_intestine, colon, sigmoid, lung, skin, mucosal, vagina","carcinoma, carcinoma, adenocarcinoma, malignant_melanoma",,,,,,,,,,,,,,
2809,221,E,H,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2810,221,E,I,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2811,221,E,K,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",paired_bladder_2022,Bladder/Urinary Tract,"hg19,17:7578188-7578188, hg38,17:7674870-7674870","hg19,17:g.7578188C>T, hg38,17:g.7674870C>T",0.897,"haematopoietic_and_lymphoid_tissue, lymph_node, oesophagus, salivary_gland, parotid, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, mucoepidermoid_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000039780095631,,,,184647,Uncertain significance,Familial melanoma;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2812,221,E,L,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2813,221,E,M,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578187-7578188, hg38,17:7674869-7674870","hg19,17:g.7578187_7578188delinsAT, hg38,17:g.7674869_7674870delinsAT",,,,,,,,2824912,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2814,221,E,N,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2815,221,E,P,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2816,221,E,Q,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2817,221,E,R,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2818,221,E,S,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2819,221,E,T,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2820,221,E,V,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674869-7674869","hg38,17:g.7674869T>A",0.901,oesophagus,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2821,221,E,W,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2822,221,E,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2823,222,P,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674867-7674867","hg38,17:g.7674867G>C",0.395,"upper_aerodigestive_tract, larynx","carcinoma, spindle_cell_carcinoma",,,,,,,,,,,,,,
2824,222,P,C,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2825,222,P,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2826,222,P,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2827,222,P,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2828,222,P,G,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2829,222,P,H,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2830,222,P,I,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2831,222,P,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2832,222,P,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","mds_iwg_2022, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024, pancan_pdmr_2025, panet_msk_erc_2023, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas","hg19,17:7578184-7578184, hg38,17:7674866-7674866, hg38,17:7674866-7674867","hg19,17:g.7578184G>A, hg38,17:g.7674866G>A, hg38,17:g.7674866_7674867delinsAA",0.585,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, eye, skin, skin, arm, skin, face","carcinoma, basal_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, myelofibrosis, primary, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, marginal_zone_lymphoma",0.0000159154570919,0.0000637226789014,,,161397,Conflicting classifications of pathogenicity,TP53-related disorder;Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck,1,,,,,,
2833,222,P,M,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2834,222,P,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2835,222,P,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578184-7578184, hg38,17:7674866-7674866","hg19,17:g.7578184G>T, hg38,17:g.7674866G>T",0.626,urinary_tract,"carcinoma, transitional_cell_carcinoma",,,,,1461784,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2836,222,P,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2837,222,P,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7578185-7578185, hg38,17:7674867-7674867","hg19,17:g.7578185G>A, hg38,17:g.7674867G>A",0.344,"pancreas, thymus, urinary_tract, bladder","carcinoma, ductal_carcinoma, carcinoma, transitional_cell_carcinoma, thymic_carcinoma",,,,,406592,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
2838,222,P,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674867-7674867","hg38,17:g.7674867G>T",0.533,"breast, upper_aerodigestive_tract, head_neck","carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2839,222,P,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2840,222,P,W,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2841,222,P,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|SH3 domain ligands (LIG_SH3_3), 216-222, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2842,223,P,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674864-7674864","hg38,17:g.7674864G>C",0.759,stomach,carcinoma,,,,,,,,,,,,,,
2843,223,P,C,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2844,223,P,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2845,223,P,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2846,223,P,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2847,223,P,G,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2848,223,P,H,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",sarcoma_msk_2022,Soft Tissue,"hg19,17:7578181-7578181, hg38,17:7674863-7674863","hg19,17:g.7578181G>T, hg38,17:g.7674863G>T",0.728,"upper_aerodigestive_tract, larynx","carcinoma, squamous_cell_carcinoma",0.0000039792442619,,,,,,,,,,,,,
2849,223,P,I,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2850,223,P,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2851,223,P,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, blca_dfarber_mskcc_2014, brca_igr_2015, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_nci60, difg_msk_2023, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc, prad_mskcc_2017, prad_organoids_msk_2022, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022","Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Diffuse Glioma, Invasive Breast Carcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7578181-7578181, hg19,17:7674863-7674863, hg38,17:7674863-7674863","hg19,17:g.7578181G>A, hg19,17:g.7674863G>A, hg38,17:g.7674863G>A",0.634,", breast, haematopoietic_and_lymphoid_tissue, large_intestine, appendix, meninges, prostate, salivary_gland, parotid, skin, shoulder, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, meningioma",,,,,234214,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
2852,223,P,M,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2853,223,P,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2854,223,P,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2855,223,P,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674863-7674863","hg38,17:g.7674863G>C",0.740,"liver, soft_tissue, striated_muscle, pelvis","carcinoma, hepatocellular_carcinoma, other, neoplasm, rhabdomyosarcoma, embryonal",,,,,,,,,,,,,,
2856,223,P,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, mds_iwg_2022, mds_mskcc_2020, ucs_jhu_2014","Bladder Urothelial Carcinoma, Myelodysplastic Syndromes, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7578182-7578182, hg19,17:7674864-7674864, hg38,17:7674864-7674864","hg19,17:g.7578182G>A, hg19,17:g.7674864G>A, hg38,17:g.7674864G>A",0.765,"adrenal_gland, adrenal_gland, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, rectum, liver","adrenal_cortical_carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, hepatocellular_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,,,,,,,,,,
2857,223,P,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_met_2021, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7578182-7578182","hg19,17:g.7578182G>T",0.786,,,,,,,,,,,,,,,,
2858,223,P,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2859,223,P,W,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2860,223,P,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2861,224,E,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, msk_ctdna_vte_2024, paired_bladder_2022, pancan_mimsi_msk_2024","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7578178-7578178, hg38,17:7674860-7674860","hg19,17:g.7578178T>G, hg38,17:g.7674860T>G",0.825,,,,,,,428892,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
2862,224,E,C,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2863,224,E,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_metabric, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_cptac_2019, coad_cptac_gdc, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, glioma_mskcc_2019, hcc_clca_2024, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_smmu_2014, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, paad_cptac_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_msk_stopsack_2021, prostate_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_jhu, soft_tissue_tcga_gdc, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Bladder Urothelial Carcinoma, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7578177-7578177, hg19,17:7674859-7674859, hg38,17:7674859-7674859","hg19,17:g.7578177C>A, hg19,17:g.7578177C>G, hg19,17:g.7674859C>A, hg19,17:g.7674859C>G, hg38,17:g.7674859C>A, hg38,17:g.7674859C>G",0.697,"biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, ascending, large_intestine, rectum, lung, oesophagus, ovary, pancreas, skin, scalp, soft_tissue, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, osteosarcoma, sarcoma",0.0000039807649438,,,,"1493447, 635390","Uncertain significance, Conflicting classifications of pathogenicity",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"1, 1",Uncertain significance,Neoplasm,1,,,
2864,224,E,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2865,224,E,G,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_msk_2025, msk_chord_2024","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7578178-7578178, hg38,17:7674860-7674860","hg19,17:g.7578178T>C, hg38,17:g.7674860T>C",0.890,"breast, central_nervous_system, brain","carcinoma, ductal_carcinoma, glioma, astrocytoma",,,,,826574,Uncertain significance,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary",2,,,,,,
2866,224,E,H,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2867,224,E,I,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2868,224,E,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad",Mixed Cancer Types,"hg19,17:7578179-7578179, hg19,17:7674861-7674861, hg38,17:7674861-7674861","hg19,17:g.7578179C>T, hg19,17:g.7674861C>T, hg38,17:g.7674861C>T",0.701,"breast, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, lung, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, Hodgkin_lymphoma",,,,,480767,Uncertain significance,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",2,,,,,,
2869,224,E,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2870,224,E,M,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2871,224,E,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2872,224,E,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2873,224,E,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",cfdna_msk_2019,Mixed Cancer Types,"hg19,17:7578179-7578179, hg38,17:7674861-7674861","hg19,17:g.7578179C>G, hg38,17:g.7674861C>G",0.533,vulva,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2874,224,E,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2875,224,E,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2876,224,E,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2877,224,E,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7578178-7578178, hg38,17:7674860-7674860","hg19,17:g.7578178T>A, hg38,17:g.7674860T>A",0.868,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2878,224,E,W,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2879,224,E,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 218-224, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 218-224, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2880,225,V,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",bcc_unige_2016,Basal Cell Carcinoma,"hg19,17:7577607-7577607, hg38,17:7674289-7674289","hg19,17:g.7577607A>G, hg38,17:g.7674289A>G",0.449,"lung, oesophagus, skin, soft_tissue, fat, leg","carcinoma, basal_cell_carcinoma, carcinoma, non_small_cell_carcinoma, liposarcoma, malignant_melanoma, other, Barrett_oesophagus",,,,,,,,,,,,,,
2881,225,V,C,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2882,225,V,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577607-7577607, hg38,17:7674289-7674289","hg19,17:g.7577607A>T, hg38,17:g.7674289A>T",0.645,"prostate, stomach, gastroesophageal_junction","carcinoma, carcinoma, small_cell_adenocarcinoma",,,,,850916,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
2883,225,V,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2884,225,V,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577608-7577608, hg38,17:7674290-7674290","hg19,17:g.7577608C>A, hg38,17:g.7674290C>A",0.704,peritoneum,"carcinoma, peritoneal_serous_surface_carcinoma",,,,,2122381,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2885,225,V,G,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674289-7674289","hg38,17:g.7674289A>C",0.644,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,,,,,,,,,,
2886,225,V,H,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2887,225,V,I,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","chol_icgc_2017, hnc_mskcc_2016, msk_impact_2017, msk_met_2021, sarcoma_msk_2022","Cholangiocarcinoma, Head and Neck, Mixed Cancer Types, Soft Tissue","hg19,17:7577608-7577608, hg38,17:7674290-7674290","hg19,17:g.7577608C>T, hg38,17:g.7674290C>T",0.388,"skin, skin, head_neck, upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma, other, actinic_cheilitis",,,,,480736,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
2888,225,V,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2889,225,V,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2890,225,V,M,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2891,225,V,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2892,225,V,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2893,225,V,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2894,225,V,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2895,225,V,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2896,225,V,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2897,225,V,W,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2898,225,V,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 220-225, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 221-225, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2899,226,G,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577604-7577604, hg38,17:7674286-7674286","hg19,17:g.7577604C>G, hg38,17:g.7674286C>G",0.767,"liver, skin","carcinoma, basal_cell_carcinoma, carcinoma, hepatocellular_carcinoma",,,,,951459,Uncertain significance,"Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",2,,,,,,
2900,226,G,C,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674287-7674287","hg38,17:g.7674287C>A",0.877,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
2901,226,G,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_impact_2017, msk_met_2021, pan_origimed_2020, sarcoma_mskcc_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7577604-7577604, hg38,17:7674286-7674286","hg19,17:g.7577604C>T, hg38,17:g.7674286C>T",0.698,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, liver, lung, oesophagus, skin, arm, soft_tissue, fibrous_tissue_and_uncertain_origin, leg","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma, other, keratosis, undifferentiated_sarcoma, pleomorphic",,,,,,,,,,,,,,
2902,226,G,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2903,226,G,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2904,226,G,H,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2905,226,G,I,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2906,226,G,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2907,226,G,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2908,226,G,M,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2909,226,G,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2910,226,G,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2911,226,G,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2912,226,G,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
2913,226,G,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",coadread_cass_2020,Colorectal Adenocarcinoma,"hg19,17:7577605-7577605, hg38,17:7674287-7674287","hg19,17:g.7577605C>T, hg38,17:g.7674287C>T",0.866,"eye, uveal_tract, lung, upper_aerodigestive_tract, mouth","carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,648028,Uncertain significance,"not provided;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1",2,,,,,,
2914,226,G,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2915,226,G,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577604-7577604, hg38,17:7674286-7674286","hg19,17:g.7577604C>A, hg38,17:g.7674286C>A",0.838,"breast, cervix, lung","carcinoma, carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma",,,,,458556,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
2916,226,G,W,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2917,226,G,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2918,227,S,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2919,227,S,C,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2920,227,S,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2921,227,S,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2922,227,S,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, pdac_msk_2024","Mixed Cancer Types, Pancreas","hg19,17:7577601-7577601, hg38,17:7674283-7674283","hg19,17:g.7577601G>A, hg38,17:g.7674283G>A",0.727,"central_nervous_system, brain, large_intestine, large_intestine, colon, ovary, pancreas, skin, face, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, other, keratosis",,,,,3634429,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2923,227,S,G,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2924,227,S,H,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2925,227,S,I,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2926,227,S,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2927,227,S,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2928,227,S,M,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2929,227,S,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2930,227,S,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","cfdna_msk_2019, lihc_tcga","Hepatocellular Carcinoma, Mixed Cancer Types","hg19,17:7577602-7577602, hg38,17:7674284-7674284","hg19,17:g.7577602A>G, hg38,17:g.7674284A>G",0.681,"lung, soft_tissue, fibrous_tissue_and_uncertain_origin, frontal_lobe","carcinoma, large_cell_neuroendocrine_carcinoma, sarcoma",,,,,,,,,,,,,,
2931,227,S,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2932,227,S,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2933,227,S,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2934,227,S,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2935,227,S,W,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2936,227,S,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674283-7674283","hg38,17:g.7674283G>T",0.772,"upper_aerodigestive_tract, larynx","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2937,228,D,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674280-7674280","hg38,17:g.7674280T>G",0.758,skin,"carcinoma, squamous_cell_carcinoma, in_situ_epithelial_neoplasm, actinic_keratosis",,,,,,,,,,,,,,
2938,228,D,C,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2939,228,D,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","stad_tcga_gdc, stad_tcga_pan_can_atlas_2018",Stomach Adenocarcinoma,"hg19,17:7577597-7577597, hg19,17:7674279-7674279, hg38,17:7674279-7674279","hg19,17:g.7577597G>C, hg19,17:g.7577597G>T, hg19,17:g.7674279G>C, hg38,17:g.7674279G>C, hg38,17:g.7674279G>T","0.370, 0.371","kidney, ovary, stomach, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, urinary_tract, bladder","Wilms_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, mucinous_adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,"954848, 926556","Uncertain significance, Conflicting classifications of pathogenicity",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,"1, 1",,,,,,
2940,228,D,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2941,228,D,G,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674280-7674280","hg38,17:g.7674280T>C",0.704,"bone, breast, genital_tract, extragonadal, brain, large_intestine, prostate","carcinoma, carcinoma, adenocarcinoma, germ_cell_tumour, seminoma, osteosarcoma",,,,,,,,,,,,,,
2942,228,D,H,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_msk_2024, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, cfdna_msk_2019, luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pancan_mimsi_msk_2024, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7577599-7577599, hg38,17:7674281-7674281","hg19,17:g.7577599C>G, hg38,17:g.7674281C>G",0.777,"breast, lung, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
2943,228,D,I,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2944,228,D,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2945,228,D,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2946,228,D,M,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2947,228,D,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, msk_chord_2024, msk_met_2021, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7577599-7577599, hg19,17:7674281-7674281, hg38,17:7674281-7674281","hg19,17:g.7577599C>T, hg19,17:g.7674281C>T, hg38,17:g.7674281C>T",0.546,"breast, liver, lung, oesophagus, pancreas, skin, leg, stomach, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,1395667,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2948,228,D,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2949,228,D,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2950,228,D,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2951,228,D,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2952,228,D,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2953,228,D,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674280-7674280","hg38,17:g.7674280T>A",0.829,ovary,"carcinoma, carcinoma, serous_carcinoma",,,,,,,,,,,,,,
2954,228,D,W,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2955,228,D,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_2), 222-228, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",mixed_pipseq_2017,Mixed Cancer Types,"hg19,17:7577599-7577599, hg38,17:7674281-7674281","hg19,17:g.7577599C>A, hg38,17:g.7674281C>A",0.849,"central_nervous_system, frontal_lobe, large_intestine, stomach","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,2450759,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
2956,229,C,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2957,229,C,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2958,229,C,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2959,229,C,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","esca_tcga, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,17:7577595-7577595, hg38,17:7674277-7674277","hg19,17:g.7577595C>A, hg38,17:g.7674277C>A",0.401,"biliary_tract, bile_duct, urinary_tract, ureter","carcinoma, adenocarcinoma, other, dysplasia-carcinoma_in_situ",,,,,,,,,,,,,,
2960,229,C,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_ch_2023,Mixed Cancer Types,"hg19,17:7577596-7577596, hg38,17:7674278-7674278","hg19,17:g.7577596A>C, hg38,17:g.7674278A>C",0.738,breast,carcinoma,,,,,1026715,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2961,229,C,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2962,229,C,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2963,229,C,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2964,229,C,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2965,229,C,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2966,229,C,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2967,229,C,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2968,229,C,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2969,229,C,R,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577596-7577596, hg38,17:7674278-7674278","hg19,17:g.7577596A>G, hg38,17:g.7674278A>G",0.754,"breast, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, squamous_cell_carcinoma",0.0000079529819706,,,,420137,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
2970,229,C,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",escc_ucla_2014,Esophageal Squamous Cell Carcinoma,"hg19,17:7577595-7577595, hg19,17:7577596-7577596, hg38,17:7674277-7674277, hg38,17:7674278-7674278","hg19,17:g.7577595C>G, hg19,17:g.7577596A>T, hg38,17:g.7674277C>G, hg38,17:g.7674278A>T","0.535, 0.600","haematopoietic_and_lymphoid_tissue, large_intestine, colon, oesophagus, salivary_gland, mouth_roof","adenoma, pleomorphic, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,582302,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
2971,229,C,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2972,229,C,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2973,229,C,W,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",pancan_pcawg_2020,Mixed Cancer Types,"hg19,17:7577594-7577594","hg19,17:g.7577594A>C",0.594,,,,,,,,,,,,,,,,
2974,229,C,Y,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_msk_npjpo_2021, luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7577595-7577595, hg38,17:7674277-7674277","hg19,17:g.7577595C>T, hg38,17:g.7674277C>T",0.389,"breast, large_intestine, colon, left, lung, skin, face, stomach","carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, squamous_cell_carcinoma",,,,,419040,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1",1,,,,,,
2975,230,T,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,17:7577593-7577593, hg38,17:7674275-7674275","hg19,17:g.7577593T>C, hg38,17:g.7674275T>C",0.856,"pancreas, skin, knee, stomach","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma",,,,,953956,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided,2,,,,,,
2976,230,T,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2977,230,T,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2978,230,T,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2979,230,T,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2980,230,T,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2981,230,T,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2982,230,T,I,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577592-7577592, hg38,17:7674274-7674274","hg19,17:g.7577592G>A, hg38,17:g.7674274G>A",0.936,"central_nervous_system, brain, central_nervous_system, cerebellum, haematopoietic_and_lymphoid_tissue, stomach, large_intestine, colon, large_intestine, rectum, pancreas, skin, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, urinary_tract, bladder","carcinoid-endocrine_tumour, non_functioning, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, primitive_neuroectodermal_tumour-medulloblastoma",,,,,1366616,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
2983,230,T,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2984,230,T,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2985,230,T,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2986,230,T,N,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674274-7674274","hg38,17:g.7674274G>T",0.875,"breast, large_intestine, colon, lung","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2987,230,T,P,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","difg_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023","Diffuse Glioma, Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7577593-7577593, hg19,17:7674275-7674275, hg38,17:7674275-7674275","hg19,17:g.7577593T>G, hg19,17:g.7674275T>G, hg38,17:g.7674275T>G",0.920,"biliary_tract, bile_duct, bone, pelvis, central_nervous_system, brain, liver, oesophagus, lower_third, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, chondrosarcoma, dedifferentiated, glioma, other, neoplasm",,,,,4539743,,,,Uncertain significance,Neoplasm,1,,,
2988,230,T,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2989,230,T,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2990,230,T,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",hdcn_msk_2025,Histiocytic and Dendritic Cell Neoplasms,"hg19,17:7577593-7577593, hg38,17:7674275-7674275","hg19,17:g.7577593T>A, hg38,17:g.7674275T>A",0.863,"breast, upper_aerodigestive_tract, larynx","carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
2991,230,T,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2992,230,T,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2993,230,T,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2994,231,T,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","lms_msk_2024, msk_chord_2024, msk_met_2021, sarcoma_mskcc_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7577590-7577590, hg38,17:7674272-7674272","hg19,17:g.7577590T>C, hg38,17:g.7674272T>C",0.905,"prostate, thyroid","carcinoma, carcinoma, papillary_carcinoma",,,,,863153,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
2995,231,T,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2996,231,T,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2997,231,T,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2998,231,T,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
2999,231,T,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3000,231,T,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3001,231,T,I,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577589-7577589, hg38,17:7674271-7674271","hg19,17:g.7577589G>A, hg38,17:g.7674271G>A",0.942,"biliary_tract, gallbladder, large_intestine, colon, large_intestine, rectum","carcinoma, adenocarcinoma",,,,,458557,Uncertain significance,Li-Fraumeni syndrome,2,,,,Tier II - Potential,Ovarian sex cord-stromal tumor,1
3002,231,T,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3003,231,T,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3004,231,T,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3005,231,T,N,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7577589-7577589, hg38,17:7674271-7674271","hg19,17:g.7577589G>T, hg38,17:g.7674271G>T",0.885,"endometrium, oesophagus","carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3006,231,T,P,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7577590-7577590, hg38,17:7674272-7674272","hg19,17:g.7577590T>G, hg38,17:g.7674272T>G",0.959,"endometrium, upper_aerodigestive_tract, mouth, buccal_mucosa","carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3007,231,T,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3008,231,T,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3009,231,T,S,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577589-7577589, hg38,17:7674271-7674271, hg38,17:7674272-7674272","hg19,17:g.7577589G>C, hg38,17:g.7674271G>C, hg38,17:g.7674272T>A","0.916, 0.922","breast, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, skin","carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma",,,,,921142,Uncertain significance,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",2,,,,,,
3010,231,T,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3011,231,T,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3012,231,T,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3013,232,I,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3014,232,I,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3015,232,I,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3016,232,I,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3017,232,I,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","cll_broad_2015, cll_broad_2022, dlbcl_dfci_2018, egc_msk_2023, hcc_jcopo_msk_2023, lcll_broad_2013, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_mind_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Large B-Cell Lymphoma, NOS, Esophagus/Stomach, Hepatocellular Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma","hg19,17:7577585-7577587, hg19,17:7577587-7577587, hg19,17:7674269-7674269, hg38,17:7674269-7674269","hg19,17:g.7577585_7577587delinsAAA, hg19,17:g.7577587T>A, hg19,17:g.7674269T>A, hg38,17:g.7674269T>A",0.840,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, pelvis, large_intestine, colon, liver, lung, oesophagus, prostate, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, vocal_cord","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, other, dysplasia, other, pneumocytoma_(sclerosing_haemangioma)",,,,,2827498,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,Likely oncogenic,Neoplasm,1,,,
3018,232,I,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3019,232,I,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3020,232,I,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3021,232,I,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",sarcoma_msk_2022,Soft Tissue,"hg19,17:7577587-7577587, hg38,17:7674269-7674269","hg19,17:g.7577587T>G, hg38,17:g.7674269T>G",0.688,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,,,,482214,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;not provided;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
3022,232,I,M,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",heme_msk_impact_2022,Mixed Cancer Types,"hg19,17:7577585-7577585, hg38,17:7674267-7674267","hg19,17:g.7577585G>C, hg38,17:g.7674267G>C",0.776,"urinary_tract, bladder, vulva","carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
3023,232,I,N,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, glioma_mskcc_2019, hgsoc_tcga_gdc, mbn_sfu_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tracerx_2017, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, read_tcga_gdc","Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, High-Grade Serous Ovarian Cancer, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Rectal Adenocarcinoma","hg19,17:7577585-7577586, hg19,17:7577586-7577586, hg19,17:7674268-7674268, hg38,17:7674268-7674268","hg19,17:g.7577585_7577586delinsAT, hg19,17:g.7577586A>T, hg19,17:g.7674268A>T, hg38,17:g.7674268A>T",0.916,"large_intestine, colon, sigmoid, liver, lung, oesophagus, ovary, stomach, thyroid, upper_aerodigestive_tract, larynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,850008,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome,2,,,,Tier II - Potential,Colorectal cancer,0
3024,232,I,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3025,232,I,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3026,232,I,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3027,232,I,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, difg_msk_2023, difg_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_cptac_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Soft Tissue","hg19,17:7577586-7577586, hg19,17:7674268-7674268, hg38,17:7674268-7674268","hg19,17:g.7577586A>C, hg19,17:g.7674268A>C, hg38,17:g.7674268A>C",0.935,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, ascending, liver, lung, oesophagus, pancreas, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_II, fibrillary, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,634756,Pathogenic,Ovarian neoplasm;Hereditary cancer-predisposing syndrome,1,,,,,,
3028,232,I,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, brca_metabric, chol_icgc_2017, coadread_genentech, dlbc_tcga, dlbc_tcga_pan_can_atlas_2018, dlbclnos_tcga_gdc, gbc_msk_2018, hcc_clca_2024, luad_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_mdacc_2013, mds_iwg_2022, mds_mskcc_2020, msk_chord_2024, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, prad_msk_stopsack_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Bladder Urothelial Carcinoma, Bowel, Cholangiocarcinoma, Colorectal Adenocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577586-7577586, hg19,17:7674268-7674268, hg38,17:7674268-7674268","hg19,17:g.7577586A>G, hg19,17:g.7674268A>G, hg38,17:g.7674268A>G",0.920,"biliary_tract, bile_duct, breast, endometrium, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, rectum, lung, oesophagus, oesophagus, lower_third, oesophagus, upper_third, small_intestine, duodenum, thymus, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, malignant_melanoma, thymoma",,,,,141224,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;not specified;Li-Fraumeni syndrome,2,,,,,,
3029,232,I,V,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674269-7674269","hg38,17:g.7674269T>C",0.419,"endometrium, large_intestine, colon, lung, oesophagus, stomach, upper_aerodigestive_tract, mouth, mouth_floor","carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3030,232,I,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3031,232,I,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3032,233,H,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3033,233,H,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3034,233,H,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",heme_msk_impact_2022,Mixed Cancer Types,"hg19,17:7577584-7577584, hg38,17:7674266-7674266","hg19,17:g.7577584G>C, hg38,17:g.7674266G>C",0.876,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
3035,233,H,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3036,233,H,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3037,233,H,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3038,233,H,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3039,233,H,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3040,233,H,L,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674265-7674265","hg38,17:g.7674265T>A",0.579,"breast, ovary","carcinoma, carcinoma, serous_carcinoma",,,,,,,,,,,,,,
3041,233,H,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3042,233,H,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3043,233,H,P,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674265-7674265","hg38,17:g.7674265T>G",0.844,"pancreas, salivary_gland, major","adenoma, pleomorphic, carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
3044,233,H,Q,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674264-7674264","hg38,17:g.7674264G>C, hg38,17:g.7674264G>T",0.669,"haematopoietic_and_lymphoid_tissue, jaw, stomach, upper_aerodigestive_tract, mouth","carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant",,,,,,,,,,,,,,
3045,233,H,R,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577583-7577583, hg38,17:7674265-7674265","hg19,17:g.7577583T>C, hg38,17:g.7674265T>C",0.717,"haematopoietic_and_lymphoid_tissue, pleura","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, mesothelioma",,,,,246388,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3046,233,H,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3047,233,H,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3048,233,H,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3049,233,H,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3050,233,H,Y,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7577584-7577584, hg38,17:7674266-7674266","hg19,17:g.7577584G>A, hg38,17:g.7674266G>A",0.690,"liver, lung, upper_lobe, small_intestine, ileum, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, renal_pelvis","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, other, hepatoblastoma",,,,,,,,,,,,,,
3051,234,Y,A,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3052,234,Y,C,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, acc_tcga, acc_tcga_pan_can_atlas_2018, ampca_bcm_2016, appendiceal_msk_2022, blca_bcan_hcrn_2022, blca_bgi, blca_cornell_2016, blca_dfarber_mskcc_2014, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, bowel_colitis_msk_2022, brca_dldccc_2022, brca_igr_2015, brca_metabric, brca_sanger, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, chol_msk_2018, cll_broad_2022, coad_silu_2022, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, dlbcl_duke_2017, escc_icgc, gbc_mskcc_2022, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, hcc_meric_2021, hcc_msk_2024, hdcn_msk_2025, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, kirc_tcga_pan_can_atlas_2018, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, makeanimpact_ccr_2023, mbn_mdacc_2013, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, meso_tcga, meso_tcga_pan_can_atlas_2018, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nhl_bcgsc_2013, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, nsclc_unito_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, plmeso_tcga_gdc, pog570_bcgsc_2020, prad_broad_2013, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_mdanderson_2023, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, rectal_radiation_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_ucologne_2015, soft_tissue_tcga_gdc, stad_oncosg_2018, stad_pfizer_uhongkong, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Adenoid Cystic Carcinoma, Adrenocortical Carcinoma, Ampullary Carcinoma, Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Histiocytic and Dendritic Cell Neoplasms, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Renal Clear Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577580-7577580, hg19,17:7674262-7674262, hg38,17:7674262-7674262","hg19,17:g.7577580T>C, hg19,17:g.7674262T>C, hg38,17:g.7674262T>C",0.945,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, cervix, endometrium, extrapulmonary, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, skin, face, skin, lip, skin, mucosal, anorectal, skin, scalp, soft_tissue, soft_tissue, striated_muscle, stomach, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","adenoma, adenoma, tubular, adnexal_tumour, malignant_adnexal_tumour, microcystic_adnexal_carcinoma, adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, chronic_myeloid_leukaemia, Ph_negative-bcr-abl_negative, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, malignant_melanoma, other, neoplasm, rhabdomyosarcoma, pleomorphic, sarcoma, thymic_carcinoma",0.0000039764593606,,,,127820,Pathogenic/Likely pathogenic,not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,Oncogenic,Neoplasm,1,,,
3053,234,Y,D,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, crc_apc_impact_2020, glioma_mskcc_2019, heme_msk_impact_2022, mbn_msk_2024, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, sarcoma_ucla_2024, stad_oncosg_2018","Colorectal Adenocarcinoma, Diffuse Glioma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577581-7577581, hg19,17:7674263-7674263, hg38,17:7674263-7674263","hg19,17:g.7577581A>C, hg19,17:g.7674263A>C, hg38,17:g.7674263A>C",0.876,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, lung, salivary_gland, parotid, stomach","Wilms_tumour, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, mucoepidermoid_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,219759,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3054,234,Y,E,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3055,234,Y,F,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674262-7674262","hg38,17:g.7674262T>A",0.686,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
3056,234,Y,G,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3057,234,Y,H,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, bowel_colitis_msk_2022, brca_metabric, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_tcga_gdc, coadread_dfci_2016, coadread_genentech, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, escc_ucla_2014, gbc_mskcc_2022, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, kirc_tcga_pub, luad_cptac_2020, luad_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lymphoma_cellline_msk_2020, mbn_msk_2024, mbn_sfu_2023, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, soft_tissue_msk_2025","Bladder Urothelial Carcinoma, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue","hg19,17:7577581-7577581, hg19,17:7674263-7674263, hg38,17:7674263-7674263","hg19,17:g.7577581A>G, hg19,17:g.7674263A>G, hg38,17:g.7674263A>G",0.890,", breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, abdomen, haematopoietic_and_lymphoid_tissue, skin, kidney, large_intestine, large_intestine, anus, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, prostate, skin, skin, arm, skin, head_neck, soft_tissue, blood_vessel, breast, stomach, stomach, gastroesophageal_junction, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, urinary_tract, urinary_tract, bladder","angiosarcoma, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, lymphoid_neoplasm, MALT_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, lymphoid_neoplasm, marginal_zone_lymphoma, malignant_melanoma, other, keratosis, other, neoplasm",,,,,376691,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1,2,Oncogenic,Neoplasm,1,,,
3058,234,Y,I,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3059,234,Y,K,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3060,234,Y,L,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3061,234,Y,M,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3062,234,Y,N,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_cptac_2020, brca_metabric, breast_cptac_gdc, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_sysucc_2022, egc_msk_2017, gbc_msk_2018, gbc_mskcc_2022, hcc_msk_2024, hgsoc_tcga_gdc, lymphoma_cellline_msk_2020, mbn_sfu_2023, mds_iwg_2022, mnm_washu_2016, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nhl_bcgsc_2013, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020","Bladder/Urinary Tract, Breast, Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Hodgkin Lymphoma, Pancreas","hg19,17:7577581-7577581, hg19,17:7674263-7674263, hg38,17:7674263-7674263, hg38,17:7674263-7674264","hg19,17:g.7577581A>T, hg19,17:g.7674263A>T, hg38,17:g.7674263A>T, hg38,17:g.7674263_7674264delinsTA",0.941,", adrenal_gland, adrenal_gland, biliary_tract, gallbladder, breast, central_nervous_system, parietooccipital, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, rectum, liver, oesophagus, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, skin, upper_aerodigestive_tract, pharynx, oropharynx",", adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, other, keratoacanthoma, other, neoplasm, other, pterygium",,,,,376692,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,2,,,,,,
3063,234,Y,P,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3064,234,Y,Q,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577579-7577581, hg38,17:7674261-7674263","hg19,17:g.7577579_7577581delinsCTG, hg38,17:g.7674261_7674263delinsCTG",,,,,,,,2751786,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3065,234,Y,R,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674262-7674263","hg38,17:g.7674262_7674263delinsCG",,breast,"carcinoma, HER-positive_carcinoma",,,,,,,,,,,,,,
3066,234,Y,S,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_dldccc_2022, ccle_broad_2025, hnsc_jhu, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020","Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate Adenocarcinoma","hg19,17:7577580-7577580, hg19,17:7674262-7674262, hg38,17:7674262-7674262","hg19,17:g.7577580T>G, hg19,17:g.7674262T>G, hg38,17:g.7674262T>G",0.936,", endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, abdomen, lung, ovary, prostate, skin, skin, forearm, testis, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, teratoma, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant, lymphoid_neoplasm, acute_lymphoblastic_leukaemia",,,,,376690,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3067,234,Y,T,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3068,234,Y,V,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3069,234,Y,W,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3070,235,N,A,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3071,235,N,C,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3072,235,N,D,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, cervix_msk_2023, gbm_tcga_pub, glioma_mskcc_2019, lung_msk_2017, msk_access_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pancan_mimsi_msk_2024, pancan_pdmr_2025, sarcoma_msk_2022, sarcoma_mskcc_2022","Adenoid Cystic Carcinoma, Bladder/Urinary Tract, Cervix, Diffuse Glioma, Lung Adenocarcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577578-7577578, hg38,17:7674260-7674260","hg19,17:g.7577578T>C, hg38,17:g.7674260T>C",0.912,"central_nervous_system, brain, cervix, large_intestine, large_intestine, colon, large_intestine, colon, right, large_intestine, rectum, liver, lung, skin, head_neck, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, synovial_sarcoma",,,,,919580,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Oncogenic,Neoplasm,1,,,
3073,235,N,E,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3074,235,N,F,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3075,235,N,G,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3076,235,N,H,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674260-7674260","hg38,17:g.7674260T>G",0.902,prostate,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3077,235,N,I,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577577-7577577, hg38,17:7674259-7674259","hg19,17:g.7577577T>A, hg38,17:g.7674259T>A",0.886,"large_intestine, rectum, skin","carcinoma, adenocarcinoma, in_situ_epithelial_neoplasm, actinic_keratosis",0.0000039763961127,,,,3673072,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3078,235,N,K,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_met_2021, paired_bladder_2022, pan_origimed_2020","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7577576-7577576","hg19,17:g.7577576G>C",0.565,,,,,,,,,,,,,,,,
3079,235,N,L,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3080,235,N,M,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674258-7674259","hg38,17:g.7674258_7674259delinsCA",,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3081,235,N,P,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3082,235,N,Q,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3083,235,N,R,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3084,235,N,S,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","difg_msk_2023, gbm_mayo_pdx_sarkaria_2019, glioma_mskcc_2019, heme_msk_impact_2022, mbn_msk_2024, mds_iwg_2022, msk_impact_2017, sarcoma_msk_2022","Diffuse Glioma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7577577-7577577, hg38,17:7674259-7674259","hg19,17:g.7577577T>C, hg38,17:g.7674259T>C",0.593,", breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, eye, uveal_tract, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, rectum, lung, meninges, oesophagus, ovary, prostate, skin, thymus, urinary_tract, bladder, urinary_tract, renal_pelvis","benign_melanocytic_nevus, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma, pleomorphic_xanthoastrocytoma, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia, haematopoietic_neoplasm, chronic_neutrophilic_leukaemia, low_malignant_potential_(borderline)_tumour, mucinous, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, meningioma, other, Barrett_oesophagus, with_high_grade_dysplasia, thymoma",0.0001789378250704,0.0003198362438432,,,127821,Benign,TP53-related disorder;Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;Rhabdomyosarcoma;not specified;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Squamous cell carcinoma of the head and neck,3,,,,,,
3085,235,N,T,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",mds_iwg_2022,Myelodysplastic Syndromes,"hg19,17:7577577-7577577, hg38,17:7674259-7674259","hg19,17:g.7577577T>G, hg38,17:g.7674259T>G",0.872,"prostate, stomach","carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma",,,,,,,,,,,,,,
3086,235,N,V,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3087,235,N,W,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3088,235,N,Y,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577578-7577578, hg38,17:7674260-7674260","hg19,17:g.7577578T>A, hg38,17:g.7674260T>A",0.932,"endometrium, upper_aerodigestive_tract, larynx","carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,188206,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3089,236,Y,A,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3090,236,Y,C,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_dfarber_mskcc_2014, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brain_cptac_2020, brca_cptac_2020, brca_mapk_hp_msk_2021, brca_metabric, brca_sanger, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, cll_broad_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_glass, difg_glass_2019, difg_tcga_gdc, dlbc_broad_2012, dlbcl_dfci_2018, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, gbm_mayo_pdx_sarkaria_2019, glioma_mskcc_2019, hcc_clca_2024, hcc_jcopo_msk_2023, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_cptac_2020, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_mdacc_2013, mbn_sfu_2023, metastatic_solid_tumors_mich_2017, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_icgc, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mich, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_oncosg_2018, stad_pfizer_uhongkong, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_tcga_pan_can_atlas_2018, utuc_msk_2019, utuc_mskcc_2015","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Upper Tract Urothelial Carcinoma","hg19,17:7577574-7577574, hg19,17:7674256-7674256, hg38,17:7674256-7674256","hg19,17:g.7577574T>C, hg19,17:g.7674256T>C, hg38,17:g.7674256T>C",0.811,"biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, small_intestine, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_lower_lobe, oesophagus, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, skin, skin, head_neck, skin, leg, skin, mucosal, female_genitourinary_system, soft_tissue, fat, upper_leg, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach, testis, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, bladder","carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, medullary_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, signet_ring_adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, chondrosarcoma, dedifferentiated, gastrointestinal_stromal_tumour, germ_cell_tumour, mixed, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, liposarcoma, pleomorphic, lymphoid_neoplasm, B_cell_lymphoma_unspecified, lymphoid_neoplasm, B_cell_prolymphocytic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, malignant_melanoma, other, neoplasm, other, neoplasm, malignant",,,,,376693,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1,1,Oncogenic,Neoplasm,1,,,
3091,236,Y,D,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mbcproject_2022, brca_smc_2018, breast_ink4_msk_2021, breast_msk_2025, coad_silu_2022, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_oncosg_2020, mbn_sfu_2023, mds_mskcc_2020, mixed_allen_2018, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancreas_msk_2024, pdac_msk_2024, skcm_dfci_2015, tmb_mskcc_2018, ucec_tcga_gdc","Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas","hg19,17:7577575-7577575, hg19,17:7674257-7674257, hg38,17:7674257-7674257","hg19,17:g.7577575A>C, hg19,17:g.7674257A>C, hg38,17:g.7674257A>C",0.845,"central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, jaw, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, stomach, large_intestine, caecum, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, pancreas, skin, back, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, sinonasal_and_nasal_cavity","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, malignant_melanoma, superficial_spreading",,,,,142183,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3092,236,Y,E,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3093,236,Y,F,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",luad_oncosg_2020,Lung Adenocarcinoma,"hg19,17:7577574-7577574, hg38,17:7674256-7674256","hg19,17:g.7577574T>A, hg38,17:g.7674256T>A",0.468,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3094,236,Y,G,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3095,236,Y,H,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, brca_igr_2015, brca_mskcc_2019, ccle_broad_2025, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, dlbcl_duke_2017, egc_msk_2023, egc_trap_ccr_msk_2023, glioma_mskcc_2019, hcc_msk_2024, ihch_msk_2021, lms_msk_2024, lung_msk_2017, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, paad_cptac_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, pog570_bcgsc_2020, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2024","Ampullary Carcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Soft Tissue","hg19,17:7577575-7577575, hg19,17:7674257-7674257, hg38,17:7674257-7674257","hg19,17:g.7577575A>G, hg19,17:g.7674257A>G, hg38,17:g.7674257A>G",0.772,"biliary_tract, bile_duct, breast, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, extranodal, large_intestine, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, skin, face, skin, forearm, skin, head_neck, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, sex_cord-stromal_tumour, granulosa_cell_tumour",,,,,216469,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
3096,236,Y,I,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3097,236,Y,K,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3098,236,Y,L,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674255-7674256","hg38,17:g.7674255_7674256delinsTA",,lung,carcinoid-endocrine_tumour,,,,,,,,,,,,,,
3099,236,Y,M,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3100,236,Y,N,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2025, crc_eo_2020, crc_msk_2017, cscc_hgsc_bcm_2014, glioma_mskcc_2019, mbn_sfu_2023, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, paad_icgc, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, prostate_dkfz_2018, sarcoma_msk_2022","Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreatic Adenocarcinoma, Prostate, Soft Tissue","hg19,17:7577575-7577575, hg19,17:7674257-7674257, hg38,17:7674257-7674257","hg19,17:g.7577575A>T, hg19,17:g.7674257A>T, hg38,17:g.7674257A>T",0.837,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, testis, large_intestine, large_intestine, caecum, large_intestine, colon, lung, oesophagus, pancreas, skin, skin, head_neck, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, M5, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, M5, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma",,,,,376694,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3101,236,Y,P,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3102,236,Y,Q,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3103,236,Y,R,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3104,236,Y,S,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_metabric, ccle_broad_2025, glioma_mskcc_2019, heme_msk_impact_2022, luad_cptac_gdc, mbn_msk_2024, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tracerx_2017, pan_origimed_2020, pancan_pcawg_2020","Basal Cell Carcinoma, Diffuse Glioma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer","hg19,17:7577573-7577574, hg19,17:7577574-7577574, hg19,17:7674256-7674256, hg38,17:7674255-7674256, hg38,17:7674256-7674256","hg19,17:g.7577573_7577574delinsAG, hg19,17:g.7577574T>G, hg19,17:g.7674256T>G, hg38,17:g.7674255_7674256delinsAG, hg38,17:g.7674256T>G",0.780,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, stomach, large_intestine, lung, oesophagus, skin, stomach, urinary_tract","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant",,,,,182966,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,Tier I - Strong,"Diffuse glioma, H3 G34 mutant",1
3105,236,Y,T,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3106,236,Y,V,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3107,236,Y,W,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3108,237,M,A,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3109,237,M,C,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3110,237,M,D,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3111,237,M,E,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3112,237,M,F,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3113,237,M,G,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3114,237,M,H,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3115,237,M,I,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ampca_bcm_2016, appendiceal_msk_2022, bcc_unige_2016, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_metabric, brca_msk_2025, brca_smc_2018, brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_mskcc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_ucsf_2021, difg_tcga_gdc, dlbcl_dfci_2018, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_tmucih_2015, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, gbc_mskcc_2022, glioma_mskcc_2019, hcc_jcopo_msk_2023, hcc_msk_2024, hcc_tcga_gdc, heme_msk_impact_2022, hgsoc_msk_2021, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_cas_2020, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lung_pdx_msk_2021, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, makeanimpact_ccr_2023, mbl_sickkids_2016, mbn_mdacc_2013, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_qcmg_uq_2016, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, plmeso_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_eururol_2017, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, sft_sysucc_2023, soft_tissue_tcga_gdc, stad_oncosg_2018, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stad_uhongkong, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucs_jhu_2014, uec_cptac_gdc, uec_msk_2024, usarc_msk_2020","Adenoid Cystic Carcinoma, Ampullary Carcinoma, Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Medulloblastoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma, Uterine Sarcoma/Mesenchymal","hg19,17:7577570-7577570, hg19,17:7674252-7674252, hg38,17:7674252-7674252","hg19,17:g.7577570C>A, hg19,17:g.7577570C>G, hg19,17:g.7577570C>T, hg19,17:g.7674252C>A, hg19,17:g.7674252C>G, hg19,17:g.7674252C>T, hg38,17:g.7674252C>A, hg38,17:g.7674252C>G, hg38,17:g.7674252C>T",0.923,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, cerebellum, central_nervous_system, occipital_lobe, central_nervous_system, supratentorial, cervix, endometrium, eye, uveal_tract, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, small_intestine, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, lung, lower_lobe, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pleura, prostate, salivary_gland, skin, skin, lip, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, soft_tissue, fibrous_tissue_and_uncertain_origin, chest_wall, soft_tissue, smooth_muscle, uterus, stomach, stomach, gastroesophageal_junction, testis, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, mouth_roof, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, bladder, urinary_tract, bladder, urachus","adenoma, adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, acinic_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, medullary_carcinoma, carcinoma, mesonephric_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, osteoclast-like_giant_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, germ_cell_tumour, seminoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M2, haematopoietic_neoplasm, acute_myeloid_leukaemia, M5, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, hyperplasia, leiomyosarcoma, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, variant, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, mesothelioma, epithelial, osteosarcoma, other, other, central_neurocytoma, other, dysplasia-in_situ_neoplasm, other, neoplasm, other, neoplasm, malignant, primitive_neuroectodermal_tumour-medulloblastoma, sarcoma, thymic_carcinoma, thymic_carcinoma, poorly_differentiated, undifferentiated-unclassified_sarcoma, mixed, undifferentiated_sarcoma, pleomorphic",0.0000039763961127,,,,"1757269, 634770, 142714","Pathogenic/Likely pathogenic, Pathogenic/Likely pathogenic, Pathogenic","Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Malignant tumor of urinary bladder;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Breast and/or ovarian cancer;not specified;not provided;Ovarian neoplasm;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome","2, 2, 3",Oncogenic,Neoplasm,1,"Tier I - Strong, Tier II - Potential","Medulloblastoma SHH activated and TP53 mutant;Primary intracranial sarcoma, DICER1-mutant|Clear cell sarcoma","1, 1"
3116,237,M,K,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, crc_eo_2020, difg_msk_2023, egc_msk_2023, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, hcc_msk_2024, hgsoc_tcga_gdc, ihch_mskcc_2020, lms_msk_2024, lung_msk_2017, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, prad_msk_stopsack_2021, prad_su2c_2019, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, stad_oncosg_2018, stad_pfizer_uhongkong, tmb_mskcc_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Bowel, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577571-7577571, hg19,17:7674253-7674253, hg38,17:7674253-7674253","hg19,17:g.7577571A>T, hg19,17:g.7674253A>T, hg38,17:g.7674253A>T",0.957,"biliary_tract, gallbladder, breast, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, scalp, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, buccal_mucosa","carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, other, neoplasm, malignant",0.0000000000000000,,,,376636,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1;Acute myeloid leukemia;Li-Fraumeni syndrome,2,Likely oncogenic,Neoplasm,1,,,
3117,237,M,L,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","hccihch_pku_2019, luad_mskimpact_2021, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, sarcoma_msk_2022","Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577572-7577572, hg19,17:7674254-7674254, hg38,17:7674254-7674254","hg19,17:g.7577572T>A, hg19,17:g.7577572T>G, hg19,17:g.7674254T>A, hg38,17:g.7674254T>A, hg38,17:g.7674254T>G",0.941,"cervix, haematopoietic_and_lymphoid_tissue, lung, ovary","carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,"2774649, 1757126","Uncertain significance, Uncertain significance",Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome,"1, 1",,,,,,
3118,237,M,N,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3119,237,M,P,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3120,237,M,Q,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3121,237,M,R,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","coadread_mskcc, mbn_mdacc_2013","Colorectal Adenocarcinoma, Mature B-Cell Neoplasms","hg19,17:7577571-7577571, hg38,17:7674253-7674253","hg19,17:g.7577571A>C, hg38,17:g.7674253A>C",0.948,"haematopoietic_and_lymphoid_tissue, lymph_node, pancreas, prostate","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, lymphoid_neoplasm",,,,,419524,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,2,,,,,,
3122,237,M,S,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3123,237,M,T,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577571-7577571, hg38,17:7674253-7674253","hg19,17:g.7577571A>G, hg38,17:g.7674253A>G",0.948,"large_intestine, colon, lung","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,481069,Uncertain significance,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;not provided;Hereditary cancer-predisposing syndrome,2,,,,,,
3124,237,M,V,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, cll_broad_2022, coad_cptac_2019, coad_cptac_gdc, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_tp53_ccr_2022, hcc_meric_2021, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, luad_oncosg_2020, msk_chord_2024, msk_met_2021, nsclc_ctdx_msk_2022, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577572-7577572, hg19,17:7674254-7674254, hg38,17:7674254-7674254","hg19,17:g.7577572T>C, hg19,17:g.7674254T>C, hg38,17:g.7674254T>C",0.937,"autonomic_ganglia, sinonasal_and_nasal_cavity, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, oesophagus, ovary, salivary_gland, mouth_roof, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, polymorphous_low_grade_adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, olfactory_neuroblastoma",,,,,182934,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
3125,237,M,W,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3126,237,M,Y,,,,,,,,,,,,"Y-based sorting signal (TRG_ENDOCYTIC_2), 234-237, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3127,238,C,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3128,238,C,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3129,238,C,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3130,238,C,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, bladder_msk_2023, blca_bcan_hcrn_2022, blca_dfarber_mskcc_2014, blca_msk_tcga_2020, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brain_cptac_gdc, brca_fuscc_2020, brca_igr_2015, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cesc_tcga, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, coadread_cass_2020, coadread_genentech, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, es_dsrct_msk_2023, escc_ucla_2014, gbc_mskcc_2022, gbm_cptac_2021, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, hccihch_pku_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_smmu_2014, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2015, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tsp, lung_msk_2017, lung_msk_pdx, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_msk_2024, mds_mskcc_2020, meso_tcga, meso_tcga_pan_can_atlas_2018, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_kunga_msk_2022, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2015, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, plmeso_tcga_gdc, prad_cdk12_mskcc_2020, prad_cpcg_2017, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_ucla_2024, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Ampullary Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, CNS/Brain, Cervical Squamous Cell Carcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577568-7577568, hg19,17:7674250-7674250, hg38,17:7674250-7674250","hg19,17:g.7577568C>A, hg19,17:g.7674250C>A, hg38,17:g.7674250C>A",0.958,"biliary_tract, bile_duct, breast, central_nervous_system, brain, cervix, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, liver, lung, meninges, oesophagus, oesophagus, middle_third, ovary, pancreas, peritoneum, appendix, prostate, salivary_gland, skin, skin, arm, skin, mucosal, vulva, soft_tissue, fibrous_tissue_and_uncertain_origin, frontal_lobe, soft_tissue, smooth_muscle, soft_tissue, smooth_muscle, uterus, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, urinary_tract, renal_pelvis","carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, blastoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, in_situ_epithelial_neoplasm, actinic_keratosis, leiomyosarcoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, meningioma, haemangiopericytic, other, neoplasm, other, pseudomyxoma_peritonei, sarcoma",,,,,376574,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3131,238,C,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_pareja_msk_2020, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coad_silu_2022, egc_mskcc_2020, heme_msk_impact_2022, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, lung_msk_2017, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, ucs_msk_2024","Colon Adenocarcinoma, Endometrial Carcinoma, Esophagus/Stomach, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature T and NK Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577569-7577569, hg19,17:7674251-7674251, hg38,17:7674251-7674251","hg19,17:g.7577569A>C, hg19,17:g.7674251A>C, hg38,17:g.7674251A>C",0.938,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, rectum, liver, lung, ovary, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, serous_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,376577,Pathogenic/Likely pathogenic,Ovarian neoplasm;Li-Fraumeni syndrome;not provided;Hereditary cancer-predisposing syndrome,2,,,,,,
3132,238,C,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3133,238,C,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3134,238,C,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3135,238,C,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3136,238,C,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3137,238,C,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3138,238,C,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3139,238,C,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3140,238,C,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_dfarber_mskcc_2014, blca_msk_tcga_2020, blca_mskcc_solit_2014, brca_metabric, brca_msk_2025, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, coad_caseccc_2015, escc_icgc, gbc_mskcc_2022, hcc_msk_2024, hcc_tcga_gdc, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, lung_msk_2017, mixed_allen_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Breast, Colon Adenocarcinoma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577569-7577569, hg19,17:7674251-7674251, hg38,17:7674251-7674251","hg19,17:g.7577569A>G, hg19,17:g.7674251A>G, hg38,17:g.7674251A>G",0.954,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, submandibular, small_intestine, ileum, testis, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, buccal_mucosa, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma_non_invasive, germ_cell_tumour, mixed, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, other, Barrett_oesophagus, with_high_grade_dysplasia",,,,,376576,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3141,238,C,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, bcc_unige_2016, brca_dldccc_2022, brca_metabric, breast_alpelisib_2020, breast_msk_2018, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cll_broad_2015, cll_broad_2022, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, glioma_mskcc_2019, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lcll_broad_2013, luad_mskcc_2023_met_organotropism, lusc_tcga_pan_can_atlas_2018, mbn_mdacc_2013, mds_iwg_2022, mixed_allen_2018, mm_broad, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pact_jhu_2011, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Ampullary Carcinoma, Basal Cell Carcinoma, Bladder/Urinary Tract, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Cystic Tumor of the Pancreas, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Plasma Cell Myeloma, Soft Tissue","hg19,17:7577568-7577568, hg19,17:7577569-7577569, hg19,17:7674250-7674250, hg19,17:7674251-7674251, hg38,17:7674250-7674250, hg38,17:7674251-7674251","hg19,17:g.7577568C>G, hg19,17:g.7577569A>T, hg19,17:g.7674250C>G, hg19,17:g.7674251A>T, hg38,17:g.7674250C>G, hg38,17:g.7674251A>T","0.946, 0.956",", biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, central_nervous_system, spinal_cord, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, kidney, liver, lung, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, skin, skin, eye, skin, face, small_intestine, jejunum, soft_tissue, blood_vessel, soft_tissue, smooth_muscle, leg, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Kaposi_sarcoma, adnexal_tumour, malignant_adnexal_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelofibrosis, primary, leiomyosarcoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, Ph-like, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, cystic_tumour, other, intraductal_papillary_neoplasm",,,,,"485039, 376575","Conflicting classifications of pathogenicity, Pathogenic/Likely pathogenic",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,"1, 2",,,,,,
3142,238,C,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3143,238,C,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3144,238,C,W,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_dldccc_2022, brca_metabric, breast_msk_2025, cscc_ucsf_2021, hcc_meric_2021, heme_msk_impact_2022, lung_msk_2017, mbn_sfu_2023, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Cutaneous Squamous Cell Carcinoma, Endometrial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Prostate Adenocarcinoma","hg19,17:7577567-7577567, hg19,17:7674249-7674249, hg38,17:7674249-7674249","hg19,17:g.7577567A>C, hg19,17:g.7674249A>C, hg38,17:g.7674249A>C",0.896,"cervix, endometrium, large_intestine, colon, lung, ovary, prostate, skin, arm, skin, chest, urinary_tract, bladder","adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, other, keratosis",,,,,161515,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Prostate cancer,2,,,,,,
3145,238,C,Y,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, bladder_msk_2024, blca_msk_tcga_2020, blca_pdx_msk_2025, bm_nsclc_mskcc_2023, brca_cptac_2020, brca_dldccc_2022, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, coad_caseccc_2015, coad_cptac_2019, coad_cptac_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_ucsf_2021, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, gbm_mayo_pdx_sarkaria_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gist_msk_2025, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_cas_2020, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, mbc_msk_2021, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mixed_allen_2018, mixed_cfdna_msk_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_cptac_2021, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_su2c_2019, prostate_msk_2024, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_tcga_gdc, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, utuc_msk_2019, utuc_pdx_msk_2019","Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gastrointestinal Stromal Tumor, Head and Neck, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Metaplastic Breast Cancer, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Upper Tract Urothelial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577568-7577568, hg19,17:7674250-7674250, hg38,17:7674250-7674250","hg19,17:g.7577568C>T, hg19,17:g.7674250C>T, hg38,17:g.7674250C>T",0.957,"biliary_tract, bile_duct, biliary_tract, gallbladder, bone, mandible, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, frontal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, breast, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, parotid, skin, skin, head_neck, small_intestine, duodenum, small_intestine, jejunum, soft_tissue, soft_tissue, fat, chest, soft_tissue, fibrous_tissue_and_uncertain_origin, soft_tissue, fibrous_tissue_and_uncertain_origin, lower_leg, soft_tissue, fibrous_tissue_and_uncertain_origin, pancreas, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, soft_tissue, nerve_sheath, chest, soft_tissue, nerve_sheath, head_neck, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder","adenoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, acinic_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal_type, carcinoma, adenoid_cystic_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, lobular_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, polycythaemia_vera, liposarcoma, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, breast_implant_associated_anaplastic_large_cell_lymphoma_invasive, ALK_negative, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, malignant_melanoma, malignant_peripheral_nerve_sheath_tumour, other, ameloblastoma, sarcoma, synovial_sarcoma, undifferentiated-unclassified_sarcoma, pleomorphic, undifferentiated_sarcoma, pleomorphic",0.0000079531084724,,,,182935,Pathogenic/Likely pathogenic,"Gallbladder cancer;Hereditary cancer-predisposing syndrome;not provided;Hereditary breast ovarian cancer syndrome;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1",2,Oncogenic,Neoplasm,1,,,
3146,239,N,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3147,239,N,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3148,239,N,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ampca_bcm_2016, bowel_colitis_msk_2022, brca_mapk_hp_msk_2021, brca_metabric, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, chol_icgc_2017, chrcc_tcga_gdc, cll_broad_2022, cll_iuopa_2015, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, dlbc_broad_2012, dlbcl_dfci_2018, dlbcl_duke_2017, egc_msk_2023, gbc_msk_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_jcopo_msk_2023, hcc_msk_2024, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_pdx, lung_nci_2022, lung_pdx_msk_2021, mbn_mdacc_2013, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_selpercatinib_2020, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, prostate_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014","Adenoid Cystic Carcinoma, Ampullary Carcinoma, Bowel, Breast, Cholangiocarcinoma, Chromophobe Renal Cell Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577566-7577566, hg19,17:7674248-7674248, hg38,17:7674248-7674248","hg19,17:g.7577566T>C, hg19,17:g.7674248T>C, hg38,17:g.7674248T>C",0.948,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, fallopian_tube, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, peritoneum, appendix, prostate, salivary_gland, salivary_gland, major, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract, bladder","carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, lobular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myeloproliferative_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, neoplasm, other, oesophagitis, other, pseudomyxoma_peritonei",,,,,234036,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary;Malignant tumor of breast",1,,,,,,
3149,239,N,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3150,239,N,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3151,239,N,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3152,239,N,H,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, cfdna_msk_2019, msk_impact_2017, msk_met_2021","Breast, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7577566-7577566, hg38,17:7674248-7674248","hg19,17:g.7577566T>G, hg38,17:g.7674248T>G",0.927,breast,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
3153,239,N,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, mds_iwg_2022, nsclc_ctdx_msk_2022, pan_origimed_2020, sarcoma_msk_2022","Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577565-7577565, hg38,17:7674247-7674247","hg19,17:g.7577565T>A, hg38,17:g.7674247T>A",0.943,urinary_tract,"carcinoma, transitional_cell_carcinoma",,,,,2748594,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3154,239,N,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, hcc_clca_2024, heme_msk_impact_2022, luad_mskimpact_2021, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_mimsi_msk_2024, prad_msk_stopsack_2021, prad_mskcc_2017, prad_organoids_msk_2022, prostate_msk_2024, sarcoma_msk_2022, ucec_msk_2018","Endometrial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577564-7577564, hg38,17:7674246-7674246","hg19,17:g.7577564G>C, hg19,17:g.7577564G>T, hg38,17:g.7674246G>C, hg38,17:g.7674246G>T",0.811,"biliary_tract, gallbladder, central_nervous_system, brain, endometrium, kidney, large_intestine, liver, prostate, upper_aerodigestive_tract, mouth, mouth_roof","Wilms_tumour, unilateral, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, oligoastrocytoma",,,,,"4189258, 385614","Pathogenic, Conflicting classifications of pathogenicity","Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome","1, 1",,,,,,
3155,239,N,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3156,239,N,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3157,239,N,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3158,239,N,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3159,239,N,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3160,239,N,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, brca_broad, brca_mapk_hp_msk_2021, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cfdna_msk_2019, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, dlbcl_dfci_2018, gbc_mskcc_2022, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, kirc_tcga, lihc_tcga, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Bladder/Urinary Tract, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577565-7577565, hg19,17:7674247-7674247, hg38,17:7674246-7674247, hg38,17:7674247-7674247","hg19,17:g.7577565T>C, hg19,17:g.7674247T>C, hg38,17:g.7674246_7674247inv, hg38,17:g.7674247T>C",0.897,"adrenal_gland, adrenal_gland, breast, central_nervous_system, brain, endometrium, extrapulmonary, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, parotid, soft_tissue, fat, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract, bladder, vulva","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucoepidermoid_carcinoma, carcinoma, normal-like_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, liposarcoma, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia",,,,,376637,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3161,239,N,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, blca_msk_2024, blca_mskcc_solit_2012, luad_cas_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, stad_oncosg_2018, stad_pfizer_uhongkong","Ampullary Carcinoma, Bladder Urothelial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,17:7577565-7577565, hg38,17:7674247-7674247","hg19,17:g.7577565T>G, hg38,17:g.7674247T>G",0.935,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, liver, lung, oesophagus, pancreas, ampulla_of_Vater, stomach, thyroid, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, oligoastrocytoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation",,,,,376638,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3162,239,N,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3163,239,N,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3164,239,N,Y,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","heme_msk_impact_2022, mbn_msk_2024","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,17:7577566-7577566, hg38,17:7674248-7674248","hg19,17:g.7577566T>A, hg38,17:g.7674248T>A",0.905,"large_intestine, large_intestine, rectum, ovary, prostate","carcinoma, carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3165,240,S,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3166,240,S,C,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","esca_tcga, hcc_clca_2024, lung_msk_mind_2020, msk_access_2021, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, stes_tcga_pub, tmb_mskcc_2018","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma, Lung, Mixed Cancer Types","hg19,17:7577563-7577563, hg38,17:7674245-7674245","hg19,17:g.7577563T>A, hg38,17:g.7674245T>A",0.923,"haematopoietic_and_lymphoid_tissue, liver, lung, oesophagus","carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, polycythaemia_vera, other, neoplasm",,,,,3972460,Likely pathogenic,Hereditary cancer-predisposing syndrome,1,,,,,,
3167,240,S,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3168,240,S,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3169,240,S,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","luad_msk_npjpo_2021, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7577562-7577563, hg38,17:7674244-7674245","hg19,17:g.7577562_7577563delinsAA, hg38,17:g.7674244_7674245delinsAA",,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3170,240,S,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, difg_msk_2023, dlbcl_duke_2017, glioma_mskcc_2019, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Bladder/Urinary Tract, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577563-7577563, hg19,17:7674245-7674245, hg38,17:7674245-7674245","hg19,17:g.7577563T>C, hg19,17:g.7674245T>C, hg38,17:g.7674245T>C",0.872,", bone, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, lung, oesophagus, soft_tissue, blood_vessel, arm, soft_tissue, blood_vessel, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, urinary_tract, bladder","angiosarcoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, chondrosarcoma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, osteosarcoma, other, intraepithelial_neoplasia, low_grade",,,,,584921,Pathogenic/Likely pathogenic,TP53-related disorder;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck,2,,,,,,
3171,240,S,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3172,240,S,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_ch_2023,Mixed Cancer Types,"hg19,17:7577562-7577562, hg38,17:7674244-7674244","hg19,17:g.7577562C>A, hg38,17:g.7674244C>A",0.883,"breast, cervix, large_intestine, oesophagus, upper_aerodigestive_tract, larynx, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,1036853,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3173,240,S,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3174,240,S,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3175,240,S,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3176,240,S,N,,,,,,,,,,,,,,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",blca_msk_2025,Bladder Urothelial Carcinoma,"hg19,17:7577562-7577562, hg38,17:7674244-7674244","hg19,17:g.7577562C>T, hg38,17:g.7674244C>T",0.750,,,,,,,2502882,Pathogenic,Acute myeloid leukemia,0,,,,,,
3177,240,S,P,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674243-7674245","hg38,17:g.7674243_7674245delinsGGG",,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3178,240,S,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3179,240,S,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, heme_msk_impact_2022, lusc_cptac_2021, lusc_cptac_gdc, mbn_msk_2024, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_utsw_2015, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577561-7577561, hg19,17:7577563-7577563, hg19,17:7674243-7674243, hg38,17:7674243-7674243, hg38,17:7674245-7674245","hg19,17:g.7577561A>C, hg19,17:g.7577561A>T, hg19,17:g.7577563T>G, hg19,17:g.7674243A>C, hg19,17:g.7674243A>T, hg38,17:g.7674243A>C, hg38,17:g.7674243A>T, hg38,17:g.7674245T>G","0.908, 0.939",", breast, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, caecum, large_intestine, colon, lung, oesophagus, pancreas, prostate, soft_tissue, blood_vessel, scalp, stomach, urinary_tract, bladder","angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, malignant_melanoma",,,,,"1504304, 826894, 458559","Uncertain significance, Conflicting classifications of pathogenicity, Uncertain significance",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;not specified|not provided;Li-Fraumeni syndrome,"2, 1, 2",,,,,,
3180,240,S,T,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674244-7674244","hg38,17:g.7674244C>G",0.800,"central_nervous_system, brain, ovary","carcinoma, glioma, oligodendroglioma",,,,,,,,,,,,,,
3181,240,S,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3182,240,S,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3183,240,S,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3184,241,S,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cll_broad_2015, cll_broad_2022, hcc_jcopo_msk_2023, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mappyacts_2022, pancan_pcawg_2020","Bladder/Urinary Tract, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577560-7577560, hg19,17:7674242-7674242, hg38,17:7674242-7674242","hg19,17:g.7577560A>C, hg19,17:g.7674242A>C, hg38,17:g.7674242A>C",0.858,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, large_intestine, colon, lung, ovary, prostate","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, serous_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, oligodendroglioma_Grade_II, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, plasma_cell_myeloma",,,,,376665,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3185,241,S,C,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_bcan_hcrn_2022, blca_cornell_2016, blca_dfarber_mskcc_2014, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_mskcc_solit_2014, brca_metabric, brca_msk_2025, brca_mskcc_2019, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, ccrcc_tcga_gdc, cellline_ccle_broad, coad_silu_2022, coadread_dfci_2016, crc_apc_impact_2020, crc_msk_2017, csf_msk_2024, gbc_shanghai_2014, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, kirc_tcga, kirc_tcga_pub, kirp_tcga, kirp_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_msk_2024, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prcc_tcga_gdc, rectal_msk_2019, sarcoma_msk_2022, sclc_ucologne_2015, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_cptac_2020, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_msk_2024, uec_cptac_gdc","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Papillary Renal Cell Carcinoma, Renal Clear Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue, Thyroid, Uterine Endometrioid Carcinoma","hg19,17:7577559-7577559, hg19,17:7674241-7674241, hg38,17:7674241-7674241","hg19,17:g.7577559G>C, hg19,17:g.7674241G>C, hg38,17:g.7674241G>C",0.952,", biliary_tract, gallbladder, bone, femur, breast, cervix, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, head_neck, stomach, thyroid, upper_aerodigestive_tract, head_neck, urinary_tract, bladder, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, papillary_renal_cell_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, M2, haematopoietic_neoplasm, acute_myeloid_leukaemia_myelodysplastic_syndrome_therapy_related_NOS, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, other, neoplasm",0.0000000000000000,,,,177791,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Likely oncogenic,Neoplasm,1,,,
3186,241,S,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3187,241,S,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3188,241,S,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, angs_painter_2020, angs_painter_2025, angs_project_painter_2018, appendiceal_msk_2022, bcc_unige_2016, bladder_columbia_msk_2018, blca_bcan_hcrn_2022, blca_bgi, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_pdx_msk_2025, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bowel_colitis_msk_2022, brca_aurora_2023, brca_bccrc, brca_mapk_hp_msk_2021, brca_metabric, brca_msk_2025, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, chol_icgc_2017, chol_tcga, chol_tcga_gdc, chol_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, cscc_dfarber_2015, cscc_hgsc_bcm_2014, cscc_ranson_2022, csf_msk_2024, difg_glass, difg_glass_2019, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbc_msk_2018, gbc_mskcc_2022, glioma_msk_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, hccihch_pku_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, ihch_smmu_2014, kich_tcga, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_nci_2022, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, mel_dfci_2019, mel_iatlas_liu_2019, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, normal_skin_keratinocytes_2024, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, skcm_broad, skcm_dfci_2015, skcm_mskcc_2014, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, skcm_vanderbilt_mskcc_2015, soft_tissue_tcga_gdc, stes_tcga_pub, thyroid_gatci_2024, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, utuc_msk_2019, utuc_pdx_msk_2019","Ampullary Carcinoma, Angiosarcoma, Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervical Squamous Cell Carcinoma, Cholangiocarcinoma, Chromophobe Renal Cell Carcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck, Head and Neck Carcinoma, Other, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Skin, Small Cell Lung Cancer, Soft Tissue, Thyroid, Upper Tract Urothelial Carcinoma","hg19,17:7577558-7577559, hg19,17:7577559-7577559, hg19,17:7674240-7674241, hg19,17:7674241-7674241, hg38,17:7674240-7674241, hg38,17:7674241-7674241","hg19,17:g.7577558_7577559delinsAA, hg19,17:g.7577559G>A, hg19,17:g.7674240_7674241delinsAA, hg19,17:g.7674241G>A, hg38,17:g.7674240_7674241delinsAA, hg38,17:g.7674241G>A",0.958,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, parietooccipital, central_nervous_system, thalamus, cervix, endometrium, eye, conjunctiva, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, kidney, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, penis, prostate, salivary_gland, skin, skin, arm, skin, extremity, skin, face, skin, forearm, skin, head_neck, skin, lower_leg, skin, mucosal, vulva, skin, scalp, skin, trunk, skin, upper_leg, small_intestine, duodenum, soft_tissue, soft_tissue, buttock, soft_tissue, fibrous_tissue_and_uncertain_origin, soft_tissue, fibrous_tissue_and_uncertain_origin, chest_wall, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, buccal_mucosa, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, adenoma-nodule-goitre, Hurthle_cell_adenoma, adnexal_tumour, malignant_adnexal_tumour, adnexal_tumour, other, sebaceoma, adnexal_tumour, sebaceous_adenoma, carcinoid-endocrine_tumour, carcinoid-endocrine_tumour, islet_cell, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, mucinous, carcinoma, endocervical_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, dermatofibrosarcoma_protuberans, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_leukaemic_transformation_of_primary_myelofibrosis, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, anaplastic_large_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, lymphomatoid_papulosis, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, in_situ_melanotic_neoplasm, malignant_melanoma, lentigo_maligna, malignant_melanoma, nodular, malignant_melanoma, superficial_spreading, other, dysplasia-in_situ_neoplasm, other, intraepithelial_neoplasia, other, neoplasm, primitive_neuroectodermal_tumour-medulloblastoma, sarcoma, undifferentiated_sarcoma, pleomorphic",0.0000039765226105,,,,12359,Pathogenic/Likely pathogenic,Hepatocellular carcinoma;not provided;Hereditary cancer-predisposing syndrome;Lip and oral cavity carcinoma;Ovarian neoplasm;Li-Fraumeni syndrome 1;Hepatoblastoma;Bone osteosarcoma;Li-Fraumeni syndrome,2,Oncogenic,Neoplasm,1,Tier I - Strong,"Medulloblastoma WNT activated;Diffuse midline glioma, H3 K27M-mutant;Spindle cell sarcoma",1
3189,241,S,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3190,241,S,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3191,241,S,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3192,241,S,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3193,241,S,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3194,241,S,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3195,241,S,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3196,241,S,P,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bowel_colitis_msk_2022, breast_msk_2025, ccle_broad_2025, chol_icgc_2017, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, hnsc_a5consortium_2025, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_cptac_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_cptac_gdc, pdac_msk_2024, pediatric_dkfz_2017, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Basal Cell Carcinoma, Bowel, Cholangiocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577560-7577560, hg19,17:7674242-7674242, hg38,17:7674242-7674242","hg19,17:g.7577560A>G, hg19,17:g.7674242A>G, hg38,17:g.7674242A>G",0.954,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, extranodal, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, sigmoid, lung, oesophagus, middle_third, pancreas, prostate, skin, urinary_tract, bladder","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, undifferentiated_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",0.0000039764593606,,,,376664,Uncertain significance,Ovarian neoplasm;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
3197,241,S,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3198,241,S,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3199,241,S,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","mixed_allen_2018, msk_chord_2024, msk_impact_2017, pan_origimed_2020, sarcoma_mskcc_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7577560-7577560, hg38,17:7674242-7674242","hg19,17:g.7577560A>T, hg38,17:g.7674242A>T",0.922,", autonomic_ganglia, breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, caecum, lung, oesophagus, upper_aerodigestive_tract, larynx, supraglottis, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, malignant_melanoma, neuroblastoma",,,,,959232,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,Tier I - Strong,"Embryonal rhabdomyosarcoma;Diffuse midline glioma, H3 K27M-mutant",1
3200,241,S,V,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,"soft_tissue, smooth_muscle",leiomyosarcoma,,,,,,,,,,,,,,
3201,241,S,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3202,241,S,Y,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_iatlas_imvigor210_2017, blca_plasmacytoid_mskcc_2016, brca_metabric, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coadread_genentech, difg_glass, difg_tcga_gdc, gbc_shanghai_2014, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, hcc_clca_2024, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga, ov_tcga_pub, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, prad_su2c_2019, sarcoma_msk_2022, sarcoma_msk_2023, skcm_broad, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, vsc_cuk_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue, Squamous Cell Carcinoma of the Vulva/Vagina, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577559-7577559, hg19,17:7674241-7674241, hg38,17:7674241-7674241","hg19,17:g.7577559G>T, hg19,17:g.7674241G>T, hg38,17:g.7674241G>T",0.960,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, brainstem, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, colon, large_intestine, rectum, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, urinary_tract, bladder, vulva",", adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, tubular_adenocarcinoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, oesophagitis",,,,,376663,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Oncogenic,Neoplasm,1,,,
3203,242,C,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3204,242,C,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3205,242,C,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3206,242,C,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_msk_tcga_2020, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bowel_colitis_msk_2022, brca_igr_2015, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, cll_broad_2015, cll_broad_2022, coadread_dfci_2016, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, egc_msk_2023, egc_mskcc_2020, escc_ucla_2014, heme_msk_impact_2022, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lcll_broad_2013, lihc_amc_prv, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_pdx, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_msk_2024, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ohnca_cptac_gdc, paad_utsw_2015, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_p1000, prad_su2c_2015, prad_su2c_2019, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sclc_ucologne_2015, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucs_jhu_2014","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagus/Stomach, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577555-7577556, hg19,17:7577556-7577556, hg19,17:7674238-7674238, hg38,17:7674237-7674238, hg38,17:7674238-7674238","hg19,17:g.7577555_7577556delinsAA, hg19,17:g.7577556C>A, hg19,17:g.7674238C>A, hg38,17:g.7674237_7674238delinsAA, hg38,17:g.7674238C>A",0.977,", biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, cerebellum, central_nervous_system, frontal_lobe, endometrium, eye, conjunctiva, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, ovary, pancreas, prostate, skin, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, glottis, upper_aerodigestive_tract, larynx, supraglottis, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","adenoma, tubulovillous, high_grade_dysplasia, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, hyperplasia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, primitive_neuroectodermal_tumour-medulloblastoma",,,,,376578,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Ovarian neoplasm,1,Oncogenic,Neoplasm,1,,,
3207,242,C,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, ccle_broad_2025, chol_icgc_2017, coadread_dfci_2016, luad_mskcc_2023_met_organotropism, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbc_msk_2021, mel_mskimpact_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022, sclc_ucologne_2015","Cholangiocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Metaplastic Breast Cancer, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577557-7577557, hg19,17:7674239-7674239, hg38,17:7674239-7674239","hg19,17:g.7577557A>C, hg19,17:g.7674239A>C, hg38,17:g.7674239A>C",0.963,"biliary_tract, bile_duct, breast, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, liver, lung, pancreas, prostate, skin, skin, ankle, skin, scalp","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_melanoma, acral_lentiginous",,,,,376581,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3208,242,C,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3209,242,C,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3210,242,C,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3211,242,C,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3212,242,C,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3213,242,C,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3214,242,C,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3215,242,C,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3216,242,C,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_aurora_2023, brca_mapk_hp_msk_2021, brca_metabric, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cll_broad_2022, crc_sysucc_2022, gbc_msk_2018, gbc_mskcc_2022, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mpcproject_broad_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga_pan_can_atlas_2018, paad_utsw_2015, pan_origimed_2020, pancan_pdmr_2025, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Prostate, Soft Tissue","hg19,17:7577557-7577557, hg19,17:7674239-7674239, hg38,17:7674239-7674239","hg19,17:g.7577557A>G, hg19,17:g.7674239A>G, hg38,17:g.7674239A>G",0.966,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, small_intestine, large_intestine, large_intestine, colon, liver, ovary, pancreas, prostate, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma",,,,,449512,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3217,242,C,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, dlbcl_dfci_2018, gbc_msk_2018, glioma_msk_2018, glioma_mskcc_2019, hcc_tcga_gdc, heme_msk_impact_2022, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lihc_tcga, luad_broad, luad_cas_2020, luad_mskcc_2023_met_organotropism, mbn_msk_2024, mds_mskcc_2020, mixed_impact_subset_2022, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, soft_tissue_tcga_gdc, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Head and Neck, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577555-7577556, hg19,17:7577556-7577556, hg19,17:7577557-7577557, hg19,17:7674238-7674238, hg19,17:7674239-7674239, hg38,17:7674237-7674238, hg38,17:7674238-7674238, hg38,17:7674239-7674239","hg19,17:g.7577555_7577556delinsCG, hg19,17:g.7577555_7577556delinsTG, hg19,17:g.7577556C>G, hg19,17:g.7577557A>T, hg19,17:g.7674238C>G, hg19,17:g.7674239A>T, hg38,17:g.7674237_7674238delinsCG, hg38,17:g.7674237_7674238delinsTG, hg38,17:g.7674238C>G, hg38,17:g.7674239A>T","0.947, 0.960","breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, soft_tissue, kidney, large_intestine, large_intestine, caecum, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, pleura, skin, eye, soft_tissue, stomach, thymus, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, tonsil, vulva","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, carcinoma, acinar_adenocarcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_II, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, mesothelioma, other, oesophagitis, sarcoma, thymic_carcinoma, small_cell_carcinoma",,,,,"2124706, 647334, 376579","Uncertain significance, Conflicting classifications of pathogenicity, Conflicting classifications of pathogenicity",Li-Fraumeni syndrome|Li-Fraumeni syndrome;Li-Fraumeni syndrome 1|Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,"1, 1, 1",,,,Tier I - Strong,Embryonal rhabdomyosarcoma,1
3218,242,C,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3219,242,C,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3220,242,C,W,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_smc_2018, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, esca_broad, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_pdmr_2025, pdac_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Endometrial Carcinoma, Esophageal Adenocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Soft Tissue","hg19,17:7577555-7577555, hg19,17:7674237-7674237, hg38,17:7674237-7674237","hg19,17:g.7577555G>C, hg19,17:g.7674237G>C, hg38,17:g.7674237G>C",0.940,"biliary_tract, bile_duct, breast, cervix, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, lung, oesophagus, ovary, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, serous_carcinoma, carcinoma, spindle_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, myelofibrosis",,,,,376580,Pathogenic,Li-Fraumeni syndrome,1,,,,,,
3221,242,C,Y,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_tcga_2020, blca_plasmacytoid_mskcc_2016, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bowel_colitis_msk_2022, brca_igr_2015, brca_metabric, brca_msk_2025, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_dfci_2016, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, difg_glass, difg_glass_2019, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgggbm_tcga_pub, lms_msk_2024, luad_cas_2020, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, mbn_msk_2024, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, ohnca_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pcnsl_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, sarcoma_msk_2022, sclc_jhu, stad_oncosg_2018, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreas, Primary DLBCL of the central nervous system, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577555-7577556, hg19,17:7577556-7577556, hg19,17:7674238-7674238, hg38,17:7674238-7674238","hg19,17:g.7577555_7577556delinsAT, hg19,17:g.7577556C>T, hg19,17:g.7674238C>T, hg38,17:g.7674238C>T",0.973,"biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, choroid_plexus, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, anus, large_intestine, caecum, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, parotid, skin, eye, skin, face, soft_tissue, fat, leg, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, follicular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, medullary_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, liposarcoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, osteosarcoma, other, choroid_plexus_carcinoma, other, hepatoblastoma, other, neoplasm",0.0000000000000000,,,,12354,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-fraumeni-like syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Familial cancer of breast,2,,,,,,
3222,243,M,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3223,243,M,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3224,243,M,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3225,243,M,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3226,243,M,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3227,243,M,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3228,243,M,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3229,243,M,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, lusc_cptac_gdc, mel_mskimpact_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, sarcoma_msk_2022, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Breast, Cutaneous Melanoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577552-7577552, hg19,17:7674234-7674234, hg38,17:7674234-7674234","hg19,17:g.7577552C>A, hg19,17:g.7577552C>G, hg19,17:g.7577552C>T, hg19,17:g.7674234C>A, hg38,17:g.7674234C>A, hg38,17:g.7674234C>G, hg38,17:g.7674234C>T",0.820,", breast, haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, oesophagus, placenta, skin, stomach, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, choriocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, other, actinic_cheilitis",,,,,840505,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3230,243,M,K,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674235-7674235","hg38,17:g.7674235A>T",0.933,"liver, prostate","carcinoma, carcinoma, hepatocellular_carcinoma",,,,,,,,,,,,,,
3231,243,M,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv",sarcoma_msk_2022,Soft Tissue,"hg19,17:7577554-7577554, hg38,17:7674236-7674236","hg19,17:g.7577554T>A, hg19,17:g.7577554T>G, hg38,17:g.7674236T>A, hg38,17:g.7674236T>G",0.763,", breast, central_nervous_system, brain, endometrium, large_intestine, lung, ovary, skin, head_neck, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, malignant_melanoma",,,,,"1758050, 186653","Uncertain significance, Uncertain significance",Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"2, 2",,,,,,
3232,243,M,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3233,243,M,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3234,243,M,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3235,243,M,R,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674235-7674235","hg38,17:g.7674235A>C",0.890,"liver, skin, head_neck","carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3236,243,M,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3237,243,M,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, pan_origimed_2020",Mixed Cancer Types,"hg19,17:7577553-7577553, hg38,17:7674234-7674235, hg38,17:7674235-7674235","hg19,17:g.7577553A>G, hg38,17:g.7674234_7674235inv, hg38,17:g.7674235A>G",0.879,"breast, haematopoietic_and_lymphoid_tissue, oesophagus, soft_tissue, striated_muscle, head_neck","carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, refractory_anaemia, lymphoid_neoplasm, other, Barrett_oesophagus, rhabdomyosarcoma, alveolar",,,,,182936,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",1,,,,,,
3238,243,M,V,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577554-7577554, hg38,17:7674236-7674236","hg19,17:g.7577554T>C, hg38,17:g.7674236T>C",0.705,"haematopoietic_and_lymphoid_tissue, lymph_node, ovary, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach","carcinoma, serous_carcinoma, gastrointestinal_stromal_tumour, lymphoid_neoplasm, MALT_lymphoma",,,,,406567,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
3239,243,M,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3240,243,M,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3241,244,G,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cfdna_msk_2019, mds_mskcc_2020, msk_chord_2024, msk_met_2021","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7577550-7577550, hg19,17:7674232-7674232, hg38,17:7674232-7674232","hg19,17:g.7577550C>G, hg19,17:g.7674232C>G, hg38,17:g.7674232C>G",0.922,"biliary_tract, gallbladder, haematopoietic_and_lymphoid_tissue, lymph_node, liver, lung, prostate, salivary_gland, parotid, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, sphenoid","carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, undifferentiated_carcinoma, lymphoid_neoplasm, other, pneumocytoma_(sclerosing_haemangioma)",,,,,458560,Pathogenic/Likely pathogenic,Lip and oral cavity carcinoma;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3242,244,G,C,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","angs_painter_2020, angs_project_painter_2018, blca_iatlas_imvigor210_2017, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_metabric, brca_smc_2018, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, chol_icgc_2017, coadread_dfci_2016, coadread_genentech, crc_nigerian_2020, crc_sysucc_2022, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, ihch_msk_2021, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mixed_allen_2018, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sclc_clcgp, sclc_ucologne_2015, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Angiosarcoma, Bladder Urothelial Carcinoma, Breast, Cholangiocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577551-7577551, hg19,17:7674233-7674233, hg38,17:7674233-7674233","hg19,17:g.7577551C>A, hg19,17:g.7674233C>A, hg38,17:g.7674233C>A",0.940,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, breast, endometrium, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, abdomen, kidney, large_intestine, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, transverse, liver, lung, lung, left_lower_lobe, lung, right_upper_lobe, oesophagus, ovary, prostate, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, urinary_tract, renal_pelvis","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, spindle_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma_non_invasive, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, myelofibrosis, lymphoid_neoplasm, mantle_cell_lymphoma, other, hepatoblastoma",,,,,376599,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Familial cancer of breast,1,Likely oncogenic,Neoplasm,1,,,
3243,244,G,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, bcc_unige_2016, blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bowel_colitis_msk_2022, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cll_broad_2022, cll_iuopa_2015, coad_tcga_gdc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, difg_glass, difg_glass_2019, dlbc_broad_2012, dlbcl_dfci_2018, egc_msk_2023, esca_broad, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gist_msk_2022, gist_msk_2023, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, lihc_amc_prv, luad_cas_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, meso_tcga, meso_tcga_pan_can_atlas_2018, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, plmeso_tcga_gdc, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_oncosg_2018, stad_pfizer_uhongkong, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_cptac_2020, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc","Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagus/Stomach, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma","hg19,17:7577550-7577550, hg19,17:7674232-7674232, hg38,17:7674232-7674232","hg19,17:g.7577550C>T, hg19,17:g.7674232C>T, hg38,17:g.7674232C>T",0.953,"biliary_tract, bile_duct, breast, central_nervous_system, brain, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, small_intestine, large_intestine, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, ascending, large_intestine, colon, left, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_lower_lobe, oesophagus, ovary, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, buccal_mucosa, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, retromolar_trigone, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, combined_small_cell_carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, mucinous, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma_Grade_III, anaplastic, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, other, intraepithelial_neoplasia, low_grade",,,,,372785,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Gastric cancer;not provided;Ovarian neoplasm,2,Oncogenic,Neoplasm,1,,,
3244,244,G,E,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674231-7674232","hg38,17:g.7674231_7674232delinsTT",,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3245,244,G,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","csf_msk_2024, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7577550-7577551, hg38,17:7674232-7674233","hg19,17:g.7577550_7577551delinsAA, hg38,17:g.7674232_7674233delinsAA",,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3246,244,G,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3247,244,G,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3248,244,G,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3249,244,G,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3250,244,G,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3251,244,G,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3252,244,G,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3253,244,G,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3254,244,G,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mskcc_2019, breast_ink4_msk_2021, breast_msk_2025, difg_tcga_gdc, gct_msk_2020, glioma_mskcc_2019, heme_msk_impact_2022, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, mbn_mdacc_2013, mds_iwg_2022, mds_mskcc_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_pik3r1_msk_2021, sarcoma_mskcc_2022","Breast, Diffuse Glioma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Prostate Adenocarcinoma, Soft Tissue, Testis","hg19,17:7577551-7577551, hg19,17:7674233-7674233, hg38,17:7674233-7674233","hg19,17:g.7577551C>G, hg19,17:g.7674233C>G, hg38,17:g.7674233C>G",0.942,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, lung, soft_tissue, blood_vessel, kidney, thyroid","carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, perivascular_epithelioid_cell_tumour_(PEComa)",,,,,3634428,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3255,244,G,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, blca_mskcc_solit_2014, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, chol_msk_2018, coad_silu_2022, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, gist_msk_2023, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, ihch_msk_2021, lgggbm_tcga_pub, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ov_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prostate_msk_2024, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, soft_tissue_tcga_gdc, tmb_mskcc_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gastrointestinal Stromal Tumor, Head and Neck Carcinoma, Other, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577551-7577551, hg19,17:7674233-7674233, hg38,17:7674233-7674233","hg19,17:g.7577551C>T, hg19,17:g.7674233C>T, hg38,17:g.7674233C>T",0.936,", biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, temporal_lobe, cervix, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, skin, soft_tissue, soft_tissue, fat, soft_tissue, fibrous_tissue_and_uncertain_origin, frontoparietal, stomach, stomach, gastroesophageal_junction, testis, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, lobular_carcinoma, carcinoma, mesonephric_carcinoma, mixed, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, micropapillary_transitional_cell_carcinoma, germ_cell_tumour, mixed, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, gliosarcoma, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm, haematopoietic_neoplasm, chronic_myeloid_leukaemia, liposarcoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, sarcoma",,,,,376600,Pathogenic,"Rhabdomyosarcoma;Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Malignant tumor of urinary bladder;Li-Fraumeni syndrome;Gastric cancer;Li-Fraumeni syndrome 1",2,Oncogenic,Neoplasm,1,Tier I - Strong,"Juvenile type testicular granulosa cell tumor;Diffuse midline glioma, H3 K27M-mutant",1
3256,244,G,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3257,244,G,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, brca_smc_2018, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, cfdna_msk_2019, coad_cptac_gdc, crc_sysucc_2022, esca_broad, glioma_mskcc_2019, hcc_clca_2024, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paad_utsw_2015, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577550-7577550, hg19,17:7674232-7674232, hg38,17:7674232-7674232","hg19,17:g.7577550C>A, hg19,17:g.7674232C>A, hg38,17:g.7674232C>A",0.949,"bone, scapula, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, soft_tissue, large_intestine, large_intestine, colon, large_intestine, colon, transverse, large_intestine, rectum, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, parotid, skin, neck, stomach, thyroid, upper_aerodigestive_tract, head_neck, urinary_tract, bladder, vulva","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mucoepidermoid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, M2, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, osteosarcoma, fibroblastic",,,,,376601,Likely pathogenic,Li-Fraumeni syndrome 1;Ovarian neoplasm,1,,,,,,
3258,244,G,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3259,244,G,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3260,245,G,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, bowel_colitis_msk_2022, breast_msk_2025, cfdna_msk_2019, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, stad_oncosg_2018, stad_pfizer_uhongkong, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc","Bladder Urothelial Carcinoma, Bowel, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577546-7577547, hg19,17:7577547-7577547, hg19,17:7674229-7674229, hg38,17:7674229-7674229","hg19,17:g.7577546_7577547delinsTG, hg19,17:g.7577547C>G, hg19,17:g.7674229C>G, hg38,17:g.7674229C>G",0.946,"breast, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, lung, oesophagus, ovary, pancreas, prostate, soft_tissue, smooth_muscle, uterus, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, leiomyoma, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,265357,Conflicting classifications of pathogenicity,"Adrenal cortex carcinoma;Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",1,Oncogenic,Neoplasm,1,,,
3261,245,G,C,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, bcc_unige_2016, blca_msk_2024, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cll_broad_2022, coad_silu_2022, coadread_dfci_2016, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_orion_2024, csf_msk_2024, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, escc_icgc, glioma_mskcc_2019, hdcn_msk_2025, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, luad_cas_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lung_pdx_msk_2021, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_mskcc_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ov_tcga, ov_tcga_pub, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sclc_ucologne_2015, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Histiocytic and Dendritic Cell Neoplasms, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577548-7577548, hg19,17:7674230-7674230, hg38,17:7674230-7674230","hg19,17:g.7577548C>A, hg19,17:g.7674230C>A, hg38,17:g.7674230C>A",0.970,"biliary_tract, bile_duct, bone, breast, central_nervous_system, brainstem, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, colon, left, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_lower_lobe, oesophagus, oesophagus, lower_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, prostate, salivary_gland, skin, skin, face, soft_tissue, striated_muscle, pelvis, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, supraglottis, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, enteric_adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, spindle_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, osteosarcoma, other, neoplasm, rhabdomyosarcoma, embryonal",,,,,12349,Pathogenic,Hereditary cancer-predisposing syndrome;Breast and/or ovarian cancer;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Oncogenic,Neoplasm,1,Tier I - Strong,Ovarian mucinous adenocarcinoma,1
3262,245,G,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2023, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_metabric, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cll_broad_2015, cll_broad_2022, cll_iuopa_2015, coad_silu_2022, coadread_dfci_2016, coadread_genentech, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_dfarber_2015, cscc_ucsf_2021, difg_glass, difg_tcga_gdc, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_trap_msk_2020, esca_broad, escc_icgc, gbc_msk_2018, gbc_mskcc_2022, hcc_jcopo_msk_2023, hcc_msk_2024, hcc_mskimpact_2018, hcc_tcga_gdc, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_smmu_2014, kirc_tcga, lgg_tcga_pan_can_atlas_2018, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_broad, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_pdx, lung_smc_2016, lusc_cptac_2021, lusc_cptac_gdc, lymphoma_cellline_msk_2020, mbl_sickkids_2016, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_impact_subset_2022, mixed_kunga_msk_2022, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nhl_bcgsc_2013, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovarian_msk_2025, ovary_cptac_gdc, paad_qcmg_uq_2016, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, panet_msk_erc_2023, pdac_msk_2024, pog570_bcgsc_2020, prad_broad, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prad_su2c_2019, prad_tcga, prad_tcga_pan_can_atlas_2018, prostate_msk_2024, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, stad_tcga_pan_can_atlas_2018, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Medulloblastoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue, Stomach Adenocarcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577546-7577547, hg19,17:7577547-7577547, hg19,17:7674229-7674229, hg38,17:7674228-7674229, hg38,17:7674229-7674229","hg19,17:g.7577546_7577547delinsAT, hg19,17:g.7577547C>T, hg19,17:g.7674229C>T, hg38,17:g.7674228_7674229delinsAT, hg38,17:g.7674229C>T",0.974,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, parietooccipital, central_nervous_system, thalamus, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, spleen, kidney, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lymph_node, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, pleura, prostate, skin, skin, chest, skin, ear, skin, face, skin, leg, skin, upper_back, skin, upper_leg, small_intestine, duodenum, small_intestine, ileum, soft_tissue, striated_muscle, groin, soft_tissue, striated_muscle, upper_leg, stomach, stomach, gastroesophageal_junction, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, urinary_tract, bladder, vulva","Wilms_tumour, adenoma, adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, adnexal_tumour, malignant_adnexal_tumour, hidradenocarcinoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, lymphoepithelioma_like_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, granulocytic_sarcoma, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelofibrosis, haematopoietic_neoplasm, myelofibrosis, primary, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, superficial_spreading, mesothelioma, biphasic, osteosarcoma, other, metaplasia, epidermoid, other, neoplasm, rhabdomyosarcoma, pleomorphic",0.0000039767123723,,,,"861760, 12355","Pathogenic, Pathogenic/Likely pathogenic","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1","1, 2",,,,Tier I - Strong,"Astrocytoma IDH-mutant;Embryonal rhabdomyosarcoma;Diffuse midline glioma, H3 K27M-mutant",1
3263,245,G,E,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674228-7674229","hg38,17:g.7674228_7674229delinsTT",,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3264,245,G,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577547-7577548, hg38,17:7674229-7674230","hg19,17:g.7577547_7577548delinsAA, hg38,17:g.7674229_7674230delinsAA",,"biliary_tract, bile_duct, liver, lung","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
3265,245,G,H,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674229-7674230","hg38,17:g.7674229_7674230delinsTG",,"large_intestine, caecum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3266,245,G,I,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_met_2021, nsclc_tcga_broad_2016","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577547-7577548","hg19,17:g.7577547_7577548delinsAT",,,,,,,,,,,,,,,,,
3267,245,G,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3268,245,G,L,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674229-7674230","hg38,17:g.7674229_7674230delinsAG",,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3269,245,G,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3270,245,G,N,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","acc_2019, hnc_mskcc_2016, msk_impact_2017, msk_met_2021","Adenoid Cystic Carcinoma, Head and Neck, Mixed Cancer Types","hg19,17:7577547-7577548, hg38,17:7674229-7674230","hg19,17:g.7577547_7577548delinsTT, hg38,17:g.7674229_7674230delinsTT",,"pancreas, skin, skin, head_neck, skin, trunk, urinary_tract, bladder","carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3271,245,G,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3272,245,G,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3273,245,G,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, glioma_mskcc_2019, hcc_msk_2024, hcc_mskimpact_2018, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, lung_msk_2017, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pediatric_dkfz_2017, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, tmb_mskcc_2018","Basal Cell Carcinoma, Bowel, Diffuse Glioma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577548-7577548, hg19,17:7674230-7674230, hg38,17:7674230-7674230","hg19,17:g.7577548C>G, hg19,17:g.7674230C>G, hg38,17:g.7674230C>G",0.961,", breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, sigmoid, liver, lung, lung, left_upper_lobe, oesophagus, oesophagus, middle_third, ovary, pancreas, prostate, skin, soft_tissue, blood_vessel, liver, stomach, thyroid, urinary_tract, bladder","adenoma, angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, malignant_melanoma",0.0000000000000000,,,,376604,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3274,245,G,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, all_phase2_target_2018_pub, all_stjude_2013, aml_ohsu_2018, aml_ohsu_2022, ampca_bcm_2016, appendiceal_msk_2022, bladder_msk_2023, blca_bcan_hcrn_2022, blca_msk_2024, blca_pdx_msk_2025, blca_plasmacytoid_mskcc_2016, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bll_target_gdc, bowel_colitis_msk_2022, brca_dfci_2020, brca_dldccc_2022, brca_fuscc_2020, brca_mapk_hp_msk_2021, brca_metabric, brca_msk_2025, brca_mskcc_2019, brca_sanger, brca_smc_2018, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cervix_msk_2023, cfdna_msk_2019, chol_icgc_2017, chol_msk_2018, cll_broad_2015, cll_broad_2022, coad_caseccc_2015, coad_cptac_2019, coad_cptac_gdc, coad_silu_2022, coad_tcga_gdc, coadread_dfci_2016, coadread_genentech, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_dd_2022, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, dlbc_broad_2012, dlbcl_dfci_2018, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_tmucih_2015, es_dsrct_msk_2023, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbc_msk_2018, gbc_mskcc_2022, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, lms_msk_2024, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbl_dkfz_2017, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, meso_tcga, meso_tcga_pan_can_atlas_2018, metastatic_solid_tumors_mich_2017, mnm_washu_2016, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, nsclc_unito_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_cptac_2021, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, plmeso_tcga_gdc, pog570_bcgsc_2020, pptc_2019, prad_cdk12_mskcc_2020, prad_cpcg_2017, prad_mcspc_mskcc_2020, prad_msk_mdanderson_2023, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_dkfz_2018, prostate_msk_2024, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_msk_2023, sarcoma_mskcc_2022, stad_oncosg_2018, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stad_uhongkong, stes_tcga_pub, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_msk_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, uec_cptac_gdc","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Ampullary Carcinoma, Appendiceal Adenocarcinoma, B-Lymphoblastic Leukemia/Lymphoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervix, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gallbladder Cancer, Head and Neck, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Medulloblastoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Thyroid, Uterine Endometrioid Carcinoma","hg19,17:7577548-7577548, hg19,17:7674230-7674230, hg38,17:7674230-7674230","hg19,17:g.7577548C>T, hg19,17:g.7674230C>T, hg38,17:g.7674230C>T",0.947,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, cerebellum, central_nervous_system, choroid_plexus, central_nervous_system, spinal_cord, central_nervous_system, temporal_lobe, central_nervous_system, thalamus, cervix, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, large_intestine, anus, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, left, large_intestine, rectum, liver, lung, meninges, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, prostate, salivary_gland, salivary_gland, parotid, skin, skin, arm, skin, chest, skin, ear, skin, eye, skin, head_neck, skin, scalp, small_intestine, duodenum, small_intestine, ileum, small_intestine, jejunum, soft_tissue, soft_tissue, blood_vessel, breast, soft_tissue, striated_muscle, soft_tissue, striated_muscle, pelvis, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, ear_canal, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, retromolar, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, adenoma, adenoma, myoepithelial, adenoma, tubulovillous, high_grade_dysplasia, adenoma, villous, adenoma-nodule-goitre, Hurthle_cell_tumour, adnexal_tumour, malignant_adnexal_tumour, extramammary_Pagets_disease, adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adnexal_tumour, sebaceous_adenoma, adrenal_cortical_carcinoma, angiosarcoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Hurthle_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, mucinous, carcinoma, adenoid_cystic_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, papillary, carcinoma, ductolobular_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, hybrid_salivary_gland_carcinoma, myoepithelial_and_salivary_duct_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, lobular_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, mucoepidermoid_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, micropapillary_transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, oligoastrocytoma_Grade_II, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_lymphoblastic_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M2, haematopoietic_neoplasm, acute_myeloid_leukaemia, M7, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelofibrosis, haematopoietic_neoplasm, myelofibrosis, primary, haematopoietic_neoplasm, myeloid_neoplasm_unspecified_therapy_related, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, meningioma, other, other, Barrett_oesophagus, with_high_grade_dysplasia, other, adenocarcinoma_in_situ, other, adenoma, other, choroid_plexus_papilloma, other, dysplasia-carcinoma_in_situ, other, dysplasia-in_situ_neoplasm, other, metaplasia, other, neoplasm, other, normal, pancreatic_intraepithelial_neoplasia_(PanIN), primitive_neuroectodermal_tumour-medulloblastoma, primitive_neuroectodermal_tumour-medulloblastoma, classic, rhabdomyosarcoma, embryonal, sarcoma",0.0000000000000000,0.0000319284802043,,,12365,Pathogenic,"TP53-related disorder;Familial ovarian cancer;Atypical teratoid rhabdoid tumor;Astrocytoma, anaplastic;Hepatocellular carcinoma;Gastric cancer;Adenocarcinoma;Colorectal cancer;Hereditary cancer-predisposing syndrome;not provided;Li-fraumeni-like syndrome;Adrenocortical carcinoma, hereditary;Malignant tumor of urinary bladder;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Breast carcinoma;See cases",3,Oncogenic,Neoplasm,1,Tier I - Strong,IDH-wildtype glioblastoma;Medulloblastoma WNT activated;Rhabdomyosarcoma,1
3275,245,G,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3276,245,G,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, blca_plasmacytoid_mskcc_2016, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_fuscc_2020, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_tcga_pub, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_tcga_gdc, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, gbc_msk_2018, gbm_mayo_pdx_sarkaria_2019, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga_pan_can_atlas_2018, luad_broad, luad_cas_2020, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2015, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_pdx, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2015, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ov_tcga, ov_tcga_pub, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sclc_ucologne_2015, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577546-7577547, hg19,17:7577547-7577547, hg19,17:7674229-7674229, hg38,17:7674228-7674229, hg38,17:7674229-7674229","hg19,17:g.7577546_7577547delinsAA, hg19,17:g.7577547C>A, hg19,17:g.7674229C>A, hg38,17:g.7674228_7674229delinsAA, hg38,17:g.7674229C>A",0.972,"biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, left_upper_lobe, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, salivary_gland, parotid, skin, skin, head_neck, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, transformed_to_small_cell_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, oligoastrocytoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, osteosarcoma, other, neoplasm",0.0000039767123723,,,,376603,Pathogenic,"not provided;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",2,Oncogenic,Neoplasm,1,,,
3277,245,G,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3278,245,G,Y,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7577547-7577548","hg19,17:g.7577547_7577548delinsTA",,,,,,,,,,,,,,,,,
3279,246,M,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3280,246,M,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3281,246,M,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3282,246,M,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3283,246,M,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3284,246,M,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3285,246,M,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3286,246,M,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_nmibc_2017, brca_fuscc_2020, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, escc_icgc, hcc_msk_2024, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, mbn_mdacc_2013, mixed_allen_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paired_bladder_2022, pan_origimed_2020, pancan_pcawg_2020, pancan_pdmr_2025, pptc_2019, sarcoma_msk_2022, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, thyroid_gatci_2024, tmb_mskcc_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Chromophobe Renal Cell Carcinoma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Thyroid","hg19,17:7577543-7577543, hg19,17:7674225-7674225, hg38,17:7674225-7674225","hg19,17:g.7577543C>A, hg19,17:g.7577543C>G, hg19,17:g.7577543C>T, hg19,17:g.7674225C>A, hg19,17:g.7674225C>G, hg19,17:g.7674225C>T, hg38,17:g.7674225C>A, hg38,17:g.7674225C>G, hg38,17:g.7674225C>T",0.838,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, anus, large_intestine, colon, liver, lung, oesophagus, oesophagus, middle_third, ovary, penis, skin, skin, chest, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, lobular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, renal_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, squamous_cell_carcinoma, verrucous, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, oligoastrocytoma, glioma, oligoastrocytoma_Grade_II, glioma, oligodendroglioma, glioma, oligodendroglioma_Grade_III, anaplastic, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, desmoplastic",,,,,"1758655, 968639, 480961","Likely pathogenic, Conflicting classifications of pathogenicity, Pathogenic/Likely pathogenic",Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome,"1, 1, 2",Oncogenic,Neoplasm,1,,,
3287,246,M,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mskcc_2019, crc_apc_impact_2020, dlbcl_dfci_2018, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, gbc_msk_2018, gbc_mskcc_2022, hcc_msk_2024, lung_msk_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ohnca_cptac_gdc, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, sarcoma_msk_2022","Colorectal Adenocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Carcinoma, Other, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue","hg19,17:7577544-7577544, hg19,17:7674226-7674226, hg38,17:7674226-7674226","hg19,17:g.7577544A>T, hg19,17:g.7674226A>T, hg38,17:g.7674226A>T",0.963,"biliary_tract, gallbladder, breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, liver, lung, oesophagus, prostate, salivary_gland, thyroid, upper_aerodigestive_tract, larynx","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, myeloproliferative_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, other, neoplasm",,,,,480764,Likely pathogenic,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,2,,,,,,
3288,246,M,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, cll_broad_2022, cll_iuopa_2015, csf_msk_2024, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, heme_msk_impact_2022, luad_mskcc_2023_met_organotropism, lung_msk_2017, mds_mskcc_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, pan_origimed_2020, sarcoma_msk_2022, tmb_mskcc_2018","Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577545-7577545, hg38,17:7674227-7674227","hg19,17:g.7577545T>A, hg19,17:g.7577545T>G, hg38,17:g.7674227T>A, hg38,17:g.7674227T>G",0.865,", biliary_tract, bile_duct, biliary_tract, gallbladder, breast, haematopoietic_and_lymphoid_tissue, large_intestine, colon, transverse, liver, lung, oesophagus, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, malignant_melanoma",,,,,"406586, 186737","Uncertain significance, Conflicting classifications of pathogenicity",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"1, 1",,,,,,
3289,246,M,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3290,246,M,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3291,246,M,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3292,246,M,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_eo_2020, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, hcc_meric_2021, hccihch_pku_2019, lgggbm_tcga_pub, mds_mskcc_2020, mel_mskimpact_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, ovary_cptac_gdc, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, rectal_msk_2022, sarcoma_msk_2022","Bowel, Cutaneous Melanoma, Diffuse Glioma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreatic Adenocarcinoma, Soft Tissue","hg19,17:7577544-7577544, hg19,17:7674226-7674226, hg38,17:7674226-7674226","hg19,17:g.7577544A>C, hg19,17:g.7674226A>C, hg38,17:g.7674226A>C",0.959,"breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, abdomen, haematopoietic_and_lymphoid_tissue, skin, large_intestine, large_intestine, colon, lung, oesophagus, ovary, pancreas, prostate, skin, skin, face, skin, trunk, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma_Grade_II, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, malignant_melanoma",,,,,127822,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
3293,246,M,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3294,246,M,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_bccrc, brca_msk_2025, ccle_broad_2019, ccle_broad_2025, crc_eo_2020, gbm_mayo_pdx_sarkaria_2019, glioma_mskcc_2019, heme_msk_impact_2022, ihch_msk_2021, ihch_mskcc_2020, lms_msk_2024, mbn_sfu_2023, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pdac_msk_2024, prad_msk_mdanderson_2023, sarcoma_msk_2022, sarcoma_mskcc_2022","Bladder Urothelial Carcinoma, Bowel, Diffuse Glioma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Soft Tissue","hg19,17:7577544-7577544, hg19,17:7674226-7674226, hg38,17:7674226-7674226","hg19,17:g.7577544A>G, hg19,17:g.7674226A>G, hg38,17:g.7674226A>G",0.956,"biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, oesophagus, pancreas, skin, thyroid, urinary_tract, bladder","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, in_situ_epithelial_neoplasm, actinic_keratosis",,,,,428886,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3295,246,M,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","angs_painter_2020, angs_painter_2025, angs_project_painter_2018, blca_iatlas_imvigor210_2017, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brca_metabric, brca_pareja_msk_2020, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cfdna_msk_2019, cll_broad_2022, coadread_dfci_2016, coadread_mskcc, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_tcga_gdc, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_tcga_gdc, heme_msk_impact_2022, ihch_msk_2021, ihch_mskcc_2020, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_pdx, mbn_msk_2024, mbn_sfu_2023, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, os_target_gdc, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, rectal_msk_2022, sarc_tcga, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucs_msk_2024, uec_cptac_gdc","Angiosarcoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Osteosarcoma, Pancreas, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Uterine Endometrioid Carcinoma","hg19,17:7577545-7577545, hg19,17:7674227-7674227, hg38,17:7674227-7674227","hg19,17:g.7577545T>C, hg19,17:g.7674227T>C, hg38,17:g.7674227T>C",0.924,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, ovary, pancreas, prostate, small_intestine, duodenum, soft_tissue, soft_tissue, blood_vessel, bladder, soft_tissue, fibrous_tissue_and_uncertain_origin, pelvis, soft_tissue, smooth_muscle, lower_extremity, soft_tissue, smooth_muscle, uterus, stomach, thyroid, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, bladder, urinary_tract, bladder, urachus","adrenal_cortical_adenoma, cortisol_producing, angiosarcoma, carcinoid-endocrine_tumour, non_functioning, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma_non_invasive, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myeloproliferative_neoplasm, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma_of_soft_parts-clear_cell_sarcoma, other, dysplasia-in_situ_neoplasm, other, neoplasm, sarcoma",,,,,100815,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,Oncogenic,Neoplasm,1,,,
3296,246,M,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3297,246,M,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3298,247,N,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3299,247,N,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3300,247,N,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7577542-7577542, hg38,17:7674224-7674224","hg19,17:g.7577542T>C, hg38,17:g.7674224T>C",0.940,"haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, prostate, soft_tissue, striated_muscle, head_neck, urinary_tract, bladder","carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, rhabdomyosarcoma, embryonal",,,,,,,,,,,,,,
3301,247,N,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3302,247,N,F,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674223-7674224","hg38,17:g.7674223_7674224inv",,breast,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
3303,247,N,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3304,247,N,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3305,247,N,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2024, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, ccle_broad_2019, ccle_genentech_2014, cellline_ccle_broad, escc_icgc, heme_msk_impact_2022, hnc_mskcc_2016, luad_broad, luad_mskcc_2023_met_organotropism, luad_tcga_pan_can_atlas_2018, lung_msk_pdx, lung_pdx_msk_2021, mbn_mdacc_2013, mbn_sfu_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_mskcc_2018, nsclc_tcga_broad_2016, pan_origimed_2020, sarcoma_mskcc_2022","Bladder Urothelial Carcinoma, Esophageal Squamous Cell Carcinoma, Head and Neck, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577540-7577541, hg19,17:7577541-7577541, hg19,17:7674223-7674223, hg38,17:7674222-7674223, hg38,17:7674223-7674223","hg19,17:g.7577540_7577541delinsTA, hg19,17:g.7577541T>A, hg19,17:g.7674223T>A, hg38,17:g.7674222_7674223delinsTA, hg38,17:g.7674223T>A",0.953,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, colon, liver, lung, oesophagus, ovary, skin, skin, head_neck, skin, leg, stomach, stomach, gastroesophageal_junction","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,184882,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome,1,,,,,,
3306,247,N,K,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674222-7674222","hg38,17:g.7674222G>T",0.889,"lung, upper_aerodigestive_tract, mouth","carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3307,247,N,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3308,247,N,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3309,247,N,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3310,247,N,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3311,247,N,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3312,247,N,S,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577541-7577541, hg38,17:7674223-7674223","hg19,17:g.7577541T>C, hg38,17:g.7674223T>C",0.935,"liver, lung, ovary, soft_tissue, fat, leg, stomach","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, liposarcoma",,,,,406595,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3313,247,N,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","mbn_sfu_2023, msk_met_2021","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,17:7577541-7577541, hg19,17:7674223-7674223, hg38,17:7674223-7674223","hg19,17:g.7577541T>G, hg19,17:g.7674223T>G, hg38,17:g.7674223T>G",0.950,"haematopoietic_and_lymphoid_tissue, lung, skin, skin, face, upper_aerodigestive_tract, mouth, mouth_floor","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, Burkitt_lymphoma, malignant_melanoma, other, pneumocytoma_(sclerosing_haemangioma)",,,,,,,,,,,,,,
3314,247,N,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3315,247,N,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3316,247,N,Y,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674224-7674224","hg38,17:g.7674224T>A",0.959,"haematopoietic_and_lymphoid_tissue, lung, skin","carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,,,,,,,,,,
3317,248,R,A,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3318,248,R,C,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674219-7674221","hg38,17:g.7674219_7674221delinsGCA",,"skin, face","benign_melanocytic_nevus, dysplastic",,,,,,,,,,,,,,
3319,248,R,D,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3320,248,R,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3321,248,R,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3322,248,R,G,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, chol_icgc_2017, crc_eo_2020, crc_msk_2017, hcc_clca_2024, hnc_mskcc_2016, lihc_amc_prv, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga, ov_tcga_pub, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Bowel, Cholangiocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Endometrial Carcinoma, Head and Neck, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue","hg19,17:7577539-7577539, hg19,17:7674221-7674221, hg38,17:7674221-7674221","hg19,17:g.7577539G>C, hg19,17:g.7674221G>C, hg38,17:g.7674221G>C",0.932,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, prostate, salivary_gland, parotid, skin, skin, head_neck, small_intestine, ileum, soft_tissue, fibrous_tissue_and_uncertain_origin, pelvis, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, urinary_tract, bladder","alveolar_soft_part_sarcoma, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, clonal_cytopenia_of_undetermined_significance, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, neoplasm",,,,,376652,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Carcinoma of colon;Li-Fraumeni syndrome,2,Likely oncogenic,Neoplasm,1,,,
3323,248,R,H,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_access_2021, msk_met_2021, nsclc_ctdx_msk_2022","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577537-7577538","hg19,17:g.7577537_7577538delinsGT",,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
3324,248,R,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3325,248,R,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3326,248,R,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bm_nsclc_mskcc_2023, brca_mapk_hp_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, ccrcc_tcga_gdc, cellline_ccle_broad, cellline_nci60, chol_icgc_2017, cll_broad_2022, coadread_dfci_2016, coadread_genentech, crc_nigerian_2020, crc_sysucc_2022, cscc_dfarber_2015, csf_msk_2024, gbm_tcga, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, gct_msk_2020, hcc_clca_2024, hcc_inserm_fr_2015, hcc_msk_2024, hgsoc_msk_2021, kirc_tcga_pan_can_atlas_2018, lihc_amc_prv, luad_broad, luad_cas_2020, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ovary_cptac_gdc, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, prad_mich, rectal_msk_2019, sarcoma_msk_2022, skcm_broad, thym_tcga, thym_tcga_gdc, thym_tcga_pan_can_atlas_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Bladder/Urinary Tract, Breast, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck Carcinoma, Other, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue, Testis, Thymoma","hg19,17:7577537-7577538, hg19,17:7577538-7577538, hg19,17:7577538-7577539, hg19,17:7674220-7674220, hg38,17:7674219-7674220, hg38,17:7674220-7674220","hg19,17:g.7577537_7577538delinsAA, hg19,17:g.7577538C>A, hg19,17:g.7577538_7577539delinsAA, hg19,17:g.7674220C>A, hg38,17:g.7674219_7674220delinsAA, hg38,17:g.7674220C>A",0.960,"biliary_tract, bile_duct, breast, central_nervous_system, brain, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, liver, lung, lung, right_lower_lobe, lung, upper_lobe, oesophagus, ovary, pancreas, prostate, skin, skin, scalp, stomach, testis, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, glottis, upper_aerodigestive_tract, larynx, supraglottis, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, tonsil, urinary_tract, urinary_tract, bladder","Wilms_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, germ_cell_tumour, germ_cell_tumour, choriocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, hyperplasia, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, desmoplastic, thymic_carcinoma",,,,,230253,Pathogenic,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",3,Oncogenic,Neoplasm,1,,,
3327,248,R,M,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3328,248,R,N,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3329,248,R,P,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_dfarber_mskcc_2014, blca_msk_tcga_2020, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, hcc_meric_2021, luad_broad, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, metastatic_solid_tumors_mich_2017, mixed_impact_subset_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, rectal_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, vsc_cuk_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Endometrial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Squamous Cell Carcinoma of the Vulva/Vagina","hg19,17:7577537-7577538, hg19,17:7577538-7577538, hg19,17:7674220-7674220, hg38,17:7674220-7674220","hg19,17:g.7577537_7577538delinsAG, hg19,17:g.7577538C>G, hg19,17:g.7674220C>G, hg38,17:g.7674220C>G",0.965,"biliary_tract, bile_duct, breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, retroperitoneum, large_intestine, large_intestine, rectum, lung, ovary, skin, upper_aerodigestive_tract, larynx, supraglottis, urinary_tract, urinary_tract, bladder, urinary_tract, renal_pelvis, vulva","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, angioimmunoblastic_T_cell_lymphoma",,,,,237954,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3330,248,R,Q,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, all_phase2_target_2018_pub, all_stjude_2013, aml_ohsu_2018, aml_ohsu_2022, aml_tcga_gdc, ampca_bcm_2016, angs_painter_2020, angs_project_painter_2018, appendiceal_msk_2022, bcc_unige_2016, bladder_columbia_msk_2018, bladder_msk_2023, blca_bcan_hcrn_2022, blca_bgi, blca_dfarber_mskcc_2014, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_nmibc_2017, blca_pdx_msk_2025, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bll_target_gdc, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brain_cptac_gdc, brca_aurora_2023, brca_broad, brca_cptac_2020, brca_dldccc_2022, brca_fuscc_2020, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_sanger, brca_smc_2018, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cervix_msk_2023, cfdna_msk_2019, chl_sccc_2023, chol_icgc_2017, cll_broad_2015, cll_broad_2022, coad_caseccc_2015, coad_cptac_gdc, coad_silu_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_genentech, coadread_mskcc, coadread_mskresistance_2022, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_dd_2022, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_orion_2024, crc_sysucc_2022, cscc_dfarber_2015, cscc_hgsc_bcm_2014, cscc_ranson_2022, cscc_ucsf_2021, csf_msk_2024, difg_glass, difg_glass_2019, difg_msk_2023, difg_tcga_gdc, dlbcl_dfci_2018, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_trap_msk_2020, es_dsrct_msk_2023, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, gbc_msk_2018, gbc_mskcc_2022, gbm_cptac_2021, gbm_mayo_pdx_sarkaria_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gct_msk_2016, gist_msk_2022, gist_msk_2023, glioma_msk_2018, glioma_mskcc_2019, hcc_msk_2024, hcc_tcga_gdc, hdcn_msk_2025, heme_msk_impact_2022, hgsoc_msk_2021, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_broad, hnsc_jhu, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, ihch_smmu_2014, kirc_tcga_pub, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lcll_broad_2013, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_broad, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lung_pdx_msk_2021, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, mbc_msk_2021, mbl_broad_2012, mbl_dkfz_2017, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_cfdna_msk_2020, mixed_kunga_msk_2022, mixed_msk_tcga_2021, mixed_pipseq_2017, mixed_selpercatinib_2020, mpcproject_broad_2021, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nccrcc_genentech_2014, nepc_wcm_2016, normal_skin_keratinocytes_2024, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ntrk_msk_2019, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_cptac_2021, paad_icgc, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancan_ped_mai_msk_2025, pancreas_cptac_gdc, pancreas_msk_2024, panet_arcnet_2017, panet_msk_2018, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, pptc_2019, prad_broad, prad_cdk12_mskcc_2020, prad_cpcg_2017, prad_fhcrc, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_dkfz_2018, prostate_msk_2024, ptad_msk_2024, rcc_iatlas_immotion150_2018, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, rectal_radiation_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_ucologne_2015, soft_tissue_msk_2023, soft_tissue_msk_2025, soft_tissue_tcga_gdc, stad_oncosg_2018, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, thyroid_gatci_2024, thyroid_mskcc_2016, tmb_mskcc_2018, uccc_nih_2017, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_ccr_msk_2022, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014, ucs_msk_2024, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc, usarc_msk_2020, utuc_igbmc_2021","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Ampullary Carcinoma, Angiosarcoma, Appendiceal Adenocarcinoma, B-Lymphoblastic Leukemia/Lymphoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cervix, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Classical Hodgkin Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gallbladder Cancer, Gastrointestinal Stromal Tumor, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Histiocytic and Dendritic Cell Neoplasms, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Medulloblastoma, Metaplastic Breast Cancer, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine Tumor, Pituitary Adenoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Renal Cell Carcinoma, Renal Clear Cell Carcinoma, Renal Non-Clear Cell Carcinoma, Rhabdomyosarcoma, Skin, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Testis, Thyroid, Upper Tract Urothelial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Clear Cell Carcinoma, Uterine Endometrioid Carcinoma, Uterine Sarcoma/Mesenchymal","hg19,17:7577537-7577538, hg19,17:7577538-7577538, hg19,17:7674219-7674220, hg19,17:7674220-7674220, hg38,17:7674219-7674220, hg38,17:7674220-7674220","hg19,17:g.7577537_7577538delinsTT, hg19,17:g.7577538C>T, hg19,17:g.7674219_7674220delinsTT, hg19,17:g.7674220C>T, hg38,17:g.7674219_7674220delinsTT, hg38,17:g.7674220C>T",0.934,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, bone, femur, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, cerebellum, central_nervous_system, choroid_plexus, central_nervous_system, frontal_lobe, central_nervous_system, medulla, central_nervous_system, parietal_lobe, central_nervous_system, pineal_gland, central_nervous_system, temporal_lobe, central_nervous_system, thalamus, cervix, endometrium, eye, uveal_tract, fallopian_tube, gastrointestinal_tract_(site_indeterminate), genital_tract, extragonadal, thyroid, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, breast, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, prostate, haematopoietic_and_lymphoid_tissue, skin, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, lung, bronchus, meninges, oesophagus, oesophagus, lower_third, oesophagus, middle_third, oesophagus, upper_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, peritoneum, pituitary, pleura, prostate, salivary_gland, salivary_gland, major, skin, skin, arm, skin, ear, skin, eye, skin, face, skin, forearm, skin, groin, skin, hand, skin, head_neck, skin, leg, skin, lip, skin, mucosal, rectum, skin, neck, skin, scalp, skin, trunk, skin, upper_arm, small_intestine, small_intestine, duodenum, small_intestine, ileum, small_intestine, jejunum, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, small_intestine, soft_tissue, smooth_muscle, uterus, soft_tissue, striated_muscle, stomach, stomach, gastroesophageal_junction, testis, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, alveolus, upper_aerodigestive_tract, mouth, alveolus_ridge, upper_aerodigestive_tract, mouth, buccal_mucosa, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, retromolar_trigone, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, urinary_tract, urinary_tract, bladder, urinary_tract, bladder, urachus, urinary_tract, renal_pelvis, urinary_tract, upper_urinary_tract, urinary_tract, ureter, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, Wilms_tumour, bilateral, adenoma, adnexal_tumour, malignant_adnexal_tumour, adnexal_tumour, malignant_adnexal_tumour, adenocarcinoma_not_otherwise_specified, adnexal_tumour, malignant_adnexal_tumour, eccrine_adenocarcinoma, adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, adnexal_tumour, malignant_adnexal_tumour, extramammary_Pagets_disease, adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adnexal_tumour, malignant_adnexal_tumour, spiradenocarcinoma, adnexal_tumour, other, sebaceoma, adnexal_tumour, sebaceous_adenoma, adrenal_cortical_carcinoma, benign_melanocytic_nevus, dysplastic, carcinoid-endocrine_tumour, carcinoid-endocrine_tumour, non_functioning, carcinoma, carcinoma, Brenner_tumour, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, acinar_adenocarcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, adenoid_cystic_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, enteric_adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, medullary_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, papillary_renal_cell_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, poorly_differentiated_carcinoma, of_unknown_primary, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, squamous_cell_carcinoma, of_unknown_primary, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, carcinoma, undifferentiated_adenocarcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, chondrosarcoma, mesenchymal, gastrointestinal_stromal_tumour, germ_cell_tumour, mixed, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, germ_cell_tumour, teratoma, somatic-type_malignancy, primitive_neuroectodermal_tumour, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, oligoastrocytoma, glioma, oligoastrocytoma_Grade_III, anaplastic, glioma, oligodendroglioma, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_leukaemia_of_ambiguous_lineage, haematopoietic_neoplasm, acute_leukaemic_transformation_of_essential_thrombocythaemia, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_lymphoblastic_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M1, haematopoietic_neoplasm, acute_myeloid_leukaemia, M4, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, myelofibrosis, primary, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, B_cell_lymphoma_unspecified, lymphoid_neoplasm, B_cell_prolymphocytic_leukaemia, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, lymphoid_neoplasm, MALT_lymphoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, Ph-like, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, angioimmunoblastic_T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, lymphoid_neoplasm, plasma_cell_myeloma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_melanoma, desmoplastic, malignant_melanoma, spindle, meningioma, meningothelial, mesothelioma, mesothelioma, epithelial, osteosarcoma, osteosarcoma, fibroblastic, other, Barrett_oesophagus, with_high_grade_dysplasia, other, choroid_plexus_carcinoma, other, cystic_tumour, other, dysplasia, high_grade-carcinoma_in_situ, other, dysplasia-carcinoma_in_situ, other, dysplasia-in_situ_neoplasm, other, intraductal_papillary_neoplasm, other, keratoacanthoma, other, neoplasm, other, neoplasm, malignant, other, normal, other, papillary_glioneuronal_tumour, other, ulcerative_colitis, dysplasia, pheochromocytoma, pheochromocytoma, malignant, primitive_neuroectodermal_tumour-medulloblastoma, primitive_neuroectodermal_tumour-medulloblastoma, SHH_subtype, primitive_neuroectodermal_tumour-medulloblastoma, classic, primitive_neuroectodermal_tumour-medulloblastoma, large_cell, pulmonary_blastoma, rhabdomyosarcoma, embryonal, sarcoma, thymic_carcinoma",0.0000119296627087,,,,12356,Pathogenic,"Colorectal cancer;TP53-related disorder;Adrenal cortex carcinoma;Carcinoma of colon;Lymphoma;Gastric cancer;Hereditary cancer-predisposing syndrome;Lip and oral cavity carcinoma;Ductal carcinoma in situ;Rhabdomyosarcoma;Sarcoma;not provided;Multiple myeloma;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Hereditary breast ovarian cancer syndrome;Malignant tumor of urinary bladder;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Familial cancer of breast;Breast carcinoma",3,Oncogenic,Colorectal cancer;Neoplasm,1,Tier I - Strong,"Adenocarcinoma of the large intestine;Medulloblastoma WNT activated;Diffuse midline glioma, H3 K27M-mutant;Embryonal rhabdomyosarcoma;Embryonal tumor with multilayered rosettes;Nasopharyngeal carcinoma",1
3331,248,R,S,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3332,248,R,T,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3333,248,R,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3334,248,R,W,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, aml_ohsu_2018, aml_ohsu_2022, aml_target_gdc, ampca_bcm_2016, angs_painter_2020, angs_painter_2025, angs_project_painter_2018, appendiceal_msk_2022, bcc_unige_2016, biliary_tract_summit_2022, bladder_msk_2023, blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_mskcc_solit_2014, blca_plasmacytoid_mskcc_2016, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brain_cptac_2020, brain_cptac_gdc, brca_bccrc, brca_bccrc_xenograft_2014, brca_cptac_2020, brca_dfci_2020, brca_fuscc_2020, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, ccrcc_irc_2014, cellline_ccle_broad, cervix_msk_2023, cfdna_msk_2019, chol_icgc_2017, chol_nus_2012, chol_tcga, chol_tcga_gdc, chol_tcga_pan_can_atlas_2018, cll_broad_2015, cll_broad_2022, coad_cptac_gdc, coad_silu_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_genentech, coadread_mskcc, coadread_mskresistance_2022, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_orion_2024, crc_sysucc_2022, cscc_dfarber_2015, cscc_hgsc_bcm_2014, cscc_ranson_2022, cscc_ucsf_2021, csf_msk_2024, difg_glass, difg_glass_2019, difg_msk_2023, difg_tcga_gdc, dlbc_broad_2012, dlbc_tcga, dlbc_tcga_pan_can_atlas_2018, dlbcl_dfci_2018, dlbcl_duke_2017, dlbclnos_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_tmucih_2015, egc_trap_ccr_msk_2023, egc_trap_msk_2020, es_dsrct_msk_2023, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, escc_ucla_2014, gbc_msk_2018, gbc_mskcc_2022, gbm_cptac_2021, gbm_mayo_pdx_sarkaria_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, gct_msk_2016, gist_msk_2022, glioma_msk_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_meric_2021, hcc_msk_2024, hcc_tcga_gdc, hccihch_pku_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_broad, luad_cas_2020, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_pdx, lung_nci_2022, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, makeanimpact_ccr_2023, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mds_tokyo_2011, mel_dfci_2019, mel_iatlas_liu_2019, mel_mskimpact_2020, mel_tsam_liang_2017, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_kunga_msk_2022, mixed_selpercatinib_2020, mm_broad, mnm_washu_2016, mpcproject_broad_2021, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nhl_bcgsc_2013, normal_skin_keratinocytes_2024, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_cptac_2021, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, panet_msk_erc_2023, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_cpcg_2017, prad_mcspc_mskcc_2020, prad_mich, prad_msk_stopsack_2021, prad_mskcc, prad_mskcc_2017, prad_organoids_msk_2022, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_dkfz_2018, prostate_msk_2024, ptad_msk_2024, rcc_iatlas_immotion150_2018, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, rectal_radiation_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_broad, skcm_mskcc_2014, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, skcm_vanderbilt_mskcc_2015, soft_tissue_tcga_gdc, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stad_uhongkong, stes_tcga_pub, thyroid_gatci_2024, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_cptac_2020, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc, usarc_msk_2020, utuc_cornell_baylor_mdacc_2019, vsc_cuk_2018, wt_target_2018_pub, wt_target_gdc","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Ampullary Carcinoma, Angiosarcoma, Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Biliary Tract, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cervix, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gallbladder Cancer, Gastrointestinal Stromal Tumor, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pituitary Adenoma, Plasma Cell Myeloma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Renal Cell Carcinoma, Renal Clear Cell Carcinoma, Skin, Soft Tissue, Squamous Cell Carcinoma of the Vulva/Vagina, Stomach Adenocarcinoma, Testis, Thyroid, Upper Tract Urothelial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma, Uterine Sarcoma/Mesenchymal, Wilms' Tumor","hg19,17:7577539-7577539, hg19,17:7577539-7577540, hg19,17:7674221-7674221, hg19,17:7674221-7674222, hg38,17:7674221-7674221, hg38,17:7674221-7674222","hg19,17:g.7577539G>A, hg19,17:g.7577539_7577540delinsAA, hg19,17:g.7674221G>A, hg19,17:g.7674221_7674222delinsAA, hg38,17:g.7674221G>A, hg38,17:g.7674221_7674222delinsAA",0.927,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, cerebrum, central_nervous_system, frontal_lobe, central_nervous_system, parietal_lobe, central_nervous_system, temporal_lobe, central_nervous_system, thalamus, cervix, endometrium, extrapulmonary, eye, conjunctiva, female_genital_tract_(site_indeterminate), genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, adrenal_gland, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, pelvis, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, skin, haematopoietic_and_lymphoid_tissue, spleen, haematopoietic_and_lymphoid_tissue, tonsil, kidney, large_intestine, large_intestine, anorectal, large_intestine, anus, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, lung, bronchus, lung, right_upper_lobe, meninges, oesophagus, oesophagus, lower_third, ovary, pancreas, pancreas, ampulla_of_Vater, parathyroid, penis, peritoneum, appendix, pleura, prostate, salivary_gland, salivary_gland, maxillary_sinus, salivary_gland, parotid, skin, skin, arm, skin, chest, skin, ear, skin, face, skin, forearm, skin, head_neck, skin, leg, skin, lower_leg, skin, scalp, skin, shoulder, skin, trunk, skin, upper_leg, small_intestine, jejunum, soft_tissue, soft_tissue, blood_vessel, abdomen, soft_tissue, fat, testis, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, soft_tissue, smooth_muscle, abdomen, soft_tissue, smooth_muscle, uterus, soft_tissue, striated_muscle, stomach, stomach, gastroesophageal_junction, thymus, thyroid, upper_aerodigestive_tract, ear_canal, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, vocal_cord, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, urinary_tract, bladder, urinary_tract, bladder, urachus, urinary_tract, renal_pelvis, urinary_tract, upper_urinary_tract, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, angiosarcoma, carcinoid-endocrine_tumour, carcinoid-endocrine_tumour, goblet_cell, carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, adenocarcinoma, transformed_to_small_cell_carcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, follicular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, invasive_mucinous_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, lobular_carcinoma, pleomorphic, carcinoma, luminal_A_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, mixed_serous_and_clear_cell_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucinous_adenocarcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, osteoclast-like_giant_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, renal_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma_non_invasive, carcinoma, tubular_adenocarcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, chondrosarcoma, dedifferentiated, fibroepithelial_neoplasm, fibroadenoma, gastrointestinal_stromal_tumour, germ_cell_tumour, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, gliosarcoma, glioma, oligodendroglioma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_essential_thrombocythaemia, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M1, haematopoietic_neoplasm, acute_myeloid_leukaemia, M4, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, refractory_anaemia, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, myelofibrosis, primary, haematopoietic_neoplasm, myeloid_neoplasm_unspecified_therapy_related, hyperplasia, in_situ_epithelial_neoplasm, Bowen_disease, in_situ_epithelial_neoplasm, actinic_keratosis, leiomyosarcoma, liposarcoma, pleomorphic, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, NK_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, Ph-like, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, lymphoid_neoplasm, plasma_cell_myeloma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma, malignant_melanoma, malignant_melanoma, desmoplastic, malignant_melanoma, nodular, malignant_melanoma, spindle, malignant_melanoma, superficial_spreading, meningioma, mesothelioma, mesothelioma, epithelial, osteosarcoma, other, Barrett_oesophagus, with_high_grade_dysplasia, other, adenosarcoma, other, cystic_tumour, other, dysplasia, other, dysplasia-in_situ_neoplasm, other, hepatoblastoma, other, intraepithelial_neoplasia, other, keratoacanthoma, other, keratosis, other, neoplasm, other, neoplasm, malignant, other, pseudomyxoma_peritonei, primitive_neuroectodermal_tumour-medulloblastoma, classic, rhabdomyosarcoma, embryonal, sarcoma, thymic_carcinoma, squamous_cell_carcinoma",0.0000039765226105,,,,"437017, 12347","Likely pathogenic, Pathogenic","Li-Fraumeni syndrome|TP53-related disorder;Congenital fibrosarcoma;Gallbladder cancer;Lip and oral cavity carcinoma;Hereditary cancer-predisposing syndrome;Gastric cancer;Breast and/or ovarian cancer;Familial pancreatic carcinoma;Malignant lymphoma, large B-cell, diffuse;not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome 1;Choroid plexus carcinoma;Li-Fraumeni syndrome","1, 3",Oncogenic,Neoplasm,1,Tier I - Strong,"Breast phyllodes tumor;Medulloblastoma SHH activated and TP53 mutant;Diffuse glioma, H3 G34 mutant;Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype;Colorectal cancer",1
3335,248,R,Y,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,"skin, face","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3336,249,R,A,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3337,249,R,C,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3338,249,R,D,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3339,249,R,E,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3340,249,R,F,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3341,249,R,G,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2023, blca_bcan_hcrn_2022, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_nigerian_2020, csf_msk_2024, difg_tcga_gdc, dlbc_broad_2012, dlbcl_dfci_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, ihch_msk_2021, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_broad, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mixed_impact_subset_2022, mixed_selpercatinib_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_cpcg_2017, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_pan_can_atlas_2018, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577534-7577536, hg19,17:7577536-7577536, hg19,17:7674218-7674218, hg38,17:7674216-7674218, hg38,17:7674218-7674218","hg19,17:g.7577534_7577536delinsACC, hg19,17:g.7577536T>C, hg19,17:g.7674218T>C, hg38,17:g.7674216_7674218delinsACC, hg38,17:g.7674218T>C",0.888,"adrenal_gland, adrenal_gland, bone, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, central_nervous_system, parietal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, skin, large_intestine, large_intestine, appendix, large_intestine, colon, ascending, large_intestine, rectum, liver, lung, oesophagus, ovary, prostate, soft_tissue, striated_muscle, head_neck, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, retromolar, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, chondrosarcoma, dedifferentiated, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, lymphoid_neoplasm, plasma_cell_myeloma, rhabdomyosarcoma, embryonal",,,,,376654,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
3342,249,R,H,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3343,249,R,I,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_impact_2017",Mixed Cancer Types,"hg19,17:7577534-7577535, hg38,17:7674216-7674217","hg19,17:g.7577534_7577535delinsAA, hg38,17:g.7674216_7674217delinsAA",,placenta,choriocarcinoma,,,,,,,,,,,,,,
3344,249,R,K,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_cptac_2020, breast_cptac_gdc, breast_msk_2025, gbm_cptac_2021, hnsc_broad, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, pancan_pcawg_2020, rectal_msk_2022, sarcoma_mskcc_2022, thyroid_mskcc_2016","Bladder Urothelial Carcinoma, Bowel, Breast, CNS/Brain, Diffuse Glioma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue, Thyroid","hg19,17:7577535-7577535, hg19,17:7674217-7674217, hg38,17:7674217-7674217","hg19,17:g.7577535C>T, hg19,17:g.7674217C>T, hg38,17:g.7674217C>T",0.893,"adrenal_gland, adrenal_gland, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lung, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, rectum, liver, lung, right_upper_lobe, oesophagus, pancreas, soft_tissue, fibrous_tissue_and_uncertain_origin, pelvis, stomach, testis, thyroid, upper_aerodigestive_tract, mouth, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, giant_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma_of_soft_parts-clear_cell_sarcoma, other, Barrett_oesophagus, other, dysplasia, sex_cord-stromal_tumour, Sertoli_cell_tumour",,,,,142241,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,Oncogenic,Neoplasm,1,,,
3345,249,R,L,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3346,249,R,M,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, blca_mskcc_solit_2012, bm_nsclc_mskcc_2023, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cfdna_msk_2019, crc_eo_2020, crc_msk_2017, es_dfarber_broad_2014, esca_tcga, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgggbm_tcga_pub, lihc_amc_prv, luad_cas_2020, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2015, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mpn_cimr_2013, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2015, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, nsclc_unito_2016, paad_qcmg_uq_2016, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, rectal_radiation_msk_2024, sarcoma_msk_2022, sclc_jhu, sft_sysucc_2023, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_msk_2018","Acute Myeloid Leukemia, Bladder Urothelial Carcinoma, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Ewing Sarcoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577535-7577535, hg19,17:7674217-7674217, hg38,17:7674217-7674217","hg19,17:g.7577535C>A, hg19,17:g.7674217C>A, hg38,17:g.7674217C>A",0.911,"bone, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, caecum, large_intestine, colon, ascending, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, paratesticular_tissues, prostate, salivary_gland, skin, face, skin, head_neck, small_intestine, jejunum, soft_tissue, smooth_muscle, uterus, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, mouth_roof, urinary_tract, renal_pelvis, urinary_tract, upper_urinary_tract","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelofibrosis, post-thrombocythaemic-polycythaemic, leiomyosarcoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, desmoplastic, other, adenosarcoma, other, mucinous_adenocarcinoma, other, neoplasm",,,,,376653,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Ovarian neoplasm;Li-Fraumeni syndrome,1,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
3347,249,R,N,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3348,249,R,P,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3349,249,R,Q,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3350,249,R,S,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, bcc_unige_2016, bladder_columbia_msk_2018, blca_iatlas_imvigor210_2017, blca_msk_2025, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_cptac_2020, brca_igr_2015, brca_metabric, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, cervix_msk_2023, chol_icgc_2017, cll_broad_2015, cll_broad_2022, coadread_dfci_2016, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_hgsc_bcm_2014, csf_msk_2024, egc_tmucih_2015, gbc_mskcc_2022, gbm_mayo_pdx_sarkaria_2019, gct_msk_2020, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, hcc_jcopo_msk_2023, hcc_meric_2021, hcc_msk_2024, hcc_mskimpact_2018, hcc_tcga_gdc, hccihch_pku_2019, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, ihch_smmu_2014, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_broad, luad_cas_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbl_broad_2012, mbl_dkfz_2017, mds_iwg_2022, mds_mskcc_2020, mixed_cfdna_msk_2020, mixed_pipseq_2017, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ovary_cptac_gdc, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, prad_mich, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_jhu, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_cptac_2020, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc","Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervix, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Medulloblastoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Testis, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma","hg19,17:7577534-7577534, hg19,17:7674216-7674216, hg38,17:7674216-7674216","hg19,17:g.7577534C>A, hg19,17:g.7577534C>G, hg19,17:g.7674216C>A, hg19,17:g.7674216C>G, hg38,17:g.7674216C>A, hg38,17:g.7674216C>G",0.769,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, lung, bronchus, lung, lower_lobe, lung, right_upper_lobe, lung, upper_lobe, oesophagus, ovary, pancreas, pleura, prostate, salivary_gland, salivary_gland, major, skin, skin, head_neck, skin, leg, soft_tissue, fibrous_tissue_and_uncertain_origin, kidney, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, urinary_tract, bladder, urinary_tract, renal_pelvis, urinary_tract, upper_urinary_tract, urinary_tract, urethra, vulva","adenoma, tubulovillous, high_grade_dysplasia, carcinoma, carcinoma, acinic_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, papillary, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, mesonephric_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, chondrosarcoma, dedifferentiated, fibroepithelial_neoplasm, phyllodes_tumour, malignant, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, plasma_cell_myeloma, lymphoid_neoplasm, plasmacytoma, mesothelioma, mesothelioma, biphasic, other, hepatoblastoma, other, keratosis, other, neoplasm, primitive_neuroectodermal_tumour-medulloblastoma, sarcoma",,,,,"406598, 12352","Conflicting classifications of pathogenicity, Pathogenic/Likely pathogenic",Li-Fraumeni syndrome 1;Li-Fraumeni syndrome|Adrenal cortex carcinoma;Hereditary cancer-predisposing syndrome;not provided;Cervical cancer;Ovarian neoplasm;Hepatocellular carcinoma;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck,"1, 2",Oncogenic,Neoplasm,1,,,
3351,249,R,T,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","angs_painter_2020, angs_painter_2025, angs_project_painter_2018, brca_pareja_msk_2020, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, glioma_mskcc_2019, lgggbm_tcga_pub, luad_broad, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_pdx, lung_nci_2022, mds_mskcc_2020, mel_mskimpact_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, thyroid_gatci_2024, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_tcga_gdc","Angiosarcoma, Bowel, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Thyroid","hg19,17:7577535-7577535, hg19,17:7674217-7674217, hg38,17:7674217-7674217","hg19,17:g.7577535C>G, hg19,17:g.7674217C>G, hg38,17:g.7674217C>G",0.921,", biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, endometrium, large_intestine, liver, lung, oesophagus, ovary, pancreas, pleura, prostate, skin, skin, face, soft_tissue, blood_vessel, breast, stomach, thyroid, upper_aerodigestive_tract, mouth","adnexal_tumour, malignant_adnexal_tumour, angiosarcoma, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lymphoepithelioma_like_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, malignant_melanoma, mesothelioma, mesothelioma, epithelial, osteosarcoma, other, keloid, other, neoplasm",,,,,376015,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1,2,,,,,,
3352,249,R,V,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674217-7674218","hg38,17:g.7674217_7674218delinsAC",,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated",,,,,,,,,,,,,,
3353,249,R,W,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ampca_bcm_2016, bcc_unige_2016, blca_msk_2025, bm_nsclc_mskcc_2023, breast_msk_2018, breast_msk_2025, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, egc_msk_2023, esca_broad, esca_tcga, escc_ucla_2014, hcc_clca_2024, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_mdacc_2013, mds_iwg_2022, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, rectal_msk_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_ucologne_2015, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Adenoid Cystic Carcinoma, Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577536-7577536, hg19,17:7674218-7674218, hg38,17:7674218-7674218","hg19,17:g.7577536T>A, hg19,17:g.7674218T>A, hg38,17:g.7674218T>A",0.846,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_lower_lobe, oesophagus, pancreas, pancreas, ampulla_of_Vater, skin, skin, leg, small_intestine, jejunum, soft_tissue, blood_vessel, abdomen, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, urinary_tract, bladder","adrenal_cortical_carcinoma, angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, classic, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_essential_thrombocythaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,141881,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,,,,,,
3354,249,R,Y,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3355,250,P,A,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577533-7577533, hg38,17:7674215-7674215","hg19,17:g.7577533G>C, hg38,17:g.7674215G>C",0.892,"breast, skin","carcinoma, carcinoma, basal_cell_carcinoma",,,,,1759142,Uncertain significance,"Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome",2,,,,,,
3356,250,P,C,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3357,250,P,D,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3358,250,P,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3359,250,P,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_msk_2025, breast_msk_2025, ccle_broad_2025, sarcoma_msk_2022","Basal Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577532-7577533, hg19,17:7674214-7674215, hg38,17:7674214-7674215","hg19,17:g.7577532_7577533delinsAA, hg19,17:g.7674214_7674215delinsAA, hg38,17:g.7674214_7674215delinsAA",,"eye, conjunctiva, lung, skin","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, other, pterygium",,,,,,,,,,,,,,
3360,250,P,G,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3361,250,P,H,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","brca_bccrc, pan_origimed_2020, sarcoma_msk_2022","Invasive Breast Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577532-7577532, hg38,17:7674214-7674214","hg19,17:g.7577532G>T, hg38,17:g.7674214G>T",0.941,"breast, large_intestine, large_intestine, colon","carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma",,,,,,,,,,,,,,
3362,250,P,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3363,250,P,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3364,250,P,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_mskcc_solit_2012, brca_aurora_2023, brca_bccrc, brca_metabric, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, chrcc_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, escc_ucla_2014, gbc_shanghai_2014, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gct_msk_2016, glioma_mskcc_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, kich_tcga, kich_tcga_pan_can_atlas_2018, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_msk_2024, mds_iwg_2022, mel_mskimpact_2020, mnm_washu_2016, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, read_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, uec_cptac_gdc","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Chromophobe Renal Cell Carcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mature T and NK Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Testis, Uterine Endometrioid Carcinoma","hg19,17:7577531-7577532, hg19,17:7577532-7577532, hg19,17:7674214-7674214, hg38,17:7674213-7674214, hg38,17:7674214-7674214","hg19,17:g.7577531_7577532delinsAA, hg19,17:g.7577532G>A, hg19,17:g.7674214G>A, hg38,17:g.7674213_7674214delinsAA, hg38,17:g.7674213_7674214delinsCA, hg38,17:g.7674214G>A",0.962,", adrenal_gland, adrenal_gland, autonomic_ganglia, biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, endometrium, female_genital_tract_(site_indeterminate), gastrointestinal_tract_(site_indeterminate), genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, skin, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, lower_lobe, lung, middle_lobe, lung, right_lower_lobe, oesophagus, ovary, pancreas, peritoneum, appendix, prostate, skin, skin, face, skin, head_neck, small_intestine, jejunum, soft_tissue, striated_muscle, pharynx, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, tongue, vulva","adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, adrenal_cortical_adenoma, carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, gastric_type, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, yolk_sac_tumour, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelofibrosis, primary, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, neuroblastoma, other, neoplasm, other, pseudomyxoma_peritonei, rhabdomyosarcoma, embryonal",,,,,420136,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,2,Likely oncogenic,Neoplasm,1,,,
3365,250,P,M,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3366,250,P,N,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674214-7674215","hg38,17:g.7674214_7674215delinsTT",,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, follicular_lymphoma",,,,,,,,,,,,,,
3367,250,P,Q,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674213-7674214","hg38,17:g.7674213_7674214delinsCT",,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3368,250,P,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",lgg_tcga_pan_can_atlas_2018,Diffuse Glioma,"hg19,17:7577532-7577532, hg38,17:7674214-7674214","hg19,17:g.7577532G>C, hg38,17:g.7674214G>C",0.963,"central_nervous_system, brain",glioma,,,,,,,,,,,,,,
3369,250,P,S,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, glioma_msk_2018, pan_origimed_2020","Basal Cell Carcinoma, Diffuse Glioma, Mixed Cancer Types","hg19,17:7577533-7577533, hg38,17:7674215-7674215","hg19,17:g.7577533G>A, hg38,17:g.7674215G>A",0.939,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, large_intestine, appendix, lung, oesophagus, pancreas, skin, skin, face, skin, head_neck, stomach, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, lobular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, other, low_grade_mucinous_neoplasm",,,,,1316970,Uncertain significance,Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;not provided,2,,,,,,
3370,250,P,T,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577533-7577533, hg38,17:7674215-7674215","hg19,17:g.7577533G>T, hg38,17:g.7674215G>T",0.949,breast,carcinoma,,,,,1759140,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
3371,250,P,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3372,250,P,W,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3373,250,P,Y,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 248-250, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 248-250, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3374,251,I,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3375,251,I,C,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3376,251,I,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3377,251,I,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3378,251,I,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, breast_msk_2018, breast_msk_2025, cfdna_msk_2019, coadread_tcga, coadread_tcga_pub, esca_tcga, hccihch_pku_2019, ilc_msk_2023, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, paired_bladder_2022, pan_origimed_2020, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, sarcoma_mskcc_2022, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder/Urinary Tract, Breast, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue","hg19,17:7577530-7577530, hg19,17:7674212-7674212, hg38,17:7674212-7674212","hg19,17:g.7577530T>A, hg19,17:g.7674212T>A, hg38,17:g.7674212T>A",0.962,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, liver, lung, oesophagus, pancreas, urinary_tract, urinary_tract, bladder, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, lobular_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma",,,,,1518844,Likely pathogenic,Li-Fraumeni syndrome,1,,,,Tier I - Strong,Adrenal cortex carcinoma,1
3379,251,I,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3380,251,I,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3381,251,I,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3382,251,I,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_sysucc_2022, hcc_msk_2024, ihch_msk_2021, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_met_2021, paired_bladder_2022, pancan_pcawg_2020, skcm_vanderbilt_mskcc_2015","Bladder/Urinary Tract, Colorectal Adenocarcinoma, Cutaneous Melanoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7577530-7577530, hg19,17:7674212-7674212, hg38,17:7674212-7674212","hg19,17:g.7577530T>G, hg19,17:g.7674212T>G, hg38,17:g.7674212T>G",0.882,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon, stomach, thyroid","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,182937,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Gastric cancer,2,,,,,,
3383,251,I,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, lms_msk_2024, mds_mskcc_2020, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, sarcoma_mskcc_2022","Acute Myeloid Leukemia, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7577528-7577528, hg38,17:7674210-7674210","hg19,17:g.7577528G>C, hg38,17:g.7674210G>C",0.779,"lung, soft_tissue, smooth_muscle, testis","carcinoma, large_cell_carcinoma, carcinoma, non_small_cell_carcinoma, leiomyosarcoma",,,,,485046,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
3384,251,I,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_dldccc_2022, brca_msk_2025, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, mds_iwg_2022, mpcproject_broad_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, prad_broad, prad_broad_2013, prad_p1000, sarcoma_msk_2022, skcm_yale, tmb_mskcc_2018","Cutaneous Melanoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577528-7577529, hg19,17:7577529-7577529, hg19,17:7674211-7674211, hg38,17:7674210-7674211, hg38,17:7674211-7674211","hg19,17:g.7577528_7577529delinsAT, hg19,17:g.7577529A>T, hg19,17:g.7674211A>T, hg38,17:g.7674210_7674211delinsAT, hg38,17:g.7674211A>T",0.927,", breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, spleen, large_intestine, large_intestine, colon, lung, oesophagus, oesophagus, lower_third, pancreas, prostate, skin, skin, eye, soft_tissue, fat, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, squamous_cell_carcinoma, of_unknown_primary, liposarcoma, well_differentiated, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, marginal_zone_lymphoma, malignant_melanoma, other, intraepithelial_neoplasia, low_grade",,,,,528254,Conflicting classifications of pathogenicity,Acute myeloid leukemia;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
3385,251,I,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3386,251,I,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3387,251,I,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3388,251,I,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, dlbcl_duke_2017, glioma_mskcc_2019, hcc_clca_2024, hgsoc_msk_2021, hgsoc_tcga_gdc, lms_msk_2024, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022","Bladder/Urinary Tract, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577529-7577529, hg19,17:7674211-7674211, hg38,17:7674211-7674211","hg19,17:g.7577529A>C, hg19,17:g.7674211A>C, hg38,17:g.7674211A>C",0.959,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, stomach, large_intestine, oesophagus, ovary, small_intestine, jejunum, stomach, upper_aerodigestive_tract, larynx, urinary_tract, bladder, urachus","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma, other, neoplasm, malignant",0.0000000000000000,,,,182967,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3389,251,I,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, crc_eo_2020, hcc_clca_2024, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, sarcoma_msk_2022","Bowel, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577529-7577529, hg19,17:7674211-7674211, hg38,17:7674211-7674211","hg19,17:g.7577529A>G, hg19,17:g.7674211A>G, hg38,17:g.7674211A>G",0.922,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, stomach","carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,439320,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,1,,,,,,
3390,251,I,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_ch_2020, msk_ch_2023",Mixed Cancer Types,"hg19,17:7577530-7577530, hg38,17:7674212-7674212","hg19,17:g.7577530T>C, hg38,17:g.7674212T>C",0.856,"breast, liver","carcinoma, carcinoma, hepatocellular_carcinoma",,,,,1759315,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided,2,,,,,,
3391,251,I,W,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3392,251,I,Y,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3393,252,L,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3394,252,L,C,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3395,252,L,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3396,252,L,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3397,252,L,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","mel_mskimpact_2020, mnm_washu_2016, msk_met_2021, stad_pfizer_uhongkong, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types, Myeloid Neoplasm, Stomach Adenocarcinoma","hg19,17:7577527-7577527, hg38,17:7674209-7674209","hg19,17:g.7577527G>A, hg38,17:g.7674209G>A",0.716,"endometrium, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, sigmoid, lung, stomach, upper_aerodigestive_tract, larynx, glottis","carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,1053765,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3398,252,L,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3399,252,L,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7577526-7577526, hg38,17:7674208-7674208","hg19,17:g.7577526A>T, hg38,17:g.7674208A>T",0.914,"central_nervous_system, brainstem, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma, gastrointestinal_stromal_tumour, glioma, diffuse_midline_glioma",,,,,,,,,,,,,,
3400,252,L,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3401,252,L,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3402,252,L,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3403,252,L,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3404,252,L,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, ccle_broad_2019, cellline_ccle_broad, cfdna_msk_2019, coadread_dfci_2016, cscc_dfarber_2015, difg_msk_2023, glioma_mskcc_2019, heme_msk_impact_2022, mds_iwg_2022, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, rectal_msk_2022, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Bowel, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas","hg19,17:7577526-7577526, hg19,17:7674208-7674208, hg38,17:7674208-7674208","hg19,17:g.7577526A>G, hg19,17:g.7674208A>G, hg38,17:g.7674208A>G",0.952,", breast, central_nervous_system, brain, central_nervous_system, brainstem, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, transverse, liver, lung, lung, right_lower_lobe, ovary, peritoneum, skin, skin, head_neck, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, other, neoplasm",,,,,12350,Conflicting classifications of pathogenicity,not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
3405,252,L,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3406,252,L,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3407,252,L,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3408,252,L,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3409,252,L,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577527-7577527, hg38,17:7674209-7674209","hg19,17:g.7577527G>C, hg38,17:g.7674209G>C",0.607,,,,,,,1759470,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
3410,252,L,W,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3411,252,L,Y,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3412,253,T,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","crc_sysucc_2022, hcc_clca_2024, hcc_meric_2021, hcc_tcga_gdc, hgsoc_tcga_gdc, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, mds_iwg_2022, msk_access_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022","Colorectal Adenocarcinoma, Endometrial Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Mixed Cancer Types, Myelodysplastic Syndromes, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577524-7577524, hg19,17:7674206-7674206, hg38,17:7674206-7674206","hg19,17:g.7577524T>C, hg19,17:g.7674206T>C, hg38,17:g.7674206T>C",0.854,"breast, kidney, large_intestine, liver, lung, ovary, prostate, skin, head_neck, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, other, neoplasm",,,,,827132,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3413,253,T,C,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3414,253,T,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7577523-7577524","hg19,17:g.7577523_7577524delinsTC",,,,,,,,,,,,,,,,,
3415,253,T,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3416,253,T,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3417,253,T,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3418,253,T,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3419,253,T,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, mel_mskimpact_2020, msk_chord_2024, msk_met_2021, pan_origimed_2020, pancan_hcmi_2025, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Cutaneous Melanoma, Esophagogastric Adenocarcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,17:7577523-7577523, hg19,17:7674205-7674205, hg38,17:7674205-7674205","hg19,17:g.7577523G>A, hg19,17:g.7674205G>A, hg38,17:g.7674205G>A",0.790,"eye, uveal_tract, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, large_intestine, rectum, meninges, oesophagus, prostate, skin, face, stomach, upper_aerodigestive_tract, mouth","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, malignant_melanoma, meningioma",,,,,837688,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3420,253,T,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3421,253,T,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3422,253,T,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3423,253,T,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","gbm_mayo_pdx_sarkaria_2019, hgsoc_tcga_gdc, lihc_riken, msk_chord_2024, msk_ctdna_vte_2024, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_pcawg_2020, prad_pik3r1_msk_2021, prostate_msk_2024","Diffuse Glioma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7577523-7577523, hg19,17:7674205-7674205, hg38,17:7674205-7674205","hg19,17:g.7577523G>T, hg19,17:g.7674205G>T, hg38,17:g.7674205G>T",0.895,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, liver, ovary","carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,505571,Uncertain significance,not specified;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3424,253,T,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","braf_msk_impact_2024, brca_smc_2018, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2025, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, hcc_msk_2024, heme_msk_impact_2022, mbn_sfu_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, thyroid_gatci_2024, ucec_ancestry_cds_msk_2023","Breast, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Thyroid","hg19,17:7577524-7577524, hg19,17:7674206-7674206, hg38,17:7674206-7674206","hg19,17:g.7577524T>G, hg19,17:g.7674206T>G, hg38,17:g.7674206T>G",0.942,"breast, large_intestine, ovary, small_intestine, stomach","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma",,,,,3148769,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3425,253,T,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3426,253,T,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3427,253,T,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, prad_fhcrc","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,17:7577523-7577523, hg19,17:7577524-7577524, hg38,17:7674205-7674205, hg38,17:7674206-7674206","hg19,17:g.7577523G>C, hg19,17:g.7577524T>A, hg38,17:g.7674205G>C, hg38,17:g.7674206T>A","0.851, 0.854","large_intestine, liver, lung, prostate, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary","carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, other, neoplasm",,,,,,,,,,,,,,
3428,253,T,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3429,253,T,W,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3430,253,T,Y,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 249-253, ggetELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3431,254,I,A,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3432,254,I,C,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3433,254,I,D,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, mbn_sfu_2023","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,17:7577520-7577521, hg19,17:7674202-7674203, hg38,17:7674202-7674203","hg19,17:g.7577520_7577521delinsTC, hg19,17:g.7674202_7674203delinsTC, hg38,17:g.7674202_7674203delinsTC",,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, MALT_lymphoma",,,,,,,,,,,,,,
3434,254,I,E,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3435,254,I,F,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","crc_msk_2017, csf_msk_2024, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ohnca_cptac_gdc, pan_origimed_2020, pancan_mimsi_msk_2024, rectal_msk_2019","Colorectal Adenocarcinoma, Head and Neck Carcinoma, Other, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577521-7577521, hg19,17:7674203-7674203, hg38,17:7674203-7674203","hg19,17:g.7577521T>A, hg19,17:g.7674203T>A, hg38,17:g.7674203T>A",0.942,"large_intestine, rectum, lung, oesophagus, prostate, thyroid","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3436,254,I,G,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3437,254,I,H,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3438,254,I,K,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3439,254,I,L,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7577521-7577521, hg38,17:7674203-7674203","hg19,17:g.7577521T>G, hg38,17:g.7674203T>G",0.871,"central_nervous_system, temporoparietal, lung","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
3440,254,I,M,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7577519-7577519, hg38,17:7674201-7674201","hg19,17:g.7577519G>C, hg38,17:g.7674201G>C",0.877,lung,"carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma",,,,,2135554,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3441,254,I,N,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","brca_smc_2018, breast_msk_2025, ccle_genentech_2014, crc_eo_2020, crc_msk_2017, ihch_msk_2021, ihch_mskcc_2020, lusc_cptac_2021, lusc_cptac_gdc, lymphoma_cellline_msk_2020, mds_iwg_2022, mds_mskcc_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018","Bowel, Colorectal Adenocarcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Soft Tissue","hg19,17:7577519-7577520, hg19,17:7577520-7577520, hg19,17:7674202-7674202, hg38,17:7674201-7674202, hg38,17:7674202-7674202","hg19,17:g.7577519_7577520delinsAT, hg19,17:g.7577520A>T, hg19,17:g.7674202A>T, hg38,17:g.7674201_7674202delinsAT, hg38,17:g.7674202A>T",0.962,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, caecum, liver, oesophagus, middle_third, ovary, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, fibrosarcoma, myxofibrosarcoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, neoplasm",,,,,"2817584, 856299","Pathogenic, Pathogenic",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,"1, 3",,,,,,
3442,254,I,P,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3443,254,I,Q,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3444,254,I,R,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3445,254,I,S,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, brca_mapk_hp_msk_2021, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cfdna_msk_2019, coadread_genentech, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, lgggbm_tcga_pub, lung_msk_2017, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, rectal_msk_2022, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Ampullary Carcinoma, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Pancreatic Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577520-7577520, hg19,17:7674202-7674202, hg38,17:7674202-7674202","hg19,17:g.7577520A>C, hg19,17:g.7674202A>C, hg38,17:g.7674202A>C",0.953,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, lung, oesophagus, pancreas, skin, mucosal, vagina, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, malignant_melanoma, nodular, primitive_neuroectodermal_tumour-medulloblastoma",0.0000000000000000,,,,659457,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Lung sarcomatoid carcinoma;Li-Fraumeni syndrome,1,,,,,,
3446,254,I,T,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, chol_icgc_2017, hcc_msk_2024, luad_cptac_2020, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025","Cholangiocarcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7577520-7577520, hg38,17:7674202-7674202","hg19,17:g.7577520A>G, hg38,17:g.7674202A>G",0.954,"biliary_tract, bile_duct, breast, central_nervous_system, brainstem, large_intestine, large_intestine, colon, oesophagus, pancreas","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,1759844,Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Acute myeloid leukemia;Li-Fraumeni syndrome 1,3,,,,,,
3447,254,I,V,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_genentech_2014, lihc_riken, lymphoma_cellline_msk_2020, mds_mskcc_2020, pancan_pcawg_2020","Hepatocellular Carcinoma, Lymphoid, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7577521-7577521, hg38,17:7674203-7674203","hg19,17:g.7577521T>C, hg38,17:g.7674203T>C",0.780,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, liver, prostate, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000159060904420,,,,406605,Likely benign,"Malignant glioma;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",3,,,,,,
3448,254,I,W,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3449,254,I,Y,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|MAPK docking motifs (DOC_MAPK_gen_1), 248-254, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3450,255,I,A,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3451,255,I,C,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3452,255,I,D,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3453,255,I,E,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3454,255,I,F,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bm_nsclc_mskcc_2023, brca_mbcproject_2022, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2025, cll_broad_2015, cll_broad_2022, coad_caseccc_2015, difg_tcga_gdc, dlbcl_duke_2017, esca_broad, escc_icgc, hcc_clca_2024, hcc_msk_2024, lcll_broad_2013, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_broad, luad_cas_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tsp, lung_msk_2017, lung_msk_mind_2020, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_organoids_msk_2022, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577518-7577518, hg19,17:7674200-7674200, hg38,17:7674200-7674200","hg19,17:g.7577518T>A, hg19,17:g.7674200T>A, hg38,17:g.7674200T>A",0.785,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, prostate, skin, skin, face, soft_tissue, blood_vessel, abdomen, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder, urachus","angiosarcoma, carcinoid-endocrine_tumour, atypical, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, spindle_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma, primitive_neuroectodermal_tumour-medulloblastoma, large_cell",,,,,376621,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
3455,255,I,G,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3456,255,I,H,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3457,255,I,K,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3458,255,I,L,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3459,255,I,M,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674198-7674198","hg38,17:g.7674198G>C",0.791,"endometrium, oesophagus","carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3460,255,I,N,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_dfci_2016, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, glioma_mskcc_2019, hnc_mskcc_2016, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, prad_su2c_2019, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Ampullary Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577517-7577517, hg19,17:7674199-7674199, hg38,17:7674199-7674199","hg19,17:g.7577517A>T, hg19,17:g.7674199A>T, hg38,17:g.7674199A>T",0.928,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, sigmoid, lung, oesophagus, pancreas, small_intestine, duodenum, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, gliosarcoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma",,,,,232289,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3461,255,I,P,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3462,255,I,Q,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3463,255,I,R,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3464,255,I,S,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coadread_cass_2020, csf_msk_2024, escc_icgc, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, hcc_jcopo_msk_2023, lgggbm_tcga_pub, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577517-7577517, hg19,17:7674199-7674199, hg38,17:7674199-7674199","hg19,17:g.7577517A>C, hg19,17:g.7674199A>C, hg38,17:g.7674199A>C",0.943,"biliary_tract, bile_duct, bone, femur, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, prostate, skin, ear, skin, face, small_intestine, jejunum, soft_tissue, smooth_muscle, uterus, thyroid, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, microcystic_adnexal_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, chondrosarcoma, dedifferentiated, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, leiomyosarcoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, other, intraductal_papillary_neoplasm",,,,,376622,Uncertain significance,Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
3465,255,I,T,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_mapk_hp_msk_2021, brca_metabric, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, csf_msk_2024, gbc_mskcc_2022, hcc_clca_2024, hcc_msk_2024, hcc_mskimpact_2018, heme_msk_impact_2022, luad_mskcc_2023_met_organotropism, mds_iwg_2022, mds_mskcc_2020, msk_access_2021, msk_ch_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, panet_msk_2018, pdac_msk_2024, prad_su2c_2019, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Bowel, Breast, Colorectal Adenocarcinoma, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine Tumor, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577516-7577517, hg19,17:7577517-7577517, hg19,17:7674199-7674199, hg38,17:7674198-7674199, hg38,17:7674199-7674199","hg19,17:g.7577516_7577517delinsAG, hg19,17:g.7577517A>G, hg19,17:g.7674199A>G, hg38,17:g.7674198_7674199delinsAG, hg38,17:g.7674199A>G",0.948,"biliary_tract, gallbladder, breast, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, caecum, liver, lung, lung, right_middle_lobe, pancreas, upper_aerodigestive_tract, mouth, retromolar, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, Hodgkin_lymphoma",,,,,376623,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3466,255,I,V,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577518-7577518, hg38,17:7674200-7674200","hg19,17:g.7577518T>C, hg38,17:g.7674200T>C",0.628,"lung, oesophagus, ovary","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,3242231,,,,,,,Tier IV - Benign/Likely benign,"Chronic myelogenous leukemia, BCR-ABL1 positive",0
3467,255,I,W,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3468,255,I,Y,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3469,256,T,A,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hcc_msk_2024, mds_iwg_2022","Hepatocellular Carcinoma, Myelodysplastic Syndromes","hg19,17:7577515-7577515, hg38,17:7674197-7674197","hg19,17:g.7577515T>C, hg38,17:g.7674197T>C",0.909,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, lung, skin, scalp, urinary_tract, bladder","carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,141011,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
3470,256,T,C,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3471,256,T,D,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3472,256,T,E,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3473,256,T,F,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3474,256,T,G,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3475,256,T,H,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3476,256,T,I,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, msk_chord_2024, paad_cptac_2021, pan_origimed_2020, pancan_pdmr_2025, pancreas_cptac_gdc, prad_p1000, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, prostate_msk_2024, sarcoma_msk_2022","Head and Neck Squamous Cell Carcinoma, Mixed Cancer Types, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577514-7577514, hg19,17:7674196-7674196, hg38,17:7674196-7674196","hg19,17:g.7577514G>A, hg19,17:g.7674196G>A, hg38,17:g.7674196G>A",0.932,"large_intestine, colon, oesophagus, middle_third, prostate, stomach, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,858889,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3477,256,T,K,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","glioma_mskcc_2019, heme_msk_impact_2022, msk_ctdna_vte_2024, msk_impact_2017, pan_origimed_2020, sarcoma_msk_2022, tmb_mskcc_2018","Diffuse Glioma, Mixed Cancer Types, Soft Tissue","hg19,17:7577514-7577514, hg38,17:7674196-7674196","hg19,17:g.7577514G>T, hg38,17:g.7674196G>T",0.936,"central_nervous_system, brain, kidney, large_intestine, liver, oesophagus","carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, sarcomatoid_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,2826159,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3478,256,T,L,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3479,256,T,M,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3480,256,T,N,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3481,256,T,P,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, brca_broad, breast_msk_2018, breast_msk_2025, coad_silu_2022, crc_sysucc_2022, gbc_mskcc_2022, hcc_msk_2024, mds_iwg_2022, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_pdmr_2025, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, prad_su2c_2019, sarcoma_msk_2022, sarcoma_mskcc_2022","Breast, CNS/Brain, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577515-7577515, hg19,17:7674197-7674197, hg38,17:7674197-7674197","hg19,17:g.7577515T>G, hg19,17:g.7674197T>G, hg38,17:g.7674197T>G",0.945,"breast, large_intestine, large_intestine, colon, transverse, lung, ovary, skin, face, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,528269,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided;Li-Fraumeni syndrome 1,1,,,,,,
3482,256,T,Q,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3483,256,T,R,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",msk_impact_2017,Mixed Cancer Types,"hg19,17:7577514-7577514, hg38,17:7674196-7674196","hg19,17:g.7577514G>C, hg38,17:g.7674196G>C",0.935,skin,"carcinoma, Merkel_cell_carcinoma",,,,,,,,,,,,,,
3484,256,T,S,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674197-7674197","hg38,17:g.7674197T>A",0.846,"bone, breast","carcinoma, osteosarcoma",,,,,,,,,,,,,,
3485,256,T,V,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3486,256,T,W,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3487,256,T,Y,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 248-256, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 250-256, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3488,257,L,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3489,257,L,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3490,257,L,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3491,257,L,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3492,257,L,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3493,257,L,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3494,257,L,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3495,257,L,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3496,257,L,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3497,257,L,M,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",hcc_msk_2024,Hepatocellular Carcinoma,"hg19,17:7577512-7577512","hg19,17:g.7577512G>T",0.843,,,,,,,,,,,,,,,,
3498,257,L,N,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3499,257,L,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_aurora_2023, brca_igr_2015, brca_metabric, brca_smc_2018, breast_msk_2025, cll_broad_2022, crc_eo_2020, crc_msk_2017, csf_msk_2024, dlbcl_duke_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, gbm_mayo_pdx_sarkaria_2019, hcc_msk_2024, hcc_tcga_gdc, heme_msk_impact_2022, ihch_msk_2021, lihc_tcga, lihc_tcga_pan_can_atlas_2018, mds_iwg_2022, mixed_kunga_msk_2022, mnm_washu_2016, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_mskcc_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, pog570_bcgsc_2020, pptc_2019, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_organoids_msk_2022, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022","Bowel, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577510-7577511, hg19,17:7577511-7577511, hg19,17:7674193-7674193, hg38,17:7674193-7674193","hg19,17:g.7577510_7577511delinsAG, hg19,17:g.7577511A>G, hg19,17:g.7674193A>G, hg38,17:g.7674193A>G",0.933,"biliary_tract, bile_duct, breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, spleen, large_intestine, large_intestine, rectum, liver, lung, oesophagus, pancreas, prostate, salivary_gland, skin, skin, mucosal, vagina, upper_aerodigestive_tract, larynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma, malignant_melanoma, other, neoplasm",,,,,458562,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1,1,,,,,,
3500,257,L,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2022, blca_bcan_hcrn_2022, blca_msk_tcga_2020, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_dldccc_2022, brca_metabric, coadread_genentech, crc_eo_2020, crc_msk_2017, hgsoc_tcga_gdc, mbn_sfu_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2019, sarcoma_msk_2022, tmb_mskcc_2018","Acute Myeloid Leukemia, Bladder Urothelial Carcinoma, Bowel, Colorectal Adenocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577511-7577511, hg19,17:7674193-7674193, hg38,17:7674193-7674193","hg19,17:g.7577511A>T, hg19,17:g.7674193A>T, hg38,17:g.7674193A>T",0.916,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, prostate, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","Wilms_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma",,,,,12372,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-fraumeni-like syndrome;Ovarian neoplasm;Li-Fraumeni syndrome,1,,,,,,
3501,257,L,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_iatlas_anders_2022, brca_mapk_hp_msk_2021, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, breast_msk_2018, breast_msk_2025, coadread_mskresistance_2022, crc_eo_2020, crc_msk_2017, egc_msk_2023, lms_msk_2024, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pdac_msk_2024, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, vsc_cuk_2018","Bowel, Breast, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophagus/Stomach, Invasive Breast Carcinoma, Mixed Cancer Types, Pancreas, Soft Tissue, Squamous Cell Carcinoma of the Vulva/Vagina","hg19,17:7577511-7577511, hg19,17:7674193-7674193, hg38,17:7674193-7674193","hg19,17:g.7577511A>C, hg19,17:g.7674193A>C, hg38,17:g.7674193A>C",0.922,", biliary_tract, gallbladder, breast, endometrium, large_intestine, colon, large_intestine, colon, sigmoid, ovary, pancreas, upper_aerodigestive_tract, head_neck, vulva","carcinoid-endocrine_tumour, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma, other, carcinoid-endocrine_tumour",,,,,142134,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3502,257,L,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3503,257,L,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3504,257,L,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, escc_ucla_2014, lms_msk_2024, mds_iwg_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, ohnca_cptac_gdc, pan_origimed_2020, pancan_pcawg_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_organoids_msk_2022, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022","Ampullary Carcinoma, Esophageal Squamous Cell Carcinoma, Head and Neck Carcinoma, Other, Mixed Cancer Types, Myelodysplastic Syndromes, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577512-7577512, hg19,17:7674194-7674194, hg38,17:7674194-7674194","hg19,17:g.7577512G>C, hg19,17:g.7674194G>C, hg38,17:g.7674194G>C",0.896,"central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, liver, lung, oesophagus, pancreas, prostate, skin, head_neck, small_intestine, duodenum","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, nodular",,,,,827201,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3505,257,L,W,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3506,257,L,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 253-257, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3507,258,E,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_plasmacytoid_mskcc_2016, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, esca_broad, glioma_mskcc_2019, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, sclc_ucologne_2015","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Diffuse Glioma, Esophageal Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Small Cell Lung Cancer","hg19,17:7577508-7577508, hg19,17:7674190-7674190, hg38,17:7674190-7674190","hg19,17:g.7577508T>G, hg19,17:g.7674190T>G, hg38,17:g.7674190T>G",0.955,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, left, lung, ovary, pleura, soft_tissue, nerve_sheath, pelvis, stomach, stomach, gastroesophageal_junction, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_leukaemic_transformation_of_essential_thrombocythaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, malignant_peripheral_nerve_sheath_tumour, mesothelioma",,,,,458563,Uncertain significance,Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3508,258,E,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3509,258,E,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, brca_igr_2015, hcc_msk_2024, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, mbn_mdacc_2013, mds_mskcc_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, rectal_msk_2022, sarcoma_msk_2022, summit_2018, ucec_ancestry_cds_msk_2023","Adenoid Cystic Carcinoma, Bowel, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue","hg19,17:7577507-7577507, hg19,17:7674189-7674189, hg38,17:7674189-7674189","hg19,17:g.7577507T>A, hg19,17:g.7577507T>G, hg19,17:g.7674189T>A, hg38,17:g.7674189T>A, hg38,17:g.7674189T>G",0.897,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, lung, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, ovary, pancreas, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, other, neoplasm",,,,,1360091,Uncertain significance,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3510,258,E,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3511,258,E,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_cptac_2020, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, chol_icgc_2017, coadread_mskcc, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, hcc_meric_2021, hcc_msk_2024, mds_iwg_2022, msk_access_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_fhcrc, read_tcga_gdc, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_oncosg_2018, tmb_mskcc_2018","Bowel, Breast, Cholangiocarcinoma, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577508-7577508, hg19,17:7674190-7674190, hg38,17:7674190-7674190","hg19,17:g.7577508T>C, hg19,17:g.7674190T>C, hg38,17:g.7674190T>C",0.952,"biliary_tract, bile_duct, breast, central_nervous_system, brain, kidney, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, oesophagus, ovary, pancreas, prostate, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic",,,,,406590,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Bone osteosarcoma;Li-Fraumeni syndrome 1,1,,,,,,
3512,258,E,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3513,258,E,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3514,258,E,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, appendiceal_msk_2022, bcc_unige_2016, bladder_columbia_msk_2018, blca_bcan_hcrn_2022, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_pdx_msk_2025, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_msk_2025, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, coadread_dfci_2016, crc_apc_impact_2020, crc_sysucc_2022, cscc_ranson_2022, cscc_ucsf_2021, csf_msk_2024, difg_glass, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, egc_trap_ccr_msk_2023, egc_trap_msk_2020, glioma_mskcc_2019, hcc_tcga_gdc, hgsoc_tcga_gdc, hnc_mskcc_2016, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_cfdna_msk_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, normal_skin_keratinocytes_2024, nsclc_tcga_broad_2016, odg_msk_2017, ov_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, rectal_msk_2022, sarcoma_msk_2022, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Ampullary Carcinoma, Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Skin, Soft Tissue, Thyroid","hg19,17:7577509-7577509, hg19,17:7577509-7577510, hg19,17:7674191-7674191, hg38,17:7674191-7674191, hg38,17:7674191-7674192","hg19,17:g.7577509C>T, hg19,17:g.7577509_7577510delinsTT, hg19,17:g.7674191C>T, hg38,17:g.7674191C>T, hg38,17:g.7674191_7674192delinsTT",0.961,", biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, testis, large_intestine, large_intestine, anorectal, large_intestine, appendix, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, peritoneum, skin, skin, arm, skin, face, skin, head_neck, skin, scalp, soft_tissue, fibrous_tissue_and_uncertain_origin, frontal_lobe, soft_tissue, striated_muscle, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, lip, urinary_tract, urinary_tract, bladder, urinary_tract, bladder, urachus, urinary_tract, ureter","adenoma, villous, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, of_unknown_primary, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, micropapillary_transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_melanoma, desmoplastic, rhabdomyosarcoma, sarcoma",,,,,"4082532, 12348","Likely pathogenic, Pathogenic/Likely pathogenic",not provided|Hereditary cancer-predisposing syndrome;not provided;not specified;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,"1, 2",Oncogenic,Neoplasm,1,,,
3515,258,E,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674190-7674191","hg38,17:g.7674190_7674191delinsAA",,"biliary_tract, gallbladder, pancreas","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
3516,258,E,M,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3517,258,E,N,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3518,258,E,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3519,258,E,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","blca_nmibc_2017, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, crc_eo_2020, csf_msk_2024, gbm_tcga_pub, glioma_mskcc_2019, ihch_smmu_2014, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancreas_msk_2024, pdac_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_vanderbilt_mskcc_2015, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Cutaneous Melanoma, Diffuse Glioma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Soft Tissue","hg19,17:7577509-7577509, hg19,17:7674191-7674191, hg38,17:7674191-7674191","hg19,17:g.7577509C>G, hg19,17:g.7674191C>G, hg38,17:g.7674191C>G",0.936,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon, liver, lung, pancreas, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
3520,258,E,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3521,258,E,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3522,258,E,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3523,258,E,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","lung_msk_2017, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7577508-7577508, hg38,17:7674190-7674190","hg19,17:g.7577508T>A, hg38,17:g.7674190T>A",0.963,"breast, central_nervous_system, brain, liver, lung, pancreas, pleura, testis, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, germ_cell_tumour, seminoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, mesothelioma, epithelial",,,,,2808296,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3524,258,E,W,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3525,258,E,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3526,259,D,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021, nepc_wcm_2016, prad_p1000","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,17:7577505-7577505, hg38,17:7674187-7674187","hg19,17:g.7577505T>G, hg38,17:g.7674187T>G",0.691,"haematopoietic_and_lymphoid_tissue, spleen, lung","carcinoma, non_small_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,2671888,Pathogenic,"Malignant lymphoma, large B-cell, diffuse",0,,,,,,
3527,259,D,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3528,259,D,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","brca_fuscc_2020, msk_chord_2024, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7577504-7577504, hg38,17:7674186-7674186","hg19,17:g.7577504G>T, hg38,17:g.7674186G>T",0.564,"haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, upper_aerodigestive_tract, larynx","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, follicular_lymphoma",,,,,,,,,,,,,,
3529,259,D,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","lusc_tcga_pub, msk_chord_2024, nsclc_tcga_broad_2016, pdac_msk_2024","Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas","hg19,17:7577505-7577506","hg19,17:g.7577505_7577506delinsAA",,,,,,,,,,,,,,,,,
3530,259,D,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_met_2021,Mixed Cancer Types,"hg19,17:7577505-7577505, hg38,17:7674187-7674187","hg19,17:g.7577505T>C, hg38,17:g.7674187T>C",0.655,"stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor","carcinoma, carcinoma, squamous_cell_carcinoma",0.0000039774716009,,,,188349,Uncertain significance,Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3531,259,D,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_iatlas_imvigor210_2017, crc_eo_2020, crc_msk_2017, metastatic_solid_tumors_mich_2017, mixed_cfdna_msk_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pancan_mimsi_msk_2024, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7577506-7577506, hg19,17:7674188-7674188, hg38,17:7674188-7674188","hg19,17:g.7577506C>G, hg19,17:g.7674188C>G, hg38,17:g.7674188C>G",0.714,"central_nervous_system, brain, cervix, large_intestine, caecum, upper_aerodigestive_tract, mouth, alveolus, vulva","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,1349622,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3532,259,D,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",acc_2019,Adenoid Cystic Carcinoma,"hg19,17:7577505-7577506","hg19,17:g.7577505_7577506delinsAT",,,,,,,,,,,,,,,,,
3533,259,D,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3534,259,D,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3535,259,D,M,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3536,259,D,N,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_bcan_hcrn_2022, blca_nmibc_2017, ccle_broad_2019, cellline_ccle_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, msk_impact_2017, msk_met_2021, paired_bladder_2022, pancan_pdmr_2025","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Head and Neck Squamous Cell Carcinoma, Mixed Cancer Types","hg19,17:7577506-7577506, hg19,17:7674188-7674188, hg38,17:7674188-7674188","hg19,17:g.7577506C>T, hg19,17:g.7674188C>T, hg38,17:g.7674188C>T",0.532,"biliary_tract, bile_duct, breast, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, rectum, ovary, soft_tissue, fibrous_tissue_and_uncertain_origin, pelvis, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_adenocarcinofibroma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma, malignant_melanoma_of_soft_parts-clear_cell_sarcoma",,,,,3634427,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3537,259,D,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3538,259,D,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3539,259,D,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3540,259,D,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674187-7674188","hg38,17:g.7674187_7674188delinsCT",,oesophagus,carcinoma,,,,,,,,,,,,,,
3541,259,D,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3542,259,D,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, egc_msk_2023, es_dsrct_msk_2023, hgsoc_msk_2021, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_ctdx_msk_2022, paad_cptac_2021, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_tcga_gdc, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, High-Grade Serous Ovarian Cancer, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577505-7577505, hg19,17:7674187-7674187, hg38,17:7674186-7674187, hg38,17:7674187-7674187","hg19,17:g.7577505T>A, hg19,17:g.7674187T>A, hg38,17:g.7674186_7674187delinsAA, hg38,17:g.7674187T>A",0.742,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, stomach, large_intestine, large_intestine, colon, ascending, liver, lung, ovary, pancreas, skin, skin, face, soft_tissue, stomach, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, in_situ_epithelial_neoplasm, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, sarcoma",,,,,485034,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
3543,259,D,W,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3544,259,D,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, bcc_unige_2016, blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brain_cptac_gdc, brca_iatlas_anders_2022, brca_metabric, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, chol_msk_2018, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_msk_2017, difg_glass, difg_glass_2019, gbc_mskcc_2022, hcc_msk_2024, hcc_mskimpact_2018, hccihch_pku_2019, heme_msk_impact_2022, hnc_mskcc_2016, ihch_msk_2021, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pub, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, rectal_msk_2019, rectal_msk_2022, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, CNS/Brain, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Gallbladder Cancer, Head and Neck, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Stomach Adenocarcinoma","hg19,17:7577506-7577506, hg19,17:7674188-7674188, hg38,17:7674188-7674188","hg19,17:g.7577506C>A, hg19,17:g.7674188C>A, hg38,17:g.7674188C>A",0.737,"adrenal_gland, adrenal_gland, autonomic_ganglia, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, breast, kidney, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, salivary_gland, major, salivary_gland, minor, salivary_gland, tongue, skin, stomach, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, adrenal_cortical_adenoma, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, metaplastic_sarcomatoid, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, breast_implant_associated_anaplastic_large_cell_lymphoma, ALK_negative, neuroblastoma, other, dysplasia, other, neoplasm",,,,,634680,Uncertain significance,Li-Fraumeni syndrome;Ovarian neoplasm,1,,,,,,
3545,260,S,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674185-7674185","hg38,17:g.7674185A>C",0.599,"haematopoietic_and_lymphoid_tissue, large_intestine, colon, sigmoid","carcinoma, adenocarcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,,,,,,,,,,
3546,260,S,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","biliary_tract_summit_2022, ccle_genentech_2014, pan_origimed_2020","Biliary Tract, Mixed Cancer Types","hg19,17:7577502-7577502, hg38,17:7674184-7674184","hg19,17:g.7577502G>C, hg38,17:g.7674184G>C",0.660,"large_intestine, oesophagus, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3547,260,S,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3548,260,S,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3549,260,S,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7577502-7577502, hg38,17:7674184-7674184","hg19,17:g.7577502G>A, hg38,17:g.7674184G>A",0.636,"breast, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,2765819,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3550,260,S,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3551,260,S,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3552,260,S,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3553,260,S,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3554,260,S,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3555,260,S,M,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3556,260,S,N,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3557,260,S,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pog570_bcgsc_2020,Mixed Cancer Types,"hg19,17:7577503-7577503, hg38,17:7674185-7674185","hg19,17:g.7577503A>G, hg38,17:g.7674185A>G",0.659,liver,"carcinoma, hepatocellular_carcinoma",,,,,,,,,,,,,,
3558,260,S,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3559,260,S,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3560,260,S,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,17:7577503-7577503","hg19,17:g.7577503A>T",0.530,"large_intestine, appendix","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3561,260,S,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3562,260,S,W,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3563,260,S,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 254-260, ggetELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577502-7577502, hg38,17:7674184-7674184","hg19,17:g.7577502G>T, hg38,17:g.7674184G>T",0.668,"cervix, oesophagus","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",0.0000039771552204,,,,231033,Likely benign,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
3564,261,S,A,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3565,261,S,C,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7674182-7674182","hg38,17:g.7674182T>A",0.547,skin,"carcinoma, basal_cell_carcinoma",,,,,,,,,,,,,,
3566,261,S,D,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3567,261,S,E,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3568,261,S,F,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3569,261,S,G,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577500-7577500, hg38,17:7674182-7674182","hg19,17:g.7577500T>C, hg38,17:g.7674182T>C",0.529,"large_intestine, lung, upper_aerodigestive_tract, mouth, tongue","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,1383522,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3570,261,S,H,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3571,261,S,I,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",crc_orion_2024,Bowel,"hg19,17:7577499-7577499, hg38,17:7674181-7674181","hg19,17:g.7577499C>A, hg38,17:g.7674181C>A",0.532,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3572,261,S,K,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3573,261,S,L,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3574,261,S,M,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3575,261,S,N,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7577499-7577499, hg38,17:7674181-7674181","hg19,17:g.7577499C>T, hg38,17:g.7674181C>T",0.446,"oesophagus, thyroid","carcinoma, papillary_carcinoma, other, Barrett_oesophagus",,,,,4427935,,,,,,,,,
3576,261,S,P,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3577,261,S,Q,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3578,261,S,R,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577500-7577500, hg38,17:7673837-7673837, hg38,17:7674182-7674182","hg19,17:g.7577500T>G, hg38,17:g.7673837A>C, hg38,17:g.7673837A>T, hg38,17:g.7674182T>G","0.390, 0.391, 0.456","haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, rectum, ovary, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, follicular_lymphoma",,,,,3708635,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3579,261,S,T,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, msk_chord_2024",Mixed Cancer Types,"hg19,17:7577499-7577499, hg19,17:7674181-7674181, hg38,17:7674181-7674181","hg19,17:g.7577499C>G, hg19,17:g.7674181C>G, hg38,17:g.7674181C>G",0.504,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, myeloproliferative_neoplasm, lymphoid_neoplasm, plasma_cell_myeloma",,,,,187005,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3580,261,S,V,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3581,261,S,W,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3582,261,S,Y,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 253-261, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3583,262,G,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3584,262,G,C,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv","nsclc_ctdx_msk_2022, pan_origimed_2020","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577154-7577154","hg19,17:g.7577154C>A",0.865,,,,,,,,,,,,,,,,
3585,262,G,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, msk_ch_2023","CNS/Brain, Mixed Cancer Types","hg19,17:7577153-7577153, hg19,17:7673835-7673835, hg38,17:7673835-7673835","hg19,17:g.7577153C>T, hg19,17:g.7673835C>T, hg38,17:g.7673835C>T",0.931,"large_intestine, prostate, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,2993845,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3586,262,G,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3587,262,G,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3588,262,G,H,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673835-7673836","hg38,17:g.7673835_7673836delinsTG",,ovary,"carcinoma, mucinous_carcinoma",,,,,,,,,,,,,,
3589,262,G,I,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7577153-7577154","hg19,17:g.7577153_7577154delinsAT",,,,,,,,,,,,,,,,,
3590,262,G,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3591,262,G,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3592,262,G,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3593,262,G,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3594,262,G,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3595,262,G,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3596,262,G,R,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577154-7577154, hg38,17:7673836-7673836","hg19,17:g.7577154C>G, hg38,17:g.7673836C>G",0.889,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,1760888,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
3597,262,G,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_msk_2025, ccle_broad_2019, ccle_broad_2025, paired_bladder_2022, sarcoma_msk_2022","Bladder/Urinary Tract, Invasive Breast Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577154-7577154, hg19,17:7673836-7673836, hg38,17:7673836-7673836","hg19,17:g.7577154C>T, hg19,17:g.7673836C>T, hg38,17:g.7673836C>T",0.876,"stomach, urinary_tract, bladder","carcinoma, intestinal_adenocarcinoma, carcinoma, transitional_cell_carcinoma",0.0000081725386357,0.0000318633698700,,,141228,Likely benign,"TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1",3,,,,,,
3598,262,G,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3599,262,G,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_metabric, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cll_broad_2022, coad_caseccc_2015, coad_cptac_2019, coad_cptac_gdc, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, egc_msk_2023, egc_mskcc_2020, glioma_mskcc_2019, hcc_msk_2024, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lms_msk_2024, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_pan_can_atlas_2018, lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_sfu_2023, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nhl_bcgsc_2013, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_icgc, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, read_tcga_gdc, sarcoma_msk_2022, sarcoma_mskcc_2022, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014, usarc_msk_2020","Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Sarcoma/Mesenchymal","hg19,17:7577153-7577153, hg19,17:7673835-7673835, hg38,17:7673835-7673835","hg19,17:g.7577153C>A, hg19,17:g.7673835C>A, hg38,17:g.7673835C>A",0.929,", breast, central_nervous_system, brain, central_nervous_system, cerebellum, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, large_intestine, rectum, liver, lung, lung, right_lower_lobe, oesophagus, oesophagus, middle_third, ovary, pancreas, prostate, skin, soft_tissue, smooth_muscle, uterus, stomach, upper_aerodigestive_tract, head_neck, urinary_tract","carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_acinar-ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, hyperplasia, complex-atypical, leiomyosarcoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, other, neoplasm",,,,,428889,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Atypical endometrial hyperplasia,1,Uncertain significance,Neoplasm,1,,,
3600,262,G,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3601,262,G,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3602,263,N,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3603,263,N,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3604,263,N,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021",Mixed Cancer Types,"hg19,17:7577151-7577151, hg38,17:7673833-7673833","hg19,17:g.7577151T>C, hg38,17:g.7673833T>C",0.315,"breast, lung, stomach","carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, non_small_cell_carcinoma",0.0001136465106462,,,,142916,Conflicting classifications of pathogenicity,Hereditary cancer;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
3605,263,N,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3606,263,N,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3607,263,N,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3608,263,N,H,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577151-7577151, hg38,17:7673833-7673833, hg38,17:7673833-7673834","hg19,17:g.7577151T>G, hg38,17:g.7673833T>G, hg38,17:g.7673833_7673834delinsGT",0.315,"large_intestine, colon, lung","carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,528251,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3609,263,N,I,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673832-7673832","hg38,17:g.7673832T>A",0.318,"large_intestine, colon","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3610,263,N,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",prad_p1000,Prostate Adenocarcinoma,"hg19,17:7577149-7577149, hg38,17:7673831-7673831","hg19,17:g.7577149A>C, hg19,17:g.7577149A>T, hg38,17:g.7673831A>C, hg38,17:g.7673831A>T",0.213,"central_nervous_system, brainstem, large_intestine","carcinoma, adenocarcinoma, glioma",,,,,485047,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
3611,263,N,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3612,263,N,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3613,263,N,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3614,263,N,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3615,263,N,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3616,263,N,S,,,,,,,,,,,,,,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",heme_msk_impact_2022,Mixed Cancer Types,"hg19,17:7577150-7577150, hg38,17:7673832-7673832","hg19,17:g.7577150T>C, hg38,17:g.7673832T>C",0.243,,,,,,,827313,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
3617,263,N,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3618,263,N,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3619,263,N,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3620,263,N,Y,,,,,,,,,,,,,,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv",crc_sysucc_2022,Colorectal Adenocarcinoma,"hg19,17:7577151-7577151, hg38,17:7673833-7673833","hg19,17:g.7577151T>A, hg38,17:g.7673833T>A",0.446,,,,,,,1364128,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3621,264,L,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3622,264,L,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3623,264,L,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3624,264,L,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3625,264,L,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3626,264,L,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3627,264,L,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3628,264,L,I,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7577148-7577148, hg38,17:7673830-7673830","hg19,17:g.7577148G>T, hg38,17:g.7673830G>T",0.378,"genital_tract, extragonadal, brain, lung, upper_aerodigestive_tract, mouth","carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, seminoma",,,,,640121,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3629,264,L,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3630,264,L,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3631,264,L,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3632,264,L,P,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577147-7577147, hg38,17:7673829-7673829","hg19,17:g.7577147A>G, hg38,17:g.7673829A>G",0.831,"upper_aerodigestive_tract, larynx","carcinoma, squamous_cell_carcinoma",,,,,480759,Uncertain significance,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3633,264,L,Q,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673829-7673829","hg38,17:g.7673829A>T",0.813,prostate,carcinoma,,,,,,,,,,,,,,
3634,264,L,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_nci60",Mixed Cancer Types,"hg19,17:7577147-7577147, hg19,17:7673829-7673829, hg38,17:7673829-7673829","hg19,17:g.7577147A>C, hg19,17:g.7673829A>C, hg38,17:g.7673829A>C",0.822,kidney,"carcinoma, renal_cell_carcinoma",,,,,,,,,,,,,,
3635,264,L,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3636,264,L,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3637,264,L,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, pdac_msk_2024","Mixed Cancer Types, Pancreas","hg19,17:7577148-7577148, hg38,17:7673830-7673830","hg19,17:g.7577148G>C, hg38,17:g.7673830G>C",0.381,breast,carcinoma,,,,,,,,,,,,,,
3638,264,L,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3639,264,L,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3640,265,L,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3641,265,L,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3642,265,L,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3643,265,L,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3644,265,L,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3645,265,L,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3646,265,L,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3647,265,L,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3648,265,L,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3649,265,L,M,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673827-7673827","hg38,17:g.7673827G>T",0.870,"biliary_tract, bile_duct, breast, pancreas","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
3650,265,L,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3651,265,L,P,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, coadread_cass_2020, coadread_dfci_2016, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, glioma_mskcc_2019, hcc_meric_2021, heme_msk_impact_2022, hgsoc_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024, sarcoma_mskcc_2022, stad_tcga_pan_can_atlas_2018, ucec_ancestry_cds_msk_2023, ucec_msk_dacruzpaula_2025","Bladder Urothelial Carcinoma, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577143-7577144, hg19,17:7577144-7577144, hg19,17:7673826-7673826, hg38,17:7673825-7673826, hg38,17:7673826-7673826","hg19,17:g.7577143_7577144delinsAG, hg19,17:g.7577144A>G, hg19,17:g.7673826A>G, hg38,17:g.7673825_7673826delinsAG, hg38,17:g.7673826A>G",0.948,", breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, small_intestine, stomach, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, mixed, glioma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, in_situ_epithelial_neoplasm, Bowen_disease, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,245777,Pathogenic/Likely pathogenic,Rhabdomyosarcoma;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3652,265,L,Q,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_msk_2025, hdcn_msk_2025, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, rcc_cptac_gdc","Histiocytic and Dendritic Cell Neoplasms, Invasive Breast Carcinoma, Mixed Cancer Types, Renal Cell Carcinoma","hg19,17:7577144-7577144, hg19,17:7673826-7673826, hg38,17:7673826-7673826","hg19,17:g.7577144A>T, hg19,17:g.7673826A>T, hg38,17:g.7673826A>T",0.964,lung,"carcinoma, small_cell_carcinoma",,,,,953467,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided,2,,,,,,
3653,265,L,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, crc_eo_2020, crc_msk_2017, difg_tcga_gdc, glioma_mskcc_2019, hcc_meric_2021, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, mbn_sfu_2023, mds_iwg_2022, mixed_impact_subset_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_hcmi_2025, rectal_msk_2022, sarcoma_msk_2022","Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7577144-7577144, hg19,17:7673826-7673826, hg38,17:7673826-7673826","hg19,17:g.7577144A>C, hg19,17:g.7673826A>C, hg38,17:g.7673826A>C",0.965,"breast, central_nervous_system, brain, large_intestine, colon, right, large_intestine, rectum, liver, oesophagus, stomach, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, squamous_cell_carcinoma, glioma",,,,,2764543,Uncertain significance,Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
3654,265,L,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3655,265,L,T,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",paad_qcmg_uq_2016,Pancreatic Adenocarcinoma,"hg19,17:7577144-7577145","hg19,17:g.7577144_7577145delinsGT",,,,,,,,,,,,,,,,,
3656,265,L,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3657,265,L,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3658,265,L,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3659,266,G,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",escc_ucla_2014,Esophageal Squamous Cell Carcinoma,"hg19,17:7577141-7577141, hg38,17:7673823-7673823","hg19,17:g.7577141C>G, hg38,17:g.7673823C>G",0.960,"large_intestine, colon, oesophagus, ovary","carcinoma, adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3660,266,G,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3661,266,G,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3662,266,G,E,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, aml_ohsu_2018, aml_ohsu_2022, ampca_bcm_2016, bcc_unige_2016, blca_bgi, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, brain_cptac_gdc, brca_broad, brca_dldccc_2022, brca_igr_2015, brca_metabric, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, chol_msk_2018, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_orion_2024, crc_sysucc_2022, cscc_ranson_2022, cscc_ucsf_2021, difg_glass, difg_glass_2019, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, escc_icgc, gbc_msk_2018, gbm_cptac_2021, gbm_mayo_pdx_sarkaria_2019, glioma_msk_2018, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, ihch_mskcc_2020, lgg_tcga, lms_msk_2024, luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, lymphoma_cellline_msk_2020, mbc_msk_2021, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga_pan_can_atlas_2018, paad_cptac_2021, paad_icgc, paad_qcmg_uq_2016, paad_tcga, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, prad_msk_stopsack_2021, prad_p1000, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_ucologne_2015, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, utuc_msk_2019, utuc_pdx_msk_2019, wt_target_gdc","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lymphoid, Mature B-Cell Neoplasms, Metaplastic Breast Cancer, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Upper Tract Urothelial Carcinoma, Wilms' Tumor","hg19,17:7577141-7577141, hg19,17:7673823-7673823, hg38,17:7673823-7673823","hg19,17:g.7577141C>T, hg19,17:g.7673823C>T, hg38,17:g.7673823C>T",0.973,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, extraskeletal, breast, central_nervous_system, brain, central_nervous_system, parietooccipital, cervix, endometrium, genital_tract, extragonadal, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, skin, skin, back, skin, ear, small_intestine, jejunum, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, urinary_tract, bladder, urinary_tract, renal_pelvis, vulva","Wilms_tumour, adenoma, adnexal_tumour, malignant_adnexal_tumour, spiradenocarcinoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, luminal_B_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, chondrosarcoma, dedifferentiated, germ_cell_tumour, seminoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, M1, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, low_malignant_potential_(borderline)_tumour, mucinous, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, malignant_melanoma, malignant_melanoma, nodular, other, metaplasia, epidermoid, other, neoplasm, other, normal",,,,,161516,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Prostate cancer;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck,2,Oncogenic,Neoplasm,1,Tier II - Potential,Pleomorphic xanthoastrocytoma,1
3663,266,G,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3664,266,G,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3665,266,G,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3666,266,G,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, mel_mskimpact_2020, msk_impact_2017, msk_met_2021","Basal Cell Carcinoma, Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7577141-7577142, hg38,17:7673823-7673824","hg19,17:g.7577141_7577142delinsTT, hg38,17:g.7673823_7673824delinsTT",,"skin, skin, head_neck","carcinoma, Merkel_cell_carcinoma, carcinoma, basal_cell_carcinoma",,,,,,,,,,,,,,
3667,266,G,L,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673823-7673824","hg38,17:g.7673823_7673824delinsAA",,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3668,266,G,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3669,266,G,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3670,266,G,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3671,266,G,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3672,266,G,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, aml_ohsu_2022, bcc_unige_2016, blca_iatlas_imvigor210_2017, bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_fuscc_2020, brca_mapk_hp_msk_2021, brca_metabric, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cll_broad_2015, cll_broad_2022, coadread_cass_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_dfarber_2015, cscc_hgsc_bcm_2014, cscc_ranson_2022, cscc_ucsf_2021, difg_msk_2023, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_trap_ccr_msk_2023, egc_trap_msk_2020, escc_ucla_2014, gbm_cptac_2021, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gbm_tcga_pub2013, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_broad, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lung_msk_pdx, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_mdacc_2013, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, mixed_msk_tcga_2021, mixed_selpercatinib_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_ch_ped_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, os_target_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, pediatric_dkfz_2017, prad_p1000, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_ucologne_2015, soft_tissue_tcga_gdc, tmb_mskcc_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucs_msk_2024","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mature T and NK Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Osteosarcoma, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577142-7577142, hg19,17:7577142-7577143, hg19,17:7673824-7673824, hg38,17:7673824-7673824, hg38,17:7673824-7673825","hg19,17:g.7577142C>G, hg19,17:g.7577142C>T, hg19,17:g.7577142_7577143delinsTT, hg19,17:g.7673824C>G, hg19,17:g.7673824C>T, hg38,17:g.7673824C>G, hg38,17:g.7673824C>T, hg38,17:g.7673824_7673825delinsTT",0.963,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, spinal_cord, central_nervous_system, temporal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, kidney, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, transverse, large_intestine, rectum, large_intestine, right, liver, lung, oesophagus, ovary, pancreas, peritoneum, peritoneum, appendix, pleura, prostate, salivary_gland, salivary_gland, major, skin, skin, chest_wall, skin, ear, skin, face, skin, head_neck, skin, knee, skin, mucosal, vulva, soft_tissue, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, urinary_tract, bladder, urinary_tract, bladder, urachus","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adnexal_tumour, sebaceous_adenoma, adrenal_cortical_adenoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, enteric_adenocarcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, chondrosarcoma, dedifferentiated, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma, malignant_melanoma, mesothelioma, epithelial, other, adenosis, other, pseudomyxoma_peritonei, other, rosette-forming_glioneuronal_tumour, primitive_neuroectodermal_tumour-medulloblastoma, sarcoma",,,,,"458566, 376605","Pathogenic, Pathogenic","Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome","2, 2",Oncogenic,Neoplasm,1,,,
3673,266,G,S,,,,,,,,,,,,,,"COSMIC,Manual annotations from saturation_mutlist.csv",,,,,,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3674,266,G,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","luad_tsp, msk_impact_2017","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7577141-7577142, hg38,17:7673823-7673824","hg19,17:g.7577141_7577142delinsGT, hg38,17:g.7673823_7673824delinsGT",,"haematopoietic_and_lymphoid_tissue, soft_tissue, lung","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
3675,266,G,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, bcc_unige_2016, bladder_msk_2023, blca_cornell_2016, bm_nsclc_mskcc_2023, brca_metabric, brca_msk_2025, brca_pareja_msk_2020, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cfdna_msk_2019, cll_broad_2015, cll_broad_2022, coad_tcga_gdc, coadread_cass_2020, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_sysucc_2022, difg_glass, difg_glass_2019, gbc_mskcc_2022, gbm_tcga, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, hcc_clca_2024, hcc_inserm_fr_2015, hcc_meric_2021, hcc_msk_2024, hcc_tcga_gdc, hgsoc_tcga_gdc, hnsc_jhu, lcll_broad_2013, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_broad, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_pdx, lung_pdx_msk_2021, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, mds_mskcc_2020, mixed_allen_2018, mpcproject_broad_2021, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_mdanderson_2023, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_msk_2024, read_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_jhu, sclc_ucologne_2015, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_tcga, ucs_tcga_pan_can_atlas_2018","Acute Myeloid Leukemia, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577141-7577141, hg19,17:7673823-7673823, hg38,17:7673823-7673823","hg19,17:g.7577141C>A, hg19,17:g.7673823C>A, hg38,17:g.7673823C>A",0.974,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, anorectal, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, thyroid, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, cheek","Wilms_tumour, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, undifferentiated_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, other, neoplasm",0.0000000000000000,,,,233303,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3676,266,G,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3677,266,G,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3678,267,R,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3679,267,R,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3680,267,R,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3681,267,R,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3682,267,R,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3683,267,R,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, breast_msk_2025, crc_eo_2020, cscc_ucsf_2021, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, lung_msk_pdx, lung_pdx_msk_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, prad_msk_mdanderson_2023, skcm_broad_brafresist_2012, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Bowel, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung, Mixed Cancer Types, Prostate, Stomach Adenocarcinoma","hg19,17:7577139-7577139, hg19,17:7673821-7673821, hg38,17:7673821-7673821","hg19,17:g.7577139G>C, hg19,17:g.7673821G>C, hg38,17:g.7673821G>C",0.946,", breast, haematopoietic_and_lymphoid_tissue, lung, penis, stomach, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, malignant_melanoma",,,,,1761541,Pathogenic,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary",2,,,,Tier I - Strong,Choroid plexus carcinoma,1
3684,267,R,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3685,267,R,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3686,267,R,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3687,267,R,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, hcc_inserm_fr_2015, luad_broad, luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pancan_mimsi_msk_2024, pancan_pcawg_2020","Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577137-7577138, hg19,17:7577138-7577138, hg19,17:7673820-7673820, hg38,17:7673819-7673820, hg38,17:7673820-7673820","hg19,17:g.7577137_7577138delinsAA, hg19,17:g.7577138C>A, hg19,17:g.7673820C>A, hg38,17:g.7673819_7673820delinsAA, hg38,17:g.7673820C>A",0.911,"haematopoietic_and_lymphoid_tissue, large_intestine, caecum, large_intestine, colon, ascending, liver, lung, oesophagus, prostate, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, plasma_cell_myeloma",,,,,852206,Uncertain significance,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",2,,,,,,
3688,267,R,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3689,267,R,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3690,267,R,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_dfci_2016, crc_sysucc_2022, cscc_dfarber_2015, difg_tcga_gdc, escc_ucla_2014, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, gist_msk_2025, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_mdacc_2013, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_pcawg_2020, pdac_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018","Breast, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Esophageal Squamous Cell Carcinoma, Gastrointestinal Stromal Tumor, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue","hg19,17:7577137-7577138, hg19,17:7577138-7577138, hg19,17:7673820-7673820, hg38,17:7673819-7673820, hg38,17:7673820-7673820","hg19,17:g.7577137_7577138delinsGG, hg19,17:g.7577138C>G, hg19,17:g.7673820C>G, hg38,17:g.7673819_7673820inv, hg38,17:g.7673820C>G",0.927,", breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, oesophagus, ovary, pancreas, penis, skin, thyroid, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,428867,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Acute myeloid leukemia;Li-Fraumeni syndrome,1,,,,,,
3691,267,R,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025, cll_broad_2015, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_tcga_gdc, hcc_msk_2024, ihch_msk_2021, lcll_broad_2013, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_msk_stopsack_2021, prad_p1000, prad_su2c_2019, prostate_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018","Bowel, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577138-7577138, hg19,17:7673820-7673820, hg38,17:7673820-7673820","hg19,17:g.7577138C>T, hg19,17:g.7673820C>T, hg38,17:g.7673820C>T",0.902,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, sigmoid, lung, oesophagus, ovary, prostate, stomach, urinary_tract, bladder","Wilms_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",0.0000120309918350,,,,127823,Likely pathogenic,"Hereditary cancer-predisposing syndrome;not specified;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Malignant tumor of breast",3,Uncertain significance,Neoplasm,1,,,
3692,267,R,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3693,267,R,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3694,267,R,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3695,267,R,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, bladder_msk_2023, blca_msk_2024, blca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, chrcc_tcga_gdc, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_tcga_gdc, egc_msk_2023, gbm_tcga_pan_can_atlas_2018, glioma_mskcc_2019, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lgg_tcga_pan_can_atlas_2018, lms_msk_2024, luad_mskcc_2023_met_organotropism, lung_msk_2017, mbl_dkfz_2017, mbl_icgc, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ohnca_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pediatric_dkfz_2017, plmeso_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rcc_cptac_gdc, sarcoma_msk_2022, sarcoma_msk_2023, sarcoma_mskcc_2022, skcm_yale, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, uec_cptac_gdc","Appendiceal Adenocarcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Chromophobe Renal Cell Carcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Head and Neck Carcinoma, Other, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Medulloblastoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Renal Cell Carcinoma, Soft Tissue, Uterine Endometrioid Carcinoma","hg19,17:7577139-7577139, hg19,17:7673821-7673821, hg38,17:7673821-7673821","hg19,17:g.7577139G>A, hg19,17:g.7673821G>A, hg38,17:g.7673821G>A",0.917,", biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, ovary, prostate, skin, skin, scalp, small_intestine, jejunum, soft_tissue, fibrous_tissue_and_uncertain_origin, endometrium, stomach, thymus, thyroid, upper_aerodigestive_tract, head_neck","adenoma, villous, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, follicular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, tubular_adenocarcinoma, endometrial_stromal_sarcoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, osteosarcoma, primitive_neuroectodermal_tumour-medulloblastoma, primitive_neuroectodermal_tumour-medulloblastoma, classic, sex_cord-stromal_tumour, granulosa_cell_tumour, thymoma, thymoma, cortical",0.0000000000000000,,,,141764,Pathogenic/Likely pathogenic,"Lip and oral cavity carcinoma;TP53-related disorder;Glioma susceptibility 1;Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;Familial cancer of breast;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Familial cancer of breast",2,Likely oncogenic,Neoplasm,1,Tier I - Strong,Medulloblastoma WNT activated,1
3696,267,R,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3697,268,N,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3698,268,N,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3699,268,N,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",rectal_msk_2022,Bowel,"hg19,17:7577136-7577136","hg19,17:g.7577136T>C",0.221,,,,,,,,,,,,,,,,
3700,268,N,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3701,268,N,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673817-7673818","hg38,17:g.7673817_7673818inv",,"urinary_tract, bladder","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3702,268,N,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3703,268,N,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673818-7673818","hg38,17:g.7673818T>G",0.404,"breast, lung, prostate, thyroid","carcinoma, carcinoma, papillary_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3704,268,N,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, lihc_amc_prv, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_pcawg_2020, rcc_iatlas_immotion150_2018, sarcoma_msk_2022","Breast, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Renal Cell Carcinoma, Soft Tissue","hg19,17:7577135-7577135, hg19,17:7673817-7673817, hg38,17:7673817-7673817","hg19,17:g.7577135T>A, hg19,17:g.7673817T>A, hg38,17:g.7673817T>A",0.511,"breast, large_intestine, colon, pancreas, peritoneum, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, lobular_carcinoma, mesothelioma",,,,,,,,,,,,,,
3705,268,N,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577134-7577134, hg38,17:7673816-7673816","hg19,17:g.7577134G>C, hg38,17:g.7673816G>C",0.344,"large_intestine, colon","adenoma, tubular",,,,,1349719,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
3706,268,N,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3707,268,N,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3708,268,N,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3709,268,N,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3710,268,N,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3711,268,N,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577135-7577135, hg38,17:7673817-7673817","hg19,17:g.7577135T>C, hg38,17:g.7673817T>C",0.327,thyroid,"carcinoma, papillary_carcinoma",,,,,2831391,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3712,268,N,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3713,268,N,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3714,268,N,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3715,268,N,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM",,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, sarc_tcga, sarc_tcga_pub","Mixed Cancer Types, Soft Tissue","hg19,17:7577136-7577136, hg38,17:7673818-7673818","hg19,17:g.7577136T>A, hg38,17:g.7673818T>A",0.561,,,,,,,827405,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
3716,269,S,A,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3717,269,S,C,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_met_2021",Mixed Cancer Types,"hg19,17:7577133-7577133, hg38,17:7673815-7673815","hg19,17:g.7577133T>A, hg38,17:g.7673815T>A",0.460,"ovary, pancreas, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,2575177,Benign,Acute myeloid leukemia,0,,,,,,
3718,269,S,D,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3719,269,S,E,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3720,269,S,F,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3721,269,S,G,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",blca_msk_2024,Bladder Urothelial Carcinoma,"hg19,17:7577133-7577133, hg38,17:7673815-7673815","hg19,17:g.7577133T>C, hg38,17:g.7673815T>C",0.688,"lung, small_intestine, ileum, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3722,269,S,H,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3723,269,S,I,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577132-7577132, hg38,17:7673814-7673814","hg19,17:g.7577132C>A, hg38,17:g.7673814C>A",0.810,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,2575169,Likely pathogenic,Acute myeloid leukemia,0,,,,,,
3724,269,S,K,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3725,269,S,L,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3726,269,S,M,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3727,269,S,N,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_ctdna_vte_2024,Mixed Cancer Types,"hg19,17:7577132-7577132, hg38,17:7673814-7673814","hg19,17:g.7577132C>T, hg38,17:g.7673814C>T",0.729,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, skin, knee","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,3076193,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
3728,269,S,P,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3729,269,S,Q,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3730,269,S,R,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","pan_origimed_2020, sarcoma_msk_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7577131-7577131, hg19,17:7577133-7577133, hg38,17:7673813-7673813, hg38,17:7673815-7673815","hg19,17:g.7577131G>C, hg19,17:g.7577133T>G, hg38,17:g.7673813G>C, hg38,17:g.7673813G>T, hg38,17:g.7673815T>G","0.793, 0.812",prostate,carcinoma,,,,,"2113149, 647256","Uncertain significance, Uncertain significance",not provided;Li-Fraumeni syndrome|Li-Fraumeni syndrome,"2, 1",,,,,,
3731,269,S,T,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7577132-7577132, hg38,17:7673814-7673814","hg19,17:g.7577132C>G, hg38,17:g.7673814C>G",0.603,"cervix, urinary_tract, bladder","carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
3732,269,S,V,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3733,269,S,W,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3734,269,S,Y,P,,,,,,,,,,PhosphoSite,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3735,270,F,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3736,270,F,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, brca_metabric, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, gbm_mayo_pdx_sarkaria_2019, hcc_msk_2024, hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_mind_2020, mixed_impact_subset_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022","Bowel, Breast, CNS/Brain, Colorectal Adenocarcinoma, Diffuse Glioma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577129-7577129, hg19,17:7673811-7673811, hg38,17:7673811-7673811","hg19,17:g.7577129A>C, hg19,17:g.7673811A>C, hg38,17:g.7673811A>C",0.929,"breast, large_intestine, large_intestine, colon, descending, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, ovary, prostate, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, squamous_cell_carcinoma, other, adenomyoepithelioma, malignant, other, neoplasm",,,,,376597,Likely pathogenic,"Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary",2,,,,,,
3737,270,F,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3738,270,F,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3739,270,F,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3740,270,F,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3741,270,F,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, cscc_hgsc_bcm_2014, escc_icgc, luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, lusc_tcga, lusc_tcga_pub, mds_iwg_2022, msk_chord_2024, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, sarcoma_msk_2022","Cutaneous Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577130-7577130, hg19,17:7673812-7673812, hg38,17:7673812-7673812","hg19,17:g.7577130A>T, hg19,17:g.7673812A>T, hg38,17:g.7673812A>T",0.938,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, ascending, lung, oesophagus, skin, head_neck, upper_aerodigestive_tract, pharynx, oropharynx",", carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm",,,,,376596,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Ovarian neoplasm,1,,,,,,
3742,270,F,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",hcc_msk_2024,Hepatocellular Carcinoma,"hg19,17:7577128-7577130","hg19,17:g.7577128_7577130delinsTTT",,,,,,,,,,,,,,,,,
3743,270,F,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","appendiceal_msk_2022, brca_metabric, brca_msk_2025, brca_sanger, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, coad_cptac_2019, coad_cptac_gdc, coadread_dfci_2016, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, difg_glass, egc_mskcc_2020, es_dfarber_broad_2014, hcc_msk_2024, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, mbn_sfu_2023, mds_iwg_2022, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tracerx_2017, ov_tcga, ov_tcga_pub, ovary_cptac_gdc, paad_cptac_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Appendiceal Adenocarcinoma, Bladder/Urinary Tract, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577128-7577128, hg19,17:7577130-7577130, hg19,17:7673810-7673810, hg19,17:7673812-7673812, hg38,17:7673810-7673810, hg38,17:7673812-7673812","hg19,17:g.7577128A>C, hg19,17:g.7577128A>T, hg19,17:g.7577130A>G, hg19,17:g.7673810A>C, hg19,17:g.7673812A>G, hg38,17:g.7673810A>C, hg38,17:g.7673810A>T, hg38,17:g.7673812A>G","0.827, 0.935","biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, lung, oesophagus, ovary, pancreas, stomach, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, essential_thrombocythaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma",,,,,"1431729, 634778","Conflicting classifications of pathogenicity, Conflicting classifications of pathogenicity","Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Breast and/or ovarian cancer;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1","1, 1",,,,,,
3744,270,F,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3745,270,F,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3746,270,F,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3747,270,F,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3748,270,F,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3749,270,F,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, crc_nigerian_2020, csf_msk_2024, difg_tcga_gdc, egc_msk_2023, gbm_tcga_pub, hgsoc_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, mpcproject_broad_2021, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, ov_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577129-7577129, hg19,17:7673811-7673811, hg38,17:7673811-7673811","hg19,17:g.7577129A>G, hg19,17:g.7673811A>G, hg38,17:g.7673811A>G",0.945,", breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, large_intestine, large_intestine, colon, liver, oesophagus, ovary, pancreas, salivary_gland, parotid, stomach, thymus, upper_aerodigestive_tract, larynx, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, micropapillary, carcinoma, endometrioid_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma, malignant_melanoma, other, neoplasm, thymic_carcinoma",,,,,376594,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,2,Likely oncogenic,Neoplasm,1,,,
3750,270,F,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3751,270,F,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_ped_mai_msk_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_tcga_gdc, summit_2018","Bowel, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577130-7577130, hg19,17:7673812-7673812, hg38,17:7673812-7673812","hg19,17:g.7577130A>C, hg19,17:g.7673812A>C, hg38,17:g.7673812A>C",0.926,"bone, extraskeletal, breast, large_intestine, colon, large_intestine, rectum, liver, lung, lung, right_lower_lobe, pancreas, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, soft_tissue, smooth_muscle, abdomen, testis, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, small_cell_carcinoma, fibrosarcoma, myxofibrosarcoma, germ_cell_tumour, seminoma, leiomyosarcoma, osteosarcoma, fibroblastic, sarcoma",,,,,376598,Pathogenic,Hereditary cancer-predisposing syndrome,1,,,,Tier I - Strong,Choroid plexus carcinoma,1
3752,270,F,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3753,270,F,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673811-7673811","hg38,17:g.7673811A>T",0.936,"breast, large_intestine, colon, oesophagus, salivary_gland, parotid, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
3754,271,E,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",blca_iatlas_imvigor210_2017,Bladder Urothelial Carcinoma,"hg19,17:7673808-7673808","hg19,17:g.7673808T>G",,,,,,,,,,,,,,,,,
3755,271,E,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3756,271,E,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",luad_cptac_gdc,Lung Adenocarcinoma,"hg19,17:7577125-7577125, hg19,17:7673807-7673807, hg38,17:7673807-7673807","hg19,17:g.7577125C>A, hg19,17:g.7673807C>G, hg38,17:g.7673807C>A, hg38,17:g.7673807C>G","0.843, 0.844","kidney, liver, oesophagus","carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,859912,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3757,271,E,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3758,271,E,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",nsclc_ctdx_msk_2022,Non-Small Cell Lung Cancer,"hg19,17:7577126-7577126, hg38,17:7673808-7673808","hg19,17:g.7577126T>C, hg38,17:g.7673808T>C",0.967,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue","carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, refractory_thrombocytopenia",,,,,2858983,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3759,271,E,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3760,271,E,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3761,271,E,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_bcan_hcrn_2022, blca_bgi, blca_cornell_2016, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_mskcc_solit_2014, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_igr_2015, brca_metabric, brca_msk_2025, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cervix_msk_2023, cesc_tcga, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, coadread_dfci_2016, crc_apc_impact_2020, crc_sysucc_2022, cscc_dfarber_2015, csf_msk_2024, difg_msk_2023, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_broad, gbc_msk_2018, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, hcc_msk_2024, heme_msk_impact_2022, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, ihch_msk_2021, lgggbm_tcga_pub, lihc_amc_prv, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, rectal_msk_2022, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucs_msk_2024","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervical Squamous Cell Carcinoma, Cervix, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577127-7577127, hg19,17:7673809-7673809, hg38,17:7673809-7673809","hg19,17:g.7577127C>T, hg19,17:g.7673809C>T, hg38,17:g.7673809C>T",0.935,", biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, cervix, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, liver, lung, lung, right_upper_lobe, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, salivary_gland, skin, skin, head_neck, skin, shoulder, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, retromolar_trigone, upper_aerodigestive_tract, pharynx, hypopharynx, piriform_sinus, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, extramammary_Pagets_disease, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, lobular_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_unilineage_dysplasia, refractory_anaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, other, hepatoblastoma",,,,,406566,Conflicting classifications of pathogenicity,"Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome",1,,,,,,
3762,271,E,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577126-7577127, hg38,17:7673808-7673809","hg19,17:g.7577126_7577127delinsAA, hg38,17:g.7673808_7673809delinsAA",,,,,,,,568838,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3763,271,E,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3764,271,E,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3765,271,E,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673808-7673809","hg38,17:g.7673808_7673809delinsGG",,"salivary_gland, major","carcinoma, ex-pleomorphic_adenoma_carcinoma",,,,,,,,,,,,,,
3766,271,E,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_msk_2025, brca_mskcc_2019, brca_sanger, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paired_bladder_2022, pancan_pcawg_2020, pancan_pdmr_2025, sarcoma_msk_2022, summit_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577127-7577127, hg19,17:7673809-7673809, hg38,17:7673809-7673809","hg19,17:g.7577127C>G, hg19,17:g.7673809C>G, hg38,17:g.7673809C>G",0.924,", breast, cervix, lung, ovary, skin, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, urinary_tract, bladder, urinary_tract, renal_pelvis","adnexal_tumour, malignant_adnexal_tumour, extramammary_Pagets_disease, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, of_unknown_primary, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, other, dysplasia-carcinoma_in_situ",,,,,3634426,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,2,,,,,,
3767,271,E,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3768,271,E,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3769,271,E,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3770,271,E,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, crc_sysucc_2022, hcc_clca_2024, hcc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, lung_nci_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, prostate_msk_2024, sarcoma_msk_2022","Colorectal Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577126-7577126, hg19,17:7673808-7673808, hg38,17:7673808-7673808","hg19,17:g.7577126T>A, hg19,17:g.7673808T>A, hg38,17:g.7673808T>A",0.972,"central_nervous_system, brain, large_intestine, colon, liver, lung, oesophagus, oesophagus, lower_third, prostate, thyroid, upper_aerodigestive_tract, head_neck, urinary_tract, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, diffuse_midline_glioma",,,,,3147994,Likely pathogenic,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3771,271,E,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3772,271,E,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 267-271, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3773,272,V,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hcc_clca_2024, mbn_sfu_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024","Hepatocellular Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Pancreatic Adenocarcinoma","hg19,17:7577123-7577123, hg19,17:7673805-7673805, hg38,17:7673805-7673805","hg19,17:g.7577123A>G, hg19,17:g.7673805A>G, hg38,17:g.7673805A>G",0.658,"breast, central_nervous_system, cerebellum, endometrium, large_intestine, colon, liver, pancreas, soft_tissue, fibrous_tissue_and_uncertain_origin, pancreas, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, other, central_neurocytoma, undifferentiated_sarcoma, pleomorphic",,,,,565884,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3774,272,V,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3775,272,V,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3776,272,V,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ccle_broad_2019, ccle_broad_2025, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, mds_iwg_2022, msk_ch_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pdac_msk_2024","Adenoid Cystic Carcinoma, Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas","hg19,17:7577123-7577123, hg19,17:7673805-7673805, hg38,17:7673805-7673805","hg19,17:g.7577123A>T, hg19,17:g.7673805A>T, hg38,17:g.7673805A>T",0.806,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, descending, lung, ovary, skin, foot, skin, leg, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity","carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",,,,,376673,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3777,272,V,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3778,272,V,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, coadread_tcga_pan_can_atlas_2018, crc_sysucc_2022, cscc_hgsc_bcm_2014, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lusc_tcga_pan_can_atlas_2018, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_mskcc_2018, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pog570_bcgsc_2020, read_tcga_gdc","Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Rectal Adenocarcinoma","hg19,17:7577123-7577123, hg19,17:7673805-7673805, hg38,17:7673805-7673805","hg19,17:g.7577123A>C, hg19,17:g.7673805A>C, hg38,17:g.7673805A>C",0.707,", breast, endometrium, large_intestine, rectum, lung, ovary, pancreas, skin, skin, face, skin, head_neck, stomach, gastroesophageal_junction","carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,233323,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Adrenocortical carcinoma, hereditary",1,,,,,,
3779,272,V,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3780,272,V,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3781,272,V,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","hnc_mskcc_2016, luad_broad, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016","Head and Neck, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577123-7577124, hg38,17:7673805-7673806","hg19,17:g.7577123_7577124delinsTT, hg38,17:g.7673805_7673806delinsTT",,"lung, skin, skin, head_neck","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3782,272,V,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_msk_tcga_2020, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brca_bccrc, brca_metabric, brca_msk_2025, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cervix_msk_2023, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, chol_icgc_2017, chol_nccs_2013, coad_tcga_gdc, coadread_mskcc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, gbc_mskcc_2022, glioma_msk_2018, glioma_mskcc_2019, hcc_msk_2024, hcc_mskimpact_2018, hgsoc_tcga_gdc, luad_cptac_2020, luad_cptac_gdc, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lusc_cptac_2021, lusc_cptac_gdc, mds_iwg_2022, mixed_allen_2018, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, ov_tcga_pan_can_atlas_2018, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sclc_ucologne_2015, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervical Squamous Cell Carcinoma, Cervix, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577124-7577124, hg19,17:7673806-7673806, hg38,17:7673806-7673806","hg19,17:g.7577124C>A, hg19,17:g.7577124C>G, hg19,17:g.7673806C>A, hg19,17:g.7673806C>G, hg38,17:g.7673806C>A, hg38,17:g.7673806C>G",0.878,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, cervix, endometrium, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, prostate, salivary_gland, ethmoid_sinus, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, carcinoid-endocrine_tumour, atypical, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, other, dysplasia-in_situ_neoplasm, other, intraepithelial_neoplasia, low_grade, primitive_neuroectodermal_tumour-medulloblastoma",,,,,"574679, 12358","Pathogenic, Pathogenic/Likely pathogenic",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,"2, 2",Oncogenic,Neoplasm,1,Tier II - Potential,Pleomorphic xanthoastrocytoma,1
3783,272,V,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, aml_ohsu_2018, aml_ohsu_2022, bcc_unige_2016, bladder_msk_2023, brain_cptac_gdc, brca_dldccc_2022, brca_metabric, brca_msk_2025, brca_mskcc_2019, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, ccrcc_tcga_gdc, cellline_ccle_broad, cfdna_msk_2019, chol_icgc_2017, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_msk_2023, difg_tcga_gdc, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, es_dsrct_msk_2023, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_cptac_2021, gbm_tcga_pub, glioma_msk_2018, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, ihch_mskcc_2020, kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, mbl_dkfz_2017, mbl_icgc, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mpcproject_broad_2021, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paad_icgc, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prad_msk_stopsack_2021, prostate_msk_2024, rectal_radiation_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_cancercell_gardner_2017, soft_tissue_msk_2025, soft_tissue_tcga_gdc, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Medulloblastoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Renal Clear Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577124-7577124, hg19,17:7577124-7577125, hg19,17:7673806-7673806, hg38,17:7673806-7673806","hg19,17:g.7577124C>T, hg19,17:g.7577124_7577125delinsTT, hg19,17:g.7673806C>T, hg38,17:g.7673806C>T",0.907,", biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, left, large_intestine, colon, sigmoid, large_intestine, left, large_intestine, rectum, liver, lung, lung, left, meninges, oesophagus, oesophagus, lower_third, oesophagus, upper_third, ovary, pancreas, prostate, skin, skin, ear, soft_tissue, soft_tissue, smooth_muscle, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, urinary_tract, bladder, urinary_tract, upper_urinary_tract, vulva","adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, acinar_adenocarcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, myeloid_neoplasm_unspecified_therapy_related, haematopoietic_neoplasm, myeloproliferative_neoplasm, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, meningioma, osteosarcoma, other, adenocarcinoma_in_situ, other, neoplasm, primitive_neuroectodermal_tumour-medulloblastoma, sarcoma",0.0000039857787415,,,,185814,Pathogenic,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome;not provided;Li-Fraumeni syndrome 1,3,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
3784,272,V,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3785,272,V,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3786,272,V,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3787,272,V,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3788,272,V,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3789,272,V,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3790,272,V,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3791,272,V,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3792,273,R,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3793,273,R,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, acc_tcga, acc_tcga_gdc, acc_tcga_pan_can_atlas_2018, all_stjude_2015, aml_ohsu_2018, aml_ohsu_2022, aml_tcga_gdc, ampca_bcm_2016, appendiceal_msk_2022, bladder_msk_2023, bladder_msk_2024, blca_bcan_hcrn_2022, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bowel_colitis_msk_2022, braf_msk_impact_2024, brca_broad, brca_cptac_2020, brca_dldccc_2022, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_pareja_msk_2020, brca_sanger, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, cll_broad_2015, cll_broad_2022, coad_caseccc_2015, coad_cptac_2019, coad_cptac_gdc, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_genentech, coadread_mskcc, coadread_mskresistance_2022, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_dd_2022, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_orion_2024, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_msk_2023, difg_tcga_gdc, dlbc_tcga, dlbc_tcga_pan_can_atlas_2018, dlbclnos_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, es_dfarber_broad_2014, es_dsrct_msk_2023, es_iocurie_2014, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, escc_ucla_2014, gbc_msk_2018, gbc_mskcc_2022, gbm_mayo_pdx_sarkaria_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gbm_tcga_pub2013, gct_msk_2020, glioma_msk_2018, glioma_mskcc_2019, hcc_msk_2024, hcc_msk_venturaa_2018, hcc_mskimpact_2018, heme_msk_impact_2022, hgsoc_msk_2021, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_jhu, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, kirc_bgi, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lcll_broad_2013, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, lgsoc_mapk_msk_2022, lihc_amc_prv, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, mbl_broad_2012, mbl_dkfz_2017, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, meso_tcga, meso_tcga_pan_can_atlas_2018, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_impact_subset_2022, mnm_washu_2016, mpnst_mskcc, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nepc_wcm_2016, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_cptac_2021, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancan_ped_mai_msk_2025, pancreas_cptac_gdc, pancreas_msk_2024, panet_msk_2018, pcnsl_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, pptc_2019, prad_broad, prad_broad_2013, prad_cdk12_mskcc_2020, prad_cpcg_2017, prad_fhcrc, prad_mcspc_mskcc_2020, prad_mich, prad_msk_mdanderson_2023, prad_msk_stopsack_2021, prad_mskcc, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_dkfz_2018, prostate_msk_2024, prostate_pcbm_swiss_2019, rcc_cptac_gdc, rcc_iatlas_immotion150_2018, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_msk_2023, sarcoma_mskcc_2022, sclc_clcgp, sclc_jhu, sclc_ucologne_2015, skcm_broad, skcm_dfci_2015, stad_oncosg_2018, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, summit_2018, thym_tcga, thym_tcga_gdc, thym_tcga_pan_can_atlas_2018, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_msk_2018, ucec_msk_2024, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014, ucs_msk_2024, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc, urcc_mskcc_2016, utuc_msk_2019, utuc_pdx_msk_2019","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Adrenocortical Carcinoma, Ampullary Carcinoma, Appendiceal Adenocarcinoma, B-Lymphoblastic Leukemia/Lymphoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gallbladder Cancer, Head and Neck, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Low-Grade Serous Ovarian Cancer, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Malignant Peripheral Nerve Sheath Tumor, Mature B-Cell Neoplasms, Medulloblastoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine Tumor, Pleural Mesothelioma, Primary DLBCL of the central nervous system, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Renal Cell Carcinoma, Renal Clear Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Testis, Thymoma, Thyroid, Unclassified Renal Cell Carcinoma, Upper Tract Urothelial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma","hg19,17:7577121-7577121, hg19,17:7577121-7577122, hg19,17:7673803-7673803, hg38,17:7673803-7673803, hg38,17:7673803-7673804","hg19,17:g.7577121G>A, hg19,17:g.7577121_7577122delinsAA, hg19,17:g.7673803G>A, hg38,17:g.7673803G>A, hg38,17:g.7673803_7673804delinsAG",0.901,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, central_nervous_system, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, cerebellum, central_nervous_system, frontal_lobe, central_nervous_system, frontotemporal, central_nervous_system, midbrain, central_nervous_system, occipital_lobe, central_nervous_system, parietal_lobe, central_nervous_system, pineal_gland, central_nervous_system, spinal_cord, central_nervous_system, temporal_lobe, central_nervous_system, thalamus, cervix, endometrium, eye, uveal_tract, gastrointestinal_tract_(site_indeterminate), genital_tract, extragonadal, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, large_intestine, anus, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, left, large_intestine, rectum, liver, lung, lung, left_lower_lobe, lung, right_lower_lobe, oesophagus, oesophagus, lower_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, peritoneum, appendix, pleura, prostate, salivary_gland, salivary_gland, major, salivary_gland, parotid, skin, skin, axilla, skin, back, skin, eye, skin, face, skin, groin, skin, hand, skin, mucosal, female_genitourinary_system, skin, scalp, skin, trunk, small_intestine, small_intestine, duodenum, small_intestine, ileum, small_intestine, jejunum, soft_tissue, blood_vessel, soft_tissue, fat, soft_tissue, fibrous_tissue_and_uncertain_origin, endometrium, stomach, stomach, gastroesophageal_junction, testis, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, glottis, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, buccal_mucosa, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, mouth_roof, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, upper_aerodigestive_tract, trachea, urinary_tract, urinary_tract, bladder, urinary_tract, bladder, urachus, urinary_tract, renal_pelvis, urinary_tract, upper_urinary_tract, urinary_tract, urethra, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, adenoma, adenoma, tubular, high_grade_dysplasia, adenoma, tubulovillous, high_grade_dysplasia, adnexal_tumour, malignant_adnexal_tumour, adnexal_tumour, malignant_adnexal_tumour, eccrine_adenocarcinoma, adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, adnexal_tumour, malignant_adnexal_tumour, hidradenocarcinoma, adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adrenal_cortical_carcinoma, adrenal_cortical_carcinoma, functioning, adrenal_cortical_neoplasm, cortisol_and_virilizing_syndrome-producing, carcinoid-endocrine_tumour, carcinoid-endocrine_tumour, goblet_cell, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Hurthle_cell_carcinoma, carcinoma, acinic_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, blastoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, collecting_duct_carcinoma, carcinoma, dedifferentiated_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, gastric_type_adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_A_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, lymphoepithelioma_like_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, mucoepidermoid_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, renal_cell_carcinoma_unclassified, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_adenocarcinofibroma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, micropapillary_transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, endometrial_stromal_sarcoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, germ_cell_tumour, mixed, germ_cell_tumour, teratoma, germ_cell_tumour, yolk_sac_tumour, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_I, pilocytic, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_III, pleomorphic_xanthoastrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, gliosarcoma, glioma, oligoastrocytoma, glioma, oligoastrocytoma_Grade_II, glioma, oligoastrocytoma_Grade_III, anaplastic, glioma, oligodendroglioma, glioma, oligodendroglioma_Grade_II, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_leukaemic_transformation_of_essential_thrombocythaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M0, haematopoietic_neoplasm, acute_myeloid_leukaemia, M5, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, M5, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, haematopoietic_neoplasm, myelofibrosis, primary, haematopoietic_neoplasm, polycythaemia_vera, liposarcoma, dedifferentiated, low_malignant_potential_(borderline)_tumour, mucinous, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, MALT_lymphoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, anaplastic_large_cell_lymphoma, ALK_positive, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, mesothelioma, epithelial, osteosarcoma, other, other, Barrett_oesophagus, with_high_grade_dysplasia, other, adenosarcoma, other, dysplasia-in_situ_neoplasm, other, high_grade_mucinous_neoplasm, other, intimal_sarcoma, other, intraepithelial_neoplasia, low_grade, other, keratoacanthoma, other, neoplasm, other, oesophagitis, other, pseudomyxoma_peritonei, other, thrombocytosis, primitive_neuroectodermal_tumour-medulloblastoma, primitive_neuroectodermal_tumour-medulloblastoma, classic, pulmonary_blastoma",0.0000119593382500,0.0000000000000000,,,43594,Pathogenic/Likely pathogenic,"TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Adrenocortical carcinoma, hereditary;Multiple myeloma;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Prostate cancer",2,Oncogenic,Neoplasm,1,Tier I - Strong,"Medulloblastoma WNT activated;Adenocarcinoma of the large intestine;Primary intracranial sarcoma, DICER1-mutant;Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype;Astrocytoma IDH-mutant;Diffuse midline glioma, H3 K27M-mutant;Embryonal rhabdomyosarcoma;Neuroblastoma",1
3794,273,R,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3795,273,R,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3796,273,R,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3797,273,R,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brain_cptac_gdc, brca_iatlas_anders_2022, brca_metabric, coadread_dfci_2016, crc_sysucc_2022, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mpn_cimr_2013, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_mskcc_2018, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pdac_msk_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","CNS/Brain, Colorectal Adenocarcinoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Non-Small Cell Lung Cancer, Pancreas","hg19,17:7577121-7577121, hg19,17:7577121-7577122, hg19,17:7673803-7673803, hg38,17:7673803-7673803","hg19,17:g.7577121G>C, hg19,17:g.7577121_7577122delinsCT, hg19,17:g.7673803G>C, hg38,17:g.7673803G>C",0.902,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, appendix, large_intestine, colon, descending, lung, oesophagus, ovary, pancreas, prostate, skin, face, skin, head_neck, stomach, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, essential_thrombocythaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, desmoplastic",,,,,634682,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Colorectal cancer;Li-Fraumeni syndrome;TP53-related disorder;Ovarian neoplasm;Li-Fraumeni syndrome 1,2,Likely oncogenic,Neoplasm,1,,,
3798,273,R,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, all_stjude_2013, aml_ohsu_2018, aml_ohsu_2022, ampca_bcm_2016, angs_painter_2020, angs_painter_2025, angs_project_painter_2018, appendiceal_msk_2022, biliary_tract_summit_2022, bladder_msk_2023, blca_bcan_hcrn_2022, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_nmibc_2017, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brain_cptac_gdc, brca_bccrc, brca_broad, brca_dldccc_2022, brca_fuscc_2020, brca_iatlas_anders_2022, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_metabric, brca_msk_2025, brca_mskcc_2019, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_alpelisib_2020, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_nci60, cfdna_msk_2019, chol_icgc_2017, chol_msk_2018, chol_tcga_gdc, cll_broad_2015, cll_broad_2022, coad_caseccc_2015, coad_cptac_2019, coad_cptac_gdc, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_genentech, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_orion_2024, crc_sysucc_2022, cscc_ucsf_2021, csf_msk_2024, difg_glass, difg_glass_2019, difg_msk_2023, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_trap_ccr_msk_2023, egc_trap_msk_2020, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, gbc_msk_2018, gbc_mskcc_2022, gbm_mayo_pdx_sarkaria_2019, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gist_msk_2022, gist_msk_2023, glioma_mskcc_2019, hcc_clca_2024, hcc_meric_2021, hcc_msk_2024, hcc_tcga_gdc, hdcn_msk_2025, heme_msk_impact_2022, hgsoc_msk_2021, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_jhu, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, ihch_mskcc_2020, ihch_smmu_2014, lcll_broad_2013, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_broad, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_pdx, lung_nci_2022, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, lymphoma_cellline_msk_2020, mbc_msk_2021, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, meso_tcga, meso_tcga_pan_can_atlas_2018, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_kunga_msk_2022, mixed_pipseq_2017, mixed_selpercatinib_2020, mm_broad, mnm_washu_2016, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_unito_2016, ntrk_msk_2019, ohnca_cptac_gdc, os_target_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovary_cptac_gdc, paad_cptac_2021, paad_icgc, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, pediatric_dkfz_2017, plmeso_tcga_gdc, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_cpcg_2017, prad_fhcrc, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_dkfz_2018, prostate_msk_2024, prostate_pcbm_swiss_2019, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, rectal_radiation_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_msk_2023, sarcoma_mskcc_2022, sclc_ucologne_2015, soft_tissue_tcga_gdc, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stad_utokyo, stes_tcga_pub, summit_2018, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022, ucec_ccr_msk_2022, ucec_cptac_2020, ucec_msk_2018, ucec_msk_dacruzpaula_2025, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014, ucs_msk_2024, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018, uec_cptac_gdc, uec_msk_2024","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Ampullary Carcinoma, Angiosarcoma, Appendiceal Adenocarcinoma, Biliary Tract, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Gastrointestinal Stromal Tumor, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Histiocytic and Dendritic Cell Neoplasms, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Lymphoid, Mature B-Cell Neoplasms, Metaplastic Breast Cancer, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Osteosarcoma, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Plasma Cell Myeloma, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Thyroid, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor, Uterine Endometrioid Carcinoma","hg19,17:7577120-7577120, hg19,17:7673802-7673802, hg38,17:7673802-7673802","hg19,17:g.7577120C>T, hg19,17:g.7673802C>T, hg38,17:g.7673802C>T",0.868,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, bone, extraskeletal, bone, femur, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, cerebellum, central_nervous_system, frontal_lobe, central_nervous_system, intraventricular, central_nervous_system, parietal_lobe, central_nervous_system, parietotemporal, central_nervous_system, spinal_cord, central_nervous_system, temporal_lobe, central_nervous_system, thalamus, cervix, endometrium, fallopian_tube, gastrointestinal_tract_(site_indeterminate), genital_tract, extragonadal, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, large_intestine, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, skin, haematopoietic_and_lymphoid_tissue, small_intestine, haematopoietic_and_lymphoid_tissue, spleen, kidney, large_intestine, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, left, large_intestine, rectum, liver, lung, lung, bronchus, lung, left_lower_lobe, lung, right_lower_lobe, lung, right_middle_lobe, lung, right_upper_lobe, lung, upper_lobe, oesophagus, oesophagus, lower_third, ovary, pancreas, pancreas, ampulla_of_Vater, parathyroid, penis, peritoneum, appendix, pleura, prostate, salivary_gland, skin, skin, axilla, skin, eye, skin, forearm, skin, hand, skin, head_neck, skin, lower_leg, skin, upper_extremity, skin, vulva, small_intestine, duodenum, soft_tissue, soft_tissue, blood_vessel, skin, breast, soft_tissue, fibrous_tissue_and_uncertain_origin, soft_tissue, fibrous_tissue_and_uncertain_origin, abdominal_wall, soft_tissue, fibrous_tissue_and_uncertain_origin, leg, soft_tissue, fibrous_tissue_and_uncertain_origin, lower_extremity, soft_tissue, fibrous_tissue_and_uncertain_origin, supraclavicular_fossa, soft_tissue, nerve_sheath, soft_tissue, smooth_muscle, uterus, soft_tissue, striated_muscle, soft_tissue, striated_muscle, orbit, stomach, stomach, gastroesophageal_junction, testis, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, buccal_mucosa, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, urinary_tract, bladder, urinary_tract, bladder, urachus, vulva",", Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, Wilms_tumour, adenoma, adnexal_tumour, malignant_adnexal_tumour, adnexal_tumour, malignant_adnexal_tumour, cylindrocarcinoma, adnexal_tumour, malignant_adnexal_tumour, microcystic_adnexal_carcinoma, adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adnexal_tumour, malignant_adnexal_tumour, spiradenocarcinoma, adrenal_cortical_carcinoma, adrenal_cortical_neoplasm, virilizing_syndrome_producing, angiosarcoma, carcinoid-endocrine_tumour, carcinoid-endocrine_tumour, goblet_cell, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, acinic_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, mucinous, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, adenocarcinoma, transformed_to_small_cell_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, basal_cell_carcinosarcoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, dedifferentiated_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, epithelial-myoepithelial_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, lobular_carcinoma, pleomorphic, carcinoma, luminal_B_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, chondrosarcoma, desmoid_tumour-fibromatosis, germ_cell_tumour, choriocarcinoma, germ_cell_tumour, yolk_sac_tumour, glioma, glioma, astrocytoma, glioma, astrocytoma, pleomorphic_xanthoastrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_III, pleomorphic_xanthoastrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, oligoastrocytoma, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_leukaemic_transformation_of_myeloproliferative_neoplasm, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M0, haematopoietic_neoplasm, acute_myeloid_leukaemia, granulocytic_sarcoma, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia, haematopoietic_neoplasm, essential_thrombocythaemia, haematopoietic_neoplasm, granulocytic_sarcoma, haematopoietic_neoplasm, myelodysplastic-myeloproliferative_neoplasm, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, polycythaemia_vera, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, anaplastic_large_cell_lymphoma, ALK_positive, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_peripheral_nerve_sheath_tumour, mesothelioma, mesothelioma, epithelial, osteosarcoma, osteosarcoma, osteoblastic, other, other, Barrett_oesophagus, with_high_grade_dysplasia, other, cystic_tumour, other, dysplasia-in_situ_neoplasm, other, intraepithelial_neoplasia, low_grade, other, neoplasm, other, neoplasm, malignant, other, normal, other, pseudomyxoma_peritonei, primitive_neuroectodermal_tumour-medulloblastoma, large_cell, rhabdomyosarcoma, rhabdomyosarcoma, embryonal, sarcoma, thymic_carcinoma, sarcomatoid_carcinoma, thymoma, epithelial_predominant, undifferentiated-unclassified_sarcoma, mixed, undifferentiated_sarcoma, pleomorphic",0.0000159328272005,,,,12366,Pathogenic,"Colorectal cancer;TP53-related disorder;Colorectal cancer;Breast and/or ovarian cancer;Gastric cancer;Rhabdomyosarcoma;Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Thyroid gland undifferentiated (anaplastic) carcinoma;Li-Fraumeni syndrome 1;Lung adenocarcinoma;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck;Familial cancer of breast;Malignant tumor of breast",3,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant;Desmoplastic small round cell tumor;Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype;Rhabdomyosarcoma;Ewing sarcoma",1
3799,273,R,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673802-7673803","hg38,17:g.7673802_7673803delinsAT",,"upper_aerodigestive_tract, larynx","other, neoplasm, malignant",,,,,,,,,,,,,,
3800,273,R,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3801,273,R,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, bladder_msk_2023, blca_iatlas_imvigor210_2017, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_cptac_2020, brca_metabric, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_icgc_2017, coadread_dfci_2016, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_tcga_gdc, gbc_mskcc_2022, gist_msk_2025, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, luad_broad, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_mskcc_2020, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mnm_washu_2016, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_ucologne_2015, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Gallbladder Cancer, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577120-7577120, hg19,17:7673802-7673802, hg38,17:7673802-7673802","hg19,17:g.7577120C>A, hg19,17:g.7673802C>A, hg38,17:g.7673802C>A",0.921,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, bone, extraskeletal, breast, central_nervous_system, brain, central_nervous_system, brainstem, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, anus, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, bronchus, lung, left, lung, lower_lobe, lung, right, lung, right_bronchus, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pleura, prostate, salivary_gland, parotid, skin, stomach, testis, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, ethmoid, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, normal-like_carcinoma, carcinoma, of_unknown_primary, carcinoma, salivary_duct_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, clonal_cytopenia_of_undetermined_significance, haematopoietic_neoplasm, myelodysplastic_syndrome, in_situ_epithelial_neoplasm, Bowen_disease, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, osteosarcoma, other, Barrett_oesophagus, with_high_grade_dysplasia, other, hepatoblastoma, other, intraepithelial_neoplasia, high_grade, pulmonary_blastoma, sex_cord-stromal_tumour, Sertoli_cell_tumour",0.0000039832068001,,,,376655,Pathogenic,"Adrenocortical carcinoma, hereditary;Ovarian neoplasm;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome",2,Oncogenic,Neoplasm;Neuroendocrine pancreatic tumor,1,Tier I - Strong,Embryonal rhabdomyosarcoma,1
3802,273,R,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3803,273,R,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3804,273,R,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","all_phase2_target_2018_pub, blca_iatlas_imvigor210_2017, brain_cptac_gdc, brca_dldccc_2022, brca_metabric, brca_sanger, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2025, cfdna_msk_2019, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, glioma_mskcc_2019, hcc_clca_2024, hgsoc_msk_2021, hgsoc_tcga_gdc, luad_broad, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022","B-Lymphoblastic Leukemia/Lymphoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Colorectal Adenocarcinoma, Diffuse Glioma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577120-7577120, hg19,17:7673802-7673802, hg38,17:7673802-7673802","hg19,17:g.7577120C>G, hg19,17:g.7673802C>G, hg38,17:g.7673802C>G",0.932,", breast, central_nervous_system, brain, central_nervous_system, cerebellum, cervix, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, skin, soft_tissue, blood_vessel, chest, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, supraglottis, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx","angiosarcoma, carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, haematopoietic_neoplasm, acute_lymphoblastic_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, malignant_melanoma",,0.0000318674314850,,,231060,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Ovarian neoplasm;Li-Fraumeni syndrome,2,,,,,,
3805,273,R,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673801-7673802","hg38,17:g.7673801_7673802delinsCT",,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
3806,273,R,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, blca_msk_2025, blca_msk_tcga_2020, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, cfdna_msk_2019, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, gct_msk_2020, hcc_tcga_gdc, heme_msk_impact_2022, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, mcl_idibips_2013, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_tracerx_2017, pan_origimed_2020, pancan_mappyacts_2022, pancan_pcawg_2020, pdac_msk_2024, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Acute Myeloid Leukemia, Bladder Urothelial Carcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mantle Cell Lymphoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue, Stomach Adenocarcinoma, Testis","hg19,17:7577121-7577121, hg19,17:7577121-7577122, hg19,17:7673803-7673803, hg38,17:7673801-7673803, hg38,17:7673803-7673803, hg38,17:7673803-7673804","hg19,17:g.7577121G>T, hg19,17:g.7577121_7577122delinsTT, hg19,17:g.7673803G>T, hg38,17:g.7673801_7673803delinsCGA, hg38,17:g.7673803G>T, hg38,17:g.7673803_7673804delinsTT",0.906,"biliary_tract, bile_duct, breast, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, spleen, kidney, large_intestine, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, parotid, soft_tissue, lung, stomach, stomach, gastroesophageal_junction, thyroid, urinary_tract, urinary_tract, bladder","adenoma, pleomorphic, carcinoid-endocrine_tumour, carcinoid-endocrine_tumour, insulinoma, carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, marginal_zone_lymphoma, sarcoma",0.0000000000000000,,,,"4530236, 376656",Pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,Tier I - Strong,Medulloblastoma WNT activated,1
3807,273,R,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3808,273,R,V,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",nsclc_tcga_broad_2016,Non-Small Cell Lung Cancer,"hg19,17:7577120-7577121","hg19,17:g.7577120_7577121delinsAC",,,,,,,,,,,,,,,,,
3809,273,R,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3810,273,R,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,17:7577120-7577121, hg38,17:7673802-7673803","hg19,17:g.7577120_7577121delinsTA, hg38,17:g.7673802_7673803delinsTA",,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
3811,274,V,A,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, cfdna_msk_2019, chol_msk_2018, coadread_dfci_2016, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_glass, difg_glass_2019, gbc_mskcc_2022, gist_msk_2022, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, lihc_riken, mbn_mdacc_2013, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ovary_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_jhu, skcm_broad, stad_uhongkong, ucec_ancestry_cds_msk_2023","Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Gallbladder Cancer, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577117-7577117, hg19,17:7673799-7673799, hg38,17:7673799-7673799","hg19,17:g.7577117A>G, hg19,17:g.7673799A>G, hg38,17:g.7673799A>G",0.847,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, skin, forearm, skin, scalp, small_intestine, jejunum, soft_tissue, nerve_sheath, chest, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_roof, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, invasive_mucinous_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_peripheral_nerve_sheath_tumour",,,,,376677,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3812,274,V,C,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, ccle_broad_2025",Mixed Cancer Types,"hg19,17:7577117-7577118, hg19,17:7673799-7673800","hg19,17:g.7577117_7577118delinsCA, hg19,17:g.7673799_7673800delinsCA",,,,,,,,,,,,,,,,,
3813,274,V,D,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_sanger, ccle_broad_2025, ccle_genentech_2014, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, gbc_msk_2018, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, luad_tcga_pan_can_atlas_2018, lung_msk_2017, mbc_msk_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, sarcoma_msk_2022, stad_pfizer_uhongkong","Colon Adenocarcinoma, Colorectal Adenocarcinoma, Gallbladder Cancer, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Metaplastic Breast Cancer, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577117-7577117, hg19,17:7673799-7673799, hg38,17:7673799-7673799","hg19,17:g.7577117A>T, hg19,17:g.7673799A>T, hg38,17:g.7673799A>T",0.889,"breast, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, colon, ascending, lung, ovary, pancreas, skin, soft_tissue, ovary, stomach, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basosquamous_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, classic, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, metaplastic_sarcomatoid, carcinoma, intestinal_adenocarcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, lymphoid_neoplasm, MALT_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, undifferentiated_sarcoma",,,,,376675,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
3814,274,V,E,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577116-7577117, hg38,17:7673798-7673799","hg19,17:g.7577116_7577117inv, hg38,17:g.7673798_7673799inv",,,,,,,,1417760,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3815,274,V,F,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, bm_nsclc_mskcc_2023, brca_sanger, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, crc_apc_impact_2020, crc_eo_2020, crc_nigerian_2020, hcc_clca_2024, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lgsoc_mapk_msk_2022, lihc_amc_prv, lms_msk_2024, luad_broad, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, mixed_pipseq_2017, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ovarian_msk_2025, paad_qcmg_uq_2016, paad_tcga, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc, prad_organoids_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_tcga_pan_can_atlas_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, usarc_msk_2020","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Low-Grade Serous Ovarian Cancer, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Uterine Sarcoma/Mesenchymal","hg19,17:7577118-7577118, hg19,17:7577118-7577119, hg19,17:7673800-7673800, hg38,17:7673800-7673800","hg19,17:g.7577118C>A, hg19,17:g.7577118_7577119delinsAC, hg19,17:g.7673800C>A, hg38,17:g.7673800C>A",0.773,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, peritoneum, appendix, prostate, soft_tissue, fibrous_tissue_and_uncertain_origin, axilla, soft_tissue, smooth_muscle, uterus, stomach, thyroid, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, glioma, haematopoietic_neoplasm, myelodysplastic_syndrome, leiomyosarcoma, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, other, neoplasm, other, pseudomyxoma_peritonei, undifferentiated-unclassified_sarcoma, pleomorphic",,,,,376674,Conflicting classifications of pathogenicity,Lip and oral cavity carcinoma;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;not provided;Hereditary cancer-predisposing syndrome,1,Oncogenic,Neoplasm,1,Tier I - Strong,Medulloblastoma SHH activated and TP53 mutant,1
3816,274,V,G,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, brca_smc_2018, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, chol_icgc_2017, egc_msk_2017, egc_msk_2023, egc_tmucih_2015, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, hgsoc_tcga_gdc, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_tcga_pan_can_atlas_2018, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prad_mich, sarcoma_msk_2022, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Breast, Cholangiocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577117-7577117, hg19,17:7673799-7673799, hg38,17:7673799-7673799","hg19,17:g.7577117A>C, hg19,17:g.7673799A>C, hg38,17:g.7673799A>C",0.865,"breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, thyroid, large_intestine, colon, large_intestine, colon, ascending, liver, lung, ovary, prostate, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, glioma, lymphoid_neoplasm, follicular_lymphoma, other, carcinoma_in_situ",,,,,376676,Conflicting classifications of pathogenicity,Lip and oral cavity carcinoma;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3817,274,V,H,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3818,274,V,I,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577118-7577118, hg38,17:7673800-7673800","hg19,17:g.7577118C>T, hg38,17:g.7673800C>T",0.367,"biliary_tract, bile_duct, breast, central_nervous_system, frontal_lobe, oesophagus, skin, knee, stomach","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, carcinoma, carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_II, gemistocytic",,,,,3460325,Benign,Hereditary cancer-predisposing syndrome,1,,,,,,
3819,274,V,K,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3820,274,V,L,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, brain_cptac_gdc, brca_mbcproject_2022, brca_metabric, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, coadread_tcga, coadread_tcga_pub, egc_msk_2023, esca_tcga, esca_tcga_pan_can_atlas_2018, hcc_clca_2024, heme_msk_impact_2022, lung_msk_2017, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_hcmi_2025, pdac_msk_2024, pog570_bcgsc_2020, read_tcga_gdc, sarcoma_msk_2022, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Adenoid Cystic Carcinoma, Breast, CNS/Brain, Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Pancreas, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7577118-7577118, hg19,17:7673800-7673800, hg38,17:7673800-7673800","hg19,17:g.7577118C>G, hg19,17:g.7673800C>G, hg38,17:g.7673800C>G",0.630,"breast, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, rectum, lung, oesophagus, ovary, pancreas, soft_tissue, blood_vessel, chest, soft_tissue, fibrous_tissue_and_uncertain_origin, kidney, stomach, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","Wilms_tumour, angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, carcinoma, undifferentiated_adenocarcinoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, sarcoma",,,,,376678,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,Uncertain significance,Neoplasm,1,,,
3821,274,V,M,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3822,274,V,N,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3823,274,V,P,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3824,274,V,Q,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3825,274,V,R,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3826,274,V,S,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3827,274,V,T,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3828,274,V,W,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3829,274,V,Y,,,,,,,,,,,,"WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 269-274, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 271-274, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3830,275,C,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3831,275,C,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3832,275,C,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3833,275,C,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, brca_metabric, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, chol_jhu_2013, cll_broad_2022, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_ranson_2022, csf_msk_2024, difg_tcga_gdc, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_ucla_2014, gbc_msk_2018, hcc_clca_2024, hcc_meric_2021, hcc_msk_2024, hnc_mskcc_2016, hnsc_jhu, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, ihch_mskcc_2020, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, luad_broad, luad_msk_npjpo_2021, luad_mskcc_2015, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, mbn_mdacc_2013, mixed_allen_2018, mixed_impact_subset_2022, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_mskcc_2015, nsclc_tcga_broad_2016, paad_qcmg_uq_2016, paad_tcga, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sclc_ucologne_2015, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Basal Cell Carcinoma, Bowel, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Head and Neck, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577114-7577114, hg19,17:7673796-7673796, hg38,17:7673795-7673796, hg38,17:7673796-7673796","hg19,17:g.7577114C>A, hg19,17:g.7673796C>A, hg38,17:g.7673795_7673796delinsGA, hg38,17:g.7673796C>A",0.981,"biliary_tract, bile_duct, biliary_tract, gallbladder, bone, pelvis, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, central_nervous_system, parietooccipital, cervix, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, spleen, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, sigmoid, liver, lung, oesophagus, ovary, pancreas, prostate, skin, skin, ear, skin, head_neck, skin, upper_arm, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ductal_carcinoma, micropapillary, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, chondrosarcoma, peripheral, glioma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, nodular",,,,,376582,Pathogenic,Ovarian neoplasm;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,Oncogenic,Neoplasm,1,Tier I - Strong,"Diffuse glioma, H3 G34 mutant",1
3834,275,C,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, ccle_broad_2019, ccle_broad_2025, cfdna_msk_2019, csf_msk_2024, difg_tcga_gdc, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024","Bladder/Urinary Tract, Diffuse Glioma, Lung Adenocarcinoma, Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7577115-7577115, hg19,17:7673797-7673797, hg38,17:7673797-7673797","hg19,17:g.7577115A>C, hg19,17:g.7673797A>C, hg38,17:g.7673797A>C",0.957,"breast, central_nervous_system, brain, central_nervous_system, cerebellum, haematopoietic_and_lymphoid_tissue, skin, oesophagus, ovary, pancreas, prostate, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,1414106,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,Uncertain significance,Neoplasm,1,,,
3835,275,C,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3836,275,C,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3837,275,C,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3838,275,C,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3839,275,C,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3840,275,C,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3841,275,C,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3842,275,C,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3843,275,C,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, crc_eo_2020, difg_glass, difg_glass_2019, difg_tcga_gdc, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_jcopo_msk_2023, hcc_msk_2024, hcc_mskimpact_2018, hcc_tcga_gdc, heme_msk_impact_2022, ihch_msk_2021, ihch_mskcc_2020, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_mskcc_2020, mbn_msk_2024, mds_iwg_2022, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, rectal_msk_2019, rectal_radiation_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, usarc_msk_2020","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Rectal Adenocarcinoma, Soft Tissue, Uterine Sarcoma/Mesenchymal","hg19,17:7577115-7577115, hg19,17:7673797-7673797, hg38,17:7673797-7673797","hg19,17:g.7577115A>G, hg19,17:g.7673797A>G, hg38,17:g.7673797A>G",0.962,"breast, central_nervous_system, brain, extrapulmonary, haematopoietic_and_lymphoid_tissue, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, small_intestine, ileum, soft_tissue, smooth_muscle, uterus, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, serous_carcinoma, carcinoma, signet_ring_adenocarcinoma, carcinoma, small_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, chronic_myeloid_leukaemia, Ph_negative-bcr-abl_negative, leiomyosarcoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, normal",,,,,376584,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
3844,275,C,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_tcga, acc_tcga_gdc, acc_tcga_pan_can_atlas_2018, glioma_mskcc_2019, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, luad_tsp, lung_msk_pdx, mm_broad, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, pdac_msk_2024, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, skcm_broad","Adrenocortical Carcinoma, Bowel, Cutaneous Melanoma, Diffuse Glioma, High-Grade Serous Ovarian Cancer, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Plasma Cell Myeloma, Prostate, Soft Tissue","hg19,17:7577114-7577114, hg19,17:7577115-7577115, hg19,17:7673796-7673796, hg38,17:7673796-7673796, hg38,17:7673797-7673797","hg19,17:g.7577114C>G, hg19,17:g.7577115A>T, hg19,17:g.7673796C>G, hg38,17:g.7673796C>G, hg38,17:g.7673797A>T","0.965, 0.982","haematopoietic_and_lymphoid_tissue, liver, lung, ovary, skin, scalp, skin, trunk, stomach, urinary_tract, bladder","carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, serous_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma",,,,,"960924, 376583","Uncertain significance, Conflicting classifications of pathogenicity",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"1, 1",,,,,,
3845,275,C,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3846,275,C,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3847,275,C,W,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, breast_msk_2025, ccle_genentech_2014, desm_broad_2015, glioma_mskcc_2019, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_pcawg_2020, sarcoma_msk_2022","Desmoplastic Melanoma, Diffuse Glioma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577113-7577113, hg19,17:7673795-7673795, hg38,17:7673795-7673795","hg19,17:g.7577113A>C, hg19,17:g.7673795A>C, hg38,17:g.7673795A>C",0.922,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, lung, oesophagus, penis, skin, skin, face, skin, lower_leg, skin, neck, skin, scalp, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, M2, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, M2, lymphoid_neoplasm, Hodgkin_lymphoma, lymphocyte_depleted, malignant_melanoma, malignant_melanoma, desmoplastic",,,,,485044,Likely pathogenic,Ovarian neoplasm;Hereditary cancer-predisposing syndrome,1,,,,,,
3848,275,C,Y,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, blca_bcan_hcrn_2022, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_igr_2015, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_sanger, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, breast_ink4_msk_2021, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, chrcc_tcga_gdc, cll_broad_2015, cll_broad_2022, coad_cptac_2019, coad_cptac_gdc, coad_tcga_gdc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_dd_2022, crc_nigerian_2020, crc_sysucc_2022, csf_msk_2024, egc_msk_2023, escc_ucla_2014, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, gist_msk_2022, gist_msk_2023, glioma_mskcc_2019, hcc_meric_2021, hcc_tcga_gdc, heme_msk_impact_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lcll_broad_2013, lgggbm_tcga_pub, lihc_tcga, lihc_tcga_pan_can_atlas_2018, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, mds_iwg_2022, mds_mskcc_2020, mixed_kunga_msk_2022, mpn_cimr_2013, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, os_target_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_mdanderson_2023, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, read_tcga_gdc, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, soft_tissue_tcga_gdc, ucec_ancestry_cds_msk_2023","Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Bowel, Breast, Chromophobe Renal Cell Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagus/Stomach, Gastrointestinal Stromal Tumor, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature T and NK Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Non-Small Cell Lung Cancer, Osteosarcoma, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7577114-7577114, hg19,17:7673796-7673796, hg38,17:7673796-7673796","hg19,17:g.7577114C>T, hg19,17:g.7673796C>T, hg38,17:g.7673796C>T",0.972,", biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, thalamus, cervix, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, meninges, oesophagus, ovary, pancreas, prostate, salivary_gland, parotid, skin, skin, face, skin, leg, small_intestine, ileum, soft_tissue, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach, stomach, gastroesophageal_junction, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract, bladder",", adenoma, adnexal_tumour, sebaceous_adenoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, medullary_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, spindle_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, gastrointestinal_stromal_tumour, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, gliosarcoma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_primary_myelofibrosis, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelofibrosis, primary, lymphoid_neoplasm, lymphoid_neoplasm, B_cell_prolymphocytic_leukaemia, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_melanoma, nodular, meningioma, osteosarcoma, sarcoma",,0.0000318633698700,,,215997,Pathogenic/Likely pathogenic,"Hereditary cancer-predisposing syndrome;not provided;Acute myeloid leukemia;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Breast carcinoma",2,Oncogenic,Neoplasm,1,,,
3849,276,A,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3850,276,A,D,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, bcc_unige_2016, blca_bcan_hcrn_2022, bm_nsclc_mskcc_2023, brca_mbcproject_2022, brca_mbcproject_wagle_2017, cfdna_msk_2019, glioma_mskcc_2019, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, luad_broad, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_mdacc_2013, meso_tcga, meso_tcga_pan_can_atlas_2018, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_mskcc_2018, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_pcawg_2020, pancan_pdmr_2025, plmeso_msk_2024, sarcoma_msk_2022, sclc_ucologne_2015","Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Diffuse Glioma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pleural Mesothelioma, Small Cell Lung Cancer, Soft Tissue","hg19,17:7577110-7577111, hg19,17:7577111-7577111, hg19,17:7673793-7673793, hg38,17:7673792-7673793, hg38,17:7673793-7673793","hg19,17:g.7577110_7577111delinsAT, hg19,17:g.7577111G>T, hg19,17:g.7673793G>T, hg38,17:g.7673792_7673793delinsAT, hg38,17:g.7673793G>T",0.951,"biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, thalamus, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, colon, lung, meninges, oesophagus, pancreas, pancreas, ampulla_of_Vater, penis, skin, skin, head_neck, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, soft_tissue, striated_muscle, prostate, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia_therapy_related, meningioma, rhabdomyosarcoma, embryonal, synovial_sarcoma",,,,,232683,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Uncertain significance,Neoplasm,1,Tier I - Strong,"Primary intracranial sarcoma, DICER1-mutant",1
3851,276,A,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3852,276,A,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7577111-7577112, hg38,17:7673793-7673794","hg19,17:g.7577111_7577112delinsAA, hg38,17:g.7673793_7673794delinsAA",,thyroid,"carcinoma, anaplastic_carcinoma",,,,,,,,,,,,,,
3853,276,A,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, crc_apc_impact_2020, crc_eo_2020, hcc_tcga_gdc, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, sarcoma_msk_2022, tmb_mskcc_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Basal Cell Carcinoma, Bowel, Colorectal Adenocarcinoma, Endometrial Carcinoma, Hepatocellular Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577111-7577111, hg19,17:7673793-7673793, hg38,17:7673793-7673793","hg19,17:g.7577111G>C, hg19,17:g.7673793G>C, hg38,17:g.7673793G>C",0.930,"biliary_tract, bile_duct, central_nervous_system, brain, endometrium, liver, lung, pancreas, skin, skin, head_neck, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, oligoastrocytoma_Grade_III, anaplastic, malignant_melanoma, superficial_spreading",,,,,185319,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,2,,,,,,
3854,276,A,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3855,276,A,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3856,276,A,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3857,276,A,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3858,276,A,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3859,276,A,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3860,276,A,P,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bm_nsclc_mskcc_2023, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_alpelisib_2020, escc_icgc, heme_msk_impact_2022, hgsoc_tcga_gdc, luad_mskcc_2023_met_organotropism, lung_msk_2017, mds_mskcc_2020, mel_mskimpact_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Breast, Cutaneous Melanoma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577112-7577112, hg19,17:7673794-7673794, hg38,17:7673794-7673794","hg19,17:g.7577112C>G, hg19,17:g.7673794C>G, hg38,17:g.7673794C>G",0.949,"biliary_tract, bile_duct, biliary_tract, gallbladder, bone, breast, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, colon, sigmoid, large_intestine, rectum, lung, oesophagus, ovary, skin, head_neck, soft_tissue, fat, stomach, thymus, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, serous_carcinoma, carcinoma, transitional_cell_carcinoma, chondrosarcoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, liposarcoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, osteosarcoma, thymoma",,,,,428893,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",1,,,,,,
3861,276,A,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3862,276,A,R,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3863,276,A,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","lung_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577112-7577112, hg38,17:7673794-7673794","hg19,17:g.7577112C>A, hg38,17:g.7673794C>A",0.850,"haematopoietic_and_lymphoid_tissue, large_intestine, lung","carcinoma, adenocarcinoma, lymphoid_neoplasm, hairy_cell_leukaemia",,,,,,,,,,,,,,
3864,276,A,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",msk_met_2021,Mixed Cancer Types,"hg19,17:7577112-7577112, hg38,17:7673794-7673794","hg19,17:g.7577112C>T, hg38,17:g.7673794C>T",0.928,"biliary_tract, bile_duct, breast, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, stomach, thyroid, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, papillary_carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,827547,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3865,276,A,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","gbm_tcga_pub, hcc_inserm_fr_2015, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023","Diffuse Glioma, Endometrial Carcinoma, Hepatocellular Carcinoma, Mixed Cancer Types","hg19,17:7577111-7577111, hg38,17:7673793-7673793","hg19,17:g.7577111G>A, hg38,17:g.7673793G>A",0.934,"breast, central_nervous_system, brain, large_intestine, caecum, large_intestine, colon, right, liver, ovary, pancreas, prostate, skin, face, upper_aerodigestive_tract, mouth, mouth_floor","adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, pleomorphic_xanthoastrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,3893198,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
3866,276,A,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3867,276,A,Y,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv",msk_chord_2024,Mixed Cancer Types,"hg19,17:7577111-7577112","hg19,17:g.7577111_7577112delinsTA",,,,,,,,,,,,,,,,,
3868,277,C,A,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3869,277,C,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3870,277,C,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3871,277,C,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_iatlas_imvigor210_2017, blca_msk_2025, blca_msk_tcga_2020, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_metabric, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, chol_msk_2018, difg_tcga_gdc, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, ihch_msk_2021, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, mbn_msk_2024, mds_iwg_2022, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_kunga_msk_2022, mm_broad, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, os_target_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, sarcoma_msk_2022, sarcoma_mskcc_2022, thyroid_mskcc_2016, tmb_mskcc_2018, uccc_nih_2017, ucec_ancestry_cds_msk_2023, ucs_msk_2024","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Cholangiocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Osteosarcoma, Plasma Cell Myeloma, Soft Tissue, Thyroid, Uterine Clear Cell Carcinoma","hg19,17:7577108-7577108, hg19,17:7673790-7673790, hg38,17:7673790-7673790","hg19,17:g.7577108C>A, hg19,17:g.7673790C>A, hg38,17:g.7673790C>A",0.932,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, liver, lung, oesophagus, ovary, skin, skin, back, skin, face, skin, shoulder, soft_tissue, striated_muscle, pharynx, stomach, thyroid, upper_aerodigestive_tract, mouth, urinary_tract, bladder","adrenal_cortical_carcinoma, adrenal_cortical_carcinoma, non_functioning, carcinoid-endocrine_tumour, typical, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma, glioma, diffuse_midline_glioma, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, M1, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, in_situ_epithelial_neoplasm, Bowen_disease, BRAF_inhibitor_related, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, nodular, osteosarcoma, rhabdomyosarcoma, embryonal",0.0000039791809254,,,,458567,Conflicting classifications of pathogenicity,TP53-related disorder;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,Oncogenic,Neoplasm,1,,,
3872,277,C,G,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hcc_inserm_fr_2015, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, msk_met_2021, pancan_mimsi_msk_2024, sarcoma_msk_2022","Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577109-7577109, hg19,17:7673791-7673791, hg38,17:7673791-7673791","hg19,17:g.7577109A>C, hg19,17:g.7673791A>C, hg38,17:g.7673791A>C",0.846,"haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, oesophagus, penis, skin, arm, soft_tissue, blood_vessel, scalp, soft_tissue, nerve_sheath, pelvis, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, pharynx, oropharynx","angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_peripheral_nerve_sheath_tumour",,,,,2757236,Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
3873,277,C,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3874,277,C,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3875,277,C,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3876,277,C,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3877,277,C,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3878,277,C,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3879,277,C,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3880,277,C,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3881,277,C,R,,,,,,,,,,,,,,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577109-7577109, hg38,17:7673791-7673791","hg19,17:g.7577109A>G, hg38,17:g.7673791A>G",0.889,"central_nervous_system, parietooccipital, large_intestine, pancreas","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,421804,Uncertain significance,not provided;Li-Fraumeni syndrome;Familial cancer of breast;Hereditary cancer-predisposing syndrome,3,,,,,,
3882,277,C,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7577108-7577108, hg19,17:7577109-7577109, hg38,17:7673790-7673790","hg19,17:g.7577108C>G, hg19,17:g.7577109A>T, hg38,17:g.7673790C>G","0.894, 0.936","haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","haematopoietic_neoplasm, acute_leukaemic_transformation_of_essential_thrombocythaemia, lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,655556,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3883,277,C,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3884,277,C,V,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3885,277,C,W,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","difg_tcga_gdc, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub",Diffuse Glioma,"hg19,17:7577107-7577107, hg19,17:7673789-7673789, hg38,17:7673789-7673789","hg19,17:g.7577107A>C, hg19,17:g.7673789A>C, hg38,17:g.7673789A>C",0.875,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, prostate, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, glioma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,1762926,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3886,277,C,Y,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, cfdna_msk_2019, heme_msk_impact_2022, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lung_msk_pdx, mds_iwg_2022, mds_mskcc_2020, mixed_selpercatinib_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paired_bladder_2022, pan_origimed_2020, pancan_pdmr_2025, prad_pik3r1_msk_2021, prostate_dkfz_2018, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022","Bladder/Urinary Tract, Diffuse Glioma, Lung, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577108-7577108, hg38,17:7673790-7673790","hg19,17:g.7577108C>T, hg38,17:g.7673790C>T",0.940,"biliary_tract, bile_duct, bone, bone, extraskeletal, breast, central_nervous_system, brain, genital_tract, extragonadal, mediastinum, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, liver, oesophagus, peritoneum, prostate, skin, skin, ear, small_intestine, ileum, stomach, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, chondrosarcoma, germ_cell_tumour, glioma, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, essential_thrombocythaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, neoplasm",0.0000000000000000,,,,185722,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Malignant tumor of breast",1,Likely oncogenic,Neoplasm,1,,,
3887,278,P,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_pareja_msk_2020, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_genentech_2014, cellline_nci60, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, heme_msk_impact_2022, hnsc_broad, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, mds_mskcc_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ohnca_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, read_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022, stes_tcga_pub","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7577106-7577106, hg19,17:7673788-7673788, hg38,17:7673788-7673788","hg19,17:g.7577106G>C, hg19,17:g.7673788G>C, hg38,17:g.7673788G>C",0.958,"biliary_tract, gallbladder, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, salivary_gland, soft_tissue, nerve_sheath, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, hypopharynx, piriform_sinus, urinary_tract, bladder",", carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, myelodysplastic_syndrome, 5q-myelodysplastic_syndrome, lymphoid_neoplasm, plasma_cell_myeloma, malignant_peripheral_nerve_sheath_tumour",,,,,376645,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Bone osteosarcoma;not provided;Ovarian neoplasm;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
3888,278,P,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3889,278,P,D,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3890,278,P,E,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3891,278,P,F,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","acc_2019, bcc_unige_2016, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cscc_ranson_2022, mel_dfci_2019, mel_iatlas_hugo_ucla_2016, mel_iatlas_liu_2019, mel_mskimpact_2020, msk_impact_2017, msk_met_2021, pancan_pdmr_2025, tmb_mskcc_2018","Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Melanoma, Mixed Cancer Types","hg19,17:7577105-7577106, hg19,17:7673787-7673788, hg38,17:7673787-7673788","hg19,17:g.7577105_7577106delinsAA, hg19,17:g.7673787_7673788delinsAA, hg38,17:g.7673787_7673788delinsAA",,"biliary_tract, bile_duct, skin, skin, ear, skin, eye, skin, face, skin, hand, skin, head_neck, skin, shoulder, skin, trunk","adnexal_tumour, malignant_adnexal_tumour, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma, malignant_melanoma, superficial_spreading",,,,,,,,,,,,,,
3892,278,P,G,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3893,278,P,H,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coadread_dfci_2016, crc_sysucc_2022, cscc_ranson_2022, egc_msk_2023, egc_mskcc_2020, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_ucla_2014, hgsoc_tcga_gdc, luad_broad, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mcl_idibips_2013, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, prad_su2c_2019, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, soft_tissue_tcga_gdc, stes_tcga_pub","Ampullary Carcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Carcinoma, Other, High-Grade Serous Ovarian Cancer, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mantle Cell Lymphoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577105-7577105, hg19,17:7673787-7673787, hg38,17:7673787-7673787","hg19,17:g.7577105G>T, hg19,17:g.7673787G>T, hg38,17:g.7673787G>T",0.950,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, prostate, soft_tissue, soft_tissue, nerve_sheath, soft_tissue, striated_muscle, uterus, upper_aerodigestive_tract, larynx","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_peripheral_nerve_sheath_tumour, rhabdomyosarcoma, pleomorphic, sarcoma",,,,,376646,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,Likely oncogenic,Neoplasm,1,,,
3894,278,P,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3895,278,P,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3896,278,P,L,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_msk_2025, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_metabric, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cll_broad_2022, coadread_cass_2020, crc_sysucc_2022, cscc_ucsf_2021, csf_msk_2024, difg_tcga_gdc, egc_msk_2023, egc_mskcc_2020, glioma_mskcc_2019, hcc_clca_2024, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_broad, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lung_msk_mind_2020, lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mel_iatlas_hugo_ucla_2016, mel_iatlas_liu_2019, mel_mskimpact_2020, mel_ucla_2016, mixed_allen_2018, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, nsclc_tcga_broad_2016, ohnca_cptac_gdc, ov_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prostate_msk_2024, sarcoma_msk_2022, skcm_mskcc_2014, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577105-7577105, hg19,17:7673787-7673787, hg38,17:7673787-7673787","hg19,17:g.7577105G>A, hg19,17:g.7673787G>A, hg38,17:g.7673787G>A",0.940,", adrenal_gland, adrenal_gland, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, extrapulmonary, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, kidney, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, penis, prostate, salivary_gland, skin, skin, back, skin, chest, skin, face, skin, forearm, skin, hand, skin, head_neck, skin, leg, skin, neck, skin, scalp, skin, trunk, skin, upper_arm, skin, upper_back, soft_tissue, blood_vessel, head_neck, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, retromolar, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, adrenal_cortical_carcinoma, angiosarcoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, luminal_B_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, malignant_melanoma, malignant_melanoma, desmoplastic, malignant_melanoma, nodular",,,,,232497,Pathogenic,Gallbladder cancer;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Ovarian neoplasm,2,,,,,,
3897,278,P,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3898,278,P,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3899,278,P,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3900,278,P,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_pdx_msk_2025, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_mapk_hp_msk_2021, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, coad_tcga_gdc, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_eo_2020, crc_msk_2017, csf_msk_2024, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, esca_broad, gbc_mskcc_2022, gbm_tcga_pub, glioma_mskcc_2019, hcc_meric_2021, hcc_msk_2024, heme_msk_impact_2022, hgsoc_msk_2021, hgsoc_tcga_gdc, luad_cptac_gdc, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_qcmg_uq_2016, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, panet_msk_erc_2023, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, skcm_dfci_2015, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Bladder Urothelial Carcinoma, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577105-7577105, hg19,17:7673787-7673787, hg38,17:7673787-7673787","hg19,17:g.7577105G>C, hg19,17:g.7673787G>C, hg38,17:g.7673787G>C",0.951,"biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, sigmoid, large_intestine, rectum, lung, oesophagus, ovary, pancreas, skin, skin, face, stomach, thyroid, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, urinary_tract, bladder","carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_myelodysplastic_syndrome_therapy_related_NOS, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, malignant_melanoma",,,,,376644,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
3901,278,P,S,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_tcga_2020, blca_nmibc_2017, bowel_colitis_msk_2022, brca_broad, brca_igr_2015, brca_metabric, brca_msk_2025, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, chol_icgc_2017, coad_cptac_2019, coad_cptac_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_mskcc, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_dfarber_2015, cscc_hgsc_bcm_2014, cscc_ucsf_2021, csf_msk_2024, egc_msk_2017, egc_msk_2023, egc_mskcc_2020, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_tcga_pub, glioma_msk_2018, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_msk_2024, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, mds_mskcc_2020, mel_iatlas_hugo_ucla_2016, mel_iatlas_liu_2019, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_impact_subset_2022, mm_broad, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nccrcc_genentech_2014, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ohnca_cptac_gdc, os_target_gdc, ov_tcga_pan_can_atlas_2018, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_pik3r1_msk_2021, prostate_msk_2024, prostate_pcbm_swiss_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_mskcc_2014, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, stes_tcga_pub, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervical Squamous Cell Carcinoma, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Osteosarcoma, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Plasma Cell Myeloma, Prostate, Prostate Adenocarcinoma, Renal Non-Clear Cell Carcinoma, Soft Tissue","hg19,17:7577106-7577106, hg19,17:7673788-7673788, hg38,17:7673788-7673788","hg19,17:g.7577106G>A, hg19,17:g.7673788G>A, hg38,17:g.7673788G>A",0.963,", biliary_tract, bile_duct, bone, humerus, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, cervix, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, prostate, salivary_gland, parotid, skin, skin, arm, skin, chest, skin, ear, skin, face, skin, head_neck, skin, scalp, skin, trunk, skin, upper_back, skin, upper_leg, soft_tissue, blood_vessel, skin, scalp, soft_tissue, smooth_muscle, inferior_vena_cava, stomach, stomach, gastroesophageal_junction, testis, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, glottis, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, retromolar, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, bladder","Wilms_tumour, angiosarcoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, adenoid_cystic_carcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, germ_cell_tumour, yolk_sac_tumour, glioma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, chronic_myeloid_leukaemia, Ph_negative-bcr-abl_negative, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, in_situ_epithelial_neoplasm, Bowen_disease, in_situ_epithelial_neoplasm, actinic_keratosis, leiomyosarcoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, desmoplastic, malignant_melanoma, spitzoid, malignant_melanoma, superficial_spreading, osteosarcoma, fibroblastic, other, intestinal_metaplasia, other, intraepithelial_neoplasia, low_grade, other, neoplasm, other, pterygium",,,,,376642,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;not provided;Li-Fraumeni syndrome 1;TP53-related disorder;Li-Fraumeni syndrome,2,,,,Tier I - Strong,Pleuropulmonary blastoma,1
3902,278,P,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bcan_hcrn_2022, brca_cptac_2020, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_cptac_gdc, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2025, chol_icgc_2017, coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, cscc_hgsc_bcm_2014, gbc_mskcc_2022, glioma_mskcc_2019, hcc_msk_2024, luad_broad, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_mskcc_2018, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, prad_pik3r1_msk_2021, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Bladder Urothelial Carcinoma, Bowel, Breast, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue","hg19,17:7577106-7577106, hg19,17:7673788-7673788, hg38,17:7673788-7673788","hg19,17:g.7577106G>T, hg19,17:g.7673788G>T, hg38,17:g.7673788G>T",0.954,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, cerebellum, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, small_intestine, kidney, large_intestine, large_intestine, colon, large_intestine, colon, descending, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, skin, head_neck, skin, trunk, small_intestine, duodenum, small_intestine, ileum, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx","adrenal_cortical_carcinoma, non_functioning, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, ductolobular_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_renal_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, fibroepithelial_neoplasm, phyllodes_tumour, glioma, astrocytoma, glioma, oligoastrocytoma_Grade_III, anaplastic, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, other, dysplasia, high_grade-carcinoma_in_situ, other, neoplasm",,,,,376643,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome 1;Poly (ADP-Ribose) polymerase inhibitor response;Li-Fraumeni syndrome,2,,,,,,
3903,278,P,V,,,,,,,,,,,,,,"cBioPortal,ClinVar,Manual annotations from saturation_mutlist.csv","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7577105-7577106, hg38,17:7673787-7673788","hg19,17:g.7577105_7577106delinsAC, hg38,17:g.7673787_7673788delinsAC",,,,,,,,3764814,,,,Likely oncogenic,Neoplasm,1,,,
3904,278,P,W,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3905,278,P,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3906,279,G,A,,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","gbc_mskcc_2022, hcc_msk_2024, msk_ctdna_vte_2024","Gallbladder Cancer, Hepatocellular Carcinoma, Mixed Cancer Types","hg19,17:7577102-7577102","hg19,17:g.7577102C>G",0.907,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
3907,279,G,C,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3908,279,G,D,,,,,,,,,,,,,,"cBioPortal,Manual annotations from saturation_mutlist.csv","luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577101-7577102","hg19,17:g.7577101_7577102delinsAT",,,,,,,,,,,,,,,,,
3909,279,G,E,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2023, blca_msk_tcga_2020, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2025, cscc_dfarber_2015, cscc_hgsc_bcm_2014, cscc_ranson_2022, cscc_ucsf_2021, csf_msk_2024, difg_tcga_gdc, glioma_mskcc_2019, hgsoc_tcga_gdc, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_mskcc_2020, mel_mskimpact_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, prad_cpcg_2017, prad_p1000, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577101-7577102, hg19,17:7577102-7577102, hg19,17:7673783-7673784, hg19,17:7673784-7673784, hg38,17:7673783-7673784, hg38,17:7673784-7673784","hg19,17:g.7577101_7577102delinsTT, hg19,17:g.7577102C>T, hg19,17:g.7673783_7673784delinsTT, hg19,17:g.7673784C>T, hg38,17:g.7673783_7673784delinsTT, hg38,17:g.7673784C>T",0.907,", biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, thalamus, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, oesophagus, oesophagus, middle_third, ovary, prostate, skin, skin, arm, skin, head_neck, skin, leg, skin, lower_extremity, skin, lower_leg, skin, trunk, small_intestine, jejunum, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma, glioma, oligodendroglioma, in_situ_epithelial_neoplasm, Bowen_disease, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, other, Barrett_oesophagus, with_high_grade_dysplasia, other, hepatoblastoma, other, normal, undifferentiated_sarcoma, pleomorphic",,,,,419454,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Ovarian neoplasm;not provided;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck;not specified;Li-Fraumeni syndrome 1,1,,,,,,
3910,279,G,F,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3911,279,G,H,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3912,279,G,I,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3913,279,G,K,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3914,279,G,L,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3915,279,G,M,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3916,279,G,N,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3917,279,G,P,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3918,279,G,Q,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3919,279,G,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, blca_bcan_hcrn_2022, blca_msk_2024, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, mbn_sfu_2023, msk_chord_2024, msk_met_2021, prad_p1000, prad_su2c_2019","Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Prostate Adenocarcinoma","hg19,17:7577103-7577103, hg19,17:7673785-7673785, hg38,17:7673785-7673785","hg19,17:g.7577103C>G, hg19,17:g.7577103C>T, hg19,17:g.7673785C>G, hg19,17:g.7673785C>T, hg38,17:g.7673785C>G, hg38,17:g.7673785C>T",0.896,"biliary_tract, gallbladder, large_intestine, large_intestine, colon, liver, lung, ovary, peritoneum, skin, skin, head_neck, skin, scalp, skin, upper_arm, small_intestine, jejunum, urinary_tract, bladder","carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, gastric_type, carcinoma, basal_cell_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, lymphoepithelioma_like_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma, other, hamartoma, other, hepatoblastoma",,,,,458568,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1",1,,,,,,
3920,279,G,S,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3921,279,G,T,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3922,279,G,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","esca_tcga, msk_chord_2024, msk_met_2021, pan_origimed_2020, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types","hg19,17:7577102-7577102, hg38,17:7673783-7673784, hg38,17:7673784-7673784","hg19,17:g.7577102C>A, hg38,17:g.7673783_7673784delinsTA, hg38,17:g.7673784C>A",0.937,"large_intestine, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,1434495,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3923,279,G,W,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2025, msk_access_2021, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7577103-7577103, hg19,17:7673785-7673785, hg38,17:7673785-7673785","hg19,17:g.7577103C>A, hg19,17:g.7673785C>A, hg38,17:g.7673785C>A",0.930,"oesophagus, skin, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,4530243,,,,,,,Tier I - Strong,Embryonal rhabdomyosarcoma,1
3924,279,G,Y,,,,,,,,,,,,,,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3925,280,R,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3926,280,R,C,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3927,280,R,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3928,280,R,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3929,280,R,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3930,280,R,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","angs_painter_2020, angs_painter_2025, angs_project_painter_2018, biliary_tract_summit_2022, bladder_msk_2023, blca_msk_2025, blca_nmibc_2017, brca_igr_2015, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cll_broad_2015, cll_broad_2022, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, difg_msk_2023, glioma_mskcc_2019, hcc_clca_2024, hccihch_pku_2019, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lung_msk_pdx, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_mdacc_2013, mbn_sfu_2023, mds_mskcc_2020, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Acute Myeloid Leukemia, Angiosarcoma, Biliary Tract, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577100-7577100, hg19,17:7673782-7673782, hg38,17:7673782-7673782","hg19,17:g.7577100T>C, hg19,17:g.7673782T>C, hg38,17:g.7673782T>C",0.924,"biliary_tract, bile_duct, bone, extraskeletal, breast, central_nervous_system, brain, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, ascending, liver, lung, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, prostate, skin, vulva, soft_tissue, blood_vessel, skin, scalp, stomach, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract, bladder, urinary_tract, upper_urinary_tract","adnexal_tumour, malignant_adnexal_tumour, spiradenocarcinoma, angiosarcoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, squamous_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, mesonephric_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, haematopoietic_neoplasm, chronic_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_ringed_sideroblasts, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, osteosarcoma, thymic_carcinoma, squamous_cell_carcinoma",,,,,376658,Conflicting classifications of pathogenicity,"Ovarian neoplasm;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not provided",1,,,,Tier II - Potential,Colorectal cancer,0
3931,280,R,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3932,280,R,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bm_nsclc_mskcc_2023, brca_dfci_2020, breast_msk_2018, breast_msk_2025, hgsoc_tcga_gdc, hnsc_mdanderson_2013, luad_cptac_gdc, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, metastatic_solid_tumors_mich_2017, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, mtnn_msk_2022, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_cptac_gdc, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, rcc_cptac_gdc, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","Basal Cell Carcinoma, Bladder/Urinary Tract, Breast, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature T and NK Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Renal Cell Carcinoma, Soft Tissue","hg19,17:7577098-7577099, hg19,17:7577099-7577099, hg19,17:7673781-7673781, hg38,17:7673781-7673781","hg19,17:g.7577098_7577099delinsAA, hg19,17:g.7577099C>A, hg19,17:g.7673781C>A, hg38,17:g.7673781C>A",0.942,", breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, rectum, lung, ovary, prostate, skin, soft_tissue, fibrous_tissue_and_uncertain_origin, lower_leg, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, vocal_cord, upper_aerodigestive_tract, mouth","adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, fibrosarcoma, myxofibrosarcoma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, dysplasia",,,,,161517,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Prostate cancer,1,,,,Tier I - Strong,"Diffuse midline glioma, H3 K27M-mutant",1
3933,280,R,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ampca_bcm_2016, bcc_unige_2016, bladder_msk_2023, blca_bcan_hcrn_2022, blca_bgi, blca_dfarber_mskcc_2014, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_mskcc_solit_2014, blca_nmibc_2017, blca_plasmacytoid_mskcc_2016, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, brca_bccrc, brca_metabric, brca_mskcc_2019, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, cesc_tcga, cesc_tcga_pan_can_atlas_2018, cfdna_msk_2019, chol_msk_2018, crc_eo_2020, cscc_hgsc_bcm_2014, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2017, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbc_mskcc_2022, hcc_msk_2024, hcc_tcga_gdc, hdcn_msk_2025, hnsc_broad, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgg_ucsf_2014, lgggbm_tcga_pub, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_cptac_2020, luad_cptac_gdc, lung_msk_2017, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_mskcc_2020, mel_mskimpact_2020, mixed_allen_2018, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ovary_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, panet_arcnet_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarcoma_msk_2022, skcm_dfci_2015, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, stes_tcga_pub, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_msk_2018, uec_cptac_gdc","Adenoid Cystic Carcinoma, Ampullary Carcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervical Squamous Cell Carcinoma, Cholangiocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Histiocytic and Dendritic Cell Neoplasms, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreatic Neuroendocrine Tumor, Prostate, Prostate Adenocarcinoma, Soft Tissue, Uterine Endometrioid Carcinoma","hg19,17:7577099-7577099, hg19,17:7577099-7577101, hg19,17:7673781-7673781, hg38,17:7673781-7673781","hg19,17:g.7577099C>T, hg19,17:g.7577099_7577101delinsTTT, hg19,17:g.7673781C>T, hg38,17:g.7673781C>T",0.935,", biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, cervix, endometrium, extrapulmonary, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, small_intestine, large_intestine, large_intestine, anus, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, prostate, salivary_gland, skin, skin, chest, skin, face, skin, head_neck, skin, lower_leg, small_intestine, duodenum, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, urinary_tract, bladder, urinary_tract, upper_urinary_tract","adnexal_tumour, malignant_adnexal_tumour, extramammary_Pagets_disease, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, lobular_carcinoma, with_extracellular_mucin, carcinoma, luminal_NS_carcinoma, carcinoma, medullary_carcinoma, carcinoma, of_unknown_primary, carcinoma, pleomorphic_carcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, spindle, malignant_melanoma, superficial_spreading",,,,,376657,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck,1,,,,,,
3934,280,R,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577098-7577100, hg38,17:7673780-7673782","hg19,17:g.7577098_7577100delinsGAG, hg38,17:g.7673780_7673782delinsGAG",,,,,,,,1042468,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
3935,280,R,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3936,280,R,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",mds_iwg_2022,Myelodysplastic Syndromes,"hg19,17:7577098-7577099","hg19,17:g.7577098_7577099delinsGT",,,,,,,,,,,,,,,,,
3937,280,R,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3938,280,R,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3939,280,R,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, all_stjude_2013, bm_nsclc_mskcc_2023, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_sysucc_2022, egc_tmucih_2015, gist_msk_2022, glioma_mskcc_2019, hcc_msk_2024, hcc_mskimpact_2018, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, mds_iwg_2022, mixed_selpercatinib_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, ucec_ancestry_cds_msk_2023","Adenoid Cystic Carcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Gastrointestinal Stromal Tumor, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577098-7577098, hg19,17:7673780-7673780, hg38,17:7673780-7673780","hg19,17:g.7577098T>A, hg19,17:g.7577098T>G, hg19,17:g.7673780T>A, hg19,17:g.7673780T>G, hg38,17:g.7673780T>A, hg38,17:g.7673780T>G",0.878,", breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, liver, lung, oesophagus, ovary, prostate, soft_tissue, fibrous_tissue_and_uncertain_origin, endometrium, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, hypopharynx, urinary_tract","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, lymphoepithelioma_like_carcinoma, carcinoma, neuroendocrine, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, endometrial_stromal_sarcoma, gastrointestinal_stromal_tumour, glioma, gliosarcoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm",,,,,"988616, 634747","Conflicting classifications of pathogenicity, Pathogenic/Likely pathogenic",Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Familial cancer of breast|Ovarian neoplasm;Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,"1, 2",,,,Tier I - Strong,Colorectal cancer,0
3940,280,R,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, ampca_bcm_2016, bladder_msk_2023, bladder_msk_2024, blca_bcan_hcrn_2022, blca_bgi, blca_cornell_2016, blca_dfarber_mskcc_2014, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_mskcc_solit_2014, blca_nmibc_2017, blca_pdx_msk_2025, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brain_cptac_gdc, brca_mbcproject_2022, brca_metabric, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, cfdna_msk_2019, chol_icgc_2017, crc_eo_2020, csf_msk_2024, egc_msk_2023, egc_mskcc_2020, gbc_msk_2018, gbc_mskcc_2022, gbm_cptac_2021, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_nci_2022, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, npc_nusingapore, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, pog570_bcgsc_2020, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, sarcoma_msk_2022, sclc_jhu, summit_2018, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucs_tcga, ucs_tcga_pan_can_atlas_2018, utuc_igbmc_2021, utuc_msk_2019, utuc_pdx_msk_2019","Acute Myeloid Leukemia, Ampullary Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cervical Squamous Cell Carcinoma, Cholangiocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Nasopharyngeal Carcinoma, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Upper Tract Urothelial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577099-7577099, hg19,17:7673781-7673781, hg38,17:7673781-7673781","hg19,17:g.7577099C>G, hg19,17:g.7673781C>G, hg38,17:g.7673781C>G",0.940,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, central_nervous_system, brain, central_nervous_system, frontal_lobe, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, large_intestine, colon, sigmoid, lung, lung, left_upper_lobe, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, penis, prostate, salivary_gland, salivary_gland, parotid, skin, eye, skin, face, small_intestine, jejunum, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, vocal_cord, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, cheek, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, retromolar_trigone, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, urinary_tract, bladder, urinary_tract, renal_pelvis, urinary_tract, upper_urinary_tract, urinary_tract, urethra, vagina, vulva","carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, acinar_adenocarcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, lobular_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, mucoepidermoid_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, in_situ_epithelial_neoplasm, Bowen_disease, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma, other, dysplasia, other, neoplasm",,,,,12368,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Nasopharyngeal carcinoma;Malignant tumor of urinary bladder;Acute myeloid leukemia;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3941,280,R,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3942,280,R,W,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3943,280,R,Y,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3944,281,D,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, lgggbm_tcga_pub, msk_met_2021, pan_origimed_2020","Diffuse Glioma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7577096-7577096, hg19,17:7673778-7673778, hg38,17:7673778-7673778","hg19,17:g.7577096T>G, hg19,17:g.7673778T>G, hg38,17:g.7673778T>G",0.977,"central_nervous_system, brain, upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,376589,Pathogenic/Likely pathogenic,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome",2,,,,Tier I - Strong,Malignant glioma,1
3945,281,D,C,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3946,281,D,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","ampca_bcm_2016, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2025, chol_msk_2018, csf_msk_2024, glioma_mskcc_2019, hcc_msk_2024, hcc_tcga_gdc, hgsoc_tcga_gdc, ihch_msk_2021, ihch_mskcc_2020, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lymphoma_cellline_msk_2020, mbn_sfu_2023, mds_iwg_2022, mixed_selpercatinib_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ntrk_msk_2019, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_tcga_gdc, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Ampullary Carcinoma, Bowel, Breast, Cholangiocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577095-7577095, hg19,17:7673777-7673777, hg38,17:7673777-7673777","hg19,17:g.7577095G>C, hg19,17:g.7577095G>T, hg19,17:g.7673777G>C, hg19,17:g.7673777G>T, hg38,17:g.7673777G>C, hg38,17:g.7673777G>T",0.909,"biliary_tract, bile_duct, bone, breast, central_nervous_system, brain, central_nervous_system, temporal_lobe, central_nervous_system, thalamus, endometrium, female_genital_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, kidney, liver, lung, oesophagus, ovary, pancreas, prostate, skin, soft_tissue, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder, vulva","Wilms_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, clear_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, chondrosarcoma, myxoid, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, lymphoplasmacytic_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, other, neoplasm, sarcoma",,,,,"406568, 376587","Pathogenic/Likely pathogenic, Conflicting classifications of pathogenicity",Hereditary cancer-predisposing syndrome;not provided;Carcinoma of colon;Ovarian neoplasm;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Ovarian neoplasm;Li-Fraumeni syndrome,"2, 1","Oncogenic, Oncogenic",Neoplasm|Neoplasm,"1, 1",Tier I - Strong,Malignant spindle cell neoplasm,1
3947,281,D,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3948,281,D,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, brain_cptac_gdc, brca_aurora_2023, brca_metabric, ccle_broad_2019, ccle_broad_2025, cll_broad_2015, cll_broad_2022, coadread_dfci_2016, gbm_cptac_2021, glioma_mskcc_2019, hcc_msk_2024, mbn_mdacc_2013, mds_mskcc_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga_pub, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_p1000, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, ucec_ancestry_cds_msk_2023, ucec_msk_2018","Acute Myeloid Leukemia, CNS/Brain, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreas, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577096-7577096, hg19,17:7673778-7673778, hg38,17:7673778-7673778","hg19,17:g.7577096T>C, hg19,17:g.7673778T>C, hg38,17:g.7673778T>C",0.974,"biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, lung, ovary, pancreas, stomach","carcinoma, carcinoma, ER-HER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_serous_and_endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, undifferentiated_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, hairy_cell_leukaemia, variant, lymphoid_neoplasm, plasma_cell_myeloma",,,,,141141,Pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3949,281,D,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2014, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_metabric, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, chol_msk_2018, coadread_cass_2020, difg_msk_2023, egc_msk_2023, egc_mskcc_2020, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, glioma_mskcc_2019, hcc_msk_2024, heme_msk_impact_2022, hgsoc_msk_2021, hgsoc_tcga_gdc, lgggbm_tcga_pub, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, mel_iatlas_hugo_ucla_2016, mel_ucla_2016, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, ov_tcga_pan_can_atlas_2018, ovary_cptac_gdc, paad_icgc, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_ped_mai_msk_2025, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, utuc_msk_2019, utuc_mskcc_2015","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Cholangiocarcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagus/Stomach, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Melanoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreatic Adenocarcinoma, Soft Tissue, Upper Tract Urothelial Carcinoma","hg19,17:7577097-7577097, hg19,17:7673779-7673779, hg38,17:7673779-7673779","hg19,17:g.7577097C>G, hg19,17:g.7673779C>G, hg38,17:g.7673779C>G",0.961,"adrenal_gland, adrenal_gland, bone, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, oesophagus, ovary, pancreas, skin, soft_tissue, smooth_muscle, uterus, stomach, thyroid, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, urinary_tract, bladder, urinary_tract, renal_pelvis, urinary_tract, upper_urinary_tract","adnexal_tumour, malignant_adnexal_tumour, extramammary_Pagets_disease, adrenal_cortical_adenoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, micropapillary_transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, leiomyosarcoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, osteosarcoma, other, hepatoblastoma",,,,,376588,Pathogenic/Likely pathogenic,Gallbladder cancer;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,Tier I - Strong,"Rhabdomyosarcoma;Diffuse midline glioma, H3 K27M-mutant",1
3950,281,D,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3951,281,D,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3952,281,D,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3953,281,D,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3954,281,D,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_bgi, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, bm_nsclc_mskcc_2023, brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, cll_broad_2015, cll_broad_2022, coadread_cass_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, difg_glass, difg_glass_2019, escc_ucla_2014, lcll_broad_2013, lms_msk_2024, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_nci_2022, mds_iwg_2022, mds_mskcc_2020, mel_mskimpact_2020, mixed_cfdna_msk_2020, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nbl_broad_2013, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, os_target_gdc, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, sarcoma_msk_2022, sarcoma_mskcc_2022, ucec_ancestry_cds_msk_2023, ucec_msk_2018, ucs_tcga, ucs_tcga_gdc, ucs_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Neuroblastoma, Non-Small Cell Lung Cancer, Osteosarcoma, Pancreas, Soft Tissue, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,17:7577097-7577097, hg19,17:7673779-7673779, hg38,17:7673779-7673779","hg19,17:g.7577097C>T, hg19,17:g.7673779C>T, hg38,17:g.7673779C>T",0.943,"adrenal_gland, adrenal_gland, autonomic_ganglia, biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, frontal_lobe, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, salivary_gland, parotid, skin, skin, face, skin, head_neck, skin, trunk, soft_tissue, smooth_muscle, stomach, urinary_tract, bladder","adrenal_cortical_carcinoma, cortisol_producing, carcinoid-endocrine_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, large_cell_undifferentiated_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_I, pilocytic, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M5, in_situ_epithelial_neoplasm, actinic_keratosis, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, malignant_melanoma, malignant_melanoma, superficial_spreading, neuroblastoma",0.0000039771552204,,,,376586,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Ovarian neoplasm,2,Likely oncogenic,Neoplasm,1,,,
3955,281,D,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv",gbm_tcga,Diffuse Glioma,"hg19,17:7577096-7577097","hg19,17:g.7577096_7577097delinsGG",,,,,,,,,,,,,,,,,
3956,281,D,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3957,281,D,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673777-7673779","hg38,17:g.7673777_7673779delinsCCG",,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
3958,281,D,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3959,281,D,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3960,281,D,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, cfdna_msk_2019, cll_broad_2022, difg_tcga_gdc, heme_msk_impact_2022, hgsoc_tcga_gdc, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, mds_iwg_2022, mds_mskcc_2020, mm_broad, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, sarcoma_msk_2022, sarcoma_mskcc_2022, summit_2018","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Glioma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Plasma Cell Myeloma, Soft Tissue","hg19,17:7577096-7577096, hg19,17:7673778-7673778, hg38,17:7673778-7673778","hg19,17:g.7577096T>A, hg19,17:g.7673778T>A, hg38,17:g.7673778T>A",0.969,", autonomic_ganglia, head_neck, carotid_body, bone, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, lung, ovary, salivary_gland, thyroid, upper_aerodigestive_tract, mouth, maxilla","adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, germ_cell_tumour, yolk_sac_tumour, glioma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, lymphoid_neoplasm, plasma_cell_myeloma, osteosarcoma, paraganglioma",,,,,182968,Pathogenic/Likely pathogenic,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",2,,,,,,
3961,281,D,W,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3962,281,D,Y,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, brca_bccrc, brca_dfci_2020, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, ccrcc_tcga_gdc, cellline_ccle_broad, crc_sysucc_2022, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbn_mdacc_2013, mds_iwg_2022, mds_mskcc_2020, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, os_target_gdc, ov_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_dkfz_2018, prostate_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Bladder/Urinary Tract, Colorectal Adenocarcinoma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Osteosarcoma, Pancreas, Prostate, Prostate Adenocarcinoma, Renal Clear Cell Carcinoma, Soft Tissue","hg19,17:7577097-7577097, hg19,17:7673779-7673779, hg38,17:7673779-7673779","hg19,17:g.7577097C>A, hg19,17:g.7673779C>A, hg38,17:g.7673779C>A",0.957,"biliary_tract, bile_duct, breast, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, haematopoietic_and_lymphoid_tissue, skin, kidney, large_intestine, colon, large_intestine, rectum, liver, lung, ovary, pancreas, prostate, stomach, gastroesophageal_junction, upper_aerodigestive_tract, head_neck, urinary_tract, upper_urinary_tract","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_ductal-neuroendocrine_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, haematopoietic_neoplasm, blastic_plasmacytoid_dendritic_cell_neoplasm, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_cytopenia_with_multilinear_dysplasia, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma",,,,,376585,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,Likely oncogenic,Neoplasm,1,Tier I - Strong,Medulloblastoma SHH activated and TP53 mutant,1
3963,282,R,A,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3964,282,R,C,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3965,282,R,D,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3966,282,R,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3967,282,R,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3968,282,R,G,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, crc_sysucc_2022, dlbcl_dfci_2018, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, gbm_mayo_pdx_sarkaria_2019, glioma_msk_2018, glioma_mskcc_2019, heme_msk_impact_2022, hnsc_jhu, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pog570_bcgsc_2020, pptc_2019, sarcoma_msk_2022, sarcoma_mskcc_2022, stad_oncosg_2018, stad_pfizer_uhongkong, ucec_ancestry_cds_msk_2023, usarc_msk_2020, utuc_cornell_baylor_mdacc_2019","Bladder Urothelial Carcinoma, Colorectal Adenocarcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Upper Tract Urothelial Carcinoma, Uterine Sarcoma/Mesenchymal","hg19,17:7577094-7577094, hg19,17:7673776-7673776, hg38,17:7673776-7673776","hg19,17:g.7577094G>C, hg19,17:g.7673776G>C, hg38,17:g.7673776G>C",0.863,", breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, breast, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, pancreas, pancreas, ampulla_of_Vater, salivary_gland, submandibular, skin, skin, face, soft_tissue, soft_tissue, smooth_muscle, uterus, stomach, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hybrid_salivary_gland_carcinoma, salivary_duct_and_adenoid_cystic_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma, glioma, oligodendroglioma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, leiomyosarcoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, malignant_histiocytosis, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, spitzoid, other, neoplasm, pancreatic_intraepithelial_neoplasia_(PanIN), sarcoma",,,,,140821,Pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
3969,282,R,H,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","lusc_tcga_pub, nsclc_tcga_broad_2016, pancan_pcawg_2020","Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577092-7577093, hg38,17:7673774-7673775","hg19,17:g.7577092_7577093delinsGT, hg38,17:g.7673774_7673775delinsAT",,lung,"carcinoma, small_cell_carcinoma",,,,,,,,,,,,,,
3970,282,R,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3971,282,R,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3972,282,R,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","crc_eo_2020, crc_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021","Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7577093-7577093, hg38,17:7673775-7673775","hg19,17:g.7577093C>A, hg38,17:g.7673775C>A",0.898,", large_intestine, large_intestine, colon, transverse, liver, skin, head_neck","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, in_situ_epithelial_neoplasm, actinic_keratosis, malignant_melanoma",,,,,182938,Uncertain significance,"Hereditary cancer-predisposing syndrome;not specified;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",3,,,,,,
3973,282,R,M,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3974,282,R,N,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3975,282,R,P,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bll_target_gdc, breast_msk_2018, ccle_broad_2025, heme_msk_impact_2022, hnc_mskcc_2016, luad_mskcc_2023_met_organotropism, lusc_cptac_2021, lusc_cptac_gdc, mbn_mdacc_2013, mds_mskcc_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022, tet_nci_2014","B-Lymphoblastic Leukemia/Lymphoma, Bladder/Urinary Tract, Breast, Head and Neck, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Soft Tissue, Thymic Epithelial Tumor","hg19,17:7577092-7577093, hg19,17:7577093-7577093, hg19,17:7673775-7673775, hg38,17:7673775-7673775","hg19,17:g.7577092_7577093delinsGG, hg19,17:g.7577093C>G, hg19,17:g.7673775C>G, hg38,17:g.7673775C>G",0.911,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, right, large_intestine, rectum, lung, oesophagus, ovary, penis, prostate, skin, hand, stomach, thymus, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, lymphoid_neoplasm, B_cell_prolymphocytic_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm, thymic_carcinoma, thymic_carcinoma, squamous_cell_carcinoma",,,,,376659,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck;Carcinoma of pancreas,2,,,,,,
3976,282,R,Q,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, aml_ohsu_2018, aml_ohsu_2022, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, egc_msk_2023, egc_msk_tp53_ccr_2022, gbc_msk_2018, gbc_mskcc_2022, glioma_mskcc_2019, hcc_msk_2024, hnsc_jhu, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, sarcoma_msk_2022","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Diffuse Glioma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Gallbladder Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7577093-7577093, hg19,17:7673775-7673775, hg38,17:7673775-7673775","hg19,17:g.7577093C>T, hg19,17:g.7673775C>T, hg38,17:g.7673775C>T",0.887,"biliary_tract, gallbladder, bone, breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, large_intestine, colon, left, large_intestine, rectum, liver, lung, oesophagus, pancreas, peritoneum, prostate, skin, skin, mucosal, female_genital_tract_(site_indeterminate), thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, papillary_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma, osteosarcoma, serrated_polyp, serrated_adenoma",0.0000039770286823,,,,237956,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;not specified;not provided;Hereditary breast ovarian cancer syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Malignant tumor of breast",1,,,,,,
3977,282,R,S,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3978,282,R,T,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3979,282,R,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3980,282,R,W,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, aml_ohsu_2018, aml_ohsu_2022, aml_target_gdc, ampca_bcm_2016, appendiceal_msk_2022, bcc_unige_2016, blca_bcan_hcrn_2022, blca_cornell_2016, blca_dfarber_mskcc_2014, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_nmibc_2017, blca_pdx_msk_2025, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bll_target_gdc, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brain_cptac_gdc, brca_aurora_2023, brca_dfci_2020, brca_igr_2015, brca_mbcproject_2022, brca_metabric, brca_smc_2018, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cervix_msk_2023, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, chl_sccc_2023, chol_icgc_2017, chol_msk_2018, chrcc_tcga_gdc, coad_caseccc_2015, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_genentech, coadread_mskcc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_dd_2022, crc_eo_2020, crc_msk_2017, crc_nigerian_2020, crc_sysucc_2022, cscc_dfarber_2015, cscc_hgsc_bcm_2014, cscc_ranson_2022, cscc_ucsf_2021, difg_glass, difg_tcga_gdc, dlbc_broad_2012, dlbcl_dfci_2018, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_trap_ccr_msk_2023, egc_trap_msk_2020, es_dsrct_msk_2023, esca_broad, esca_tcga, esca_tcga_gdc, esca_tcga_pan_can_atlas_2018, escc_icgc, gbc_mskcc_2022, gbm_cptac_2021, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, gbm_tcga_pub2013, glioma_mskcc_2019, hcc_clca_2024, hcc_inserm_fr_2015, hcc_meric_2021, hcc_msk_2024, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_broad, hnsc_jhu, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lihc_amc_prv, lms_msk_2024, luad_broad, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mbl_dkfz_2017, mbl_icgc, mbl_sickkids_2016, mbn_msk_2024, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, mel_iatlas_hugo_ucla_2016, mel_ucla_2016, metastatic_solid_tumors_mich_2017, mixed_cfdna_msk_2020, mnm_washu_2016, mpcproject_broad_2021, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, msk_spectrum_tme_2022, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_unito_2016, ohnca_cptac_gdc, os_target_gdc, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, ovarian_msk_2025, ovary_cptac_gdc, paad_cptac_2021, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paad_utsw_2015, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, panet_msk_erc_2023, pdac_msk_2024, pediatric_dkfz_2017, pog570_bcgsc_2020, pptc_2019, prad_cdk12_mskcc_2020, prad_cpcg_2017, prad_mcspc_mskcc_2020, prad_msk_mdanderson_2023, prad_msk_stopsack_2021, prad_mskcc_2017, prad_organoids_msk_2022, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2015, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_dkfz_2018, prostate_msk_2024, ptad_msk_2024, read_tcga_gdc, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sarcoma_ucla_2024, sclc_ucologne_2015, skcm_broad, skcm_vanderbilt_mskcc_2015, soft_tissue_msk_2025, stad_oncosg_2018, stad_pfizer_uhongkong, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_msk_2022, ucec_cptac_2020, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_msk_2024, uec_cptac_gdc, wt_target_gdc","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Ampullary Carcinoma, Appendiceal Adenocarcinoma, B-Lymphoblastic Leukemia/Lymphoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, CNS/Brain, Cervical Squamous Cell Carcinoma, Cervix, Cholangiocarcinoma, Chromophobe Renal Cell Carcinoma, Classical Hodgkin Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gallbladder Cancer, Head and Neck, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Medulloblastoma, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Osteosarcoma, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Pituitary Adenoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Thyroid, Uterine Endometrioid Carcinoma, Wilms' Tumor","hg19,17:7577094-7577094, hg19,17:7577094-7577095, hg19,17:7673776-7673776, hg19,17:7673776-7673777, hg38,17:7673776-7673776, hg38,17:7673776-7673777","hg19,17:g.7577094G>A, hg19,17:g.7577094_7577095delinsAA, hg19,17:g.7673776G>A, hg19,17:g.7673776_7673777delinsAA, hg38,17:g.7673776G>A, hg38,17:g.7673776_7673777delinsAA",0.896,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, bone, extraskeletal, bone, humerus, breast, central_nervous_system, brain, central_nervous_system, brainstem, central_nervous_system, temporal_lobe, cervix, endometrium, extrapulmonary, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, breast, haematopoietic_and_lymphoid_tissue, gallbladder, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, anorectal, large_intestine, anus, large_intestine, appendix, large_intestine, caecum, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, descending, large_intestine, colon, left, large_intestine, colon, right, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, left, large_intestine, rectum, liver, lung, lung, right_lower_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, peritoneum, pleura, prostate, salivary_gland, parotid, skin, skin, arm, skin, chest, skin, ear, skin, face, skin, head_neck, skin, mucosal, urinary_tract, skin, mucosal, vulva, skin, shoulder, skin, trunk, skin, upper_leg, small_intestine, duodenum, small_intestine, jejunum, soft_tissue, soft_tissue, blood_vessel, soft_tissue, fibrous_tissue_and_uncertain_origin, temporal_lobe, soft_tissue, fibrous_tissue_and_uncertain_origin, upper_leg, soft_tissue, fibrous_tissue_and_uncertain_origin, uterus, soft_tissue, smooth_muscle, stomach, stomach, gastroesophageal_junction, testis, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, lip, upper_aerodigestive_tract, mouth, maxilla, upper_aerodigestive_tract, mouth, mouth_floor, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, hypopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, urinary_tract, bladder, urinary_tract, bladder, urachus, urinary_tract, renal_pelvis, urinary_tract, ureter, urinary_tract, urethra, vulva","Wilms_tumour, adenoma, adenoma, tubulovillous, adrenal_cortical_carcinoma, angiosarcoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, blastoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endocervical_adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, follicular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, large_cell_undifferentiated_carcinoma, carcinoma, lobular_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, mucinous_carcinoma, carcinoma, neuroendocrine_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, normal-like_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, poorly_cohesive_adenocarcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, signet_ring_adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, carcinoma, undifferentiated_adenocarcinoma, chondrosarcoma, dedifferentiated, germ_cell_tumour, yolk_sac_tumour, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, gliosarcoma, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_leukaemia_of_ambiguous_lineage, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, haematopoietic_neoplasm, myelofibrosis, primary, in_situ_epithelial_neoplasm, in_situ_epithelial_neoplasm, actinic_keratosis, leiomyosarcoma, low_malignant_potential_(borderline)_tumour, mucinous, lymphoid_neoplasm, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing, lymphoid_neoplasm, T_cell_large_granular_lymphocytic_leukaemia, gamma-delta, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, lymphoid_neoplasm, breast_implant_associated_anaplastic_large_cell_lymphoma_invasive, ALK_negative, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, peripheral_T_cell_lymphoma_unspecified, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, mesothelioma, mesothelioma, sarcomatous-fibrous, osteosarcoma, other, other, dysplasia-carcinoma_in_situ, other, dysplasia-in_situ_neoplasm, other, keratosis, other, metaplasia, epidermoid, other, neoplasm, other, normal, pancreatic_intraepithelial_neoplasia_(PanIN), primitive_neuroectodermal_tumour-medulloblastoma, primitive_neuroectodermal_tumour-medulloblastoma, classic, sarcoma, thymic_carcinoma, thymoma, undifferentiated-unclassified_sarcoma, mixed",0.0000039775665248,,,,12364,Pathogenic/Likely pathogenic,"Astrocytoma, anaplastic;TP53-related disorder;Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype;Colorectal cancer;Hereditary cancer-predisposing syndrome;Li-fraumeni-like syndrome;not provided;Adrenocortical carcinoma, hereditary;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck",2,Oncogenic,Neoplasm,1,Tier I - Strong,"Medulloblastoma WNT activated;Melanoma;Signet ring cell carcinoma;Diffuse glioma, H3 G34 mutant;Juvenile type testicular granulosa cell tumor;Diffuse midline glioma, H3 K27M-mutant;Low grade glioma;Astrocytoma IDH-mutant;Colorectal cancer;Rhabdomyosarcoma",1
3981,282,R,Y,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3982,283,R,A,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3983,283,R,C,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","aml_ohsu_2018, aml_ohsu_2022, breast_msk_2025, ccle_genentech_2014, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, mds_iwg_2022, mds_mskcc_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023, ucs_msk_2024","Acute Myeloid Leukemia, Bowel, Colorectal Adenocarcinoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7577091-7577091, hg38,17:7673773-7673773","hg19,17:g.7577091G>A, hg38,17:g.7673773G>A",0.740,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, large_intestine, colon, transverse, large_intestine, rectum, lung, ovary, pancreas, parathyroid, prostate, salivary_gland, skin, small_intestine, ileum, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach, thyroid, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, medullary_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, gastrointestinal_stromal_tumour, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, ependymoma, glioma, oligoastrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, chronic_myeloid_leukaemia, haematopoietic_neoplasm, myeloproliferative_neoplasm, malignant_melanoma, other, neoplasm",0.0000715876551066,0.0000955779278705,,,127824,Likely benign,Malignant glioma;Bone osteosarcoma;Hereditary cancer-predisposing syndrome;not specified;not provided;Neoplasm of stomach;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Malignant tumor of breast,3,,,,,,
3984,283,R,D,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3985,283,R,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3986,283,R,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3987,283,R,G,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_met_2021, sarcoma_msk_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7577091-7577091, hg38,17:7673773-7673773","hg19,17:g.7577091G>C, hg38,17:g.7673773G>C",0.714,"oesophagus, skin, mucosal, female_genital_tract_(site_indeterminate), urinary_tract, bladder","carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, malignant_melanoma",,,,,580186,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
3988,283,R,H,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","ccle_broad_2019, coad_tcga_gdc, coadread_dfci_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, mbn_sfu_2023, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_unito_2016, pan_origimed_2020, pancan_mimsi_msk_2024, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, sft_sysucc_2023, ucec_ancestry_cds_msk_2023","Colon Adenocarcinoma, Colorectal Adenocarcinoma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7577090-7577090, hg19,17:7673772-7673772, hg38,17:7673772-7673772","hg19,17:g.7577090C>T, hg19,17:g.7673772C>T, hg38,17:g.7673772C>T",0.836,"central_nervous_system, brain, cervix, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, large_intestine, lung, oesophagus, oesophagus, lower_third, prostate, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, urinary_tract, bladder, urinary_tract, upper_urinary_tract","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, papillary_adenocarcinoma, carcinoma, pleomorphic_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, NK-T_cell_lymphoma",0.0000397690215230,,,,142324,Uncertain significance,"TP53-related disorder;Astrocytoma;Hereditary cancer-predisposing syndrome;not specified;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",2,,,,,,
3989,283,R,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3990,283,R,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3991,283,R,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","msk_chord_2024, msk_ctdna_vte_2024, tmb_mskcc_2018",Mixed Cancer Types,"hg19,17:7577090-7577090, hg38,17:7673772-7673772","hg19,17:g.7577090C>A, hg38,17:g.7673772C>A",0.685,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, lymph_node, ovary, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
3992,283,R,M,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3993,283,R,N,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3994,283,R,P,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_tcga_2020, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, brca_fuscc_2020, brca_msk_2025, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, hcc_clca_2024, hcc_meric_2021, hcc_msk_2024, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, luad_broad, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_tracerx_2017, nsclc_unito_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, ucec_ccr_cfdna_msk_2022","Bladder Urothelial Carcinoma, Bowel, Breast, Colorectal Adenocarcinoma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Soft Tissue","hg19,17:7577089-7577090, hg19,17:7577090-7577090, hg19,17:7673772-7673772, hg38,17:7673772-7673772","hg19,17:g.7577089_7577090delinsAG, hg19,17:g.7577090C>G, hg19,17:g.7673772C>G, hg38,17:g.7673772C>G",0.804,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, small_intestine, large_intestine, rectum, liver, lung, oesophagus, oesophagus, middle_third, pancreas, penis, soft_tissue, blood_vessel, liver, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, oropharynx, urinary_tract, bladder, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, large_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, oligoastrocytoma, haematopoietic_neoplasm, myelodysplastic_syndrome, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, perivascular_epithelioid_cell_tumour_(PEComa)",,,,,486555,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1,1,,,,,,
3995,283,R,Q,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3996,283,R,S,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673773-7673773","hg38,17:g.7673773G>T",0.687,stomach,"carcinoma, adenocarcinoma",0.0000039770919504,,,,,,,,,,,,,
3997,283,R,T,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3998,283,R,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
3999,283,R,W,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4000,283,R,Y,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4001,284,T,A,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577088-7577088, hg38,17:7673770-7673770","hg19,17:g.7577088T>C, hg38,17:g.7673770T>C",0.460,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, large_intestine","carcinoma, adenocarcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,964952,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4002,284,T,C,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4003,284,T,D,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4004,284,T,E,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4005,284,T,F,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4006,284,T,G,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4007,284,T,H,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4008,284,T,I,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577087-7577087, hg38,17:7673769-7673769","hg19,17:g.7577087G>A, hg38,17:g.7673769G>A",0.699,"large_intestine, colon, lung","carcinoma, carcinoma, adenocarcinoma",,,,,216471,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,3,,,,,,
4009,284,T,K,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4010,284,T,L,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4011,284,T,M,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4012,284,T,N,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4013,284,T,P,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_msk_2025, ccle_broad_2019, ccle_genentech_2014, egc_msk_2023, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, lung_msk_pdx, lusc_tcga, lusc_tcga_pub, msk_chord_2024, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, pancan_mappyacts_2022, pancan_mimsi_msk_2024, sarcoma_msk_2022","Bladder Urothelial Carcinoma, Esophagus/Stomach, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577088-7577088, hg19,17:7673770-7673770, hg38,17:7673770-7673770","hg19,17:g.7577088T>G, hg19,17:g.7673770T>G, hg38,17:g.7673770T>G",0.569,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, large_intestine, colon, lung, ovary, stomach, upper_aerodigestive_tract, larynx","carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, M2, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia",,,,,1763670,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
4014,284,T,Q,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4015,284,T,R,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577087-7577087, hg38,17:7673769-7673769","hg19,17:g.7577087G>C, hg38,17:g.7673769G>C",0.728,,,,,,,2679230,Uncertain significance,"Adrenocortical carcinoma, hereditary",1,,,,,,
4016,284,T,S,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_met_2021, sarcoma_mskcc_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7577088-7577088, hg38,17:7673770-7673770","hg19,17:g.7577088T>A, hg38,17:g.7673770T>A",0.495,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,458571,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided,1,,,,,,
4017,284,T,V,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4018,284,T,W,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4019,284,T,Y,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 282-284, ggetELM|PCSK cleavage site (CLV_PCSK_FUR_1), 280-284, ggetELM|PCSK cleavage site (CLV_PCSK_KEX2_1), 282-284, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4020,285,E,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673766-7673766","hg38,17:g.7673766T>G",0.910,"biliary_tract, gallbladder, salivary_gland, maxilla","carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma",,,,,,,,,,,,,,
4021,285,E,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4022,285,E,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,Manual annotations from saturation_mutlist.csv","brca_metabric, lusc_cptac_gdc, ohnca_cptac_gdc","Head and Neck Carcinoma, Other, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma","hg19,17:7577083-7577083, hg19,17:7673765-7673765","hg19,17:g.7577083C>A, hg19,17:g.7673765C>A",0.524,,,,,,,,,,,,,,,,
4023,285,E,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4024,285,E,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hcc_clca_2024, msk_ch_2020, msk_ch_2023, msk_chord_2024","Hepatocellular Carcinoma, Mixed Cancer Types","hg19,17:7577084-7577084, hg38,17:7673766-7673766","hg19,17:g.7577084T>C, hg38,17:g.7673766T>C",0.923,"haematopoietic_and_lymphoid_tissue, large_intestine, liver, lung, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,919894,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
4025,285,E,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4026,285,E,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4027,285,E,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","acc_2019, ampca_bcm_2016, appendiceal_msk_2022, bcc_unige_2016, bladder_columbia_msk_2018, bladder_msk_2023, bladder_msk_2024, blca_bcan_hcrn_2022, blca_bgi, blca_cornell_2016, blca_dfarber_mskcc_2014, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_mskcc_solit_2012, blca_mskcc_solit_2014, blca_nmibc_2017, blca_pdx_msk_2025, blca_plasmacytoid_mskcc_2016, blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, bowel_colitis_msk_2022, brca_bccrc, brca_broad, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_mbcproject_wagle_2017, brca_metabric, brca_msk_2025, brca_mskcc_2019, brca_smc_2018, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cellline_nci60, cesc_tcga, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, cfdna_msk_2019, chol_icgc_2017, cll_broad_2022, coad_silu_2022, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_ucsf_2021, dlbcl_dfci_2018, dlbcl_duke_2017, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, egc_trap_ccr_msk_2023, egc_trap_msk_2020, es_dsrct_msk_2023, escc_ucla_2014, gbc_msk_2018, gbc_mskcc_2022, glioma_mskcc_2019, hcc_msk_2024, hccihch_pku_2019, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ilc_msk_2023, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_oncosg_2020, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lusc_cptac_2021, lusc_cptac_gdc, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, mixed_allen_2018, mixed_cfdna_msk_2020, mixed_selpercatinib_2020, msk_access_2021, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, npc_nusingapore, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, ohnca_cptac_gdc, paad_qcmg_uq_2016, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, pptc_2019, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_p1000, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prad_tcga_pub, prostate_msk_2024, rcc_iatlas_immotion150_2018, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, sclc_clcgp, sclc_ucologne_2015, soft_tissue_msk_2025, stad_oncosg_2018, stad_pfizer_uhongkong, summit_2018, thyroid_gatci_2024, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, uec_cptac_gdc, utuc_cornell_baylor_mdacc_2019, utuc_mskcc_2015","Adenoid Cystic Carcinoma, Ampullary Carcinoma, Appendiceal Adenocarcinoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cervical Squamous Cell Carcinoma, Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Ewing Sarcoma, Gallbladder Cancer, Head and Neck Carcinoma, Other, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Nasopharyngeal Carcinoma, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Renal Cell Carcinoma, Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma, Thyroid, Upper Tract Urothelial Carcinoma, Uterine Endometrioid Carcinoma","hg19,17:7577083-7577085, hg19,17:7577085-7577085, hg19,17:7673767-7673767, hg38,17:7673765-7673767, hg38,17:7673767-7673767","hg19,17:g.7577083_7577085delinsTTT, hg19,17:g.7577085C>T, hg19,17:g.7673767C>T, hg38,17:g.7673765_7673767delinsTTT, hg38,17:g.7673767C>T",0.910,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, bone, bone, femur, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, cervix, endometrium, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, head_neck, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, kidney, large_intestine, large_intestine, anorectal, large_intestine, appendix, large_intestine, colon, large_intestine, colon, descending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, lung, right_lower_lobe, oesophagus, oesophagus, lower_third, oesophagus, middle_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, pleura, prostate, salivary_gland, skin, skin, arm, skin, chest, skin, face, skin, head_neck, skin, scalp, soft_tissue, nerve_sheath, arm, stomach, testis, thymus, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, vocal_cord, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, urinary_tract, urinary_tract, bladder, urinary_tract, bladder, urachus, urinary_tract, renal_pelvis, urinary_tract, upper_urinary_tract, urinary_tract, ureter, vulva","Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour, adnexal_tumour, malignant_adnexal_tumour, eccrine_adenocarcinoma, adnexal_tumour, sebaceous_adenoma, adrenal_cortical_carcinoma, carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, lobular_carcinoma, with_extracellular_mucin, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_cell_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, nasopharyngeal_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, pleomorphic_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, spindle_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, carcinoma, tubular_adenocarcinoma, germ_cell_tumour, mixed, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_II, gemistocytic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_peripheral_nerve_sheath_tumour, mesothelioma, epithelial, osteosarcoma, other, dysplasia, other, keratosis, other, neoplasm, malignant, thymic_carcinoma",,,,,420133,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Poly (ADP-Ribose) polymerase inhibitor response,2,Oncogenic,Neoplasm,1,Tier I - Strong,Adrenal cortex carcinoma,1
4028,285,E,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4029,285,E,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4030,285,E,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4031,285,E,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4032,285,E,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_mbcproject_2022, brca_mskcc_2019, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, paired_bladder_2022, thyroid_gatci_2024","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Thyroid","hg19,17:7577085-7577085, hg19,17:7673767-7673767, hg38,17:7673767-7673767","hg19,17:g.7577085C>G, hg19,17:g.7673767C>G, hg38,17:g.7673767C>G",0.883,"large_intestine, colon, sigmoid, large_intestine, rectum, lung, ovary, skin, trunk, urinary_tract, urinary_tract, bladder","adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma",,,,,954095,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
4033,285,E,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4034,285,E,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4035,285,E,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4036,285,E,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","blca_tcga, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, bm_nsclc_mskcc_2023, ccle_broad_2019, ccle_broad_2025, chol_jhu_2013, crc_sysucc_2022, esca_tcga, esca_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, luad_tsp, lung_msk_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, pan_origimed_2020, pcpg_tcga, pcpg_tcga_pan_can_atlas_2018, pcpg_tcga_pub, sarcoma_msk_2022, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Cholangiocarcinoma, Colorectal Adenocarcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Lung Adenocarcinoma, Miscellaneous Neuroepithelial Tumor, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577084-7577084, hg19,17:7673766-7673766, hg38,17:7673766-7673766","hg19,17:g.7577084T>A, hg19,17:g.7673766T>A, hg38,17:g.7673766T>A",0.936,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, central_nervous_system, brain, large_intestine, liver, lung, pancreas, skin, face, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, urinary_tract, bladder","adrenal_cortical_carcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, gastrointestinal_stromal_tumour, primitive_neuroectodermal_tumour-medulloblastoma",0.0000000000000000,,,,12384,Pathogenic,"ADRENOCORTICAL CARCINOMA, PEDIATRIC;Choroid plexus carcinoma;Li-Fraumeni syndrome",1,Oncogenic,Neoplasm,1,,,
4037,285,E,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4038,285,E,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4039,286,E,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bll_target_gdc, bm_nsclc_mskcc_2023, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, hcc_msk_2024, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, sarcoma_msk_2022, ucec_ancestry_cds_msk_2023","B-Lymphoblastic Leukemia/Lymphoma, Endometrial Carcinoma, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7577081-7577081, hg19,17:7673763-7673763, hg38,17:7673763-7673763","hg19,17:g.7577081T>G, hg19,17:g.7673763T>G, hg38,17:g.7673763T>G",0.913,"breast, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, mediastinum, kidney, large_intestine, lung","Wilms_tumour, carcinoma, carcinoma, adenocarcinoma, carcinoma, luminal_B_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,,,,376593,Likely pathogenic,Li-Fraumeni syndrome 1,1,,,,,,
4040,286,E,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4041,286,E,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","hcc_clca_2024, hcc_inserm_fr_2015",Hepatocellular Carcinoma,"hg19,17:7577080-7577080, hg38,17:7673762-7673762","hg19,17:g.7577080T>G, hg38,17:g.7673762T>A, hg38,17:g.7673762T>G",0.765,"breast, liver, thyroid, urinary_tract","carcinoma, anaplastic_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, lobular_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,3893866,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4042,286,E,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4043,286,E,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_metabric, breast_msk_2025, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, hccihch_pku_2019, heme_msk_impact_2022, hgsoc_tcga_gdc, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, mbn_sfu_2023, mds_iwg_2022, mds_mskcc_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_mimsi_msk_2024, prad_msk_stopsack_2021, prostate_msk_2024, read_tcga_gdc, rectal_msk_2022, sarcoma_msk_2022, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stes_tcga_pub, ucec_ancestry_cds_msk_2023","Acute Myeloid Leukemia, Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma","hg19,17:7577081-7577081, hg19,17:7673763-7673763, hg38,17:7673763-7673763","hg19,17:g.7577081T>C, hg19,17:g.7673763T>C, hg38,17:g.7673763T>C",0.913,"breast, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, kidney, large_intestine, large_intestine, colon, large_intestine, colon, descending, large_intestine, rectum, lung, oesophagus, ovary, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, mouth_floor, urinary_tract, bladder","adenoma, carcinoma, carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, glioma, astrocytoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, Burkitt_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,,,,376590,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4044,286,E,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4045,286,E,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4046,286,E,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","angs_painter_2020, angs_painter_2025, angs_project_painter_2018, bcc_unige_2016, blca_cornell_2016, blca_iatlas_imvigor210_2017, blca_msk_2024, blca_msk_2025, blca_msk_tcga_2020, blca_nmibc_2017, blca_plasmacytoid_mskcc_2016, bowel_colitis_msk_2022, brca_cptac_2020, brca_igr_2015, brca_msk_2025, brca_sanger, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_alpelisib_2020, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, cfdna_msk_2019, chol_icgc_2017, chol_msk_2018, coad_cptac_2019, coad_cptac_gdc, coad_tcga_gdc, coadread_mskcc, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, cscc_dfarber_2015, cscc_hgsc_bcm_2014, cscc_ranson_2022, cscc_ucsf_2021, csf_msk_2024, dlbc_broad_2012, dlbcl_dfci_2018, egc_msk_2017, egc_msk_2023, egc_msk_tp53_ccr_2022, egc_mskcc_2020, esca_tcga, escc_icgc, glioma_mskcc_2019, hcc_inserm_fr_2015, hcc_msk_2024, hcc_tcga_gdc, hdcn_msk_2025, heme_msk_impact_2022, hgsoc_tcga_gdc, hnc_mskcc_2016, hnsc_jhu, hnsc_mdanderson_2013, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, lihc_amc_prv, lihc_tcga, lihc_tcga_pan_can_atlas_2018, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_nci_2022, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_mskcc_2020, mel_ucla_2016, metastatic_solid_tumors_mich_2017, mnm_washu_2016, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, paad_cptac_2021, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pancreas_msk_2024, pdac_msk_2024, pog570_bcgsc_2020, pptc_2019, prad_cdk12_mskcc_2020, prad_msk_mdanderson_2023, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prad_su2c_2019, prostate_msk_2024, read_tcga_gdc, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, skcm_yale, soft_tissue_tcga_gdc, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023, utuc_msk_2019, utuc_mskcc_2015","Angiosarcoma, Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High-Grade Serous Ovarian Cancer, Histiocytic and Dendritic Cell Neoplasms, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Melanoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Rectal Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Upper Tract Urothelial Carcinoma","hg19,17:7577082-7577082, hg19,17:7577082-7577083, hg19,17:7673764-7673764, hg19,17:7673764-7673765, hg38,17:7673764-7673764, hg38,17:7673764-7673765","hg19,17:g.7577082C>T, hg19,17:g.7577082_7577083delinsTT, hg19,17:g.7673764C>T, hg19,17:g.7673764_7673765delinsTT, hg38,17:g.7673764C>T, hg38,17:g.7673764_7673765delinsTT",0.949,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, biliary_tract, gallbladder, breast, central_nervous_system, brain, central_nervous_system, cerebellum, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, spleen, large_intestine, large_intestine, appendix, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, large_intestine, rectum, liver, lung, oesophagus, oesophagus, lower_third, ovary, pancreas, prostate, skin, skin, chest, skin, ear, skin, face, skin, hand, skin, head_neck, skin, neck, skin, scalp, skin, trunk, small_intestine, small_intestine, ileum, soft_tissue, soft_tissue, smooth_muscle, breast, soft_tissue, smooth_muscle, leg, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, larynx, vocal_cord, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, buccal_mucosa, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, tongue, upper_aerodigestive_tract, pharynx, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, urinary_tract, urinary_tract, bladder, vulva","adnexal_tumour, malignant_adnexal_tumour, spiradenocarcinoma, adnexal_tumour, other, sebaceoma, adrenal_cortical_carcinoma, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, Merkel_cell_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, intestinal, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, lobular_carcinoma, carcinoma, lobular_carcinoma, pleomorphic, carcinoma, medullary_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, papillary_carcinoma, carcinoma, serous_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligodendroglioma, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related, in_situ_epithelial_neoplasm, Bowen_disease, leiomyosarcoma, lymphoid_neoplasm, lymphoid_neoplasm, Hodgkin_lymphoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, Richter_transformation, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mantle_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, desmoplastic, malignant_melanoma, superficial_spreading, other, central_neurocytoma, other, dysplasia, other, high_grade_mucinous_neoplasm, other, neoplasm, malignant, sarcoma",,,,,183752,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided;Li-Fraumeni syndrome 1,2,Oncogenic,Vulvar adenocarcinoma of mammary gland type;Neoplasm,1,Tier I - Strong,Spindle cell sarcoma;Medulloblastoma WNT activated,1
4047,286,E,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4048,286,E,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4049,286,E,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4050,286,E,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4051,286,E,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, blca_msk_2024, blca_msk_tcga_2020, brca_metabric, brca_msk_2025, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, coadread_cass_2020, egc_msk_2023, glioma_mskcc_2019, hcc_jcopo_msk_2023, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, ohnca_cptac_gdc, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, tmb_mskcc_2018","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Colorectal Adenocarcinoma, Diffuse Glioma, Esophagus/Stomach, Head and Neck Carcinoma, Other, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7577082-7577082, hg19,17:7673764-7673764, hg38,17:7673764-7673764","hg19,17:g.7577082C>G, hg19,17:g.7673764C>G, hg38,17:g.7673764C>G",0.905,"breast, central_nervous_system, brain, endometrium, eye, conjunctiva, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, rectum, lung, oesophagus, pancreas, prostate, skin, urinary_tract, urinary_tract, bladder, urinary_tract, urethra","carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, other, pterygium",,,,,376591,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,Likely oncogenic,Neoplasm,1,,,
4052,286,E,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4053,286,E,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4054,286,E,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4055,286,E,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, chol_icgc_2017, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, hnc_mskcc_2016, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, mbn_mdacc_2013, mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pog570_bcgsc_2020, rectal_msk_2019, sarcoma_msk_2022","Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Head and Neck, Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Soft Tissue","hg19,17:7577081-7577081, hg19,17:7673763-7673763, hg38,17:7673763-7673763","hg19,17:g.7577081T>A, hg19,17:g.7673763T>A, hg38,17:g.7673763T>A",0.916,"breast, central_nervous_system, brain, endometrium, gastrointestinal_tract_(site_indeterminate), haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, large_intestine, rectum, liver, lung, oesophagus, ovary, skin, skin, head_neck, soft_tissue, blood_vessel, head_neck, stomach, upper_aerodigestive_tract, head_neck, urinary_tract, urinary_tract, renal_pelvis","angiosarcoma, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, poorly_cohesive_adenocarcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, dysplasia-carcinoma_in_situ",,,,,376592,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4056,286,E,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4057,286,E,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4058,287,E,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673760-7673760","hg38,17:g.7673760T>G",0.562,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4059,287,E,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4060,287,E,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar,Manual annotations from saturation_mutlist.csv","blca_iatlas_imvigor210_2017, blca_msk_2025, blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cesc_tcga, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pancan_mimsi_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, tmb_mskcc_2018, ucec_ancestry_cds_msk_2023","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577077-7577077, hg19,17:7673759-7673759, hg38,17:7673759-7673759","hg19,17:g.7577077C>A, hg19,17:g.7577077C>G, hg19,17:g.7673759C>A, hg19,17:g.7673759C>G, hg38,17:g.7673759C>A, hg38,17:g.7673759C>G",0.405,"breast, cervix, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, colon, right, liver, lung, pleura, upper_aerodigestive_tract, larynx, urinary_tract, urinary_tract, bladder, urinary_tract, upper_urinary_tract, vulva","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, lobular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, carcinoma, undifferentiated_carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, mesothelioma, epithelial, other, neoplasm, malignant",0.0000079527922254,,,,"925213, 422130","Uncertain significance, Conflicting classifications of pathogenicity",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Hereditary breast ovarian cancer syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,"2, 1",Uncertain significance,Neoplasm,1,,,
4061,287,E,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4062,287,E,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673760-7673760","hg38,17:g.7673760T>C",0.626,breast,"carcinoma, carcinoma_in_situ, ductal_carcinoma_in_situ",,,,,,,,,,,,,,
4063,287,E,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4064,287,E,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4065,287,E,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","bcc_unige_2016, bladder_msk_2024, blca_iatlas_imvigor210_2017, blca_msk_2025, brca_msk_2025, breast_msk_2025, cfdna_msk_2019, gbc_msk_2018, hnc_mskcc_2016, ilc_msk_2023, mds_iwg_2022, metastatic_solid_tumors_mich_2017, mixed_cfdna_msk_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020, tmb_mskcc_2018","Basal Cell Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Breast, Gallbladder Cancer, Head and Neck, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7577079-7577079, hg19,17:7673761-7673761, hg38,17:7673761-7673761","hg19,17:g.7577079C>T, hg19,17:g.7673761C>T, hg38,17:g.7673761C>T",0.583,", breast, liver, pancreas, penis, skin, skin, arm, skin, face, skin, head_neck, skin, knee, small_intestine, jejunum, stomach, thyroid, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, adnexal_tumour, sebaceous_adenoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, nasopharyngeal_carcinoma, non_keratinizing, carcinoma, papillary_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, malignant_melanoma",0.0000039765226105,,,,141781,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4066,287,E,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4067,287,E,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4068,287,E,N,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4069,287,E,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4070,287,E,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv","bladder_msk_2023, blca_iatlas_imvigor210_2017, blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, msk_access_2021, msk_chord_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7577079-7577079, hg19,17:7673761-7673761, hg38,17:7673761-7673761","hg19,17:g.7577079C>G, hg19,17:g.7673761C>G, hg38,17:g.7673761C>G",0.623,"lung, skin, eye, upper_aerodigestive_tract, larynx, vocal_cord, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, other, dysplasia",,,,,,,,,,,,,,
4071,287,E,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4072,287,E,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4073,287,E,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4074,287,E,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673760-7673760","hg38,17:g.7673760T>A",0.644,bone,Ewing_sarcoma-peripheral_primitive_neuroectodermal_tumour,,,,,,,,,,,,,,
4075,287,E,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4076,287,E,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4077,288,N,A,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4078,288,N,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4079,288,N,D,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",hcc_clca_2024,Hepatocellular Carcinoma,"hg19,17:7577076-7577076, hg38,17:7673758-7673758","hg19,17:g.7577076T>C, hg38,17:g.7673758T>C",0.513,"upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, squamous_cell_carcinoma",,,,,1024822,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4080,288,N,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4081,288,N,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4082,288,N,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4083,288,N,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673758-7673758","hg38,17:g.7673758T>G",0.554,breast,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
4084,288,N,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4085,288,N,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673756-7673756","hg38,17:g.7673756A>T",0.679,stomach,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4086,288,N,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4087,288,N,M,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4088,288,N,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4089,288,N,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4090,288,N,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4091,288,N,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"cBioPortal,COSMIC,Manual annotations from saturation_mutlist.csv",nsclc_ctdx_msk_2022,Non-Small Cell Lung Cancer,"hg19,17:7577075-7577075, hg38,17:7673757-7673757","hg19,17:g.7577075T>C, hg38,17:g.7673757T>C",0.480,"biliary_tract, bile_duct, lung, prostate, skin, leg, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, urinary_tract","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
4092,288,N,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577075-7577075, hg38,17:7673757-7673757","hg19,17:g.7577075T>G, hg38,17:g.7673757T>G",0.633,,,,,,,2119726,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4093,288,N,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4094,288,N,W,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4095,288,N,Y,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM|FHA phosphopeptide ligands (LIG_FHA_2), 282-288, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673758-7673758","hg38,17:g.7673758T>A",0.665,"liver, soft_tissue, blood_vessel, head_neck, stomach","angiosarcoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma",,,,,,,,,,,,,,
4096,289,L,A,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4097,289,L,C,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4098,289,L,D,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4099,289,L,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4100,289,L,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, hnc_mskcc_2016, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, pancan_pdmr_2025, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Head and Neck, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7577073-7577073, hg38,17:7673755-7673755","hg19,17:g.7577073G>A, hg38,17:g.7673755G>A",0.344,"breast, haematopoietic_and_lymphoid_tissue, skin, large_intestine, colon, skin, skin, face, upper_aerodigestive_tract, larynx","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, lymphomatoid_papulosis",,,,,822635,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4101,289,L,G,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4102,289,L,H,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4103,289,L,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv","msk_chord_2024, ucec_ancestry_cds_msk_2023, ucs_msk_2024","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7577073-7577073, hg38,17:7673755-7673755","hg19,17:g.7577073G>T, hg38,17:g.7673755G>T",0.349,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,1439164,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4104,289,L,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4105,289,L,M,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4106,289,L,N,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4107,289,L,P,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,"COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",,,"hg19,17:7577072-7577072, hg38,17:7673754-7673754","hg19,17:g.7577072A>G, hg38,17:g.7673754A>G",0.518,"lung, oesophagus","carcinoma, adenocarcinoma",,,,,1172923,Likely benign,Li-Fraumeni syndrome 1,3,,,,,,
4108,289,L,Q,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4109,289,L,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,"COSMIC,Manual annotations from saturation_mutlist.csv",,,"hg38,17:7673754-7673754","hg38,17:g.7673754A>C",0.426,"central_nervous_system, brain","glioma, astrocytoma",,,,,,,,,,,,,,
4110,289,L,S,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4111,289,L,T,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4112,289,L,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,"cBioPortal,COSMIC,ClinVar,Manual annotations from saturation_mutlist.csv",paired_bladder_2022,Bladder/Urinary Tract,"hg19,17:7577073-7577073, hg38,17:7673755-7673755","hg19,17:g.7577073G>C, hg38,17:g.7673755G>C",0.399,lung,"carcinoma, squamous_cell_carcinoma",,,,,496049,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;not provided,1,,,,,,
4113,289,L,W,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4114,289,L,Y,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 282-289, ggetELM",,Manual annotations from saturation_mutlist.csv,,,,,,,,,,,,,,,,,,,,,
4115,290,R,C,,Me,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_broad_2019, cellline_ccle_broad, cscc_dfarber_2015, cscc_ranson_2022, msk_impact_2017, msk_met_2021, pancan_pcawg_2020, pancan_pdmr_2025, sarcoma_msk_2022, skcm_broad, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7577070-7577070, hg19,17:7673752-7673752, hg38,17:7673752-7673752","hg19,17:g.7577070G>A, hg19,17:g.7673752G>A, hg38,17:g.7673752G>A",0.709,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, colon, skin, skin, scalp, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, sinonasal_and_nasal_cavity, sinus, maxillary, vulva","carcinoma, adenocarcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, spindle_cell_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_leukaemic_transformation_of_primary_myelofibrosis, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma",0.0000119290934684,0.0000318633698700,,,216472,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,,,
4116,290,R,G,,Me,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,ClinVar,,,"hg19,17:7577070-7577070, hg38,17:7673752-7673752","hg19,17:g.7577070G>C, hg38,17:g.7673752G>C",0.567,,,,,,,628970,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4117,290,R,H,,Me,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,"cBioPortal,COSMIC,ClinVar","bladder_msk_2023, brca_msk_2025, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, crc_eo_2020, crc_msk_2017, dlbcl_duke_2017, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, mds_iwg_2022, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pdmr_2025, sarcoma_msk_2022, summit_2018","Bladder/Urinary Tract, Bowel, Breast, Colorectal Adenocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7577069-7577069, hg19,17:7673751-7673751, hg38,17:7673751-7673751","hg19,17:g.7577069C>T, hg19,17:g.7673751C>T, hg38,17:g.7673751C>T",0.584,", breast, central_nervous_system, frontal_lobe, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, skin, large_intestine, large_intestine, caecum, large_intestine, colon, pancreas, prostate, skin, stomach, upper_aerodigestive_tract, mouth, urinary_tract, bladder, urinary_tract, upper_urinary_tract","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, lobular_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts, in_situ_epithelial_neoplasm, actinic_keratosis, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, post_transplant_lymphoproliferative_disorder, diffuse_large_B_cell_lymphoma, malignant_melanoma, malignant_melanoma, nodular",0.0001550806817188,0.0001274209989806,,,127825,Benign,Familial ovarian cancer;TP53-related disorder;Hereditary cancer-predisposing syndrome;Breast and/or ovarian cancer;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4118,290,R,L,,Me,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,"cBioPortal,COSMIC,ClinVar","mds_mskcc_2020, msk_met_2021, paired_bladder_2022, sarcoma_msk_2022","Bladder/Urinary Tract, Mixed Cancer Types, Myelodysplastic Syndromes, Soft Tissue","hg19,17:7577069-7577069, hg38,17:7673751-7673751","hg19,17:g.7577069C>A, hg38,17:g.7673751C>A",0.651,"ovary, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, vulva","carcinoma, carcinoma, squamous_cell_carcinoma",,,,,633445,Uncertain significance,Hereditary cancer-predisposing syndrome;Bone marrow failure syndrome 5;not specified;Li-Fraumeni syndrome,2,,,,,,
4119,290,R,P,,Me,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,"cBioPortal,ClinVar",nsclc_ctdx_msk_2022,Non-Small Cell Lung Cancer,"hg19,17:7577069-7577069, hg38,17:7673751-7673751","hg19,17:g.7577069C>G, hg38,17:g.7673751C>G",0.613,,,,,,,458572,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4120,290,R,S,,Me,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577070-7577071, hg38,17:7673752-7673752, hg38,17:7673752-7673753","hg19,17:g.7577070_7577071delinsTT, hg38,17:g.7673752G>T, hg38,17:g.7673752_7673753delinsTT",0.605,cervix,"carcinoma, squamous_cell_carcinoma",,,,,1338368,Uncertain significance,not specified,1,,,,,,
4121,291,K,E,,,Ubq,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,17:7577067-7577067, hg38,17:7673749-7673749","hg19,17:g.7577067T>C, hg38,17:g.7673749T>C",0.557,"biliary_tract, bile_duct, lung, soft_tissue","carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma, sarcoma",,,,,480951,Conflicting classifications of pathogenicity,"Li-Fraumeni syndrome 1;Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided",1,,,,,,
4122,291,K,L,,,Ubq,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,cBioPortal,"ccle_broad_2019, ccle_broad_2025",Mixed Cancer Types,"hg19,17:7577066-7577067, hg19,17:7673748-7673749","hg19,17:g.7577066_7577067delinsAA, hg19,17:g.7673748_7673749delinsAA",,,,,,,,,,,,,,,,,
4123,291,K,M,,,Ubq,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,"cBioPortal,COSMIC",ccle_genentech_2014,Mixed Cancer Types,"hg19,17:7577066-7577066, hg38,17:7673748-7673748","hg19,17:g.7577066T>A, hg38,17:g.7673748T>A",0.796,"lung, ovary","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",,,,,,,,,,,,,,
4124,291,K,N,,,Ubq,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_msk_2025, msk_chord_2024, pan_origimed_2020, thyroid_gatci_2024","Invasive Breast Carcinoma, Mixed Cancer Types, Thyroid","hg19,17:7577065-7577065, hg19,17:7673747-7673747, hg38,17:7673747-7673747","hg19,17:g.7577065C>A, hg19,17:g.7577065C>G, hg19,17:g.7673747C>G, hg38,17:g.7673747C>G",0.568,"breast, haematopoietic_and_lymphoid_tissue, pancreas, urinary_tract, bladder","carcinoma, carcinoma, ductal_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma, lymphoid_neoplasm, Hodgkin_lymphoma",,,,,629930,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
4125,291,K,Q,,,Ubq,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar","msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7577067-7577067, hg19,17:7577067-7577068, hg38,17:7673749-7673749, hg38,17:7673749-7673750","hg19,17:g.7577067T>G, hg19,17:g.7577067_7577068delinsGT, hg38,17:g.7673749T>G, hg38,17:g.7673749_7673750delinsGT",0.610,"soft_tissue, striated_muscle, arm","rhabdomyosarcoma, alveolar",,,,,"1061526, 406594","Uncertain significance, Uncertain significance",Li-Fraumeni syndrome|Li-Fraumeni syndrome,"1, 1",,,,,,
4126,291,K,R,,,Ubq,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,COSMIC,,,"hg38,17:7673748-7673748","hg38,17:g.7673748T>C",0.694,"central_nervous_system, brain, lung, pancreas, upper_aerodigestive_tract, mouth, tongue","carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, other, dysplasia-in_situ_neoplasm",0.0000079526657336,,,,,,,,,,,,,
4127,291,K,T,,,Ubq,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 289-291, ggetELM",,COSMIC,,,"hg38,17:7673748-7673748","hg38,17:g.7673748T>G",0.791,"lung, prostate, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma, in_situ_neoplasm, glandular_intraepithelial_neoplasia_Grade_III",,,,,,,,,,,,,,
4128,292,K,E,,,Ubq,,,Ac,,,,,PhosphoSite,,,"COSMIC,ClinVar",,,"hg19,17:7577064-7577064, hg38,17:7673746-7673746","hg19,17:g.7577064T>C, hg38,17:g.7673746T>C",0.510,"urinary_tract, bladder","carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma",,,,,1006477,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4129,292,K,I,,,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014",Mixed Cancer Types,"hg19,17:7577063-7577063, hg19,17:7673745-7673745, hg38,17:7673745-7673745","hg19,17:g.7577063T>A, hg19,17:g.7673745T>A, hg38,17:g.7673745T>A",0.832,lung,"carcinoma, adenocarcinoma",,,,,12378,Uncertain significance,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,2,,,,,,
4130,292,K,N,,,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar,ClinVar","msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7577062-7577062, hg38,17:7673744-7673744","hg19,17:g.7577062T>A, hg19,17:g.7577062T>G, hg38,17:g.7673744T>A, hg38,17:g.7673744T>G",0.450,"liver, lung, upper_aerodigestive_tract, mouth, tongue","carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,"2679235, 1718571","Uncertain significance, Uncertain significance","Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome","2, 1",,,,,,
4131,292,K,R,,,Ubq,,,Ac,,,,,PhosphoSite,,,"COSMIC,ClinVar",,,"hg19,17:7577063-7577063, hg38,17:7673745-7673745","hg19,17:g.7577063T>C, hg38,17:g.7673745T>C",0.473,"cervix, large_intestine, colon, descending, oesophagus, stomach, thyroid","carcinoma, carcinoma, adenocarcinoma, carcinoma, follicular_carcinoma, carcinoma, squamous_cell_carcinoma",,0.0000318552497452,,,406577,Likely benign,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
4132,292,K,T,,,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar",sarcoma_msk_2022,Soft Tissue,"hg19,17:7577063-7577063, hg38,17:7673745-7673745","hg19,17:g.7577063T>G, hg38,17:g.7673745T>G",0.580,"large_intestine, rectum, upper_aerodigestive_tract, larynx, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,1021706,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome",1,,,,,,
4133,293,G,A,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7673742-7673742","hg38,17:g.7673742C>G",0.254,"large_intestine, colon, right","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4134,293,G,E,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7673742-7673742","hg38,17:g.7673742C>T",0.242,"lung, pancreas, skin, arm","carcinoma, Merkel_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4135,293,G,R,,,,,,,,,,,,,,"COSMIC,ClinVar,ClinVar",,,"hg19,17:7577061-7577061, hg38,17:7673743-7673743","hg19,17:g.7577061C>G, hg19,17:g.7577061C>T, hg38,17:g.7673743C>G, hg38,17:g.7673743C>T",0.402,"large_intestine, colon, lung, right_upper_lobe, ovary, skin, face, thyroid, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, transitional_cell_carcinoma, other, keratoacanthoma_BRAF_inhibitor_related",0.0000079528554728,,,,"1365220, 230208","Uncertain significance, Conflicting classifications of pathogenicity",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,"1, 1",,,,,,
4136,293,G,V,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7673742-7673742","hg38,17:g.7673742C>A",0.528,"biliary_tract, bile_duct, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4137,293,G,W,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar","msk_ch_2023, sarcoma_msk_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7577061-7577061, hg38,17:7673743-7673743","hg19,17:g.7577061C>A, hg38,17:g.7673743C>A",0.675,"biliary_tract, bile_duct, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, lung","carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, essential_thrombocythaemia",0.0000079528554728,0.0000318532203606,,,127826,Likely benign,Hereditary cancer-predisposing syndrome;not specified;Familial cancer of breast;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4138,294,E,A,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,ClinVar,,,"hg19,17:7577057-7577057, hg38,17:7673739-7673739","hg19,17:g.7577057T>G, hg38,17:g.7673739T>G",0.371,,,,,,,1494469,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4139,294,E,D,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673738-7673738","hg38,17:g.7673738C>A",0.324,"lung, skin, lower_leg, soft_tissue, fibrous_tissue_and_uncertain_origin","carcinoma, non_small_cell_carcinoma, inflammatory_myofibroblastic_tumour, malignant_melanoma, superficial_spreading",,,,,,,,,,,,,,
4140,294,E,G,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673739-7673739","hg38,17:g.7673739T>C",0.297,"central_nervous_system, brain, urinary_tract, bladder","carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic",,,,,,,,,,,,,,
4141,294,E,K,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577058-7577058, hg38,17:7673740-7673740","hg19,17:g.7577058C>T, hg38,17:g.7673740C>T",0.371,"breast, oesophagus, skin, face, soft_tissue, fibrous_tissue_and_uncertain_origin, abdominal_wall, stomach, urinary_tract, bladder","adnexal_tumour, other, sebaceoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, dermatofibrosarcoma_protuberans",,,,,1001614,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4142,294,E,Q,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"cBioPortal,COSMIC","msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7577058-7577058, hg38,17:7673740-7673740","hg19,17:g.7577058C>G, hg38,17:g.7673740C>G",0.321,"breast, lung, stomach","carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4143,294,E,V,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673739-7673739","hg38,17:g.7673739T>A",0.355,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
4144,295,P,A,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673737-7673737","hg38,17:g.7673737G>C",0.350,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,,,,,,,,,,
4145,295,P,H,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577054-7577054, hg38,17:7673736-7673736","hg19,17:g.7577054G>T, hg38,17:g.7673736G>T",0.258,"soft_tissue, striated_muscle, head_neck","rhabdomyosarcoma, alveolar",,,,,3340041,Uncertain significance,not specified,1,,,,,,
4146,295,P,L,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577054-7577054, hg38,17:7673736-7673736","hg19,17:g.7577054G>A, hg38,17:g.7673736G>A",0.337,"breast, haematopoietic_and_lymphoid_tissue, placenta, skin, head_neck, soft_tissue, fibrous_tissue_and_uncertain_origin, gastrointestinal_tract_(site_indeterminate), stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, gastrointestinal_stromal_tumour, haematopoietic_neoplasm, blast_phase_chronic_myeloid_leukaemia, hydatidiform_mole",0.0000198813481145,0.0000318572793883,,,420974,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
4147,295,P,R,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673736-7673736","hg38,17:g.7673736G>C",0.325,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4148,295,P,S,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577055-7577055, hg38,17:7673737-7673737","hg19,17:g.7577055G>A, hg38,17:g.7673737G>A",0.308,"large_intestine, colon, ascending, lung","carcinoma, adenocarcinoma, carcinoma, large_cell_carcinoma",,0.0001592965464509,,,428862,Likely benign,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
4149,295,P,T,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673737-7673737","hg38,17:g.7673737G>T",0.391,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,,,,,,,,,,,
4150,296,H,D,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,17:7577052-7577052","hg19,17:g.7577052G>C",0.423,,,,,,,,,,,,,,,,
4151,296,H,L,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673733-7673733","hg38,17:g.7673733T>A",0.387,"lung, oesophagus","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4152,296,H,N,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673734-7673734","hg38,17:g.7673734G>T",0.283,"breast, prostate","carcinoma, carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4153,296,H,P,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673733-7673733","hg38,17:g.7673733T>G",0.389,"upper_aerodigestive_tract, larynx","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4154,296,H,Q,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,17:7577050-7577050, hg38,17:7673732-7673732","hg19,17:g.7577050G>T, hg38,17:g.7673732G>C",0.349,"large_intestine, colon","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4155,296,H,R,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577051-7577051, hg38,17:7673733-7673733","hg19,17:g.7577051T>C, hg38,17:g.7673733T>C",0.328,breast,carcinoma,,,,,100816,Likely pathogenic,not provided,0,,,,,,
4156,296,H,Y,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, msk_chord_2024, msk_ctdna_vte_2024, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7577052-7577052, hg19,17:7673734-7673734, hg38,17:7673734-7673734","hg19,17:g.7577052G>A, hg19,17:g.7673734G>A, hg38,17:g.7673734G>A",0.368,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, stomach, liver, lung, oesophagus, pancreas, skin, lip","adnexal_tumour, malignant_adnexal_tumour, microcystic_adnexal_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm",,,,,132973,Likely benign,Sarcoma;Hereditary cancer-predisposing syndrome;not specified;not provided;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome,3,,,,,,
4157,297,H,L,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673730-7673730","hg38,17:g.7673730T>A",0.354,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4158,297,H,N,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673731-7673731","hg38,17:g.7673731G>T",0.336,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
4159,297,H,P,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673730-7673730","hg38,17:g.7673730T>G",0.349,cervix,"in_situ_neoplasm, cervical_intraepithelial_neoplasia_Grade_III",,,,,,,,,,,,,,
4160,297,H,Q,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"ClinVar,ClinVar",,,"hg19,17:7577047-7577047, hg38,17:7673729-7673729","hg19,17:g.7577047G>C, hg19,17:g.7577047G>T, hg38,17:g.7673729G>C, hg38,17:g.7673729G>T",0.296,,,,,,,"926470, 660046","Uncertain significance, Uncertain significance",Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome,"2, 1",,,,,,
4161,297,H,R,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,ClinVar,,,"hg19,17:7577048-7577048, hg38,17:7673730-7673730","hg19,17:g.7577048T>C, hg38,17:g.7673730T>C",0.294,,,,,,,231990,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
4162,297,H,Y,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"cBioPortal,COSMIC,ClinVar",bcc_unige_2016,Basal Cell Carcinoma,"hg19,17:7577049-7577049, hg38,17:7673731-7673731, hg38,17:7673731-7673732","hg19,17:g.7577049G>A, hg38,17:g.7673731G>A, hg38,17:g.7673731_7673732delinsAA",0.304,"eye, conjunctiva, haematopoietic_and_lymphoid_tissue, large_intestine, lung, skin, skin, arm","carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia",,,,,1933263,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4163,298,E,A,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577045-7577045, hg38,17:7673727-7673727","hg19,17:g.7577045T>G, hg38,17:g.7673727T>G",0.375,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,2679238,Uncertain significance,"Adrenocortical carcinoma, hereditary",1,,,,,,
4164,298,E,D,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577044-7577044, hg38,17:7673726-7673726","hg19,17:g.7577044C>G, hg38,17:g.7673726C>G",0.308,"breast, central_nervous_system, cerebellum","carcinoma, ductal_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,2863364,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4165,298,E,G,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577045-7577045, hg38,17:7673727-7673727","hg19,17:g.7577045T>C, hg38,17:g.7673727T>C",0.402,pancreas,"carcinoma, ductal_carcinoma",,,,,927512,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4166,298,E,K,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_ch_2020, msk_ch_2023, msk_chord_2024, sarcoma_msk_2022","Mixed Cancer Types, Soft Tissue","hg19,17:7577046-7577046, hg38,17:7673728-7673728","hg19,17:g.7577046C>T, hg38,17:g.7673728C>T",0.286,"endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity, pancreas","carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, haematopoietic_neoplasm, myeloproliferative_neoplasm, lymphoid_neoplasm, NK-T_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000119288088687,,,,141483,Benign,Hereditary cancer-predisposing syndrome;not provided;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Carcinoma of colon;Malignant tumor of breast,3,,,,,,
4167,298,E,Q,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,17:7577046-7577046, hg38,17:7673728-7673728","hg19,17:g.7577046C>G, hg38,17:g.7673728C>G",0.191,"breast, salivary_gland, parotid, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, ex-pleomorphic_adenoma_carcinoma, carcinoma, squamous_cell_carcinoma",0.0000039762696229,,,,1495821,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4168,298,E,V,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 294-298, ggetELM",,COSMIC,,,"hg38,17:7673727-7673727","hg38,17:g.7673727T>A",0.414,"lung, stomach","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4169,299,L,P,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7577042-7577042, hg38,17:7673724-7673724","hg19,17:g.7577042A>G, hg38,17:g.7673724A>G",0.338,pancreas,carcinoma,,,,,2036477,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4170,299,L,V,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7673725-7673725","hg38,17:g.7673725G>C",0.352,"haematopoietic_and_lymphoid_tissue, sinonasal_and_nasal_cavity","lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,,,,,,,,,,
4171,300,P,A,,,,,,,,,,,,,,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7577040-7577040, hg38,17:7673722-7673722","hg19,17:g.7577040G>C, hg38,17:g.7673722G>C",0.392,"haematopoietic_and_lymphoid_tissue, skin, oesophagus","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,,,,,,,,,,
4172,300,P,L,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7577039-7577039, hg38,17:7673721-7673721","hg19,17:g.7577039G>A, hg38,17:g.7673721G>A",0.499,", endometrium, eye, uveal_tract, oesophagus, ovary, stomach, upper_aerodigestive_tract, mouth, cheek","adenoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, serous_carcinoma, malignant_melanoma, other, leukoplakia-hyperplakia-erythroplakia",,,,,1765377,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4173,300,P,R,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7673721-7673721","hg38,17:g.7673721G>C",0.476,"skin, arm","carcinoma, basal_cell_carcinoma",,,,,,,,,,,,,,
4174,300,P,S,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7577040-7577040, hg38,17:7673722-7673722","hg19,17:g.7577040G>A, hg38,17:g.7673722G>A",0.302,"liver, pancreas, skin, skin, face, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","adnexal_tumour, other, sebaceoma, adnexal_tumour, sebaceous_adenoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,3634425,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4175,301,P,A,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7577037-7577037, hg38,17:7673719-7673719","hg19,17:g.7577037G>C, hg38,17:g.7673719G>C",0.368,breast,carcinoma,,,,,1332597,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4176,301,P,L,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7577036-7577036, hg38,17:7673718-7673718","hg19,17:g.7577036G>A, hg38,17:g.7673718G>A",0.328,"urinary_tract, bladder",carcinoma,,,,,481049,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4177,301,P,Q,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7673718-7673718","hg38,17:g.7673718G>T",0.359,breast,carcinoma,,,,,,,,,,,,,,
4178,301,P,S,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7577037-7577037, hg38,17:7673719-7673719","hg19,17:g.7577037G>A, hg38,17:g.7673719G>A",0.354,"lung, skin, face, stomach","adnexal_tumour, other, sebaceoma, adnexal_tumour, sebaceous_adenoma, carcinoma, diffuse_adenocarcinoma, carcinoma, large_cell_carcinoma",,,,,1469089,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4179,301,P,T,,,,,,,,,,,,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,17:7577037-7577037, hg38,17:7673719-7673719","hg19,17:g.7577037G>T, hg38,17:g.7673719G>T",0.310,"skin, upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,,,,,,,,,,
4180,302,G,A,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7577033-7577033, hg38,17:7673715-7673715","hg19,17:g.7577033C>G, hg38,17:g.7673715C>G",0.314,,,,,,,3328162,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4181,302,G,E,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar",nsclc_unito_2016,Non-Small Cell Lung Cancer,"hg19,17:7577033-7577033, hg38,17:7673715-7673715","hg19,17:g.7577033C>T, hg38,17:g.7673715C>T",0.331,"large_intestine, appendix, large_intestine, rectum, oesophagus, upper_aerodigestive_tract, pharynx, oropharynx","carcinoid-endocrine_tumour, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,406591,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4182,302,G,R,,,,,,,,,,,,,,"COSMIC,ClinVar,ClinVar",,,"hg19,17:7577034-7577034, hg38,17:7673716-7673716","hg19,17:g.7577034C>G, hg19,17:g.7577034C>T, hg38,17:g.7673716C>G, hg38,17:g.7673716C>T","0.373, 0.374","breast, urinary_tract","carcinoma, basal_(triple-negative)_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,"1047514, 216473","Conflicting classifications of pathogenicity, Uncertain significance",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Li-Fraumeni syndrome,"1, 1",,,,,,
4183,302,G,V,,,,,,,,,,,,,,cBioPortal,"sarc_tcga, sarc_tcga_pub",Soft Tissue,"hg19,17:7577033-7577033","hg19,17:g.7577033C>A",0.503,,,,,,,,,,,,,,,,
4184,303,S,C,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7673713-7673713","hg38,17:g.7673713T>A",0.479,"oesophagus, prostate","carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4185,303,S,G,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7577031-7577031, hg38,17:7673713-7673713","hg19,17:g.7577031T>C, hg38,17:g.7673713T>C",0.370,,,,,,,142332,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,3,,,,,,
4186,303,S,N,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7577030-7577030, hg38,17:7673712-7673712","hg19,17:g.7577030C>T, hg38,17:g.7673712C>T",0.264,"breast, large_intestine, appendix, urinary_tract, bladder","carcinoid-endocrine_tumour, carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,230695,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4187,303,S,R,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7577029-7577029, hg38,17:7673711-7673711","hg19,17:g.7577029G>C, hg38,17:g.7673711G>C",0.565,,,,,,,1024359,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4188,303,S,T,,,,,,,,,,,,,,COSMIC,,,"hg38,17:7673712-7673712","hg38,17:g.7673712C>G",0.315,"haematopoietic_and_lymphoid_tissue, oesophagus, skin","carcinoma, carcinoma, basal_cell_carcinoma, haematopoietic_neoplasm, essential_thrombocythaemia",,,,,,,,,,,,,,
4189,304,T,A,P,,,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar",msk_ch_2023,Mixed Cancer Types,"hg19,17:7577028-7577028, hg38,17:7673710-7673710","hg19,17:g.7577028T>C, hg38,17:g.7673710T>C",0.272,"breast, large_intestine, oesophagus, upper_aerodigestive_tract, mouth, gingiva, upper_aerodigestive_tract, mouth, mouth_floor","carcinoma, adenocarcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, squamous_cell_carcinoma",0.0000159050784916,,,,142702,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4190,304,T,I,P,,,,,,,,,,PhosphoSite,,,"COSMIC,ClinVar",,,"hg19,17:7577027-7577027, hg38,17:7673709-7673709","hg19,17:g.7577027G>A, hg38,17:g.7673709G>A",0.253,"large_intestine, soft_tissue, fibrous_tissue_and_uncertain_origin, stomach","carcinoma, adenocarcinoma, gastrointestinal_stromal_tumour",,,,,1020758,Uncertain significance,not provided;Li-Fraumeni syndrome,2,,,,,,
4191,304,T,N,P,,,,,,,,,,PhosphoSite,,,COSMIC,,,"hg38,17:7673709-7673709","hg38,17:g.7673709G>T",0.199,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
4192,304,T,S,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7577027-7577027, hg38,17:7673709-7673709","hg19,17:g.7577027G>C, hg38,17:g.7673709G>C",0.221,,,,,,,3634424,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4193,305,K,E,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673707-7673707","hg38,17:g.7673707T>C",0.652,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,,,,,,,,,,,,,
4194,305,K,N,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673705-7673705","hg38,17:g.7673705C>A, hg38,17:g.7673705C>G",0.615,"haematopoietic_and_lymphoid_tissue, lymph_node, oesophagus, upper_aerodigestive_tract, larynx","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,,,,,,,,,,
4195,305,K,R,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673706-7673706","hg38,17:g.7673706T>C",0.572,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, upper_aerodigestive_tract, mouth, lip","carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, Hodgkin_lymphoma, nodular_sclerosing",,,,,,,,,,,,,,
4196,305,K,T,,,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,17:7577024-7577024, hg38,17:7673706-7673706","hg19,17:g.7577024T>G, hg38,17:g.7673706T>G",0.680,"haematopoietic_and_lymphoid_tissue, mediastinum, large_intestine, colon, oesophagus","carcinoma, adenocarcinoma, lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma, other, Barrett_oesophagus",,,,,,,,,,,,,,
4197,306,R,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7577022-7577022, hg38,17:7673704-7673704","hg19,17:g.7577022G>C, hg38,17:g.7673704G>C",0.741,,,,,,,3328176,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4198,306,R,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673703-7673703","hg38,17:g.7673703C>G",0.790,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4199,306,R,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,COSMIC,ClinVar","blca_msk_2025, brca_msk_2025, gbc_msk_2018, msk_impact_2017","Bladder Urothelial Carcinoma, Gallbladder Cancer, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7577021-7577021, hg38,17:7673703-7673703","hg19,17:g.7577021C>T, hg38,17:g.7673703C>T",0.764,", breast, haematopoietic_and_lymphoid_tissue, lymph_node, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, carcinoma, ductal_carcinoma, carcinoma, of_unknown_primary, lymphoid_neoplasm, Hodgkin_lymphoma, mixed_cellularity",0.0000039763961127,,,,458574,Conflicting classifications of pathogenicity,"Squamous cell carcinoma of the head and neck;Hereditary cancer-predisposing syndrome;Familial cancer of breast;not specified;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome;Familial cancer of breast",1,,,,,,
4200,307,A,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7576926-7576926, hg38,17:7673608-7673608","hg19,17:g.7576926G>C, hg38,17:g.7673608G>C",0.431,,,,,,,485027,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4201,307,A,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,COSMIC,ClinVar",heme_msk_impact_2022,Mixed Cancer Types,"hg19,17:7577019-7577019, hg38,17:7673701-7673701","hg19,17:g.7577019C>G, hg38,17:g.7673701C>G",0.491,"haematopoietic_and_lymphoid_tissue, breast","lymphoid_neoplasm, breast_implant_associated_anaplastic_large_cell_lymphoma, ALK_negative",,,,,1766148,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
4202,307,A,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673701-7673701","hg38,17:g.7673701C>A",0.432,skin,malignant_melanoma,,,,,,,,,,,,,,
4203,307,A,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7577019-7577019, hg38,17:7673701-7673701","hg19,17:g.7577019C>T, hg38,17:g.7673701C>T",0.371,"oesophagus, upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma, other, Barrett_oesophagus",,,,,2809879,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4204,307,A,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_KEX2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 305-307, ggetELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_broad_2019, ccle_genentech_2014, chol_icgc_2017, cll_broad_2015, cll_broad_2022, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub, lgggbm_tcga_pub, pan_origimed_2020","Cholangiocarcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Glioma, Mixed Cancer Types","hg19,17:7576926-7576926, hg19,17:7673608-7673608, hg38,17:7673608-7673608","hg19,17:g.7576926G>A, hg19,17:g.7673608G>A, hg38,17:g.7673608G>A",0.427,"biliary_tract, bile_duct, central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, oesophagus, upper_aerodigestive_tract, head_neck","carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,666137,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4205,308,L,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673606-7673606","hg38,17:g.7673606G>T",0.406,"liver, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4206,308,L,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673606-7673606","hg38,17:g.7673606G>C",0.427,"ovary, soft_tissue, striated_muscle, pharynx","carcinoma, mucinous_carcinoma, rhabdomyosarcoma, embryonal",,,,,,,,,,,,,,
4207,309,P,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,ClinVar","mel_mskimpact_2020, msk_met_2021, nsclc_ctdx_msk_2022","Cutaneous Melanoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7576920-7576920, hg38,17:7673602-7673602","hg19,17:g.7576920G>A, hg38,17:g.7673602G>A",0.535,,,,,,,1471105,Uncertain significance,"Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",2,,,,,,
4208,309,P,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673602-7673602","hg38,17:g.7673602G>C",0.440,"upper_aerodigestive_tract, mouth, retromolar","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4209,309,P,S,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_nci60",Mixed Cancer Types,"hg19,17:7576921-7576921, hg19,17:7673603-7673603, hg38,17:7673603-7673603","hg19,17:g.7576921G>A, hg19,17:g.7673603G>A, hg38,17:g.7673603G>A",0.607,"large_intestine, large_intestine, colon, upper_aerodigestive_tract, mouth","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,458575,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4210,309,P,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 305-309, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7576921-7576921, hg38,17:7673603-7673603","hg19,17:g.7576921G>T, hg38,17:g.7673603G>T",0.546,,,,,,,3634423,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4211,310,N,D,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576918-7576918, hg38,17:7673600-7673600","hg19,17:g.7576918T>C, hg38,17:g.7673600T>C",0.340,"haematopoietic_and_lymphoid_tissue, large_intestine, rectum","carcinoma, adenocarcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,,651517,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4212,310,N,H,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576918-7576918, hg38,17:7673600-7673600","hg19,17:g.7576918T>G, hg38,17:g.7673600T>G",0.350,lung,"carcinoma, squamous_cell_carcinoma",,,,,2841682,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4213,310,N,I,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7576917-7576917, hg38,17:7673599-7673599","hg19,17:g.7576917T>A, hg38,17:g.7673599T>A",0.384,,,,,,,1720175,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4214,310,N,K,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"ClinVar,ClinVar",,,"hg19,17:7576916-7576916, hg38,17:7673598-7673598","hg19,17:g.7576916G>C, hg19,17:g.7576916G>T, hg38,17:g.7673598G>C, hg38,17:g.7673598G>T","0.195, 0.196",,,0.0000079529187212,,,,"428879, 234067","Likely benign, Conflicting classifications of pathogenicity",Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,"1, 1",,,,,,
4215,310,N,L,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673598-7673600","hg38,17:g.7673598_7673600delinsCAA",,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4216,310,N,S,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7576917-7576917, hg38,17:7673599-7673599","hg19,17:g.7576917T>C, hg38,17:g.7673599T>C",0.352,,,,,,,1766454,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4217,310,N,T,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673599-7673599","hg38,17:g.7673599T>G",0.366,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4218,311,N,D,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673597-7673597","hg38,17:g.7673597T>C",0.220,"skin, shoulder","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4219,311,N,H,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576915-7576915, hg38,17:7673597-7673597","hg19,17:g.7576915T>G, hg38,17:g.7673597T>G",0.234,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,528240,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4220,311,N,I,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,cBioPortal,nsclc_ctdx_msk_2022,Non-Small Cell Lung Cancer,"hg19,17:7576914-7576914","hg19,17:g.7576914T>A",0.378,,,,,,,,,,,,,,,,
4221,311,N,K,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673595-7673595","hg38,17:g.7673595G>C",0.311,ovary,"carcinoma, serous_carcinoma",,,,,,,,,,,,,,
4222,311,N,S,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7576914-7576914, hg38,17:7673596-7673596","hg19,17:g.7576914T>C, hg38,17:g.7673596T>C",0.312,,,,,,,406589,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
4223,311,N,T,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7576914-7576914, hg38,17:7673596-7673596","hg19,17:g.7576914T>G, hg38,17:g.7673596T>G",0.372,,,,,,,219969,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
4224,311,N,Y,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673597-7673597","hg38,17:g.7673597T>A",0.315,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,,,,,,,,,,
4225,312,T,A,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576912-7576912, hg38,17:7673594-7673594","hg19,17:g.7576912T>C, hg38,17:g.7673594T>C",0.478,large_intestine,"carcinoma, adenocarcinoma",,,,,2679231,Uncertain significance,"Adrenocortical carcinoma, hereditary",1,,,,,,
4226,312,T,I,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,COSMIC,ClinVar","difg_glass, difg_glass_2019, pan_origimed_2020, pancan_pcawg_2020","Diffuse Glioma, Mixed Cancer Types","hg19,17:7576911-7576911, hg38,17:7673593-7673593","hg19,17:g.7576911G>A, hg38,17:g.7673593G>A",0.520,"pancreas, urinary_tract, bladder","carcinoma, ductal_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,1697592,Uncertain significance,not specified;Li-Fraumeni syndrome,2,,,,,,
4227,312,T,N,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7576911-7576911, hg38,17:7673593-7673593","hg19,17:g.7576911G>T, hg38,17:g.7673593G>T",0.455,,,,,,,1766672,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4228,312,T,S,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,COSMIC,ClinVar",mds_iwg_2022,Myelodysplastic Syndromes,"hg19,17:7576911-7576911, hg38,17:7673593-7673593, hg38,17:7673594-7673594","hg19,17:g.7576911G>C, hg38,17:g.7673593G>C, hg38,17:g.7673594T>A","0.397, 0.405","haematopoietic_and_lymphoid_tissue, ovary, upper_aerodigestive_tract, mouth","carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, plasma_cell_myeloma",0.0000675976587352,0.0001274047649382,,,141102,Benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4229,313,S,C,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,"hg38,17:7673591-7673591","hg38,17:g.7673591T>A",0.458,lung,"carcinoma, small_cell_carcinoma",,,,,,,,,,,,,,
4230,313,S,G,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,,,,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
4231,313,S,N,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576908-7576908, hg38,17:7673590-7673590","hg19,17:g.7576908C>T, hg38,17:g.7673590C>T",0.345,"central_nervous_system, brain, ovary","carcinoma, serous_carcinoma, glioma, astrocytoma",,,,,2450750,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4232,313,S,T,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,COSMIC,,,,,,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
4233,314,S,C,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,COSMIC,ClinVar",npc_nusingapore,Nasopharyngeal Carcinoma,"hg19,17:7576905-7576905, hg38,17:7673587-7673587","hg19,17:g.7576905G>C, hg38,17:g.7673587G>C",0.430,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma",,,,,848532,Uncertain significance,"Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",2,,,,,,
4234,314,S,F,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576905-7576905, hg38,17:7673587-7673587","hg19,17:g.7576905G>A, hg38,17:g.7673587G>A",0.526,"liver, pleura","carcinoma, hepatocellular_carcinoma, mesothelioma, mesothelioma, epithelial",0.0000039763644895,,,,406587,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",1,,,,,,
4235,315,S,C,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"cBioPortal,COSMIC,ClinVar","ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018",Endometrial Carcinoma,"hg19,17:7576902-7576902, hg19,17:7673584-7673584, hg38,17:7673584-7673584","hg19,17:g.7576902G>C, hg19,17:g.7673584G>C, hg38,17:g.7673584G>C",0.531,"endometrium, upper_aerodigestive_tract, mouth","carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,927085,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4236,315,S,F,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7576902-7576902, hg38,17:7673584-7673584","hg19,17:g.7576902G>A, hg38,17:g.7673584G>A",0.519,,,,,,,1009427,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4237,315,S,P,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576903-7576903, hg38,17:7673585-7673585","hg19,17:g.7576903A>G, hg38,17:g.7673585A>G",0.555,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,2891760,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4238,315,S,T,P,,,,,,,,,,PhosphoSite,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM",,ClinVar,,,"hg19,17:7576903-7576903, hg38,17:7673585-7673585","hg19,17:g.7576903A>T, hg38,17:g.7673585A>T",0.426,,,0.0000119296627087,,,,185212,Likely benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome,3,,,,,,
4239,316,P,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM",,"cBioPortal,COSMIC,ClinVar","bcc_unige_2016, msk_chord_2024, msk_met_2021, rectal_msk_2022, skcm_broad","Basal Cell Carcinoma, Bowel, Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7576899-7576899, hg38,17:7673581-7673581","hg19,17:g.7576899G>A, hg38,17:g.7673581G>A",0.585,"large_intestine, colon, skin, skin, neck, thyroid, upper_aerodigestive_tract, larynx, supraglottis","carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,528273,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4240,316,P,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM",,"cBioPortal,COSMIC,ClinVar",nsclc_ctdx_msk_2022,Non-Small Cell Lung Cancer,"hg19,17:7576900-7576900, hg38,17:7673582-7673582","hg19,17:g.7576900G>A, hg38,17:g.7673582G>A",0.441,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,823268,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4241,316,P,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM",,ClinVar,,,"hg19,17:7576900-7576900, hg38,17:7673582-7673582","hg19,17:g.7576900G>T, hg38,17:g.7673582G>T",0.426,,,0.0000039764909853,,,,230382,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,3,,,,,,
4242,317,Q,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM",,ClinVar,,,"hg19,17:7576895-7576895, hg38,17:7673577-7673577","hg19,17:g.7576895C>A, hg38,17:g.7673577C>A",0.397,,,,,,,406585,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4243,317,Q,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576897-7576897, hg38,17:7673579-7673579","hg19,17:g.7576897G>T, hg38,17:g.7673579G>T",0.321,"endometrium, large_intestine, rectum","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0000039766491164,0.0000318471337580,,,231008,Benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,,,
4244,317,Q,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM",,ClinVar,,,"hg19,17:7576896-7576896, hg38,17:7673578-7673578","hg19,17:g.7576896T>A, hg38,17:g.7673578T>A",0.395,,,,,,,855943,Uncertain significance,"Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",2,,,,,,
4245,317,Q,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM",,"cBioPortal,COSMIC",nsclc_ctdx_msk_2022,Non-Small Cell Lung Cancer,"hg19,17:7576896-7576896, hg38,17:7673578-7673578","hg19,17:g.7576896T>G, hg38,17:g.7673578T>G",0.424,"urinary_tract, bladder",carcinoma,,,,,,,,,,,,,,
4246,317,Q,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 312-317, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_metabric, pancan_pdmr_2025","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7576896-7576896, hg38,17:7673578-7673578","hg19,17:g.7576896T>C, hg38,17:g.7673578T>C",0.366,"bone, large_intestine, ovary, skin, hand","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma, osteosarcoma",0.0000039767756303,,,,581024,Conflicting classifications of pathogenicity,TP53-related disorder;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4247,318,P,A,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,COSMIC,,,"hg38,17:7673576-7673576","hg38,17:g.7673576G>C",0.335,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4248,318,P,L,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,"cBioPortal,ClinVar",brca_aurora_2023,Invasive Breast Carcinoma,"hg19,17:7576893-7576893, hg19,17:7673575-7673575, hg38,17:7673575-7673575","hg19,17:g.7576893G>A, hg19,17:g.7673575G>A, hg38,17:g.7673575G>A",0.358,,,,,,,492627,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4249,318,P,R,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,"cBioPortal,ClinVar",ccle_genentech_2014,Mixed Cancer Types,"hg19,17:7576893-7576893, hg38,17:7673575-7673575","hg19,17:g.7576893G>C, hg38,17:g.7673575G>C",0.336,,,,,,,2081538,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4250,318,P,S,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,ClinVar,,,"hg19,17:7576894-7576894, hg38,17:7673576-7673576","hg19,17:g.7576894G>A, hg38,17:g.7673576G>A",0.302,,,,,,,2575170,Benign,Acute myeloid leukemia,0,,,,,,
4251,318,P,T,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,cBioPortal,ccle_genentech_2014,Mixed Cancer Types,"hg19,17:7576894-7576894","hg19,17:g.7576894G>T",0.329,,,,,,,,,,,,,,,,
4252,319,K,E,,,Ubq,,,Ac,,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,COSMIC,,,"hg38,17:7673573-7673573","hg38,17:g.7673573T>C",0.787,"skin, upper_aerodigestive_tract, larynx, glottis","carcinoma, basal_cell_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4253,319,K,M,,,Ubq,,,Ac,,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,cBioPortal,msk_ctdna_vte_2024,Mixed Cancer Types,"hg19,17:7576890-7576890","hg19,17:g.7576890T>A",0.863,,,,,,,,,,,,,,,,
4254,319,K,N,,,Ubq,,,Ac,,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, msk_chord_2024, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, thyroid_gatci_2024, tmb_mskcc_2018","Bowel, Cervical Squamous Cell Carcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types, Thyroid","hg19,17:7576889-7576889, hg19,17:7673571-7673571, hg38,17:7673571-7673571","hg19,17:g.7576889C>A, hg19,17:g.7576889C>G, hg19,17:g.7673571C>G, hg38,17:g.7673571C>A, hg38,17:g.7673571C>G",0.839,"cervix, large_intestine, caecum, lung, ovary, urinary_tract","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, germ_cell_tumour, teratoma, benign, squamous_cell_carcinoma",,,,,,,,,,,,,,
4255,319,K,R,,,Ubq,,,Ac,,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,COSMIC,,,"hg38,17:7673572-7673572","hg38,17:g.7673572T>C",0.718,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4256,319,K,T,,,Ubq,,,Ac,,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,ClinVar,,,"hg19,17:7576890-7576890, hg38,17:7673572-7673572","hg19,17:g.7576890T>G, hg38,17:g.7673572T>G",0.855,,,,,,,3328169,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4257,320,K,E,,,Ubq,,,Ac,Sumo,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,"cBioPortal,COSMIC",lusc_tcga_pan_can_atlas_2018,Lung Squamous Cell Carcinoma,"hg19,17:7576888-7576888, hg38,17:7673570-7673570","hg19,17:g.7576888T>C, hg38,17:g.7673570T>C",0.759,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4258,320,K,N,,,Ubq,,,Ac,Sumo,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,"cBioPortal,COSMIC","bladder_msk_2023, blca_msk_tcga_2020, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, msk_access_2021, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, paired_bladder_2022, pan_origimed_2020","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7576886-7576886, hg19,17:7673568-7673568, hg38,17:7673568-7673568","hg19,17:g.7576886C>A, hg19,17:g.7576886C>G, hg19,17:g.7673568C>G, hg38,17:g.7673568C>G",0.706,"breast, lung, ovary, urinary_tract, bladder","carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,,,,,,,,,,
4259,320,K,R,,,Ubq,,,Ac,Sumo,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,cBioPortal,"msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,17:7576887-7576887","hg19,17:g.7576887T>C",0.605,,,,,,,,,,,,,,,,
4260,320,K,T,,,Ubq,,,Ac,Sumo,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,ClinVar,,,"hg19,17:7576887-7576887, hg38,17:7673569-7673569","hg19,17:g.7576887T>G, hg38,17:g.7673569T>G",0.800,,,,,,,3071811,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
4261,321,K,T,,,Ubq,,,,,,,,PhosphoSite,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,ClinVar,,,"hg19,17:7576884-7576884, hg38,17:7673566-7673566","hg19,17:g.7576884T>G, hg38,17:g.7673566T>G",0.700,,,,,,,3893199,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4262,322,P,A,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,ClinVar,,,"hg19,17:7576882-7576882, hg38,17:7673564-7673564","hg19,17:g.7576882G>C, hg38,17:g.7673564G>C",0.429,,,,,,,1720306,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4263,322,P,L,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,"cBioPortal,COSMIC","crc_apc_impact_2020, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7576881-7576881, hg38,17:7673563-7673563","hg19,17:g.7576881G>A, hg38,17:g.7673563G>A",0.367,"peritoneum, skin, arm","carcinoma, peritoneal_serous_surface_carcinoma, other, keratosis",,,,,,,,,,,,,,
4264,322,P,R,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576881-7576881, hg38,17:7673563-7673563","hg19,17:g.7576881G>C, hg38,17:g.7673563G>C",0.505,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,2679228,Uncertain significance,"Adrenocortical carcinoma, hereditary",1,,,,,,
4265,322,P,S,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,ClinVar,,,"hg19,17:7576882-7576882, hg38,17:7673564-7673564","hg19,17:g.7576882G>A, hg38,17:g.7673564G>A",0.474,,,,,,,216475,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4266,322,P,T,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,ClinVar,,,"hg19,17:7576882-7576882, hg38,17:7673564-7673564","hg19,17:g.7576882G>T, hg38,17:g.7673564G>T",0.555,,,,,,,231553,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4267,323,L,G,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,COSMIC,,,"hg38,17:7673560-7673561","hg38,17:g.7673560_7673561delinsCC",,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4268,323,L,M,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,COSMIC,,,"hg38,17:7673561-7673561","hg38,17:g.7673561G>T",0.362,liver,"carcinoma, hepatocellular_carcinoma",,,,,,,,,,,,,,
4269,323,L,P,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576878-7576878, hg38,17:7673560-7673560","hg19,17:g.7576878A>G, hg38,17:g.7673560A>G",0.392,"skin, arm","other, keratosis",,,,,823403,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4270,323,L,R,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,COSMIC,,,"hg38,17:7673560-7673560","hg38,17:g.7673560A>C",0.477,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4271,323,L,V,,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_Bipartite_1), 305-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 316-323, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 318-323, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576879-7576879, hg38,17:7673561-7673561","hg19,17:g.7576879G>C, hg38,17:g.7673561G>C",0.288,ovary,"carcinoma, serous_carcinoma",,0.0001273641979240,,,2679234,Uncertain significance,"Adrenocortical carcinoma, hereditary",1,,,,,,
4272,324,D,A,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM",,"cBioPortal,COSMIC","msk_chord_2024, msk_impact_2017, msk_met_2021, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prostate_msk_2024","Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7576875-7576875, hg38,17:7673557-7673557","hg19,17:g.7576875T>G, hg38,17:g.7673557T>G",0.811,prostate,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4273,324,D,E,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM",,"cBioPortal,COSMIC,ClinVar",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7576874-7576874, hg38,17:7673556-7673556","hg19,17:g.7576874A>T, hg38,17:g.7673556A>C, hg38,17:g.7673556A>T",0.615,"ovary, skin","carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,2450758,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4274,324,D,G,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,17:7576875-7576875, hg38,17:7673557-7673557","hg19,17:g.7576875T>C, hg38,17:g.7673557T>C",0.808,"large_intestine, colon, descending","carcinoma, adenocarcinoma",0.0000039770286823,,,,,,,,,,,,,
4275,324,D,H,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576876-7576876, hg38,17:7673558-7673558","hg19,17:g.7576876C>G, hg38,17:g.7673558C>G",0.634,"soft_tissue, blood_vessel, heart",angiosarcoma,0.0000079540573647,,,,420950,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4276,324,D,N,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM",,"cBioPortal,COSMIC,ClinVar",blca_msk_2025,Bladder Urothelial Carcinoma,"hg19,17:7576876-7576876, hg38,17:7673558-7673558","hg19,17:g.7576876C>T, hg38,17:g.7673558C>T",0.665,"central_nervous_system, parietooccipital","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000039770286823,,,,2578516,Benign,Acute myeloid leukemia,0,,,,,,
4277,324,D,S,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM",,COSMIC,,,"hg38,17:7673557-7673558","hg38,17:g.7673557_7673558delinsCT",,pancreas,"carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
4278,324,D,Y,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 318-324, ggetELM",,ClinVar,,,"hg19,17:7576876-7576876, hg38,17:7673558-7673558","hg19,17:g.7576876C>A, hg38,17:g.7673558C>A",0.768,,,,,,,630832,Uncertain significance,Hereditary cancer-predisposing syndrome,2,,,,,,
4279,325,G,A,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,"cBioPortal,COSMIC","blca_cornell_2016, blca_mskcc_solit_2014, msk_met_2021, paired_bladder_2022, pan_origimed_2020","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7576872-7576872, hg38,17:7673554-7673554","hg19,17:g.7576872C>G, hg38,17:g.7673554C>G",0.271,"urinary_tract, bladder",carcinoma,,,,,,,,,,,,,,
4280,325,G,E,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_metabric, brca_msk_2025, breast_msk_2025, msk_chord_2024","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7576872-7576872, hg38,17:7673554-7673554","hg19,17:g.7576872C>T, hg38,17:g.7673554C>T",0.315,breast,carcinoma,,,,,480952,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",1,,,,,,
4281,325,G,R,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,ClinVar,,,"hg19,17:7576873-7576873, hg38,17:7673555-7673555","hg19,17:g.7576873C>T, hg38,17:g.7673555C>T",0.461,,,,,,,480740,Conflicting classifications of pathogenicity,not specified;Hereditary cancer-predisposing syndrome,1,,,,,,
4282,325,G,V,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,"cBioPortal,COSMIC,ClinVar","luad_mskcc_2015, mixed_allen_2018","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7576872-7576872, hg38,17:7673554-7673554","hg19,17:g.7576872C>A, hg38,17:g.7673554C>A",0.680,"lung, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",0.0000039774083207,,,,12367,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Non-Hodgkin lymphoma;Li-Fraumeni syndrome;Familial colorectal cancer,1,,,,,,
4283,326,E,D,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,"ClinVar,ClinVar",,,"hg19,17:7576868-7576868, hg38,17:7673550-7673550","hg19,17:g.7576868T>A, hg19,17:g.7576868T>G, hg38,17:g.7673550T>A, hg38,17:g.7673550T>G",0.702,,,0.0000039774399605,,,,"3972458, 1021810","Likely benign, Uncertain significance","Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome","1, 2",,,,,,
4284,326,E,K,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,"cBioPortal,COSMIC","ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, lms_msk_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, sarcoma_mskcc_2022, usarc_msk_2020","Mixed Cancer Types, Soft Tissue, Uterine Sarcoma/Mesenchymal","hg19,17:7576870-7576870, hg19,17:7673552-7673552, hg38,17:7673552-7673552","hg19,17:g.7576870C>T, hg19,17:g.7673552C>T, hg38,17:g.7673552C>T",0.842,"large_intestine, colon, oesophagus, soft_tissue, smooth_muscle, uterus, urinary_tract","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, leiomyosarcoma",,,,,,,,,,,,,,
4285,326,E,Q,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,"cBioPortal,COSMIC",brca_metabric,Invasive Breast Carcinoma,"hg19,17:7576870-7576870, hg38,17:7673552-7673552","hg19,17:g.7576870C>G, hg38,17:g.7673552C>G",0.792,"urinary_tract, bladder","carcinoma, small_cell_carcinoma",,,,,,,,,,,,,,
4286,326,E,V,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,ClinVar,,,"hg19,17:7576869-7576869, hg38,17:7673551-7673551","hg19,17:g.7576869T>A, hg38,17:g.7673551T>A",0.874,,,,,,,2578514,Likely pathogenic,Acute myeloid leukemia,0,,,,,,
4287,327,Y,C,P,,,,,,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,ClinVar,,,"hg19,17:7576866-7576866, hg38,17:7673548-7673548","hg19,17:g.7576866T>C, hg38,17:g.7673548T>C",0.658,,,,,,,2783073,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4288,327,Y,D,P,,,,,,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,COSMIC,,,"hg38,17:7673549-7673549","hg38,17:g.7673549A>C",0.723,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4289,327,Y,N,P,,,,,,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,COSMIC,,,"hg38,17:7673549-7673549","hg38,17:g.7673549A>T",0.718,"skin, head_neck","malignant_melanoma, superficial_spreading",,,,,,,,,,,,,,
4290,328,F,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,"cBioPortal,COSMIC,ClinVar",sarcoma_msk_2022,Soft Tissue,"hg19,17:7576863-7576863, hg38,17:7673545-7673545","hg19,17:g.7576863A>G, hg38,17:g.7673545A>G",0.859,large_intestine,"carcinoma, adenocarcinoma",,,,,648339,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4291,328,F,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,COSMIC,,,"hg38,17:7673546-7673546","hg38,17:g.7673546A>C",0.932,stomach,carcinoma,,,,,,,,,,,,,,
4292,329,T,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,ClinVar,,,"hg19,17:7576861-7576861, hg38,17:7673543-7673543","hg19,17:g.7576861T>C, hg38,17:g.7673543T>C",0.835,,,,,,,939133,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4293,329,T,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,"cBioPortal,COSMIC,ClinVar",cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,17:7576859-7576860, hg19,17:7576860-7576860, hg38,17:7673541-7673542, hg38,17:7673542-7673542","hg19,17:g.7576859_7576860delinsAA, hg19,17:g.7576860G>A, hg38,17:g.7673541_7673542delinsAA, hg38,17:g.7673542G>A",0.758,"central_nervous_system, brain, skin, ear, upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma, glioma, oligodendroglioma_Grade_III, anaplastic",0.0000039778829707,,,,652718,Conflicting classifications of pathogenicity,not specified;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4294,330,L,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7576858-7576858, hg38,17:7673540-7673540","hg19,17:g.7576858G>A, hg38,17:g.7673540G>A",0.856,"large_intestine, colon, skin, ear, soft_tissue, blood_vessel, skin, scalp","angiosarcoma, carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,1024800,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4295,330,L,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,"cBioPortal,COSMIC,ClinVar","luad_mskcc_2023_met_organotropism, mel_mskimpact_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, prostate_msk_2024, sarcoma_msk_2022, tmb_mskcc_2018","Cutaneous Melanoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Soft Tissue","hg19,17:7576857-7576857, hg38,17:7673539-7673539","hg19,17:g.7576857A>T, hg38,17:g.7673539A>T",0.943,"liver, lung, oesophagus, ovary, skin","carcinoma, carcinoma, carcinosarcoma-malignant_mesodermal_mixed_tumour, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,1409387,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4296,330,L,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,"cBioPortal,COSMIC","pancan_mimsi_msk_2024, skcm_tcga_pan_can_atlas_2018, ucec_ancestry_cds_msk_2023","Cutaneous Melanoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7576858-7576858, hg38,17:7673540-7673540","hg19,17:g.7576858G>T, hg38,17:g.7673540G>T",0.772,skin,malignant_melanoma,,,,,,,,,,,,,,
4297,330,L,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_mapk_hp_msk_2021, breast_msk_2018, breast_msk_2025, lihc_amc_prv, mds_iwg_2022, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_pdmr_2025, prad_p1000, prad_su2c_2019, sarcoma_msk_2022","Breast, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7576857-7576857, hg38,17:7673539-7673539","hg19,17:g.7576857A>G, hg38,17:g.7673539A>G",0.957,"breast, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, haematopoietic_neoplasm, myelodysplastic_syndrome, refractory_anaemia_with_excess_blasts",,,,,651580,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4298,330,L,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 324-330, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 326-330, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 327-330, ggetELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 327-330, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_metabric, csf_msk_2024, lms_msk_2024, luad_msk_npjpo_2021, luad_mskcc_2023_met_organotropism, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, pan_origimed_2020, skcm_tcga, skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7576857-7576857, hg19,17:7673539-7673539, hg38,17:7673539-7673539","hg19,17:g.7576857A>C, hg19,17:g.7673539A>C, hg38,17:g.7673539A>C",0.943,"breast, liver, pancreas, pleura, skin, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, carcinoma, ductal_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, malignant_melanoma, mesothelioma, epithelial",,,,,1510133,Uncertain significance,not provided;Li-Fraumeni syndrome,2,,,,,,
4299,331,Q,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,ClinVar,,,"hg19,17:7576855-7576855, hg38,17:7673537-7673537","hg19,17:g.7576855G>C, hg38,17:g.7673537G>C",0.522,,,,,,,1950710,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4300,331,Q,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar","bm_nsclc_mskcc_2023, brca_metabric, coadread_tcga, coadread_tcga_pub, crc_eo_2020, crc_orion_2024, difg_glass, difg_glass_2019, hgsoc_tcga_gdc, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lms_msk_2024, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lung_msk_2017, lung_msk_mind_2020, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_iwg_2022, metastatic_solid_tumors_mich_2017, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_mskcc_2018, nsclc_tcga_broad_2016, ov_tcga_pan_can_atlas_2018, paad_icgc, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, prad_organoids_msk_2022, prad_su2c_2019, rectal_msk_2022, sarcoma_msk_2022, thyroid_gatci_2024","Bowel, Colorectal Adenocarcinoma, Diffuse Glioma, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma, Soft Tissue, Thyroid","hg19,17:7576853-7576853, hg19,17:7673535-7673535, hg38,17:7673535-7673535","hg19,17:g.7576853C>A, hg19,17:g.7576853C>G, hg19,17:g.7673535C>A, hg19,17:g.7673535C>G, hg38,17:g.7673535C>A, hg38,17:g.7673535C>G","0.580, 0.582","breast, central_nervous_system, brain, endometrium, haematopoietic_and_lymphoid_tissue, large_intestine, colon, large_intestine, colon, transverse, liver, lung, oesophagus, oesophagus, middle_third, ovary, pancreas, salivary_gland, parotid, upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mucoepidermoid_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, haematopoietic_neoplasm, myelodysplastic_syndrome_therapy_related",,,,,"2832740, 1497451","Uncertain significance, Uncertain significance",Li-Fraumeni syndrome|Li-Fraumeni syndrome,"1, 1",Uncertain significance,Neoplasm,1,,,
4301,331,Q,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,ClinVar,,,"hg19,17:7576855-7576855, hg38,17:7673537-7673537","hg19,17:g.7576855G>T, hg38,17:g.7673537G>T",0.467,,,,,,,823553,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
4302,331,Q,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,17:7576854-7576854","hg19,17:g.7576854T>A",0.761,,,,,,,,,,,,,,,,
4303,331,Q,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,COSMIC,,,"hg38,17:7673535-7673536, hg38,17:7673536-7673536","hg38,17:g.7673535_7673536delinsTG, hg38,17:g.7673536T>G",0.741,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4304,331,Q,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SFK_2), 325-331, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, pan_origimed_2020, prad_organoids_msk_2022","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,17:7576854-7576854, hg19,17:7673536-7673536, hg38,17:7673536-7673536","hg19,17:g.7576854T>C, hg19,17:g.7673536T>C, hg38,17:g.7673536T>C",0.592,"large_intestine, large_intestine, colon, ascending","carcinoma, adenocarcinoma",,,,,421319,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4305,332,I,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC","brca_msk_2025, breast_msk_2025, hcc_tcga_gdc, lihc_tcga, lihc_tcga_pan_can_atlas_2018, msk_chord_2024, pediatric_dkfz_2017","Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7574033-7574033, hg19,17:7670715-7670715, hg38,17:7670715-7670715","hg19,17:g.7574033T>A, hg19,17:g.7670715T>A, hg38,17:g.7670715T>A",0.869,liver,"carcinoma, hepatocellular_carcinoma",,,,,,,,,,,,,,
4306,332,I,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,ClinVar,,,"hg19,17:7574033-7574033, hg38,17:7670715-7670715","hg19,17:g.7574033T>G, hg38,17:g.7670715T>G",0.743,,,,,,,4189263,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4307,332,I,M,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,ClinVar,,,"hg19,17:7574031-7574031, hg38,17:7670713-7670713","hg19,17:g.7574031G>C, hg38,17:g.7670713G>C",0.798,,,,,,,458583,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4308,332,I,N,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC,ClinVar","luad_mskcc_2020, msk_chord_2024, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7574032-7574032, hg38,17:7670714-7670714","hg19,17:g.7574032A>T, hg38,17:g.7670714A>T",0.926,"lung, right_upper_lobe, skin, upper_leg","carcinoma, adenocarcinoma, malignant_melanoma, nodular",,,,,1768732,Likely pathogenic,Hereditary cancer-predisposing syndrome,1,,,,,,
4309,332,I,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC","luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, summit_2018","Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7574032-7574032, hg38,17:7670714-7670714","hg19,17:g.7574032A>C, hg38,17:g.7670714A>C",0.949,"adrenal_gland, adrenal_gland, haematopoietic_and_lymphoid_tissue, lung","adrenal_cortical_carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia",,,,,,,,,,,,,,
4310,332,I,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,ClinVar,,,"hg19,17:7574032-7574032, hg38,17:7670714-7670714","hg19,17:g.7574032A>G, hg38,17:g.7670714A>G",0.945,,,,,,,1768734,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4311,332,I,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,COSMIC,,,"hg38,17:7670715-7670715","hg38,17:g.7670715T>C",0.416,ovary,carcinoma,,,,,,,,,,,,,,
4312,333,R,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC,ClinVar","cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, coadread_tcga_pan_can_atlas_2018, mds_mskcc_2020, msk_chord_2024, msk_met_2021, ovarian_msk_2025, pancan_mimsi_msk_2024, prad_msk_stopsack_2021, prostate_msk_2024, sft_sysucc_2023","Cervical Squamous Cell Carcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Ovary/Fallopian Tube, Prostate, Prostate Adenocarcinoma","hg19,17:7574030-7574030, hg19,17:7670712-7670712, hg38,17:7670712-7670712","hg19,17:g.7574030G>A, hg19,17:g.7670712G>A, hg38,17:g.7670712G>A",0.862,"haematopoietic_and_lymphoid_tissue, large_intestine, colon, stomach, gastroesophageal_junction, upper_aerodigestive_tract, pharynx, nasopharynx, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, adenocarcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, nasopharyngeal_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia",0.0000239513308956,,,,184745,Likely benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;not provided;not specified;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Squamous cell carcinoma of the head and neck,3,,,,,,
4313,333,R,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,ClinVar,,,"hg19,17:7574030-7574030, hg38,17:7670712-7670712","hg19,17:g.7574030G>C, hg38,17:g.7670712G>C",0.855,,,0.0000039918884826,,,,4427925,,,,,,,,,
4314,333,R,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7574029-7574029, hg38,17:7670711-7670711","hg19,17:g.7574029C>T, hg38,17:g.7670711C>T",0.554,", large_intestine, colon, thymus","carcinoma, adenocarcinoma, malignant_melanoma, thymic_carcinoma",0.0000439006090212,0.0000318410494810,,,142273,Benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4315,333,R,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021, nsclc_ctdx_msk_2022, stad_oncosg_2018, stad_pfizer_uhongkong","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Stomach Adenocarcinoma","hg19,17:7574029-7574029, hg38,17:7670711-7670711","hg19,17:g.7574029C>G, hg38,17:g.7670711C>G",0.829,stomach,"carcinoma, intestinal_adenocarcinoma",,,,,,,,,,,,,,
4316,333,R,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 327-333, ggetELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,17:7574030-7574030","hg19,17:g.7574030G>T",0.850,,,,,,,,,,,,,,,,
4317,334,G,A,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC","hcc_clca_2024, luad_broad, nsclc_tcga_broad_2016","Hepatocellular Carcinoma, Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,17:7574026-7574026, hg38,17:7670708-7670708","hg19,17:g.7574026C>G, hg38,17:g.7670708C>G",0.936,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4318,334,G,E,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC,ClinVar","mel_dfci_2019, mel_iatlas_liu_2019, msk_met_2021","Melanoma, Mixed Cancer Types","hg19,17:7574026-7574026, hg19,17:7670708-7670708, hg38,17:7670708-7670708","hg19,17:g.7574026C>T, hg19,17:g.7670708C>T, hg38,17:g.7670708C>T",0.950,"biliary_tract, bile_duct, stomach","carcinoma, adenocarcinoma",,0.0000318613394507,,,951578,Uncertain significance,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",2,,,,,,
4319,334,G,L,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC","bm_nsclc_mskcc_2023, luad_mskcc_2023_met_organotropism, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7574026-7574027, hg38,17:7670708-7670709","hg19,17:g.7574026_7574027delinsAA, hg38,17:g.7670708_7670709delinsAA",,prostate,carcinoma,,,,,,,,,,,,,,
4320,334,G,R,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,ClinVar,ClinVar",egc_msk_2023,Esophagus/Stomach,"hg19,17:7574027-7574027, hg38,17:7670709-7670709","hg19,17:g.7574027C>G, hg19,17:g.7574027C>T, hg38,17:g.7670709C>G, hg38,17:g.7670709C>T",0.957,,,0.0000039906459259,,,,"186086, 182969","Conflicting classifications of pathogenicity, Uncertain significance","Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome","1, 3",,,,,,
4321,334,G,V,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_metabric, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, hccihch_pku_2019, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, pan_origimed_2020, sclc_jhu, stad_utokyo, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Breast, Endometrial Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Stomach Adenocarcinoma","hg19,17:7574025-7574026, hg19,17:7574026-7574026, hg19,17:7670708-7670708, hg38,17:7670708-7670708","hg19,17:g.7574025_7574026delinsAA, hg19,17:g.7574026C>A, hg19,17:g.7670708C>A, hg38,17:g.7670708C>A",0.951,", breast, endometrium, liver, lung, lung, right_upper_lobe, pancreas, skin, stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, gingiva","adnexal_tumour, malignant_adnexal_tumour, eccrine_porocarcinoma, carcinoma, carcinoma, adenocarcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, other, neoplasm, pancreatic_intraepithelial_neoplasia_(PanIN)",,,,,3764945,,,,Likely oncogenic,Neoplasm,1,,,
4322,334,G,W,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC,ClinVar","bm_nsclc_mskcc_2023, braf_msk_impact_2024, hccihch_pku_2019, luad_cptac_2020, luad_cptac_gdc, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tsp, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsgct_tcga_gdc, pan_origimed_2020, sarcoma_msk_2022, tgct_tcga, tgct_tcga_pan_can_atlas_2018","Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Seminomatous Germ Cell Tumor, Non-Small Cell Lung Cancer, Soft Tissue, Testis","hg19,17:7574027-7574027, hg19,17:7670709-7670709, hg38,17:7670709-7670709","hg19,17:g.7574027C>A, hg19,17:g.7670709C>A, hg38,17:g.7670709C>A",0.948,"biliary_tract, bile_duct, haematopoietic_and_lymphoid_tissue, liver, lung, lung, right_upper_lobe, parathyroid, salivary_gland, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, large_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, non_small_cell_carcinoma, carcinoma, salivary_duct_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, other, intraepithelial_neoplasia, non_invasive-carcinoma_in_situ",,,,,428876,Likely pathogenic,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,2,,,,,,
4323,335,R,C,,Me,,,,,,,,,PhosphoSite,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC,ClinVar","cervix_msk_2023, msk_ch_2020, msk_ch_2023, msk_met_2021, pan_origimed_2020","Cervix, Mixed Cancer Types","hg19,17:7574024-7574024, hg38,17:7670706-7670706","hg19,17:g.7574024G>A, hg38,17:g.7670706G>A",0.819,"central_nervous_system, brain","glioma, oligodendroglioma_Grade_III, anaplastic",,,,,141159,Likely benign,"Hereditary cancer-predisposing syndrome;not provided;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",3,,,,,,
4324,335,R,H,,Me,,,,,,,,,PhosphoSite,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"cBioPortal,COSMIC,ClinVar","mds_iwg_2022, pan_origimed_2020","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7574023-7574023, hg38,17:7670705-7670705","hg19,17:g.7574023C>T, hg38,17:g.7670705C>T",0.629,"large_intestine, rectum, thyroid","carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma",0.0000039884176352,,,,480738,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4325,335,R,L,,Me,,,,,,,,,PhosphoSite,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7574023-7574023, hg38,17:7670705-7670705","hg19,17:g.7574023C>A, hg38,17:g.7670705C>A",0.775,"upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,,3328160,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4326,335,R,P,,Me,,,,,,,,,PhosphoSite,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,ClinVar,,,"hg19,17:7574023-7574023, hg38,17:7670705-7670705","hg19,17:g.7574023C>G, hg38,17:g.7670705C>G",0.875,,,,,,,840626,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4327,335,R,S,,Me,,,,,,,,,PhosphoSite,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 332-335, ggetELM",,cBioPortal,tgct_tcga,Non-Seminomatous Germ Cell Tumor,"hg19,17:7574024-7574024","hg19,17:g.7574024G>T",0.832,,,,,,,,,,,,,,,,
4328,336,E,A,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,17:7574020-7574020","hg19,17:g.7574020T>G",0.350,,,,,,,,,,,,,,,,
4329,336,E,G,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,17:7574020-7574020, hg38,17:7670702-7670702","hg19,17:g.7574020T>C, hg38,17:g.7670702T>C",0.357,"lung, ovary","carcinoma, carcinoma, squamous_cell_carcinoma",,,,,3780730,Uncertain significance,Familial cancer of breast,1,,,,,,
4330,336,E,K,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,COSMIC,,,"hg38,17:7670703-7670703","hg38,17:g.7670703C>T",0.203,"central_nervous_system, brain, large_intestine, colon, left, skin, shoulder, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, papillary_transitional_cell_carcinoma_non_invasive, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
4331,336,E,Q,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,ClinVar,,,"hg19,17:7574021-7574021, hg38,17:7670703-7670703","hg19,17:g.7574021C>G, hg38,17:g.7670703C>G",0.322,,,,,,,2450754,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4332,337,R,C,,Me,,,,,,,,,PhosphoSite,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,COSMIC,ClinVar","acc_2019, aml_ohsu_2018, aml_ohsu_2022, aml_tcga_gdc, blca_bcan_hcrn_2022, blca_msk_2024, blca_pdx_msk_2025, bm_nsclc_mskcc_2023, brca_broad, brca_cptac_2020, brca_igr_2015, brca_mapk_hp_msk_2021, brca_mbcproject_2022, brca_metabric, brca_msk_2025, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, cellline_ccle_broad, chol_icgc_2017, chol_msk_2018, coad_tcga_gdc, coadread_cass_2020, coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, crc_apc_impact_2020, crc_eo_2020, crc_msk_2017, crc_sysucc_2022, csf_msk_2024, difg_glass, difg_glass_2019, difg_tcga_gdc, egc_msk_2023, gbm_mayo_pdx_sarkaria_2019, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, glioma_mskcc_2019, hcc_clca_2024, hcc_jcopo_msk_2023, hcc_msk_2024, hcc_mskimpact_2018, hccihch_pku_2019, heme_msk_impact_2022, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_msk_2021, laml_tcga, laml_tcga_pan_can_atlas_2018, laml_tcga_pub, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, lms_msk_2024, luad_cas_2020, luad_mskcc_2023_met_organotropism, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, lung_msk_2017, lung_msk_mind_2020, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mds_iwg_2022, mds_mskcc_2020, mixed_allen_2018, mixed_cfdna_msk_2020, mnm_washu_2016, msk_access_2021, msk_ch_2020, msk_ch_2023, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, nsclc_unito_2016, ntrk_msk_2019, ov_tcga, ov_tcga_pub, paad_cptac_2021, paad_qcmg_uq_2016, paad_tcga, paad_tcga_gdc, paad_tcga_pan_can_atlas_2018, paired_bladder_2022, pan_origimed_2020, pancan_hcmi_2025, pancan_mappyacts_2022, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pancreas_cptac_gdc, pdac_msk_2024, pediatric_dkfz_2017, plmeso_msk_2024, pptc_2019, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_p1000, prad_pik3r1_msk_2021, prad_su2c_2019, prad_tcga, prad_tcga_gdc, prad_tcga_pan_can_atlas_2018, prostate_msk_2024, ptad_msk_2024, rectal_msk_2019, rectal_msk_2022, sarcoma_msk_2022, sarcoma_mskcc_2022, skcm_vanderbilt_mskcc_2015, stad_oncosg_2018, stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, thyroid_gatci_2024, tmb_mskcc_2018, uccc_nih_2017, ucec_ancestry_cds_msk_2023, ucs_msk_2024, usarc_msk_2020, wt_target_2018_pub","Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Bowel, Breast, Cholangiocarcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Cutaneous Melanoma, Diffuse Glioma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma, High-Grade Serous Ovarian Cancer, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Myeloid Neoplasm, Non-Small Cell Lung Cancer, Pancreas, Pancreatic Adenocarcinoma, Pituitary Adenoma, Pleural Mesothelioma, Prostate, Prostate Adenocarcinoma, Soft Tissue, Stomach Adenocarcinoma, Thyroid, Uterine Clear Cell Carcinoma, Uterine Sarcoma/Mesenchymal, Wilms' Tumor","hg19,17:7574018-7574018, hg19,17:7670700-7670700, hg38,17:7670700-7670700","hg19,17:g.7574018G>A, hg19,17:g.7670700G>A, hg38,17:g.7670700G>A",0.715,", adrenal_gland, adrenal_gland, biliary_tract, bile_duct, breast, central_nervous_system, brain, central_nervous_system, frontal_lobe, endometrium, haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, skin, kidney, large_intestine, large_intestine, anus, large_intestine, caecum, large_intestine, colon, large_intestine, colon, sigmoid, large_intestine, colon, transverse, large_intestine, rectum, liver, lung, lung, right_upper_lobe, oesophagus, oesophagus, middle_third, oesophagus, upper_third, ovary, pancreas, pancreas, ampulla_of_Vater, penis, peritoneum, prostate, salivary_gland, skin, scalp, soft_tissue, smooth_muscle, endometrium, soft_tissue, striated_muscle, trunk, stomach, stomach, gastroesophageal_junction, thyroid, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, mouth, tongue, urinary_tract, bladder, vulva","Wilms_tumour, adrenal_cortical_carcinoma, adrenal_cortical_carcinoma, functioning, carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, adenocarcinoma, of_unknown_primary, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, clear_cell_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, follicular_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, metaplastic_carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, mucinous_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, peritoneal_serous_surface_carcinoma, carcinoma, poorly_differentiated_carcinoma, carcinoma, renal_medullary_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, glioma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, oligoastrocytoma_Grade_II, haematopoietic_neoplasm, acute_myeloid_leukaemia, haematopoietic_neoplasm, acute_myeloid_leukaemia, M4, haematopoietic_neoplasm, acute_myeloid_leukaemia_associated_with_MDS, M4, haematopoietic_neoplasm, acute_myeloid_leukaemia_myelodysplastic_syndrome_therapy_related_NOS, haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related, leiomyosarcoma, lymphoid_neoplasm, B_cell_lymphoma_unspecified, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome, lymphoid_neoplasm, plasma_cell_myeloma, malignant_melanoma, malignant_melanoma, desmoplastic, other, neoplasm, rhabdomyosarcoma, embryonal",0.0000000000000000,,,,142536,Pathogenic,"Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome",3,Oncogenic,Neoplasm,1,,,
4333,337,R,G,,Me,,,,,,,,,PhosphoSite,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,COSMIC,ClinVar","lung_msk_2017, msk_chord_2024, msk_impact_2017, ntrk_msk_2019, pan_origimed_2020, sarcoma_msk_2022, soft_tissue_msk_2025","Lung Adenocarcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7574018-7574018, hg38,17:7670700-7670700","hg19,17:g.7574018G>C, hg38,17:g.7670700G>C",0.752,"large_intestine, rectum, lung","carcinoma, adenocarcinoma",,,,,237938,Likely pathogenic,Li-Fraumeni syndrome,3,,,,,,
4334,337,R,H,,Me,,,,,,,,,PhosphoSite,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,COSMIC,ClinVar","acc_tcga, acc_tcga_gdc, acc_tcga_pan_can_atlas_2018, blca_iatlas_imvigor210_2017, brca_metabric, breast_msk_2025, cesc_tcga, cesc_tcga_gdc, cesc_tcga_pan_can_atlas_2018, chrcc_tcga_gdc, csf_msk_2024, gbc_mskcc_2022, hcc_msk_2024, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub, lihc_amc_prv, lms_msk_2024, luad_mskcc_2023_met_organotropism, mds_iwg_2022, mixed_selpercatinib_2020, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, nsclc_ctdx_msk_2022, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pcawg_2020, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prostate_msk_2024, sarcoma_msk_2022, thyroid_mskcc_2016","Adrenocortical Carcinoma, Bladder Urothelial Carcinoma, Cervical Squamous Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue, Thyroid","hg19,17:7574017-7574017, hg19,17:7670699-7670699, hg38,17:7670699-7670699","hg19,17:g.7574017C>T, hg19,17:g.7670699C>T, hg38,17:g.7670699C>T",0.693,"adrenal_gland, adrenal_gland, adrenal_gland, autonomic_ganglia, central_nervous_system, brain, central_nervous_system, parietal_lobe, cervix, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, liver, lung, meninges, pancreas, parathyroid, prostate, skin, head_neck, soft_tissue, smooth_muscle, uterus, thyroid","adrenal_cortical_carcinoma, non_functioning, carcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, leiomyosarcoma, lymphoid_neoplasm, plasma_cell_myeloma, meningioma, meningothelial, neuroblastoma, pheochromocytoma",0.0000119595289540,,,,12379,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance","TP53-related disorder;Colorectal cancer;Gastric cancer;Hereditary cancer-predisposing syndrome;Breast neoplasm;not provided;Adrenocortical carcinoma, hereditary;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome 1;ADRENOCORTICAL CARCINOMA, PEDIATRIC;Li-Fraumeni syndrome;Squamous cell carcinoma of the head and neck",2,,,,Tier II - Potential,Neuroblastoma,1
4335,337,R,L,,Me,,,,,,,,,PhosphoSite,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,COSMIC,ClinVar","aml_ohsu_2018, aml_ohsu_2022, blca_iatlas_imvigor210_2017, blca_msk_2024, bm_nsclc_mskcc_2023, brca_metabric, brca_msk_2025, brca_tcga_pub2015, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, coad_tcga_gdc, coadread_genentech, coadread_tcga_pan_can_atlas_2018, crc_eo_2020, crc_msk_2017, hcc_clca_2024, hcc_inserm_fr_2015, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, ihch_smmu_2014, lms_msk_2024, luad_broad, luad_cas_2020, luad_cptac_2020, luad_cptac_gdc, luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, luad_tcga, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, luad_tsp, lung_msk_2017, lung_msk_pdx, lusc_cptac_2021, lusc_cptac_gdc, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mds_mskcc_2020, metastatic_solid_tumors_mich_2017, msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nccrcc_genentech_2014, nsclc_ctdx_msk_2022, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, nsclc_tracerx_2017, ovary_cptac_gdc, paad_utsw_2015, pan_origimed_2020, pancan_hcmi_2025, pancan_mimsi_msk_2024, pancan_pcawg_2020, pancan_pdmr_2025, pdac_msk_2024, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_pik3r1_msk_2021, prostate_msk_2024, rectal_msk_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarcoma_msk_2022, sarcoma_mskcc_2022, soft_tissue_tcga_gdc, tmb_mskcc_2018, usarc_msk_2020","Acute Myeloid Leukemia, Bladder Urothelial Carcinoma, Bowel, Breast, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Ovary/Fallopian Tube, Pancreas, Pancreatic Adenocarcinoma, Prostate, Prostate Adenocarcinoma, Renal Non-Clear Cell Carcinoma, Soft Tissue, Uterine Sarcoma/Mesenchymal","hg19,17:7574017-7574017, hg19,17:7670699-7670699, hg38,17:7670699-7670699","hg19,17:g.7574017C>A, hg19,17:g.7670699C>A, hg38,17:g.7670699C>A",0.765,"biliary_tract, bile_duct, bone, breast, haematopoietic_and_lymphoid_tissue, kidney, large_intestine, colon, large_intestine, colon, ascending, large_intestine, colon, sigmoid, liver, lung, lung, right_upper_lobe, oesophagus, oesophagus, lower_third, pancreas, penis, prostate, small_intestine, soft_tissue, smooth_muscle, uterus, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, mouth, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder","carcinoid-endocrine_tumour, carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma, carcinoma, combined_large_cell_neuroendocrine_carcinoma, squamous_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma, carcinoma, mixed_adenosquamous_carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing_non_differentiated, carcinoma, sarcomatoid_carcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma, leiomyosarcoma, lymphoid_neoplasm, plasma_cell_myeloma, osteosarcoma, other, dysplasia-in_situ_neoplasm, other, neoplasm",,,,,142828,Likely pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,Tier I - Strong,Rhabdomyosarcoma,1
4336,337,R,P,,Me,,,,,,,,,PhosphoSite,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,COSMIC,ClinVar","luad_broad, luad_mskcc_2023_met_organotropism, luad_tcga_gdc, luad_tcga_pan_can_atlas_2018, lusc_cptac_2021, lusc_cptac_gdc, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7574017-7574017, hg19,17:7670699-7670699, hg38,17:7670699-7670699","hg19,17:g.7574017C>G, hg19,17:g.7670699C>G, hg38,17:g.7670699C>G",0.792,", extrapulmonary, lung, urinary_tract, bladder",", carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, of_unknown_primary, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,,,,177879,Likely pathogenic,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4337,337,R,S,,Me,,,,,,,,,PhosphoSite,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,COSMIC,ClinVar","blca_tcga_gdc, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, coadread_tcga_pan_can_atlas_2018, escc_icgc, mds_iwg_2022, msk_impact_2017, msk_met_2021, read_tcga_gdc","Bladder Urothelial Carcinoma, Colorectal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Rectal Adenocarcinoma","hg19,17:7574018-7574018, hg19,17:7670700-7670700, hg38,17:7670700-7670700","hg19,17:g.7574018G>T, hg19,17:g.7670700G>T, hg38,17:g.7670700G>T",0.725,"biliary_tract, bile_duct, biliary_tract, gallbladder, large_intestine, rectum, oesophagus, skin, stomach, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,1019612,Likely pathogenic,Li-Fraumeni syndrome,3,,,,,,
4338,338,F,C,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,ClinVar","msk_chord_2024, stad_oncosg_2018","Mixed Cancer Types, Stomach Adenocarcinoma","hg19,17:7574014-7574014, hg38,17:7670696-7670696","hg19,17:g.7574014A>C, hg38,17:g.7670696A>C",0.584,,,,,,,628432,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
4339,338,F,I,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,COSMIC","chrcc_tcga_gdc, kich_tcga, kich_tcga_pan_can_atlas_2018, kich_tcga_pub",Chromophobe Renal Cell Carcinoma,"hg19,17:7574015-7574015, hg19,17:7670697-7670697, hg38,17:7670697-7670697","hg19,17:g.7574015A>T, hg19,17:g.7670697A>T, hg38,17:g.7670697A>T",0.691,"breast, kidney","carcinoma, carcinoma, chromophobe_renal_cell_carcinoma",,,,,,,,,,,,,,
4340,338,F,L,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,COSMIC,ClinVar","stad_oncosg_2018, stad_pfizer_uhongkong",Stomach Adenocarcinoma,"hg19,17:7574013-7574013, hg19,17:7574015-7574015, hg38,17:7670695-7670695","hg19,17:g.7574013G>C, hg19,17:g.7574015A>G, hg38,17:g.7670695G>C","0.587, 0.681",stomach,"carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable",0.0000039852704405,,,,482226,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4341,338,F,S,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,"cBioPortal,ClinVar","msk_access_2021, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021, prad_msk_stopsack_2021, prostate_msk_2024","Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7574014-7574014, hg38,17:7670696-7670696","hg19,17:g.7574014A>G, hg38,17:g.7670696A>G",0.610,,,,,,,423398,Uncertain significance,"not provided;Hereditary cancer-predisposing syndrome;Familial cancer of breast;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Breast-ovarian cancer, familial, susceptibility to, 1",2,,,,,,
4342,338,F,V,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM",,cBioPortal,hcc_meric_2021,Hepatocellular Carcinoma,"hg19,17:7574015-7574015","hg19,17:g.7574015A>C",0.695,,,,,,,,,,,,,,,,
4343,339,E,G,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,ClinVar","msk_ch_2020, msk_ch_2023",Mixed Cancer Types,"hg19,17:7574011-7574011, hg38,17:7670693-7670693","hg19,17:g.7574011T>C, hg38,17:g.7670693T>C",0.855,,,,,,,822016,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4344,339,E,K,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar",nsclc_ctdx_msk_2022,Non-Small Cell Lung Cancer,"hg19,17:7574012-7574012, hg38,17:7670694-7670694","hg19,17:g.7574012C>T, hg38,17:g.7670694C>T",0.469,"large_intestine, large_intestine, colon, ascending, pancreas, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",0.0000637658517922,0.0000637186185803,,,142846,Conflicting classifications of pathogenicity,TP53-related disorder;Hereditary cancer-predisposing syndrome;Familial cancer of breast;not specified;not provided;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
4345,339,E,Q,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7574012-7574012, hg38,17:7670694-7670694","hg19,17:g.7574012C>G, hg38,17:g.7670694C>G",0.698,breast,carcinoma,0.0000079707314740,,,,141893,Likely benign,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;not provided;Li-Fraumeni syndrome,3,,,,,,
4346,339,E,V,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7574011-7574011, hg38,17:7670693-7670693","hg19,17:g.7574011T>A, hg38,17:g.7670693T>A",0.856,,,0.0000039851433855,,,,959616,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4347,340,M,I,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"COSMIC,ClinVar,ClinVar,ClinVar",,,"hg19,17:7574007-7574007, hg38,17:7670689-7670689","hg19,17:g.7574007C>A, hg19,17:g.7574007C>G, hg19,17:g.7574007C>T, hg38,17:g.7670689C>A, hg38,17:g.7670689C>G, hg38,17:g.7670689C>T",0.265,"stomach, urinary_tract","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,,,,"3256325, 1759327, 1020154","Likely benign, Likely benign, Conflicting classifications of pathogenicity",not specified|Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"1, 1, 1",,,,,,
4348,340,M,K,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7574008-7574008, hg38,17:7670690-7670690","hg19,17:g.7574008A>T, hg38,17:g.7670690A>T",0.837,,,,,,,818264,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
4349,340,M,R,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,COSMIC,,,"hg38,17:7670690-7670690","hg38,17:g.7670690A>C",0.832,"soft_tissue, blood_vessel, skin, scalp",angiosarcoma,,,,,,,,,,,,,,
4350,340,M,T,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,cBioPortal,mbl_sickkids_2016,Medulloblastoma,"hg19,17:7574008-7574008","hg19,17:g.7574008A>G",0.587,,,,,,,,,,,,,,,,
4351,340,M,V,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,COSMIC,,,"hg38,17:7670691-7670691","hg38,17:g.7670691T>C",0.382,"large_intestine, colon, pancreas",", carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4352,341,F,C,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC","hcc_msk_2024, luad_mskcc_2023_met_organotropism, mds_iwg_2022, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, ucec_ancestry_cds_msk_2023","Endometrial Carcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7574005-7574005, hg38,17:7670687-7670687","hg19,17:g.7574005A>C, hg38,17:g.7670687A>C",0.820,"pleura, prostate","carcinoma, mesothelioma, epithelial",,,,,,,,,,,,,,
4353,341,F,I,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7574006-7574006, hg38,17:7670688-7670688","hg19,17:g.7574006A>T, hg38,17:g.7670688A>T",0.244,,,,,,,1395664,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4354,341,F,L,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar","hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, pan_origimed_2020","Head and Neck Squamous Cell Carcinoma, Mixed Cancer Types","hg19,17:7574004-7574004, hg19,17:7670686-7670686, hg38,17:7670686-7670686","hg19,17:g.7574004G>C, hg19,17:g.7574004G>T, hg19,17:g.7670686G>C, hg38,17:g.7670686G>C, hg38,17:g.7670686G>T",0.201,", upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,"3071734, 2585878","Conflicting classifications of pathogenicity, Likely benign",Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome,"1, 1",,,,,,
4355,341,F,S,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_tcga, brca_tcga_gdc, brca_tcga_pub2015, cscc_ucsf_2021, gct_msk_2016, mds_iwg_2022, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025","Cutaneous Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Testis","hg19,17:7574005-7574005, hg19,17:7574005-7574006, hg19,17:7670687-7670687, hg38,17:7670687-7670687, hg38,17:7670687-7670688","hg19,17:g.7574005A>G, hg19,17:g.7574005_7574006delinsCT, hg19,17:g.7670687A>G, hg38,17:g.7670687A>G, hg38,17:g.7670687_7670688delinsCT",0.880,"breast, genital_tract, extragonadal, mediastinum, skin, ear","carcinoma, carcinoma, squamous_cell_carcinoma, germ_cell_tumour, choriocarcinoma",,,,,2450748,Likely pathogenic,Hereditary cancer-predisposing syndrome,1,,,,,,
4356,341,F,V,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC","hcc_msk_2024, hcc_tcga_gdc, lihc_tcga, lihc_tcga_pan_can_atlas_2018, sarcoma_msk_2023","Hepatocellular Carcinoma, Mixed Cancer Types","hg19,17:7574006-7574006, hg19,17:7670688-7670688, hg38,17:7670688-7670688","hg19,17:g.7574006A>C, hg19,17:g.7670688A>C, hg38,17:g.7670688A>C",0.464,"breast, liver","carcinoma, ER-PR-positive_carcinoma, carcinoma, hepatocellular_carcinoma",,,,,,,,,,,,,,
4357,341,F,Y,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 336-341, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,cBioPortal,"glioma_mskcc_2019, luad_cptac_2020, luad_cptac_gdc, msk_chord_2024, msk_ctdna_vte_2024, msk_met_2021","Diffuse Glioma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7574005-7574005, hg19,17:7670687-7670687","hg19,17:g.7574005A>T, hg19,17:g.7670687A>T",0.765,,,,,,,,,,,,,,,,
4358,342,R,G,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,ClinVar,,,"hg19,17:7574003-7574003, hg38,17:7670685-7670685","hg19,17:g.7574003G>C, hg38,17:g.7670685G>C",0.533,,,,,,,1769035,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
4359,342,R,L,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,ClinVar,ClinVar","hcc_msk_2024, kirp_tcga, pancan_mappyacts_2022","Hepatocellular Carcinoma, Mixed Cancer Types, Papillary Renal Cell Carcinoma","hg19,17:7574002-7574002, hg19,17:7574002-7574003, hg19,17:7670684-7670684, hg38,17:7670684-7670684, hg38,17:7670684-7670685","hg19,17:g.7574002C>A, hg19,17:g.7574002_7574003delinsAA, hg19,17:g.7670684C>A, hg38,17:g.7670684C>A, hg38,17:g.7670684_7670685delinsAA",0.151,,,,,,,"1055894, 822031","Uncertain significance, Benign",Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome,"1, 1",,,,,,
4360,342,R,P,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,COSMIC,ClinVar","acc_2019, bm_nsclc_mskcc_2023, brca_metabric, brca_tcga, brca_tcga_gdc, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, breast_ink4_msk_2021, breast_msk_2018, breast_msk_2025, csf_msk_2024, glioma_mskcc_2019, lms_msk_2024, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, msk_ch_2023, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mappyacts_2022, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017, prad_su2c_2019, prostate_msk_2024, sarcoma_msk_2022, sarcoma_mskcc_2022, thyroid_mskcc_2016, tmb_mskcc_2018, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, wt_target_2018_pub, wt_target_gdc","Adenoid Cystic Carcinoma, Breast, Diffuse Glioma, Endometrial Carcinoma, Invasive Breast Carcinoma, Lung, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Prostate, Prostate Adenocarcinoma, Soft Tissue, Thyroid, Wilms' Tumor","hg19,17:7574002-7574002, hg19,17:7670684-7670684, hg38,17:7670684-7670684","hg19,17:g.7574002C>G, hg19,17:g.7670684C>G, hg38,17:g.7670684C>G",0.650,"adrenal_gland, adrenal_gland, bone, breast, central_nervous_system, brain, central_nervous_system, medulla, central_nervous_system, supratentorial, endometrium, kidney, large_intestine, colon, left, liver, lung, ovary, prostate, salivary_gland, skin, lower_leg, thyroid","Wilms_tumour, adrenal_cortical_carcinoma, functioning, carcinoma, carcinoma, acinar_adenocarcinoma, carcinoma, adenocarcinoma, carcinoma, anaplastic_carcinoma, carcinoma, basal_(triple-negative)_carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, hormone_receptor-positive_carcinoma, carcinoma, luminal_NS_carcinoma, carcinoma, metaplastic_carcinoma, carcinoma, serous_carcinoma, fibroepithelial_neoplasm, phyllodes_tumour, malignant, glioma, astrocytoma, glioma, astrocytoma_Grade_III, anaplastic, glioma, ependymoma, hyperplasia, atypical, malignant_melanoma, superficial_spreading, osteosarcoma",,,,,215996,Pathogenic,Hereditary cancer-predisposing syndrome;not provided;Ovarian neoplasm;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,Tier I - Strong,"Diffuse glioma, H3 G34 mutant",1
4361,342,R,Q,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,COSMIC,ClinVar",sarcoma_msk_2022,Soft Tissue,"hg19,17:7574002-7574002, hg38,17:7670684-7670684","hg19,17:g.7574002C>T, hg38,17:g.7670684C>T",0.104,"stomach, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, larynx","carcinoma, carcinoma, mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable, carcinoma, squamous_cell_carcinoma",0.0000079683814624,,,,233136,Likely benign,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,3,,,,,,
4362,343,E,A,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,17:7573999-7573999","hg19,17:g.7573999T>G",0.454,,,,,,,,,,,,,,,,
4363,343,E,D,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"ClinVar,ClinVar",,,"hg19,17:7573998-7573998, hg38,17:7670680-7670680","hg19,17:g.7573998C>A, hg19,17:g.7573998C>G, hg38,17:g.7670680C>A, hg38,17:g.7670680C>G",0.364,,,,,,,"3460327, 2679227","Benign, Uncertain significance","Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary","1, 1",,,,,,
4364,343,E,G,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,cBioPortal,msk_chord_2024,Mixed Cancer Types,"hg19,17:7573999-7573999","hg19,17:g.7573999T>C",0.407,,,,,,,,,,,,,,,,
4365,343,E,K,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,17:7574000-7574000","hg19,17:g.7574000C>T",0.137,,,,,,,,,,,,,,,,
4366,343,E,Q,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,ClinVar,,,"hg19,17:7574000-7574000, hg38,17:7670682-7670682","hg19,17:g.7574000C>G, hg38,17:g.7670682C>G",0.197,,,,,,,1015453,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,1,,,,,,
4367,343,E,V,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBA_1), 338-343, ggetELM|APCC activator-binding ABBA motif (LIG_APCC_ABBAyCdc20_2), 337-343, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,COSMIC,,,"hg38,17:7670681-7670681","hg38,17:g.7670681T>A",0.418,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4368,344,L,M,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,ClinVar","crc_eo_2020, msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024","Bowel, Mixed Cancer Types","hg19,17:7573997-7573997, hg38,17:7670679-7670679","hg19,17:g.7573997G>T, hg38,17:g.7670679G>T",0.485,,,,,,,1771001,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4369,344,L,P,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_igr_2015, breast_msk_2025, ccle_broad_2025, ccle_genentech_2014, hcc_meric_2021, lymphoma_cellline_msk_2020, mnm_washu_2016, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, pancan_pdmr_2025, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prostate_msk_2024, sarcoma_msk_2022","Hepatocellular Carcinoma, Invasive Breast Carcinoma, Lymphoid, Mixed Cancer Types, Myeloid Neoplasm, Prostate, Prostate Adenocarcinoma, Soft Tissue","hg19,17:7573996-7573996, hg19,17:7670678-7670678, hg38,17:7670678-7670678","hg19,17:g.7573996A>G, hg19,17:g.7670678A>G, hg38,17:g.7670678A>G",0.862,"bone, humerus, breast, haematopoietic_and_lymphoid_tissue, kidney, pancreas, prostate, upper_aerodigestive_tract, head_neck, upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, chondrosarcoma, central, lymphoid_neoplasm, NK_cell_leukaemia",,,,,12375,Likely pathogenic,"Adrenal cortex carcinoma;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1;Adrenocortical carcinoma, hereditary",3,,,,,,
4370,344,L,Q,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,COSMIC","ctcl_columbia_2015, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancreas_msk_2024, pdac_msk_2024","Mixed Cancer Types, Non-Hodgkin Lymphoma, Pancreas","hg19,17:7573996-7573996, hg38,17:7670678-7670678","hg19,17:g.7573996A>T, hg38,17:g.7670678A>T",0.813,"haematopoietic_and_lymphoid_tissue, skin, pancreas","carcinoma, ductal_carcinoma, lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,,,,,,,,,,,
4371,344,L,R,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_metabric, ihch_smmu_2014, lung_msk_2017, msk_impact_2017, msk_met_2021, pan_origimed_2020, sarcoma_msk_2022, sclc_jhu","Intrahepatic Cholangiocarcinoma, Invasive Breast Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Small Cell Lung Cancer, Soft Tissue","hg19,17:7573996-7573996, hg38,17:7670678-7670678","hg19,17:g.7573996A>C, hg38,17:g.7670678A>C",0.858,"biliary_tract, bile_duct, breast, large_intestine, colon, lung, soft_tissue, fibrous_tissue_and_uncertain_origin, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma, carcinoma, small_cell_carcinoma, carcinoma, squamous_cell_carcinoma, synovial_sarcoma",,,,,2758378,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4372,344,L,V,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 336-344, ggetELM|Atg8 protein family ligands (LIG_LIR_Nem_3), 339-344, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,ClinVar,,,"hg19,17:7573997-7573997, hg38,17:7670679-7670679","hg19,17:g.7573997G>C, hg38,17:g.7670679G>C",0.261,,,,,,,956897,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
4373,345,N,D,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_gdc, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,17:7573994-7573994, hg19,17:7670676-7670676, hg38,17:7670676-7670676","hg19,17:g.7573994T>C, hg19,17:g.7670676T>C, hg38,17:g.7670676T>C",0.753,stomach,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4374,345,N,I,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,COSMIC,,,"hg38,17:7670675-7670675","hg38,17:g.7670675T>A",0.838,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia",,,,,,,,,,,,,,
4375,345,N,S,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,ClinVar","ccle_broad_2019, ccle_broad_2025, gbc_mskcc_2022, hcc_msk_2024, nsclc_ctdx_msk_2022","Gallbladder Cancer, Hepatocellular Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7573993-7573993, hg19,17:7670675-7670675, hg38,17:7670675-7670675","hg19,17:g.7573993T>C, hg19,17:g.7670675T>C, hg38,17:g.7670675T>C",0.663,,,,,,,3679774,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4376,346,E,A,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,COSMIC,,,"hg38,17:7670672-7670672","hg38,17:g.7670672T>G",0.803,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4377,346,E,D,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,ClinVar",blca_iatlas_imvigor210_2017,Bladder Urothelial Carcinoma,"hg19,17:7573989-7573989, hg19,17:7670671-7670671, hg38,17:7670671-7670671","hg19,17:g.7573989C>G, hg19,17:g.7670671C>A, hg38,17:g.7670671C>G",0.238,,,,,,,480755,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4378,346,E,G,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,ClinVar,,,"hg19,17:7573990-7573990, hg38,17:7670672-7670672","hg19,17:g.7573990T>C, hg38,17:g.7670672T>C",0.859,,,,,,,3011115,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4379,346,E,K,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM|Apicomplexan export motif (TRG_Pf-PMV_PEXEL_1), 342-346, ggetELM",,"cBioPortal,COSMIC,ClinVar","msk_met_2021, paired_bladder_2022, pan_origimed_2020, pancan_mimsi_msk_2024","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7573991-7573991, hg38,17:7670673-7670673","hg19,17:g.7573991C>T, hg38,17:g.7670673C>T",0.816,"large_intestine, caecum","adenoma, tubular",,,,,646925,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4380,347,A,D,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar","crc_eo_2020, crc_msk_2017, hcc_msk_2024, heme_msk_impact_2022, lung_msk_2017, mds_mskcc_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020","Bowel, Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7573987-7573987, hg38,17:7670669-7670669","hg19,17:g.7573987G>T, hg38,17:g.7670669G>T",0.812,"large_intestine, rectum, lung, ovary","carcinoma, adenocarcinoma, germ_cell_tumour, yolk_sac_tumour",,,,,43587,Pathogenic,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4381,347,A,F,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7573987-7573988, hg38,17:7670669-7670670","hg19,17:g.7573987_7573988delinsAA, hg38,17:g.7670669_7670670delinsAA",,,,,,,,2039935,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4382,347,A,G,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7573987-7573987, hg38,17:7670669-7670669","hg19,17:g.7573987G>C, hg38,17:g.7670669G>C",0.329,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,2683739,Likely benign,Hereditary breast ovarian cancer syndrome,1,,,,,,
4383,347,A,P,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC","bowel_colitis_msk_2022, breast_msk_2018, breast_msk_2025, ccle_broad_2019, ccle_broad_2025, crc_dd_2022, msk_chord_2024, msk_ctdna_vte_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_mimsi_msk_2024, ptad_msk_2024, rectal_msk_2022","Bowel, Breast, Colorectal Adenocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Pituitary Adenoma","hg19,17:7573988-7573988, hg19,17:7670670-7670670, hg38,17:7670670-7670670","hg19,17:g.7573988C>G, hg19,17:g.7670670C>G, hg38,17:g.7670670C>G",0.776,"breast, central_nervous_system, temporal_lobe, lung","carcinoma, ductal_carcinoma, carcinoma, non_small_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
4384,347,A,S,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7573988-7573988, hg38,17:7670670-7670670","hg19,17:g.7573988C>A, hg38,17:g.7670670C>A",0.342,,,,,,,1773570,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4385,347,A,T,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_igr_2015, breast_ink4_msk_2021, breast_msk_2025, hcc_clca_2024, msk_chord_2024, msk_ctdna_vte_2024, nsclc_ctdx_msk_2022, sarcoma_msk_2022","Breast, Hepatocellular Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer, Soft Tissue","hg19,17:7573988-7573988, hg38,17:7670670-7670670","hg19,17:g.7573988C>T, hg38,17:g.7670670C>T",0.648,"breast, central_nervous_system, brain, central_nervous_system, cerebellum, cervix, large_intestine, caecum","adenoma, tubular, carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, ER-positive_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_II, fibrillary, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, glioma, diffuse_midline_glioma",,,,,662690,Uncertain significance,"not provided;Malignant tumor of urinary bladder;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Familial cancer of breast",3,,,,Tier I - Strong,Rhabdomyosarcoma,1
4386,347,A,V,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar","acc_2019, bcc_unige_2016, ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014, cellline_ccle_broad, heme_msk_impact_2022, hnsc_a5consortium_2025, msk_chord_2024, pan_origimed_2020, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018","Adenoid Cystic Carcinoma, Basal Cell Carcinoma, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Mixed Cancer Types","hg19,17:7573986-7573987, hg19,17:7573987-7573987, hg19,17:7670668-7670669, hg19,17:7670669-7670669, hg38,17:7670669-7670669","hg19,17:g.7573986_7573987delinsAA, hg19,17:g.7573987G>A, hg19,17:g.7670668_7670669delinsAA, hg19,17:g.7670669G>A, hg38,17:g.7670669G>A",0.774,"haematopoietic_and_lymphoid_tissue, skin","carcinoma, basal_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",,,,,422725,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
4387,348,L,F,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC","blca_cornell_2016, brca_metabric, lusc_tcga, lusc_tcga_gdc, lusc_tcga_pan_can_atlas_2018, mixed_allen_2018","Bladder Urothelial Carcinoma, Invasive Breast Carcinoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types","hg19,17:7573983-7573983, hg19,17:7670665-7670665, hg38,17:7670665-7670665","hg19,17:g.7573983C>A, hg19,17:g.7573983C>G, hg19,17:g.7670665C>A, hg38,17:g.7670665C>A, hg38,17:g.7670665C>G","0.712, 0.714","liver, lung, ovary","carcinoma, carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma, carcinoma, sarcomatoid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4388,348,L,S,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar","brca_metabric, hnsc_tcga, hnsc_tcga_gdc, hnsc_tcga_pan_can_atlas_2018, lms_msk_2024","Head and Neck Squamous Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7573984-7573984, hg19,17:7670666-7670666, hg38,17:7670666-7670666","hg19,17:g.7573984A>G, hg19,17:g.7670666A>G, hg38,17:g.7670666A>G",0.948,"soft_tissue, fat, upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma, liposarcoma, pleomorphic",,,,,2746088,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4389,348,L,V,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7573985-7573985, hg38,17:7670667-7670667","hg19,17:g.7573985A>C, hg38,17:g.7670667A>C",0.811,,,,,,,406571,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4390,348,L,W,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC","msk_ch_2020, msk_chord_2024, msk_impact_2017, msk_met_2021, nccrcc_genentech_2014, pdac_msk_2024","Mixed Cancer Types, Pancreas, Renal Non-Clear Cell Carcinoma","hg19,17:7573984-7573984, hg38,17:7670666-7670666","hg19,17:g.7573984A>C, hg38,17:g.7670666A>C",0.926,"kidney, pancreas","carcinoma, chromophobe_renal_cell_carcinoma, carcinoma, ductal_carcinoma",,,,,,,,,,,,,,
4391,349,E,G,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7573981-7573981, hg38,17:7670663-7670663","hg19,17:g.7573981T>C, hg38,17:g.7670663T>C",0.864,,,,,,,1775423,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4392,349,E,K,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7573982-7573982, hg38,17:7670664-7670664","hg19,17:g.7573982C>T, hg38,17:g.7670664C>T",0.875,,,,,,,839717,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4393,349,E,Q,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7573982-7573982, hg38,17:7670664-7670664","hg19,17:g.7573982C>G, hg38,17:g.7670664C>G",0.761,,,,,,,657729,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4394,350,L,F,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7573979-7573979, hg38,17:7670661-7670661","hg19,17:g.7573979G>A, hg38,17:g.7670661G>A",0.453,large_intestine,"carcinoma, adenocarcinoma",0.0000000000000000,,,,481022,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4395,350,L,I,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,cBioPortal,"msk_met_2021, pancan_mimsi_msk_2024, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,17:7573979-7573979","hg19,17:g.7573979G>T",0.421,,,,,,,,,,,,,,,,
4396,350,L,P,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar","ccle_broad_2025, egc_tmucih_2015, mds_mskcc_2020, msk_ch_2020, msk_ch_2023, thyroid_gatci_2024","Esophagogastric Adenocarcinoma, Mixed Cancer Types, Myelodysplastic Syndromes, Thyroid","hg19,17:7573978-7573978, hg19,17:7670659-7670660, hg19,17:7670660-7670660, hg38,17:7670660-7670660","hg19,17:g.7573978A>G, hg19,17:g.7670659_7670660delinsAG, hg19,17:g.7670660A>G, hg38,17:g.7670660A>G",0.864,"lung, prostate, stomach","carcinoma, carcinoma, adenocarcinoma",,,,,2450751,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
4397,350,L,R,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7573978-7573978, hg38,17:7670660-7670660","hg19,17:g.7573978A>C, hg38,17:g.7670660A>C",0.818,,,,,,,4189250,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4398,350,L,V,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 343-350, ggetELM|WDR5 WD40 repeat (blade 5,6)-binding ligand (LIG_WD40_WDR5_VDV_2), 346-350, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7573979-7573979, hg38,17:7670661-7670661","hg19,17:g.7573979G>C, hg38,17:g.7670661G>C",0.438,pancreas,"carcinoma, ductal_carcinoma",0.0000039839367670,,,,854234,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",1,,,,,,
4399,351,K,E,,,Ubq,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar","hcc_msk_venturaa_2018, ihch_smmu_2014, lms_msk_2024, msk_chord_2024, pancan_mappyacts_2022, sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub, soft_tissue_tcga_gdc","Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Mixed Cancer Types, Soft Tissue","hg19,17:7573976-7573976, hg19,17:7670658-7670658, hg38,17:7670658-7670658","hg19,17:g.7573976T>C, hg19,17:g.7670658T>C, hg38,17:g.7670658T>C",0.458,"adrenal_gland, adrenal_gland, biliary_tract, bile_duct, skin, abdomen, soft_tissue, soft_tissue, smooth_muscle, abdomen","adrenal_cortical_carcinoma, non_functioning, carcinoma, adenocarcinoma, leiomyosarcoma, malignant_melanoma, sarcoma",,,,,72340,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
4400,351,K,N,,,Ubq,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar","kirc_tcga, kirc_tcga_pub, msk_ctdna_vte_2024","Mixed Cancer Types, Renal Clear Cell Carcinoma","hg19,17:7573974-7573974, hg38,17:7670656-7670656","hg19,17:g.7573974C>A, hg38,17:g.7670656C>A",0.463,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,,822085,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
4401,351,K,R,,,Ubq,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7573975-7573975, hg38,17:7670657-7670657","hg19,17:g.7573975T>C, hg38,17:g.7670657T>C",0.367,"small_intestine, jejunum","carcinoma, adenocarcinoma",,,,,458513,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4402,352,D,A,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,COSMIC,,,"hg38,17:7670654-7670654","hg38,17:g.7670654T>G",0.595,lung,"carcinoma, non_small_cell_carcinoma",,,,,,,,,,,,,,
4403,352,D,E,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,ClinVar,,,"hg19,17:7573971-7573971, hg38,17:7670653-7670653","hg19,17:g.7573971A>C, hg38,17:g.7670653A>C",0.312,,,,,,,1778759,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4404,352,D,G,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,COSMIC,,,"hg38,17:7670654-7670654","hg38,17:g.7670654T>C",0.655,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4405,352,D,H,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,ClinVar","luad_mskcc_2023_met_organotropism, msk_chord_2024","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7573973-7573973, hg38,17:7670655-7670655","hg19,17:g.7573973C>G, hg38,17:g.7670655C>G",0.656,,,,,,,2847409,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4406,352,D,N,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,COSMIC,ClinVar",hnsc_a5consortium_2025,Head and Neck Squamous Cell Carcinoma,"hg19,17:7573973-7573973, hg19,17:7670655-7670655, hg38,17:7670655-7670655","hg19,17:g.7573973C>T, hg19,17:g.7670655C>T, hg38,17:g.7670655C>T",0.536,"haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, rectum","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,3240620,Uncertain significance,"Adrenocortical carcinoma, hereditary",1,,,,,,
4407,352,D,Y,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 339-352, ggetELM",,"cBioPortal,ClinVar",brca_metabric,Invasive Breast Carcinoma,"hg19,17:7573973-7573973, hg38,17:7670655-7670655","hg19,17:g.7573973C>A, hg38,17:g.7670655C>A",0.699,,,,,,,481148,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4408,353,A,D,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM",,cBioPortal,glioma_mskcc_2019,Diffuse Glioma,"hg19,17:7573969-7573969","hg19,17:g.7573969G>T",0.662,,,,,,,,,,,,,,,,
4409,353,A,S,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM",,"cBioPortal,ClinVar",msk_ctdna_vte_2024,Mixed Cancer Types,"hg19,17:7573970-7573970, hg38,17:7670652-7670652","hg19,17:g.7573970C>A, hg38,17:g.7670652C>A",0.281,,,,,,,2126647,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4410,353,A,T,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM",,"cBioPortal,COSMIC",rectal_msk_2022,Bowel,"hg19,17:7573970-7573970, hg38,17:7670652-7670652","hg19,17:g.7573970C>T, hg38,17:g.7670652C>T",0.301,"urinary_tract, bladder",carcinoma,,,,,,,,,,,,,,
4411,353,A,V,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 349-353, ggetELM|Actin-binding motifs (LIG_Actin_WH2_1), 337-353, ggetELM",,"cBioPortal,COSMIC",msk_chord_2024,Mixed Cancer Types,"hg19,17:7573969-7573969, hg38,17:7670651-7670651","hg19,17:g.7573969G>A, hg38,17:g.7670651G>A",0.274,"large_intestine, large_intestine, caecum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4412,354,Q,E,,,,,,,,,,,,,,"cBioPortal,ClinVar",luad_oncosg_2020,Lung Adenocarcinoma,"hg19,17:7573967-7573967, hg38,17:7670649-7670649","hg19,17:g.7573967G>C, hg38,17:g.7670649G>C",0.208,,,,,,,1061283,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4413,354,Q,H,,,,,,,,,,,,,,"cBioPortal,COSMIC",msk_chord_2024,Mixed Cancer Types,"hg19,17:7573965-7573965, hg38,17:7670647-7670647","hg19,17:g.7573965C>A, hg38,17:g.7670647C>A",0.151,lung,"carcinoma, large_cell_carcinoma",,,,,,,,,,,,,,
4414,354,Q,K,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7573967-7573967, hg38,17:7670649-7670649","hg19,17:g.7573967G>T, hg38,17:g.7670649G>T",0.210,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",0.0000199311180560,,,,231485,Benign,Colorectal polyposis;Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4415,354,Q,L,,,,,,,,,,,,,,"cBioPortal,ClinVar","hcc_msk_2024, msk_met_2021","Hepatocellular Carcinoma, Mixed Cancer Types","hg19,17:7573966-7573966, hg38,17:7670648-7670648","hg19,17:g.7573966T>A, hg38,17:g.7670648T>A",0.186,,,,,,,3232047,Benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4416,354,Q,P,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7573966-7573966, hg38,17:7670648-7670648","hg19,17:g.7573966T>G, hg38,17:g.7670648T>G",0.293,,,,,,,3328171,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4417,354,Q,R,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar","msk_chord_2024, msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7573966-7573966, hg38,17:7670648-7670648","hg19,17:g.7573966T>C, hg38,17:g.7670648T>C",0.173,"breast, kidney","Wilms_tumour, carcinoma",0.0000079727650346,,,,629928,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4418,355,A,D,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7573963-7573963, hg38,17:7670645-7670645","hg19,17:g.7573963G>T, hg38,17:g.7670645G>T",0.210,,,,,,,2774647,Uncertain significance,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
4419,355,A,G,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7573963-7573963, hg38,17:7670645-7670645","hg19,17:g.7573963G>C, hg38,17:g.7670645G>C",0.295,,,,,,,1046623,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,1,,,,,,
4420,355,A,P,,,,,,,,,,,,,,cBioPortal,"msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7573964-7573964","hg19,17:g.7573964C>G",0.284,,,,,,,,,,,,,,,,
4421,355,A,S,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7573964-7573964, hg38,17:7670646-7670646","hg19,17:g.7573964C>A, hg38,17:g.7670646C>A",0.212,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,,1468494,Uncertain significance,Familial cancer of breast;Li-Fraumeni syndrome,2,,,,,,
4422,355,A,T,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar",luad_tcga_pan_can_atlas_2018,Lung Adenocarcinoma,"hg19,17:7573964-7573964, hg38,17:7670646-7670646, hg38,17:7670646-7670647","hg19,17:g.7573964C>T, hg38,17:g.7670646C>T, hg38,17:g.7670646_7670647delinsTT",0.241,"lung, right_lower_lobe, skin, face, skin, head_neck","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma, nodular",0.0000039861282736,,,,1781085,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4423,355,A,V,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7573963-7573963, hg38,17:7670645-7670645","hg19,17:g.7573963G>A, hg38,17:g.7670645G>A",0.353,cervix,"carcinoma, small_cell_carcinoma",,,,,528241,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary",1,,,,,,
4424,356,G,A,,,,,,,,,,,,,,"cBioPortal,ClinVar","bladder_msk_2023, msk_ctdna_vte_2024, msk_met_2021, paired_bladder_2022, tmb_mskcc_2018","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7573960-7573960, hg38,17:7670642-7670642","hg19,17:g.7573960C>G, hg38,17:g.7670642C>G",0.172,,,,,,,1716142,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4425,356,G,E,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7573960-7573960, hg38,17:7670642-7670642","hg19,17:g.7573960C>T, hg38,17:g.7670642C>T",0.174,,,,,,,3460336,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4426,356,G,R,,,,,,,,,,,,,,"COSMIC,ClinVar,ClinVar",,,"hg19,17:7573961-7573961, hg38,17:7670643-7670643","hg19,17:g.7573961C>G, hg19,17:g.7573961C>T, hg38,17:g.7670643C>G, hg38,17:g.7670643C>T",0.138,"pancreas, skin, face","adnexal_tumour, malignant_adnexal_tumour, endocrine_mucin-producing_sweat_gland_carcinoma, carcinoma, ductal_carcinoma",0.0000039872090334,,,,"2774646, 234059","Conflicting classifications of pathogenicity, Likely benign",Hereditary cancer-predisposing syndrome|TP53-related disorder;Hereditary cancer-predisposing syndrome;not provided;not specified;Li-Fraumeni syndrome,"1, 3",,,,,,
4427,356,G,W,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7573961-7573961, hg38,17:7670643-7670643","hg19,17:g.7573961C>A, hg38,17:g.7670643C>A",0.265,"endometrium, vulva","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,1998185,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4428,357,K,E,,,Ubq,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7573958-7573958, hg38,17:7670640-7670640","hg19,17:g.7573958T>C, hg38,17:g.7670640T>C",0.114,,,,,,,584919,Uncertain significance,Squamous cell carcinoma of the head and neck,1,,,,,,
4429,357,K,R,,,Ubq,,,,,,,,PhosphoSite,,,cBioPortal,hcc_meric_2021,Hepatocellular Carcinoma,"hg19,17:7573957-7573957","hg19,17:g.7573957T>C",0.136,,,0.0000039876860256,,,,,,,,,,,,,
4430,357,K,T,,,Ubq,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7573957-7573957, hg38,17:7670639-7670639","hg19,17:g.7573957T>G, hg38,17:g.7670639T>G",0.191,,,,,,,2820330,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4431,358,E,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7573955-7573955, hg38,17:7670637-7670637","hg19,17:g.7573955C>T, hg38,17:g.7670637C>T",0.304,"haematopoietic_and_lymphoid_tissue, lymph_node, skin, chest_wall","adnexal_tumour, malignant_adnexal_tumour, sebaceous_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,,142105,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4432,358,E,Q,,,,,,,,,,,,,,"cBioPortal,COSMIC",blca_cornell_2016,Bladder Urothelial Carcinoma,"hg19,17:7573955-7573955, hg38,17:7670637-7670637","hg19,17:g.7573955C>G, hg38,17:g.7670637C>G",0.354,lung,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4433,358,E,V,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar",sarcoma_msk_2022,Soft Tissue,"hg19,17:7573954-7573954, hg38,17:7670636-7670636","hg19,17:g.7573954T>A, hg38,17:g.7670636T>A",0.481,"adrenal_gland, adrenal_gland, haematopoietic_and_lymphoid_tissue, lung","adrenal_cortical_carcinoma, carcinoma, non_small_cell_carcinoma, haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia",0.0000199446336969,,,,230534,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Familial cancer of breast;not specified;not provided;Li-Fraumeni syndrome,1,,,,,,
4434,359,P,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573951-7573951, hg38,17:7670633-7670633","hg19,17:g.7573951G>C, hg38,17:g.7670633G>C",0.379,,,,,,,1171953,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4435,359,P,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,COSMIC,,,"hg38,17:7670634-7670634","hg38,17:g.7670634G>A",0.331,"central_nervous_system, brain, large_intestine","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,,,,,,,,,,
4436,360,G,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7573948-7573948, hg38,17:7670630-7670630","hg19,17:g.7573948C>G, hg38,17:g.7670630C>G",0.301,"salivary_gland, parotid, small_intestine, ileum, soft_tissue, blood_vessel, central_nervous_system, upper_aerodigestive_tract, mouth","carcinoma, adenocarcinoma, carcinoma, salivary_duct_carcinoma, carcinoma, squamous_cell_carcinoma, haemangioblastoma",0.0001916626736943,0.0001911924032885,,,142003,Benign,Hereditary cancer-predisposing syndrome;Breast and/or ovarian cancer;not specified;Familial cancer of breast;not provided;Hereditary breast ovarian cancer syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,3,,,,,,
4437,360,G,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,"cBioPortal,ClinVar",pan_origimed_2020,Mixed Cancer Types,"hg19,17:7573948-7573948, hg38,17:7670630-7670630","hg19,17:g.7573948C>T, hg38,17:g.7670630C>T",0.254,,,0.0000039929723686,,,,230306,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;not provided;Li-Fraumeni syndrome,1,,,,,,
4438,360,G,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,"cBioPortal,ClinVar,ClinVar",paired_bladder_2022,Bladder/Urinary Tract,"hg19,17:7573949-7573949, hg38,17:7670631-7670631","hg19,17:g.7573949C>G, hg19,17:g.7573949C>T, hg38,17:g.7670631C>G, hg38,17:g.7670631C>T","0.352, 0.354",,,0.0000039922709634,0.0000318613394507,,,"1785528, 186887","Uncertain significance, Conflicting classifications of pathogenicity",Hereditary cancer-predisposing syndrome|TP53-related disorder;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,"1, 1",,,,,,
4439,360,G,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,"cBioPortal,COSMIC,ClinVar","blca_bcan_hcrn_2022, ccle_broad_2019, mds_iwg_2022","Bladder Urothelial Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,17:7573948-7573948, hg38,17:7670630-7670630","hg19,17:g.7573948C>A, hg38,17:g.7670630C>A",0.325,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",0.0000559016131608,,,,142552,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4440,360,G,W,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573949-7573949, hg38,17:7670631-7670631","hg19,17:g.7573949C>A, hg38,17:g.7670631C>A",0.376,,,,,,,480753,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4441,361,G,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,"cBioPortal,COSMIC,ClinVar",skcm_yale,Cutaneous Melanoma,"hg19,17:7573945-7573945, hg38,17:7670627-7670627","hg19,17:g.7573945C>T, hg38,17:g.7670627C>T",0.283,"cervix, skin","carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,,141331,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
4442,361,G,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,17:7573945-7573946, hg38,17:7670627-7670628","hg19,17:g.7573945_7573946delinsTT, hg38,17:g.7670627_7670628delinsTT",,skin,"carcinoma, basal_cell_carcinoma",,,,,,,,,,,,,,
4443,361,G,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar",blca_iatlas_imvigor210_2017,Bladder Urothelial Carcinoma,"hg19,17:7573946-7573946, hg19,17:7670628-7670628, hg38,17:7670628-7670628","hg19,17:g.7573946C>G, hg19,17:g.7573946C>T, hg19,17:g.7670628C>T, hg38,17:g.7670628C>G, hg38,17:g.7670628C>T",0.364,"salivary_gland, parotid","carcinoma, salivary_duct_carcinoma",,,,,"1961562, 480761","Uncertain significance, Uncertain significance","Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome","2, 2",,,,,,
4444,362,S,C,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573943-7573943, hg38,17:7670625-7670625","hg19,17:g.7573943T>A, hg38,17:g.7670625T>A",0.444,,,0.0000039990722152,,,,458515,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4445,362,S,G,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,"cBioPortal,ClinVar","luad_mskcc_2023_met_organotropism, msk_met_2021, nsclc_ctdx_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,17:7573943-7573943, hg38,17:7670625-7670625","hg19,17:g.7573943T>C, hg38,17:g.7670625T>C",0.430,,,,,,,1205464,Uncertain significance,not provided,1,,,,,,
4446,362,S,I,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573942-7573942, hg38,17:7670624-7670624","hg19,17:g.7573942C>A, hg38,17:g.7670624C>A",0.540,,,0.0000039976973263,,,,485048,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4447,362,S,N,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573942-7573942, hg38,17:7670624-7670624","hg19,17:g.7573942C>T, hg38,17:g.7670624C>T",0.345,,,0.0000039976973263,,,,458516,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4448,362,S,R,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,"cBioPortal,ClinVar","msk_met_2021, prad_msk_stopsack_2021, prostate_msk_2024","Mixed Cancer Types, Prostate, Prostate Adenocarcinoma","hg19,17:7573941-7573941, hg19,17:7573943-7573943, hg38,17:7670623-7670623","hg19,17:g.7573941G>T, hg19,17:g.7573943T>G, hg38,17:g.7670623G>T","0.540, 0.551",,,,,,,2078374,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4449,363,R,G,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573940-7573940, hg38,17:7670622-7670622","hg19,17:g.7573940T>C, hg38,17:g.7670622T>C",0.328,,,0.0000039991681730,,,,188151,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4450,363,R,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573939-7573939, hg38,17:7670621-7670621","hg19,17:g.7573939C>T, hg38,17:g.7670621C>T",0.266,,,,,,,233244,Uncertain significance,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
4451,363,R,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573939-7573940, hg38,17:7670621-7670622","hg19,17:g.7573939_7573940inv, hg38,17:g.7670621_7670622inv",,,,,,,,3240618,Uncertain significance,"Adrenocortical carcinoma, hereditary",1,,,,,,
4452,363,R,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573938-7573938, hg38,17:7670620-7670620","hg19,17:g.7573938C>A, hg38,17:g.7670620C>A",0.455,,,,,,,945439,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4453,363,R,W,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 359-363, ggetELM",,ClinVar,,,"hg19,17:7573940-7573940, hg38,17:7670622-7670622","hg19,17:g.7573940T>A, hg38,17:g.7670622T>A",0.486,,,,,,,4552983,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4454,364,A,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,COSMIC,,,"hg38,17:7670618-7670618","hg38,17:g.7670618G>T",0.445,endometrium,"carcinoma, endometrioid_carcinoma",,,,,,,,,,,,,,
4455,364,A,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573937-7573937, hg38,17:7670619-7670619","hg19,17:g.7573937C>A, hg38,17:g.7670619C>A",0.378,,,,,,,848951,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4456,364,A,T,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,"cBioPortal,COSMIC,ClinVar","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,17:7573937-7573937, hg38,17:7670619-7670619","hg19,17:g.7573937C>T, hg38,17:g.7670619C>T",0.343,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon, ascending, ovary","glioma, astrocytoma_Grade_III, anaplastic, haematopoietic_neoplasm, acute_myeloid_leukaemia, other, neoplasm, serrated_polyp, serrated_adenoma",,,,,1414768,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4457,364,A,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573936-7573936, hg38,17:7670618-7670618","hg19,17:g.7573936G>A, hg38,17:g.7670618G>A",0.422,,,,,,,568955,Uncertain significance,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,2,,,,,,
4458,365,H,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,cBioPortal,brca_msk_2025,Invasive Breast Carcinoma,"hg19,17:7573934-7573934","hg19,17:g.7573934G>T",0.476,,,,,,,,,,,,,,,,
4459,365,H,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573933-7573933, hg38,17:7670615-7670615","hg19,17:g.7573933T>G, hg38,17:g.7670615T>G",0.528,,,,,,,1790091,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4460,365,H,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7573934-7573934, hg38,17:7670616-7670616","hg19,17:g.7573934G>A, hg38,17:g.7670616G>A",0.714,stomach,"carcinoma, squamous_cell_carcinoma",,,,,80708,Likely benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Malignant tumor of breast,3,,,,,,
4461,366,S,A,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,"cBioPortal,COSMIC,ClinVar","mds_iwg_2022, sarcoma_msk_2022","Myelodysplastic Syndromes, Soft Tissue","hg19,17:7573931-7573931, hg38,17:7670613-7670613","hg19,17:g.7573931A>C, hg38,17:g.7670613A>C",0.585,"haematopoietic_and_lymphoid_tissue, pancreas, skin, upper_arm","carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, lymphoid_neoplasm, acute_lymphoblastic_leukaemia",0.0000601240961344,,,,135360,Benign,TP53-related disorder;Breast and/or ovarian cancer;Hereditary cancer-predisposing syndrome;not specified;not provided;Squamous cell carcinoma of the head and neck;Li-Fraumeni syndrome;Malignant tumor of breast,3,,,,,,
4462,366,S,C,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573930-7573930, hg38,17:7670612-7670612","hg19,17:g.7573930G>C, hg38,17:g.7670612G>C",0.454,,,,,,,927316,Uncertain significance,Hereditary cancer-predisposing syndrome,2,,,,,,
4463,366,S,F,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,"cBioPortal,ClinVar",metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,17:7573930-7573930, hg38,17:7670612-7670612","hg19,17:g.7573930G>A, hg38,17:g.7670612G>A",0.461,,,,,,,2565396,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4464,366,S,P,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573931-7573931, hg38,17:7670613-7670613","hg19,17:g.7573931A>G, hg38,17:g.7670613A>G",0.327,,,,,,,528252,Uncertain significance,Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
4465,366,S,T,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7573931-7573931, hg38,17:7670613-7670613","hg19,17:g.7573931A>T, hg38,17:g.7670613A>T",0.398,salivary_gland,"carcinoma, mucoepidermoid_carcinoma",,,,,2005578,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4466,366,S,Y,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573930-7573930, hg38,17:7670612-7670612","hg19,17:g.7573930G>T, hg38,17:g.7670612G>T",0.477,,,,,,,2762393,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4467,367,S,G,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573928-7573928, hg38,17:7670610-7670610","hg19,17:g.7573928T>C, hg38,17:g.7670610T>C",0.514,,,,,,,231953,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,2,,,,,,
4468,367,S,T,P,,,,,,,,,,PhosphoSite,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573927-7573927, hg38,17:7670609-7670609","hg19,17:g.7573927C>G, hg38,17:g.7670609C>G",0.462,,,,,,,858737,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4469,368,H,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573007-7573007, hg38,17:7669689-7669689","hg19,17:g.7573007G>C, hg38,17:g.7669689G>C",0.338,,,,,,,4189262,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4470,368,H,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573007-7573007, hg38,17:7669689-7669689","hg19,17:g.7573007G>T, hg38,17:g.7669689G>T",0.284,,,,,,,919211,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,2,,,,,,
4471,368,H,Q,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,"ClinVar,ClinVar",,,"hg19,17:7573005-7573005, hg38,17:7669687-7669687","hg19,17:g.7573005G>C, hg19,17:g.7573005G>T, hg38,17:g.7669687G>C, hg38,17:g.7669687G>T",0.271,,,0.0000039804797274,,,,"657014, 485038","Conflicting classifications of pathogenicity, Conflicting classifications of pathogenicity","Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome 1","1, 1",,,,,,
4472,368,H,R,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573006-7573006, hg38,17:7669688-7669688","hg19,17:g.7573006T>C, hg38,17:g.7669688T>C",0.361,,,,,,,1386302,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4473,368,H,Y,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 364-368, ggetELM",,ClinVar,,,"hg19,17:7573007-7573007, hg38,17:7669689-7669689","hg19,17:g.7573007G>A, hg38,17:g.7669689G>A",0.345,,,,,,,188342,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,3,,,,,,
4474,369,L,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4475,370,K,M,,Me,Ubq,,,Ac,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7573000-7573000, hg38,17:7669682-7669682","hg19,17:g.7573000T>A, hg38,17:g.7669682T>A",0.609,,,,,,,1794493,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4476,370,K,Q,,Me,Ubq,,,Ac,,,,,PhosphoSite,,,"cBioPortal,COSMIC",msk_ctdna_vte_2024,Mixed Cancer Types,"hg19,17:7573001-7573001, hg38,17:7669683-7669683","hg19,17:g.7573001T>G, hg38,17:g.7669683T>G",0.490,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4477,370,K,T,,Me,Ubq,,,Ac,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7573000-7573000, hg38,17:7669682-7669682","hg19,17:g.7573000T>G, hg38,17:g.7669682T>G",0.620,,,,,,,1510904,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4478,371,S,F,P,,,,,,,,,,PhosphoSite,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,17:7572997-7572997","hg19,17:g.7572997G>A",0.422,,,,,,,,,,,,,,,,
4479,371,S,P,P,,,,,,,,,,PhosphoSite,,,COSMIC,,,"hg38,17:7669680-7669680","hg38,17:g.7669680A>G",0.316,"skin, lower_leg","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4480,371,S,Y,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7572997-7572997, hg38,17:7669679-7669679","hg19,17:g.7572997G>T, hg38,17:g.7669679G>T",0.466,,,,,,,1482750,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4481,372,K,R,,Me,Ubq,,,Ac,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7572994-7572994, hg38,17:7669676-7669676","hg19,17:g.7572994T>C, hg38,17:g.7669676T>C",0.517,,,,,,,230970,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;TP53-related disorder,1,,,,,,
4482,372,K,T,,Me,Ubq,,,Ac,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7572994-7572994, hg38,17:7669676-7669676","hg19,17:g.7572994T>G, hg38,17:g.7669676T>G",0.608,,,,,,,439315,Uncertain significance,not specified,1,,,,,,
4483,373,K,M,,Me,Ubq,,,Ac,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7572991-7572991, hg38,17:7669673-7669673","hg19,17:g.7572991T>A, hg38,17:g.7669673T>A",0.613,,,,,,,1059527,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4484,373,K,N,,Me,Ubq,,,Ac,,,,,PhosphoSite,,,"ClinVar,ClinVar",,,"hg19,17:7572990-7572990, hg38,17:7669672-7669672","hg19,17:g.7572990C>A, hg19,17:g.7572990C>G, hg38,17:g.7669672C>A, hg38,17:g.7669672C>G","0.469, 0.470",,,,,,,"3328167, 839498","Uncertain significance, Conflicting classifications of pathogenicity",Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,"1, 1",,,,,,
4485,373,K,R,,Me,Ubq,,,Ac,,,,,PhosphoSite,,,"COSMIC,ClinVar",,,"hg19,17:7572991-7572991, hg38,17:7669673-7669673","hg19,17:g.7572991T>C, hg38,17:g.7669673T>C",0.407,"central_nervous_system, cerebellum","glioma, astrocytoma_Grade_III, anaplastic",,,,,577458,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
4486,374,G,C,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7572989-7572989, hg38,17:7669671-7669671","hg19,17:g.7572989C>A, hg38,17:g.7669671C>A",0.605,oesophagus,"carcinoma, carcinoma, squamous_cell_carcinoma",0.0000039787059657,,,,665996,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4487,374,G,D,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7572988-7572988, hg38,17:7669670-7669670","hg19,17:g.7572988C>T, hg38,17:g.7669670C>T",0.469,,,,,,,2719153,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4488,374,G,R,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7572989-7572989, hg38,17:7669671-7669671","hg19,17:g.7572989C>G, hg38,17:g.7669671C>G",0.368,,,0.0000039787059657,0.0000318694626809,,,230269,Benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,3,,,,,,
4489,374,G,S,,,,,,,,,,,,,,"COSMIC,ClinVar",,,"hg19,17:7572989-7572989, hg38,17:7669671-7669671","hg19,17:g.7572989C>T, hg38,17:g.7669671C>T",0.546,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, NK-T_cell_lymphoma",,,,,141583,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",1,,,,,,
4490,374,G,V,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7572988-7572988, hg38,17:7669670-7669670","hg19,17:g.7572988C>A, hg38,17:g.7669670C>A",0.612,,,,,,,1797938,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4491,375,Q,H,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7572984-7572984, hg38,17:7669666-7669666","hg19,17:g.7572984C>A, hg38,17:g.7669666C>A",0.446,,,,,,,1799016,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4492,375,Q,K,,,,,,,,,,,,,,"cBioPortal,COSMIC,ClinVar","bcc_unige_2016, gbm_tcga, gbm_tcga_gdc, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, lgggbm_tcga_pub, msk_chord_2024, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancreas_msk_2024, pdac_msk_2024, sarcoma_msk_2022","Basal Cell Carcinoma, Diffuse Glioma, Mixed Cancer Types, Pancreas, Soft Tissue","hg19,17:7572986-7572986, hg19,17:7669668-7669668, hg38,17:7669668-7669668","hg19,17:g.7572986G>T, hg19,17:g.7669668G>T, hg38,17:g.7669668G>T",0.339,"breast, central_nervous_system, brain, pancreas, skin","carcinoma, basal_cell_carcinoma, carcinoma, ductal_carcinoma, carcinoma, lobular_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,1798385,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4493,376,S,A,P,,,,,,,,,,PhosphoSite,,,COSMIC,,,"hg38,17:7669665-7669665","hg38,17:g.7669665A>C",0.410,"upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4494,376,S,C,P,,,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,17:7572982-7572982, hg38,17:7669664-7669664","hg19,17:g.7572982G>C, hg38,17:g.7669664G>C",0.481,cervix,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4495,376,S,F,P,,,,,,,,,,PhosphoSite,,,"COSMIC,ClinVar",,,"hg19,17:7572982-7572982, hg38,17:7669664-7669664","hg19,17:g.7572982G>A, hg38,17:g.7669664G>A",0.557,"large_intestine, upper_aerodigestive_tract, mouth","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,,492573,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4496,376,S,T,P,,,,,,,,,,PhosphoSite,,,COSMIC,,,"hg38,17:7669665-7669665","hg38,17:g.7669665A>T",0.379,"upper_aerodigestive_tract, larynx","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4497,377,T,A,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7572980-7572980, hg38,17:7669662-7669662","hg19,17:g.7572980T>C, hg38,17:g.7669662T>C",0.283,,,,,,,569094,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;not provided,2,,,,,,
4498,377,T,I,P,,,,,,,,,,PhosphoSite,,,"COSMIC,ClinVar",,,"hg19,17:7572979-7572979, hg38,17:7669661-7669661","hg19,17:g.7572979G>A, hg38,17:g.7669661G>A",0.477,"kidney, upper_aerodigestive_tract, pharynx, oropharynx","Wilms_tumour, carcinoma, squamous_cell_carcinoma",,,,,822222,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4499,377,T,P,P,,,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC,ClinVar","gbm_mayo_pdx_sarkaria_2019, utuc_cornell_baylor_mdacc_2019","Diffuse Glioma, Upper Tract Urothelial Carcinoma","hg19,17:7572980-7572980, hg38,17:7669662-7669662","hg19,17:g.7572980T>G, hg38,17:g.7669662T>G",0.349,"breast, haematopoietic_and_lymphoid_tissue, large_intestine, colon, skin, urinary_tract, bladder","carcinoma, carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma, carcinoma, basal_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia, normal_karyotype, haematopoietic_neoplasm, chronic_myeloid_leukaemia, Ph_negative-bcr-abl_negative, haematopoietic_neoplasm, chronic_neutrophilic_leukaemia, haematopoietic_neoplasm, myelodysplastic-myeloproliferative_neoplasm-unclassifiable, haematopoietic_neoplasm, myelodysplastic_syndrome, haematopoietic_neoplasm, myeloid_neoplasm, haematopoietic_neoplasm, myeloproliferative_neoplasm_unclassifiable",0.0002870078421861,0.0000000000000000,,,975959,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Hereditary cancer-predisposing syndrome,1,,,,,,
4500,377,T,S,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,17:7572980-7572980, hg38,17:7669662-7669662","hg19,17:g.7572980T>A, hg38,17:g.7669662T>A",0.317,,,0.0000040423639745,,,,3634422,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4501,378,S,A,P,,,,,,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,cBioPortal,heme_msk_impact_2022,Mixed Cancer Types,"hg19,17:7572977-7572977","hg19,17:g.7572977A>C",0.506,,,,,,,,,,,,,,,,
4502,378,S,C,P,,,,,,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,ClinVar,,,"hg19,17:7572976-7572976, hg38,17:7669658-7669658","hg19,17:g.7572976G>C, hg38,17:g.7669658G>C",0.498,,,,,,,480749,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,1,,,,,,
4503,378,S,F,P,,,,,,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,"cBioPortal,COSMIC","bcc_unige_2016, cscc_ranson_2022, desm_broad_2015","Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Desmoplastic Melanoma","hg19,17:7572976-7572976, hg19,17:7669658-7669658, hg38,17:7669658-7669658","hg19,17:g.7572976G>A, hg19,17:g.7669658G>A, hg38,17:g.7669658G>A",0.585,"kidney, skin, skin, trunk","Wilms_tumour, carcinoma, basal_cell_carcinoma, malignant_melanoma, desmoplastic",,,,,,,,,,,,,,
4504,378,S,P,P,,,,,,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,cBioPortal,cellline_nci60,Mixed Cancer Types,"hg19,17:7572977-7572977","hg19,17:g.7572977A>G",0.449,,,0.0001161533223855,0.0000000000000000,,,,,,,,,,,,
4505,378,S,T,P,,,,,,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,ClinVar,,,"hg19,17:7572977-7572977, hg38,17:7669659-7669659","hg19,17:g.7572977A>T, hg38,17:g.7669659A>T",0.497,,,,,,,3972449,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4506,378,S,Y,P,,,,,,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,ClinVar,,,"hg19,17:7572976-7572976, hg38,17:7669658-7669658","hg19,17:g.7572976G>T, hg38,17:g.7669658G>T",0.600,,,,,,,3068296,Uncertain significance,"Adrenocortical carcinoma, hereditary",1,,,,,,
4507,379,R,C,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM",,"cBioPortal,COSMIC,ClinVar","ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018",Endometrial Carcinoma,"hg19,17:7572974-7572974, hg19,17:7669656-7669656, hg38,17:7669656-7669656","hg19,17:g.7572974G>A, hg19,17:g.7669656G>A, hg38,17:g.7669656G>A",0.310,"kidney, upper_aerodigestive_tract, pharynx, oropharynx","Wilms_tumour, carcinoma, squamous_cell_carcinoma",0.0000039775032417,,,,186611,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
4508,379,R,H,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM",,"cBioPortal,COSMIC,ClinVar",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,17:7572973-7572973, hg38,17:7669655-7669655","hg19,17:g.7572973C>T, hg38,17:g.7669655C>T",0.338,"breast, central_nervous_system, brain, kidney","Wilms_tumour, carcinoma, lobular_carcinoma, with_extracellular_mucin, glioma, astrocytoma_Grade_I, pilocytic",0.0000039774399605,0.0000318735258494,,,246221,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4509,379,R,L,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM",,ClinVar,,,"hg19,17:7572973-7572973, hg38,17:7669655-7669655","hg19,17:g.7572973C>A, hg38,17:g.7669655C>A",0.345,,,,,,,216463,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4510,379,R,P,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM",,COSMIC,,,"hg38,17:7669655-7669655","hg38,17:g.7669655C>G",0.409,kidney,Wilms_tumour,,,,,,,,,,,,,,
4511,379,R,S,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM",,ClinVar,,,"hg19,17:7572974-7572974, hg38,17:7669656-7669656","hg19,17:g.7572974G>T, hg38,17:g.7669656G>T",0.363,,,0.0000039775032417,,,,186762,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4512,380,H,R,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM",,ClinVar,,,"hg19,17:7572970-7572970, hg38,17:7669652-7669652","hg19,17:g.7572970T>C, hg38,17:g.7669652T>C",0.420,,,,,,,2123066,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4513,380,H,Y,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM",,COSMIC,,,"hg38,17:7669653-7669653","hg38,17:g.7669653G>A",0.615,"kidney, upper_aerodigestive_tract, pharynx, oropharynx","Wilms_tumour, carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4514,381,K,E,,,Ubq,,,Ac,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM",,ClinVar,,,"hg19,17:7572968-7572968, hg38,17:7669650-7669650","hg19,17:g.7572968T>C, hg38,17:g.7669650T>C",0.598,,,,,,,976475,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
4515,381,K,N,,,Ubq,,,Ac,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM",,"cBioPortal,COSMIC",skcm_broad,Cutaneous Melanoma,"hg19,17:7572966-7572966, hg38,17:7669648-7669648","hg19,17:g.7572966T>A, hg38,17:g.7669648T>A",0.646,"skin, neck",malignant_melanoma,,,,,,,,,,,,,,
4516,382,K,I,,Me,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,ClinVar,,,"hg19,17:7572964-7572964, hg38,17:7669646-7669646","hg19,17:g.7572964T>A, hg38,17:g.7669646T>A",0.667,,,,,,,1732327,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4517,382,K,T,,Me,Ubq,,,Ac,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,ClinVar,,,"hg19,17:7572964-7572964, hg38,17:7669646-7669646","hg19,17:g.7572964T>G, hg38,17:g.7669646T>G",0.645,,,,,,,860528,Uncertain significance,"Hereditary cancer-predisposing syndrome;Adrenocortical carcinoma, hereditary;Li-Fraumeni syndrome",2,,,,,,
4518,383,L,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,"COSMIC,ClinVar",,,"hg19,17:7572962-7572962, hg38,17:7669644-7669644","hg19,17:g.7572962G>A, hg38,17:g.7669644G>A",0.426,urinary_tract,"carcinoma, transitional_cell_carcinoma",,,,,619733,Conflicting classifications of pathogenicity,not provided;Hereditary cancer-predisposing syndrome,1,,,,,,
4519,383,L,P,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,ClinVar,,,"hg19,17:7572961-7572961, hg38,17:7669643-7669643","hg19,17:g.7572961A>G, hg38,17:g.7669643A>G",0.274,,,,,,,3232048,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4520,384,M,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,"cBioPortal,COSMIC,ClinVar","bladder_msk_2023, bladder_msk_2024, blca_msk_2025, msk_impact_2017, msk_met_2021, pancan_mimsi_msk_2024, utuc_msk_2019, utuc_pdx_msk_2019","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types, Upper Tract Urothelial Carcinoma","hg19,17:7572957-7572957, hg38,17:7669639-7669639","hg19,17:g.7572957C>T, hg38,17:g.7669639C>T",0.232,"urinary_tract, upper_urinary_tract","carcinoma, transitional_cell_carcinoma",,,,,639734,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4521,384,M,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,ClinVar,,,"hg19,17:7572959-7572959, hg38,17:7669641-7669641","hg19,17:g.7572959T>A, hg38,17:g.7669641T>A",0.260,,,,,,,1493091,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4522,384,M,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,ClinVar,,,"hg19,17:7572958-7572958, hg38,17:7669640-7669640","hg19,17:g.7572958A>C, hg38,17:g.7669640A>C",0.483,,,,,,,458521,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4523,384,M,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,ClinVar,,,"hg19,17:7572958-7572958, hg38,17:7669640-7669640","hg19,17:g.7572958A>G, hg38,17:g.7669640A>G",0.329,,,0.0000039763012446,,,,406575,Benign,not provided;Hereditary cancer-predisposing syndrome;not specified;Li-Fraumeni syndrome 1;Li-Fraumeni syndrome,3,,,,,,
4524,384,M,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,"cBioPortal,ClinVar",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,17:7572959-7572959, hg38,17:7669641-7669641","hg19,17:g.7572959T>C, hg38,17:g.7669641T>C",0.355,,,,,,,182939,Likely benign,TP53-related disorder;Hereditary cancer-predisposing syndrome;not specified;not provided;Li-Fraumeni syndrome,3,,,,,,
4525,385,F,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,"cBioPortal,COSMIC,ClinVar,ClinVar","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018",Bladder Urothelial Carcinoma,"hg19,17:7572954-7572954, hg19,17:7572956-7572956, hg38,17:7669636-7669636, hg38,17:7669638-7669638","hg19,17:g.7572954G>T, hg19,17:g.7572956A>G, hg38,17:g.7669636G>T, hg38,17:g.7669638A>G","0.203, 0.286","urinary_tract, bladder",carcinoma,,,,,"1735082, 485029","Likely benign, Likely benign",Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome,"1, 1",,,,,,
4526,385,F,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,cBioPortal,msk_chord_2024,Mixed Cancer Types,"hg19,17:7572956-7572956","hg19,17:g.7572956A>C",0.228,,,,,,,,,,,,,,,,
4527,386,K,N,,Me,Ubq,,,Ac,Sumo,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,COSMIC,,,"hg38,17:7669633-7669633","hg38,17:g.7669633C>G",0.668,breast,"carcinoma, ER-positive_carcinoma, carcinoma, luminal_NS_carcinoma",,,,,,,,,,,,,,
4528,386,K,R,,Me,Ubq,,,Ac,Sumo,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 382-386, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 379-386, ggetELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 380-386, ggetELM|USP7 binding motif (DOC_USP7_UBL2_3), 382-386, ggetELM",,ClinVar,,,"hg19,17:7572952-7572952, hg38,17:7669634-7669634","hg19,17:g.7572952T>C, hg38,17:g.7669634T>C",0.577,,,,,,,818446,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4529,387,T,P,P,,,,,,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,ClinVar,,,"hg19,17:7572950-7572950, hg38,17:7669632-7669632","hg19,17:g.7572950T>G, hg38,17:g.7669632T>G",0.462,,,,,,,2585882,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4530,387,T,R,P,,,,,,,,,,PhosphoSite,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,ClinVar,,,"hg19,17:7572949-7572949, hg38,17:7669631-7669631","hg19,17:g.7572949G>C, hg38,17:g.7669631G>C",0.353,,,0.0000039762696229,,,,485050,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4531,388,E,A,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,ClinVar,,,"hg19,17:7572946-7572946, hg38,17:7669628-7669628","hg19,17:g.7572946T>G, hg38,17:g.7669628T>G",0.547,,,0.0000039762696229,,,,141425,Likely benign,Hereditary cancer-predisposing syndrome;not provided;Li-Fraumeni syndrome,3,,,,,,
4532,388,E,D,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,"ClinVar,ClinVar",,,"hg19,17:7572945-7572945, hg38,17:7669627-7669627","hg19,17:g.7572945T>A, hg19,17:g.7572945T>G, hg38,17:g.7669627T>A, hg38,17:g.7669627T>G",0.480,,,,,,,"4553123, 1737684","Likely benign, Likely benign",Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome,"1, 1",,,,,,
4533,388,E,K,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,cBioPortal,"msk_met_2021, paired_bladder_2022, tmb_mskcc_2018","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7572947-7572947","hg19,17:g.7572947C>T",0.615,,,,,,,,,,,,,,,,
4534,388,E,Q,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 378-388, ggetELM",,"cBioPortal,COSMIC,ClinVar",msk_chord_2024,Mixed Cancer Types,"hg19,17:7572947-7572947, hg38,17:7669629-7669629","hg19,17:g.7572947C>G, hg38,17:g.7669629C>G",0.493,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,,1737291,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
4535,389,G,E,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,COSMIC,,,"hg38,17:7669625-7669625","hg38,17:g.7669625C>T",0.390,"haematopoietic_and_lymphoid_tissue, upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_leukaemia",,,,,,,,,,,,,,
4536,389,G,R,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,ClinVar,,,"hg19,17:7572944-7572944, hg38,17:7669626-7669626","hg19,17:g.7572944C>T, hg38,17:g.7669626C>T",0.446,,,,0.0000318471337580,,,458522,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4537,389,G,V,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,COSMIC,,,"hg38,17:7669625-7669625","hg38,17:g.7669625C>A",0.356,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4538,389,G,W,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,"cBioPortal,ClinVar","ccle_broad_2019, ccle_broad_2025",Mixed Cancer Types,"hg19,17:7572944-7572944, hg19,17:7669626-7669626, hg38,17:7669626-7669626","hg19,17:g.7572944C>A, hg19,17:g.7669626C>A, hg38,17:g.7669626C>A",0.471,,,,,,,156517,Uncertain significance,Li-Fraumeni syndrome 1,0,,,,,,
4539,390,P,H,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,cBioPortal,"esca_tcga, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,17:7572940-7572940","hg19,17:g.7572940G>T",0.385,,,,,,,,,,,,,,,,
4540,390,P,L,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,COSMIC,,,"hg38,17:7669622-7669622","hg38,17:g.7669622G>A",0.316,"skin, chest","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
4541,390,P,S,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,cBioPortal,"msk_met_2021, pancan_mimsi_msk_2024",Mixed Cancer Types,"hg19,17:7572941-7572941","hg19,17:g.7572941G>A",0.352,,,,,,,,,,,,,,,,
4542,390,P,T,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,ClinVar,,,"hg19,17:7572941-7572941, hg38,17:7669623-7669623","hg19,17:g.7572941G>T, hg38,17:g.7669623G>T",0.433,,,,,,,818485,Uncertain significance,Hereditary cancer-predisposing syndrome,1,,,,,,
4543,391,D,E,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,ClinVar,,,"hg19,17:7572936-7572936, hg38,17:7669618-7669618","hg19,17:g.7572936G>C, hg38,17:g.7669618G>C",0.586,,,,,,,629063,Uncertain significance,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,2,,,,,,
4544,391,D,H,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,cBioPortal,"brca_msk_2025, breast_msk_2025, msk_chord_2024","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,17:7572938-7572938","hg19,17:g.7572938C>G",0.619,,,,,,,,,,,,,,,,
4545,391,D,N,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,"cBioPortal,COSMIC,ClinVar","luad_broad, pan_origimed_2020","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7572938-7572938, hg38,17:7669620-7669620","hg19,17:g.7572938C>T, hg38,17:g.7669620C>T",0.455,lung,"carcinoma, adenocarcinoma",,,,,3232049,Conflicting classifications of pathogenicity,"Adrenocortical carcinoma, hereditary;Hereditary cancer-predisposing syndrome",1,,,,,,
4546,391,D,Y,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,COSMIC,,,"hg38,17:7669620-7669620","hg38,17:g.7669620C>A",0.697,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
4547,392,S,L,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,"cBioPortal,COSMIC","luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_chord_2024, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,17:7572934-7572934, hg38,17:7669616-7669616","hg19,17:g.7572934G>A, hg38,17:g.7669616G>A",0.612,breast,carcinoma,,,,,,,,,,,,,,
4548,392,S,P,P,,,,,,,,,,PhosphoSite,"Caspase cleavage motif (CLV_C14_Caspase3-7), 388-392, ggetELM",,"cBioPortal,COSMIC,ClinVar","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,17:7572935-7572935, hg38,17:7669617-7669617","hg19,17:g.7572935A>G, hg38,17:g.7669617A>G",0.670,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,,2095568,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4549,393,D,E,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7572930-7572930, hg38,17:7669612-7669612","hg19,17:g.7572930G>C, hg38,17:g.7669612G>C",0.521,,,,,,,1026463,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome,1,,,,,,
4550,393,D,G,,,,,,,,,,,,,,"cBioPortal,ClinVar","msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,17:7572931-7572931, hg38,17:7669613-7669613","hg19,17:g.7572931T>C, hg38,17:g.7669613T>C",0.674,,,,,,,3619316,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4551,393,D,H,,,,,,,,,,,,,,"cBioPortal,ClinVar","msk_chord_2024, ohnca_cptac_gdc, paired_bladder_2022","Bladder/Urinary Tract, Head and Neck Carcinoma, Other, Mixed Cancer Types","hg19,17:7572932-7572932, hg19,17:7669614-7669614, hg38,17:7669614-7669614","hg19,17:g.7572932C>G, hg19,17:g.7669614C>G, hg38,17:g.7669614C>G",0.609,,,,,,,818502,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome;Li-Fraumeni syndrome;Li-Fraumeni syndrome 1,1,,,,,,
4552,393,D,N,,,,,,,,,,,,,,"cBioPortal,ClinVar","blca_iatlas_imvigor210_2017, msk_chord_2024","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,17:7572932-7572932, hg19,17:7669614-7669614, hg38,17:7669614-7669614","hg19,17:g.7572932C>T, hg19,17:g.7669614C>T, hg38,17:g.7669614C>T",0.535,,,,,,,492574,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1;Li-Fraumeni syndrome;Hereditary cancer-predisposing syndrome,1,,,,,,
4553,393,D,V,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7572931-7572931, hg38,17:7669613-7669613","hg19,17:g.7572931T>A, hg38,17:g.7669613T>A",0.690,,,,,,,3634421,Uncertain significance,Li-Fraumeni syndrome,1,,,,,,
4554,393,D,Y,,,,,,,,,,,,,,ClinVar,,,"hg19,17:7572932-7572932, hg38,17:7669614-7669614","hg19,17:g.7572932C>A, hg38,17:g.7669614C>A",0.646,,,0.0000039762063810,,,,1741120,Likely benign,Hereditary cancer-predisposing syndrome,1,,,,,,
